data_2rt3_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2rt3 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 206' ' ' ARG . . . . . 0.812 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 45.2 mtm180 . . . . . 0 C--O 1.222 -0.381 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -103.23 105.17 15.4 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 118.984 0.811 . . . . 0.0 111.759 -170.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.44 ' HB ' ' HB ' ' A' ' 246' ' ' VAL . 61.3 t -138.31 126.76 30.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.571 179.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' PHE . . . . . 0.57 ' O ' ' HA ' ' A' ' 272' ' ' ILE . 17.9 t80 -117.31 131.73 56.75 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.659 178.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.507 ' HG ' HG22 ' A' ' 272' ' ' ILE . 2.5 mp -112.85 115.18 28.06 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.46 175.179 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . 0.569 ' O ' ' HB2' ' A' ' 212' ' ' ASN . . . -124.59 67.18 0.52 Allowed Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.664 -0.779 . . . . 0.0 113.227 -177.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . 0.583 ' HB2' ' HG3' ' A' ' 271' ' ' ARG . 2.5 t30 168.93 51.29 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.124 0.57 . . . . 0.0 110.039 172.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.493 HD21 ' HG2' ' A' ' 270' ' ' ARG . 1.0 OUTLIER -92.38 162.75 29.04 Favored Pre-proline 0 C--N 1.313 -0.983 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.108 -179.972 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.429 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 71.9 Cg_endo -79.66 156.09 24.37 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 122.109 1.872 . . . . 0.0 111.333 174.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 39.6 t-20 -70.61 128.01 34.63 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 178.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 106.07 -7.04 40.6 Favored Glycine 0 C--N 1.315 -0.606 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.88 -178.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' ILE . . . . . 0.6 HG22 HG21 ' A' ' 237' ' ' ILE . 5.2 tp -59.83 126.71 18.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.124 0.488 . . . . 0.0 110.649 178.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' THR . . . . . 0.512 HG22 ' HG3' ' A' ' 221' ' ' GLU . 6.9 t -112.43 154.87 25.16 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-O 121.251 0.548 . . . . 0.0 110.581 -179.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -58.88 -40.86 85.64 Favored 'General case' 0 C--O 1.21 -0.979 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.867 -176.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -50.74 -36.81 38.32 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 123.727 0.642 . . . . 0.0 111.262 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . 0.512 ' HG3' HG22 ' A' ' 218' ' ' THR . 42.2 mt-10 -68.47 -53.98 19.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.599 179.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . 0.487 HD13 HD11 ' A' ' 237' ' ' ILE . 7.2 mt -61.96 -40.86 88.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.429 179.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' ARG . . . . . 0.75 ' HG3' HD13 ' A' ' 235' ' ' ILE . 61.7 mtp180 -53.99 -62.07 1.89 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.976 0.417 . . . . 0.0 111.955 174.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -59.03 -22.76 61.2 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.27 -178.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -89.07 -31.3 18.1 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.864 -177.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.822 HD21 ' HZ ' ' A' ' 248' ' ' PHE . 8.6 mp -106.56 -19.54 13.64 Favored 'General case' 0 C--O 1.223 -0.298 0 N-CA-C 112.257 0.465 . . . . 0.0 112.257 -170.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' GLU . . . . . 0.671 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 38.7 mt-10 -70.82 -26.35 0.95 Allowed Pre-proline 0 C--N 1.323 -0.556 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -175.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' PRO . . . . . 0.671 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 74.1 Cg_endo -65.33 -25.86 56.43 Favored 'Trans proline' 0 C--N 1.36 1.139 0 C-N-CA 121.202 1.268 . . . . 0.0 111.908 -178.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . 0.484 ' CE1' ' HA ' ' A' ' 226' ' ' LEU . 2.7 p90 -111.01 -17.37 13.29 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.726 173.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . -162.33 93.49 0.12 Allowed Glycine 0 N--CA 1.442 -0.949 0 C-N-CA 120.397 -0.906 . . . . 0.0 111.897 -173.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . 0.505 ' HA ' ' HG2' ' A' ' 227' ' ' GLU . 17.5 Cg_endo -60.93 136.6 66.88 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.136 1.891 . . . . 0.0 111.677 178.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.834 HG21 HG11 ' A' ' 246' ' ' VAL . 2.8 mp -113.07 148.81 15.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.867 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -109.9 -20.2 12.84 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 120.894 0.378 . . . . 0.0 110.964 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . 0.538 ' HB3' ' HB2' ' A' ' 247' ' ' HIS . 31.3 tt0 -143.39 121.78 12.37 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.58 -176.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . 0.75 HD13 ' HG3' ' A' ' 223' ' ' ARG . 14.2 mt -137.7 107.48 4.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.601 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 54.7 tttp -113.33 112.53 23.84 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.442 -178.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' ILE . . . . . 0.6 HG21 HG22 ' A' ' 217' ' ' ILE . 86.3 mt -103.2 121.72 54.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.902 -178.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.564 ' HB ' HG13 ' A' ' 243' ' ' ILE . 41.5 t -101.84 86.71 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 170.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 13.8 t -64.87 -22.22 66.95 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.792 -176.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -62.82 -30.92 71.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.534 177.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . 0.577 ' HB2' HG12 ' A' ' 243' ' ' ILE . 83.2 mtt180 -117.45 3.75 12.48 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.732 -176.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 16.8 m120 67.14 27.24 8.6 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.086 175.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.577 HG12 ' HB2' ' A' ' 241' ' ' ARG . 1.4 pt -122.73 151.54 26.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.526 -175.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . 0.446 ' HB2' ' HB2' ' A' ' 210' ' ' LEU . . . -143.7 138.04 28.59 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.227 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -108.52 117.54 34.43 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.478 178.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . 0.834 HG11 HG21 ' A' ' 232' ' ' ILE . 0.4 OUTLIER -113.94 138.47 43.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -176.209 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' HIS . . . . . 0.812 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 55.1 m170 -118.39 102.95 9.33 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.337 0.589 . . . . 0.0 111.147 175.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . 0.822 ' HZ ' HD21 ' A' ' 226' ' ' LEU . 33.6 m-85 -85.5 105.38 16.06 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.215 178.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.412 ' H ' HD23 ' A' ' 249' ' ' LEU . 0.1 OUTLIER -44.15 -45.34 8.22 Favored 'General case' 0 N--CA 1.467 0.398 0 O-C-N 124.389 1.056 . . . . 0.0 113.108 -173.474 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -95.86 142.89 27.57 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.401 -0.52 . . . . 0.0 110.209 177.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' ILE . . . . . 0.592 ' O ' HG13 ' A' ' 255' ' ' ILE . 0.2 OUTLIER -61.2 -42.5 93.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 -178.045 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -70.7 -28.38 64.7 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.001 -176.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -61.32 -41.48 97.08 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.146 178.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' ALA . . . . . 0.514 ' HB1' ' HB2' ' A' ' 248' ' ' PHE . . . -68.51 -41.45 79.94 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.67 178.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.621 ' HA ' ' OH ' ' A' ' 274' ' ' TYR . 11.4 mt -56.41 -59.89 2.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.402 -177.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . 0.484 ' O ' ' HG2' ' A' ' 260' ' ' GLU . 12.2 ptmt -61.63 -40.47 95.0 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.254 -177.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -63.3 -48.86 76.3 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 111.686 0.254 . . . . 0.0 111.686 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 50.5 t -66.45 -24.0 32.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.957 0.408 . . . . 0.0 111.114 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 19.3 mm-40 -83.8 -24.82 30.86 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 177.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . 0.484 ' HG2' ' O ' ' A' ' 256' ' ' LYS . 27.5 mm-40 -95.17 -31.43 13.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.611 0.243 . . . . 0.0 111.273 -176.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.812 ' HA ' ' HE3' ' A' ' 267' ' ' TRP . 0.7 OUTLIER -52.17 -50.92 76.3 Favored Pre-proline 0 CA--C 1.537 0.471 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.255 179.362 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 262' ' ' PRO . . . . . 0.555 ' HD2' ' N ' ' A' ' 261' ' ' LEU . 42.0 Cg_endo -67.47 -17.87 49.02 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.441 2.094 . . . . 0.0 112.97 -178.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 59.0 mt -91.57 -5.58 53.78 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.068 0.461 . . . . 0.0 111.561 -177.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 264' ' ' ASN . . . . . 0.415 ' O ' ' HB2' ' A' ' 268' ' ' SER . 13.7 m-80 -105.34 145.89 31.68 Favored Pre-proline 0 C--N 1.313 -1.017 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.712 -175.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -68.18 -26.65 36.03 Favored 'Trans proline' 0 C--N 1.334 -0.229 0 C-N-CA 123.332 2.688 . . . . 0.0 112.583 -170.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . 0.445 ' HE3' ' NE1' ' A' ' 267' ' ' TRP . 0.0 OUTLIER -86.17 -46.3 10.53 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.958 0.885 . . . . 0.0 109.25 -178.837 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 267' ' ' TRP . . . . . 0.812 ' HE3' ' HA ' ' A' ' 261' ' ' LEU . 8.0 m0 -82.52 -24.12 34.25 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.478 -1.237 . . . . 0.0 110.6 -172.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 268' ' ' SER . . . . . 0.415 ' HB2' ' O ' ' A' ' 264' ' ' ASN . 22.4 t -65.58 -18.01 65.0 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.034 0.445 . . . . 0.0 110.581 176.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -73.65 -13.75 61.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.316 0.579 . . . . 0.0 109.879 176.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 270' ' ' ARG . . . . . 0.513 ' HA ' ' HB3' ' A' ' 212' ' ' ASN . 0.0 OUTLIER -109.95 147.4 33.51 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.742 -179.705 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . 0.583 ' HG3' ' HB2' ' A' ' 212' ' ' ASN . 40.6 mtm180 -98.06 106.15 18.4 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.106 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . 0.6 HG23 HD22 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -116.61 143.33 27.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.147 -177.451 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 273' ' ' TYR . . . . . 0.412 ' CZ ' ' HD2' ' A' ' 209' ' ' PHE . 1.5 p90 -150.57 167.75 26.32 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.4 172.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 274' ' ' TYR . . . . . 0.621 ' OH ' ' HA ' ' A' ' 255' ' ' ILE . 74.2 m-85 . . . . . 0 N--CA 1.449 -0.524 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.948 172.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' ARG . . . . . 0.823 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 7.7 mtp180 . . . . . 0 C--O 1.219 -0.549 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 70.5 m-20 -106.6 105.8 16.01 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 118.953 0.797 . . . . 0.0 111.9 -172.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.467 ' HB ' ' HB ' ' A' ' 246' ' ' VAL . 59.4 t -135.4 118.19 22.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.041 177.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' PHE . . . . . 0.425 ' HE1' ' HB ' ' A' ' 243' ' ' ILE . 2.3 t80 -116.92 125.13 51.01 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.263 -176.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.51 ' HG ' HG22 ' A' ' 272' ' ' ILE . 5.6 mp -107.65 132.19 53.58 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.265 178.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . 0.536 ' HA2' HG22 ' A' ' 243' ' ' ILE . . . -137.64 62.09 0.58 Allowed Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.309 -0.948 . . . . 0.0 113.326 -179.304 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . 0.548 ' HB2' ' HG2' ' A' ' 271' ' ' ARG . 38.8 t30 177.64 38.38 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.775 0.321 . . . . 0.0 110.598 175.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.488 HD22 HD22 ' A' ' 210' ' ' LEU . 1.0 OUTLIER -87.26 158.82 51.8 Favored Pre-proline 0 C--N 1.319 -0.74 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 178.828 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.402 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 83.8 Cg_endo -78.42 161.47 28.47 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.403 2.068 . . . . 0.0 110.994 176.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . 0.581 ' HA ' ' OG1' ' A' ' 239' ' ' THR . 9.1 t-20 -78.41 127.46 32.22 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -179.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 108.21 -6.27 34.33 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.485 -176.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' ILE . . . . . 0.634 HG21 HG21 ' A' ' 237' ' ' ILE . 4.5 tp -61.57 129.41 24.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.884 0.373 . . . . 0.0 110.309 177.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' THR . . . . . 0.473 ' CG2' ' HG3' ' A' ' 221' ' ' GLU . 15.2 t -112.83 155.9 23.84 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.4 0.619 . . . . 0.0 110.605 -179.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.422 ' CD ' ' H ' ' A' ' 219' ' ' GLU . 8.0 mp0 -63.95 -34.77 78.73 Favored 'General case' 0 C--O 1.206 -1.211 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.936 -176.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -54.69 -35.67 63.84 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 123.335 0.397 . . . . 0.0 110.591 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . 0.515 ' O ' ' HG2' ' A' ' 224' ' ' GLU . 46.1 mt-10 -67.03 -58.64 4.54 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.276 177.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . 0.5 HD13 HD12 ' A' ' 237' ' ' ILE . 7.8 mt -61.24 -38.48 79.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.63 -178.068 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' ARG . . . . . 0.69 ' HG3' HD11 ' A' ' 235' ' ' ILE . 51.2 mtp180 -54.17 -63.14 1.25 Allowed 'General case' 0 CA--C 1.508 -0.645 0 CA-C-O 121.125 0.488 . . . . 0.0 111.693 174.358 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.515 ' HG2' ' O ' ' A' ' 221' ' ' GLU . 17.7 pt-20 -60.48 -17.38 44.69 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.03 -177.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' ASP . . . . . 0.512 ' HB3' ' CZ2' ' A' ' 267' ' ' TRP . 13.7 m-20 -89.23 -33.76 16.87 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.371 -179.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.718 HD23 ' HZ ' ' A' ' 248' ' ' PHE . 7.7 mp -106.98 -11.48 15.67 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 111.979 0.362 . . . . 0.0 111.979 -171.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' GLU . . . . . 0.621 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 53.3 mm-40 -62.97 -36.0 22.19 Favored Pre-proline 0 C--N 1.325 -0.468 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -178.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' PRO . . . . . 0.621 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 85.7 Cg_endo -66.21 -31.1 45.31 Favored 'Trans proline' 0 C--N 1.358 1.071 0 C-N-CA 121.43 1.42 . . . . 0.0 112.163 -173.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . 0.5 ' CZ ' ' HA ' ' A' ' 226' ' ' LEU . 4.0 p90 -110.21 -0.73 17.7 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.628 177.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . 0.434 ' CA ' ' HB2' ' A' ' 253' ' ' ALA . . . -177.21 94.61 0.1 OUTLIER Glycine 0 N--CA 1.441 -1.002 0 C-N-CA 119.658 -1.258 . . . . 0.0 112.64 -178.095 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . 0.413 ' HD2' ' HA2' ' A' ' 230' ' ' GLY . 17.1 Cg_endo -59.53 131.54 40.98 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 121.877 1.718 . . . . 0.0 111.246 175.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.769 HG23 HG13 ' A' ' 246' ' ' VAL . 2.7 mp -106.86 151.9 8.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.423 178.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' ASP . . . . . 0.499 ' CG ' HD23 ' A' ' 249' ' ' LEU . 34.2 m-20 -109.93 -23.62 11.25 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.786 0.326 . . . . 0.0 110.223 179.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . 0.407 ' HB3' ' HB2' ' A' ' 247' ' ' HIS . 13.7 tt0 -143.43 126.83 16.77 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.843 -177.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . 0.69 HD11 ' HG3' ' A' ' 223' ' ' ARG . 15.6 mt -139.52 113.49 6.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.903 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -121.12 116.67 25.43 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.33 -178.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' ILE . . . . . 0.634 HG21 HG21 ' A' ' 217' ' ' ILE . 86.7 mt -104.76 126.01 59.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.434 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.566 ' HB ' HG13 ' A' ' 243' ' ' ILE . 42.1 t -103.8 85.51 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.046 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 169.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' THR . . . . . 0.581 ' OG1' ' HA ' ' A' ' 215' ' ' ASN . 11.7 t -71.04 -16.56 62.61 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.637 -173.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -65.36 -33.0 74.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.117 174.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . 0.509 ' HB2' HG12 ' A' ' 243' ' ' ILE . 71.1 mtt180 -110.74 3.18 18.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.085 -178.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' ASN . . . . . 0.445 ' O ' HD11 ' A' ' 213' ' ' LEU . 16.1 m120 68.35 23.7 7.55 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.108 177.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.566 HG13 ' HB ' ' A' ' 238' ' ' VAL . 1.5 pt -122.43 150.65 26.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.466 -174.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . 0.413 ' HB2' ' HB2' ' A' ' 210' ' ' LEU . . . -143.19 139.47 30.32 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.053 0.454 . . . . 0.0 111.668 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -109.3 115.78 30.63 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.765 178.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . 0.769 HG13 HG23 ' A' ' 232' ' ' ILE . 1.3 t -112.3 134.89 53.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -179.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' HIS . . . . . 0.823 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 33.5 m170 -112.98 101.7 9.72 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.016 -0.674 . . . . 0.0 111.309 177.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . 0.718 ' HZ ' HD23 ' A' ' 226' ' ' LEU . 34.5 m-85 -86.28 104.25 15.63 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-N 115.089 -0.96 . . . . 0.0 111.651 179.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.499 HD23 ' CG ' ' A' ' 233' ' ' ASP . 0.0 OUTLIER -42.85 -48.17 5.71 Favored 'General case' 0 N--CA 1.465 0.306 0 O-C-N 124.506 1.129 . . . . 0.0 112.975 -175.192 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 -93.37 141.4 28.49 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.112 176.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' ILE . . . . . 0.627 ' O ' HG13 ' A' ' 255' ' ' ILE . 0.3 OUTLIER -61.71 -39.94 85.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.027 -178.549 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -68.64 -31.72 71.07 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.995 -176.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . 0.434 ' HB2' ' CA ' ' A' ' 230' ' ' GLY . . . -61.68 -41.81 98.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.298 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' ALA . . . . . 0.517 ' HB3' ' HB2' ' A' ' 248' ' ' PHE . . . -67.17 -41.72 85.47 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.409 178.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.627 HG13 ' O ' ' A' ' 251' ' ' ILE . 10.6 mt -57.37 -59.45 3.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.065 -178.385 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . 0.412 ' O ' ' HG2' ' A' ' 260' ' ' GLU . 13.9 ptmt -62.27 -40.33 95.86 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.305 -177.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -61.55 -48.93 78.74 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.668 0.271 . . . . 0.0 111.184 178.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . 0.486 HG12 HG12 ' A' ' 272' ' ' ILE . 53.5 t -65.86 -26.33 38.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.907 0.384 . . . . 0.0 111.107 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 28.7 mm-40 -84.94 -24.61 28.31 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 178.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . 0.412 ' HG2' ' O ' ' A' ' 256' ' ' LYS . 71.9 mm-40 -95.3 -31.42 13.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.595 0.236 . . . . 0.0 111.026 -176.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.709 HD13 ' CE3' ' A' ' 267' ' ' TRP . 0.4 OUTLIER -50.91 -51.04 70.78 Favored Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.266 178.727 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 262' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' A' ' 261' ' ' LEU . 43.3 Cg_endo -67.42 -14.62 43.16 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.465 2.11 . . . . 0.0 112.698 -177.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 52.6 mt -92.43 -4.69 53.34 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.175 0.512 . . . . 0.0 111.367 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 264' ' ' ASN . . . . . 0.407 ' O ' ' HB2' ' A' ' 268' ' ' SER . 10.9 m-80 -106.18 149.42 38.15 Favored Pre-proline 0 C--N 1.315 -0.929 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.998 -175.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -63.9 -38.58 37.74 Favored 'Trans proline' 0 N--CA 1.465 -0.171 0 C-N-CA 123.421 2.747 . . . . 0.0 112.534 -169.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 7.1 mtpt -84.62 -45.09 12.86 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 121.648 0.737 . . . . 0.0 109.376 -177.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 267' ' ' TRP . . . . . 0.709 ' CE3' HD13 ' A' ' 261' ' ' LEU . 12.9 m0 -77.37 -27.6 52.63 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.737 -1.12 . . . . 0.0 111.058 -171.078 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 268' ' ' SER . . . . . 0.407 ' HB2' ' O ' ' A' ' 264' ' ' ASN . 12.0 t -65.47 -21.93 66.69 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.934 0.397 . . . . 0.0 110.547 178.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -72.7 -22.66 60.86 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.301 0.572 . . . . 0.0 110.069 177.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 270' ' ' ARG . . . . . 0.479 ' HA ' ' HB3' ' A' ' 212' ' ' ASN . 5.4 mpt_? -92.98 141.3 28.56 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 178.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . 0.548 ' HG2' ' HB2' ' A' ' 212' ' ' ASN . 37.5 mmt180 -93.02 105.93 17.96 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 178.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . 0.621 HG21 HD23 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -114.33 142.65 26.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.242 0.544 . . . . 0.0 111.42 -176.902 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -152.35 169.29 22.89 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.55 173.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 . . . . . 0 C--N 1.322 -0.592 0 CA-C-O 120.692 0.282 . . . . 0.0 110.41 173.607 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' ARG . . . . . 0.882 ' HE ' ' HA ' ' A' ' 249' ' ' LEU . 16.9 mtp180 . . . . . 0 C--O 1.22 -0.483 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -109.9 107.02 16.8 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-N 118.988 0.813 . . . . 0.0 112.493 -174.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.531 ' HB ' ' HB ' ' A' ' 246' ' ' VAL . 60.8 t -135.3 127.11 46.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 114.878 -1.055 . . . . 0.0 109.148 177.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' PHE . . . . . 0.442 ' O ' ' HA ' ' A' ' 272' ' ' ILE . 6.8 t80 -122.37 127.41 49.71 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-O 120.725 0.298 . . . . 0.0 110.307 -178.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.502 ' HG ' HG23 ' A' ' 272' ' ' ILE . 4.7 mp -109.77 126.03 53.32 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.335 176.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . 0.571 ' HA2' HG22 ' A' ' 243' ' ' ILE . . . -130.65 57.49 0.72 Allowed Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.265 -0.969 . . . . 0.0 113.373 -178.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . 0.498 ' HB3' ' HA ' ' A' ' 270' ' ' ARG . 2.8 t30 177.4 49.74 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.061 0.458 . . . . 0.0 110.509 177.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.488 HD23 HD21 ' A' ' 210' ' ' LEU . 1.0 OUTLIER -97.39 159.05 32.09 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.184 178.722 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.414 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 95.8 Cg_endo -79.85 154.46 23.09 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.326 2.017 . . . . 0.0 112.15 178.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . 0.531 ' HA ' ' OG1' ' A' ' 239' ' ' THR . 8.8 m120 -66.31 121.21 14.74 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.032 177.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 108.86 -1.97 31.86 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.451 -0.88 . . . . 0.0 112.876 -177.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' ILE . . . . . 0.559 HG22 HG21 ' A' ' 237' ' ' ILE . 5.7 tp -64.08 128.0 25.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.046 0.451 . . . . 0.0 110.525 175.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' THR . . . . . 0.498 HG21 ' HG3' ' A' ' 221' ' ' GLU . 4.9 t -114.22 157.55 22.54 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.119 0.485 . . . . 0.0 110.575 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -61.66 -40.31 94.48 Favored 'General case' 0 C--O 1.208 -1.11 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.41 -175.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -51.46 -35.81 41.44 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 123.514 0.509 . . . . 0.0 111.029 -179.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . 0.498 ' HG3' HG21 ' A' ' 218' ' ' THR . 43.4 mt-10 -67.65 -55.9 11.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.303 178.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . 0.487 HD13 HD13 ' A' ' 237' ' ' ILE . 8.0 mt -60.95 -41.21 88.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.537 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' ARG . . . . . 0.618 ' HG3' HD11 ' A' ' 235' ' ' ILE . 26.1 mtp180 -56.55 -61.81 2.16 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 175.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -57.16 -21.64 34.43 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.625 -178.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' ASP . . . . . 0.434 ' HB3' ' CZ2' ' A' ' 267' ' ' TRP . 12.8 m-20 -87.27 -33.98 19.07 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.746 -178.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.783 HD21 ' HZ ' ' A' ' 248' ' ' PHE . 7.7 mp -106.83 -18.01 14.05 Favored 'General case' 0 C--O 1.224 -0.247 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -170.008 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' GLU . . . . . 0.666 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 35.7 mt-10 -65.79 -31.58 4.95 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -175.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' PRO . . . . . 0.666 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 72.0 Cg_endo -65.94 -29.94 48.94 Favored 'Trans proline' 0 C--N 1.359 1.085 0 C-N-CA 121.459 1.439 . . . . 0.0 112.3 -176.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . 0.488 ' CE1' ' HA ' ' A' ' 226' ' ' LEU . 3.6 p90 -111.06 -4.22 15.18 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.579 176.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . -172.08 95.73 0.11 Allowed Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.127 -1.035 . . . . 0.0 112.478 -176.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -61.58 133.64 46.68 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.174 1.916 . . . . 0.0 111.43 177.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.785 HG21 HG11 ' A' ' 246' ' ' VAL . 2.5 mp -110.42 151.3 12.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.925 178.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' ASP . . . . . 0.424 ' OD2' HD21 ' A' ' 249' ' ' LEU . 6.7 m-20 -110.89 -25.49 9.82 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.92 177.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . 0.59 ' HB3' ' HB2' ' A' ' 247' ' ' HIS . 16.8 tt0 -138.82 120.57 15.3 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.551 -174.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . 0.618 HD11 ' HG3' ' A' ' 223' ' ' ARG . 11.1 mt -137.08 107.73 5.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.99 178.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 63.1 tttp -115.81 113.79 23.87 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.364 -177.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' ILE . . . . . 0.559 HG21 HG22 ' A' ' 217' ' ' ILE . 86.4 mt -102.13 125.71 56.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-O 121.134 0.492 . . . . 0.0 110.955 -179.18 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.537 ' HB ' HG13 ' A' ' 243' ' ' ILE . 57.7 t -108.81 87.31 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 171.155 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' THR . . . . . 0.531 ' OG1' ' HA ' ' A' ' 215' ' ' ASN . 14.4 t -68.91 -12.62 61.79 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.529 -177.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 18.6 mp0 -63.01 -35.48 80.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.986 175.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . 0.657 ' HB2' HG12 ' A' ' 243' ' ' ILE . 66.8 mtp180 -115.58 4.2 14.13 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.1 179.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' ASN . . . . . 0.437 ' O ' HD11 ' A' ' 213' ' ' LEU . 15.9 m120 65.85 30.56 9.93 Favored 'General case' 0 N--CA 1.465 0.278 0 O-C-N 123.446 0.466 . . . . 0.0 110.743 178.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.657 HG12 ' HB2' ' A' ' 241' ' ' ARG . 1.3 pt -122.06 149.72 25.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.158 -175.081 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -142.36 138.14 30.98 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.048 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -109.54 120.79 43.57 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.881 179.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . 0.785 HG11 HG21 ' A' ' 232' ' ' ILE . 0.5 OUTLIER -116.3 136.16 54.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.981 -176.385 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' HIS . . . . . 0.828 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 20.1 m170 -114.45 102.97 10.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.191 0.519 . . . . 0.0 111.23 175.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . 0.783 ' HZ ' HD21 ' A' ' 226' ' ' LEU . 29.7 m-85 -85.76 103.79 14.86 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.014 178.006 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.882 ' HA ' ' HE ' ' A' ' 206' ' ' ARG . 0.1 OUTLIER -44.64 -39.28 4.91 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 124.218 0.949 . . . . 0.0 113.311 -172.998 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 57.9 m-20 -100.17 144.71 28.88 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 178.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' ILE . . . . . 0.568 ' O ' HG13 ' A' ' 255' ' ' ILE . 0.3 OUTLIER -63.89 -43.3 97.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -176.618 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -68.63 -31.12 70.04 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.111 -177.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -58.25 -42.88 87.39 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.541 179.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' ALA . . . . . 0.541 ' HB3' ' HB2' ' A' ' 248' ' ' PHE . . . -68.52 -41.67 79.63 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.614 178.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.568 HG13 ' O ' ' A' ' 251' ' ' ILE . 8.4 mt -57.03 -58.47 5.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.456 -177.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . 0.405 ' O ' ' HG2' ' A' ' 260' ' ' GLU . 11.1 ptmt -63.81 -38.79 92.42 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.395 -177.201 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -63.19 -49.83 72.72 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.632 0.253 . . . . 0.0 111.297 178.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . 0.547 HG13 HG12 ' A' ' 272' ' ' ILE . 70.3 t -66.8 -22.9 30.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 120.883 0.373 . . . . 0.0 111.09 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . 0.429 ' HG3' ' O ' ' A' ' 255' ' ' ILE . 63.9 mt-30 -83.53 -24.1 31.8 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 176.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . 0.405 ' HG2' ' O ' ' A' ' 256' ' ' LYS . 42.4 mm-40 -94.75 -33.61 12.84 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.868 0.366 . . . . 0.0 110.893 -176.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.706 HD13 ' CE3' ' A' ' 267' ' ' TRP . 0.9 OUTLIER -51.57 -50.91 74.23 Favored Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.508 -179.777 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 262' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' A' ' 261' ' ' LEU . 44.5 Cg_endo -67.5 -15.4 45.08 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.378 2.052 . . . . 0.0 112.679 -177.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 59.2 mt -96.66 0.55 49.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.062 0.458 . . . . 0.0 111.673 -177.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 -107.05 148.6 37.31 Favored Pre-proline 0 C--N 1.314 -0.94 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.34 -177.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -64.11 -35.28 54.19 Favored 'Trans proline' 0 C--O 1.23 0.092 0 C-N-CA 123.509 2.806 . . . . 0.0 112.411 -172.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 3.5 mtpt -86.11 -45.17 11.63 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 121.643 0.735 . . . . 0.0 109.738 -178.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 267' ' ' TRP . . . . . 0.706 ' CE3' HD13 ' A' ' 261' ' ' LEU . 15.4 m0 -78.03 -28.53 49.06 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 114.772 -1.104 . . . . 0.0 111.14 -172.222 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 23.0 t -68.51 -15.11 63.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.797 0.332 . . . . 0.0 110.812 178.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -73.76 -17.32 61.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.41 0.624 . . . . 0.0 109.631 174.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 270' ' ' ARG . . . . . 0.498 ' HA ' ' HB3' ' A' ' 212' ' ' ASN . 4.7 mpt_? -97.43 154.72 17.29 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.444 177.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' A' ' 271' ' ' ARG . 39.5 mmt-85 -104.5 105.78 16.02 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 174.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . 0.601 HG22 HD22 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -115.65 141.14 34.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-O 121.306 0.574 . . . . 0.0 111.536 -177.09 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -152.37 169.8 21.65 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.363 171.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 274' ' ' TYR . . . . . 0.42 ' OH ' ' HA ' ' A' ' 255' ' ' ILE . 84.4 m-85 . . . . . 0 C--N 1.324 -0.531 0 CA-C-O 120.983 0.42 . . . . 0.0 110.755 176.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' ARG . . . . . 0.758 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 39.4 mtm180 . . . . . 0 N--CA 1.463 0.223 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -108.96 105.63 15.24 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 119.053 0.842 . . . . 0.0 111.824 -170.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 63.4 t -137.43 123.09 26.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 114.605 -1.179 . . . . 0.0 109.18 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' PHE . . . . . 0.435 ' CE1' ' HB ' ' A' ' 243' ' ' ILE . 4.0 t80 -120.0 128.18 53.3 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.723 0.297 . . . . 0.0 110.655 -178.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.487 ' HG ' HG23 ' A' ' 272' ' ' ILE . 4.8 mp -108.27 126.53 52.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.534 177.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . 0.566 ' HA2' HG21 ' A' ' 243' ' ' ILE . . . -132.92 59.96 0.68 Allowed Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.702 -0.761 . . . . 0.0 113.445 -178.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . 0.487 ' HB3' ' HA ' ' A' ' 270' ' ' ARG . 3.4 t30 178.22 42.11 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.279 0.561 . . . . 0.0 109.815 177.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.713 HD23 ' HG2' ' A' ' 270' ' ' ARG . 1.0 OUTLIER -89.57 163.52 32.86 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.098 -179.94 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.498 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 89.2 Cg_endo -81.62 161.65 19.23 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 122.383 2.055 . . . . 0.0 111.342 175.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -72.94 128.19 34.75 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.574 176.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 103.94 -5.56 46.65 Favored Glycine 0 C--N 1.313 -0.722 0 C-N-CA 120.446 -0.883 . . . . 0.0 113.039 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' ILE . . . . . 0.6 HG23 HG22 ' A' ' 237' ' ' ILE . 5.1 tp -58.56 128.36 19.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.973 0.416 . . . . 0.0 110.734 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' THR . . . . . 0.432 ' CG2' ' HG3' ' A' ' 221' ' ' GLU . 14.9 t -112.28 157.24 21.19 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-O 121.394 0.616 . . . . 0.0 110.975 -178.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.417 ' CD ' ' H ' ' A' ' 219' ' ' GLU . 3.9 mp0 -62.36 -36.7 83.09 Favored 'General case' 0 C--O 1.207 -1.16 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.591 -177.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' ASP . . . . . 0.457 ' O ' ' HG2' ' A' ' 224' ' ' GLU . 37.4 t70 -50.1 -40.14 44.89 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 123.745 0.653 . . . . 0.0 111.144 179.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . 0.432 ' HG3' ' CG2' ' A' ' 218' ' ' THR . 41.6 mt-10 -68.74 -56.96 6.41 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.326 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . 0.478 HD13 HD11 ' A' ' 237' ' ' ILE . 7.5 mt -60.05 -42.25 89.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.743 -179.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' ARG . . . . . 0.72 ' HG3' HD11 ' A' ' 235' ' ' ILE . 53.9 mtp85 -54.3 -63.56 1.11 Allowed 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 176.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.457 ' HG2' ' O ' ' A' ' 220' ' ' ASP . 14.4 pt-20 -60.52 -20.36 59.98 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.975 -176.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -88.69 -32.29 18.06 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.553 -177.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.68 HD22 ' HZ ' ' A' ' 248' ' ' PHE . 8.6 mp -107.32 -18.76 13.79 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -170.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' GLU . . . . . 0.672 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 31.5 mt-10 -71.48 -25.33 0.78 Allowed Pre-proline 0 C--N 1.324 -0.5 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -175.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' PRO . . . . . 0.672 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 74.2 Cg_endo -65.76 -28.84 51.35 Favored 'Trans proline' 0 C--N 1.359 1.102 0 CA-C-N 120.692 1.283 . . . . 0.0 112.019 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . 0.463 ' CE1' ' HA ' ' A' ' 226' ' ' LEU . 3.7 p90 -110.92 -2.08 16.17 Favored 'General case' 0 C--O 1.224 -0.249 0 C-N-CA 120.921 -0.311 . . . . 0.0 111.463 174.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . 0.463 ' CA ' ' HB2' ' A' ' 253' ' ' ALA . . . -174.21 94.31 0.1 OUTLIER Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 120.249 -0.977 . . . . 0.0 112.23 -177.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -62.74 130.14 28.59 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 121.975 1.784 . . . . 0.0 111.401 178.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.818 HG21 HG12 ' A' ' 246' ' ' VAL . 2.8 mp -106.4 152.33 8.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.442 178.12 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' ASP . . . . . 0.405 ' CG ' HD23 ' A' ' 249' ' ' LEU . 23.4 m-20 -111.29 -26.98 8.87 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.762 176.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . 0.42 ' HB3' ' HB2' ' A' ' 247' ' ' HIS . 20.4 tt0 -136.97 120.51 17.12 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.635 -175.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . 0.72 HD11 ' HG3' ' A' ' 223' ' ' ARG . 20.0 mt -134.99 105.8 6.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.675 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -111.58 109.45 19.37 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.321 -175.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' ILE . . . . . 0.6 HG22 HG23 ' A' ' 217' ' ' ILE . 87.4 mt -101.23 122.28 53.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 121.286 0.565 . . . . 0.0 111.155 -177.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.563 ' HB ' HG13 ' A' ' 243' ' ' ILE . 46.5 t -103.63 87.39 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 170.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 11.6 t -67.5 -19.31 65.31 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.463 -176.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -65.98 -29.56 69.97 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.696 176.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . 0.528 ' HB2' HG12 ' A' ' 243' ' ' ILE . 98.9 mtt180 -117.39 4.85 12.52 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.803 -179.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 15.9 m120 64.81 27.24 12.96 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.988 176.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.566 HG21 ' HA2' ' A' ' 211' ' ' GLY . 1.4 pt -122.4 148.9 25.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.165 -175.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -142.41 137.58 30.51 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.969 0.414 . . . . 0.0 111.556 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -105.51 120.31 41.31 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.894 177.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . 0.818 HG12 HG21 ' A' ' 232' ' ' ILE . 0.2 OUTLIER -115.11 132.15 65.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -178.558 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' HIS . . . . . 0.758 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 50.1 m170 -111.43 102.58 10.94 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.164 -0.614 . . . . 0.0 111.311 176.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . 0.68 ' HZ ' HD22 ' A' ' 226' ' ' LEU . 33.2 m-85 -86.04 103.28 14.58 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.068 178.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.405 HD23 ' CG ' ' A' ' 233' ' ' ASP . 0.1 OUTLIER -43.7 -39.52 3.7 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 124.139 0.899 . . . . 0.0 113.342 -175.8 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -96.51 144.92 26.16 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.512 177.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' ILE . . . . . 0.554 ' O ' HG13 ' A' ' 255' ' ' ILE . 0.2 OUTLIER -64.06 -43.22 97.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.723 -178.83 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -72.03 -30.78 65.54 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.672 -176.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . 0.463 ' HB2' ' CA ' ' A' ' 230' ' ' GLY . . . -58.72 -41.93 87.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.217 178.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' ALA . . . . . 0.55 ' HB2' ' HB2' ' A' ' 248' ' ' PHE . . . -69.24 -40.61 77.81 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.821 178.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.651 ' HA ' ' HH ' ' A' ' 274' ' ' TYR . 6.5 mt -57.84 -60.85 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.453 -177.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . 0.442 ' O ' ' HG2' ' A' ' 260' ' ' GLU . 11.8 ptmt -61.98 -38.45 88.62 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.396 -177.062 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -61.47 -48.51 80.78 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.617 0.246 . . . . 0.0 111.182 178.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . 0.523 HG13 HG12 ' A' ' 272' ' ' ILE . 69.7 t -66.92 -23.97 31.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.892 0.377 . . . . 0.0 110.972 179.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -83.42 -26.93 29.93 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 177.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . 0.442 ' HG2' ' O ' ' A' ' 256' ' ' LYS . 51.1 mm-40 -94.74 -30.97 14.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.72 0.295 . . . . 0.0 111.223 -174.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.688 HD12 ' CE3' ' A' ' 267' ' ' TRP . 0.6 OUTLIER -52.85 -50.74 79.78 Favored Pre-proline 0 CA--C 1.538 0.51 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.375 179.366 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 262' ' ' PRO . . . . . 0.54 ' HD2' ' N ' ' A' ' 261' ' ' LEU . 41.2 Cg_endo -67.47 -16.46 47.53 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.357 2.038 . . . . 0.0 112.667 -178.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 59.1 mt -89.77 -7.83 53.56 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.235 0.54 . . . . 0.0 111.574 -177.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -106.38 148.17 36.24 Favored Pre-proline 0 C--N 1.311 -1.068 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.897 -174.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -64.1 -36.4 48.05 Favored 'Trans proline' 0 C--N 1.334 -0.208 0 C-N-CA 123.512 2.808 . . . . 0.0 112.584 -169.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 8.2 mtpt -86.23 -44.58 12.04 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 121.558 0.694 . . . . 0.0 109.791 -176.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 267' ' ' TRP . . . . . 0.688 ' CE3' HD12 ' A' ' 261' ' ' LEU . 11.2 m0 -76.49 -28.57 56.51 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.519 -174.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 22.9 t -64.18 -21.61 66.63 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.712 0.292 . . . . 0.0 110.532 177.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 64.2 mttm -70.53 -16.67 62.91 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-O 121.299 0.571 . . . . 0.0 110.087 176.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 270' ' ' ARG . . . . . 0.713 ' HG2' HD23 ' A' ' 213' ' ' LEU . 3.1 mpt_? -103.4 146.25 28.78 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.646 -179.076 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . 0.436 ' NE ' ' HA ' ' A' ' 271' ' ' ARG . 4.9 mmp_? -97.44 107.59 20.13 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 178.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . 0.617 HG21 HD22 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -116.15 142.22 30.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.141 0.496 . . . . 0.0 111.174 -176.967 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -150.93 167.68 26.83 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.661 172.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 274' ' ' TYR . . . . . 0.651 ' HH ' ' HA ' ' A' ' 255' ' ' ILE . 87.2 m-85 . . . . . 0 C--N 1.32 -0.691 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.072 173.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' ARG . . . . . 0.803 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 41.9 mtm180 . . . . . 0 C--O 1.221 -0.404 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -106.0 105.34 15.33 Favored 'General case' 0 CA--C 1.511 -0.542 0 C-N-CA 120.166 -0.614 . . . . 0.0 111.128 -171.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.442 ' HB ' ' HB ' ' A' ' 246' ' ' VAL . 64.6 t -137.24 115.25 13.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.361 177.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' PHE . . . . . 0.441 ' HE1' ' HB ' ' A' ' 243' ' ' ILE . 3.2 t80 -111.68 124.77 53.02 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.364 -175.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.499 ' HG ' HG23 ' A' ' 272' ' ' ILE . 5.6 mp -107.34 129.48 54.9 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.561 177.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . 0.545 ' HA2' HG22 ' A' ' 243' ' ' ILE . . . -138.26 63.28 0.56 Allowed Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.656 -0.783 . . . . 0.0 113.208 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . 0.525 ' HB3' ' HA ' ' A' ' 270' ' ' ARG . 3.5 t30 -179.01 34.86 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.355 0.597 . . . . 0.0 109.969 178.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.79 HD21 ' HG2' ' A' ' 270' ' ' ARG . 1.2 mt -87.77 163.73 37.12 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.868 -179.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.441 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 91.3 Cg_endo -81.98 165.83 17.14 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 122.261 1.974 . . . . 0.0 110.772 172.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -78.7 129.21 34.44 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 177.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 105.25 -6.29 42.46 Favored Glycine 0 C--N 1.315 -0.617 0 C-N-CA 120.557 -0.83 . . . . 0.0 113.211 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' ILE . . . . . 0.705 HG22 HG23 ' A' ' 237' ' ' ILE . 4.6 tp -58.88 131.19 23.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-O 120.929 0.395 . . . . 0.0 110.743 179.083 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' THR . . . . . 0.447 ' CG2' ' HG3' ' A' ' 221' ' ' GLU . 10.7 t -112.39 157.44 21.04 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-O 121.625 0.726 . . . . 0.0 111.206 -179.138 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -62.79 -34.72 77.85 Favored 'General case' 0 C--O 1.209 -1.075 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.987 -177.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -54.4 -36.19 63.68 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.924 0.392 . . . . 0.0 110.81 -179.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . 0.447 ' HG3' ' CG2' ' A' ' 218' ' ' THR . 44.4 mt-10 -70.56 -55.47 8.8 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.371 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . 0.482 HD12 HD13 ' A' ' 237' ' ' ILE . 6.7 mt -62.03 -40.56 87.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.693 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' ARG . . . . . 0.816 ' HG3' HD11 ' A' ' 235' ' ' ILE . 17.2 mtp180 -54.22 -62.34 1.72 Allowed 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 175.161 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -57.74 -21.31 40.42 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.962 -178.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' ASP . . . . . 0.429 ' CG ' ' HE1' ' A' ' 267' ' ' TRP . 24.9 m-20 -87.77 -33.02 18.81 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.978 -178.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.702 HD23 ' HZ ' ' A' ' 248' ' ' PHE . 8.1 mp -107.98 -17.83 13.95 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -169.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' GLU . . . . . 0.652 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 46.1 mt-10 -69.79 -26.03 1.01 Allowed Pre-proline 0 C--N 1.324 -0.517 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -175.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' PRO . . . . . 0.652 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 84.7 Cg_endo -67.64 -27.28 38.74 Favored 'Trans proline' 0 C--N 1.36 1.139 0 C-N-CA 121.359 1.373 . . . . 0.0 112.488 -178.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . 0.468 ' CZ ' ' HA ' ' A' ' 226' ' ' LEU . 2.6 p90 -110.64 -14.66 14.01 Favored 'General case' 0 C--O 1.222 -0.364 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.557 175.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . -161.27 91.97 0.11 Allowed Glycine 0 N--CA 1.438 -1.178 0 C-N-CA 120.441 -0.885 . . . . 0.0 111.223 -175.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -58.72 131.8 44.28 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 121.859 1.706 . . . . 0.0 111.155 178.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.723 HG21 HG12 ' A' ' 246' ' ' VAL . 2.7 mp -108.17 151.7 10.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.92 177.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' ASP . . . . . 0.471 ' CG ' HD23 ' A' ' 249' ' ' LEU . 15.6 m-20 -112.77 -23.06 10.37 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 120.915 0.388 . . . . 0.0 110.147 178.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . 0.556 ' HB3' ' HB2' ' A' ' 247' ' ' HIS . 36.1 tt0 -143.99 120.1 10.77 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.841 -176.076 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . 0.816 HD11 ' HG3' ' A' ' 223' ' ' ARG . 14.8 mt -131.52 115.63 29.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.92 178.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 65.9 tttp -120.81 113.66 20.48 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.37 -178.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' ILE . . . . . 0.705 HG23 HG22 ' A' ' 217' ' ' ILE . 80.8 mt -102.85 123.71 56.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.683 -179.062 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.545 ' HB ' HG13 ' A' ' 243' ' ' ILE . 39.9 t -102.06 87.09 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 172.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 13.9 t -65.33 -18.21 65.13 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.726 -177.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -64.93 -31.05 72.09 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.538 176.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . 0.734 ' HB2' HG12 ' A' ' 243' ' ' ILE . 48.7 mtt180 -116.29 3.53 13.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.944 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 13.3 m120 66.91 27.28 9.0 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.81 177.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.734 HG12 ' HB2' ' A' ' 241' ' ' ARG . 1.7 pt -122.2 155.53 27.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.156 -173.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . 0.442 ' HB2' ' HB2' ' A' ' 210' ' ' LEU . . . -143.92 138.3 28.43 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.019 0.438 . . . . 0.0 111.579 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -107.68 109.11 20.63 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.702 176.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . 0.723 HG12 HG21 ' A' ' 232' ' ' ILE . 1.3 t -103.2 133.3 47.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' HIS . . . . . 0.803 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 40.9 m170 -112.49 101.56 9.72 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.496 0.665 . . . . 0.0 111.128 178.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . 0.702 ' HZ ' HD23 ' A' ' 226' ' ' LEU . 33.5 m-85 -85.87 102.92 14.14 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.744 -1.116 . . . . 0.0 111.429 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.471 HD23 ' CG ' ' A' ' 233' ' ' ASP . 0.1 OUTLIER -40.27 -46.45 2.29 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 124.422 1.076 . . . . 0.0 113.117 -174.835 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -97.39 139.54 33.18 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.858 0.361 . . . . 0.0 110.325 177.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' ILE . . . . . 0.65 ' O ' HG13 ' A' ' 255' ' ' ILE . 0.2 OUTLIER -57.53 -40.62 75.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.675 179.995 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -68.93 -33.15 73.27 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.183 -176.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -59.85 -40.28 88.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.483 179.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 254' ' ' ALA . . . . . 0.479 ' HB2' ' HB2' ' A' ' 248' ' ' PHE . . . -68.88 -41.58 78.14 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.757 178.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.65 HG13 ' O ' ' A' ' 251' ' ' ILE . 14.4 mt -56.06 -59.62 2.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.293 -177.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 12.6 ptmt -62.28 -40.19 95.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.422 -177.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -62.05 -49.28 76.63 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.586 0.231 . . . . 0.0 111.323 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . 0.44 HG13 HG12 ' A' ' 272' ' ' ILE . 53.7 t -64.89 -24.38 35.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.078 0.465 . . . . 0.0 110.892 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 71.6 mm-40 -84.83 -24.53 28.59 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 178.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 58.4 mm-40 -95.89 -33.89 12.03 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.769 0.319 . . . . 0.0 111.081 -175.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.739 HD12 ' CE3' ' A' ' 267' ' ' TRP . 0.6 OUTLIER -52.05 -49.54 83.69 Favored Pre-proline 0 CA--C 1.539 0.523 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.724 -179.013 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 262' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 261' ' ' LEU . 43.6 Cg_endo -67.46 -15.25 44.85 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.446 2.097 . . . . 0.0 113.052 -178.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 54.3 mt -92.09 -4.99 53.61 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.269 0.557 . . . . 0.0 111.449 -178.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 -106.94 149.97 39.21 Favored Pre-proline 0 C--N 1.312 -1.029 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.367 -173.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.25 -37.66 30.56 Favored 'Trans proline' 0 N--CA 1.465 -0.159 0 C-N-CA 123.172 2.581 . . . . 0.0 112.79 -169.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 12.6 mtpt -86.63 -44.33 11.95 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 121.531 0.682 . . . . 0.0 109.788 -177.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 267' ' ' TRP . . . . . 0.739 ' CE3' HD12 ' A' ' 261' ' ' LEU . 10.6 m0 -75.34 -28.85 59.77 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.9 -173.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 34.7 t -65.02 -20.89 66.72 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.151 0.501 . . . . 0.0 110.555 176.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . 0.418 ' C ' ' HD2' ' A' ' 270' ' ' ARG . 97.6 mttt -76.84 -6.2 51.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.238 176.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 270' ' ' ARG . . . . . 0.79 ' HG2' HD21 ' A' ' 213' ' ' LEU . 3.3 mpt_? -114.97 141.64 47.7 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.021 177.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . 0.765 ' HE ' ' HA ' ' A' ' 271' ' ' ARG . 0.8 OUTLIER -93.05 108.36 19.96 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 -179.769 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . 0.597 HG21 HD22 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -117.31 140.91 38.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.361 0.6 . . . . 0.0 110.823 -178.556 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -152.42 170.15 20.81 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.55 173.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 . . . . . 0 C--N 1.33 -0.264 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 171.793 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' ARG . . . . . 0.745 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 46.3 mtp180 . . . . . 0 C--O 1.223 -0.337 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -110.93 106.34 15.43 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.1 0.476 . . . . 0.0 111.643 -171.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.461 ' HB ' ' HB ' ' A' ' 246' ' ' VAL . 57.7 t -136.87 117.97 18.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.552 179.102 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' PHE . . . . . 0.498 ' O ' ' HA ' ' A' ' 272' ' ' ILE . 5.8 t80 -113.28 125.35 54.2 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.463 -177.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.514 ' HG ' ' CG2' ' A' ' 272' ' ' ILE . 5.5 mp -107.8 130.09 55.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.595 177.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . 0.575 ' HA2' HG22 ' A' ' 243' ' ' ILE . . . -132.13 53.01 0.81 Allowed Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.503 -0.856 . . . . 0.0 113.951 -178.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . 0.452 ' HB3' ' HA ' ' A' ' 270' ' ' ARG . 36.3 t30 179.72 52.73 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.037 0.446 . . . . 0.0 111.288 174.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.503 HD21 HD21 ' A' ' 210' ' ' LEU . 1.0 OUTLIER -94.65 159.43 33.55 Favored Pre-proline 0 C--N 1.314 -0.96 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.444 177.509 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.461 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 87.1 Cg_endo -78.42 169.48 19.93 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 122.701 2.267 . . . . 0.0 111.638 178.109 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . 0.493 ' HA ' ' OG1' ' A' ' 239' ' ' THR . 3.9 p-10 -77.49 134.02 38.43 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 98.27 -6.27 61.41 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.398 -0.906 . . . . 0.0 112.857 178.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' ILE . . . . . 0.709 HG22 HG23 ' A' ' 237' ' ' ILE . 4.1 tp -58.15 126.11 15.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 CA-C-O 121.294 0.568 . . . . 0.0 110.724 -178.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' THR . . . . . 0.49 ' CG2' ' HG3' ' A' ' 221' ' ' GLU . 8.8 t -109.22 157.49 18.76 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 121.429 0.633 . . . . 0.0 110.847 -178.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.416 ' H ' ' CD ' ' A' ' 219' ' ' GLU . 2.6 mp0 -62.05 -36.24 81.03 Favored 'General case' 0 C--O 1.209 -1.028 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.455 -177.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' ASP . . . . . 0.532 ' O ' ' HG2' ' A' ' 224' ' ' GLU . 30.7 t70 -55.08 -37.56 66.96 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 123.741 0.651 . . . . 0.0 110.683 -178.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . 0.49 ' HG3' ' CG2' ' A' ' 218' ' ' THR . 45.9 mt-10 -65.97 -55.24 17.78 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.02 179.184 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . 0.442 HD12 HD12 ' A' ' 237' ' ' ILE . 6.7 mt -62.52 -38.84 82.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.656 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' ARG . . . . . 0.848 ' HG3' HD11 ' A' ' 235' ' ' ILE . 63.4 mtp180 -56.47 -62.53 1.66 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.981 0.42 . . . . 0.0 112.066 175.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.532 ' HG2' ' O ' ' A' ' 220' ' ' ASP . 7.0 pt-20 -58.73 -24.74 62.08 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.149 -178.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' ASP . . . . . 0.48 ' HB3' ' CZ2' ' A' ' 267' ' ' TRP . 8.0 m-20 -85.98 -32.5 21.5 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.596 -176.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.74 HD21 ' HZ ' ' A' ' 248' ' ' PHE . 8.4 mp -107.11 -17.49 14.15 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -170.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' GLU . . . . . 0.663 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 37.6 mt-10 -70.71 -27.96 1.2 Allowed Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -176.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' PRO . . . . . 0.663 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 74.4 Cg_endo -65.47 -27.09 54.58 Favored 'Trans proline' 0 C--N 1.359 1.089 0 C-N-CA 121.313 1.342 . . . . 0.0 111.818 -177.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . 0.474 ' CE1' ' HA ' ' A' ' 226' ' ' LEU . 3.2 p90 -111.01 -7.89 14.5 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.879 -0.328 . . . . 0.0 111.65 173.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . 0.487 ' CA ' ' HB2' ' A' ' 253' ' ' ALA . . . -169.69 93.8 0.1 Allowed Glycine 0 N--CA 1.442 -0.954 0 C-N-CA 120.104 -1.046 . . . . 0.0 112.454 -174.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . 0.428 ' HA ' ' HG2' ' A' ' 227' ' ' GLU . 15.3 Cg_endo -59.52 131.79 42.43 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 122.038 1.825 . . . . 0.0 111.759 178.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.725 HG21 HG12 ' A' ' 246' ' ' VAL . 2.8 mp -108.53 152.95 10.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.108 177.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' ASP . . . . . 0.418 ' OD2' HD21 ' A' ' 249' ' ' LEU . 16.3 m-20 -116.1 -18.39 10.63 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 120.708 0.289 . . . . 0.0 111.059 178.005 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . 0.405 ' H ' HG22 ' A' ' 232' ' ' ILE . 23.0 tt0 -145.57 121.69 10.78 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.033 -179.118 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . 0.848 HD11 ' HG3' ' A' ' 223' ' ' ARG . 13.6 mt -133.65 109.79 13.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.045 177.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -113.93 121.29 43.49 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.363 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' ILE . . . . . 0.709 HG23 HG22 ' A' ' 217' ' ' ILE . 53.7 mt -111.85 127.97 68.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.361 -177.221 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.558 ' HB ' HG13 ' A' ' 243' ' ' ILE . 44.8 t -109.58 88.07 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 170.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' THR . . . . . 0.493 ' OG1' ' HA ' ' A' ' 215' ' ' ASN . 12.4 t -64.0 -24.66 67.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.643 -175.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -61.8 -39.0 90.19 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.084 0.469 . . . . 0.0 110.647 178.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . 0.654 ' HB2' HG12 ' A' ' 243' ' ' ILE . 63.9 mtt180 -104.28 0.11 28.92 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.47 -177.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 69.01 25.7 5.85 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.054 177.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.654 HG12 ' HB2' ' A' ' 241' ' ' ARG . 1.4 pt -121.71 151.29 25.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-O 120.835 0.35 . . . . 0.0 111.579 -172.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -145.89 141.5 27.88 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.169 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -111.15 114.42 27.66 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.91 178.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . 0.725 HG12 HG21 ' A' ' 232' ' ' ILE . 1.4 t -108.67 138.35 36.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.665 -178.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' HIS . . . . . 0.745 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 27.1 m170 -115.89 102.15 9.42 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.113 -0.635 . . . . 0.0 111.182 177.016 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . 0.74 ' HZ ' HD21 ' A' ' 226' ' ' LEU . 35.3 m-85 -86.86 100.74 12.77 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.22 179.036 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.418 HD21 ' OD2' ' A' ' 233' ' ' ASP . 0.1 OUTLIER -43.24 -41.55 3.92 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 124.533 1.146 . . . . 0.0 112.693 -175.841 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 250' ' ' ASN . . . . . 0.432 ' HB2' ' HB3' ' A' ' 253' ' ' ALA . 59.4 m-20 -94.6 137.89 33.14 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 251' ' ' ILE . . . . . 0.578 ' O ' HG13 ' A' ' 255' ' ' ILE . 0.2 OUTLIER -60.98 -43.51 96.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -178.933 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -71.32 -27.52 63.45 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.666 -176.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . 0.487 ' HB2' ' CA ' ' A' ' 230' ' ' GLY . . . -62.73 -42.37 99.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.204 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 254' ' ' ALA . . . . . 0.513 ' HB3' ' HB2' ' A' ' 248' ' ' PHE . . . -67.38 -41.89 84.26 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.614 178.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.578 HG13 ' O ' ' A' ' 251' ' ' ILE . 9.8 mt -56.17 -60.26 2.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.285 -177.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 12.7 ptmt -62.6 -36.22 82.06 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.553 -176.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -65.73 -49.41 68.55 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 122.981 0.176 . . . . 0.0 111.438 178.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . 0.556 HG11 HG12 ' A' ' 272' ' ' ILE . 60.9 t -63.5 -25.5 38.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.976 0.417 . . . . 0.0 110.838 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -83.96 -25.45 30.04 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.11 -0.495 . . . . 0.0 112.187 178.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 46.5 mm-40 -95.05 -30.88 13.85 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-O 120.665 0.269 . . . . 0.0 111.283 -175.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.718 HD13 ' CE3' ' A' ' 267' ' ' TRP . 1.0 OUTLIER -52.42 -50.45 79.83 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.251 179.625 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 262' ' ' PRO . . . . . 0.554 ' HD2' ' N ' ' A' ' 261' ' ' LEU . 43.2 Cg_endo -66.99 -14.48 43.81 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.399 2.066 . . . . 0.0 112.909 -178.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 55.6 mt -96.34 -3.91 42.96 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.899 0.381 . . . . 0.0 111.827 -178.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 264' ' ' ASN . . . . . 0.434 ' HB2' ' CE3' ' A' ' 267' ' ' TRP . 13.1 m-80 -106.72 149.78 38.85 Favored Pre-proline 0 C--N 1.317 -0.84 0 N-CA-C 112.662 0.615 . . . . 0.0 112.662 -174.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -63.22 -35.66 62.09 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 123.771 2.981 . . . . 0.0 113.189 -168.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . 0.432 ' HE3' ' HB2' ' A' ' 266' ' ' LYS . 0.0 OUTLIER -86.93 -45.74 10.53 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 121.791 0.805 . . . . 0.0 109.298 -179.616 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 267' ' ' TRP . . . . . 0.718 ' CE3' HD13 ' A' ' 261' ' ' LEU . 9.1 m0 -76.46 -29.29 56.86 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 114.362 -1.29 . . . . 0.0 111.309 -170.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 23.2 t -64.92 -16.54 63.42 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.742 0.306 . . . . 0.0 111.547 -179.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -87.17 -13.16 44.82 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.095 0.474 . . . . 0.0 110.183 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 270' ' ' ARG . . . . . 0.452 ' HA ' ' HB3' ' A' ' 212' ' ' ASN . 6.9 mpt_? -88.32 166.75 14.07 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 173.11 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . 0.446 ' HA ' ' HD3' ' A' ' 271' ' ' ARG . 45.1 mmt-85 -120.4 106.58 11.98 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 177.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . 0.591 HG23 HD21 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -119.58 141.94 37.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.461 0.648 . . . . 0.0 111.903 -174.411 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -151.76 169.73 21.49 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.613 171.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 . . . . . 0 C--N 1.324 -0.521 0 CA-C-O 120.873 0.368 . . . . 0.0 110.49 176.615 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' ARG . . . . . 0.815 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 8.0 mtm180 . . . . . 0 C--O 1.221 -0.398 0 N-CA-C 114.579 1.325 . . . . 0.0 114.579 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -104.98 105.6 15.71 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 119.09 0.859 . . . . 0.0 112.161 -172.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.48 ' HB ' ' HB ' ' A' ' 246' ' ' VAL . 65.1 t -133.69 114.7 20.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 114.569 -1.196 . . . . 0.0 109.199 177.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' PHE . . . . . 0.444 ' HB3' ' CE1' ' A' ' 273' ' ' TYR . 1.5 t80 -113.6 122.64 47.83 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.061 -176.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.518 ' HG ' HG22 ' A' ' 272' ' ' ILE . 6.4 mp -105.35 136.95 43.95 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.463 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . 0.514 ' HA2' HG23 ' A' ' 243' ' ' ILE . . . -144.58 68.55 0.42 Allowed Glycine 0 N--CA 1.448 -0.567 0 C-N-CA 120.422 -0.894 . . . . 0.0 113.19 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . 0.531 ' HB3' ' HA ' ' A' ' 270' ' ' ARG . 20.5 t30 173.66 37.57 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.092 0.473 . . . . 0.0 109.992 176.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.767 HD23 ' HG2' ' A' ' 270' ' ' ARG . 0.9 OUTLIER -86.59 159.91 51.67 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.71 -176.758 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.479 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 98.6 Cg_endo -77.67 162.94 29.67 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.76 2.307 . . . . 0.0 112.046 178.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -76.04 117.68 18.0 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.771 178.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 109.02 -0.94 31.53 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.292 -0.956 . . . . 0.0 113.011 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' ILE . . . . . 0.694 HG22 HG23 ' A' ' 237' ' ' ILE . 6.2 tp -60.76 130.19 24.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.046 0.451 . . . . 0.0 110.852 177.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' THR . . . . . 0.435 ' CG2' ' HG3' ' A' ' 221' ' ' GLU . 12.1 t -114.07 156.24 24.51 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 121.722 0.772 . . . . 0.0 110.969 178.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -60.74 -35.31 76.06 Favored 'General case' 0 C--O 1.208 -1.089 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.093 -178.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -56.11 -35.68 67.35 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 123.433 0.458 . . . . 0.0 110.689 -178.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . 0.435 ' HG3' ' CG2' ' A' ' 218' ' ' THR . 43.6 mt-10 -68.44 -56.43 8.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.122 178.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . 0.466 HD11 HD13 ' A' ' 237' ' ' ILE . 7.6 mt -60.45 -39.66 81.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.434 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' ARG . . . . . 0.744 ' HG3' HD13 ' A' ' 235' ' ' ILE . 33.6 mtp180 -55.88 -63.1 1.29 Allowed 'General case' 0 CA--C 1.509 -0.627 0 CA-C-O 120.935 0.398 . . . . 0.0 112.05 175.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -58.04 -22.1 48.5 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.813 -177.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -86.44 -34.21 20.19 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.621 -177.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.7 HD21 ' HZ ' ' A' ' 248' ' ' PHE . 8.1 mp -105.98 -18.54 14.01 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -169.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' GLU . . . . . 0.648 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 53.7 mt-10 -67.52 -30.32 2.89 Favored Pre-proline 0 C--N 1.326 -0.432 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -176.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' PRO . . . . . 0.648 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 71.7 Cg_endo -65.29 -28.71 55.2 Favored 'Trans proline' 0 C--N 1.36 1.146 0 C-N-CA 121.147 1.231 . . . . 0.0 112.089 -176.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . 0.505 ' CE1' ' HA ' ' A' ' 226' ' ' LEU . 3.1 p90 -110.84 -4.7 15.13 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.737 0.303 . . . . 0.0 111.725 175.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . 0.441 ' CA ' ' HB1' ' A' ' 253' ' ' ALA . . . -171.95 97.83 0.12 Allowed Glycine 0 N--CA 1.443 -0.895 0 C-N-CA 120.274 -0.965 . . . . 0.0 112.311 -175.136 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -64.65 131.45 29.52 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 121.778 1.652 . . . . 0.0 111.527 178.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.722 HG22 HG11 ' A' ' 246' ' ' VAL . 2.7 mp -107.77 151.97 9.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.563 177.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' ASP . . . . . 0.407 ' CG ' HD22 ' A' ' 249' ' ' LEU . 10.6 m-20 -109.42 -28.56 8.87 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.122 0.487 . . . . 0.0 110.168 176.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . 0.583 ' HB3' ' HB2' ' A' ' 247' ' ' HIS . 26.6 tt0 -136.28 122.54 20.49 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.748 -174.082 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . 0.744 HD13 ' HG3' ' A' ' 223' ' ' ARG . 14.1 mt -138.45 112.99 8.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.763 178.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -125.35 118.23 25.47 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.41 -179.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' ILE . . . . . 0.694 HG23 HG22 ' A' ' 217' ' ' ILE . 44.9 mt -104.97 115.64 47.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.821 -178.137 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.534 ' HB ' HG13 ' A' ' 243' ' ' ILE . 21.9 t -94.08 87.77 2.22 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 173.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 11.1 t -64.28 -23.69 67.39 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.393 -176.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -64.27 -23.4 67.29 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.152 178.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . 0.694 ' HB2' HG12 ' A' ' 243' ' ' ILE . 97.1 mtt180 -120.21 -0.13 10.54 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.244 176.253 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 19.2 m120 63.55 29.65 15.24 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.137 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.694 HG12 ' HB2' ' A' ' 241' ' ' ARG . 1.2 pt -121.78 154.33 26.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.76 -175.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . 0.508 ' HB3' ' HB2' ' A' ' 210' ' ' LEU . . . -142.29 138.8 31.59 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.11 0.481 . . . . 0.0 111.788 -178.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -106.33 113.81 27.56 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.62 177.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . 0.722 HG11 HG22 ' A' ' 232' ' ' ILE . 1.0 OUTLIER -112.77 130.58 66.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -179.817 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' HIS . . . . . 0.815 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 28.0 m170 -111.19 102.44 10.87 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.024 -0.67 . . . . 0.0 111.373 177.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . 0.7 ' HZ ' HD21 ' A' ' 226' ' ' LEU . 36.9 m-85 -84.61 101.92 12.51 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.599 177.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.407 HD22 ' CG ' ' A' ' 233' ' ' ASP . 0.1 OUTLIER -44.43 -39.12 4.49 Favored 'General case' 0 N--CA 1.465 0.294 0 O-C-N 124.568 1.167 . . . . 0.0 112.956 -174.875 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 50.5 m-20 -99.88 143.16 30.42 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.056 178.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 251' ' ' ILE . . . . . 0.611 ' O ' HG13 ' A' ' 255' ' ' ILE . 0.2 OUTLIER -63.76 -44.62 98.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.138 -176.56 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -68.35 -29.93 68.77 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 120.606 0.241 . . . . 0.0 110.768 -176.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . 0.441 ' HB1' ' CA ' ' A' ' 230' ' ' GLY . . . -61.25 -42.41 98.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.285 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 254' ' ' ALA . . . . . 0.52 ' HB3' ' HB2' ' A' ' 248' ' ' PHE . . . -67.33 -41.33 85.42 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.719 178.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.699 ' O ' ' HG2' ' A' ' 259' ' ' GLN . 15.1 mt -57.05 -62.41 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.096 -177.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . 0.477 ' O ' ' HG2' ' A' ' 260' ' ' GLU . 10.1 ptmt -59.81 -38.42 81.93 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.109 -176.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -63.19 -49.76 72.98 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.59 0.233 . . . . 0.0 111.428 178.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . 0.45 HG11 HG12 ' A' ' 272' ' ' ILE . 52.7 t -66.36 -24.43 33.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.048 0.451 . . . . 0.0 111.119 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . 0.699 ' HG2' ' O ' ' A' ' 255' ' ' ILE . 78.9 mm-40 -84.13 -26.87 28.56 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.933 178.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . 0.477 ' HG2' ' O ' ' A' ' 256' ' ' LYS . 53.3 mm-40 -95.52 -31.65 13.23 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 122.702 0.401 . . . . 0.0 111.532 -175.033 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.795 ' HA ' ' HE3' ' A' ' 267' ' ' TRP . 0.7 OUTLIER -50.81 -51.03 70.2 Favored Pre-proline 0 CA--C 1.537 0.445 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.501 178.888 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 262' ' ' PRO . . . . . 0.557 ' HD2' ' N ' ' A' ' 261' ' ' LEU . 37.8 Cg_endo -66.11 -15.69 49.43 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.287 1.991 . . . . 0.0 112.538 -177.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 57.6 mt -88.66 -9.34 52.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.967 0.413 . . . . 0.0 111.745 -177.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -105.44 148.82 36.99 Favored Pre-proline 0 C--N 1.314 -0.968 0 N-CA-C 112.586 0.588 . . . . 0.0 112.586 -172.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -61.52 -36.11 78.47 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 123.711 2.941 . . . . 0.0 112.61 -171.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 7.6 mtpt -85.99 -45.07 11.81 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 121.542 0.687 . . . . 0.0 109.608 -176.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 267' ' ' TRP . . . . . 0.795 ' HE3' ' HA ' ' A' ' 261' ' ' LEU . 11.2 m0 -78.29 -28.16 47.49 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.686 -173.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 23.9 t -63.94 -17.96 63.77 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.802 0.334 . . . . 0.0 110.802 177.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -73.81 -21.71 60.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.23 0.538 . . . . 0.0 110.097 176.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 270' ' ' ARG . . . . . 0.767 ' HG2' HD23 ' A' ' 213' ' ' LEU . 3.1 mpt_? -102.19 141.7 34.61 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.913 -176.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . 0.447 ' HG2' ' HB2' ' A' ' 212' ' ' ASN . 26.5 mmt180 -93.17 109.45 20.95 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.237 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . 0.604 HG23 HD23 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -117.95 139.31 45.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.424 0.63 . . . . 0.0 111.012 -177.203 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 273' ' ' TYR . . . . . 0.444 ' CE1' ' HB3' ' A' ' 209' ' ' PHE . 6.0 p90 -151.78 168.79 23.97 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.73 176.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 274' ' ' TYR . . . . . 0.416 ' OH ' ' HA ' ' A' ' 255' ' ' ILE . 85.5 m-85 . . . . . 0 C--N 1.32 -0.686 0 CA-C-O 120.895 0.378 . . . . 0.0 110.523 174.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' ARG . . . . . 0.733 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 63.4 mtm180 . . . . . 0 C--O 1.223 -0.319 0 N-CA-C 114.579 1.325 . . . . 0.0 114.579 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -100.78 105.81 17.16 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 118.95 0.795 . . . . 0.0 111.528 -171.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.456 ' HB ' ' HB ' ' A' ' 246' ' ' VAL . 58.4 t -137.22 125.91 34.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.362 176.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' PHE . . . . . 0.453 ' HE1' ' HB ' ' A' ' 243' ' ' ILE . 3.3 t80 -125.61 121.37 33.36 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.75 -176.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.504 ' HG ' HG21 ' A' ' 272' ' ' ILE . 5.4 mp -103.79 134.67 46.7 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.298 177.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . 0.53 ' HA2' HG23 ' A' ' 243' ' ' ILE . . . -143.13 65.96 0.47 Allowed Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.493 -0.86 . . . . 0.0 112.908 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . 0.525 ' HB3' ' HA ' ' A' ' 270' ' ' ARG . 1.6 t-20 174.83 39.54 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.252 0.549 . . . . 0.0 110.125 178.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.465 ' HB3' ' HD2' ' A' ' 214' ' ' PRO . 0.5 OUTLIER -89.96 162.82 34.33 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.985 -179.617 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.465 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 74.9 Cg_endo -83.8 169.27 12.0 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.739 2.293 . . . . 0.0 111.396 175.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -78.92 134.58 36.86 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 177.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 103.32 -9.78 53.89 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.468 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' ILE . . . . . 0.591 HG23 HG21 ' A' ' 237' ' ' ILE . 4.9 tp -59.85 128.08 20.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-O 121.071 0.462 . . . . 0.0 110.494 178.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' THR . . . . . 0.426 ' CG2' ' HG2' ' A' ' 221' ' ' GLU . 9.0 t -114.43 158.28 21.77 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-O 121.252 0.548 . . . . 0.0 110.575 179.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.424 ' H ' ' CD ' ' A' ' 219' ' ' GLU . 1.3 mp0 -62.3 -39.35 92.68 Favored 'General case' 0 C--O 1.21 -0.975 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.809 -175.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -52.33 -37.82 56.98 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 123.676 0.61 . . . . 0.0 111.234 -178.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . 0.426 ' HG2' ' CG2' ' A' ' 218' ' ' THR . 47.5 mm-40 -68.16 -53.57 24.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.367 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . 0.488 HD13 HD13 ' A' ' 237' ' ' ILE . 8.0 mt -62.0 -42.33 94.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.254 179.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' ARG . . . . . 0.683 ' HG3' HD13 ' A' ' 235' ' ' ILE . 66.4 mtp180 -53.27 -63.15 1.24 Allowed 'General case' 0 CA--C 1.507 -0.7 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 175.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -57.16 -23.91 50.72 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.782 -177.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -83.37 -33.1 25.88 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.592 -178.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.771 HD21 ' HZ ' ' A' ' 248' ' ' PHE . 7.7 mp -106.0 -15.51 14.88 Favored 'General case' 0 C--O 1.224 -0.253 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -171.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' GLU . . . . . 0.633 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 43.6 mm-40 -61.62 -37.62 42.67 Favored Pre-proline 0 C--N 1.328 -0.366 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -177.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' PRO . . . . . 0.633 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 85.1 Cg_endo -66.08 -29.07 48.6 Favored 'Trans proline' 0 C--N 1.358 1.039 0 C-N-CA 121.638 1.558 . . . . 0.0 112.414 -172.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . 0.517 ' CE1' ' HA ' ' A' ' 226' ' ' LEU . 3.5 p90 -110.56 -11.06 14.5 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.449 -0.5 . . . . 0.0 111.999 176.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . 0.422 ' CA ' ' HB3' ' A' ' 253' ' ' ALA . . . -164.93 92.4 0.11 Allowed Glycine 0 N--CA 1.44 -1.048 0 C-N-CA 120.282 -0.961 . . . . 0.0 112.01 -175.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -60.41 130.18 32.75 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.126 1.884 . . . . 0.0 111.319 178.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.847 HG21 HG12 ' A' ' 246' ' ' VAL . 2.3 mp -109.17 152.22 11.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.898 179.135 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -112.99 -23.47 10.04 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.985 0.421 . . . . 0.0 110.675 176.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . 0.522 ' HB3' ' HB2' ' A' ' 247' ' ' HIS . 35.1 tt0 -139.36 120.47 14.67 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.721 -175.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . 0.683 HD13 ' HG3' ' A' ' 223' ' ' ARG . 13.7 mt -136.61 112.3 11.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.037 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -120.32 110.74 16.91 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.57 -177.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' ILE . . . . . 0.591 HG21 HG23 ' A' ' 217' ' ' ILE . 72.6 mt -98.85 117.55 44.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.791 -178.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.587 ' HB ' HG13 ' A' ' 243' ' ' ILE . 24.3 t -97.97 88.29 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 174.044 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 8.8 t -65.04 -24.33 67.45 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.455 -175.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -66.93 -21.49 65.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.329 0.585 . . . . 0.0 110.339 178.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . 0.611 ' CB ' HG12 ' A' ' 243' ' ' ILE . 33.4 mmt180 -117.91 -2.73 11.26 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.906 -178.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 17.4 m120 66.35 25.33 10.41 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.73 178.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.611 HG12 ' CB ' ' A' ' 241' ' ' ARG . 2.8 pt -122.33 153.1 26.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.01 -173.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . 0.461 ' HB3' ' HB2' ' A' ' 210' ' ' LEU . . . -142.14 134.92 28.47 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.897 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -105.89 120.13 40.95 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.821 178.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . 0.847 HG12 HG21 ' A' ' 232' ' ' ILE . 0.2 OUTLIER -116.95 133.38 63.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -177.079 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' HIS . . . . . 0.733 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 41.3 m170 -115.05 102.81 10.29 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.067 -0.653 . . . . 0.0 111.195 177.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . 0.771 ' HZ ' HD21 ' A' ' 226' ' ' LEU . 28.2 m-85 -86.67 104.52 16.15 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.333 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.411 ' H ' HD23 ' A' ' 249' ' ' LEU . 0.1 OUTLIER -41.92 -46.44 4.05 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 124.405 1.066 . . . . 0.0 113.111 -175.766 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 250' ' ' ASN . . . . . 0.409 ' N ' HD21 ' A' ' 250' ' ' ASN . 0.9 OUTLIER -94.02 145.64 24.51 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.296 178.092 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 251' ' ' ILE . . . . . 0.599 ' O ' HG13 ' A' ' 255' ' ' ILE . 0.2 OUTLIER -63.38 -41.72 93.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -179.705 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -70.69 -31.2 68.0 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 120.783 0.325 . . . . 0.0 110.57 -174.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . 0.422 ' HB3' ' CA ' ' A' ' 230' ' ' GLY . . . -59.5 -43.56 93.33 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.253 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 254' ' ' ALA . . . . . 0.531 ' HB3' ' HB2' ' A' ' 248' ' ' PHE . . . -68.44 -39.73 81.42 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.915 179.103 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.615 ' HA ' ' HH ' ' A' ' 274' ' ' TYR . 7.9 mt -56.95 -61.97 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.21 -177.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . 0.504 ' O ' ' HG2' ' A' ' 260' ' ' GLU . 10.7 ptmt -61.43 -40.57 94.93 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.512 -176.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -60.44 -49.53 77.21 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.72 0.295 . . . . 0.0 111.365 178.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . 0.426 HG12 HG12 ' A' ' 272' ' ' ILE . 51.7 t -67.24 -23.34 30.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 120.98 0.419 . . . . 0.0 111.206 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . 0.521 ' HG3' ' O ' ' A' ' 255' ' ' ILE . 54.2 mt-30 -83.28 -27.39 29.86 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 122.193 -0.317 . . . . 0.0 111.54 177.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . 0.504 ' HG2' ' O ' ' A' ' 256' ' ' LYS . 30.2 mm-40 -95.62 -30.16 13.94 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.33 -173.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.705 ' HA ' ' HE3' ' A' ' 267' ' ' TRP . 0.7 OUTLIER -51.79 -51.41 70.61 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.382 178.096 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 262' ' ' PRO . . . . . 0.555 ' HD2' ' N ' ' A' ' 261' ' ' LEU . 42.6 Cg_endo -67.07 -15.83 47.68 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.408 2.072 . . . . 0.0 112.84 -177.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 60.6 mt -94.94 -3.09 49.24 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.291 0.567 . . . . 0.0 111.832 -177.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 264' ' ' ASN . . . . . 0.462 ' O ' ' HB2' ' A' ' 268' ' ' SER . 13.3 m-80 -105.91 147.99 35.73 Favored Pre-proline 0 C--N 1.314 -0.947 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.321 -177.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -66.92 -32.87 34.71 Favored 'Trans proline' 0 C--N 1.334 -0.195 0 C-N-CA 123.35 2.7 . . . . 0.0 112.733 -168.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 3.8 mtpt -86.21 -44.53 12.1 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.517 0.675 . . . . 0.0 109.51 -178.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 267' ' ' TRP . . . . . 0.705 ' HE3' ' HA ' ' A' ' 261' ' ' LEU . 13.5 m0 -77.16 -28.15 54.02 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.874 -174.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 268' ' ' SER . . . . . 0.462 ' HB2' ' O ' ' A' ' 264' ' ' ASN . 8.0 t -68.68 -15.12 63.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.035 0.445 . . . . 0.0 110.504 178.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -74.65 -14.67 60.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.856 174.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 270' ' ' ARG . . . . . 0.525 ' HA ' ' HB3' ' A' ' 212' ' ' ASN . 4.1 mpt_? -99.37 162.65 12.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.838 178.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . 0.41 ' HG2' ' CB ' ' A' ' 212' ' ' ASN . 36.7 mmt180 -112.14 105.76 14.2 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 174.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . 0.611 HG22 HD23 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -116.87 140.91 37.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.373 0.606 . . . . 0.0 111.34 -175.817 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -151.66 167.99 26.41 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.805 172.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 274' ' ' TYR . . . . . 0.615 ' HH ' ' HA ' ' A' ' 255' ' ' ILE . 85.9 m-85 . . . . . 0 C--N 1.321 -0.65 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.402 174.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' ARG . . . . . 0.793 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 57.1 mtp180 . . . . . 0 C--O 1.224 -0.281 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -108.36 105.79 15.64 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 119.85 -0.74 . . . . 0.0 112.041 -175.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.43 ' HB ' ' HB ' ' A' ' 246' ' ' VAL . 67.9 t -133.49 113.48 18.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 114.691 -1.141 . . . . 0.0 109.153 176.199 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' PHE . . . . . 0.432 ' HE1' ' HB ' ' A' ' 243' ' ' ILE . 1.7 t80 -112.05 122.37 47.58 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.094 -175.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.5 ' HG ' HG21 ' A' ' 272' ' ' ILE . 5.4 mp -104.8 131.13 52.64 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.257 178.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . 0.53 ' HA2' HG21 ' A' ' 243' ' ' ILE . . . -137.16 64.1 0.57 Allowed Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.217 -0.992 . . . . 0.0 113.636 -178.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . 0.518 ' HB3' ' HA ' ' A' ' 270' ' ' ARG . 30.6 t30 175.81 37.15 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.055 0.455 . . . . 0.0 109.93 174.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.554 HD23 ' HG2' ' A' ' 270' ' ' ARG . 1.0 OUTLIER -81.8 158.26 68.17 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.849 -176.792 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.438 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 73.4 Cg_endo -74.89 152.47 41.38 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 122.351 2.034 . . . . 0.0 111.522 177.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -70.04 116.17 10.1 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.237 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 108.5 1.68 32.88 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.487 -0.863 . . . . 0.0 112.639 -177.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' ILE . . . . . 0.691 HG21 HG21 ' A' ' 237' ' ' ILE . 5.1 tp -60.66 130.54 24.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.0 0.428 . . . . 0.0 110.502 176.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' THR . . . . . 0.471 HG22 ' HG3' ' A' ' 221' ' ' GLU . 11.6 t -113.5 158.45 20.7 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.379 0.609 . . . . 0.0 110.949 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.464 ' CD ' ' H ' ' A' ' 219' ' ' GLU . 5.8 mp0 -61.85 -42.5 99.11 Favored 'General case' 0 C--O 1.21 -1.023 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.581 -176.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -48.18 -38.42 18.1 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 123.839 0.712 . . . . 0.0 111.547 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . 0.471 ' HG3' HG22 ' A' ' 218' ' ' THR . 42.3 mt-10 -66.22 -57.9 6.56 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.281 178.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . 0.481 HD13 HD12 ' A' ' 237' ' ' ILE . 8.4 mt -61.45 -41.3 89.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.602 -178.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' ARG . . . . . 0.723 ' HG3' HD11 ' A' ' 235' ' ' ILE . 48.7 mtp180 -53.63 -62.7 1.48 Allowed 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 175.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -58.27 -22.89 54.33 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.756 -177.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' ASP . . . . . 0.472 ' HB3' ' CZ2' ' A' ' 267' ' ' TRP . 10.7 m-20 -86.2 -32.26 21.3 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.844 -177.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.79 HD22 ' HZ ' ' A' ' 248' ' ' PHE . 7.7 mp -106.68 -15.31 14.79 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -170.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' GLU . . . . . 0.612 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 23.2 mm-40 -60.4 -38.38 57.16 Favored Pre-proline 0 C--N 1.327 -0.393 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -178.108 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' PRO . . . . . 0.612 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 96.1 Cg_endo -66.78 -26.47 45.12 Favored 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 121.587 1.525 . . . . 0.0 112.485 -171.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . 0.514 ' CZ ' ' HA ' ' A' ' 226' ' ' LEU . 3.6 p90 -111.21 -9.19 14.33 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.958 175.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . 0.444 ' CA ' ' HB3' ' A' ' 253' ' ' ALA . . . -169.05 99.1 0.15 Allowed Glycine 0 N--CA 1.442 -0.942 0 C-N-CA 120.033 -1.079 . . . . 0.0 112.268 -175.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -65.86 131.43 27.32 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 121.808 1.672 . . . . 0.0 111.532 178.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.806 HG23 HG12 ' A' ' 246' ' ' VAL . 2.1 mp -108.68 151.51 10.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.437 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' ASP . . . . . 0.441 ' CG ' HD23 ' A' ' 249' ' ' LEU . 38.0 m-20 -114.56 -19.89 10.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.848 0.356 . . . . 0.0 110.75 177.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . 0.473 ' HB3' ' HB2' ' A' ' 247' ' ' HIS . 9.4 tt0 -143.62 121.22 11.8 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.73 -177.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . 0.723 HD11 ' HG3' ' A' ' 223' ' ' ARG . 12.1 mt -135.09 108.52 9.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.964 -179.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 61.9 tttp -115.9 112.47 21.94 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.411 -178.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' ILE . . . . . 0.691 HG21 HG21 ' A' ' 217' ' ' ILE . 67.0 mt -102.35 124.1 56.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-O 121.017 0.436 . . . . 0.0 110.783 -179.544 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.521 ' HB ' HG13 ' A' ' 243' ' ' ILE . 61.2 t -105.23 87.68 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 171.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 13.2 t -69.84 -16.53 63.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.381 -177.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -62.06 -34.04 75.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.202 175.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . 0.74 ' HB2' HG12 ' A' ' 243' ' ' ILE . 77.0 mtt180 -112.88 -0.28 14.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.527 178.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 17.9 m120 67.46 29.64 7.2 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.847 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.74 HG12 ' HB2' ' A' ' 241' ' ' ARG . 1.3 pt -122.3 151.68 26.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.037 -175.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . 0.419 ' HB1' ' HB2' ' A' ' 210' ' ' LEU . . . -141.3 138.19 32.98 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.046 0.451 . . . . 0.0 111.849 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -107.27 108.05 19.28 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.836 177.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . 0.806 HG12 HG23 ' A' ' 232' ' ' ILE . 0.9 OUTLIER -106.12 133.57 50.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 -179.288 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' HIS . . . . . 0.793 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 41.8 m170 -112.27 101.97 10.16 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.486 0.66 . . . . 0.0 111.295 178.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . 0.79 ' HZ ' HD22 ' A' ' 226' ' ' LEU . 33.7 m-85 -86.65 101.28 13.11 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.99 -1.004 . . . . 0.0 111.33 179.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.441 HD23 ' CG ' ' A' ' 233' ' ' ASP . 0.1 OUTLIER -42.26 -48.05 4.88 Favored 'General case' 0 N--CA 1.465 0.312 0 O-C-N 124.367 1.042 . . . . 0.0 112.583 -176.611 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 250' ' ' ASN . . . . . 0.417 ' HB2' ' HB2' ' A' ' 253' ' ' ALA . 9.0 m120 -84.95 138.18 32.65 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 178.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 251' ' ' ILE . . . . . 0.568 ' O ' HG13 ' A' ' 255' ' ' ILE . 0.2 OUTLIER -62.38 -43.69 98.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -179.609 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -68.98 -30.12 68.47 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.901 -177.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . 0.444 ' HB3' ' CA ' ' A' ' 230' ' ' GLY . . . -60.72 -41.74 95.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.32 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 254' ' ' ALA . . . . . 0.544 ' HB3' ' HB2' ' A' ' 248' ' ' PHE . . . -67.87 -41.29 83.08 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.591 178.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.647 ' HA ' ' HH ' ' A' ' 274' ' ' TYR . 11.7 mt -56.05 -60.84 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.159 -178.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 10.0 ptmt -62.66 -38.84 91.92 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.622 -176.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -61.96 -47.97 82.46 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.557 0.218 . . . . 0.0 111.349 178.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . 0.529 HG13 HG12 ' A' ' 272' ' ' ILE . 54.6 t -65.15 -25.14 36.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.878 0.371 . . . . 0.0 110.931 178.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -83.71 -23.61 31.59 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 178.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -94.93 -34.93 12.21 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.826 0.345 . . . . 0.0 110.689 -175.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.726 ' HA ' ' HE3' ' A' ' 267' ' ' TRP . 0.7 OUTLIER -51.57 -50.48 76.73 Favored Pre-proline 0 CA--C 1.538 0.503 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.578 -178.296 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 262' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' A' ' 261' ' ' LEU . 37.3 Cg_endo -66.35 -20.6 55.02 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.222 1.948 . . . . 0.0 112.544 -177.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 65.8 mt -90.65 -2.22 57.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.292 0.568 . . . . 0.0 111.551 -175.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 12.2 m-80 -106.71 148.93 37.77 Favored Pre-proline 0 C--N 1.315 -0.916 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.938 -176.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -65.59 -34.2 42.82 Favored 'Trans proline' 0 C--O 1.23 0.11 0 C-N-CA 123.367 2.711 . . . . 0.0 112.604 -171.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 5.1 mtpt -86.05 -45.23 11.62 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 121.812 0.815 . . . . 0.0 109.747 -177.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 267' ' ' TRP . . . . . 0.726 ' HE3' ' HA ' ' A' ' 261' ' ' LEU . 11.3 m0 -78.75 -26.02 44.57 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.722 -172.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 37.3 t -61.41 -22.15 64.75 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.758 0.313 . . . . 0.0 111.01 177.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -71.15 -18.08 62.52 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.242 0.544 . . . . 0.0 110.481 176.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 270' ' ' ARG . . . . . 0.554 ' HG2' HD23 ' A' ' 213' ' ' LEU . 0.0 OUTLIER -101.9 140.56 36.02 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.475 -179.932 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . 0.744 ' HE ' ' HA ' ' A' ' 271' ' ' ARG . 0.2 OUTLIER -95.62 105.77 17.8 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.777 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . 0.63 HG22 HD21 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -115.24 144.07 23.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.352 0.596 . . . . 0.0 111.285 -174.693 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -151.87 169.46 22.22 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.421 174.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 274' ' ' TYR . . . . . 0.647 ' HH ' ' HA ' ' A' ' 255' ' ' ILE . 70.4 m-85 . . . . . 0 N--CA 1.449 -0.519 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 171.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' ARG . . . . . 0.806 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 24.7 mtp-105 . . . . . 0 C--O 1.222 -0.388 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -101.3 106.04 17.18 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 118.681 0.673 . . . . 0.0 111.562 -172.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 60.0 t -138.57 119.69 16.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.936 176.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' PHE . . . . . 0.433 ' O ' ' HA ' ' A' ' 272' ' ' ILE . 4.3 t80 -116.31 125.64 52.43 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.49 -177.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.522 ' HB2' ' HB1' ' A' ' 244' ' ' ALA . 6.2 mp -110.7 133.96 52.88 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.612 178.194 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . 0.512 ' HA2' HG22 ' A' ' 243' ' ' ILE . . . -138.94 65.9 0.53 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.591 -0.814 . . . . 0.0 113.351 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . 0.473 ' HB2' ' O ' ' A' ' 211' ' ' GLY . 25.1 t30 172.05 42.77 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.831 0.348 . . . . 0.0 110.617 177.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.462 HD13 ' O ' ' A' ' 242' ' ' ASN . 1.2 mp -91.23 160.32 37.57 Favored Pre-proline 0 C--N 1.322 -0.591 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.268 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.408 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 92.7 Cg_endo -82.49 166.76 15.62 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 122.637 2.225 . . . . 0.0 112.202 177.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -73.36 125.87 28.83 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.324 0.583 . . . . 0.0 111.139 178.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 106.01 -8.78 42.6 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.839 178.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' ILE . . . . . 0.778 HG23 HG21 ' A' ' 237' ' ' ILE . 5.0 tp -57.99 125.92 14.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.338 0.59 . . . . 0.0 110.625 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' THR . . . . . 0.456 ' CG2' ' HG3' ' A' ' 221' ' ' GLU . 11.1 t -114.42 157.88 22.3 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.751 -178.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -61.34 -35.53 77.67 Favored 'General case' 0 C--O 1.209 -1.056 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.936 -177.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' ASP . . . . . 0.425 ' O ' ' HG2' ' A' ' 224' ' ' GLU . 29.5 t70 -51.32 -40.0 58.14 Favored 'General case' 0 C--N 1.32 -0.702 0 O-C-N 123.632 0.582 . . . . 0.0 111.109 178.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . 0.456 ' HG3' ' CG2' ' A' ' 218' ' ' THR . 44.4 mt-10 -70.01 -54.13 14.59 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.562 -179.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . 0.484 HD11 HD12 ' A' ' 237' ' ' ILE . 11.8 mt -60.98 -42.29 92.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.616 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' ARG . . . . . 0.802 ' HG3' HD12 ' A' ' 235' ' ' ILE . 38.9 mtp180 -53.87 -63.09 1.26 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 174.279 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.425 ' HG2' ' O ' ' A' ' 220' ' ' ASP . 15.4 pt-20 -57.7 -22.16 44.67 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.19 -177.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' ASP . . . . . 0.489 ' HB3' ' CZ2' ' A' ' 267' ' ' TRP . 27.0 m-20 -89.62 -31.88 17.34 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.973 -177.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.845 HD22 ' HZ ' ' A' ' 248' ' ' PHE . 8.3 mp -107.05 -17.46 14.17 Favored 'General case' 0 C--O 1.224 -0.282 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -169.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' GLU . . . . . 0.665 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 58.6 mt-10 -69.6 -26.91 1.15 Allowed Pre-proline 0 C--N 1.323 -0.568 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -175.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' PRO . . . . . 0.665 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 72.3 Cg_endo -66.25 -27.84 48.06 Favored 'Trans proline' 0 C--N 1.36 1.179 0 C-N-CA 121.247 1.298 . . . . 0.0 111.916 -178.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . 0.479 ' CZ ' ' HA ' ' A' ' 226' ' ' LEU . 3.6 p90 -110.6 -9.36 14.55 Favored 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.66 174.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . 0.402 ' CA ' ' HB3' ' A' ' 253' ' ' ALA . . . -168.35 93.77 0.11 Allowed Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 120.18 -1.01 . . . . 0.0 112.109 -175.336 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -59.76 133.59 52.08 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.214 1.943 . . . . 0.0 111.393 177.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.822 HG21 HG12 ' A' ' 246' ' ' VAL . 2.4 mp -111.4 151.59 13.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.309 177.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' ASP . . . . . 0.406 ' OD2' HD21 ' A' ' 249' ' ' LEU . 14.9 m-20 -115.51 -20.08 10.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.76 0.314 . . . . 0.0 111.227 177.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . 0.519 ' HB3' ' HB2' ' A' ' 247' ' ' HIS . 22.9 tt0 -142.77 120.48 11.86 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.279 -176.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . 0.802 HD12 ' HG3' ' A' ' 223' ' ' ARG . 17.2 mt -136.3 116.28 17.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.889 -179.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -122.2 116.11 23.58 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.849 0.357 . . . . 0.0 110.457 178.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' ILE . . . . . 0.778 HG21 HG23 ' A' ' 217' ' ' ILE . 33.4 mt -104.57 115.47 46.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.248 179.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.558 ' HB ' HG13 ' A' ' 243' ' ' ILE . 45.5 t -94.26 87.0 2.04 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.152 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 173.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 8.8 t -65.32 -22.29 66.81 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.482 -177.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -60.32 -29.12 68.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.565 176.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . 0.747 ' HB2' HG12 ' A' ' 243' ' ' ILE . 73.9 mtt180 -120.0 0.43 10.77 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.797 -179.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' ASN . . . . . 0.462 ' O ' HD13 ' A' ' 213' ' ' LEU . 92.1 m-20 66.16 29.72 9.66 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.194 179.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.747 HG12 ' HB2' ' A' ' 241' ' ' ARG . 1.3 pt -121.92 151.34 25.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.792 -176.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . 0.522 ' HB1' ' HB2' ' A' ' 210' ' ' LEU . . . -141.55 138.77 32.92 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.103 0.477 . . . . 0.0 111.55 -178.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -110.78 111.43 22.6 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.677 176.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . 0.822 HG12 HG21 ' A' ' 232' ' ' ILE . 0.8 OUTLIER -108.16 134.89 48.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -179.234 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 247' ' ' HIS . . . . . 0.806 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 46.1 m80 -116.06 101.72 9.0 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 119.995 -0.682 . . . . 0.0 111.457 178.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . 0.845 ' HZ ' HD22 ' A' ' 226' ' ' LEU . 29.9 m-85 -84.67 104.67 14.85 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.716 -1.129 . . . . 0.0 111.113 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.54 ' HA ' ' HE ' ' A' ' 206' ' ' ARG . 0.1 OUTLIER -42.82 -42.56 3.66 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 124.194 0.934 . . . . 0.0 113.058 -174.11 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 47.4 m-20 -95.51 143.8 26.53 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 251' ' ' ILE . . . . . 0.522 ' O ' HG13 ' A' ' 255' ' ' ILE . 0.2 OUTLIER -63.56 -45.0 98.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -177.594 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -70.79 -29.14 65.25 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-O 120.625 0.25 . . . . 0.0 110.791 -176.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . 0.402 ' HB3' ' CA ' ' A' ' 230' ' ' GLY . . . -58.6 -42.7 88.71 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.36 178.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 254' ' ' ALA . . . . . 0.552 ' HB2' ' HB2' ' A' ' 248' ' ' PHE . . . -67.29 -42.0 84.49 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.626 178.025 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.522 HG13 ' O ' ' A' ' 251' ' ' ILE . 8.5 mt -56.95 -61.31 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.539 -177.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 12.3 ptmt -60.41 -38.52 84.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.271 -177.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -62.75 -47.91 81.47 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.741 0.305 . . . . 0.0 111.211 178.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 44.4 t -66.18 -23.54 32.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.011 0.434 . . . . 0.0 111.023 179.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . 0.487 ' HG3' ' O ' ' A' ' 255' ' ' ILE . 50.8 mt-30 -83.53 -27.8 29.09 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.825 177.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -96.02 -28.89 14.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.69 0.281 . . . . 0.0 111.59 -173.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.72 ' HA ' ' HE3' ' A' ' 267' ' ' TRP . 0.7 OUTLIER -54.1 -50.04 86.62 Favored Pre-proline 0 CA--C 1.536 0.437 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.516 179.252 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 262' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 261' ' ' LEU . 41.2 Cg_endo -66.41 -13.76 41.27 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.271 1.981 . . . . 0.0 112.419 -179.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 60.8 mt -91.15 -8.0 49.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.929 0.395 . . . . 0.0 112.0 -178.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -106.11 149.8 38.57 Favored Pre-proline 0 C--O 1.211 -0.964 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.974 -177.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 265' ' ' PRO . . . . . 0.415 ' O ' ' HG3' ' A' ' 269' ' ' LYS . 47.3 Cg_endo -67.28 -33.28 30.98 Favored 'Trans proline' 0 C--O 1.224 -0.21 0 C-N-CA 123.325 2.684 . . . . 0.0 112.804 -171.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . 0.471 ' HB2' ' HE3' ' A' ' 266' ' ' LYS . 0.0 OUTLIER -83.35 -45.91 13.19 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 121.732 0.777 . . . . 0.0 109.224 -179.376 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 267' ' ' TRP . . . . . 0.72 ' HE3' ' HA ' ' A' ' 261' ' ' LEU . 14.3 m0 -76.49 -29.75 56.96 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.909 -172.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 24.1 t -63.84 -23.12 67.23 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.896 0.379 . . . . 0.0 110.72 178.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . 0.415 ' HG3' ' O ' ' A' ' 265' ' ' PRO . 93.4 mttt -70.82 -19.08 62.7 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.283 0.563 . . . . 0.0 109.695 178.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 270' ' ' ARG . . . . . 0.433 ' HA ' ' HB3' ' A' ' 212' ' ' ASN . 4.7 mpt_? -93.25 146.49 23.66 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.476 176.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 6.6 mmp_? -99.33 106.07 18.13 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 173.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . 0.59 HG23 HD23 ' A' ' 261' ' ' LEU . 0.1 OUTLIER -117.73 142.34 32.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.336 0.589 . . . . 0.0 111.552 -176.673 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -150.61 168.87 23.0 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.254 170.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 . . . . . 0 C--N 1.324 -0.509 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 175.095 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' ARG . . . . . 0.732 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 15.0 mtm180 . . . . . 0 C--O 1.224 -0.256 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 19.3 m-80 -100.65 105.64 17.03 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 118.876 0.762 . . . . 0.0 111.332 -172.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.487 ' HB ' ' HB ' ' A' ' 246' ' ' VAL . 60.3 t -137.36 127.76 38.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.24 176.375 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' PHE . . . . . 0.59 ' HB3' ' CE1' ' A' ' 273' ' ' TYR . 1.8 t80 -127.44 128.18 45.33 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 -177.514 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.522 ' HG ' HG23 ' A' ' 272' ' ' ILE . 5.9 mp -111.02 134.0 52.96 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.505 179.032 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . 0.53 ' HA2' HG21 ' A' ' 243' ' ' ILE . . . -138.94 65.68 0.53 Allowed Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.098 -1.048 . . . . 0.0 113.328 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . 0.566 ' HB2' ' HG3' ' A' ' 271' ' ' ARG . 3.3 t30 174.83 40.92 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.24 0.543 . . . . 0.0 110.105 175.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.585 ' HA ' ' HG3' ' A' ' 270' ' ' ARG . 1.0 OUTLIER -85.81 155.85 58.53 Favored Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.811 -177.693 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -79.79 169.14 18.5 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.81 2.34 . . . . 0.0 112.059 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -78.69 124.05 27.79 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 108.52 -2.83 32.53 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.592 -0.814 . . . . 0.0 112.613 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 6.0 tp -65.14 125.18 21.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-O 121.255 0.55 . . . . 0.0 111.194 179.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' THR . . . . . 0.45 HG22 ' HG3' ' A' ' 221' ' ' GLU . 15.0 t -114.4 161.05 18.45 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.561 177.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 9.3 mp0 -62.81 -38.04 89.11 Favored 'General case' 0 C--O 1.208 -1.105 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.059 -178.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' ASP . . . . . 0.489 ' O ' ' HG2' ' A' ' 224' ' ' GLU . 26.2 t70 -51.63 -37.87 52.21 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 123.618 0.574 . . . . 0.0 110.813 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . 0.45 ' HG3' HG22 ' A' ' 218' ' ' THR . 41.9 mt-10 -67.49 -57.5 6.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.4 178.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . 0.462 HG22 HD22 ' A' ' 226' ' ' LEU . 6.9 mt -58.29 -41.67 81.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.351 -179.604 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' ARG . . . . . 0.703 ' HG3' HD11 ' A' ' 235' ' ' ILE . 37.3 mtp180 -57.12 -62.84 1.47 Allowed 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 175.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.489 ' HG2' ' O ' ' A' ' 220' ' ' ASP . 11.1 pt-20 -59.32 -20.8 57.49 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.083 -177.023 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' ASP . . . . . 0.465 ' HB3' ' CZ2' ' A' ' 267' ' ' TRP . 3.3 m-20 -90.58 -31.43 16.69 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.637 -177.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.671 HD23 ' HZ ' ' A' ' 248' ' ' PHE . 8.2 mp -107.45 -19.1 13.68 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -171.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 227' ' ' GLU . . . . . 0.68 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 48.1 mt-10 -73.34 -22.24 0.49 Allowed Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 113.264 0.839 . . . . 0.0 113.264 -175.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 228' ' ' PRO . . . . . 0.68 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 74.3 Cg_endo -66.59 -28.17 45.21 Favored 'Trans proline' 0 C--N 1.361 1.223 0 CA-C-N 120.747 1.302 . . . . 0.0 111.895 178.357 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . 0.484 ' CE1' ' HA ' ' A' ' 226' ' ' LEU . 2.9 p90 -110.71 -5.66 14.96 Favored 'General case' 0 C--O 1.225 -0.237 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.609 174.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . 0.49 ' CA ' ' HB3' ' A' ' 253' ' ' ALA . . . -174.6 95.59 0.1 Allowed Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 119.945 -1.121 . . . . 0.0 112.554 -175.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . 0.457 ' HA ' ' HG2' ' A' ' 227' ' ' GLU . 19.2 Cg_endo -60.75 135.69 61.7 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.264 1.976 . . . . 0.0 111.584 177.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.712 HG22 HG12 ' A' ' 246' ' ' VAL . 3.3 mp -108.6 151.31 10.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.488 178.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 233' ' ' ASP . . . . . 0.432 ' CG ' HD23 ' A' ' 249' ' ' LEU . 12.7 m-20 -107.07 -25.58 11.52 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.001 0.429 . . . . 0.0 110.831 178.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . 0.441 ' HB3' ' HB2' ' A' ' 247' ' ' HIS . 12.9 tt0 -145.1 120.28 10.15 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.749 -173.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . 0.703 HD11 ' HG3' ' A' ' 223' ' ' ARG . 24.0 mt -133.04 107.59 11.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.8 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -113.75 110.58 20.38 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.605 -175.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 237' ' ' ILE . . . . . 0.443 HD13 HD13 ' A' ' 222' ' ' ILE . 89.3 mt -100.76 121.52 51.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.262 0.553 . . . . 0.0 111.188 -178.43 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.49 ' HB ' HG13 ' A' ' 243' ' ' ILE . 46.1 t -108.97 87.22 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 172.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 13.9 t -68.33 -20.36 64.73 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.193 -177.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -57.91 -30.84 66.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.154 175.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . 0.653 ' HB2' HG12 ' A' ' 243' ' ' ILE . 98.8 mtt180 -118.26 4.41 11.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.732 177.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 17.5 m120 64.71 29.14 12.95 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.224 178.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.653 HG12 ' HB2' ' A' ' 241' ' ' ARG . 1.3 pt -122.19 151.64 26.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.31 -174.448 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -142.02 135.9 29.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.005 0.431 . . . . 0.0 111.446 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -103.91 114.42 28.66 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.702 178.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . 0.712 HG12 HG22 ' A' ' 232' ' ' ILE . 0.4 OUTLIER -110.35 132.17 59.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -179.349 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 247' ' ' HIS . . . . . 0.732 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 28.1 m80 -114.81 102.76 10.3 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 119.96 -0.696 . . . . 0.0 111.348 177.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . 0.671 ' HZ ' HD23 ' A' ' 226' ' ' LEU . 37.4 m-85 -86.18 102.98 14.39 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 114.887 -1.051 . . . . 0.0 111.33 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.432 HD23 ' CG ' ' A' ' 233' ' ' ASP . 0.2 OUTLIER -46.28 -37.9 7.92 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 124.437 1.086 . . . . 0.0 112.797 -175.789 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 250' ' ' ASN . . . . . 0.446 ' HB2' ' HB1' ' A' ' 253' ' ' ALA . 55.0 m-20 -97.27 136.32 37.93 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 178.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 251' ' ' ILE . . . . . 0.603 ' O ' HG13 ' A' ' 255' ' ' ILE . 0.2 OUTLIER -60.62 -43.41 94.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -179.094 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -70.96 -27.82 64.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.903 -176.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . 0.49 ' HB3' ' CA ' ' A' ' 230' ' ' GLY . . . -62.5 -41.72 99.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.215 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 254' ' ' ALA . . . . . 0.524 ' HB1' ' HB2' ' A' ' 248' ' ' PHE . . . -67.41 -41.96 84.04 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.645 178.391 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.675 ' HA ' ' OH ' ' A' ' 274' ' ' TYR . 13.5 mt -55.9 -61.25 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.297 -177.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 13.3 ptmt -62.37 -38.23 88.77 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.425 -176.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -64.48 -49.98 69.26 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 111.512 0.189 . . . . 0.0 111.512 179.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . 0.451 HG12 HG12 ' A' ' 272' ' ' ILE . 53.3 t -66.47 -22.79 30.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.01 0.434 . . . . 0.0 111.081 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -84.44 -24.61 29.47 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 175.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -90.55 -35.63 14.94 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.884 0.373 . . . . 0.0 111.032 -178.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.764 HD13 ' CE3' ' A' ' 267' ' ' TRP . 0.9 OUTLIER -52.24 -47.17 93.25 Favored Pre-proline 0 CA--C 1.54 0.576 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.79 -178.252 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 262' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 261' ' ' LEU . 39.1 Cg_endo -69.38 -21.86 34.64 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.257 1.971 . . . . 0.0 112.74 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 57.0 mt -90.02 -0.35 57.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.4 0.619 . . . . 0.0 111.114 -176.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 264' ' ' ASN . . . . . 0.453 ' O ' ' HB2' ' A' ' 268' ' ' SER . 12.1 m-80 -107.0 148.92 37.89 Favored Pre-proline 0 C--N 1.316 -0.857 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.757 -178.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -67.54 -41.74 8.18 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 123.074 2.516 . . . . 0.0 112.474 -171.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . 0.423 ' HE2' ' HB2' ' A' ' 266' ' ' LYS . 2.6 mtpt -80.9 -45.1 17.29 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-O 121.615 0.722 . . . . 0.0 109.784 -175.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 267' ' ' TRP . . . . . 0.764 ' CE3' HD13 ' A' ' 261' ' ' LEU . 22.6 m0 -72.83 -28.79 62.76 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.549 -175.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 268' ' ' SER . . . . . 0.453 ' HB2' ' O ' ' A' ' 264' ' ' ASN . 23.1 t -66.57 -20.05 65.92 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 120.952 -0.299 . . . . 0.0 111.013 178.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -71.44 -15.73 62.35 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.336 0.589 . . . . 0.0 109.721 175.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 270' ' ' ARG . . . . . 0.585 ' HG3' ' HA ' ' A' ' 213' ' ' LEU . 0.0 OUTLIER -104.09 139.9 38.53 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.713 175.71 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . 0.566 ' HG3' ' HB2' ' A' ' 212' ' ' ASN . 15.3 mtm180 -93.22 105.36 17.45 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . 0.579 HG22 HD23 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -110.21 141.88 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-O 121.423 0.63 . . . . 0.0 110.857 -175.14 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 273' ' ' TYR . . . . . 0.59 ' CE1' ' HB3' ' A' ' 209' ' ' PHE . 4.6 p90 -152.78 167.75 27.98 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.83 174.136 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 274' ' ' TYR . . . . . 0.675 ' OH ' ' HA ' ' A' ' 255' ' ' ILE . 90.1 m-85 . . . . . 0 C--N 1.318 -0.795 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.266 172.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' ARG . . . . . 0.802 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 49.0 mtp180 . . . . . 0 CA--C 1.537 0.476 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 69.6 m-20 -100.86 106.13 17.47 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 119.125 0.875 . . . . 0.0 112.041 -173.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.48 ' HB ' ' HB ' ' A' ' 246' ' ' VAL . 59.5 t -136.02 117.6 19.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.607 178.094 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -115.47 123.38 48.42 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.752 0.31 . . . . 0.0 110.5 -177.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.469 ' HG ' HG22 ' A' ' 272' ' ' ILE . 5.9 mp -106.89 133.81 50.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.57 178.064 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . 0.519 ' HA2' HG22 ' A' ' 243' ' ' ILE . . . -143.39 65.78 0.47 Allowed Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.618 -0.801 . . . . 0.0 113.088 179.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . 0.511 ' HB3' ' HA ' ' A' ' 270' ' ' ARG . 50.5 t30 177.05 39.85 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.325 0.583 . . . . 0.0 109.733 177.315 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.738 HD22 ' HG2' ' A' ' 270' ' ' ARG . 1.2 mt -89.53 165.2 26.55 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.156 -179.269 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.493 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 78.5 Cg_endo -83.66 167.77 13.0 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 122.423 2.082 . . . . 0.0 111.14 174.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . 0.474 ' HA ' ' OG1' ' A' ' 239' ' ' THR . 40.9 t-20 -79.21 125.71 29.82 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 177.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 105.96 -3.92 38.7 Favored Glycine 0 C--N 1.314 -0.661 0 C-N-CA 120.458 -0.877 . . . . 0.0 113.082 -179.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' ILE . . . . . 0.672 HG23 HG23 ' A' ' 237' ' ' ILE . 5.0 tp -59.29 126.32 16.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.041 0.448 . . . . 0.0 110.436 178.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' THR . . . . . 0.478 ' CG2' ' HG3' ' A' ' 221' ' ' GLU . 10.6 t -111.11 156.81 20.8 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.321 0.582 . . . . 0.0 110.839 -178.041 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.43 ' CD ' ' H ' ' A' ' 219' ' ' GLU . 18.4 mp0 -62.28 -36.59 82.55 Favored 'General case' 0 C--O 1.21 -1.011 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.449 -177.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -50.98 -36.37 38.75 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.018 178.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . 0.478 ' HG3' ' CG2' ' A' ' 218' ' ' THR . 42.3 mt-10 -70.94 -59.46 2.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.798 178.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . 0.466 HD13 HD11 ' A' ' 237' ' ' ILE . 7.6 mt -60.21 -39.85 81.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.469 -178.189 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' ARG . . . . . 0.635 ' HG3' HD13 ' A' ' 235' ' ' ILE . 52.1 mtp180 -55.2 -62.27 1.78 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 174.088 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -55.71 -25.17 38.71 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.82 -178.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -86.3 -31.62 21.5 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.435 -176.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.782 HD22 ' HZ ' ' A' ' 248' ' ' PHE . 7.3 mp -108.43 -16.03 14.32 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -171.379 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 227' ' ' GLU . . . . . 0.623 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 34.8 mm-40 -61.55 -37.25 39.27 Favored Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -177.108 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 228' ' ' PRO . . . . . 0.623 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 96.7 Cg_endo -66.3 -30.57 45.13 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 121.5 1.467 . . . . 0.0 112.247 -172.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . 0.5 ' CE1' ' HA ' ' A' ' 226' ' ' LEU . 4.3 p90 -110.88 3.22 18.73 Favored 'General case' 0 C--O 1.221 -0.43 0 C-N-CA 120.591 -0.443 . . . . 0.0 111.346 176.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . 0.457 ' CA ' ' HB3' ' A' ' 253' ' ' ALA . . . -179.82 97.13 0.11 Allowed Glycine 0 N--CA 1.44 -1.041 0 C-N-CA 119.666 -1.254 . . . . 0.0 112.609 -178.061 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . 0.403 ' HD2' ' HA2' ' A' ' 230' ' ' GLY . 29.0 Cg_endo -64.17 134.31 41.91 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 121.772 1.648 . . . . 0.0 111.031 177.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.746 HG21 HG12 ' A' ' 246' ' ' VAL . 2.9 mp -108.59 150.65 11.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.97 178.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 233' ' ' ASP . . . . . 0.465 ' CG ' HD21 ' A' ' 249' ' ' LEU . 20.7 m-20 -107.44 -26.96 10.72 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.153 0.502 . . . . 0.0 110.446 178.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . 0.497 ' HB3' ' HB2' ' A' ' 247' ' ' HIS . 29.5 tt0 -142.24 120.31 12.13 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.612 -173.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . 0.635 HD13 ' HG3' ' A' ' 223' ' ' ARG . 13.5 mt -134.17 111.89 15.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.001 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 35.2 ttmt -115.66 112.61 22.36 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.349 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 237' ' ' ILE . . . . . 0.672 HG23 HG23 ' A' ' 217' ' ' ILE . 85.3 mt -102.13 121.62 53.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-O 121.1 0.476 . . . . 0.0 110.841 178.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.541 ' HB ' HG13 ' A' ' 243' ' ' ILE . 39.2 t -104.46 87.07 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 172.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 239' ' ' THR . . . . . 0.474 ' OG1' ' HA ' ' A' ' 215' ' ' ASN . 9.6 t -70.04 -15.33 62.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.222 -175.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -66.7 -32.73 74.23 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.133 175.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . 0.531 ' HB2' HG12 ' A' ' 243' ' ' ILE . 81.1 mtt180 -114.98 3.25 14.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.859 -178.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 67.66 24.87 8.32 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.288 176.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.541 HG13 ' HB ' ' A' ' 238' ' ' VAL . 1.8 pt -122.33 153.27 26.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.293 -175.009 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . 0.446 ' HB1' ' HB2' ' A' ' 210' ' ' LEU . . . -143.7 140.05 29.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.119 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -111.03 115.13 28.93 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.757 177.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . 0.746 HG12 HG21 ' A' ' 232' ' ' ILE . 1.1 t -111.81 136.05 49.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 -178.007 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 247' ' ' HIS . . . . . 0.802 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 44.0 m80 -117.41 102.62 9.37 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.594 0.711 . . . . 0.0 111.287 176.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . 0.782 ' HZ ' HD22 ' A' ' 226' ' ' LEU . 34.7 m-85 -85.38 104.61 15.35 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.634 -1.166 . . . . 0.0 111.516 -179.435 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.465 HD21 ' CG ' ' A' ' 233' ' ' ASP . 0.2 OUTLIER -46.57 -39.5 11.17 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 124.41 1.069 . . . . 0.0 112.929 -174.526 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 250' ' ' ASN . . . . . 0.424 ' HB2' ' HB2' ' A' ' 253' ' ' ALA . 47.5 m-80 -92.93 141.51 28.33 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 177.045 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 251' ' ' ILE . . . . . 0.587 ' O ' HG13 ' A' ' 255' ' ' ILE . 0.1 OUTLIER -62.84 -44.05 99.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.316 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -70.1 -29.8 66.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.91 -176.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . 0.457 ' HB3' ' CA ' ' A' ' 230' ' ' GLY . . . -60.36 -42.84 96.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.135 179.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 254' ' ' ALA . . . . . 0.512 ' HB1' ' HB2' ' A' ' 248' ' ' PHE . . . -67.96 -41.68 82.05 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.479 179.23 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.587 HG13 ' O ' ' A' ' 251' ' ' ILE . 11.2 mt -56.69 -60.78 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.108 -177.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . 0.459 ' HE2' ' HB2' ' A' ' 229' ' ' PHE . 15.0 ptmt -62.25 -38.74 90.43 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.406 -177.275 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -62.9 -49.99 72.63 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.661 0.267 . . . . 0.0 111.45 178.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . 0.475 HG13 HG12 ' A' ' 272' ' ' ILE . 55.6 t -65.07 -26.48 40.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.805 0.336 . . . . 0.0 110.994 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 16.9 mm-40 -84.64 -23.04 29.68 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 178.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -94.7 -32.03 13.54 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.813 0.34 . . . . 0.0 111.158 -176.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.743 ' HA ' ' HE3' ' A' ' 267' ' ' TRP . 0.8 OUTLIER -52.49 -49.54 85.15 Favored Pre-proline 0 CA--C 1.541 0.614 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.511 179.769 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 262' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 261' ' ' LEU . 53.3 Cg_endo -69.16 -11.0 30.56 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.512 2.142 . . . . 0.0 112.565 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 43.5 mt -92.07 -9.09 43.94 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.037 0.446 . . . . 0.0 111.555 -179.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 264' ' ' ASN . . . . . 0.416 ' HB2' ' CE3' ' A' ' 267' ' ' TRP . 3.5 m-20 -106.9 149.7 38.85 Favored Pre-proline 0 C--N 1.314 -0.942 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.258 -176.315 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -67.73 -32.04 31.0 Favored 'Trans proline' 0 CA--C 1.521 -0.129 0 C-N-CA 123.383 2.722 . . . . 0.0 112.738 -171.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . 0.447 ' HE3' ' HB2' ' A' ' 266' ' ' LYS . 0.0 OUTLIER -84.77 -45.64 12.18 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 121.574 0.702 . . . . 0.0 109.24 -179.113 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 267' ' ' TRP . . . . . 0.743 ' HE3' ' HA ' ' A' ' 261' ' ' LEU . 12.6 m0 -76.88 -31.07 56.51 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.934 -172.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 17.7 t -68.3 -15.96 63.77 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.617 179.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -77.05 -7.71 56.16 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.218 0.533 . . . . 0.0 109.953 174.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 270' ' ' ARG . . . . . 0.738 ' HG2' HD22 ' A' ' 213' ' ' LEU . 3.7 mpt_? -110.82 143.89 40.69 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.92 178.303 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 36.0 mmt180 -91.99 106.42 18.44 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 110.021 -0.362 . . . . 0.0 110.021 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . 0.608 HG23 HD23 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -118.27 140.35 42.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.377 0.608 . . . . 0.0 110.718 179.701 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -152.39 168.96 23.77 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.38 173.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 . . . . . 0 C--N 1.324 -0.532 0 CA-C-O 120.713 0.292 . . . . 0.0 110.257 174.127 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' ARG . . . . . 0.872 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 0.6 OUTLIER . . . . . 0 C--O 1.219 -0.539 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -106.38 105.95 16.24 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 118.555 0.616 . . . . 0.0 111.442 -173.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.505 ' HB ' ' HB ' ' A' ' 246' ' ' VAL . 66.5 t -137.62 119.75 18.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.309 177.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -115.22 124.32 51.11 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.816 0.341 . . . . 0.0 110.469 -177.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.504 ' HG ' HG23 ' A' ' 272' ' ' ILE . 5.4 mp -107.31 129.44 54.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.275 177.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . 0.536 ' HA2' HG22 ' A' ' 243' ' ' ILE . . . -136.65 59.43 0.64 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.394 -0.908 . . . . 0.0 113.266 -178.268 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . 0.535 ' HB3' ' HA ' ' A' ' 270' ' ' ARG . 1.7 t30 177.03 43.53 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.027 0.442 . . . . 0.0 110.063 177.017 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.552 HD21 ' HG2' ' A' ' 270' ' ' ARG . 1.2 mt -87.01 164.09 37.8 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.041 -177.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.544 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 73.0 Cg_endo -76.51 169.03 22.65 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.365 2.043 . . . . 0.0 111.763 175.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 -78.5 130.17 35.7 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.897 179.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 91.48 3.78 68.79 Favored Glycine 0 C--N 1.317 -0.499 0 C-N-CA 120.732 -0.747 . . . . 0.0 113.188 177.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' ILE . . . . . 0.636 HG21 HG22 ' A' ' 237' ' ' ILE . 4.5 tp -58.82 128.55 19.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.34 0.591 . . . . 0.0 111.153 -178.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 218' ' ' THR . . . . . 0.463 ' CG2' ' HG3' ' A' ' 221' ' ' GLU . 14.5 t -111.91 156.17 22.49 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 121.367 0.603 . . . . 0.0 110.839 -178.248 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -62.41 -35.45 79.26 Favored 'General case' 0 C--O 1.209 -1.052 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.654 -177.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -48.89 -40.63 30.57 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.033 177.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . 0.463 ' HG3' ' CG2' ' A' ' 218' ' ' THR . 43.2 mt-10 -70.69 -56.01 7.38 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.751 -178.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . 0.455 ' O ' HD11 ' A' ' 226' ' ' LEU . 10.6 mt -61.41 -45.21 99.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.632 -178.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' ARG . . . . . 0.756 ' HG3' HD11 ' A' ' 235' ' ' ILE . 64.2 mtp180 -54.01 -62.46 1.64 Allowed 'General case' 0 CA--C 1.505 -0.786 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 176.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -55.68 -24.25 33.13 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.731 -177.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 225' ' ' ASP . . . . . 0.46 ' HB3' ' CZ2' ' A' ' 267' ' ' TRP . 8.9 m-20 -86.0 -32.14 21.65 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.955 -178.432 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.832 HD21 ' HZ ' ' A' ' 248' ' ' PHE . 7.3 mp -104.99 -15.1 15.21 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.959 -0.297 . . . . 0.0 111.669 -172.095 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 227' ' ' GLU . . . . . 0.621 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 42.7 mm-40 -61.46 -36.58 33.38 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -177.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 228' ' ' PRO . . . . . 0.621 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 97.5 Cg_endo -67.13 -27.03 42.18 Favored 'Trans proline' 0 C--N 1.358 1.03 0 C-N-CA 121.66 1.573 . . . . 0.0 112.377 -173.002 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . 0.513 ' CE1' ' HA ' ' A' ' 226' ' ' LEU . 2.9 p90 -110.78 -14.14 14.05 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.411 -0.516 . . . . 0.0 111.825 176.025 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . 0.475 ' CA ' ' HB3' ' A' ' 253' ' ' ALA . . . -164.08 97.73 0.15 Allowed Glycine 0 N--CA 1.44 -1.099 0 C-N-CA 120.479 -0.867 . . . . 0.0 112.05 -174.176 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -65.05 135.68 44.89 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 121.747 1.631 . . . . 0.0 111.136 178.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.666 HG21 HG12 ' A' ' 246' ' ' VAL . 2.4 mp -112.11 148.95 14.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.919 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 233' ' ' ASP . . . . . 0.442 ' OD2' HD23 ' A' ' 249' ' ' LEU . 8.8 m-20 -109.3 -24.66 10.97 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.111 0.481 . . . . 0.0 110.369 178.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . 0.568 ' HB3' ' HB2' ' A' ' 247' ' ' HIS . 22.9 tt0 -142.09 122.01 13.62 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.543 -174.318 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . 0.756 HD11 ' HG3' ' A' ' 223' ' ' ARG . 8.1 mt -135.52 105.52 5.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 121.512 0.672 . . . . 0.0 109.927 178.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -108.35 107.51 18.12 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.993 -177.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 237' ' ' ILE . . . . . 0.636 HG22 HG21 ' A' ' 217' ' ' ILE . 81.3 mt -101.19 125.43 55.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.947 -178.287 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.533 ' HB ' HG13 ' A' ' 243' ' ' ILE . 41.2 t -109.67 88.05 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 170.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 15.3 t -69.94 -12.34 61.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.356 -176.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -69.02 -35.26 76.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.311 176.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . 0.597 ' HB2' HG12 ' A' ' 243' ' ' ILE . 90.7 mtt180 -113.75 5.12 16.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.6 -178.238 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 68.06 24.84 7.66 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.381 176.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.597 HG12 ' HB2' ' A' ' 241' ' ' ARG . 1.5 pt -122.31 150.79 25.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.823 -173.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -144.13 137.78 27.73 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.243 179.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -107.19 110.98 23.18 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.539 177.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . 0.666 HG12 HG21 ' A' ' 232' ' ' ILE . 1.5 t -107.86 134.91 48.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.872 -177.01 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 247' ' ' HIS . . . . . 0.872 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 36.2 m170 -113.87 101.93 9.73 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.358 0.599 . . . . 0.0 111.382 177.528 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . 0.832 ' HZ ' HD21 ' A' ' 226' ' ' LEU . 35.1 m-85 -85.39 101.27 12.45 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.952 178.031 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.442 HD23 ' OD2' ' A' ' 233' ' ' ASP . 0.1 OUTLIER -43.96 -38.94 3.73 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 124.293 0.996 . . . . 0.0 112.881 -174.41 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 250' ' ' ASN . . . . . 0.452 ' HB2' ' HB1' ' A' ' 253' ' ' ALA . 2.6 m-20 -94.34 139.19 31.4 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 176.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 251' ' ' ILE . . . . . 0.584 ' O ' HG13 ' A' ' 255' ' ' ILE . 0.2 OUTLIER -62.71 -41.24 91.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.962 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -72.08 -28.66 63.45 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.741 -177.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . 0.475 ' HB3' ' CA ' ' A' ' 230' ' ' GLY . . . -61.34 -41.37 96.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.25 178.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 254' ' ' ALA . . . . . 0.506 ' HB1' ' HB2' ' A' ' 248' ' ' PHE . . . -68.7 -40.74 79.87 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.724 178.509 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.86 ' HA ' ' HH ' ' A' ' 274' ' ' TYR . 7.5 mt -56.14 -60.59 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.348 -178.247 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . 0.423 ' O ' ' HG2' ' A' ' 260' ' ' GLU . 9.9 ptmt -61.36 -41.49 97.16 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.513 -177.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -62.14 -49.81 74.39 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.693 0.283 . . . . 0.0 111.464 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . 0.423 HG13 HG12 ' A' ' 272' ' ' ILE . 41.2 t -64.84 -26.52 40.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.897 0.38 . . . . 0.0 111.121 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . 0.405 ' HG3' ' O ' ' A' ' 255' ' ' ILE . 53.3 mt-30 -84.64 -23.08 29.66 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 178.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . 0.423 ' HG2' ' O ' ' A' ' 256' ' ' LYS . 49.5 mm-40 -95.31 -32.48 12.95 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.611 0.243 . . . . 0.0 111.158 -176.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.777 HD13 ' CE3' ' A' ' 267' ' ' TRP . 0.6 OUTLIER -50.44 -49.92 74.63 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.549 179.506 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 262' ' ' PRO . . . . . 0.564 ' HD2' ' N ' ' A' ' 261' ' ' LEU . 40.4 Cg_endo -67.25 -17.14 49.84 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.416 2.078 . . . . 0.0 112.972 -178.422 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 55.2 mt -91.63 -3.56 56.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.248 0.547 . . . . 0.0 111.493 -178.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -106.64 148.82 37.53 Favored Pre-proline 0 C--N 1.314 -0.962 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.839 -175.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -65.41 -35.98 37.0 Favored 'Trans proline' 0 C--O 1.23 0.108 0 C-N-CA 123.557 2.838 . . . . 0.0 112.902 -169.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 9.7 mtpt -86.53 -45.08 11.42 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.671 0.748 . . . . 0.0 109.685 -177.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 267' ' ' TRP . . . . . 0.777 ' CE3' HD13 ' A' ' 261' ' ' LEU . 11.6 m0 -76.34 -29.35 57.21 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.87 -173.34 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 38.0 t -62.32 -21.98 65.69 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.822 0.344 . . . . 0.0 110.853 178.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -71.46 -16.59 62.38 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.106 0.479 . . . . 0.0 110.276 177.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 270' ' ' ARG . . . . . 0.552 ' HG2' HD21 ' A' ' 213' ' ' LEU . 0.0 OUTLIER -100.26 146.31 27.06 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.495 178.554 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 9.9 mmp_? -95.4 105.92 17.93 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 176.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . 0.606 HG22 HD23 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -115.86 141.87 31.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.546 0.688 . . . . 0.0 111.285 -177.952 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -151.69 169.24 22.65 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.354 -0.839 . . . . 0.0 108.966 172.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 274' ' ' TYR . . . . . 0.86 ' HH ' ' HA ' ' A' ' 255' ' ' ILE . 75.6 m-85 . . . . . 0 C--N 1.323 -0.586 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 173.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' ARG . . . . . 0.773 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 48.7 mtp180 . . . . . 0 C--O 1.221 -0.4 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -116.25 107.41 14.82 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.805 0.336 . . . . 0.0 111.19 -173.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.537 ' HB ' ' HB ' ' A' ' 246' ' ' VAL . 99.7 t -135.68 124.89 40.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.726 179.352 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' PHE . . . . . 0.405 ' O ' ' HA ' ' A' ' 272' ' ' ILE . 3.9 t80 -117.27 122.93 45.31 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.744 0.307 . . . . 0.0 110.446 -177.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.529 ' O ' ' HA ' ' A' ' 243' ' ' ILE . 5.5 mp -106.01 132.76 51.71 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.039 176.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . 0.542 ' HA2' HG21 ' A' ' 243' ' ' ILE . . . -140.75 59.32 0.57 Allowed Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.441 -0.885 . . . . 0.0 113.475 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . 0.53 ' HB3' ' HA ' ' A' ' 270' ' ' ARG . 57.5 t30 -179.17 33.4 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.328 0.585 . . . . 0.0 110.156 175.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.625 HD21 ' HG2' ' A' ' 270' ' ' ARG . 2.0 mt -76.27 161.13 76.13 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.113 -177.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.426 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 66.3 Cg_endo -73.98 162.18 39.62 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.253 1.969 . . . . 0.0 111.023 174.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -77.6 120.99 23.33 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 178.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 106.94 -1.58 35.7 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.193 -1.003 . . . . 0.0 113.046 -179.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' ILE . . . . . 0.659 HG22 HG21 ' A' ' 237' ' ' ILE . 4.5 tp -59.31 128.48 20.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.961 0.41 . . . . 0.0 110.803 179.036 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 218' ' ' THR . . . . . 0.449 HG23 ' HG3' ' A' ' 221' ' ' GLU . 9.8 t -113.56 158.84 20.27 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-O 121.296 0.569 . . . . 0.0 110.91 -178.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.46 ' CD ' ' H ' ' A' ' 219' ' ' GLU . 7.0 mp0 -62.39 -39.33 92.87 Favored 'General case' 0 C--O 1.21 -0.978 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.138 -174.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 220' ' ' ASP . . . . . 0.458 ' O ' ' HG2' ' A' ' 224' ' ' GLU . 16.3 t70 -54.22 -35.04 62.0 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 123.429 0.455 . . . . 0.0 110.987 -178.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . 0.449 ' HG3' HG23 ' A' ' 218' ' ' THR . 45.9 mt-10 -67.27 -57.2 7.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.325 178.22 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . 0.448 HD13 HD13 ' A' ' 237' ' ' ILE . 6.9 mt -60.28 -41.79 88.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.563 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' ARG . . . . . 0.716 ' HG3' HD13 ' A' ' 235' ' ' ILE . 64.0 mtp180 -53.19 -62.8 1.42 Allowed 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 174.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.458 ' HG2' ' O ' ' A' ' 220' ' ' ASP . 8.8 pt-20 -58.53 -23.51 58.4 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.849 -176.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -88.55 -31.75 18.51 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.697 -176.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.755 HD22 ' HZ ' ' A' ' 248' ' ' PHE . 8.0 mp -105.7 -19.31 13.8 Favored 'General case' 0 CA--C 1.517 -0.307 0 C-N-CA 120.684 -0.406 . . . . 0.0 112.085 -171.333 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 227' ' ' GLU . . . . . 0.648 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 33.9 mt-10 -64.82 -33.55 8.68 Favored Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -176.471 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 228' ' ' PRO . . . . . 0.648 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 75.8 Cg_endo -65.63 -29.16 52.2 Favored 'Trans proline' 0 C--N 1.358 1.05 0 C-N-CA 121.34 1.36 . . . . 0.0 112.014 -175.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . 0.526 ' CE1' ' HA ' ' A' ' 226' ' ' LEU . 4.4 p90 -111.16 3.97 18.91 Favored 'General case' 0 C--O 1.223 -0.338 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.366 174.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . 0.576 ' CA ' ' HB3' ' A' ' 253' ' ' ALA . . . 178.8 99.88 0.13 Allowed Glycine 0 N--CA 1.441 -1.007 0 C-N-CA 120.045 -1.074 . . . . 0.0 112.725 -177.168 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -66.34 134.98 38.03 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 121.833 1.689 . . . . 0.0 111.28 178.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.661 HG22 HG13 ' A' ' 246' ' ' VAL . 3.5 mp -106.48 151.96 8.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.28 178.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 233' ' ' ASP . . . . . 0.541 ' OD2' ' HB3' ' A' ' 249' ' ' LEU . 8.9 m-20 -104.54 -28.8 11.07 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.3 179.215 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -151.66 130.55 12.5 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.825 -173.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . 0.716 HD13 ' HG3' ' A' ' 223' ' ' ARG . 15.0 mt -136.7 110.26 8.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.923 -179.322 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.423 ' O ' ' HA ' ' A' ' 244' ' ' ALA . 84.9 tttt -111.29 112.42 24.17 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.131 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 237' ' ' ILE . . . . . 0.659 HG21 HG22 ' A' ' 217' ' ' ILE . 78.2 mt -104.79 118.06 51.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 121.084 0.468 . . . . 0.0 111.12 -179.529 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.575 ' HB ' HG13 ' A' ' 243' ' ' ILE . 46.8 t -99.2 87.81 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 171.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 9.5 t -64.94 -21.03 66.76 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.466 -175.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -58.13 -38.71 77.04 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.718 175.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . 0.681 ' HB2' HG12 ' A' ' 243' ' ' ILE . 72.4 mtp180 -112.41 3.0 16.66 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.39 -177.134 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 14.8 m120 66.07 28.87 10.24 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.877 0.37 . . . . 0.0 110.543 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.681 HG12 ' HB2' ' A' ' 241' ' ' ARG . 1.2 pt -121.35 150.34 24.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.312 -174.24 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . 0.476 ' HB2' ' HB2' ' A' ' 210' ' ' LEU . . . -144.75 140.7 28.7 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.674 -178.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -111.19 115.51 29.5 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.433 177.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . 0.661 HG13 HG22 ' A' ' 232' ' ' ILE . 1.6 t -113.48 139.63 37.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.312 -174.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 247' ' ' HIS . . . . . 0.773 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 59.4 m170 -111.38 101.93 10.35 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.459 176.478 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . 0.755 ' HZ ' HD22 ' A' ' 226' ' ' LEU . 39.6 m-85 -89.28 98.52 11.81 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.164 176.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.663 ' HA ' ' HE ' ' A' ' 206' ' ' ARG . 0.2 OUTLIER -47.58 -44.62 26.46 Favored 'General case' 0 N--CA 1.464 0.232 0 O-C-N 124.24 0.962 . . . . 0.0 112.618 -173.509 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 250' ' ' ASN . . . . . 0.426 ' HB2' ' HB2' ' A' ' 253' ' ' ALA . 12.5 m120 -85.81 135.78 33.58 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 176.373 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 251' ' ' ILE . . . . . 0.582 ' O ' HG13 ' A' ' 255' ' ' ILE . 0.2 OUTLIER -62.63 -40.69 89.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 -177.411 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -70.78 -27.38 63.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.524 -177.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . 0.576 ' HB3' ' CA ' ' A' ' 230' ' ' GLY . . . -62.87 -41.36 99.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.106 -179.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 254' ' ' ALA . . . . . 0.538 ' HB3' ' HB2' ' A' ' 248' ' ' PHE . . . -69.13 -41.04 77.87 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.561 178.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.699 ' HA ' ' HH ' ' A' ' 274' ' ' TYR . 11.0 mt -56.05 -60.74 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.045 -178.398 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . 0.426 ' O ' ' HG2' ' A' ' 260' ' ' GLU . 13.5 ptmt -63.3 -39.78 95.52 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.496 -176.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -61.29 -48.16 82.67 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.71 0.29 . . . . 0.0 111.351 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . 0.504 HG12 HG12 ' A' ' 272' ' ' ILE . 54.9 t -66.76 -24.38 32.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.995 179.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 16.5 mm100 -84.52 -25.94 28.42 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 177.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . 0.426 ' HG2' ' O ' ' A' ' 256' ' ' LYS . 59.3 mm-40 -93.89 -33.96 13.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.634 0.254 . . . . 0.0 110.987 -175.243 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.722 HD11 ' CE3' ' A' ' 267' ' ' TRP . 0.8 OUTLIER -51.6 -51.32 70.78 Favored Pre-proline 0 CA--C 1.537 0.478 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.515 -179.619 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 262' ' ' PRO . . . . . 0.557 ' HD2' ' N ' ' A' ' 261' ' ' LEU . 43.1 Cg_endo -66.75 -17.57 52.41 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.381 2.054 . . . . 0.0 112.762 -177.496 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 62.9 mt -95.22 -1.19 52.16 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.274 0.559 . . . . 0.0 111.525 -176.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 264' ' ' ASN . . . . . 0.467 ' O ' ' HB2' ' A' ' 268' ' ' SER . 14.4 m-80 -105.62 148.69 36.84 Favored Pre-proline 0 C--N 1.317 -0.846 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.244 -178.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -63.05 -40.84 31.6 Favored 'Trans proline' 0 C--N 1.335 -0.143 0 C-N-CA 123.298 2.666 . . . . 0.0 112.74 -169.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 12.6 mtpt -86.2 -42.71 13.59 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.461 0.648 . . . . 0.0 110.133 -176.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 267' ' ' TRP . . . . . 0.722 ' CE3' HD11 ' A' ' 261' ' ' LEU . 17.1 m0 -73.98 -28.04 61.28 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.835 -176.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 268' ' ' SER . . . . . 0.467 ' HB2' ' O ' ' A' ' 264' ' ' ASN . 12.8 t -65.71 -18.32 65.25 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.186 0.517 . . . . 0.0 110.577 177.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -71.71 -9.04 57.68 Favored 'General case' 0 C--O 1.225 -0.224 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.105 174.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 270' ' ' ARG . . . . . 0.625 ' HG2' HD21 ' A' ' 213' ' ' LEU . 0.0 OUTLIER -112.86 143.17 44.57 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.392 -179.745 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 35.5 mmt180 -94.2 109.0 20.83 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.283 177.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . 0.605 HG23 HD23 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -121.91 140.91 44.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.418 0.628 . . . . 0.0 111.38 -178.627 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -152.26 169.86 21.45 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.372 174.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 274' ' ' TYR . . . . . 0.699 ' HH ' ' HA ' ' A' ' 255' ' ' ILE . 74.2 m-85 . . . . . 0 C--N 1.321 -0.662 0 CA-C-O 121.224 0.535 . . . . 0.0 109.827 176.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' ARG . . . . . 0.775 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 29.8 mtm180 . . . . . 0 C--O 1.223 -0.339 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 18.9 m-80 -108.18 106.19 16.26 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-O 121.232 0.539 . . . . 0.0 111.385 -173.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.461 ' HB ' ' HB ' ' A' ' 246' ' ' VAL . 61.1 t -134.56 111.93 14.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.012 177.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' PHE . . . . . 0.413 ' HE1' ' HB ' ' A' ' 243' ' ' ILE . 1.7 t80 -109.96 122.08 46.74 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.973 0.416 . . . . 0.0 110.361 -174.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.559 ' HG ' HG22 ' A' ' 272' ' ' ILE . 6.2 mp -106.81 133.93 50.73 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.613 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . 0.546 ' HA2' HG21 ' A' ' 243' ' ' ILE . . . -136.92 61.3 0.61 Allowed Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.548 -0.834 . . . . 0.0 113.097 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . 0.438 ' HB2' ' O ' ' A' ' 211' ' ' GLY . 2.3 t30 175.61 53.92 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.066 0.46 . . . . 0.0 110.612 175.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.613 HD21 ' HG2' ' A' ' 270' ' ' ARG . 0.7 OUTLIER -102.53 155.6 36.31 Favored Pre-proline 0 C--N 1.316 -0.862 0 N-CA-C 110.043 -0.355 . . . . 0.0 110.043 178.012 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -77.18 165.82 27.36 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.502 2.135 . . . . 0.0 112.163 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -75.94 118.82 19.12 Favored 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 177.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 109.51 2.59 30.93 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.255 -0.974 . . . . 0.0 112.56 -178.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 217' ' ' ILE . . . . . 0.626 HG23 HG22 ' A' ' 237' ' ' ILE . 6.3 tp -68.23 129.03 32.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.941 0.401 . . . . 0.0 110.36 175.306 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 218' ' ' THR . . . . . 0.464 ' CG2' ' HG3' ' A' ' 221' ' ' GLU . 10.6 t -113.65 156.84 23.0 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-O 121.397 0.618 . . . . 0.0 111.041 179.147 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.476 ' CD ' ' H ' ' A' ' 219' ' ' GLU . 5.1 mp0 -60.92 -35.98 78.11 Favored 'General case' 0 C--O 1.21 -0.986 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.615 -179.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -54.39 -35.69 63.12 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.845 -179.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . 0.464 ' HG3' ' CG2' ' A' ' 218' ' ' THR . 42.9 mt-10 -69.91 -57.65 4.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.565 178.426 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . 0.46 HD13 HD13 ' A' ' 237' ' ' ILE . 8.1 mt -59.49 -42.81 89.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.488 -178.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 223' ' ' ARG . . . . . 0.816 ' HG3' HD11 ' A' ' 235' ' ' ILE . 45.0 mtp85 -55.86 -61.92 2.04 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 176.197 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -57.19 -21.73 35.49 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.925 -178.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -89.67 -30.73 17.89 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 116.021 -0.536 . . . . 0.0 112.055 -178.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.705 HD21 ' HZ ' ' A' ' 248' ' ' PHE . 8.4 mp -106.41 -19.26 13.74 Favored 'General case' 0 C--O 1.225 -0.215 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -171.207 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 227' ' ' GLU . . . . . 0.656 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 41.4 mt-10 -66.87 -31.43 3.99 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -175.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 228' ' ' PRO . . . . . 0.656 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 71.7 Cg_endo -65.73 -28.13 51.99 Favored 'Trans proline' 0 C--N 1.357 1.013 0 C-N-CA 121.442 1.428 . . . . 0.0 112.16 -176.225 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . 0.478 ' CE1' ' HA ' ' A' ' 226' ' ' LEU . 3.8 p90 -111.04 -0.72 16.55 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.752 0.31 . . . . 0.0 111.399 173.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . 0.564 ' CA ' ' HB3' ' A' ' 253' ' ' ALA . . . -175.43 95.51 0.1 Allowed Glycine 0 N--CA 1.442 -0.914 0 C-N-CA 120.128 -1.034 . . . . 0.0 112.466 -176.248 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -62.45 130.47 30.19 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.12 1.88 . . . . 0.0 111.634 178.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.718 HG22 HG12 ' A' ' 246' ' ' VAL . 2.4 mp -109.47 148.26 13.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.315 178.166 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 233' ' ' ASP . . . . . 0.46 ' CG ' HD22 ' A' ' 249' ' ' LEU . 44.4 m-20 -110.18 -24.26 10.8 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.003 0.43 . . . . 0.0 110.704 179.106 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -142.8 122.13 13.08 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.548 -174.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . 0.816 HD11 ' HG3' ' A' ' 223' ' ' ARG . 10.5 mt -135.95 110.96 11.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.912 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.426 ' O ' ' HA ' ' A' ' 244' ' ' ALA . 62.4 tttp -113.31 110.55 20.54 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.541 -176.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 237' ' ' ILE . . . . . 0.626 HG22 HG23 ' A' ' 217' ' ' ILE . 76.2 mt -101.84 119.51 50.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.115 0.484 . . . . 0.0 111.041 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.554 ' HB ' HG13 ' A' ' 243' ' ' ILE . 43.6 t -103.98 88.24 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 173.395 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 10.0 t -62.48 -25.13 67.84 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.16 -177.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -55.59 -39.98 71.44 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 121.069 0.462 . . . . 0.0 110.392 176.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . 0.696 ' HB2' HG12 ' A' ' 243' ' ' ILE . 99.2 mtt180 -111.31 5.86 20.09 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.847 -178.296 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 16.6 m120 62.93 28.76 16.44 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.083 177.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.696 HG12 ' HB2' ' A' ' 241' ' ' ARG . 1.3 pt -121.28 154.22 25.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.104 -173.025 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . 0.426 ' HA ' ' O ' ' A' ' 236' ' ' LYS . . . -144.92 138.37 26.85 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.441 -178.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -107.09 114.17 28.08 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.394 177.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . 0.718 HG12 HG22 ' A' ' 232' ' ' ILE . 0.7 OUTLIER -109.83 127.82 66.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -179.229 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 247' ' ' HIS . . . . . 0.775 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 48.9 m170 -107.95 101.83 11.06 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.038 -0.665 . . . . 0.0 111.319 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . 0.705 ' HZ ' HD21 ' A' ' 226' ' ' LEU . 34.1 m-85 -87.49 99.18 11.84 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.149 178.322 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.46 HD22 ' CG ' ' A' ' 233' ' ' ASP . 0.1 OUTLIER -42.27 -43.3 3.39 Favored 'General case' 0 N--CA 1.467 0.375 0 O-C-N 124.564 1.165 . . . . 0.0 112.651 -177.612 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 57.1 m-20 -90.87 135.36 33.78 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 177.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 251' ' ' ILE . . . . . 0.546 ' O ' HG13 ' A' ' 255' ' ' ILE . 0.2 OUTLIER -62.99 -40.96 91.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -178.69 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -69.06 -31.77 70.77 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 120.786 0.327 . . . . 0.0 110.662 -177.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . 0.564 ' HB3' ' CA ' ' A' ' 230' ' ' GLY . . . -59.53 -42.14 91.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.353 179.095 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 254' ' ' ALA . . . . . 0.531 ' HB3' ' HB2' ' A' ' 248' ' ' PHE . . . -68.24 -40.52 81.96 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.655 178.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.791 ' HA ' ' HH ' ' A' ' 274' ' ' TYR . 6.9 mt -56.49 -61.13 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.272 -178.305 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 12.8 ptmt -62.3 -39.23 92.32 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.439 -177.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -62.09 -48.88 78.2 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.639 0.257 . . . . 0.0 111.508 179.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . 0.517 HG12 HG12 ' A' ' 272' ' ' ILE . 70.1 t -66.3 -23.34 31.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.009 0.433 . . . . 0.0 111.05 179.062 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -85.06 -21.76 29.24 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 177.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -95.32 -36.75 11.27 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.895 0.379 . . . . 0.0 110.911 -177.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.716 HD12 ' CE3' ' A' ' 267' ' ' TRP . 1.1 mp -51.94 -47.74 90.22 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.956 -177.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 262' ' ' PRO . . . . . 0.558 ' HD2' ' N ' ' A' ' 261' ' ' LEU . 41.1 Cg_endo -67.49 -19.05 49.27 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.145 1.896 . . . . 0.0 112.711 -178.592 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 65.6 mt -95.53 -3.72 46.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.971 0.415 . . . . 0.0 111.811 -175.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 264' ' ' ASN . . . . . 0.474 ' O ' ' HB2' ' A' ' 268' ' ' SER . 14.1 m-80 -105.65 148.42 36.38 Favored Pre-proline 0 C--N 1.316 -0.878 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.761 -176.408 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -67.32 -32.97 31.65 Favored 'Trans proline' 0 N--CA 1.466 -0.098 0 C-N-CA 123.255 2.636 . . . . 0.0 112.652 -169.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.2 -45.13 12.3 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-O 121.825 0.821 . . . . 0.0 109.289 -178.31 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 267' ' ' TRP . . . . . 0.716 ' CE3' HD12 ' A' ' 261' ' ' LEU . 10.2 m0 -78.76 -25.23 44.43 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.947 -172.611 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 268' ' ' SER . . . . . 0.474 ' HB2' ' O ' ' A' ' 264' ' ' ASN . 12.5 t -66.8 -19.13 65.68 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.834 0.35 . . . . 0.0 110.782 178.199 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -71.7 -21.51 61.77 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 121.013 0.435 . . . . 0.0 110.239 175.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 270' ' ' ARG . . . . . 0.613 ' HG2' HD21 ' A' ' 213' ' ' LEU . 2.6 mpt_? -99.76 141.43 32.58 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.424 -178.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -94.13 106.2 18.18 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . 0.61 HG23 HD21 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -112.48 141.38 28.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.992 0.425 . . . . 0.0 111.207 -176.093 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -152.6 168.86 24.2 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.158 171.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 274' ' ' TYR . . . . . 0.791 ' HH ' ' HA ' ' A' ' 255' ' ' ILE . 64.7 m-85 . . . . . 0 C--N 1.325 -0.473 0 CA-C-O 120.81 0.338 . . . . 0.0 110.577 173.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' ARG . . . . . 0.844 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 30.7 mtm180 . . . . . 0 C--O 1.22 -0.477 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -104.42 105.16 15.18 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 119.974 -0.691 . . . . 0.0 111.496 -171.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 61.9 t -136.14 116.33 17.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.384 177.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' PHE . . . . . 0.428 ' O ' ' HA ' ' A' ' 272' ' ' ILE . 3.4 t80 -113.5 126.52 55.4 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.447 -176.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.456 HD22 HD23 ' A' ' 213' ' ' LEU . 5.6 mp -110.65 131.37 55.11 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.553 178.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . 0.52 ' HA2' HG23 ' A' ' 243' ' ' ILE . . . -139.07 66.46 0.52 Allowed Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.621 -0.799 . . . . 0.0 113.396 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . 0.53 ' HB3' ' HA ' ' A' ' 270' ' ' ARG . 40.2 t30 177.08 36.47 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.183 0.516 . . . . 0.0 110.014 176.437 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.825 HD22 ' HG2' ' A' ' 270' ' ' ARG . 1.3 mt -89.16 158.27 46.9 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.466 -178.131 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -81.98 163.96 17.88 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.541 2.16 . . . . 0.0 111.42 176.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . 0.516 ' HA ' ' OG1' ' A' ' 239' ' ' THR . 14.8 m120 -78.42 127.89 32.84 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.104 178.334 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 108.76 -8.87 34.41 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.473 -177.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 217' ' ' ILE . . . . . 0.645 HG23 HG23 ' A' ' 237' ' ' ILE . 4.3 tp -61.41 126.85 20.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-O 121.146 0.498 . . . . 0.0 110.376 178.063 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 218' ' ' THR . . . . . 0.504 HG21 ' HG3' ' A' ' 221' ' ' GLU . 5.1 t -113.77 161.2 17.83 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 121.35 0.595 . . . . 0.0 110.999 -178.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.482 ' CD ' ' H ' ' A' ' 219' ' ' GLU . 7.7 mp0 -62.84 -41.7 99.45 Favored 'General case' 0 C--O 1.209 -1.035 0 CA-C-N 115.113 -0.948 . . . . 0.0 109.887 -175.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -50.33 -37.16 35.34 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 123.584 0.553 . . . . 0.0 111.175 -179.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . 0.504 ' HG3' HG21 ' A' ' 218' ' ' THR . 44.6 mt-10 -68.44 -56.23 9.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.553 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . 0.457 HD13 HD13 ' A' ' 237' ' ' ILE . 6.9 mt -62.17 -40.64 88.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.382 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 223' ' ' ARG . . . . . 0.608 ' HG3' HD11 ' A' ' 235' ' ' ILE . 25.6 mtp85 -53.15 -64.12 0.92 Allowed 'General case' 0 CA--C 1.509 -0.631 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 174.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -58.04 -21.02 43.44 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.855 -176.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -86.22 -33.31 20.79 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.703 -178.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.792 HD22 ' HZ ' ' A' ' 248' ' ' PHE . 7.5 mp -107.2 -14.44 14.9 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -171.173 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 227' ' ' GLU . . . . . 0.609 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 24.5 mm-40 -61.01 -37.68 46.87 Favored Pre-proline 0 C--N 1.328 -0.353 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -178.322 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 228' ' ' PRO . . . . . 0.609 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 97.2 Cg_endo -66.52 -27.51 46.25 Favored 'Trans proline' 0 C--N 1.36 1.134 0 C-N-CA 121.687 1.591 . . . . 0.0 112.295 -171.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . 0.53 ' CZ ' ' HA ' ' A' ' 226' ' ' LEU . 3.8 p90 -110.91 -7.05 14.6 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.686 176.308 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . 0.416 ' CA ' ' HB1' ' A' ' 253' ' ' ALA . . . -171.8 98.72 0.13 Allowed Glycine 0 N--CA 1.442 -0.906 0 C-N-CA 120.045 -1.074 . . . . 0.0 112.347 -175.643 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -63.9 133.17 37.59 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 121.904 1.736 . . . . 0.0 111.256 177.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.84 HG21 HG11 ' A' ' 246' ' ' VAL . 2.4 mp -109.54 147.7 13.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.905 178.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 233' ' ' ASP . . . . . 0.444 ' CG ' HD22 ' A' ' 249' ' ' LEU . 14.4 m-20 -108.89 -24.46 11.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.731 178.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . 0.57 ' HB3' ' HB2' ' A' ' 247' ' ' HIS . 21.4 tt0 -140.06 121.81 15.4 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.305 -173.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . 0.608 HD11 ' HG3' ' A' ' 223' ' ' ARG . 18.6 mt -136.83 111.14 9.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.111 0.481 . . . . 0.0 110.158 -178.357 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 22.1 ttmm -115.77 109.34 17.54 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.41 -179.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 237' ' ' ILE . . . . . 0.645 HG23 HG23 ' A' ' 217' ' ' ILE . 73.2 mt -99.72 118.24 46.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-O 121.043 0.449 . . . . 0.0 110.323 177.156 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.538 ' HB ' HG13 ' A' ' 243' ' ' ILE . 40.8 t -102.14 86.1 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 172.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 239' ' ' THR . . . . . 0.516 ' OG1' ' HA ' ' A' ' 215' ' ' ASN . 8.9 t -70.19 -19.02 63.2 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.274 -176.045 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -60.83 -33.62 73.31 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.951 174.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . 0.419 ' HB2' HG12 ' A' ' 243' ' ' ILE . 98.9 mtt180 -114.94 4.24 14.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.791 -179.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 17.3 m120 65.93 27.76 10.77 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.23 0.612 . . . . 0.0 111.419 176.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.538 HG13 ' HB ' ' A' ' 238' ' ' VAL . 1.4 pt -123.07 155.08 28.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.294 -175.48 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . 0.434 ' HB3' ' HB2' ' A' ' 210' ' ' LEU . . . -144.38 141.47 29.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.989 0.423 . . . . 0.0 111.569 179.284 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -112.73 115.41 28.49 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.64 176.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . 0.84 HG11 HG21 ' A' ' 232' ' ' ILE . 0.3 OUTLIER -111.48 129.41 66.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 -179.124 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 247' ' ' HIS . . . . . 0.844 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 32.4 m170 -107.79 102.78 11.96 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.006 -0.677 . . . . 0.0 111.357 178.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . 0.792 ' HZ ' HD22 ' A' ' 226' ' ' LEU . 33.2 m-85 -84.82 103.17 13.66 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.811 177.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.444 HD22 ' CG ' ' A' ' 233' ' ' ASP . 0.1 OUTLIER -43.29 -39.46 3.06 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 124.505 1.128 . . . . 0.0 113.068 -174.306 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -99.71 137.94 37.49 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 176.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 251' ' ' ILE . . . . . 0.592 ' O ' HG13 ' A' ' 255' ' ' ILE . 0.2 OUTLIER -58.51 -41.65 82.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.918 -179.289 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -69.22 -30.67 68.88 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 116.756 -0.202 . . . . 0.0 111.09 -176.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . 0.416 ' HB1' ' CA ' ' A' ' 230' ' ' GLY . . . -62.35 -39.14 92.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.221 178.523 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 254' ' ' ALA . . . . . 0.549 ' HB3' ' HB2' ' A' ' 248' ' ' PHE . . . -69.53 -41.79 75.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.799 178.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.592 HG13 ' O ' ' A' ' 251' ' ' ILE . 11.4 mt -56.11 -60.61 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.105 -178.049 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . 0.512 ' O ' ' HG2' ' A' ' 260' ' ' GLU . 12.3 ptmt -61.22 -39.73 91.34 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.515 -178.347 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -62.61 -47.9 81.75 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.628 0.252 . . . . 0.0 111.4 179.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . 0.455 HG13 HG12 ' A' ' 272' ' ' ILE . 53.7 t -66.63 -26.27 36.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.9 0.381 . . . . 0.0 111.221 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . 0.532 ' HA ' ' OE1' ' A' ' 259' ' ' GLN . 10.4 mm-40 -84.3 -28.71 26.94 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 177.469 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . 0.512 ' HG2' ' O ' ' A' ' 256' ' ' LYS . 37.1 mm-40 -92.91 -26.02 17.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.445 0.164 . . . . 0.0 111.423 -175.279 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.786 ' HA ' ' HE3' ' A' ' 267' ' ' TRP . 0.6 OUTLIER -54.23 -52.55 67.84 Favored Pre-proline 0 CA--C 1.537 0.465 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.981 176.412 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 262' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 261' ' ' LEU . 37.7 Cg_endo -67.18 -15.92 47.45 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.503 2.135 . . . . 0.0 112.828 -178.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 259' ' ' GLN . 46.1 mt -85.06 -9.07 58.36 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.126 0.489 . . . . 0.0 111.151 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 -105.15 148.7 36.64 Favored Pre-proline 0 C--N 1.316 -0.887 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.108 -175.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -66.38 -34.73 33.81 Favored 'Trans proline' 0 C--N 1.336 -0.085 0 C-N-CA 123.546 2.831 . . . . 0.0 112.689 -170.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 5.1 mtpt -86.25 -45.22 11.48 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 121.465 0.65 . . . . 0.0 109.714 -177.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 267' ' ' TRP . . . . . 0.786 ' HE3' ' HA ' ' A' ' 261' ' ' LEU . 14.3 m0 -75.97 -30.11 58.5 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.757 -173.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 29.5 t -65.9 -18.81 65.59 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.958 0.409 . . . . 0.0 110.749 178.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . 0.403 ' C ' ' HD2' ' A' ' 270' ' ' ARG . 96.8 mttt -77.3 -8.38 57.54 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 121.139 0.495 . . . . 0.0 110.206 176.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 270' ' ' ARG . . . . . 0.825 ' HG2' HD22 ' A' ' 213' ' ' LEU . 3.6 mpt_? -111.11 141.51 44.51 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 178.061 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 31.9 mmm180 -92.36 110.27 21.67 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 -176.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . 0.588 HG22 HD21 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -121.46 142.41 37.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.534 0.683 . . . . 0.0 111.571 -178.259 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -151.76 169.31 22.51 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.679 173.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 . . . . . 0 C--N 1.324 -0.533 0 O-C-N 123.117 0.261 . . . . 0.0 110.301 175.221 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' ARG . . . . . 0.826 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 59.6 mtm180 . . . . . 0 C--O 1.222 -0.383 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -100.08 104.66 16.24 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 119.743 -0.783 . . . . 0.0 111.213 -172.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 67.8 t -137.45 123.73 27.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.134 176.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' PHE . . . . . 0.414 ' HE1' ' HB ' ' A' ' 243' ' ' ILE . 4.2 t80 -121.38 125.41 46.89 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 120.752 0.311 . . . . 0.0 110.251 -177.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.533 ' HG ' HG23 ' A' ' 272' ' ' ILE . 4.6 mp -108.28 126.09 52.43 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.39 177.427 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . 0.564 ' HA2' HG22 ' A' ' 243' ' ' ILE . . . -129.76 57.52 0.72 Allowed Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.304 -0.951 . . . . 0.0 113.343 -178.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . 0.542 ' HB3' ' HA ' ' A' ' 270' ' ' ARG . 2.1 t30 178.19 45.12 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.045 0.45 . . . . 0.0 111.027 178.166 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.451 HD21 HD22 ' A' ' 210' ' ' LEU . 0.7 OUTLIER -92.94 160.99 32.72 Favored Pre-proline 0 C--N 1.317 -0.814 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 176.971 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.432 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 87.9 Cg_endo -80.17 165.23 21.58 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.527 2.151 . . . . 0.0 111.188 176.06 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . 0.506 ' HA ' ' OG1' ' A' ' 239' ' ' THR . 28.2 t-20 -78.72 128.19 33.09 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 106.6 -2.98 36.57 Favored Glycine 0 C--N 1.315 -0.622 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.589 -178.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 217' ' ' ILE . . . . . 0.71 HG22 HG22 ' A' ' 237' ' ' ILE . 4.5 tp -64.71 127.99 26.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.224 0.535 . . . . 0.0 110.71 177.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 14.1 t -113.92 155.75 25.24 Favored 'General case' 0 C--O 1.24 0.602 0 CA-C-O 121.328 0.585 . . . . 0.0 111.075 -178.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -61.25 -37.26 82.44 Favored 'General case' 0 C--O 1.209 -1.055 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.365 -177.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -51.71 -36.0 45.15 Favored 'General case' 0 C--N 1.321 -0.632 0 O-C-N 123.464 0.478 . . . . 0.0 111.064 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -73.58 -55.56 6.15 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.316 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . 0.458 HD11 HD12 ' A' ' 237' ' ' ILE . 11.1 mt -60.17 -43.66 93.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.63 -179.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 223' ' ' ARG . . . . . 0.648 ' HG3' HD12 ' A' ' 235' ' ' ILE . 51.2 mtp180 -52.19 -63.11 1.25 Allowed 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 175.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -60.13 -19.46 53.69 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.077 -177.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 225' ' ' ASP . . . . . 0.49 ' HB3' ' CZ2' ' A' ' 267' ' ' TRP . 19.6 m-20 -87.32 -33.18 19.3 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.569 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.781 HD23 ' HZ ' ' A' ' 248' ' ' PHE . 8.2 mp -106.73 -18.25 14.0 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -170.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 227' ' ' GLU . . . . . 0.661 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 40.6 mt-10 -71.16 -24.41 0.72 Allowed Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -175.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 228' ' ' PRO . . . . . 0.661 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 74.7 Cg_endo -67.73 -26.76 38.69 Favored 'Trans proline' 0 C--N 1.36 1.184 0 C-N-CA 121.286 1.324 . . . . 0.0 112.05 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . 0.518 ' CZ ' ' HA ' ' A' ' 226' ' ' LEU . 3.6 p90 -110.55 -12.82 14.32 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.674 174.217 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . 0.461 ' HA2' ' HB2' ' A' ' 253' ' ' ALA . . . -165.01 96.06 0.13 Allowed Glycine 0 N--CA 1.441 -1.021 0 C-N-CA 120.319 -0.943 . . . . 0.0 111.939 -175.13 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -63.36 130.55 28.85 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.157 1.905 . . . . 0.0 111.423 178.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.957 HG21 HG13 ' A' ' 246' ' ' VAL . 2.1 mp -109.8 146.3 15.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.387 178.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 233' ' ' ASP . . . . . 0.517 ' OD2' HD23 ' A' ' 249' ' ' LEU . 7.7 m-20 -109.92 -22.43 11.86 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.909 0.385 . . . . 0.0 110.755 177.282 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . 0.577 ' HB3' ' HB2' ' A' ' 247' ' ' HIS . 30.9 tt0 -135.23 119.5 17.78 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.404 -176.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . 0.648 HD12 ' HG3' ' A' ' 223' ' ' ARG . 15.2 mt -136.96 106.57 4.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.852 -179.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -112.46 108.55 17.73 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.37 -179.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 237' ' ' ILE . . . . . 0.71 HG22 HG22 ' A' ' 217' ' ' ILE . 66.3 mt -99.99 117.77 45.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.548 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.588 ' HB ' HG13 ' A' ' 243' ' ' ILE . 45.2 t -100.1 87.44 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 172.523 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 239' ' ' THR . . . . . 0.506 ' OG1' ' HA ' ' A' ' 215' ' ' ASN . 14.0 t -64.77 -20.68 66.5 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.647 -175.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -67.74 -28.32 67.54 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.896 178.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . 0.535 ' HB2' HG12 ' A' ' 243' ' ' ILE . 81.9 mtt180 -120.13 5.12 10.82 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.653 -176.609 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 18.2 m120 66.12 24.75 10.86 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.33 175.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.588 HG13 ' HB ' ' A' ' 238' ' ' VAL . 1.6 pt -122.01 149.45 25.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.51 -173.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . 0.407 ' HB3' ' HB2' ' A' ' 210' ' ' LEU . . . -141.58 135.31 29.93 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.187 179.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -107.06 112.87 26.0 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.579 177.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . 0.957 HG13 HG21 ' A' ' 232' ' ' ILE . 0.1 OUTLIER -112.5 128.81 68.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.876 -176.944 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 247' ' ' HIS . . . . . 0.826 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 27.4 m170 -109.57 104.04 13.01 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.362 0.601 . . . . 0.0 111.313 178.398 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . 0.781 ' HZ ' HD23 ' A' ' 226' ' ' LEU . 30.4 m-85 -86.49 99.99 12.06 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.669 178.473 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.517 HD23 ' OD2' ' A' ' 233' ' ' ASP . 0.0 OUTLIER -37.37 -49.3 0.98 Allowed 'General case' 0 N--CA 1.469 0.511 0 O-C-N 124.654 1.221 . . . . 0.0 113.334 -176.131 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -90.95 139.48 30.72 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.109 177.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 251' ' ' ILE . . . . . 0.513 ' O ' HG13 ' A' ' 255' ' ' ILE . 0.2 OUTLIER -59.55 -41.35 84.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.047 -176.795 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -71.99 -30.88 65.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.981 -175.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . 0.461 ' HB2' ' HA2' ' A' ' 230' ' ' GLY . . . -59.33 -39.58 83.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.391 178.06 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 254' ' ' ALA . . . . . 0.567 ' HB3' ' HB2' ' A' ' 248' ' ' PHE . . . -69.19 -41.91 76.53 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.693 178.229 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.516 ' HA ' ' OH ' ' A' ' 274' ' ' TYR . 8.4 mt -56.97 -60.85 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.247 -177.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . 0.478 ' O ' ' HG2' ' A' ' 260' ' ' GLU . 10.8 ptmt -61.17 -38.5 86.7 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.339 -177.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -61.95 -48.53 80.0 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.625 0.25 . . . . 0.0 111.344 178.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . 0.49 HG12 HG12 ' A' ' 272' ' ' ILE . 55.3 t -68.37 -24.02 29.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.878 0.371 . . . . 0.0 111.057 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -84.52 -23.78 29.63 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 177.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . 0.478 ' HG2' ' O ' ' A' ' 256' ' ' LYS . 68.7 mm-40 -95.83 -31.68 13.04 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.679 0.276 . . . . 0.0 110.972 -176.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.743 ' HA ' ' HE3' ' A' ' 267' ' ' TRP . 0.7 OUTLIER -52.46 -49.13 87.29 Favored Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.689 179.849 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 262' ' ' PRO . . . . . 0.561 ' HD2' ' N ' ' A' ' 261' ' ' LEU . 48.6 Cg_endo -67.75 -15.7 44.81 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.352 2.035 . . . . 0.0 112.81 -178.434 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 56.4 mt -87.45 -8.66 56.23 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.499 0.666 . . . . 0.0 111.072 -178.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 -106.77 149.64 38.7 Favored Pre-proline 0 C--N 1.311 -1.065 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.133 -171.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -65.36 -39.44 22.44 Favored 'Trans proline' 0 C--O 1.231 0.137 0 C-N-CA 123.424 2.749 . . . . 0.0 112.768 -168.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 10.1 mtpt -86.33 -44.42 12.1 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.385 0.612 . . . . 0.0 109.615 -176.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 267' ' ' TRP . . . . . 0.743 ' HE3' ' HA ' ' A' ' 261' ' ' LEU . 17.7 m0 -70.98 -32.34 69.16 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.008 -0.997 . . . . 0.0 110.869 -175.414 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 22.7 t -64.19 -24.26 67.61 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.739 0.305 . . . . 0.0 110.799 179.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -71.02 -15.6 62.57 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.239 0.543 . . . . 0.0 110.124 177.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 270' ' ' ARG . . . . . 0.542 ' HA ' ' HB3' ' A' ' 212' ' ' ASN . 1.6 mpt_? -93.84 156.03 16.87 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.13 174.17 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 6.1 mmp_? -103.82 105.54 15.78 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 173.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . 0.604 HG21 HD21 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -113.45 138.25 43.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.303 0.573 . . . . 0.0 110.667 -176.571 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -152.85 167.77 27.98 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.149 175.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 274' ' ' TYR . . . . . 0.516 ' OH ' ' HA ' ' A' ' 255' ' ' ILE . 80.6 m-85 . . . . . 0 C--N 1.321 -0.645 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.537 173.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 206' ' ' ARG . . . . . 0.827 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 44.0 mtp180 . . . . . 0 C--O 1.219 -0.505 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -97.5 106.34 18.64 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 119.246 0.93 . . . . 0.0 112.146 -169.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.486 ' HB ' ' HB ' ' A' ' 246' ' ' VAL . 57.3 t -137.28 121.21 22.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.076 -0.966 . . . . 0.0 109.819 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 209' ' ' PHE . . . . . 0.437 ' O ' ' HA ' ' A' ' 272' ' ' ILE . 10.5 t80 -114.57 126.81 55.34 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.743 0.306 . . . . 0.0 110.906 -178.244 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.468 ' HG ' HG21 ' A' ' 272' ' ' ILE . 4.8 mp -110.3 128.07 55.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.372 175.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . 0.532 ' HA2' HG23 ' A' ' 243' ' ' ILE . . . -137.82 66.32 0.54 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.383 -0.913 . . . . 0.0 113.046 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . 0.562 ' HB3' ' HA ' ' A' ' 270' ' ' ARG . 3.4 t30 177.58 43.07 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.332 0.586 . . . . 0.0 110.004 176.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.648 HD22 ' HG2' ' A' ' 270' ' ' ARG . 1.1 mt -94.83 161.16 29.48 Favored Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.966 -179.474 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -83.05 167.9 13.9 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.458 2.105 . . . . 0.0 111.533 176.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . 0.475 ' HA ' ' OG1' ' A' ' 239' ' ' THR . 53.7 t30 -78.28 124.69 28.37 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.078 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 107.78 -4.38 34.32 Favored Glycine 0 C--N 1.314 -0.663 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.925 -177.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 217' ' ' ILE . . . . . 0.656 HG21 HG23 ' A' ' 237' ' ' ILE . 5.1 tp -60.75 126.74 19.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.05 0.453 . . . . 0.0 110.384 177.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 218' ' ' THR . . . . . 0.458 HG23 ' HG3' ' A' ' 221' ' ' GLU . 15.1 t -114.43 158.77 21.11 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.076 0.465 . . . . 0.0 111.077 -178.116 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.637 ' HB3' ' HD2' ' A' ' 223' ' ' ARG . 2.3 mp0 -57.88 -44.46 86.68 Favored 'General case' 0 C--O 1.205 -1.274 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.523 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -42.75 -39.69 2.54 Favored 'General case' 0 C--N 1.319 -0.728 0 O-C-N 123.959 0.787 . . . . 0.0 111.66 178.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . 0.458 ' HG3' HG23 ' A' ' 218' ' ' THR . 43.7 mt-10 -70.74 -60.54 2.19 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.876 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . 0.492 HD12 HD13 ' A' ' 237' ' ' ILE . 10.8 mt -62.64 -41.6 92.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.665 -176.393 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 223' ' ' ARG . . . . . 0.824 ' HG3' HD11 ' A' ' 235' ' ' ILE . 46.3 mtt-85 -54.85 -62.28 1.76 Allowed 'General case' 0 CA--C 1.507 -0.678 0 CA-C-N 116.21 -0.45 . . . . 0.0 112.162 176.163 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -56.03 -25.23 43.89 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.47 -178.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 225' ' ' ASP . . . . . 0.472 ' HB3' ' CZ2' ' A' ' 267' ' ' TRP . 19.3 m-20 -83.22 -33.3 26.14 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.615 -176.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.809 HD23 ' HZ ' ' A' ' 248' ' ' PHE . 7.2 mp -106.72 -12.16 15.61 Favored 'General case' 0 C--O 1.224 -0.242 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -171.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 227' ' ' GLU . . . . . 0.63 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 15.1 mm-40 -62.31 -37.23 34.81 Favored Pre-proline 0 C--N 1.327 -0.387 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.211 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 228' ' ' PRO . . . . . 0.63 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 71.7 Cg_endo -65.33 -30.3 53.93 Favored 'Trans proline' 0 C--N 1.358 1.046 0 C-N-CA 121.569 1.513 . . . . 0.0 112.248 -172.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . 0.507 ' CE1' ' HA ' ' A' ' 226' ' ' LEU . 3.5 p90 -110.53 -6.69 14.84 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.935 177.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . 0.492 ' CA ' ' HB2' ' A' ' 253' ' ' ALA . . . -170.2 96.19 0.11 Allowed Glycine 0 N--CA 1.441 -1.006 0 C-N-CA 119.849 -1.167 . . . . 0.0 112.395 -176.139 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . 0.427 ' HA ' ' OE2' ' A' ' 227' ' ' GLU . 17.9 Cg_endo -63.21 129.76 26.59 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 121.704 1.603 . . . . 0.0 111.41 178.557 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.687 HG22 HG12 ' A' ' 246' ' ' VAL . 2.3 mp -107.38 151.99 9.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.644 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -114.51 -21.77 10.15 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.645 177.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . 0.422 ' HB3' ' HB2' ' A' ' 247' ' ' HIS . 21.5 tt0 -141.19 120.42 12.99 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.648 -178.011 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . 0.824 HD11 ' HG3' ' A' ' 223' ' ' ARG . 6.1 mt -134.61 106.23 7.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.311 177.292 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.422 ' HE3' ' HB2' ' A' ' 236' ' ' LYS . 35.0 ttmt -106.58 107.46 18.48 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.981 -177.314 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 237' ' ' ILE . . . . . 0.656 HG23 HG21 ' A' ' 217' ' ' ILE . 87.9 mt -100.62 114.31 39.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-O 121.267 0.556 . . . . 0.0 110.52 -179.394 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.52 ' HB ' HG13 ' A' ' 243' ' ' ILE . 45.9 t -100.52 85.87 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 173.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 239' ' ' THR . . . . . 0.475 ' OG1' ' HA ' ' A' ' 215' ' ' ASN . 12.3 t -71.75 -13.04 61.59 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.075 -176.079 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -57.37 -41.83 80.95 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.804 170.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . 0.504 ' HB2' HG12 ' A' ' 243' ' ' ILE . 75.3 mtt180 -116.06 8.79 14.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.126 -177.271 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 68.7 25.9 6.3 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.298 174.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.532 HG23 ' HA2' ' A' ' 211' ' ' GLY . 2.1 pt -122.23 151.14 25.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.33 -173.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . 0.443 ' HB3' ' HB2' ' A' ' 210' ' ' LEU . . . -141.52 135.61 30.35 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.977 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -108.8 115.08 29.4 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.688 177.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . 0.687 HG12 HG22 ' A' ' 232' ' ' ILE . 1.5 t -108.71 141.02 25.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.612 -176.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 247' ' ' HIS . . . . . 0.827 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 11.5 m80 -122.39 101.94 7.8 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.584 0.707 . . . . 0.0 111.668 174.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . 0.809 ' HZ ' HD23 ' A' ' 226' ' ' LEU . 33.2 m-85 -84.87 101.95 12.7 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 114.581 -1.19 . . . . 0.0 110.896 178.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.402 HD23 ' H ' ' A' ' 249' ' ' LEU . 0.1 OUTLIER -43.62 -39.37 3.5 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 124.344 1.028 . . . . 0.0 112.882 -175.92 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 250' ' ' ASN . . . . . 0.408 ' HB2' ' HB3' ' A' ' 253' ' ' ALA . 37.5 m-20 -93.73 140.17 29.96 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.128 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 251' ' ' ILE . . . . . 0.527 ' O ' HG13 ' A' ' 255' ' ' ILE . 0.2 OUTLIER -63.4 -43.95 98.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -178.75 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . 0.414 ' O ' ' HG2' ' A' ' 256' ' ' LYS . . . -70.16 -30.72 67.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.647 0.26 . . . . 0.0 110.617 -177.303 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . 0.492 ' HB2' ' CA ' ' A' ' 230' ' ' GLY . . . -58.14 -44.12 87.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.261 178.487 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 254' ' ' ALA . . . . . 0.541 ' HB1' ' HB2' ' A' ' 248' ' ' PHE . . . -68.56 -39.58 81.0 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.566 178.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.724 ' HA ' ' HH ' ' A' ' 274' ' ' TYR . 3.5 mt -57.37 -60.89 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.513 -179.219 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . 0.414 ' HG2' ' O ' ' A' ' 252' ' ' ALA . 13.2 ptmt -62.92 -38.67 91.9 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.184 -176.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -61.96 -49.95 74.08 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.514 0.19 . . . . 0.0 111.514 179.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . 0.483 HG13 HG12 ' A' ' 272' ' ' ILE . 53.0 t -64.21 -27.19 42.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.1 0.476 . . . . 0.0 110.998 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -84.53 -21.25 30.58 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 178.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . 0.405 ' HG2' ' O ' ' A' ' 256' ' ' LYS . 67.1 mm-40 -94.81 -33.27 12.93 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 122.677 0.391 . . . . 0.0 110.989 -177.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.754 ' HA ' ' HE3' ' A' ' 267' ' ' TRP . 0.7 OUTLIER -51.84 -50.67 76.58 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.666 -178.915 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 262' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 261' ' ' LEU . 37.1 Cg_endo -66.76 -17.12 51.99 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.442 2.094 . . . . 0.0 112.807 -178.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 54.0 mt -90.27 -5.82 55.88 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.138 0.494 . . . . 0.0 111.624 -177.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 17.1 m-80 -107.13 149.73 39.0 Favored Pre-proline 0 C--N 1.315 -0.922 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.507 -174.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -65.51 -37.57 29.15 Favored 'Trans proline' 0 N--CA 1.465 -0.16 0 C-N-CA 123.432 2.754 . . . . 0.0 112.825 -171.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . 0.446 ' HE3' ' HB2' ' A' ' 266' ' ' LYS . 0.0 OUTLIER -82.8 -44.77 15.14 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 121.736 0.779 . . . . 0.0 109.251 -177.139 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 267' ' ' TRP . . . . . 0.754 ' HE3' ' HA ' ' A' ' 261' ' ' LEU . 10.4 m0 -77.29 -29.39 53.72 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.581 -1.19 . . . . 0.0 111.115 -172.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 19.4 t -66.4 -17.56 64.85 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.976 0.417 . . . . 0.0 110.406 178.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -78.02 -8.08 57.72 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.237 0.542 . . . . 0.0 110.182 176.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 270' ' ' ARG . . . . . 0.648 ' HG2' HD22 ' A' ' 213' ' ' LEU . 3.6 mpt_? -108.97 165.02 11.89 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.816 177.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -111.59 119.12 37.63 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 177.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . 0.588 HG23 HD23 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -128.97 143.25 41.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.139 0.495 . . . . 0.0 111.476 -179.276 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -151.69 169.5 22.01 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.942 170.414 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 274' ' ' TYR . . . . . 0.724 ' HH ' ' HA ' ' A' ' 255' ' ' ILE . 69.9 m-85 . . . . . 0 C--N 1.324 -0.53 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 172.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 206' ' ' ARG . . . . . 0.78 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 19.0 mtm180 . . . . . 0 C--O 1.223 -0.33 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 16.9 m-80 -105.93 105.64 15.77 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 118.816 0.734 . . . . 0.0 111.644 -172.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 61.5 t -134.36 109.16 11.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.035 176.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 209' ' ' PHE . . . . . 0.428 ' HE1' ' HB ' ' A' ' 243' ' ' ILE . 2.6 t80 -106.33 124.7 49.99 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.183 -175.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.532 ' HG ' HG23 ' A' ' 272' ' ' ILE . 6.1 mp -109.17 132.87 53.71 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.167 178.388 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . 0.552 ' HA2' HG22 ' A' ' 243' ' ' ILE . . . -138.05 60.7 0.59 Allowed Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.235 -0.983 . . . . 0.0 113.326 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . 0.533 ' HB3' ' HA ' ' A' ' 270' ' ' ARG . 2.5 t30 179.95 41.38 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.938 0.399 . . . . 0.0 110.67 177.103 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.436 HD21 HD21 ' A' ' 210' ' ' LEU . 1.4 mp -93.77 157.29 38.41 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.545 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.409 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 86.9 Cg_endo -77.72 169.87 20.06 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.764 2.31 . . . . 0.0 112.472 179.39 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . 0.578 ' HA ' ' OG1' ' A' ' 239' ' ' THR . 13.9 m120 -78.36 123.76 27.35 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.634 176.482 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 108.75 -8.75 34.36 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.358 -0.925 . . . . 0.0 112.865 179.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 217' ' ' ILE . . . . . 0.604 HG23 HG22 ' A' ' 237' ' ' ILE . 4.8 tp -58.99 128.69 20.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.889 0.345 . . . . 0.0 110.107 178.347 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 218' ' ' THR . . . . . 0.454 HG22 ' HG3' ' A' ' 221' ' ' GLU . 7.1 t -114.1 161.62 17.52 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.447 0.641 . . . . 0.0 111.235 -179.449 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.498 ' CD ' ' H ' ' A' ' 219' ' ' GLU . 1.6 mp0 -64.31 -40.4 95.84 Favored 'General case' 0 C--O 1.21 -0.99 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.849 -175.171 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 220' ' ' ASP . . . . . 0.527 ' O ' ' HG2' ' A' ' 224' ' ' GLU . 38.6 t70 -48.46 -41.44 29.54 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 123.803 0.689 . . . . 0.0 111.187 178.215 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . 0.454 ' HG3' HG22 ' A' ' 218' ' ' THR . 43.4 mt-10 -65.45 -56.81 10.43 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.332 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . 0.455 HD13 HD11 ' A' ' 237' ' ' ILE . 7.5 mt -61.07 -39.92 83.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.668 -179.117 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 223' ' ' ARG . . . . . 0.817 ' HG3' HD12 ' A' ' 235' ' ' ILE . 26.0 mtp180 -55.83 -62.77 1.47 Allowed 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 175.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.527 ' HG2' ' O ' ' A' ' 220' ' ' ASP . 9.1 pt-20 -60.92 -18.03 54.41 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.958 -178.057 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 225' ' ' ASP . . . . . 0.507 ' HB3' ' CZ2' ' A' ' 267' ' ' TRP . 44.0 m-20 -88.11 -35.2 17.6 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.288 -179.059 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.71 HD21 ' HZ ' ' A' ' 248' ' ' PHE . 8.0 mp -107.05 -17.63 14.12 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -169.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 227' ' ' GLU . . . . . 0.661 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 41.4 mt-10 -68.81 -27.27 1.33 Allowed Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -176.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 228' ' ' PRO . . . . . 0.661 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 71.6 Cg_endo -66.61 -27.83 45.33 Favored 'Trans proline' 0 C--N 1.36 1.171 0 C-N-CA 121.319 1.346 . . . . 0.0 111.94 -178.308 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . 0.531 ' CZ ' ' HA ' ' A' ' 226' ' ' LEU . 3.7 p90 -110.82 -7.6 14.6 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-O 120.734 0.302 . . . . 0.0 111.631 174.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . -170.09 95.55 0.11 Allowed Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.373 -0.918 . . . . 0.0 111.957 -175.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -60.94 132.43 42.15 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.016 1.811 . . . . 0.0 111.578 178.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.793 HG22 HG13 ' A' ' 246' ' ' VAL . 2.6 mp -109.99 149.92 12.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.766 178.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 233' ' ' ASP . . . . . 0.444 ' OD2' HD21 ' A' ' 249' ' ' LEU . 15.3 m-20 -115.63 -14.73 11.45 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.412 179.034 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . 0.471 ' HB3' ' HB2' ' A' ' 247' ' ' HIS . 29.7 tt0 -148.35 120.87 8.52 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.518 -179.293 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . 0.817 HD12 ' HG3' ' A' ' 223' ' ' ARG . 17.1 mt -134.32 107.94 10.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.001 179.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -112.73 115.72 28.97 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.582 -177.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 237' ' ' ILE . . . . . 0.604 HG22 HG23 ' A' ' 217' ' ' ILE . 68.8 mt -104.74 121.88 57.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.932 -178.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 45.1 t -110.57 86.82 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 171.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 239' ' ' THR . . . . . 0.578 ' OG1' ' HA ' ' A' ' 215' ' ' ASN . 8.2 t -68.16 -19.89 64.83 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.405 -175.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -56.19 -37.57 69.79 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.359 174.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . 0.45 ' HB2' HG12 ' A' ' 243' ' ' ILE . 98.8 mtt180 -107.05 0.25 23.45 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.776 179.215 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 242' ' ' ASN . . . . . 0.427 ' O ' HD11 ' A' ' 213' ' ' LEU . 18.7 m120 65.63 29.12 11.06 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.472 -179.284 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.552 HG22 ' HA2' ' A' ' 211' ' ' GLY . 1.7 pp -122.22 157.24 26.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.604 -174.255 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -149.13 141.05 23.73 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.034 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -109.81 113.77 26.78 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.851 177.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . 0.793 HG13 HG22 ' A' ' 232' ' ' ILE . 0.2 OUTLIER -107.47 126.33 63.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.434 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 247' ' ' HIS . . . . . 0.78 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 51.8 m170 -105.83 102.6 12.03 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.183 -0.607 . . . . 0.0 111.244 179.699 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . 0.71 ' HZ ' HD21 ' A' ' 226' ' ' LEU . 34.6 m-85 -87.38 102.37 14.47 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.887 -1.051 . . . . 0.0 111.274 178.581 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.444 HD21 ' OD2' ' A' ' 233' ' ' ASP . 0.0 OUTLIER -40.94 -47.21 2.96 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 124.512 1.132 . . . . 0.0 113.382 -174.881 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -93.84 144.68 25.21 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.252 177.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 251' ' ' ILE . . . . . 0.583 ' O ' HG13 ' A' ' 255' ' ' ILE . 0.2 OUTLIER -61.33 -41.82 91.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.328 -177.167 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -71.34 -30.39 66.13 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 120.58 0.228 . . . . 0.0 110.952 -175.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -57.27 -41.59 79.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.208 177.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 254' ' ' ALA . . . . . 0.515 ' HB2' ' HB2' ' A' ' 248' ' ' PHE . . . -69.77 -40.64 75.96 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.594 178.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.713 ' HA ' ' HH ' ' A' ' 274' ' ' TYR . 12.8 mt -57.38 -60.85 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.249 -178.367 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 10.6 ptmt -61.77 -38.12 86.84 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.552 -176.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -62.98 -49.38 74.91 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 111.556 0.206 . . . . 0.0 111.556 178.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . 0.4 HG11 HG12 ' A' ' 272' ' ' ILE . 52.3 t -65.21 -23.47 33.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.985 0.421 . . . . 0.0 110.86 179.251 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -83.75 -25.91 30.14 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 177.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -94.27 -33.09 13.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.842 0.353 . . . . 0.0 111.069 -175.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.705 HD13 ' CE3' ' A' ' 267' ' ' TRP . 0.7 OUTLIER -52.15 -49.63 83.51 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.483 -179.703 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 262' ' ' PRO . . . . . 0.545 ' HD2' ' N ' ' A' ' 261' ' ' LEU . 50.6 Cg_endo -68.63 -14.18 38.85 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.486 2.124 . . . . 0.0 112.863 -178.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 60.1 mt -91.19 -6.22 53.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.476 0.655 . . . . 0.0 111.207 -179.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -106.64 149.13 38.02 Favored Pre-proline 0 C--N 1.315 -0.93 0 CA-C-N 115.346 -0.843 . . . . 0.0 112.272 -174.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -66.46 -36.92 24.77 Favored 'Trans proline' 0 CA--C 1.527 0.136 0 C-N-CA 123.429 2.753 . . . . 0.0 112.919 -171.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -86.07 -44.28 12.41 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-O 121.579 0.704 . . . . 0.0 109.935 -178.27 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 267' ' ' TRP . . . . . 0.705 ' CE3' HD13 ' A' ' 261' ' ' LEU . 15.9 m0 -74.54 -27.97 60.75 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.873 -174.503 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 33.1 t -67.8 -18.11 64.74 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.889 0.376 . . . . 0.0 110.679 176.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -71.34 -19.3 62.32 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.394 0.616 . . . . 0.0 109.571 175.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 270' ' ' ARG . . . . . 0.533 ' HA ' ' HB3' ' A' ' 212' ' ' ASN . 5.0 mpt_? -95.09 156.11 16.45 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.537 177.484 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . 0.405 ' HA ' ' NE ' ' A' ' 271' ' ' ARG . 4.9 mmp_? -105.48 106.3 16.74 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 172.452 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . 0.597 HG21 HD22 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -115.62 138.42 46.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.401 0.619 . . . . 0.0 111.155 -175.407 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -151.6 169.11 22.92 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.857 174.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 274' ' ' TYR . . . . . 0.713 ' HH ' ' HA ' ' A' ' 255' ' ' ILE . 77.8 m-85 . . . . . 0 C--N 1.321 -0.652 0 CA-C-O 120.862 0.363 . . . . 0.0 110.496 175.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 206' ' ' ARG . . . . . 0.773 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 31.2 mtm180 . . . . . 0 C--O 1.223 -0.312 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -105.51 104.95 14.78 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.156 0.503 . . . . 0.0 111.472 -172.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.429 ' HB ' ' HB ' ' A' ' 246' ' ' VAL . 58.8 t -134.63 117.43 23.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.33 177.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 209' ' ' PHE . . . . . 0.4 ' HE1' ' HB ' ' A' ' 243' ' ' ILE . 3.1 t80 -114.46 123.97 50.75 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 120.951 0.405 . . . . 0.0 110.463 -177.024 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.534 ' HG ' HG22 ' A' ' 272' ' ' ILE . 6.1 mp -107.86 135.21 49.65 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.172 176.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . 0.536 ' HA2' HG22 ' A' ' 243' ' ' ILE . . . -142.9 61.74 0.52 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.229 -0.986 . . . . 0.0 113.249 179.247 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 37.7 t30 179.03 41.94 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.928 0.394 . . . . 0.0 110.253 178.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.462 HD12 ' O ' ' A' ' 242' ' ' ASN . 1.1 mp -92.51 159.93 35.72 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.392 -179.304 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.436 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 91.6 Cg_endo -79.63 162.84 24.34 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.541 2.161 . . . . 0.0 111.739 176.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -77.41 119.92 21.69 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.541 179.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 109.72 0.52 30.58 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.473 -0.87 . . . . 0.0 112.615 -177.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 217' ' ' ILE . . . . . 0.591 HG21 HG21 ' A' ' 237' ' ' ILE . 5.5 tp -64.49 129.01 27.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.863 0.364 . . . . 0.0 110.163 175.174 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 218' ' ' THR . . . . . 0.443 ' CG2' ' HG3' ' A' ' 221' ' ' GLU . 15.1 t -113.66 154.27 27.52 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 121.523 0.678 . . . . 0.0 110.917 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -62.78 -33.56 75.44 Favored 'General case' 0 C--O 1.206 -1.193 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.934 -178.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 220' ' ' ASP . . . . . 0.431 ' O ' ' HG2' ' A' ' 224' ' ' GLU . 15.7 t70 -49.48 -38.89 31.64 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.021 0.439 . . . . 0.0 110.811 176.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . 0.443 ' HG3' ' CG2' ' A' ' 218' ' ' THR . 42.1 mt-10 -70.77 -58.09 3.98 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.314 179.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . 0.46 HD12 HD13 ' A' ' 237' ' ' ILE . 8.6 mt -58.5 -41.79 82.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.815 -178.446 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 223' ' ' ARG . . . . . 0.652 ' CG ' HD11 ' A' ' 235' ' ' ILE . 49.4 mtp180 -57.61 -62.24 1.93 Allowed 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 177.585 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.431 ' HG2' ' O ' ' A' ' 220' ' ' ASP . 6.4 pt-20 -57.57 -24.23 55.07 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.731 -178.51 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -86.79 -31.42 20.9 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.854 -176.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.701 HD23 ' HZ ' ' A' ' 248' ' ' PHE . 8.0 mp -105.39 -20.21 13.56 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 120.609 -0.436 . . . . 0.0 112.167 -171.401 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 227' ' ' GLU . . . . . 0.662 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 36.6 mt-10 -68.99 -27.71 1.41 Allowed Pre-proline 0 C--N 1.325 -0.492 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -176.314 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 228' ' ' PRO . . . . . 0.662 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 71.5 Cg_endo -66.72 -28.77 43.66 Favored 'Trans proline' 0 C--N 1.359 1.081 0 C-N-CA 121.254 1.302 . . . . 0.0 112.07 -178.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . 0.502 ' CE1' ' HA ' ' A' ' 226' ' ' LEU . 3.9 p90 -111.15 4.13 19.06 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-O 120.69 0.281 . . . . 0.0 111.353 173.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . 0.499 ' CA ' ' HB2' ' A' ' 253' ' ' ALA . . . 177.25 98.9 0.11 Allowed Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 119.837 -1.173 . . . . 0.0 112.748 -177.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . 0.522 ' HA ' ' HG2' ' A' ' 227' ' ' GLU . 22.7 Cg_endo -63.38 134.29 44.32 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 121.904 1.736 . . . . 0.0 111.34 177.213 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.755 HG21 HG13 ' A' ' 246' ' ' VAL . 3.2 mp -107.7 151.06 9.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.642 178.208 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 233' ' ' ASP . . . . . 0.48 ' CG ' HD22 ' A' ' 249' ' ' LEU . 9.9 m-20 -106.84 -25.33 11.73 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.05 0.452 . . . . 0.0 110.319 178.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . 0.402 ' HB3' ' HB2' ' A' ' 247' ' ' HIS . 30.8 tt0 -145.15 122.85 11.84 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.862 -175.057 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . 0.652 HD11 ' CG ' ' A' ' 223' ' ' ARG . 13.5 mt -136.13 109.35 8.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.909 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -119.21 120.42 37.01 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.475 -178.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 237' ' ' ILE . . . . . 0.591 HG21 HG21 ' A' ' 217' ' ' ILE . 64.7 mt -106.19 117.46 51.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.596 179.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.566 ' HB ' HG13 ' A' ' 243' ' ' ILE . 42.4 t -97.7 86.52 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 173.327 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 3.8 t -64.44 -23.15 67.19 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.291 -177.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -59.48 -36.08 75.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.073 0.463 . . . . 0.0 110.396 176.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . 0.641 ' HB2' HG12 ' A' ' 243' ' ' ILE . 74.6 mtt180 -113.91 3.37 15.39 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.632 -176.425 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 242' ' ' ASN . . . . . 0.462 ' O ' HD12 ' A' ' 213' ' ' LEU . 14.1 m120 66.42 27.36 9.92 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.996 176.502 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.641 HG12 ' HB2' ' A' ' 241' ' ' ARG . 1.5 pt -122.28 153.25 26.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.088 -174.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . 0.418 ' HB3' ' HB2' ' A' ' 210' ' ' LEU . . . -143.78 140.45 29.92 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.012 0.434 . . . . 0.0 111.083 -179.11 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -110.57 117.89 34.75 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.788 178.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . 0.755 HG13 HG21 ' A' ' 232' ' ' ILE . 0.6 OUTLIER -113.41 129.25 69.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -179.594 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 247' ' ' HIS . . . . . 0.773 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 48.2 m170 -109.33 101.9 10.85 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.064 -0.654 . . . . 0.0 111.414 178.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . 0.701 ' HZ ' HD23 ' A' ' 226' ' ' LEU . 41.5 m-85 -87.14 100.88 12.98 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.18 178.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.48 HD22 ' CG ' ' A' ' 233' ' ' ASP . 0.1 OUTLIER -43.86 -45.77 7.64 Favored 'General case' 0 N--CA 1.463 0.217 0 O-C-N 124.464 1.102 . . . . 0.0 112.62 -176.174 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 250' ' ' ASN . . . . . 0.419 ' HB2' ' HB1' ' A' ' 253' ' ' ALA . 13.4 m120 -86.35 136.88 32.97 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 177.313 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 251' ' ' ILE . . . . . 0.58 ' O ' HG13 ' A' ' 255' ' ' ILE . 0.2 OUTLIER -60.76 -43.17 94.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.272 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -69.23 -30.74 68.96 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.027 -177.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . 0.499 ' HB2' ' CA ' ' A' ' 230' ' ' GLY . . . -61.69 -39.98 93.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.384 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 254' ' ' ALA . . . . . 0.533 ' HB1' ' HB2' ' A' ' 248' ' ' PHE . . . -69.14 -41.91 76.7 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.59 178.678 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.58 HG13 ' O ' ' A' ' 251' ' ' ILE . 11.7 mt -55.89 -60.91 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.054 -177.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 13.7 ptmt -62.17 -38.12 87.85 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.607 -176.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -64.7 -48.63 73.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.587 0.232 . . . . 0.0 111.422 178.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 43.0 t -65.96 -23.27 31.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 120.865 0.365 . . . . 0.0 110.96 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . 0.553 ' HA ' ' OE1' ' A' ' 259' ' ' GLN . 9.9 mm-40 -84.83 -25.81 27.86 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 176.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 48.9 mm-40 -89.5 -36.44 15.39 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-O 120.791 0.329 . . . . 0.0 111.026 -177.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.734 HD13 ' CE3' ' A' ' 267' ' ' TRP . 0.8 OUTLIER -51.71 -48.3 87.69 Favored Pre-proline 0 CA--C 1.54 0.568 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.656 -178.808 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 262' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 261' ' ' LEU . 55.9 Cg_endo -69.67 -16.53 37.99 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.5 2.133 . . . . 0.0 112.926 -179.229 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 66.2 mt -92.8 -3.62 54.39 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.344 0.592 . . . . 0.0 111.162 -177.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -106.14 149.95 38.76 Favored Pre-proline 0 C--N 1.313 -1.002 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.376 -176.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -65.56 -41.47 15.02 Favored 'Trans proline' 0 C--N 1.34 0.124 0 C-N-CA 123.284 2.656 . . . . 0.0 112.774 -168.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 16.0 mtpt -86.89 -44.67 11.49 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.198 0.523 . . . . 0.0 109.799 -175.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 267' ' ' TRP . . . . . 0.734 ' CE3' HD13 ' A' ' 261' ' ' LEU . 24.4 m0 -67.81 -33.51 74.93 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.802 -176.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 29.1 t -63.94 -24.29 67.67 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.99 0.424 . . . . 0.0 111.014 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -71.78 -16.44 62.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.188 0.518 . . . . 0.0 110.134 177.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 270' ' ' ARG . . . . . 0.417 ' HB3' HD23 ' A' ' 210' ' ' LEU . 5.2 mpt_? -93.99 144.88 25.07 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 173.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . 0.476 ' O ' ' HA ' ' A' ' 210' ' ' LEU . 5.0 mmp_? -94.2 105.76 17.75 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 177.05 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . 0.6 HG23 HD22 ' A' ' 261' ' ' LEU . 0.1 OUTLIER -116.93 136.56 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 CA-C-O 121.634 0.73 . . . . 0.0 111.24 -177.665 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -152.07 167.99 26.68 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.826 173.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 274' ' ' TYR . . . . . 0.541 ' OH ' ' HA ' ' A' ' 255' ' ' ILE . 90.9 m-85 . . . . . 0 C--N 1.319 -0.735 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.244 173.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 56.8 m-80 . . . . . 0 N--CA 1.48 1.052 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 21.8 t -139.84 94.44 2.77 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -149.4 -179.49 7.11 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.989 -176.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' SER . . . . . 0.57 ' HA ' HD23 ' A' ' 196' ' ' LEU . 20.8 m -76.2 -51.94 11.07 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.804 -179.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 64.86 -88.64 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.016 0.526 . . . . 0.0 110.508 -177.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 5.1 p -127.38 6.86 6.37 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.395 0.617 . . . . 0.0 109.98 175.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' SER . . . . . 0.451 ' O ' ' HB3' ' A' ' 191' ' ' SER . 6.2 m -100.03 138.02 37.68 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.628 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 3.3 m -86.37 90.37 3.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-O 121.523 0.678 . . . . 0.0 112.166 -179.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . 0.593 ' O ' HG22 ' A' ' 199' ' ' VAL . 4.1 mm? -78.53 -16.05 57.91 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.497 0.665 . . . . 0.0 109.522 174.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 63.2 tp -64.85 -18.31 65.03 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.273 173.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -91.17 -27.96 18.17 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.307 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.593 HG22 ' O ' ' A' ' 196' ' ' LEU . 4.3 m -76.86 -11.27 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.119 0 CA-C-O 121.171 0.51 . . . . 0.0 110.643 -174.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 14.7 mm-40 -99.81 14.67 29.52 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.539 -179.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . 0.469 ' HB2' ' HD2' ' A' ' 274' ' ' TYR . 26.1 mm-40 -112.3 162.78 15.14 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.2 -177.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 7.8 t -167.32 -173.71 2.35 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 177.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 74.32 49.82 11.29 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.787 178.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -156.29 107.32 2.44 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.671 0.272 . . . . 0.0 110.424 178.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' CYS . . . . . 0.534 ' CA ' HG12 ' A' ' 251' ' ' ILE . 19.2 p -87.68 146.47 25.68 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 178.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . 0.812 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 45.2 mtm180 56.59 0.69 0.07 Allowed 'General case' 0 C--O 1.222 -0.381 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 177.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -103.23 105.17 15.4 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 118.984 0.811 . . . . 0.0 111.759 -170.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.44 ' HB ' ' HB ' ' A' ' 246' ' ' VAL . 61.3 t -138.31 126.76 30.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.571 179.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' PHE . . . . . 0.57 ' O ' ' HA ' ' A' ' 272' ' ' ILE . 17.9 t80 -117.31 131.73 56.75 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.659 178.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.507 ' HG ' HG22 ' A' ' 272' ' ' ILE . 2.5 mp -112.85 115.18 28.06 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.46 175.179 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . 0.569 ' O ' ' HB2' ' A' ' 212' ' ' ASN . . . -124.59 67.18 0.52 Allowed Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.664 -0.779 . . . . 0.0 113.227 -177.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . 0.583 ' HB2' ' HG3' ' A' ' 271' ' ' ARG . 2.5 t30 168.93 51.29 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.124 0.57 . . . . 0.0 110.039 172.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.493 HD21 ' HG2' ' A' ' 270' ' ' ARG . 1.0 OUTLIER -92.38 162.75 29.04 Favored Pre-proline 0 C--N 1.313 -0.983 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.108 -179.972 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.429 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 71.9 Cg_endo -79.66 156.09 24.37 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 122.109 1.872 . . . . 0.0 111.333 174.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 39.6 t-20 -70.61 128.01 34.63 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 178.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 106.07 -7.04 40.6 Favored Glycine 0 C--N 1.315 -0.606 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.88 -178.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . 0.6 HG22 HG21 ' A' ' 237' ' ' ILE . 5.2 tp -59.83 126.71 18.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.124 0.488 . . . . 0.0 110.649 178.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' THR . . . . . 0.512 HG22 ' HG3' ' A' ' 221' ' ' GLU . 6.9 t -112.43 154.87 25.16 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-O 121.251 0.548 . . . . 0.0 110.581 -179.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -58.88 -40.86 85.64 Favored 'General case' 0 C--O 1.21 -0.979 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.867 -176.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -50.74 -36.81 38.32 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 123.727 0.642 . . . . 0.0 111.262 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . 0.512 ' HG3' HG22 ' A' ' 218' ' ' THR . 42.2 mt-10 -68.47 -53.98 19.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.599 179.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . 0.487 HD13 HD11 ' A' ' 237' ' ' ILE . 7.2 mt -61.96 -40.86 88.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.429 179.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . 0.75 ' HG3' HD13 ' A' ' 235' ' ' ILE . 61.7 mtp180 -53.99 -62.07 1.89 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.976 0.417 . . . . 0.0 111.955 174.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -59.03 -22.76 61.2 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.27 -178.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -89.07 -31.3 18.1 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.864 -177.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.822 HD21 ' HZ ' ' A' ' 248' ' ' PHE . 8.6 mp -106.56 -19.54 13.64 Favored 'General case' 0 C--O 1.223 -0.298 0 N-CA-C 112.257 0.465 . . . . 0.0 112.257 -170.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . 0.671 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 38.7 mt-10 -70.82 -26.35 0.95 Allowed Pre-proline 0 C--N 1.323 -0.556 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -175.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . 0.671 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 74.1 Cg_endo -65.33 -25.86 56.43 Favored 'Trans proline' 0 C--N 1.36 1.139 0 C-N-CA 121.202 1.268 . . . . 0.0 111.908 -178.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . 0.484 ' CE1' ' HA ' ' A' ' 226' ' ' LEU . 2.7 p90 -111.01 -17.37 13.29 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.726 173.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . -162.33 93.49 0.12 Allowed Glycine 0 N--CA 1.442 -0.949 0 C-N-CA 120.397 -0.906 . . . . 0.0 111.897 -173.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . 0.505 ' HA ' ' HG2' ' A' ' 227' ' ' GLU . 17.5 Cg_endo -60.93 136.6 66.88 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.136 1.891 . . . . 0.0 111.677 178.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.834 HG21 HG11 ' A' ' 246' ' ' VAL . 2.8 mp -113.07 148.81 15.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.867 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -109.9 -20.2 12.84 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 120.894 0.378 . . . . 0.0 110.964 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . 0.538 ' HB3' ' HB2' ' A' ' 247' ' ' HIS . 31.3 tt0 -143.39 121.78 12.37 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.58 -176.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . 0.75 HD13 ' HG3' ' A' ' 223' ' ' ARG . 14.2 mt -137.7 107.48 4.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.601 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 54.7 tttp -113.33 112.53 23.84 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.442 -178.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' ILE . . . . . 0.6 HG21 HG22 ' A' ' 217' ' ' ILE . 86.3 mt -103.2 121.72 54.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.902 -178.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.564 ' HB ' HG13 ' A' ' 243' ' ' ILE . 41.5 t -101.84 86.71 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 170.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 13.8 t -64.87 -22.22 66.95 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.792 -176.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -62.82 -30.92 71.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.534 177.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . 0.577 ' HB2' HG12 ' A' ' 243' ' ' ILE . 83.2 mtt180 -117.45 3.75 12.48 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.732 -176.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 16.8 m120 67.14 27.24 8.6 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.086 175.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.577 HG12 ' HB2' ' A' ' 241' ' ' ARG . 1.4 pt -122.73 151.54 26.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.526 -175.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . 0.446 ' HB2' ' HB2' ' A' ' 210' ' ' LEU . . . -143.7 138.04 28.59 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.227 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' PHE . . . . . 0.773 ' HZ ' ' HB ' ' A' ' 281' ' ' VAL . 21.5 m-85 -108.52 117.54 34.43 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.478 178.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . 0.834 HG11 HG21 ' A' ' 232' ' ' ILE . 0.4 OUTLIER -113.94 138.47 43.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -176.209 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' HIS . . . . . 0.812 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 55.1 m170 -118.39 102.95 9.33 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.337 0.589 . . . . 0.0 111.147 175.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . 0.822 ' HZ ' HD21 ' A' ' 226' ' ' LEU . 33.6 m-85 -85.5 105.38 16.06 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.215 178.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.412 ' H ' HD23 ' A' ' 249' ' ' LEU . 0.1 OUTLIER -44.15 -45.34 8.22 Favored 'General case' 0 N--CA 1.467 0.398 0 O-C-N 124.389 1.056 . . . . 0.0 113.108 -173.474 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -95.86 142.89 27.57 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.401 -0.52 . . . . 0.0 110.209 177.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . 0.592 ' O ' HG13 ' A' ' 255' ' ' ILE . 0.2 OUTLIER -61.2 -42.5 93.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 -178.045 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -70.7 -28.38 64.7 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.001 -176.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -61.32 -41.48 97.08 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.146 178.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . 0.514 ' HB1' ' HB2' ' A' ' 248' ' ' PHE . . . -68.51 -41.45 79.94 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.67 178.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.621 ' HA ' ' OH ' ' A' ' 274' ' ' TYR . 11.4 mt -56.41 -59.89 2.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.402 -177.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . 0.484 ' O ' ' HG2' ' A' ' 260' ' ' GLU . 12.2 ptmt -61.63 -40.47 95.0 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.254 -177.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -63.3 -48.86 76.3 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 111.686 0.254 . . . . 0.0 111.686 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 50.5 t -66.45 -24.0 32.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.957 0.408 . . . . 0.0 111.114 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 19.3 mm-40 -83.8 -24.82 30.86 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 177.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . 0.484 ' HG2' ' O ' ' A' ' 256' ' ' LYS . 27.5 mm-40 -95.17 -31.43 13.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.611 0.243 . . . . 0.0 111.273 -176.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.812 ' HA ' ' HE3' ' A' ' 267' ' ' TRP . 0.7 OUTLIER -52.17 -50.92 76.3 Favored Pre-proline 0 CA--C 1.537 0.471 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.255 179.362 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' PRO . . . . . 0.555 ' HD2' ' N ' ' A' ' 261' ' ' LEU . 42.0 Cg_endo -67.47 -17.87 49.02 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.441 2.094 . . . . 0.0 112.97 -178.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 59.0 mt -91.57 -5.58 53.78 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.068 0.461 . . . . 0.0 111.561 -177.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' ASN . . . . . 0.415 ' O ' ' HB2' ' A' ' 268' ' ' SER . 13.7 m-80 -105.34 145.89 31.68 Favored Pre-proline 0 C--N 1.313 -1.017 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.712 -175.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -68.18 -26.65 36.03 Favored 'Trans proline' 0 C--N 1.334 -0.229 0 C-N-CA 123.332 2.688 . . . . 0.0 112.583 -170.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.445 ' HE3' ' NE1' ' A' ' 267' ' ' TRP . 0.0 OUTLIER -86.17 -46.3 10.53 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.958 0.885 . . . . 0.0 109.25 -178.837 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' TRP . . . . . 0.812 ' HE3' ' HA ' ' A' ' 261' ' ' LEU . 8.0 m0 -82.52 -24.12 34.25 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.478 -1.237 . . . . 0.0 110.6 -172.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' SER . . . . . 0.415 ' HB2' ' O ' ' A' ' 264' ' ' ASN . 22.4 t -65.58 -18.01 65.0 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.034 0.445 . . . . 0.0 110.581 176.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -73.65 -13.75 61.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.316 0.579 . . . . 0.0 109.879 176.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' ARG . . . . . 0.513 ' HA ' ' HB3' ' A' ' 212' ' ' ASN . 0.0 OUTLIER -109.95 147.4 33.51 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.742 -179.705 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . 0.583 ' HG3' ' HB2' ' A' ' 212' ' ' ASN . 40.6 mtm180 -98.06 106.15 18.4 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.106 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . 0.6 HG23 HD22 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -116.61 143.33 27.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.147 -177.451 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' TYR . . . . . 0.412 ' CZ ' ' HD2' ' A' ' 209' ' ' PHE . 1.5 p90 -150.57 167.75 26.32 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.4 172.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' TYR . . . . . 0.621 ' OH ' ' HA ' ' A' ' 255' ' ' ILE . 74.2 m-85 -66.66 118.53 10.35 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.948 172.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -73.64 115.36 5.0 Favored Glycine 0 N--CA 1.44 -1.077 0 C-N-CA 120.334 -0.936 . . . . 0.0 112.205 -177.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . 0.725 ' HB2' ' HB2' ' A' ' 284' ' ' LYS . 38.8 mmt180 -77.27 133.04 38.94 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 174.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' ASP . . . . . 0.627 ' CG ' ' H ' ' A' ' 278' ' ' ARG . 30.0 t70 59.56 -164.96 0.2 Allowed 'General case' 0 CA--C 1.539 0.553 0 O-C-N 123.7 0.625 . . . . 0.0 109.761 -174.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' ARG . . . . . 0.627 ' H ' ' CG ' ' A' ' 277' ' ' ASP . 3.8 mpt_? -99.26 -19.94 16.83 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.264 0.555 . . . . 0.0 109.662 -177.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' CYS . . . . . . . . . . . . . 24.1 m -95.44 31.15 2.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.142 -175.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -74.45 82.23 1.95 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.777 -178.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' VAL . . . . . 0.773 ' HB ' ' HZ ' ' A' ' 245' ' ' PHE . 11.7 p -126.94 -26.32 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.149 173.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -152.82 -50.33 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 177.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 91.7 mt -107.62 101.47 10.79 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 175.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . 0.725 ' HB2' ' HB2' ' A' ' 276' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.662 -0.685 . . . . 0.0 110.285 -177.29 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 . . . . . 0 N--CA 1.479 0.979 0 CA-C-O 121.017 0.436 . . . . 0.0 110.471 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 40.9 m -114.65 -18.25 11.45 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.792 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.552 ' HB3' HD22 ' A' ' 263' ' ' LEU . . . -155.89 -179.28 7.98 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.573 -178.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 43.8 m -98.61 -42.36 7.3 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.887 0.375 . . . . 0.0 110.121 177.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -159.1 -56.25 0.06 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.048 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 71.5 m 62.89 81.92 0.19 Allowed 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.528 0.68 . . . . 0.0 109.463 -170.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 16.1 m -73.54 179.33 4.14 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.346 -174.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . 0.779 HG23 ' HE2' ' A' ' 274' ' ' TYR . 0.0 OUTLIER -127.78 51.12 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.397 -178.734 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 26.4 tp 60.9 29.47 19.03 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.645 0.736 . . . . 0.0 109.67 -179.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 9.2 mp 65.03 14.58 9.46 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 114.752 -1.113 . . . . 0.0 111.204 -177.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . 60.41 24.12 13.68 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.665 179.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.459 HG23 ' HG3' ' A' ' 200' ' ' GLN . 31.5 m -65.41 -22.71 31.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.767 0.318 . . . . 0.0 111.624 -178.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' GLN . . . . . 0.459 ' HG3' HG23 ' A' ' 199' ' ' VAL . 46.1 mt-30 -117.98 13.49 13.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.105 0.479 . . . . 0.0 110.122 176.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 -145.72 31.96 1.05 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.557 -173.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 17.5 m -69.49 -37.87 77.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.135 -176.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -118.76 39.97 2.4 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 120.366 -0.921 . . . . 0.0 112.429 -175.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -87.19 88.62 7.74 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 121.164 0.507 . . . . 0.0 109.645 178.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' CYS . . . . . 0.555 ' HA ' HG12 ' A' ' 251' ' ' ILE . 5.4 m -87.05 145.56 26.43 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.222 -176.265 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . 0.823 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 7.7 mtp180 55.15 6.65 0.15 Allowed 'General case' 0 C--O 1.219 -0.549 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 70.5 m-20 -106.6 105.8 16.01 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 118.953 0.797 . . . . 0.0 111.9 -172.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.467 ' HB ' ' HB ' ' A' ' 246' ' ' VAL . 59.4 t -135.4 118.19 22.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.041 177.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' PHE . . . . . 0.425 ' HE1' ' HB ' ' A' ' 243' ' ' ILE . 2.3 t80 -116.92 125.13 51.01 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.263 -176.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.51 ' HG ' HG22 ' A' ' 272' ' ' ILE . 5.6 mp -107.65 132.19 53.58 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.265 178.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . 0.536 ' HA2' HG22 ' A' ' 243' ' ' ILE . . . -137.64 62.09 0.58 Allowed Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.309 -0.948 . . . . 0.0 113.326 -179.304 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . 0.548 ' HB2' ' HG2' ' A' ' 271' ' ' ARG . 38.8 t30 177.64 38.38 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.775 0.321 . . . . 0.0 110.598 175.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.488 HD22 HD22 ' A' ' 210' ' ' LEU . 1.0 OUTLIER -87.26 158.82 51.8 Favored Pre-proline 0 C--N 1.319 -0.74 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 178.828 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.402 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 83.8 Cg_endo -78.42 161.47 28.47 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.403 2.068 . . . . 0.0 110.994 176.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . 0.581 ' HA ' ' OG1' ' A' ' 239' ' ' THR . 9.1 t-20 -78.41 127.46 32.22 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -179.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 108.21 -6.27 34.33 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.485 -176.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . 0.634 HG21 HG21 ' A' ' 237' ' ' ILE . 4.5 tp -61.57 129.41 24.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.884 0.373 . . . . 0.0 110.309 177.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' THR . . . . . 0.473 ' CG2' ' HG3' ' A' ' 221' ' ' GLU . 15.2 t -112.83 155.9 23.84 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.4 0.619 . . . . 0.0 110.605 -179.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.422 ' CD ' ' H ' ' A' ' 219' ' ' GLU . 8.0 mp0 -63.95 -34.77 78.73 Favored 'General case' 0 C--O 1.206 -1.211 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.936 -176.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -54.69 -35.67 63.84 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 123.335 0.397 . . . . 0.0 110.591 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . 0.515 ' O ' ' HG2' ' A' ' 224' ' ' GLU . 46.1 mt-10 -67.03 -58.64 4.54 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.276 177.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . 0.5 HD13 HD12 ' A' ' 237' ' ' ILE . 7.8 mt -61.24 -38.48 79.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.63 -178.068 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . 0.69 ' HG3' HD11 ' A' ' 235' ' ' ILE . 51.2 mtp180 -54.17 -63.14 1.25 Allowed 'General case' 0 CA--C 1.508 -0.645 0 CA-C-O 121.125 0.488 . . . . 0.0 111.693 174.358 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.515 ' HG2' ' O ' ' A' ' 221' ' ' GLU . 17.7 pt-20 -60.48 -17.38 44.69 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.03 -177.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' ASP . . . . . 0.512 ' HB3' ' CZ2' ' A' ' 267' ' ' TRP . 13.7 m-20 -89.23 -33.76 16.87 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.371 -179.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.718 HD23 ' HZ ' ' A' ' 248' ' ' PHE . 7.7 mp -106.98 -11.48 15.67 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 111.979 0.362 . . . . 0.0 111.979 -171.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . 0.621 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 53.3 mm-40 -62.97 -36.0 22.19 Favored Pre-proline 0 C--N 1.325 -0.468 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -178.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . 0.621 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 85.7 Cg_endo -66.21 -31.1 45.31 Favored 'Trans proline' 0 C--N 1.358 1.071 0 C-N-CA 121.43 1.42 . . . . 0.0 112.163 -173.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . 0.5 ' CZ ' ' HA ' ' A' ' 226' ' ' LEU . 4.0 p90 -110.21 -0.73 17.7 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.628 177.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . 0.434 ' CA ' ' HB2' ' A' ' 253' ' ' ALA . . . -177.21 94.61 0.1 OUTLIER Glycine 0 N--CA 1.441 -1.002 0 C-N-CA 119.658 -1.258 . . . . 0.0 112.64 -178.095 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . 0.413 ' HD2' ' HA2' ' A' ' 230' ' ' GLY . 17.1 Cg_endo -59.53 131.54 40.98 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 121.877 1.718 . . . . 0.0 111.246 175.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.769 HG23 HG13 ' A' ' 246' ' ' VAL . 2.7 mp -106.86 151.9 8.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.423 178.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . 0.499 ' CG ' HD23 ' A' ' 249' ' ' LEU . 34.2 m-20 -109.93 -23.62 11.25 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.786 0.326 . . . . 0.0 110.223 179.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . 0.407 ' HB3' ' HB2' ' A' ' 247' ' ' HIS . 13.7 tt0 -143.43 126.83 16.77 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.843 -177.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . 0.69 HD11 ' HG3' ' A' ' 223' ' ' ARG . 15.6 mt -139.52 113.49 6.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.903 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -121.12 116.67 25.43 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.33 -178.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' ILE . . . . . 0.634 HG21 HG21 ' A' ' 217' ' ' ILE . 86.7 mt -104.76 126.01 59.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.434 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.566 ' HB ' HG13 ' A' ' 243' ' ' ILE . 42.1 t -103.8 85.51 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.046 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 169.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' THR . . . . . 0.581 ' OG1' ' HA ' ' A' ' 215' ' ' ASN . 11.7 t -71.04 -16.56 62.61 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.637 -173.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -65.36 -33.0 74.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.117 174.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . 0.509 ' HB2' HG12 ' A' ' 243' ' ' ILE . 71.1 mtt180 -110.74 3.18 18.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.085 -178.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' ASN . . . . . 0.445 ' O ' HD11 ' A' ' 213' ' ' LEU . 16.1 m120 68.35 23.7 7.55 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.108 177.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.566 HG13 ' HB ' ' A' ' 238' ' ' VAL . 1.5 pt -122.43 150.65 26.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.466 -174.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . 0.413 ' HB2' ' HB2' ' A' ' 210' ' ' LEU . . . -143.19 139.47 30.32 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.053 0.454 . . . . 0.0 111.668 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -109.3 115.78 30.63 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.765 178.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . 0.769 HG13 HG23 ' A' ' 232' ' ' ILE . 1.3 t -112.3 134.89 53.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -179.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' HIS . . . . . 0.823 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 33.5 m170 -112.98 101.7 9.72 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.016 -0.674 . . . . 0.0 111.309 177.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . 0.718 ' HZ ' HD23 ' A' ' 226' ' ' LEU . 34.5 m-85 -86.28 104.25 15.63 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-N 115.089 -0.96 . . . . 0.0 111.651 179.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.499 HD23 ' CG ' ' A' ' 233' ' ' ASP . 0.0 OUTLIER -42.85 -48.17 5.71 Favored 'General case' 0 N--CA 1.465 0.306 0 O-C-N 124.506 1.129 . . . . 0.0 112.975 -175.192 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 -93.37 141.4 28.49 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.112 176.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . 0.627 ' O ' HG13 ' A' ' 255' ' ' ILE . 0.3 OUTLIER -61.71 -39.94 85.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.027 -178.549 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -68.64 -31.72 71.07 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.995 -176.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . 0.434 ' HB2' ' CA ' ' A' ' 230' ' ' GLY . . . -61.68 -41.81 98.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.298 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . 0.517 ' HB3' ' HB2' ' A' ' 248' ' ' PHE . . . -67.17 -41.72 85.47 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.409 178.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.627 HG13 ' O ' ' A' ' 251' ' ' ILE . 10.6 mt -57.37 -59.45 3.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.065 -178.385 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . 0.412 ' O ' ' HG2' ' A' ' 260' ' ' GLU . 13.9 ptmt -62.27 -40.33 95.86 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.305 -177.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -61.55 -48.93 78.74 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.668 0.271 . . . . 0.0 111.184 178.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . 0.486 HG12 HG12 ' A' ' 272' ' ' ILE . 53.5 t -65.86 -26.33 38.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.907 0.384 . . . . 0.0 111.107 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 28.7 mm-40 -84.94 -24.61 28.31 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 178.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . 0.412 ' HG2' ' O ' ' A' ' 256' ' ' LYS . 71.9 mm-40 -95.3 -31.42 13.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.595 0.236 . . . . 0.0 111.026 -176.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.709 HD13 ' CE3' ' A' ' 267' ' ' TRP . 0.4 OUTLIER -50.91 -51.04 70.78 Favored Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.266 178.727 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' A' ' 261' ' ' LEU . 43.3 Cg_endo -67.42 -14.62 43.16 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.465 2.11 . . . . 0.0 112.698 -177.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . 0.552 HD22 ' HB3' ' A' ' 190' ' ' ALA . 52.6 mt -92.43 -4.69 53.34 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.175 0.512 . . . . 0.0 111.367 -179.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' ASN . . . . . 0.407 ' O ' ' HB2' ' A' ' 268' ' ' SER . 10.9 m-80 -106.18 149.42 38.15 Favored Pre-proline 0 C--N 1.315 -0.929 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.998 -175.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -63.9 -38.58 37.74 Favored 'Trans proline' 0 N--CA 1.465 -0.171 0 C-N-CA 123.421 2.747 . . . . 0.0 112.534 -169.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 7.1 mtpt -84.62 -45.09 12.86 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 121.648 0.737 . . . . 0.0 109.376 -177.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' TRP . . . . . 0.709 ' CE3' HD13 ' A' ' 261' ' ' LEU . 12.9 m0 -77.37 -27.6 52.63 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.737 -1.12 . . . . 0.0 111.058 -171.078 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' SER . . . . . 0.407 ' HB2' ' O ' ' A' ' 264' ' ' ASN . 12.0 t -65.47 -21.93 66.69 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.934 0.397 . . . . 0.0 110.547 178.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -72.7 -22.66 60.86 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.301 0.572 . . . . 0.0 110.069 177.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' ARG . . . . . 0.479 ' HA ' ' HB3' ' A' ' 212' ' ' ASN . 5.4 mpt_? -92.98 141.3 28.56 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 178.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . 0.548 ' HG2' ' HB2' ' A' ' 212' ' ' ASN . 37.5 mmt180 -93.02 105.93 17.96 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 178.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . 0.621 HG21 HD23 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -114.33 142.65 26.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.242 0.544 . . . . 0.0 111.42 -176.902 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -152.35 169.29 22.89 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.55 173.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 274' ' ' TYR . . . . . 0.779 ' HE2' HG23 ' A' ' 195' ' ' VAL . 85.2 m-85 -64.3 136.93 57.62 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.692 0.282 . . . . 0.0 110.41 173.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -65.93 171.46 26.96 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.053 176.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . 0.476 ' O ' ' HB3' ' A' ' 277' ' ' ASP . 16.5 mmt180 -87.49 152.67 22.03 Favored 'General case' 0 C--N 1.32 -0.702 0 O-C-N 122.735 -0.273 . . . . 0.0 110.335 -177.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 277' ' ' ASP . . . . . 0.476 ' HB3' ' O ' ' A' ' 276' ' ' ARG . 8.9 t70 68.55 150.07 0.07 Allowed 'General case' 0 CA--C 1.533 0.326 0 O-C-N 124.106 0.879 . . . . 0.0 110.678 -173.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 278' ' ' ARG . . . . . . . . . . . . . 60.9 mtt-85 -73.78 -35.08 64.92 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 122.082 -0.386 . . . . 0.0 111.626 -177.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' CYS . . . . . . . . . . . . . 73.1 m 59.71 25.15 14.09 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.299 0.571 . . . . 0.0 110.769 -175.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -110.5 18.8 19.4 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.144 -179.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 9.2 p -88.86 -19.16 7.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.655 -177.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -135.96 63.94 0.58 Allowed Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.118 178.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 83.4 mt -103.78 130.48 51.32 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.844 0.354 . . . . 0.0 110.552 178.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . 0.777 ' HE2' ' HA ' ' A' ' 284' ' ' LYS . 0.5 OUTLIER . . . . . 0 C--O 1.247 0.947 0 CA-C-O 118.511 -0.756 . . . . 0.0 109.941 178.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 . . . . . 0 N--CA 1.482 1.163 0 CA-C-O 120.734 0.302 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 17.0 p -87.33 -41.52 13.57 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.308 0.575 . . . . 0.0 110.119 176.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -118.47 -179.13 3.7 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.844 177.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 25.1 m 66.83 17.72 10.58 Favored 'General case' 0 N--CA 1.463 0.186 0 O-C-N 123.552 0.533 . . . . 0.0 110.682 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -93.6 160.37 14.81 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 178.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 13.3 m -73.41 92.56 1.86 Allowed 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.409 178.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 17.5 m -70.43 95.49 1.05 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 176.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 16.5 m -134.94 139.84 46.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.149 -175.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 89.0 mt -80.33 -4.0 51.71 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 167.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 56.9 tp -64.77 -23.37 67.22 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.742 -1.117 . . . . 0.0 109.165 169.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -64.34 -32.59 74.25 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.364 177.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 33.2 m -103.51 12.32 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 177.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 47.66 30.03 1.66 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.937 1.295 . . . . 0.0 113.203 177.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -139.33 124.89 19.34 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.17 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 48.7 m -159.42 127.88 5.09 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.375 -179.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -82.87 48.17 3.96 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.939 -0.648 . . . . 0.0 111.986 177.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . 0.733 ' HA ' ' HA ' ' A' ' 280' ' ' ALA . . . -111.67 101.61 9.97 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 -179.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' CYS . . . . . 0.514 ' HA ' HG12 ' A' ' 251' ' ' ILE . 2.4 m -87.27 145.58 26.31 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -177.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . 0.882 ' HE ' ' HA ' ' A' ' 249' ' ' LEU . 16.9 mtp180 54.2 9.14 0.21 Allowed 'General case' 0 C--O 1.22 -0.483 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 176.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . 0.62 HD22 ' HB2' ' A' ' 277' ' ' ASP . 11.0 m120 -109.9 107.02 16.8 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-N 118.988 0.813 . . . . 0.0 112.493 -174.083 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.531 ' HB ' ' HB ' ' A' ' 246' ' ' VAL . 60.8 t -135.3 127.11 46.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 114.878 -1.055 . . . . 0.0 109.148 177.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' PHE . . . . . 0.442 ' O ' ' HA ' ' A' ' 272' ' ' ILE . 6.8 t80 -122.37 127.41 49.71 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-O 120.725 0.298 . . . . 0.0 110.307 -178.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.502 ' HG ' HG23 ' A' ' 272' ' ' ILE . 4.7 mp -109.77 126.03 53.32 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.335 176.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . 0.571 ' HA2' HG22 ' A' ' 243' ' ' ILE . . . -130.65 57.49 0.72 Allowed Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.265 -0.969 . . . . 0.0 113.373 -178.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . 0.498 ' HB3' ' HA ' ' A' ' 270' ' ' ARG . 2.8 t30 177.4 49.74 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.061 0.458 . . . . 0.0 110.509 177.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.488 HD23 HD21 ' A' ' 210' ' ' LEU . 1.0 OUTLIER -97.39 159.05 32.09 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.184 178.722 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.414 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 95.8 Cg_endo -79.85 154.46 23.09 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.326 2.017 . . . . 0.0 112.15 178.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . 0.531 ' HA ' ' OG1' ' A' ' 239' ' ' THR . 8.8 m120 -66.31 121.21 14.74 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.032 177.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 108.86 -1.97 31.86 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.451 -0.88 . . . . 0.0 112.876 -177.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . 0.559 HG22 HG21 ' A' ' 237' ' ' ILE . 5.7 tp -64.08 128.0 25.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.046 0.451 . . . . 0.0 110.525 175.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' THR . . . . . 0.498 HG21 ' HG3' ' A' ' 221' ' ' GLU . 4.9 t -114.22 157.55 22.54 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.119 0.485 . . . . 0.0 110.575 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -61.66 -40.31 94.48 Favored 'General case' 0 C--O 1.208 -1.11 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.41 -175.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -51.46 -35.81 41.44 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 123.514 0.509 . . . . 0.0 111.029 -179.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . 0.498 ' HG3' HG21 ' A' ' 218' ' ' THR . 43.4 mt-10 -67.65 -55.9 11.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.303 178.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . 0.487 HD13 HD13 ' A' ' 237' ' ' ILE . 8.0 mt -60.95 -41.21 88.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.537 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . 0.618 ' HG3' HD11 ' A' ' 235' ' ' ILE . 26.1 mtp180 -56.55 -61.81 2.16 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 175.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -57.16 -21.64 34.43 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.625 -178.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' ASP . . . . . 0.434 ' HB3' ' CZ2' ' A' ' 267' ' ' TRP . 12.8 m-20 -87.27 -33.98 19.07 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.746 -178.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.783 HD21 ' HZ ' ' A' ' 248' ' ' PHE . 7.7 mp -106.83 -18.01 14.05 Favored 'General case' 0 C--O 1.224 -0.247 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -170.008 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . 0.666 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 35.7 mt-10 -65.79 -31.58 4.95 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -175.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . 0.666 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 72.0 Cg_endo -65.94 -29.94 48.94 Favored 'Trans proline' 0 C--N 1.359 1.085 0 C-N-CA 121.459 1.439 . . . . 0.0 112.3 -176.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . 0.488 ' CE1' ' HA ' ' A' ' 226' ' ' LEU . 3.6 p90 -111.06 -4.22 15.18 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.579 176.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . -172.08 95.73 0.11 Allowed Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.127 -1.035 . . . . 0.0 112.478 -176.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -61.58 133.64 46.68 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.174 1.916 . . . . 0.0 111.43 177.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.785 HG21 HG11 ' A' ' 246' ' ' VAL . 2.5 mp -110.42 151.3 12.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.925 178.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . 0.424 ' OD2' HD21 ' A' ' 249' ' ' LEU . 6.7 m-20 -110.89 -25.49 9.82 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.92 177.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . 0.59 ' HB3' ' HB2' ' A' ' 247' ' ' HIS . 16.8 tt0 -138.82 120.57 15.3 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.551 -174.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . 0.618 HD11 ' HG3' ' A' ' 223' ' ' ARG . 11.1 mt -137.08 107.73 5.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.99 178.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 63.1 tttp -115.81 113.79 23.87 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.364 -177.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' ILE . . . . . 0.559 HG21 HG22 ' A' ' 217' ' ' ILE . 86.4 mt -102.13 125.71 56.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-O 121.134 0.492 . . . . 0.0 110.955 -179.18 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.537 ' HB ' HG13 ' A' ' 243' ' ' ILE . 57.7 t -108.81 87.31 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 171.155 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' THR . . . . . 0.531 ' OG1' ' HA ' ' A' ' 215' ' ' ASN . 14.4 t -68.91 -12.62 61.79 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.529 -177.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 18.6 mp0 -63.01 -35.48 80.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.986 175.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . 0.657 ' HB2' HG12 ' A' ' 243' ' ' ILE . 66.8 mtp180 -115.58 4.2 14.13 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.1 179.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' ASN . . . . . 0.437 ' O ' HD11 ' A' ' 213' ' ' LEU . 15.9 m120 65.85 30.56 9.93 Favored 'General case' 0 N--CA 1.465 0.278 0 O-C-N 123.446 0.466 . . . . 0.0 110.743 178.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.657 HG12 ' HB2' ' A' ' 241' ' ' ARG . 1.3 pt -122.06 149.72 25.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.158 -175.081 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -142.36 138.14 30.98 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.048 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -109.54 120.79 43.57 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.881 179.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . 0.785 HG11 HG21 ' A' ' 232' ' ' ILE . 0.5 OUTLIER -116.3 136.16 54.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.981 -176.385 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' HIS . . . . . 0.828 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 20.1 m170 -114.45 102.97 10.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.191 0.519 . . . . 0.0 111.23 175.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . 0.783 ' HZ ' HD21 ' A' ' 226' ' ' LEU . 29.7 m-85 -85.76 103.79 14.86 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.014 178.006 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.882 ' HA ' ' HE ' ' A' ' 206' ' ' ARG . 0.1 OUTLIER -44.64 -39.28 4.91 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 124.218 0.949 . . . . 0.0 113.311 -172.998 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 57.9 m-20 -100.17 144.71 28.88 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 178.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . 0.568 ' O ' HG13 ' A' ' 255' ' ' ILE . 0.3 OUTLIER -63.89 -43.3 97.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -176.618 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -68.63 -31.12 70.04 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.111 -177.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -58.25 -42.88 87.39 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.541 179.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . 0.541 ' HB3' ' HB2' ' A' ' 248' ' ' PHE . . . -68.52 -41.67 79.63 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.614 178.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.568 HG13 ' O ' ' A' ' 251' ' ' ILE . 8.4 mt -57.03 -58.47 5.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.456 -177.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . 0.405 ' O ' ' HG2' ' A' ' 260' ' ' GLU . 11.1 ptmt -63.81 -38.79 92.42 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.395 -177.201 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -63.19 -49.83 72.72 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.632 0.253 . . . . 0.0 111.297 178.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . 0.547 HG13 HG12 ' A' ' 272' ' ' ILE . 70.3 t -66.8 -22.9 30.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 120.883 0.373 . . . . 0.0 111.09 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . 0.429 ' HG3' ' O ' ' A' ' 255' ' ' ILE . 63.9 mt-30 -83.53 -24.1 31.8 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 176.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . 0.405 ' HG2' ' O ' ' A' ' 256' ' ' LYS . 42.4 mm-40 -94.75 -33.61 12.84 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.868 0.366 . . . . 0.0 110.893 -176.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.706 HD13 ' CE3' ' A' ' 267' ' ' TRP . 0.9 OUTLIER -51.57 -50.91 74.23 Favored Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.508 -179.777 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' A' ' 261' ' ' LEU . 44.5 Cg_endo -67.5 -15.4 45.08 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.378 2.052 . . . . 0.0 112.679 -177.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 59.2 mt -96.66 0.55 49.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.062 0.458 . . . . 0.0 111.673 -177.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 -107.05 148.6 37.31 Favored Pre-proline 0 C--N 1.314 -0.94 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.34 -177.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -64.11 -35.28 54.19 Favored 'Trans proline' 0 C--O 1.23 0.092 0 C-N-CA 123.509 2.806 . . . . 0.0 112.411 -172.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 3.5 mtpt -86.11 -45.17 11.63 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 121.643 0.735 . . . . 0.0 109.738 -178.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' TRP . . . . . 0.706 ' CE3' HD13 ' A' ' 261' ' ' LEU . 15.4 m0 -78.03 -28.53 49.06 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 114.772 -1.104 . . . . 0.0 111.14 -172.222 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 23.0 t -68.51 -15.11 63.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.797 0.332 . . . . 0.0 110.812 178.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -73.76 -17.32 61.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.41 0.624 . . . . 0.0 109.631 174.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' ARG . . . . . 0.498 ' HA ' ' HB3' ' A' ' 212' ' ' ASN . 4.7 mpt_? -97.43 154.72 17.29 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.444 177.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' A' ' 271' ' ' ARG . 39.5 mmt-85 -104.5 105.78 16.02 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 174.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . 0.601 HG22 HD22 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -115.65 141.14 34.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-O 121.306 0.574 . . . . 0.0 111.536 -177.09 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -152.37 169.8 21.65 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.363 171.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 274' ' ' TYR . . . . . 0.42 ' OH ' ' HA ' ' A' ' 255' ' ' ILE . 84.4 m-85 -63.5 124.71 22.03 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.983 0.42 . . . . 0.0 110.755 176.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -76.28 -175.02 39.09 Favored Glycine 0 CA--C 1.518 0.221 0 CA-C-N 115.62 -0.718 . . . . 0.0 113.726 -172.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . 0.502 ' HG2' HD23 ' A' ' 283' ' ' LEU . 49.9 mtm180 -103.21 131.53 50.17 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.681 0.277 . . . . 0.0 111.094 -176.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 277' ' ' ASP . . . . . 0.62 ' HB2' HD22 ' A' ' 207' ' ' ASN . 26.3 t70 -172.4 165.66 5.77 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.833 -179.026 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 278' ' ' ARG . . . . . 0.477 ' HD2' ' N ' ' A' ' 279' ' ' CYS . 7.1 ppt_? -69.87 -20.09 63.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.323 179.015 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' CYS . . . . . 0.477 ' N ' ' HD2' ' A' ' 278' ' ' ARG . 35.2 t -101.51 21.55 14.1 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.532 0.682 . . . . 0.0 109.826 178.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . 0.733 ' HA ' ' HA ' ' A' ' 204' ' ' ALA . . . -125.83 93.06 3.73 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.785 -178.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 7.8 p -88.62 17.45 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 122.097 0.951 . . . . 0.0 109.727 178.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -85.83 -1.56 87.03 Favored Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.021 173.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 283' ' ' LEU . . . . . 0.502 HD23 ' HG2' ' A' ' 276' ' ' ARG . 33.4 tp -100.29 88.25 3.64 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.053 -0.573 . . . . 0.0 109.93 179.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 61.8 tttm . . . . . 0 C--O 1.247 0.943 0 CA-C-O 118.254 -0.879 . . . . 0.0 109.94 -178.008 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 . . . . . 0 N--CA 1.479 0.986 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 12.7 m -55.27 -64.14 0.94 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.359 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . 68.88 -59.34 0.47 Allowed 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.474 0.71 . . . . 0.0 111.485 -176.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 17.0 m -90.8 30.1 1.24 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.6 0.238 . . . . 0.0 111.48 -177.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -121.63 -45.51 2.29 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.445 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 17.2 m 69.5 -84.28 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.058 175.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 11.5 m -64.06 149.65 47.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.61 0.243 . . . . 0.0 111.217 -174.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . 0.623 HG11 ' HB2' ' A' ' 273' ' ' TYR . 3.5 m -101.55 -3.23 9.44 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.612 0 CA-C-O 120.827 0.346 . . . . 0.0 111.516 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . 0.496 ' O ' HD23 ' A' ' 196' ' ' LEU . 2.4 tt 51.79 71.22 0.47 Allowed 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.911 -176.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 27.7 tp 61.26 9.83 2.72 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.812 -178.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.559 ' HA ' ' HB ' ' A' ' 195' ' ' VAL . . . 63.74 20.16 12.09 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 123.065 0.546 . . . . 0.0 111.657 178.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 196' ' ' LEU . 31.3 m -98.68 22.99 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.086 0.469 . . . . 0.0 110.968 -178.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 25.9 mm-40 -115.01 28.82 8.45 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.185 -178.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 50.95 76.81 0.14 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-O 121.254 0.549 . . . . 0.0 111.137 -176.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 20.3 m -127.04 21.81 6.76 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.278 -177.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -59.25 94.52 0.06 OUTLIER Glycine 0 C--N 1.334 0.419 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.986 -175.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -103.01 149.49 24.49 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.565 -0.317 . . . . 0.0 110.161 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' CYS . . . . . 0.673 ' HB2' HG12 ' A' ' 251' ' ' ILE . 35.7 t -91.16 145.61 24.53 Favored 'General case' 0 CA--C 1.508 -0.666 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.13 -178.136 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . 0.758 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 39.4 mtm180 48.97 1.13 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -108.96 105.63 15.24 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 119.053 0.842 . . . . 0.0 111.824 -170.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 63.4 t -137.43 123.09 26.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 114.605 -1.179 . . . . 0.0 109.18 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' PHE . . . . . 0.435 ' CE1' ' HB ' ' A' ' 243' ' ' ILE . 4.0 t80 -120.0 128.18 53.3 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.723 0.297 . . . . 0.0 110.655 -178.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.487 ' HG ' HG23 ' A' ' 272' ' ' ILE . 4.8 mp -108.27 126.53 52.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.534 177.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . 0.566 ' HA2' HG21 ' A' ' 243' ' ' ILE . . . -132.92 59.96 0.68 Allowed Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.702 -0.761 . . . . 0.0 113.445 -178.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . 0.487 ' HB3' ' HA ' ' A' ' 270' ' ' ARG . 3.4 t30 178.22 42.11 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.279 0.561 . . . . 0.0 109.815 177.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.713 HD23 ' HG2' ' A' ' 270' ' ' ARG . 1.0 OUTLIER -89.57 163.52 32.86 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.098 -179.94 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.498 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 89.2 Cg_endo -81.62 161.65 19.23 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 122.383 2.055 . . . . 0.0 111.342 175.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -72.94 128.19 34.75 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.574 176.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 103.94 -5.56 46.65 Favored Glycine 0 C--N 1.313 -0.722 0 C-N-CA 120.446 -0.883 . . . . 0.0 113.039 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . 0.6 HG23 HG22 ' A' ' 237' ' ' ILE . 5.1 tp -58.56 128.36 19.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.973 0.416 . . . . 0.0 110.734 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' THR . . . . . 0.432 ' CG2' ' HG3' ' A' ' 221' ' ' GLU . 14.9 t -112.28 157.24 21.19 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-O 121.394 0.616 . . . . 0.0 110.975 -178.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.417 ' CD ' ' H ' ' A' ' 219' ' ' GLU . 3.9 mp0 -62.36 -36.7 83.09 Favored 'General case' 0 C--O 1.207 -1.16 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.591 -177.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' ASP . . . . . 0.457 ' O ' ' HG2' ' A' ' 224' ' ' GLU . 37.4 t70 -50.1 -40.14 44.89 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 123.745 0.653 . . . . 0.0 111.144 179.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . 0.432 ' HG3' ' CG2' ' A' ' 218' ' ' THR . 41.6 mt-10 -68.74 -56.96 6.41 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.326 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . 0.478 HD13 HD11 ' A' ' 237' ' ' ILE . 7.5 mt -60.05 -42.25 89.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.743 -179.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . 0.72 ' HG3' HD11 ' A' ' 235' ' ' ILE . 53.9 mtp85 -54.3 -63.56 1.11 Allowed 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 176.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.457 ' HG2' ' O ' ' A' ' 220' ' ' ASP . 14.4 pt-20 -60.52 -20.36 59.98 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.975 -176.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -88.69 -32.29 18.06 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.553 -177.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.68 HD22 ' HZ ' ' A' ' 248' ' ' PHE . 8.6 mp -107.32 -18.76 13.79 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -170.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . 0.672 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 31.5 mt-10 -71.48 -25.33 0.78 Allowed Pre-proline 0 C--N 1.324 -0.5 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -175.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . 0.672 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 74.2 Cg_endo -65.76 -28.84 51.35 Favored 'Trans proline' 0 C--N 1.359 1.102 0 CA-C-N 120.692 1.283 . . . . 0.0 112.019 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . 0.463 ' CE1' ' HA ' ' A' ' 226' ' ' LEU . 3.7 p90 -110.92 -2.08 16.17 Favored 'General case' 0 C--O 1.224 -0.249 0 C-N-CA 120.921 -0.311 . . . . 0.0 111.463 174.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . 0.463 ' CA ' ' HB2' ' A' ' 253' ' ' ALA . . . -174.21 94.31 0.1 OUTLIER Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 120.249 -0.977 . . . . 0.0 112.23 -177.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -62.74 130.14 28.59 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 121.975 1.784 . . . . 0.0 111.401 178.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.818 HG21 HG12 ' A' ' 246' ' ' VAL . 2.8 mp -106.4 152.33 8.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.442 178.12 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . 0.405 ' CG ' HD23 ' A' ' 249' ' ' LEU . 23.4 m-20 -111.29 -26.98 8.87 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.762 176.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . 0.42 ' HB3' ' HB2' ' A' ' 247' ' ' HIS . 20.4 tt0 -136.97 120.51 17.12 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.635 -175.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . 0.72 HD11 ' HG3' ' A' ' 223' ' ' ARG . 20.0 mt -134.99 105.8 6.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.675 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.413 ' HE2' HD21 ' A' ' 283' ' ' LEU . 86.8 tttt -111.58 109.45 19.37 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.321 -175.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' ILE . . . . . 0.6 HG22 HG23 ' A' ' 217' ' ' ILE . 87.4 mt -101.23 122.28 53.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 121.286 0.565 . . . . 0.0 111.155 -177.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.563 ' HB ' HG13 ' A' ' 243' ' ' ILE . 46.5 t -103.63 87.39 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 170.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 11.6 t -67.5 -19.31 65.31 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.463 -176.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -65.98 -29.56 69.97 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.696 176.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . 0.528 ' HB2' HG12 ' A' ' 243' ' ' ILE . 98.9 mtt180 -117.39 4.85 12.52 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.803 -179.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 15.9 m120 64.81 27.24 12.96 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.988 176.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.566 HG21 ' HA2' ' A' ' 211' ' ' GLY . 1.4 pt -122.4 148.9 25.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.165 -175.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -142.41 137.58 30.51 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.969 0.414 . . . . 0.0 111.556 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' PHE . . . . . 0.473 ' HE2' ' HB1' ' A' ' 280' ' ' ALA . 34.1 m-85 -105.51 120.31 41.31 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.894 177.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . 0.818 HG12 HG21 ' A' ' 232' ' ' ILE . 0.2 OUTLIER -115.11 132.15 65.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -178.558 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' HIS . . . . . 0.758 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 50.1 m170 -111.43 102.58 10.94 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.164 -0.614 . . . . 0.0 111.311 176.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . 0.68 ' HZ ' HD22 ' A' ' 226' ' ' LEU . 33.2 m-85 -86.04 103.28 14.58 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.068 178.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.405 HD23 ' CG ' ' A' ' 233' ' ' ASP . 0.1 OUTLIER -43.7 -39.52 3.7 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 124.139 0.899 . . . . 0.0 113.342 -175.8 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -96.51 144.92 26.16 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.512 177.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . 0.673 HG12 ' HB2' ' A' ' 205' ' ' CYS . 0.2 OUTLIER -64.06 -43.22 97.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.723 -178.83 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -72.03 -30.78 65.54 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.672 -176.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . 0.463 ' HB2' ' CA ' ' A' ' 230' ' ' GLY . . . -58.72 -41.93 87.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.217 178.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . 0.55 ' HB2' ' HB2' ' A' ' 248' ' ' PHE . . . -69.24 -40.61 77.81 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.821 178.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.651 ' HA ' ' HH ' ' A' ' 274' ' ' TYR . 6.5 mt -57.84 -60.85 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.453 -177.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . 0.442 ' O ' ' HG2' ' A' ' 260' ' ' GLU . 11.8 ptmt -61.98 -38.45 88.62 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.396 -177.062 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -61.47 -48.51 80.78 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.617 0.246 . . . . 0.0 111.182 178.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . 0.523 HG13 HG12 ' A' ' 272' ' ' ILE . 69.7 t -66.92 -23.97 31.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.892 0.377 . . . . 0.0 110.972 179.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -83.42 -26.93 29.93 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 177.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . 0.442 ' HG2' ' O ' ' A' ' 256' ' ' LYS . 51.1 mm-40 -94.74 -30.97 14.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.72 0.295 . . . . 0.0 111.223 -174.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.688 HD12 ' CE3' ' A' ' 267' ' ' TRP . 0.6 OUTLIER -52.85 -50.74 79.78 Favored Pre-proline 0 CA--C 1.538 0.51 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.375 179.366 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' PRO . . . . . 0.54 ' HD2' ' N ' ' A' ' 261' ' ' LEU . 41.2 Cg_endo -67.47 -16.46 47.53 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.357 2.038 . . . . 0.0 112.667 -178.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 59.1 mt -89.77 -7.83 53.56 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.235 0.54 . . . . 0.0 111.574 -177.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -106.38 148.17 36.24 Favored Pre-proline 0 C--N 1.311 -1.068 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.897 -174.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -64.1 -36.4 48.05 Favored 'Trans proline' 0 C--N 1.334 -0.208 0 C-N-CA 123.512 2.808 . . . . 0.0 112.584 -169.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 8.2 mtpt -86.23 -44.58 12.04 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 121.558 0.694 . . . . 0.0 109.791 -176.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' TRP . . . . . 0.688 ' CE3' HD12 ' A' ' 261' ' ' LEU . 11.2 m0 -76.49 -28.57 56.51 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.519 -174.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 22.9 t -64.18 -21.61 66.63 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.712 0.292 . . . . 0.0 110.532 177.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 64.2 mttm -70.53 -16.67 62.91 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-O 121.299 0.571 . . . . 0.0 110.087 176.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' ARG . . . . . 0.713 ' HG2' HD23 ' A' ' 213' ' ' LEU . 3.1 mpt_? -103.4 146.25 28.78 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.646 -179.076 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . 0.436 ' NE ' ' HA ' ' A' ' 271' ' ' ARG . 4.9 mmp_? -97.44 107.59 20.13 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 178.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . 0.617 HG21 HD22 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -116.15 142.22 30.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.141 0.496 . . . . 0.0 111.174 -176.967 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 273' ' ' TYR . . . . . 0.623 ' HB2' HG11 ' A' ' 195' ' ' VAL . 3.0 p90 -150.93 167.68 26.83 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.661 172.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 274' ' ' TYR . . . . . 0.651 ' HH ' ' HA ' ' A' ' 255' ' ' ILE . 87.2 m-85 -67.35 138.78 57.02 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.072 173.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -88.4 107.55 3.35 Favored Glycine 0 N--CA 1.441 -0.968 0 C-N-CA 120.172 -1.013 . . . . 0.0 112.34 -178.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . 0.422 ' N ' ' HD3' ' A' ' 276' ' ' ARG . 0.0 OUTLIER -123.42 101.06 7.14 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.689 0.757 . . . . 0.0 110.254 175.834 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 26.2 t70 179.28 144.37 0.15 Allowed 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.363 -1.289 . . . . 0.0 109.442 -173.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 278' ' ' ARG . . . . . . . . . . . . . 34.6 ptt85 -89.58 -13.6 36.89 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -175.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' CYS . . . . . . . . . . . . . 68.7 m -97.22 -2.41 42.86 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.441 0.639 . . . . 0.0 110.031 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . 0.473 ' HB1' ' HE2' ' A' ' 245' ' ' PHE . . . -86.84 13.87 8.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.935 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 14.7 p -88.4 -18.62 7.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.39 176.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -160.2 100.82 0.19 Allowed Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.835 178.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 283' ' ' LEU . . . . . 0.413 HD21 ' HE2' ' A' ' 236' ' ' LYS . 3.9 pp -73.05 153.08 41.0 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.053 0.454 . . . . 0.0 111.309 -173.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.245 0.866 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.443 179.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 . . . . . 0 N--CA 1.479 1.007 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 21.6 m -98.3 115.23 27.97 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.985 0.421 . . . . 0.0 110.698 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -88.27 -16.45 33.12 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.028 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 47.4 m -116.97 163.68 15.85 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.386 178.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -96.39 131.75 42.62 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.171 -178.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 17.0 m -109.71 133.34 53.24 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.143 177.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 73.2 m 59.43 -171.03 0.13 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.513 -176.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . 0.466 HG12 ' HG3' ' A' ' 262' ' ' PRO . 3.3 m -126.94 78.35 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 121.61 0.719 . . . . 0.0 111.777 176.096 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . 0.573 ' O ' HG22 ' A' ' 199' ' ' VAL . 65.9 mt -77.51 -13.97 59.79 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 122.089 0.947 . . . . 0.0 108.836 174.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 1.018 ' HB3' ' HB3' ' A' ' 273' ' ' TYR . 98.3 mt -70.5 -13.49 62.13 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.327 -1.306 . . . . 0.0 109.531 172.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -111.43 -3.79 15.09 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.353 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.573 HG22 ' O ' ' A' ' 196' ' ' LEU . 13.6 m -86.53 -11.1 11.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.052 178.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -81.01 66.3 6.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.856 0.836 . . . . 0.0 109.813 175.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -79.1 95.04 5.45 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.147 -177.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 16.9 m -105.9 28.06 7.94 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.805 179.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 68.25 48.25 53.59 Favored Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.357 -176.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . 0.621 ' HB3' ' HB2' ' A' ' 207' ' ' ASN . . . -91.0 89.34 7.39 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 121.208 0.528 . . . . 0.0 111.322 -175.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' CYS . . . . . 0.503 ' HA ' HG12 ' A' ' 251' ' ' ILE . 10.1 p -88.02 146.98 25.22 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 173.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . 0.803 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 41.9 mtm180 56.81 5.03 0.19 Allowed 'General case' 0 C--O 1.221 -0.404 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -178.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . 0.621 ' HB2' ' HB3' ' A' ' 204' ' ' ALA . 82.6 m-20 -106.0 105.34 15.33 Favored 'General case' 0 CA--C 1.511 -0.542 0 C-N-CA 120.166 -0.614 . . . . 0.0 111.128 -171.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.442 ' HB ' ' HB ' ' A' ' 246' ' ' VAL . 64.6 t -137.24 115.25 13.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.361 177.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' PHE . . . . . 0.494 ' HB2' ' HA2' ' A' ' 275' ' ' GLY . 3.2 t80 -111.68 124.77 53.02 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.364 -175.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.499 ' HG ' HG23 ' A' ' 272' ' ' ILE . 5.6 mp -107.34 129.48 54.9 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.561 177.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . 0.545 ' HA2' HG22 ' A' ' 243' ' ' ILE . . . -138.26 63.28 0.56 Allowed Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.656 -0.783 . . . . 0.0 113.208 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . 0.525 ' HB3' ' HA ' ' A' ' 270' ' ' ARG . 3.5 t30 -179.01 34.86 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.355 0.597 . . . . 0.0 109.969 178.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.79 HD21 ' HG2' ' A' ' 270' ' ' ARG . 1.2 mt -87.77 163.73 37.12 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.868 -179.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.441 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 91.3 Cg_endo -81.98 165.83 17.14 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 122.261 1.974 . . . . 0.0 110.772 172.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -78.7 129.21 34.44 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 177.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 105.25 -6.29 42.46 Favored Glycine 0 C--N 1.315 -0.617 0 C-N-CA 120.557 -0.83 . . . . 0.0 113.211 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . 0.705 HG22 HG23 ' A' ' 237' ' ' ILE . 4.6 tp -58.88 131.19 23.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-O 120.929 0.395 . . . . 0.0 110.743 179.083 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' THR . . . . . 0.447 ' CG2' ' HG3' ' A' ' 221' ' ' GLU . 10.7 t -112.39 157.44 21.04 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-O 121.625 0.726 . . . . 0.0 111.206 -179.138 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -62.79 -34.72 77.85 Favored 'General case' 0 C--O 1.209 -1.075 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.987 -177.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -54.4 -36.19 63.68 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.924 0.392 . . . . 0.0 110.81 -179.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . 0.447 ' HG3' ' CG2' ' A' ' 218' ' ' THR . 44.4 mt-10 -70.56 -55.47 8.8 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.371 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . 0.482 HD12 HD13 ' A' ' 237' ' ' ILE . 6.7 mt -62.03 -40.56 87.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.693 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . 0.816 ' HG3' HD11 ' A' ' 235' ' ' ILE . 17.2 mtp180 -54.22 -62.34 1.72 Allowed 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 175.161 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -57.74 -21.31 40.42 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.962 -178.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' ASP . . . . . 0.429 ' CG ' ' HE1' ' A' ' 267' ' ' TRP . 24.9 m-20 -87.77 -33.02 18.81 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.978 -178.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.702 HD23 ' HZ ' ' A' ' 248' ' ' PHE . 8.1 mp -107.98 -17.83 13.95 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -169.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . 0.652 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 46.1 mt-10 -69.79 -26.03 1.01 Allowed Pre-proline 0 C--N 1.324 -0.517 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -175.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . 0.652 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 84.7 Cg_endo -67.64 -27.28 38.74 Favored 'Trans proline' 0 C--N 1.36 1.139 0 C-N-CA 121.359 1.373 . . . . 0.0 112.488 -178.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . 0.468 ' CZ ' ' HA ' ' A' ' 226' ' ' LEU . 2.6 p90 -110.64 -14.66 14.01 Favored 'General case' 0 C--O 1.222 -0.364 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.557 175.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . -161.27 91.97 0.11 Allowed Glycine 0 N--CA 1.438 -1.178 0 C-N-CA 120.441 -0.885 . . . . 0.0 111.223 -175.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -58.72 131.8 44.28 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 121.859 1.706 . . . . 0.0 111.155 178.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.723 HG21 HG12 ' A' ' 246' ' ' VAL . 2.7 mp -108.17 151.7 10.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.92 177.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . 0.471 ' CG ' HD23 ' A' ' 249' ' ' LEU . 15.6 m-20 -112.77 -23.06 10.37 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 120.915 0.388 . . . . 0.0 110.147 178.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . 0.556 ' HB3' ' HB2' ' A' ' 247' ' ' HIS . 36.1 tt0 -143.99 120.1 10.77 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.841 -176.076 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . 0.816 HD11 ' HG3' ' A' ' 223' ' ' ARG . 14.8 mt -131.52 115.63 29.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.92 178.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 65.9 tttp -120.81 113.66 20.48 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.37 -178.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' ILE . . . . . 0.705 HG23 HG22 ' A' ' 217' ' ' ILE . 80.8 mt -102.85 123.71 56.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.683 -179.062 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.545 ' HB ' HG13 ' A' ' 243' ' ' ILE . 39.9 t -102.06 87.09 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 172.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 13.9 t -65.33 -18.21 65.13 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.726 -177.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -64.93 -31.05 72.09 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.538 176.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . 0.734 ' HB2' HG12 ' A' ' 243' ' ' ILE . 48.7 mtt180 -116.29 3.53 13.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.944 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 13.3 m120 66.91 27.28 9.0 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.81 177.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.734 HG12 ' HB2' ' A' ' 241' ' ' ARG . 1.7 pt -122.2 155.53 27.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.156 -173.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . 0.442 ' HB2' ' HB2' ' A' ' 210' ' ' LEU . . . -143.92 138.3 28.43 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.019 0.438 . . . . 0.0 111.579 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -107.68 109.11 20.63 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.702 176.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . 0.723 HG12 HG21 ' A' ' 232' ' ' ILE . 1.3 t -103.2 133.3 47.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' HIS . . . . . 0.803 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 40.9 m170 -112.49 101.56 9.72 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.496 0.665 . . . . 0.0 111.128 178.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . 0.702 ' HZ ' HD23 ' A' ' 226' ' ' LEU . 33.5 m-85 -85.87 102.92 14.14 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.744 -1.116 . . . . 0.0 111.429 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.471 HD23 ' CG ' ' A' ' 233' ' ' ASP . 0.1 OUTLIER -40.27 -46.45 2.29 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 124.422 1.076 . . . . 0.0 113.117 -174.835 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -97.39 139.54 33.18 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.858 0.361 . . . . 0.0 110.325 177.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . 0.65 ' O ' HG13 ' A' ' 255' ' ' ILE . 0.2 OUTLIER -57.53 -40.62 75.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.675 179.995 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -68.93 -33.15 73.27 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.183 -176.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -59.85 -40.28 88.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.483 179.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . 0.479 ' HB2' ' HB2' ' A' ' 248' ' ' PHE . . . -68.88 -41.58 78.14 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.757 178.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.65 HG13 ' O ' ' A' ' 251' ' ' ILE . 14.4 mt -56.06 -59.62 2.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.293 -177.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 12.6 ptmt -62.28 -40.19 95.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.422 -177.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -62.05 -49.28 76.63 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.586 0.231 . . . . 0.0 111.323 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . 0.44 HG13 HG12 ' A' ' 272' ' ' ILE . 53.7 t -64.89 -24.38 35.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.078 0.465 . . . . 0.0 110.892 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 71.6 mm-40 -84.83 -24.53 28.59 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 178.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 58.4 mm-40 -95.89 -33.89 12.03 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.769 0.319 . . . . 0.0 111.081 -175.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.739 HD12 ' CE3' ' A' ' 267' ' ' TRP . 0.6 OUTLIER -52.05 -49.54 83.69 Favored Pre-proline 0 CA--C 1.539 0.523 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.724 -179.013 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 261' ' ' LEU . 43.6 Cg_endo -67.46 -15.25 44.85 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.446 2.097 . . . . 0.0 113.052 -178.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 54.3 mt -92.09 -4.99 53.61 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.269 0.557 . . . . 0.0 111.449 -178.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 -106.94 149.97 39.21 Favored Pre-proline 0 C--N 1.312 -1.029 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.367 -173.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.25 -37.66 30.56 Favored 'Trans proline' 0 N--CA 1.465 -0.159 0 C-N-CA 123.172 2.581 . . . . 0.0 112.79 -169.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 12.6 mtpt -86.63 -44.33 11.95 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 121.531 0.682 . . . . 0.0 109.788 -177.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' TRP . . . . . 0.739 ' CE3' HD12 ' A' ' 261' ' ' LEU . 10.6 m0 -75.34 -28.85 59.77 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.9 -173.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 34.7 t -65.02 -20.89 66.72 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.151 0.501 . . . . 0.0 110.555 176.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . 0.418 ' C ' ' HD2' ' A' ' 270' ' ' ARG . 97.6 mttt -76.84 -6.2 51.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.238 176.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' ARG . . . . . 0.79 ' HG2' HD21 ' A' ' 213' ' ' LEU . 3.3 mpt_? -114.97 141.64 47.7 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.021 177.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . 0.765 ' HE ' ' HA ' ' A' ' 271' ' ' ARG . 0.8 OUTLIER -93.05 108.36 19.96 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 -179.769 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . 0.597 HG21 HD22 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -117.31 140.91 38.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.361 0.6 . . . . 0.0 110.823 -178.556 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 273' ' ' TYR . . . . . 1.018 ' HB3' ' HB3' ' A' ' 197' ' ' LEU . 5.2 p90 -152.42 170.15 20.81 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.55 173.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -53.32 115.54 1.96 Allowed 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 171.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 275' ' ' GLY . . . . . 0.494 ' HA2' ' HB2' ' A' ' 209' ' ' PHE . . . -52.83 129.35 38.4 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.363 -0.835 . . . . 0.0 113.439 -173.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 65.2 mtt180 -94.92 121.66 36.75 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 178.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -159.02 136.18 9.78 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.131 -178.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 278' ' ' ARG . . . . . 0.462 ' HD3' ' SG ' ' A' ' 279' ' ' CYS . 0.1 OUTLIER -80.37 -7.19 58.99 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.407 -172.272 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 279' ' ' CYS . . . . . 0.462 ' SG ' ' HD3' ' A' ' 278' ' ' ARG . 80.9 m -105.18 -4.64 21.53 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.103 0.478 . . . . 0.0 110.599 177.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . 0.486 ' HB1' HD22 ' A' ' 207' ' ' ASN . . . -102.18 90.46 3.94 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.365 -177.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 3.3 m -86.25 -44.31 16.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.225 177.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 166.07 -141.83 7.25 Favored Glycine 0 N--CA 1.431 -1.662 0 C-N-CA 120.653 -0.784 . . . . 0.0 111.627 -178.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 96.5 mt -86.95 85.42 7.26 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.134 0.492 . . . . 0.0 110.634 -178.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . 0.412 ' HB3' ' HE3' ' A' ' 284' ' ' LYS . 1.3 tmmt? . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.193 -0.908 . . . . 0.0 109.144 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 . . . . . 0 N--CA 1.481 1.113 0 N-CA-C 111.053 0.02 . . . . 0.0 111.053 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 50.7 m 57.46 87.2 0.07 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.418 0.628 . . . . 0.0 111.014 -177.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -97.72 10.81 39.1 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.824 -177.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 75.5 m 66.34 178.49 0.21 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.26 -178.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -133.16 107.77 8.39 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 177.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' SER . . . . . 0.958 ' HB2' ' HB3' ' A' ' 271' ' ' ARG . 45.1 m -152.7 95.0 1.95 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.281 0.562 . . . . 0.0 110.492 -175.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' SER . . . . . 0.44 ' HA ' ' O ' ' A' ' 272' ' ' ILE . 55.6 m -156.31 -165.04 1.81 Allowed 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 177.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . 0.497 ' HB ' ' HA ' ' A' ' 198' ' ' ALA . 3.7 m -73.31 89.46 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 C-N-CA 120.53 -0.468 . . . . 0.0 109.743 172.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . 0.535 HD22 ' H ' ' A' ' 196' ' ' LEU . 1.7 mm? -53.76 93.95 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.455 -176.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 6.4 mp 51.62 25.05 2.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.273 0.559 . . . . 0.0 110.317 -174.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.497 ' HA ' ' HB ' ' A' ' 195' ' ' VAL . . . 65.03 25.11 12.62 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 114.901 -1.045 . . . . 0.0 112.567 -178.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 196' ' ' LEU . 22.6 m -75.46 -24.21 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.987 177.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' GLN . . . . . 0.432 ' HG3' HG21 ' A' ' 199' ' ' VAL . 46.6 mt-30 -124.77 92.1 3.58 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.328 177.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -101.23 -36.72 8.82 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.279 174.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 46.5 m 67.59 -5.44 0.78 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.559 176.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 60.25 49.47 78.23 Favored Glycine 0 C--N 1.333 0.365 0 N-CA-C 111.639 -0.584 . . . . 0.0 111.639 -177.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . 0.8 ' HB3' ' HB2' ' A' ' 207' ' ' ASN . . . -92.07 130.56 37.77 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -172.216 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' CYS . . . . . 0.832 ' HB3' HG12 ' A' ' 251' ' ' ILE . 9.8 p -108.33 147.65 31.19 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 169.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . 0.745 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 46.3 mtp180 57.65 5.04 0.29 Allowed 'General case' 0 C--O 1.223 -0.337 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -179.208 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . 0.8 ' HB2' ' HB3' ' A' ' 204' ' ' ALA . 84.6 m-20 -110.93 106.34 15.43 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.1 0.476 . . . . 0.0 111.643 -171.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.461 ' HB ' ' HB ' ' A' ' 246' ' ' VAL . 57.7 t -136.87 117.97 18.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.552 179.102 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' PHE . . . . . 0.498 ' O ' ' HA ' ' A' ' 272' ' ' ILE . 5.8 t80 -113.28 125.35 54.2 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.463 -177.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.514 ' HG ' ' CG2' ' A' ' 272' ' ' ILE . 5.5 mp -107.8 130.09 55.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.595 177.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . 0.575 ' HA2' HG22 ' A' ' 243' ' ' ILE . . . -132.13 53.01 0.81 Allowed Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.503 -0.856 . . . . 0.0 113.951 -178.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . 0.452 ' HB3' ' HA ' ' A' ' 270' ' ' ARG . 36.3 t30 179.72 52.73 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.037 0.446 . . . . 0.0 111.288 174.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.503 HD21 HD21 ' A' ' 210' ' ' LEU . 1.0 OUTLIER -94.65 159.43 33.55 Favored Pre-proline 0 C--N 1.314 -0.96 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.444 177.509 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.461 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 87.1 Cg_endo -78.42 169.48 19.93 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 122.701 2.267 . . . . 0.0 111.638 178.109 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . 0.493 ' HA ' ' OG1' ' A' ' 239' ' ' THR . 3.9 p-10 -77.49 134.02 38.43 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 98.27 -6.27 61.41 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.398 -0.906 . . . . 0.0 112.857 178.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . 0.709 HG22 HG23 ' A' ' 237' ' ' ILE . 4.1 tp -58.15 126.11 15.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 CA-C-O 121.294 0.568 . . . . 0.0 110.724 -178.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' THR . . . . . 0.49 ' CG2' ' HG3' ' A' ' 221' ' ' GLU . 8.8 t -109.22 157.49 18.76 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 121.429 0.633 . . . . 0.0 110.847 -178.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.416 ' H ' ' CD ' ' A' ' 219' ' ' GLU . 2.6 mp0 -62.05 -36.24 81.03 Favored 'General case' 0 C--O 1.209 -1.028 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.455 -177.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' ASP . . . . . 0.532 ' O ' ' HG2' ' A' ' 224' ' ' GLU . 30.7 t70 -55.08 -37.56 66.96 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 123.741 0.651 . . . . 0.0 110.683 -178.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . 0.49 ' HG3' ' CG2' ' A' ' 218' ' ' THR . 45.9 mt-10 -65.97 -55.24 17.78 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.02 179.184 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . 0.442 HD12 HD12 ' A' ' 237' ' ' ILE . 6.7 mt -62.52 -38.84 82.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.656 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . 0.848 ' HG3' HD11 ' A' ' 235' ' ' ILE . 63.4 mtp180 -56.47 -62.53 1.66 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.981 0.42 . . . . 0.0 112.066 175.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.532 ' HG2' ' O ' ' A' ' 220' ' ' ASP . 7.0 pt-20 -58.73 -24.74 62.08 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.149 -178.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' ASP . . . . . 0.48 ' HB3' ' CZ2' ' A' ' 267' ' ' TRP . 8.0 m-20 -85.98 -32.5 21.5 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.596 -176.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.74 HD21 ' HZ ' ' A' ' 248' ' ' PHE . 8.4 mp -107.11 -17.49 14.15 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -170.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . 0.663 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 37.6 mt-10 -70.71 -27.96 1.2 Allowed Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -176.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . 0.663 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 74.4 Cg_endo -65.47 -27.09 54.58 Favored 'Trans proline' 0 C--N 1.359 1.089 0 C-N-CA 121.313 1.342 . . . . 0.0 111.818 -177.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . 0.474 ' CE1' ' HA ' ' A' ' 226' ' ' LEU . 3.2 p90 -111.01 -7.89 14.5 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.879 -0.328 . . . . 0.0 111.65 173.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . 0.487 ' CA ' ' HB2' ' A' ' 253' ' ' ALA . . . -169.69 93.8 0.1 Allowed Glycine 0 N--CA 1.442 -0.954 0 C-N-CA 120.104 -1.046 . . . . 0.0 112.454 -174.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . 0.428 ' HA ' ' HG2' ' A' ' 227' ' ' GLU . 15.3 Cg_endo -59.52 131.79 42.43 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 122.038 1.825 . . . . 0.0 111.759 178.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.725 HG21 HG12 ' A' ' 246' ' ' VAL . 2.8 mp -108.53 152.95 10.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.108 177.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . 0.418 ' OD2' HD21 ' A' ' 249' ' ' LEU . 16.3 m-20 -116.1 -18.39 10.63 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 120.708 0.289 . . . . 0.0 111.059 178.005 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . 0.405 ' H ' HG22 ' A' ' 232' ' ' ILE . 23.0 tt0 -145.57 121.69 10.78 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.033 -179.118 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . 0.848 HD11 ' HG3' ' A' ' 223' ' ' ARG . 13.6 mt -133.65 109.79 13.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.045 177.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -113.93 121.29 43.49 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.363 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' ILE . . . . . 0.709 HG23 HG22 ' A' ' 217' ' ' ILE . 53.7 mt -111.85 127.97 68.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.361 -177.221 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.558 ' HB ' HG13 ' A' ' 243' ' ' ILE . 44.8 t -109.58 88.07 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 170.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' THR . . . . . 0.493 ' OG1' ' HA ' ' A' ' 215' ' ' ASN . 12.4 t -64.0 -24.66 67.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.643 -175.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -61.8 -39.0 90.19 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.084 0.469 . . . . 0.0 110.647 178.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . 0.654 ' HB2' HG12 ' A' ' 243' ' ' ILE . 63.9 mtt180 -104.28 0.11 28.92 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.47 -177.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 69.01 25.7 5.85 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.054 177.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.654 HG12 ' HB2' ' A' ' 241' ' ' ARG . 1.4 pt -121.71 151.29 25.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-O 120.835 0.35 . . . . 0.0 111.579 -172.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -145.89 141.5 27.88 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.169 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -111.15 114.42 27.66 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.91 178.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . 0.725 HG12 HG21 ' A' ' 232' ' ' ILE . 1.4 t -108.67 138.35 36.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.665 -178.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' HIS . . . . . 0.745 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 27.1 m170 -115.89 102.15 9.42 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.113 -0.635 . . . . 0.0 111.182 177.016 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . 0.74 ' HZ ' HD21 ' A' ' 226' ' ' LEU . 35.3 m-85 -86.86 100.74 12.77 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.22 179.036 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.418 HD21 ' OD2' ' A' ' 233' ' ' ASP . 0.1 OUTLIER -43.24 -41.55 3.92 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 124.533 1.146 . . . . 0.0 112.693 -175.841 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . 0.432 ' HB2' ' HB3' ' A' ' 253' ' ' ALA . 59.4 m-20 -94.6 137.89 33.14 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . 0.832 HG12 ' HB3' ' A' ' 205' ' ' CYS . 0.2 OUTLIER -60.98 -43.51 96.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -178.933 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -71.32 -27.52 63.45 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.666 -176.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . 0.487 ' HB2' ' CA ' ' A' ' 230' ' ' GLY . . . -62.73 -42.37 99.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.204 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . 0.513 ' HB3' ' HB2' ' A' ' 248' ' ' PHE . . . -67.38 -41.89 84.26 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.614 178.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.578 HG13 ' O ' ' A' ' 251' ' ' ILE . 9.8 mt -56.17 -60.26 2.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.285 -177.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 12.7 ptmt -62.6 -36.22 82.06 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.553 -176.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -65.73 -49.41 68.55 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 122.981 0.176 . . . . 0.0 111.438 178.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . 0.556 HG11 HG12 ' A' ' 272' ' ' ILE . 60.9 t -63.5 -25.5 38.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.976 0.417 . . . . 0.0 110.838 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -83.96 -25.45 30.04 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.11 -0.495 . . . . 0.0 112.187 178.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 46.5 mm-40 -95.05 -30.88 13.85 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-O 120.665 0.269 . . . . 0.0 111.283 -175.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.718 HD13 ' CE3' ' A' ' 267' ' ' TRP . 1.0 OUTLIER -52.42 -50.45 79.83 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.251 179.625 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' PRO . . . . . 0.554 ' HD2' ' N ' ' A' ' 261' ' ' LEU . 43.2 Cg_endo -66.99 -14.48 43.81 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.399 2.066 . . . . 0.0 112.909 -178.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 55.6 mt -96.34 -3.91 42.96 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.899 0.381 . . . . 0.0 111.827 -178.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' ASN . . . . . 0.434 ' HB2' ' CE3' ' A' ' 267' ' ' TRP . 13.1 m-80 -106.72 149.78 38.85 Favored Pre-proline 0 C--N 1.317 -0.84 0 N-CA-C 112.662 0.615 . . . . 0.0 112.662 -174.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -63.22 -35.66 62.09 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 123.771 2.981 . . . . 0.0 113.189 -168.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.432 ' HE3' ' HB2' ' A' ' 266' ' ' LYS . 0.0 OUTLIER -86.93 -45.74 10.53 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 121.791 0.805 . . . . 0.0 109.298 -179.616 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' TRP . . . . . 0.718 ' CE3' HD13 ' A' ' 261' ' ' LEU . 9.1 m0 -76.46 -29.29 56.86 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 114.362 -1.29 . . . . 0.0 111.309 -170.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 23.2 t -64.92 -16.54 63.42 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.742 0.306 . . . . 0.0 111.547 -179.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -87.17 -13.16 44.82 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.095 0.474 . . . . 0.0 110.183 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 270' ' ' ARG . . . . . 0.452 ' HA ' ' HB3' ' A' ' 212' ' ' ASN . 6.9 mpt_? -88.32 166.75 14.07 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 173.11 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . 0.958 ' HB3' ' HB2' ' A' ' 193' ' ' SER . 45.1 mmt-85 -120.4 106.58 11.98 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 177.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . 0.591 HG23 HD21 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -119.58 141.94 37.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.461 0.648 . . . . 0.0 111.903 -174.411 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -151.76 169.73 21.49 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.613 171.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 274' ' ' TYR . . . . . 0.582 ' HB3' ' HB2' ' A' ' 204' ' ' ALA . 72.0 m-85 -63.23 127.74 32.65 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.873 0.368 . . . . 0.0 110.49 176.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -82.13 159.06 38.97 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.997 -0.621 . . . . 0.0 113.22 -175.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 58.7 mtt180 -98.18 6.1 47.83 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 122.162 0.982 . . . . 0.0 109.746 177.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -68.35 174.94 3.61 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 113.35 -1.75 . . . . 0.0 109.886 176.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 278' ' ' ARG . . . . . . . . . . . . . 13.7 ptt180 -147.45 8.5 0.91 Allowed 'General case' 0 C--N 1.327 -0.402 0 O-C-N 121.9 -0.5 . . . . 0.0 111.653 177.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 279' ' ' CYS . . . . . . . . . . . . . 22.7 t 64.43 21.97 12.61 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.664 177.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . 0.659 ' HB2' HD12 ' A' ' 283' ' ' LEU . . . -163.28 98.06 0.91 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.685 -175.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 281' ' ' VAL . . . . . 0.401 ' O ' HG12 ' A' ' 281' ' ' VAL . 6.1 p -136.35 99.73 2.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 121.756 0.788 . . . . 0.0 110.137 178.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 79.85 80.18 0.81 Allowed Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.535 -0.84 . . . . 0.0 111.217 -176.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 283' ' ' LEU . . . . . 0.659 HD12 ' HB2' ' A' ' 280' ' ' ALA . 5.4 mp -98.48 13.6 31.18 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.653 0.74 . . . . 0.0 109.992 -177.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . 0.614 ' HZ1' ' HB3' ' A' ' 284' ' ' LYS . 6.6 ttpm? . . . . . 0 C--N 1.315 -0.907 0 CA-C-N 114.743 -1.117 . . . . 0.0 108.899 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 47.6 t30 . . . . . 0 N--CA 1.479 1.019 0 CA-C-O 120.653 0.263 . . . . 0.0 110.503 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 11.6 p -90.76 164.74 13.99 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 175.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -80.83 99.13 8.14 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.831 0.348 . . . . 0.0 110.789 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 51.2 m -89.32 108.51 19.67 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.133 178.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -163.06 172.19 15.33 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.639 -175.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 12.9 t -74.58 -173.79 1.89 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 176.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 18.3 m -84.68 39.13 0.73 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.63 0.729 . . . . 0.0 110.93 -178.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 1.7 m -101.92 137.46 29.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.252 -178.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . 0.469 ' O ' HG22 ' A' ' 199' ' ' VAL . 7.4 tt -59.29 95.36 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 O-C-N 123.725 0.641 . . . . 0.0 109.426 177.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 4.0 mm? 55.11 20.24 3.22 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.339 -0.846 . . . . 0.0 112.608 178.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . 57.26 16.69 3.21 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.469 HG22 ' O ' ' A' ' 196' ' ' LEU . 35.5 m -95.89 4.54 8.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.173 0.511 . . . . 0.0 110.366 -179.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -107.01 87.58 2.54 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-O 121.756 0.789 . . . . 0.0 110.249 177.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -116.35 -7.82 11.7 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.109 -0.95 . . . . 0.0 108.896 173.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 8.6 t -159.0 177.12 11.47 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 114.305 -1.316 . . . . 0.0 107.676 177.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 91.68 -53.37 3.03 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.388 -0.911 . . . . 0.0 112.807 178.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -64.09 114.1 3.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.899 0.38 . . . . 0.0 110.838 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' CYS . . . . . 0.677 ' SG ' ' HG3' ' A' ' 206' ' ' ARG . 40.4 t -97.7 150.32 21.33 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.873 -176.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . 0.815 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 8.0 mtm180 55.43 -0.61 0.04 OUTLIER 'General case' 0 C--O 1.221 -0.398 0 N-CA-C 114.579 1.325 . . . . 0.0 114.579 177.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . 0.422 ' ND2' ' HB2' ' A' ' 277' ' ' ASP . 13.3 m-80 -104.98 105.6 15.71 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 119.09 0.859 . . . . 0.0 112.161 -172.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.48 ' HB ' ' HB ' ' A' ' 246' ' ' VAL . 65.1 t -133.69 114.7 20.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 114.569 -1.196 . . . . 0.0 109.199 177.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' PHE . . . . . 0.444 ' HB3' ' CE1' ' A' ' 273' ' ' TYR . 1.5 t80 -113.6 122.64 47.83 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.061 -176.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.518 ' HG ' HG22 ' A' ' 272' ' ' ILE . 6.4 mp -105.35 136.95 43.95 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.463 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . 0.514 ' HA2' HG23 ' A' ' 243' ' ' ILE . . . -144.58 68.55 0.42 Allowed Glycine 0 N--CA 1.448 -0.567 0 C-N-CA 120.422 -0.894 . . . . 0.0 113.19 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . 0.531 ' HB3' ' HA ' ' A' ' 270' ' ' ARG . 20.5 t30 173.66 37.57 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.092 0.473 . . . . 0.0 109.992 176.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.767 HD23 ' HG2' ' A' ' 270' ' ' ARG . 0.9 OUTLIER -86.59 159.91 51.67 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.71 -176.758 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.479 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 98.6 Cg_endo -77.67 162.94 29.67 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.76 2.307 . . . . 0.0 112.046 178.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -76.04 117.68 18.0 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.771 178.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 109.02 -0.94 31.53 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.292 -0.956 . . . . 0.0 113.011 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . 0.694 HG22 HG23 ' A' ' 237' ' ' ILE . 6.2 tp -60.76 130.19 24.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.046 0.451 . . . . 0.0 110.852 177.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' THR . . . . . 0.435 ' CG2' ' HG3' ' A' ' 221' ' ' GLU . 12.1 t -114.07 156.24 24.51 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 121.722 0.772 . . . . 0.0 110.969 178.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -60.74 -35.31 76.06 Favored 'General case' 0 C--O 1.208 -1.089 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.093 -178.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -56.11 -35.68 67.35 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 123.433 0.458 . . . . 0.0 110.689 -178.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . 0.435 ' HG3' ' CG2' ' A' ' 218' ' ' THR . 43.6 mt-10 -68.44 -56.43 8.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.122 178.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . 0.466 HD11 HD13 ' A' ' 237' ' ' ILE . 7.6 mt -60.45 -39.66 81.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.434 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . 0.744 ' HG3' HD13 ' A' ' 235' ' ' ILE . 33.6 mtp180 -55.88 -63.1 1.29 Allowed 'General case' 0 CA--C 1.509 -0.627 0 CA-C-O 120.935 0.398 . . . . 0.0 112.05 175.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -58.04 -22.1 48.5 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.813 -177.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -86.44 -34.21 20.19 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.621 -177.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.7 HD21 ' HZ ' ' A' ' 248' ' ' PHE . 8.1 mp -105.98 -18.54 14.01 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -169.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . 0.648 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 53.7 mt-10 -67.52 -30.32 2.89 Favored Pre-proline 0 C--N 1.326 -0.432 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -176.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . 0.648 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 71.7 Cg_endo -65.29 -28.71 55.2 Favored 'Trans proline' 0 C--N 1.36 1.146 0 C-N-CA 121.147 1.231 . . . . 0.0 112.089 -176.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . 0.505 ' CE1' ' HA ' ' A' ' 226' ' ' LEU . 3.1 p90 -110.84 -4.7 15.13 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.737 0.303 . . . . 0.0 111.725 175.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . 0.441 ' CA ' ' HB1' ' A' ' 253' ' ' ALA . . . -171.95 97.83 0.12 Allowed Glycine 0 N--CA 1.443 -0.895 0 C-N-CA 120.274 -0.965 . . . . 0.0 112.311 -175.136 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -64.65 131.45 29.52 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 121.778 1.652 . . . . 0.0 111.527 178.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.722 HG22 HG11 ' A' ' 246' ' ' VAL . 2.7 mp -107.77 151.97 9.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.563 177.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . 0.407 ' CG ' HD22 ' A' ' 249' ' ' LEU . 10.6 m-20 -109.42 -28.56 8.87 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.122 0.487 . . . . 0.0 110.168 176.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . 0.583 ' HB3' ' HB2' ' A' ' 247' ' ' HIS . 26.6 tt0 -136.28 122.54 20.49 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.748 -174.082 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . 0.744 HD13 ' HG3' ' A' ' 223' ' ' ARG . 14.1 mt -138.45 112.99 8.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.763 178.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -125.35 118.23 25.47 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.41 -179.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' ILE . . . . . 0.694 HG23 HG22 ' A' ' 217' ' ' ILE . 44.9 mt -104.97 115.64 47.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.821 -178.137 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.534 ' HB ' HG13 ' A' ' 243' ' ' ILE . 21.9 t -94.08 87.77 2.22 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 173.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 11.1 t -64.28 -23.69 67.39 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.393 -176.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -64.27 -23.4 67.29 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.152 178.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . 0.694 ' HB2' HG12 ' A' ' 243' ' ' ILE . 97.1 mtt180 -120.21 -0.13 10.54 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.244 176.253 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 19.2 m120 63.55 29.65 15.24 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.137 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.694 HG12 ' HB2' ' A' ' 241' ' ' ARG . 1.2 pt -121.78 154.33 26.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.76 -175.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . 0.508 ' HB3' ' HB2' ' A' ' 210' ' ' LEU . . . -142.29 138.8 31.59 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.11 0.481 . . . . 0.0 111.788 -178.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -106.33 113.81 27.56 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.62 177.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . 0.722 HG11 HG22 ' A' ' 232' ' ' ILE . 1.0 OUTLIER -112.77 130.58 66.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -179.817 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' HIS . . . . . 0.815 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 28.0 m170 -111.19 102.44 10.87 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.024 -0.67 . . . . 0.0 111.373 177.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . 0.7 ' HZ ' HD21 ' A' ' 226' ' ' LEU . 36.9 m-85 -84.61 101.92 12.51 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.599 177.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.407 HD22 ' CG ' ' A' ' 233' ' ' ASP . 0.1 OUTLIER -44.43 -39.12 4.49 Favored 'General case' 0 N--CA 1.465 0.294 0 O-C-N 124.568 1.167 . . . . 0.0 112.956 -174.875 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 50.5 m-20 -99.88 143.16 30.42 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.056 178.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . 0.611 ' O ' HG13 ' A' ' 255' ' ' ILE . 0.2 OUTLIER -63.76 -44.62 98.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.138 -176.56 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -68.35 -29.93 68.77 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 120.606 0.241 . . . . 0.0 110.768 -176.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . 0.441 ' HB1' ' CA ' ' A' ' 230' ' ' GLY . . . -61.25 -42.41 98.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.285 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . 0.52 ' HB3' ' HB2' ' A' ' 248' ' ' PHE . . . -67.33 -41.33 85.42 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.719 178.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.699 ' O ' ' HG2' ' A' ' 259' ' ' GLN . 15.1 mt -57.05 -62.41 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.096 -177.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . 0.477 ' O ' ' HG2' ' A' ' 260' ' ' GLU . 10.1 ptmt -59.81 -38.42 81.93 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.109 -176.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -63.19 -49.76 72.98 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.59 0.233 . . . . 0.0 111.428 178.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . 0.45 HG11 HG12 ' A' ' 272' ' ' ILE . 52.7 t -66.36 -24.43 33.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.048 0.451 . . . . 0.0 111.119 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . 0.699 ' HG2' ' O ' ' A' ' 255' ' ' ILE . 78.9 mm-40 -84.13 -26.87 28.56 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.933 178.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . 0.477 ' HG2' ' O ' ' A' ' 256' ' ' LYS . 53.3 mm-40 -95.52 -31.65 13.23 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 122.702 0.401 . . . . 0.0 111.532 -175.033 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.795 ' HA ' ' HE3' ' A' ' 267' ' ' TRP . 0.7 OUTLIER -50.81 -51.03 70.2 Favored Pre-proline 0 CA--C 1.537 0.445 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.501 178.888 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' PRO . . . . . 0.557 ' HD2' ' N ' ' A' ' 261' ' ' LEU . 37.8 Cg_endo -66.11 -15.69 49.43 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.287 1.991 . . . . 0.0 112.538 -177.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 57.6 mt -88.66 -9.34 52.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.967 0.413 . . . . 0.0 111.745 -177.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -105.44 148.82 36.99 Favored Pre-proline 0 C--N 1.314 -0.968 0 N-CA-C 112.586 0.588 . . . . 0.0 112.586 -172.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -61.52 -36.11 78.47 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 123.711 2.941 . . . . 0.0 112.61 -171.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 7.6 mtpt -85.99 -45.07 11.81 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 121.542 0.687 . . . . 0.0 109.608 -176.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' TRP . . . . . 0.795 ' HE3' ' HA ' ' A' ' 261' ' ' LEU . 11.2 m0 -78.29 -28.16 47.49 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.686 -173.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 23.9 t -63.94 -17.96 63.77 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.802 0.334 . . . . 0.0 110.802 177.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -73.81 -21.71 60.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.23 0.538 . . . . 0.0 110.097 176.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 270' ' ' ARG . . . . . 0.767 ' HG2' HD23 ' A' ' 213' ' ' LEU . 3.1 mpt_? -102.19 141.7 34.61 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.913 -176.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . 0.447 ' HG2' ' HB2' ' A' ' 212' ' ' ASN . 26.5 mmt180 -93.17 109.45 20.95 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.237 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . 0.604 HG23 HD23 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -117.95 139.31 45.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.424 0.63 . . . . 0.0 111.012 -177.203 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 273' ' ' TYR . . . . . 0.444 ' CE1' ' HB3' ' A' ' 209' ' ' PHE . 6.0 p90 -151.78 168.79 23.97 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.73 176.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 274' ' ' TYR . . . . . 0.416 ' OH ' ' HA ' ' A' ' 255' ' ' ILE . 85.5 m-85 -68.09 135.96 53.01 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.895 0.378 . . . . 0.0 110.523 174.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -79.37 -137.94 1.56 Allowed Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.908 -0.663 . . . . 0.0 111.536 176.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 73.5 mmt-85 -124.76 118.68 26.96 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 179.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 277' ' ' ASP . . . . . 0.562 ' CG ' ' HG ' ' A' ' 279' ' ' CYS . 9.4 t0 -115.79 138.91 50.68 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.765 -168.151 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 278' ' ' ARG . . . . . 0.52 ' HA ' HD12 ' A' ' 283' ' ' LEU . 54.4 mtm180 -103.66 -11.85 17.4 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.584 -176.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 279' ' ' CYS . . . . . 0.562 ' HG ' ' CG ' ' A' ' 277' ' ' ASP . 29.4 p -87.98 36.34 0.77 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.453 0.644 . . . . 0.0 110.458 -177.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -142.49 159.13 42.84 Favored 'General case' 0 N--CA 1.429 -1.521 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 3.7 p -70.47 76.91 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-O 122.277 1.037 . . . . 0.0 111.054 179.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -144.34 15.03 2.07 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.202 175.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 283' ' ' LEU . . . . . 0.52 HD12 ' HA ' ' A' ' 278' ' ' ARG . 9.3 mp -115.36 95.69 5.29 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.329 -0.435 . . . . 0.0 109.94 -178.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . 0.611 ' HB3' ' HZ2' ' A' ' 284' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.869 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -178.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 . . . . . 0 N--CA 1.482 1.142 0 CA-C-O 120.892 0.377 . . . . 0.0 111.028 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 53.7 m -125.16 -32.7 2.96 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.181 175.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -139.19 178.57 7.08 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.362 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 17.2 m -62.97 -40.6 98.2 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.068 0.461 . . . . 0.0 110.18 177.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 -153.47 119.64 5.45 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.354 178.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 64.4 m -81.58 10.37 6.07 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -178.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 42.5 m 69.89 13.77 7.96 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 122.789 0.436 . . . . 0.0 112.035 175.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . 0.406 ' HB ' ' HA ' ' A' ' 198' ' ' ALA . 4.8 m -112.31 116.11 51.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.142 0.496 . . . . 0.0 111.536 178.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . 0.458 ' O ' HG23 ' A' ' 199' ' ' VAL . 10.0 tt -60.46 101.57 0.14 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.669 175.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 8.3 mp 53.03 23.56 3.0 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.842 178.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.406 ' HA ' ' HB ' ' A' ' 195' ' ' VAL . . . 56.51 31.04 18.22 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.108 -179.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 196' ' ' LEU . 29.0 m -77.37 6.48 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 121.157 0.503 . . . . 0.0 111.34 179.08 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' GLN . . . . . 0.407 ' HG3' ' HB2' ' A' ' 273' ' ' TYR . 11.2 mm-40 -96.47 105.13 17.17 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 176.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . 0.465 ' OE1' ' HG3' ' A' ' 278' ' ' ARG . 96.1 mt-30 -28.72 105.58 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 O-C-N 125.34 1.65 . . . . 0.0 112.268 179.053 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 61.8 p -65.57 -34.13 77.53 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 121.231 0.538 . . . . 0.0 110.114 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -90.01 53.15 3.6 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.523 177.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -106.74 122.0 45.5 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 178.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' CYS . . . . . 0.61 ' HB3' HG12 ' A' ' 251' ' ' ILE . 7.6 p -86.78 146.35 26.28 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.673 -0.411 . . . . 0.0 109.979 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . 0.733 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 63.4 mtm180 56.71 -3.73 0.04 OUTLIER 'General case' 0 C--O 1.223 -0.319 0 N-CA-C 114.579 1.325 . . . . 0.0 114.579 176.143 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . 0.417 ' ND2' ' HA ' ' A' ' 278' ' ' ARG . 77.4 m-20 -100.78 105.81 17.16 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 118.95 0.795 . . . . 0.0 111.528 -171.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.456 ' HB ' ' HB ' ' A' ' 246' ' ' VAL . 58.4 t -137.22 125.91 34.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.362 176.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' PHE . . . . . 0.453 ' HE1' ' HB ' ' A' ' 243' ' ' ILE . 3.3 t80 -125.61 121.37 33.36 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.75 -176.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.504 ' HG ' HG21 ' A' ' 272' ' ' ILE . 5.4 mp -103.79 134.67 46.7 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.298 177.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . 0.53 ' HA2' HG23 ' A' ' 243' ' ' ILE . . . -143.13 65.96 0.47 Allowed Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.493 -0.86 . . . . 0.0 112.908 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . 0.525 ' HB3' ' HA ' ' A' ' 270' ' ' ARG . 1.6 t-20 174.83 39.54 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.252 0.549 . . . . 0.0 110.125 178.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.465 ' HB3' ' HD2' ' A' ' 214' ' ' PRO . 0.5 OUTLIER -89.96 162.82 34.33 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.985 -179.617 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.465 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 74.9 Cg_endo -83.8 169.27 12.0 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.739 2.293 . . . . 0.0 111.396 175.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -78.92 134.58 36.86 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 177.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 103.32 -9.78 53.89 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.468 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . 0.591 HG23 HG21 ' A' ' 237' ' ' ILE . 4.9 tp -59.85 128.08 20.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-O 121.071 0.462 . . . . 0.0 110.494 178.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' THR . . . . . 0.426 ' CG2' ' HG2' ' A' ' 221' ' ' GLU . 9.0 t -114.43 158.28 21.77 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-O 121.252 0.548 . . . . 0.0 110.575 179.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.424 ' H ' ' CD ' ' A' ' 219' ' ' GLU . 1.3 mp0 -62.3 -39.35 92.68 Favored 'General case' 0 C--O 1.21 -0.975 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.809 -175.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -52.33 -37.82 56.98 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 123.676 0.61 . . . . 0.0 111.234 -178.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . 0.426 ' HG2' ' CG2' ' A' ' 218' ' ' THR . 47.5 mm-40 -68.16 -53.57 24.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.367 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . 0.488 HD13 HD13 ' A' ' 237' ' ' ILE . 8.0 mt -62.0 -42.33 94.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.254 179.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . 0.683 ' HG3' HD13 ' A' ' 235' ' ' ILE . 66.4 mtp180 -53.27 -63.15 1.24 Allowed 'General case' 0 CA--C 1.507 -0.7 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 175.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -57.16 -23.91 50.72 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.782 -177.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -83.37 -33.1 25.88 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.592 -178.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.771 HD21 ' HZ ' ' A' ' 248' ' ' PHE . 7.7 mp -106.0 -15.51 14.88 Favored 'General case' 0 C--O 1.224 -0.253 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -171.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . 0.633 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 43.6 mm-40 -61.62 -37.62 42.67 Favored Pre-proline 0 C--N 1.328 -0.366 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -177.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . 0.633 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 85.1 Cg_endo -66.08 -29.07 48.6 Favored 'Trans proline' 0 C--N 1.358 1.039 0 C-N-CA 121.638 1.558 . . . . 0.0 112.414 -172.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . 0.517 ' CE1' ' HA ' ' A' ' 226' ' ' LEU . 3.5 p90 -110.56 -11.06 14.5 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.449 -0.5 . . . . 0.0 111.999 176.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . 0.422 ' CA ' ' HB3' ' A' ' 253' ' ' ALA . . . -164.93 92.4 0.11 Allowed Glycine 0 N--CA 1.44 -1.048 0 C-N-CA 120.282 -0.961 . . . . 0.0 112.01 -175.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -60.41 130.18 32.75 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.126 1.884 . . . . 0.0 111.319 178.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.847 HG21 HG12 ' A' ' 246' ' ' VAL . 2.3 mp -109.17 152.22 11.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.898 179.135 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -112.99 -23.47 10.04 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.985 0.421 . . . . 0.0 110.675 176.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . 0.522 ' HB3' ' HB2' ' A' ' 247' ' ' HIS . 35.1 tt0 -139.36 120.47 14.67 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.721 -175.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . 0.683 HD13 ' HG3' ' A' ' 223' ' ' ARG . 13.7 mt -136.61 112.3 11.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.037 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -120.32 110.74 16.91 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.57 -177.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' ILE . . . . . 0.591 HG21 HG23 ' A' ' 217' ' ' ILE . 72.6 mt -98.85 117.55 44.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.791 -178.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.587 ' HB ' HG13 ' A' ' 243' ' ' ILE . 24.3 t -97.97 88.29 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 174.044 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 8.8 t -65.04 -24.33 67.45 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.455 -175.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -66.93 -21.49 65.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.329 0.585 . . . . 0.0 110.339 178.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . 0.611 ' CB ' HG12 ' A' ' 243' ' ' ILE . 33.4 mmt180 -117.91 -2.73 11.26 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.906 -178.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 17.4 m120 66.35 25.33 10.41 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.73 178.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.611 HG12 ' CB ' ' A' ' 241' ' ' ARG . 2.8 pt -122.33 153.1 26.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.01 -173.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . 0.461 ' HB3' ' HB2' ' A' ' 210' ' ' LEU . . . -142.14 134.92 28.47 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.897 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -105.89 120.13 40.95 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.821 178.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . 0.847 HG12 HG21 ' A' ' 232' ' ' ILE . 0.2 OUTLIER -116.95 133.38 63.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -177.079 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' HIS . . . . . 0.733 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 41.3 m170 -115.05 102.81 10.29 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.067 -0.653 . . . . 0.0 111.195 177.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . 0.771 ' HZ ' HD21 ' A' ' 226' ' ' LEU . 28.2 m-85 -86.67 104.52 16.15 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.333 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.411 ' H ' HD23 ' A' ' 249' ' ' LEU . 0.1 OUTLIER -41.92 -46.44 4.05 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 124.405 1.066 . . . . 0.0 113.111 -175.766 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . 0.409 ' N ' HD21 ' A' ' 250' ' ' ASN . 0.9 OUTLIER -94.02 145.64 24.51 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.296 178.092 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . 0.61 HG12 ' HB3' ' A' ' 205' ' ' CYS . 0.2 OUTLIER -63.38 -41.72 93.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -179.705 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -70.69 -31.2 68.0 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 120.783 0.325 . . . . 0.0 110.57 -174.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . 0.422 ' HB3' ' CA ' ' A' ' 230' ' ' GLY . . . -59.5 -43.56 93.33 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.253 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . 0.531 ' HB3' ' HB2' ' A' ' 248' ' ' PHE . . . -68.44 -39.73 81.42 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.915 179.103 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.615 ' HA ' ' HH ' ' A' ' 274' ' ' TYR . 7.9 mt -56.95 -61.97 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.21 -177.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . 0.504 ' O ' ' HG2' ' A' ' 260' ' ' GLU . 10.7 ptmt -61.43 -40.57 94.93 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.512 -176.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -60.44 -49.53 77.21 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.72 0.295 . . . . 0.0 111.365 178.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . 0.426 HG12 HG12 ' A' ' 272' ' ' ILE . 51.7 t -67.24 -23.34 30.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 120.98 0.419 . . . . 0.0 111.206 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . 0.521 ' HG3' ' O ' ' A' ' 255' ' ' ILE . 54.2 mt-30 -83.28 -27.39 29.86 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 122.193 -0.317 . . . . 0.0 111.54 177.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . 0.504 ' HG2' ' O ' ' A' ' 256' ' ' LYS . 30.2 mm-40 -95.62 -30.16 13.94 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.33 -173.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.705 ' HA ' ' HE3' ' A' ' 267' ' ' TRP . 0.7 OUTLIER -51.79 -51.41 70.61 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.382 178.096 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' PRO . . . . . 0.555 ' HD2' ' N ' ' A' ' 261' ' ' LEU . 42.6 Cg_endo -67.07 -15.83 47.68 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.408 2.072 . . . . 0.0 112.84 -177.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 60.6 mt -94.94 -3.09 49.24 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.291 0.567 . . . . 0.0 111.832 -177.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' ASN . . . . . 0.462 ' O ' ' HB2' ' A' ' 268' ' ' SER . 13.3 m-80 -105.91 147.99 35.73 Favored Pre-proline 0 C--N 1.314 -0.947 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.321 -177.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -66.92 -32.87 34.71 Favored 'Trans proline' 0 C--N 1.334 -0.195 0 C-N-CA 123.35 2.7 . . . . 0.0 112.733 -168.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 3.8 mtpt -86.21 -44.53 12.1 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.517 0.675 . . . . 0.0 109.51 -178.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' TRP . . . . . 0.705 ' HE3' ' HA ' ' A' ' 261' ' ' LEU . 13.5 m0 -77.16 -28.15 54.02 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.874 -174.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' SER . . . . . 0.462 ' HB2' ' O ' ' A' ' 264' ' ' ASN . 8.0 t -68.68 -15.12 63.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.035 0.445 . . . . 0.0 110.504 178.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -74.65 -14.67 60.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.856 174.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 270' ' ' ARG . . . . . 0.525 ' HA ' ' HB3' ' A' ' 212' ' ' ASN . 4.1 mpt_? -99.37 162.65 12.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.838 178.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . 0.41 ' HG2' ' CB ' ' A' ' 212' ' ' ASN . 36.7 mmt180 -112.14 105.76 14.2 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 174.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . 0.611 HG22 HD23 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -116.87 140.91 37.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.373 0.606 . . . . 0.0 111.34 -175.817 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 273' ' ' TYR . . . . . 0.407 ' HB2' ' HG3' ' A' ' 200' ' ' GLN . 2.0 p90 -151.66 167.99 26.41 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.805 172.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 274' ' ' TYR . . . . . 0.615 ' HH ' ' HA ' ' A' ' 255' ' ' ILE . 85.9 m-85 -67.09 138.0 56.79 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.402 174.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -60.44 118.13 13.78 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.724 -0.75 . . . . 0.0 111.593 178.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . 0.449 ' N ' ' HD3' ' A' ' 276' ' ' ARG . 0.1 OUTLIER -52.25 126.86 20.21 Favored 'General case' 0 C--O 1.238 0.46 0 O-C-N 123.915 0.421 . . . . 0.0 111.069 -178.295 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 12.0 t70 67.4 122.95 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 O-C-N 124.307 1.004 . . . . 0.0 111.459 -176.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 278' ' ' ARG . . . . . 0.465 ' HG3' ' OE1' ' A' ' 201' ' ' GLN . 25.2 mtp180 -67.48 -18.65 65.15 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.653 -174.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 279' ' ' CYS . . . . . . . . . . . . . 11.4 m -91.51 20.75 5.08 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.85 0.357 . . . . 0.0 110.396 -179.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -67.01 91.97 0.22 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.789 178.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 11.0 p -124.65 -8.37 6.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.759 -178.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -84.44 67.08 3.76 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.383 -177.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 82.8 mt -105.74 79.79 1.48 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.087 0.47 . . . . 0.0 110.648 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.622 -0.704 . . . . 0.0 110.111 178.974 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 . . . . . 0 N--CA 1.48 1.056 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 47.4 t -167.32 111.84 0.71 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.92 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -86.8 109.2 19.11 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.032 177.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 8.1 p -98.89 129.62 45.25 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.797 -179.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -74.93 132.75 41.66 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.967 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 14.9 m -84.19 64.94 8.53 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.728 0.299 . . . . 0.0 110.724 -177.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' SER . . . . . 0.748 ' HA ' ' HD2' ' A' ' 273' ' ' TYR . 7.4 m 60.86 -168.53 0.17 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.108 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . 0.507 HG13 ' HG3' ' A' ' 200' ' ' GLN . 3.8 m -86.31 123.58 39.74 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.453 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.187 173.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . 0.413 ' C ' HD22 ' A' ' 196' ' ' LEU . 9.0 tt -62.48 99.13 0.13 Allowed 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 176.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 81.5 mt 55.39 24.87 7.03 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.382 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.472 ' HA ' ' HB ' ' A' ' 195' ' ' VAL . . . 57.1 35.04 25.8 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.778 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 29.8 m -69.46 -24.25 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-O 120.754 0.312 . . . . 0.0 111.245 178.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' GLN . . . . . 0.507 ' HG3' HG13 ' A' ' 195' ' ' VAL . 7.4 pt20 -108.35 82.02 1.56 Allowed 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 121.449 0.642 . . . . 0.0 110.999 176.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . 0.43 ' HG3' ' O ' ' A' ' 198' ' ' ALA . 25.6 mt-30 -103.14 40.16 1.44 Allowed 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 174.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 20.8 m -58.09 150.01 22.17 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.812 -177.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -74.4 72.66 1.43 Allowed Glycine 0 N--CA 1.449 -0.462 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.599 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -91.55 122.54 34.22 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 175.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' CYS . . . . . 0.661 ' HB3' HG12 ' A' ' 251' ' ' ILE . 15.6 p -87.15 145.96 26.21 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.644 -177.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . 0.793 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 57.1 mtp180 56.25 3.97 0.12 Allowed 'General case' 0 C--O 1.224 -0.281 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 175.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . 0.444 HD22 ' HB3' ' A' ' 277' ' ' ASP . 4.4 m-20 -108.36 105.79 15.64 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 119.85 -0.74 . . . . 0.0 112.041 -175.204 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.43 ' HB ' ' HB ' ' A' ' 246' ' ' VAL . 67.9 t -133.49 113.48 18.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 114.691 -1.141 . . . . 0.0 109.153 176.199 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' PHE . . . . . 0.432 ' HE1' ' HB ' ' A' ' 243' ' ' ILE . 1.7 t80 -112.05 122.37 47.58 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.094 -175.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.5 ' HG ' HG21 ' A' ' 272' ' ' ILE . 5.4 mp -104.8 131.13 52.64 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.257 178.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . 0.53 ' HA2' HG21 ' A' ' 243' ' ' ILE . . . -137.16 64.1 0.57 Allowed Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.217 -0.992 . . . . 0.0 113.636 -178.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . 0.518 ' HB3' ' HA ' ' A' ' 270' ' ' ARG . 30.6 t30 175.81 37.15 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.055 0.455 . . . . 0.0 109.93 174.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.554 HD23 ' HG2' ' A' ' 270' ' ' ARG . 1.0 OUTLIER -81.8 158.26 68.17 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.849 -176.792 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.438 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 73.4 Cg_endo -74.89 152.47 41.38 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 122.351 2.034 . . . . 0.0 111.522 177.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -70.04 116.17 10.1 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.237 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 108.5 1.68 32.88 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.487 -0.863 . . . . 0.0 112.639 -177.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . 0.691 HG21 HG21 ' A' ' 237' ' ' ILE . 5.1 tp -60.66 130.54 24.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.0 0.428 . . . . 0.0 110.502 176.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' THR . . . . . 0.471 HG22 ' HG3' ' A' ' 221' ' ' GLU . 11.6 t -113.5 158.45 20.7 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.379 0.609 . . . . 0.0 110.949 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.464 ' CD ' ' H ' ' A' ' 219' ' ' GLU . 5.8 mp0 -61.85 -42.5 99.11 Favored 'General case' 0 C--O 1.21 -1.023 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.581 -176.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -48.18 -38.42 18.1 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 123.839 0.712 . . . . 0.0 111.547 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . 0.471 ' HG3' HG22 ' A' ' 218' ' ' THR . 42.3 mt-10 -66.22 -57.9 6.56 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.281 178.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . 0.481 HD13 HD12 ' A' ' 237' ' ' ILE . 8.4 mt -61.45 -41.3 89.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.602 -178.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . 0.723 ' HG3' HD11 ' A' ' 235' ' ' ILE . 48.7 mtp180 -53.63 -62.7 1.48 Allowed 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 175.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -58.27 -22.89 54.33 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.756 -177.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' ASP . . . . . 0.472 ' HB3' ' CZ2' ' A' ' 267' ' ' TRP . 10.7 m-20 -86.2 -32.26 21.3 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.844 -177.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.79 HD22 ' HZ ' ' A' ' 248' ' ' PHE . 7.7 mp -106.68 -15.31 14.79 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -170.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . 0.612 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 23.2 mm-40 -60.4 -38.38 57.16 Favored Pre-proline 0 C--N 1.327 -0.393 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -178.108 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . 0.612 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 96.1 Cg_endo -66.78 -26.47 45.12 Favored 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 121.587 1.525 . . . . 0.0 112.485 -171.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . 0.514 ' CZ ' ' HA ' ' A' ' 226' ' ' LEU . 3.6 p90 -111.21 -9.19 14.33 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.958 175.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . 0.444 ' CA ' ' HB3' ' A' ' 253' ' ' ALA . . . -169.05 99.1 0.15 Allowed Glycine 0 N--CA 1.442 -0.942 0 C-N-CA 120.033 -1.079 . . . . 0.0 112.268 -175.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -65.86 131.43 27.32 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 121.808 1.672 . . . . 0.0 111.532 178.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.806 HG23 HG12 ' A' ' 246' ' ' VAL . 2.1 mp -108.68 151.51 10.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.437 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . 0.441 ' CG ' HD23 ' A' ' 249' ' ' LEU . 38.0 m-20 -114.56 -19.89 10.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.848 0.356 . . . . 0.0 110.75 177.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . 0.473 ' HB3' ' HB2' ' A' ' 247' ' ' HIS . 9.4 tt0 -143.62 121.22 11.8 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.73 -177.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . 0.723 HD11 ' HG3' ' A' ' 223' ' ' ARG . 12.1 mt -135.09 108.52 9.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.964 -179.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 61.9 tttp -115.9 112.47 21.94 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.411 -178.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' ILE . . . . . 0.691 HG21 HG21 ' A' ' 217' ' ' ILE . 67.0 mt -102.35 124.1 56.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-O 121.017 0.436 . . . . 0.0 110.783 -179.544 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.521 ' HB ' HG13 ' A' ' 243' ' ' ILE . 61.2 t -105.23 87.68 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 171.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 13.2 t -69.84 -16.53 63.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.381 -177.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -62.06 -34.04 75.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.202 175.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . 0.74 ' HB2' HG12 ' A' ' 243' ' ' ILE . 77.0 mtt180 -112.88 -0.28 14.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.527 178.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 17.9 m120 67.46 29.64 7.2 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.847 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.74 HG12 ' HB2' ' A' ' 241' ' ' ARG . 1.3 pt -122.3 151.68 26.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.037 -175.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . 0.419 ' HB1' ' HB2' ' A' ' 210' ' ' LEU . . . -141.3 138.19 32.98 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.046 0.451 . . . . 0.0 111.849 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -107.27 108.05 19.28 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.836 177.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . 0.806 HG12 HG23 ' A' ' 232' ' ' ILE . 0.9 OUTLIER -106.12 133.57 50.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 -179.288 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' HIS . . . . . 0.793 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 41.8 m170 -112.27 101.97 10.16 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.486 0.66 . . . . 0.0 111.295 178.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . 0.79 ' HZ ' HD22 ' A' ' 226' ' ' LEU . 33.7 m-85 -86.65 101.28 13.11 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.99 -1.004 . . . . 0.0 111.33 179.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.441 HD23 ' CG ' ' A' ' 233' ' ' ASP . 0.1 OUTLIER -42.26 -48.05 4.88 Favored 'General case' 0 N--CA 1.465 0.312 0 O-C-N 124.367 1.042 . . . . 0.0 112.583 -176.611 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . 0.417 ' HB2' ' HB2' ' A' ' 253' ' ' ALA . 9.0 m120 -84.95 138.18 32.65 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 178.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . 0.661 HG12 ' HB3' ' A' ' 205' ' ' CYS . 0.2 OUTLIER -62.38 -43.69 98.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -179.609 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -68.98 -30.12 68.47 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.901 -177.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . 0.444 ' HB3' ' CA ' ' A' ' 230' ' ' GLY . . . -60.72 -41.74 95.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.32 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . 0.544 ' HB3' ' HB2' ' A' ' 248' ' ' PHE . . . -67.87 -41.29 83.08 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.591 178.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.647 ' HA ' ' HH ' ' A' ' 274' ' ' TYR . 11.7 mt -56.05 -60.84 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.159 -178.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 10.0 ptmt -62.66 -38.84 91.92 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.622 -176.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -61.96 -47.97 82.46 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.557 0.218 . . . . 0.0 111.349 178.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . 0.529 HG13 HG12 ' A' ' 272' ' ' ILE . 54.6 t -65.15 -25.14 36.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.878 0.371 . . . . 0.0 110.931 178.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -83.71 -23.61 31.59 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 178.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -94.93 -34.93 12.21 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.826 0.345 . . . . 0.0 110.689 -175.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.726 ' HA ' ' HE3' ' A' ' 267' ' ' TRP . 0.7 OUTLIER -51.57 -50.48 76.73 Favored Pre-proline 0 CA--C 1.538 0.503 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.578 -178.296 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' A' ' 261' ' ' LEU . 37.3 Cg_endo -66.35 -20.6 55.02 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.222 1.948 . . . . 0.0 112.544 -177.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 65.8 mt -90.65 -2.22 57.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.292 0.568 . . . . 0.0 111.551 -175.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 12.2 m-80 -106.71 148.93 37.77 Favored Pre-proline 0 C--N 1.315 -0.916 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.938 -176.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -65.59 -34.2 42.82 Favored 'Trans proline' 0 C--O 1.23 0.11 0 C-N-CA 123.367 2.711 . . . . 0.0 112.604 -171.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 5.1 mtpt -86.05 -45.23 11.62 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 121.812 0.815 . . . . 0.0 109.747 -177.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' TRP . . . . . 0.726 ' HE3' ' HA ' ' A' ' 261' ' ' LEU . 11.3 m0 -78.75 -26.02 44.57 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.722 -172.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 37.3 t -61.41 -22.15 64.75 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.758 0.313 . . . . 0.0 111.01 177.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -71.15 -18.08 62.52 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.242 0.544 . . . . 0.0 110.481 176.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 270' ' ' ARG . . . . . 0.554 ' HG2' HD23 ' A' ' 213' ' ' LEU . 0.0 OUTLIER -101.9 140.56 36.02 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.475 -179.932 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . 0.744 ' HE ' ' HA ' ' A' ' 271' ' ' ARG . 0.2 OUTLIER -95.62 105.77 17.8 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.777 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . 0.63 HG22 HD21 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -115.24 144.07 23.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.352 0.596 . . . . 0.0 111.285 -174.693 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 273' ' ' TYR . . . . . 0.748 ' HD2' ' HA ' ' A' ' 194' ' ' SER . 5.0 p90 -151.87 169.46 22.22 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.421 174.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 274' ' ' TYR . . . . . 0.647 ' HH ' ' HA ' ' A' ' 255' ' ' ILE . 70.4 m-85 -62.34 115.0 3.81 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 171.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -83.13 169.15 47.69 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.717 -0.754 . . . . 0.0 113.111 -170.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 24.7 ptt180 -110.24 141.45 43.19 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 176.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 277' ' ' ASP . . . . . 0.444 ' HB3' HD22 ' A' ' 207' ' ' ASN . 21.9 t70 -159.21 164.27 35.21 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.822 0.344 . . . . 0.0 110.93 -170.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 278' ' ' ARG . . . . . . . . . . . . . 21.5 ptt180 -56.55 -33.71 66.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.386 -0.825 . . . . 0.0 112.21 179.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 279' ' ' CYS . . . . . . . . . . . . . 42.7 t -110.17 67.19 0.64 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -176.66 -171.91 0.41 Allowed 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.408 -176.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 2.9 p -151.39 110.06 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 115.025 -0.988 . . . . 0.0 110.055 178.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -75.8 -76.75 0.77 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.805 178.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 32.5 tp -140.09 90.56 2.38 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 177.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 60.7 tttm . . . . . 0 C--O 1.247 0.941 0 CA-C-O 118.376 -0.821 . . . . 0.0 109.832 -175.462 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 15.6 m120 . . . . . 0 N--CA 1.479 1.018 0 CA-C-O 120.806 0.336 . . . . 0.0 110.582 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 9.0 t -150.79 100.76 2.85 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 176.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -100.74 -21.24 15.25 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.925 -173.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 50.7 p 50.71 -84.43 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.976 0.91 . . . . 0.0 112.119 -176.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 63.0 t30 70.57 -70.11 0.16 Allowed 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.836 0.855 . . . . 0.0 111.981 176.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 5.6 p -80.31 -1.76 42.37 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.093 0.473 . . . . 0.0 111.14 -178.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 3.9 m -109.56 74.7 0.91 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.888 177.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . 0.531 ' HB ' ' HA ' ' A' ' 198' ' ' ALA . 13.9 m 35.27 100.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 -177.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . 0.538 ' O ' HG23 ' A' ' 199' ' ' VAL . 8.3 tt -55.32 102.81 0.08 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.596 174.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 94.7 mt 54.27 16.24 1.17 Allowed 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.407 0.683 . . . . 0.0 112.364 178.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.531 ' HA ' ' HB ' ' A' ' 195' ' ' VAL . . . 57.62 17.71 4.19 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.055 0.542 . . . . 0.0 112.042 -176.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 196' ' ' LEU . 33.7 m -84.17 -21.56 8.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.298 0.571 . . . . 0.0 110.465 -179.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -92.53 75.0 5.14 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.475 0.655 . . . . 0.0 110.65 -179.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -124.39 111.08 15.35 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.744 178.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' SER . . . . . 0.526 ' HA ' ' HA ' ' A' ' 281' ' ' VAL . 15.0 m -85.25 -56.21 3.65 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 174.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.506 ' HA3' ' HG ' ' A' ' 283' ' ' LEU . . . 160.35 51.75 0.01 OUTLIER Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.642 -179.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.3 101.72 1.26 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.015 0.436 . . . . 0.0 110.404 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' CYS . . . . . 0.446 ' CA ' HG12 ' A' ' 251' ' ' ILE . 2.5 m -87.48 146.16 25.94 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.984 -0.746 . . . . 0.0 108.984 -178.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . 0.806 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 24.7 mtp-105 55.52 4.98 0.11 Allowed 'General case' 0 C--O 1.222 -0.388 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 177.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -101.3 106.04 17.18 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 118.681 0.673 . . . . 0.0 111.562 -172.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 60.0 t -138.57 119.69 16.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.936 176.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' PHE . . . . . 0.433 ' O ' ' HA ' ' A' ' 272' ' ' ILE . 4.3 t80 -116.31 125.64 52.43 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.49 -177.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.522 ' HB2' ' HB1' ' A' ' 244' ' ' ALA . 6.2 mp -110.7 133.96 52.88 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.612 178.194 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . 0.512 ' HA2' HG22 ' A' ' 243' ' ' ILE . . . -138.94 65.9 0.53 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.591 -0.814 . . . . 0.0 113.351 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . 0.473 ' HB2' ' O ' ' A' ' 211' ' ' GLY . 25.1 t30 172.05 42.77 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.831 0.348 . . . . 0.0 110.617 177.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.462 HD13 ' O ' ' A' ' 242' ' ' ASN . 1.2 mp -91.23 160.32 37.57 Favored Pre-proline 0 C--N 1.322 -0.591 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.268 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.408 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 92.7 Cg_endo -82.49 166.76 15.62 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 122.637 2.225 . . . . 0.0 112.202 177.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -73.36 125.87 28.83 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.324 0.583 . . . . 0.0 111.139 178.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 106.01 -8.78 42.6 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.839 178.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . 0.778 HG23 HG21 ' A' ' 237' ' ' ILE . 5.0 tp -57.99 125.92 14.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.338 0.59 . . . . 0.0 110.625 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' THR . . . . . 0.456 ' CG2' ' HG3' ' A' ' 221' ' ' GLU . 11.1 t -114.42 157.88 22.3 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.751 -178.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -61.34 -35.53 77.67 Favored 'General case' 0 C--O 1.209 -1.056 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.936 -177.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' ASP . . . . . 0.425 ' O ' ' HG2' ' A' ' 224' ' ' GLU . 29.5 t70 -51.32 -40.0 58.14 Favored 'General case' 0 C--N 1.32 -0.702 0 O-C-N 123.632 0.582 . . . . 0.0 111.109 178.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . 0.456 ' HG3' ' CG2' ' A' ' 218' ' ' THR . 44.4 mt-10 -70.01 -54.13 14.59 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.562 -179.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . 0.484 HD11 HD12 ' A' ' 237' ' ' ILE . 11.8 mt -60.98 -42.29 92.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.616 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . 0.802 ' HG3' HD12 ' A' ' 235' ' ' ILE . 38.9 mtp180 -53.87 -63.09 1.26 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 174.279 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.425 ' HG2' ' O ' ' A' ' 220' ' ' ASP . 15.4 pt-20 -57.7 -22.16 44.67 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.19 -177.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' ASP . . . . . 0.489 ' HB3' ' CZ2' ' A' ' 267' ' ' TRP . 27.0 m-20 -89.62 -31.88 17.34 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.973 -177.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.845 HD22 ' HZ ' ' A' ' 248' ' ' PHE . 8.3 mp -107.05 -17.46 14.17 Favored 'General case' 0 C--O 1.224 -0.282 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -169.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . 0.665 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 58.6 mt-10 -69.6 -26.91 1.15 Allowed Pre-proline 0 C--N 1.323 -0.568 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -175.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . 0.665 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 72.3 Cg_endo -66.25 -27.84 48.06 Favored 'Trans proline' 0 C--N 1.36 1.179 0 C-N-CA 121.247 1.298 . . . . 0.0 111.916 -178.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . 0.479 ' CZ ' ' HA ' ' A' ' 226' ' ' LEU . 3.6 p90 -110.6 -9.36 14.55 Favored 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.66 174.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . 0.402 ' CA ' ' HB3' ' A' ' 253' ' ' ALA . . . -168.35 93.77 0.11 Allowed Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 120.18 -1.01 . . . . 0.0 112.109 -175.336 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -59.76 133.59 52.08 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.214 1.943 . . . . 0.0 111.393 177.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.822 HG21 HG12 ' A' ' 246' ' ' VAL . 2.4 mp -111.4 151.59 13.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.309 177.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . 0.406 ' OD2' HD21 ' A' ' 249' ' ' LEU . 14.9 m-20 -115.51 -20.08 10.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.76 0.314 . . . . 0.0 111.227 177.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . 0.519 ' HB3' ' HB2' ' A' ' 247' ' ' HIS . 22.9 tt0 -142.77 120.48 11.86 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.279 -176.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . 0.802 HD12 ' HG3' ' A' ' 223' ' ' ARG . 17.2 mt -136.3 116.28 17.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.889 -179.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -122.2 116.11 23.58 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.849 0.357 . . . . 0.0 110.457 178.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' ILE . . . . . 0.778 HG21 HG23 ' A' ' 217' ' ' ILE . 33.4 mt -104.57 115.47 46.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.248 179.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.558 ' HB ' HG13 ' A' ' 243' ' ' ILE . 45.5 t -94.26 87.0 2.04 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.152 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 173.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 8.8 t -65.32 -22.29 66.81 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.482 -177.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -60.32 -29.12 68.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.565 176.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . 0.747 ' HB2' HG12 ' A' ' 243' ' ' ILE . 73.9 mtt180 -120.0 0.43 10.77 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.797 -179.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' ASN . . . . . 0.462 ' O ' HD13 ' A' ' 213' ' ' LEU . 92.1 m-20 66.16 29.72 9.66 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.194 179.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.747 HG12 ' HB2' ' A' ' 241' ' ' ARG . 1.3 pt -121.92 151.34 25.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.792 -176.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . 0.522 ' HB1' ' HB2' ' A' ' 210' ' ' LEU . . . -141.55 138.77 32.92 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.103 0.477 . . . . 0.0 111.55 -178.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -110.78 111.43 22.6 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.677 176.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . 0.822 HG12 HG21 ' A' ' 232' ' ' ILE . 0.8 OUTLIER -108.16 134.89 48.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -179.234 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' HIS . . . . . 0.806 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 46.1 m80 -116.06 101.72 9.0 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 119.995 -0.682 . . . . 0.0 111.457 178.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . 0.845 ' HZ ' HD22 ' A' ' 226' ' ' LEU . 29.9 m-85 -84.67 104.67 14.85 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.716 -1.129 . . . . 0.0 111.113 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.54 ' HA ' ' HE ' ' A' ' 206' ' ' ARG . 0.1 OUTLIER -42.82 -42.56 3.66 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 124.194 0.934 . . . . 0.0 113.058 -174.11 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 47.4 m-20 -95.51 143.8 26.53 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . 0.522 ' O ' HG13 ' A' ' 255' ' ' ILE . 0.2 OUTLIER -63.56 -45.0 98.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -177.594 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -70.79 -29.14 65.25 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-O 120.625 0.25 . . . . 0.0 110.791 -176.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . 0.402 ' HB3' ' CA ' ' A' ' 230' ' ' GLY . . . -58.6 -42.7 88.71 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.36 178.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . 0.552 ' HB2' ' HB2' ' A' ' 248' ' ' PHE . . . -67.29 -42.0 84.49 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.626 178.025 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.522 HG13 ' O ' ' A' ' 251' ' ' ILE . 8.5 mt -56.95 -61.31 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.539 -177.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 12.3 ptmt -60.41 -38.52 84.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.271 -177.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -62.75 -47.91 81.47 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.741 0.305 . . . . 0.0 111.211 178.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 44.4 t -66.18 -23.54 32.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.011 0.434 . . . . 0.0 111.023 179.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . 0.487 ' HG3' ' O ' ' A' ' 255' ' ' ILE . 50.8 mt-30 -83.53 -27.8 29.09 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.825 177.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -96.02 -28.89 14.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.69 0.281 . . . . 0.0 111.59 -173.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.72 ' HA ' ' HE3' ' A' ' 267' ' ' TRP . 0.7 OUTLIER -54.1 -50.04 86.62 Favored Pre-proline 0 CA--C 1.536 0.437 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.516 179.252 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 261' ' ' LEU . 41.2 Cg_endo -66.41 -13.76 41.27 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.271 1.981 . . . . 0.0 112.419 -179.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 60.8 mt -91.15 -8.0 49.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.929 0.395 . . . . 0.0 112.0 -178.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -106.11 149.8 38.57 Favored Pre-proline 0 C--O 1.211 -0.964 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.974 -177.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 265' ' ' PRO . . . . . 0.415 ' O ' ' HG3' ' A' ' 269' ' ' LYS . 47.3 Cg_endo -67.28 -33.28 30.98 Favored 'Trans proline' 0 C--O 1.224 -0.21 0 C-N-CA 123.325 2.684 . . . . 0.0 112.804 -171.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.471 ' HB2' ' HE3' ' A' ' 266' ' ' LYS . 0.0 OUTLIER -83.35 -45.91 13.19 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 121.732 0.777 . . . . 0.0 109.224 -179.376 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' TRP . . . . . 0.72 ' HE3' ' HA ' ' A' ' 261' ' ' LEU . 14.3 m0 -76.49 -29.75 56.96 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.909 -172.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 24.1 t -63.84 -23.12 67.23 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.896 0.379 . . . . 0.0 110.72 178.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . 0.415 ' HG3' ' O ' ' A' ' 265' ' ' PRO . 93.4 mttt -70.82 -19.08 62.7 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.283 0.563 . . . . 0.0 109.695 178.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 270' ' ' ARG . . . . . 0.433 ' HA ' ' HB3' ' A' ' 212' ' ' ASN . 4.7 mpt_? -93.25 146.49 23.66 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.476 176.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 6.6 mmp_? -99.33 106.07 18.13 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 173.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . 0.59 HG23 HD23 ' A' ' 261' ' ' LEU . 0.1 OUTLIER -117.73 142.34 32.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.336 0.589 . . . . 0.0 111.552 -176.673 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -150.61 168.87 23.0 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.254 170.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -58.74 132.59 54.35 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 175.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -72.89 78.22 0.77 Allowed Glycine 0 CA--C 1.507 -0.459 0 C-N-CA 121.173 -0.537 . . . . 0.0 112.131 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 76.9 mtp180 64.41 135.54 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.874 0 C-N-CA 124.4 1.08 . . . . 0.0 113.207 -176.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -141.96 151.64 42.74 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.172 -1.376 . . . . 0.0 108.638 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 278' ' ' ARG . . . . . . . . . . . . . 65.0 mtp180 -64.5 -24.85 67.75 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 111.614 0.228 . . . . 0.0 111.614 -175.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 279' ' ' CYS . . . . . . . . . . . . . 77.5 m 52.31 45.88 27.67 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.384 0.611 . . . . 0.0 110.288 -175.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -141.11 24.19 2.16 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.308 -177.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 281' ' ' VAL . . . . . 0.526 ' HA ' ' HA ' ' A' ' 202' ' ' SER . 7.6 p 38.29 86.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 124.325 1.05 . . . . 0.0 113.045 -177.229 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 178.16 131.14 1.5 Allowed Glycine 0 N--CA 1.447 -0.567 0 CA-C-N 115.131 -0.94 . . . . 0.0 111.248 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 283' ' ' LEU . . . . . 0.506 ' HG ' ' HA3' ' A' ' 203' ' ' GLY . 5.1 mp -93.51 -170.58 2.4 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.862 0.331 . . . . 0.0 110.461 -176.026 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 10.8 ptmm? . . . . . 0 C--O 1.247 0.929 0 CA-C-O 118.296 -0.859 . . . . 0.0 110.883 178.578 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 9.7 t30 . . . . . 0 N--CA 1.479 1.007 0 CA-C-O 120.896 0.379 . . . . 0.0 110.758 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' SER . . . . . 0.476 ' HB3' ' HA ' ' A' ' 192' ' ' ASN . 17.3 m -109.05 93.7 4.65 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 175.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -66.07 -63.68 1.03 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.643 -178.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 39.7 t -84.16 -25.86 29.28 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 177.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . 0.476 ' HA ' ' HB3' ' A' ' 189' ' ' SER . 49.5 t30 63.89 91.53 0.07 Allowed 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.419 -175.244 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 33.8 m -85.55 6.75 25.78 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.981 -178.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 15.4 m 60.9 30.58 19.72 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.604 174.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . 0.547 ' CG2' ' HA ' ' A' ' 198' ' ' ALA . 0.3 OUTLIER -125.79 150.28 31.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.396 -176.77 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . 0.628 ' O ' HG22 ' A' ' 199' ' ' VAL . 5.5 tt -60.85 97.13 0.05 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 176.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 98.4 mt 52.21 25.11 3.13 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.212 -0.904 . . . . 0.0 112.682 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.547 ' HA ' ' CG2' ' A' ' 195' ' ' VAL . . . 59.01 18.17 6.06 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 179.18 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.628 HG22 ' O ' ' A' ' 196' ' ' LEU . 21.3 m -91.54 -7.84 10.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.351 0.596 . . . . 0.0 110.16 177.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -83.86 78.66 9.68 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.347 178.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . 0.405 ' HA ' ' OE1' ' A' ' 201' ' ' GLN . 15.4 mm-40 -92.05 -4.19 54.76 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.644 0.735 . . . . 0.0 109.625 174.227 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 28.1 m -150.89 168.92 23.03 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.032 -0.986 . . . . 0.0 109.24 176.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.428 ' C ' ' HA ' ' A' ' 279' ' ' CYS . . . 98.11 -48.33 1.44 Allowed Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.811 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . 0.519 ' HA ' ' OD2' ' A' ' 277' ' ' ASP . . . -67.19 102.89 1.11 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.95 0.405 . . . . 0.0 110.49 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' CYS . . . . . 0.559 ' SG ' ' HG3' ' A' ' 206' ' ' ARG . 35.2 t -88.48 148.27 24.25 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.74 -176.331 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . 0.732 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 15.0 mtm180 51.86 -0.7 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 179.182 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 19.3 m-80 -100.65 105.64 17.03 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 118.876 0.762 . . . . 0.0 111.332 -172.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.487 ' HB ' ' HB ' ' A' ' 246' ' ' VAL . 60.3 t -137.36 127.76 38.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.24 176.375 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' PHE . . . . . 0.59 ' HB3' ' CE1' ' A' ' 273' ' ' TYR . 1.8 t80 -127.44 128.18 45.33 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 -177.514 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.522 ' HG ' HG23 ' A' ' 272' ' ' ILE . 5.9 mp -111.02 134.0 52.96 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.505 179.032 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . 0.53 ' HA2' HG21 ' A' ' 243' ' ' ILE . . . -138.94 65.68 0.53 Allowed Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.098 -1.048 . . . . 0.0 113.328 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . 0.566 ' HB2' ' HG3' ' A' ' 271' ' ' ARG . 3.3 t30 174.83 40.92 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.24 0.543 . . . . 0.0 110.105 175.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.585 ' HA ' ' HG3' ' A' ' 270' ' ' ARG . 1.0 OUTLIER -85.81 155.85 58.53 Favored Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.811 -177.693 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -79.79 169.14 18.5 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.81 2.34 . . . . 0.0 112.059 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -78.69 124.05 27.79 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 108.52 -2.83 32.53 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.592 -0.814 . . . . 0.0 112.613 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 6.0 tp -65.14 125.18 21.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-O 121.255 0.55 . . . . 0.0 111.194 179.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' THR . . . . . 0.45 HG22 ' HG3' ' A' ' 221' ' ' GLU . 15.0 t -114.4 161.05 18.45 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.561 177.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 9.3 mp0 -62.81 -38.04 89.11 Favored 'General case' 0 C--O 1.208 -1.105 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.059 -178.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' ASP . . . . . 0.489 ' O ' ' HG2' ' A' ' 224' ' ' GLU . 26.2 t70 -51.63 -37.87 52.21 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 123.618 0.574 . . . . 0.0 110.813 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . 0.45 ' HG3' HG22 ' A' ' 218' ' ' THR . 41.9 mt-10 -67.49 -57.5 6.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.4 178.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . 0.462 HG22 HD22 ' A' ' 226' ' ' LEU . 6.9 mt -58.29 -41.67 81.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.351 -179.604 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . 0.703 ' HG3' HD11 ' A' ' 235' ' ' ILE . 37.3 mtp180 -57.12 -62.84 1.47 Allowed 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 175.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.489 ' HG2' ' O ' ' A' ' 220' ' ' ASP . 11.1 pt-20 -59.32 -20.8 57.49 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.083 -177.023 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' ASP . . . . . 0.465 ' HB3' ' CZ2' ' A' ' 267' ' ' TRP . 3.3 m-20 -90.58 -31.43 16.69 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.637 -177.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.671 HD23 ' HZ ' ' A' ' 248' ' ' PHE . 8.2 mp -107.45 -19.1 13.68 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -171.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . 0.68 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 48.1 mt-10 -73.34 -22.24 0.49 Allowed Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 113.264 0.839 . . . . 0.0 113.264 -175.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . 0.68 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 74.3 Cg_endo -66.59 -28.17 45.21 Favored 'Trans proline' 0 C--N 1.361 1.223 0 CA-C-N 120.747 1.302 . . . . 0.0 111.895 178.357 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . 0.484 ' CE1' ' HA ' ' A' ' 226' ' ' LEU . 2.9 p90 -110.71 -5.66 14.96 Favored 'General case' 0 C--O 1.225 -0.237 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.609 174.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . 0.49 ' CA ' ' HB3' ' A' ' 253' ' ' ALA . . . -174.6 95.59 0.1 Allowed Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 119.945 -1.121 . . . . 0.0 112.554 -175.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . 0.457 ' HA ' ' HG2' ' A' ' 227' ' ' GLU . 19.2 Cg_endo -60.75 135.69 61.7 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.264 1.976 . . . . 0.0 111.584 177.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.712 HG22 HG12 ' A' ' 246' ' ' VAL . 3.3 mp -108.6 151.31 10.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.488 178.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . 0.432 ' CG ' HD23 ' A' ' 249' ' ' LEU . 12.7 m-20 -107.07 -25.58 11.52 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.001 0.429 . . . . 0.0 110.831 178.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . 0.441 ' HB3' ' HB2' ' A' ' 247' ' ' HIS . 12.9 tt0 -145.1 120.28 10.15 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.749 -173.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . 0.703 HD11 ' HG3' ' A' ' 223' ' ' ARG . 24.0 mt -133.04 107.59 11.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.8 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -113.75 110.58 20.38 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.605 -175.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' ILE . . . . . 0.443 HD13 HD13 ' A' ' 222' ' ' ILE . 89.3 mt -100.76 121.52 51.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.262 0.553 . . . . 0.0 111.188 -178.43 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.49 ' HB ' HG13 ' A' ' 243' ' ' ILE . 46.1 t -108.97 87.22 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 172.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 13.9 t -68.33 -20.36 64.73 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.193 -177.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -57.91 -30.84 66.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.154 175.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . 0.653 ' HB2' HG12 ' A' ' 243' ' ' ILE . 98.8 mtt180 -118.26 4.41 11.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.732 177.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 17.5 m120 64.71 29.14 12.95 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.224 178.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.653 HG12 ' HB2' ' A' ' 241' ' ' ARG . 1.3 pt -122.19 151.64 26.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.31 -174.448 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -142.02 135.9 29.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.005 0.431 . . . . 0.0 111.446 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -103.91 114.42 28.66 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.702 178.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . 0.712 HG12 HG22 ' A' ' 232' ' ' ILE . 0.4 OUTLIER -110.35 132.17 59.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -179.349 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' HIS . . . . . 0.732 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 28.1 m80 -114.81 102.76 10.3 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 119.96 -0.696 . . . . 0.0 111.348 177.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . 0.671 ' HZ ' HD23 ' A' ' 226' ' ' LEU . 37.4 m-85 -86.18 102.98 14.39 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 114.887 -1.051 . . . . 0.0 111.33 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.432 HD23 ' CG ' ' A' ' 233' ' ' ASP . 0.2 OUTLIER -46.28 -37.9 7.92 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 124.437 1.086 . . . . 0.0 112.797 -175.789 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . 0.446 ' HB2' ' HB1' ' A' ' 253' ' ' ALA . 55.0 m-20 -97.27 136.32 37.93 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 178.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . 0.603 ' O ' HG13 ' A' ' 255' ' ' ILE . 0.2 OUTLIER -60.62 -43.41 94.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -179.094 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -70.96 -27.82 64.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.903 -176.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . 0.49 ' HB3' ' CA ' ' A' ' 230' ' ' GLY . . . -62.5 -41.72 99.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.215 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . 0.524 ' HB1' ' HB2' ' A' ' 248' ' ' PHE . . . -67.41 -41.96 84.04 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.645 178.391 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.675 ' HA ' ' OH ' ' A' ' 274' ' ' TYR . 13.5 mt -55.9 -61.25 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.297 -177.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 13.3 ptmt -62.37 -38.23 88.77 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.425 -176.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -64.48 -49.98 69.26 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 111.512 0.189 . . . . 0.0 111.512 179.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . 0.451 HG12 HG12 ' A' ' 272' ' ' ILE . 53.3 t -66.47 -22.79 30.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.01 0.434 . . . . 0.0 111.081 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -84.44 -24.61 29.47 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 175.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -90.55 -35.63 14.94 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.884 0.373 . . . . 0.0 111.032 -178.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.764 HD13 ' CE3' ' A' ' 267' ' ' TRP . 0.9 OUTLIER -52.24 -47.17 93.25 Favored Pre-proline 0 CA--C 1.54 0.576 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.79 -178.252 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 262' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 261' ' ' LEU . 39.1 Cg_endo -69.38 -21.86 34.64 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.257 1.971 . . . . 0.0 112.74 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 57.0 mt -90.02 -0.35 57.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.4 0.619 . . . . 0.0 111.114 -176.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 264' ' ' ASN . . . . . 0.453 ' O ' ' HB2' ' A' ' 268' ' ' SER . 12.1 m-80 -107.0 148.92 37.89 Favored Pre-proline 0 C--N 1.316 -0.857 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.757 -178.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -67.54 -41.74 8.18 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 123.074 2.516 . . . . 0.0 112.474 -171.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.423 ' HE2' ' HB2' ' A' ' 266' ' ' LYS . 2.6 mtpt -80.9 -45.1 17.29 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-O 121.615 0.722 . . . . 0.0 109.784 -175.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 267' ' ' TRP . . . . . 0.764 ' CE3' HD13 ' A' ' 261' ' ' LEU . 22.6 m0 -72.83 -28.79 62.76 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.549 -175.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 268' ' ' SER . . . . . 0.453 ' HB2' ' O ' ' A' ' 264' ' ' ASN . 23.1 t -66.57 -20.05 65.92 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 120.952 -0.299 . . . . 0.0 111.013 178.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -71.44 -15.73 62.35 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.336 0.589 . . . . 0.0 109.721 175.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 270' ' ' ARG . . . . . 0.585 ' HG3' ' HA ' ' A' ' 213' ' ' LEU . 0.0 OUTLIER -104.09 139.9 38.53 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.713 175.71 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . 0.566 ' HG3' ' HB2' ' A' ' 212' ' ' ASN . 15.3 mtm180 -93.22 105.36 17.45 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . 0.579 HG22 HD23 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -110.21 141.88 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-O 121.423 0.63 . . . . 0.0 110.857 -175.14 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 273' ' ' TYR . . . . . 0.59 ' CE1' ' HB3' ' A' ' 209' ' ' PHE . 4.6 p90 -152.78 167.75 27.98 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.83 174.136 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 274' ' ' TYR . . . . . 0.675 ' OH ' ' HA ' ' A' ' 255' ' ' ILE . 90.1 m-85 -69.38 136.49 51.75 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.266 172.323 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -67.99 -177.71 12.57 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.815 -0.707 . . . . 0.0 111.628 176.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 17.6 ptt180 -78.16 111.38 14.04 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.954 0.883 . . . . 0.0 110.81 -177.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 277' ' ' ASP . . . . . 0.519 ' OD2' ' HA ' ' A' ' 204' ' ' ALA . 31.3 t70 -157.59 146.68 19.75 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 114.475 -1.238 . . . . 0.0 109.205 -177.095 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 278' ' ' ARG . . . . . . . . . . . . . 74.5 mtt180 -104.26 50.56 0.79 Allowed 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.451 0.644 . . . . 0.0 110.424 -177.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 279' ' ' CYS . . . . . 0.428 ' HA ' ' C ' ' A' ' 203' ' ' GLY . 81.1 m 56.5 58.65 4.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.602 179.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -114.78 94.91 4.98 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.989 -177.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 6.4 p -90.72 -32.55 5.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.115 178.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -142.26 -119.86 1.52 Allowed Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.567 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 3.6 tt -136.24 95.62 3.22 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 63.9 tttm . . . . . 0 C--O 1.247 0.931 0 CA-C-O 118.43 -0.795 . . . . 0.0 109.774 -177.235 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 . . . . . 0 N--CA 1.48 1.049 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 43.9 m -76.63 -32.25 57.89 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.958 0.409 . . . . 0.0 110.443 178.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -83.46 -177.23 6.66 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.338 177.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 22.2 m -54.85 122.48 10.89 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.352 176.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -79.83 77.84 6.46 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.698 0.285 . . . . 0.0 110.593 -178.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' SER . . . . . 0.441 ' HA ' ' OE1' ' A' ' 259' ' ' GLN . 6.7 p -156.53 140.59 16.37 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.729 179.48 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' SER . . . . . 0.522 ' HB3' ' HG3' ' A' ' 262' ' ' PRO . 12.9 p -100.18 -0.7 38.28 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.311 0.577 . . . . 0.0 110.928 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 3.1 m -111.69 128.34 68.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.62 -177.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 7.1 tt -56.77 95.96 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.539 175.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 9.8 mp 53.48 18.08 1.29 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.632 179.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . 50.64 36.83 14.84 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 120.906 0.384 . . . . 0.0 111.158 -177.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 27.0 m -63.55 -22.38 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -175.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -78.49 72.38 5.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.841 0.353 . . . . 0.0 111.396 -179.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . 0.657 HE22 ' HB2' ' A' ' 283' ' ' LEU . 76.8 mt-30 54.46 33.03 17.86 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.377 -0.829 . . . . 0.0 112.139 175.174 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 37.2 t 71.12 -67.87 0.24 Allowed 'General case' 0 N--CA 1.465 0.29 0 O-C-N 123.843 0.715 . . . . 0.0 111.606 177.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -154.93 132.32 3.42 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.299 -176.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -102.49 145.59 29.35 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 110.008 -0.368 . . . . 0.0 110.008 178.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' CYS . . . . . 0.889 ' HB3' HG12 ' A' ' 251' ' ' ILE . 26.1 p -87.63 145.82 26.01 Favored 'General case' 0 CA--C 1.51 -0.567 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 177.289 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . 0.802 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 49.0 mtp180 57.04 -5.99 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 177.241 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 69.6 m-20 -100.86 106.13 17.47 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 119.125 0.875 . . . . 0.0 112.041 -173.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.48 ' HB ' ' HB ' ' A' ' 246' ' ' VAL . 59.5 t -136.02 117.6 19.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.607 178.094 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -115.47 123.38 48.42 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.752 0.31 . . . . 0.0 110.5 -177.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.469 ' HG ' HG22 ' A' ' 272' ' ' ILE . 5.9 mp -106.89 133.81 50.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.57 178.064 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . 0.519 ' HA2' HG22 ' A' ' 243' ' ' ILE . . . -143.39 65.78 0.47 Allowed Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.618 -0.801 . . . . 0.0 113.088 179.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . 0.511 ' HB3' ' HA ' ' A' ' 270' ' ' ARG . 50.5 t30 177.05 39.85 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.325 0.583 . . . . 0.0 109.733 177.315 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.738 HD22 ' HG2' ' A' ' 270' ' ' ARG . 1.2 mt -89.53 165.2 26.55 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.156 -179.269 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.493 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 78.5 Cg_endo -83.66 167.77 13.0 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 122.423 2.082 . . . . 0.0 111.14 174.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . 0.474 ' HA ' ' OG1' ' A' ' 239' ' ' THR . 40.9 t-20 -79.21 125.71 29.82 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 177.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 105.96 -3.92 38.7 Favored Glycine 0 C--N 1.314 -0.661 0 C-N-CA 120.458 -0.877 . . . . 0.0 113.082 -179.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . 0.672 HG23 HG23 ' A' ' 237' ' ' ILE . 5.0 tp -59.29 126.32 16.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.041 0.448 . . . . 0.0 110.436 178.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' THR . . . . . 0.478 ' CG2' ' HG3' ' A' ' 221' ' ' GLU . 10.6 t -111.11 156.81 20.8 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.321 0.582 . . . . 0.0 110.839 -178.041 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.43 ' CD ' ' H ' ' A' ' 219' ' ' GLU . 18.4 mp0 -62.28 -36.59 82.55 Favored 'General case' 0 C--O 1.21 -1.011 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.449 -177.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -50.98 -36.37 38.75 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.018 178.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . 0.478 ' HG3' ' CG2' ' A' ' 218' ' ' THR . 42.3 mt-10 -70.94 -59.46 2.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.798 178.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . 0.466 HD13 HD11 ' A' ' 237' ' ' ILE . 7.6 mt -60.21 -39.85 81.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.469 -178.189 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . 0.635 ' HG3' HD13 ' A' ' 235' ' ' ILE . 52.1 mtp180 -55.2 -62.27 1.78 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 174.088 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -55.71 -25.17 38.71 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.82 -178.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -86.3 -31.62 21.5 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.435 -176.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.782 HD22 ' HZ ' ' A' ' 248' ' ' PHE . 7.3 mp -108.43 -16.03 14.32 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -171.379 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . 0.623 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 34.8 mm-40 -61.55 -37.25 39.27 Favored Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -177.108 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . 0.623 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 96.7 Cg_endo -66.3 -30.57 45.13 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 121.5 1.467 . . . . 0.0 112.247 -172.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . 0.5 ' CE1' ' HA ' ' A' ' 226' ' ' LEU . 4.3 p90 -110.88 3.22 18.73 Favored 'General case' 0 C--O 1.221 -0.43 0 C-N-CA 120.591 -0.443 . . . . 0.0 111.346 176.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . 0.457 ' CA ' ' HB3' ' A' ' 253' ' ' ALA . . . -179.82 97.13 0.11 Allowed Glycine 0 N--CA 1.44 -1.041 0 C-N-CA 119.666 -1.254 . . . . 0.0 112.609 -178.061 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . 0.403 ' HD2' ' HA2' ' A' ' 230' ' ' GLY . 29.0 Cg_endo -64.17 134.31 41.91 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 121.772 1.648 . . . . 0.0 111.031 177.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.746 HG21 HG12 ' A' ' 246' ' ' VAL . 2.9 mp -108.59 150.65 11.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.97 178.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . 0.465 ' CG ' HD21 ' A' ' 249' ' ' LEU . 20.7 m-20 -107.44 -26.96 10.72 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.153 0.502 . . . . 0.0 110.446 178.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . 0.497 ' HB3' ' HB2' ' A' ' 247' ' ' HIS . 29.5 tt0 -142.24 120.31 12.13 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.612 -173.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . 0.635 HD13 ' HG3' ' A' ' 223' ' ' ARG . 13.5 mt -134.17 111.89 15.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.001 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 35.2 ttmt -115.66 112.61 22.36 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.349 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' ILE . . . . . 0.672 HG23 HG23 ' A' ' 217' ' ' ILE . 85.3 mt -102.13 121.62 53.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-O 121.1 0.476 . . . . 0.0 110.841 178.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.541 ' HB ' HG13 ' A' ' 243' ' ' ILE . 39.2 t -104.46 87.07 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 172.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' THR . . . . . 0.474 ' OG1' ' HA ' ' A' ' 215' ' ' ASN . 9.6 t -70.04 -15.33 62.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.222 -175.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -66.7 -32.73 74.23 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.133 175.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . 0.531 ' HB2' HG12 ' A' ' 243' ' ' ILE . 81.1 mtt180 -114.98 3.25 14.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.859 -178.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 67.66 24.87 8.32 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.288 176.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.541 HG13 ' HB ' ' A' ' 238' ' ' VAL . 1.8 pt -122.33 153.27 26.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.293 -175.009 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . 0.446 ' HB1' ' HB2' ' A' ' 210' ' ' LEU . . . -143.7 140.05 29.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.119 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -111.03 115.13 28.93 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.757 177.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . 0.746 HG12 HG21 ' A' ' 232' ' ' ILE . 1.1 t -111.81 136.05 49.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 -178.007 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' HIS . . . . . 0.802 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 44.0 m80 -117.41 102.62 9.37 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.594 0.711 . . . . 0.0 111.287 176.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . 0.782 ' HZ ' HD22 ' A' ' 226' ' ' LEU . 34.7 m-85 -85.38 104.61 15.35 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.634 -1.166 . . . . 0.0 111.516 -179.435 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.465 HD21 ' CG ' ' A' ' 233' ' ' ASP . 0.2 OUTLIER -46.57 -39.5 11.17 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 124.41 1.069 . . . . 0.0 112.929 -174.526 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . 0.424 ' HB2' ' HB2' ' A' ' 253' ' ' ALA . 47.5 m-80 -92.93 141.51 28.33 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 177.045 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . 0.889 HG12 ' HB3' ' A' ' 205' ' ' CYS . 0.1 OUTLIER -62.84 -44.05 99.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.316 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -70.1 -29.8 66.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.91 -176.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . 0.457 ' HB3' ' CA ' ' A' ' 230' ' ' GLY . . . -60.36 -42.84 96.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.135 179.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . 0.512 ' HB1' ' HB2' ' A' ' 248' ' ' PHE . . . -67.96 -41.68 82.05 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.479 179.23 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.587 HG13 ' O ' ' A' ' 251' ' ' ILE . 11.2 mt -56.69 -60.78 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.108 -177.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . 0.459 ' HE2' ' HB2' ' A' ' 229' ' ' PHE . 15.0 ptmt -62.25 -38.74 90.43 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.406 -177.275 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -62.9 -49.99 72.63 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.661 0.267 . . . . 0.0 111.45 178.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . 0.475 HG13 HG12 ' A' ' 272' ' ' ILE . 55.6 t -65.07 -26.48 40.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.805 0.336 . . . . 0.0 110.994 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . 0.441 ' OE1' ' HA ' ' A' ' 193' ' ' SER . 16.9 mm-40 -84.64 -23.04 29.68 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 178.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -94.7 -32.03 13.54 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.813 0.34 . . . . 0.0 111.158 -176.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.743 ' HA ' ' HE3' ' A' ' 267' ' ' TRP . 0.8 OUTLIER -52.49 -49.54 85.15 Favored Pre-proline 0 CA--C 1.541 0.614 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.511 179.769 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 262' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 261' ' ' LEU . 53.3 Cg_endo -69.16 -11.0 30.56 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.512 2.142 . . . . 0.0 112.565 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 43.5 mt -92.07 -9.09 43.94 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.037 0.446 . . . . 0.0 111.555 -179.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 264' ' ' ASN . . . . . 0.416 ' HB2' ' CE3' ' A' ' 267' ' ' TRP . 3.5 m-20 -106.9 149.7 38.85 Favored Pre-proline 0 C--N 1.314 -0.942 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.258 -176.315 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -67.73 -32.04 31.0 Favored 'Trans proline' 0 CA--C 1.521 -0.129 0 C-N-CA 123.383 2.722 . . . . 0.0 112.738 -171.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.447 ' HE3' ' HB2' ' A' ' 266' ' ' LYS . 0.0 OUTLIER -84.77 -45.64 12.18 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 121.574 0.702 . . . . 0.0 109.24 -179.113 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 267' ' ' TRP . . . . . 0.743 ' HE3' ' HA ' ' A' ' 261' ' ' LEU . 12.6 m0 -76.88 -31.07 56.51 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.934 -172.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 17.7 t -68.3 -15.96 63.77 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.617 179.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -77.05 -7.71 56.16 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.218 0.533 . . . . 0.0 109.953 174.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 270' ' ' ARG . . . . . 0.738 ' HG2' HD22 ' A' ' 213' ' ' LEU . 3.7 mpt_? -110.82 143.89 40.69 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.92 178.303 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 36.0 mmt180 -91.99 106.42 18.44 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 110.021 -0.362 . . . . 0.0 110.021 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . 0.608 HG23 HD23 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -118.27 140.35 42.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.377 0.608 . . . . 0.0 110.718 179.701 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -152.39 168.96 23.77 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.38 173.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -61.13 119.63 8.75 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.713 0.292 . . . . 0.0 110.257 174.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -84.16 -173.27 49.69 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.864 -0.684 . . . . 0.0 111.906 178.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . 0.591 ' O ' ' HD2' ' A' ' 276' ' ' ARG . 0.2 OUTLIER -124.62 143.69 50.58 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.052 0.453 . . . . 0.0 111.081 -178.821 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -172.3 140.5 1.13 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.516 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 278' ' ' ARG . . . . . 0.552 ' HD2' ' N ' ' A' ' 278' ' ' ARG . 6.6 mpt_? -90.01 -2.76 58.19 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.257 -170.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 279' ' ' CYS . . . . . . . . . . . . . 63.5 m -104.92 0.04 27.46 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.307 0.575 . . . . 0.0 109.913 175.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -130.88 29.23 4.75 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.676 -177.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 281' ' ' VAL . . . . . 0.419 ' O ' HG23 ' A' ' 281' ' ' VAL . 14.5 p 37.34 44.62 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-O 122.499 1.142 . . . . 0.0 112.359 -177.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -115.12 85.98 0.4 Allowed Glycine 0 N--CA 1.444 -0.788 0 N-CA-C 110.244 -1.142 . . . . 0.0 110.244 175.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 283' ' ' LEU . . . . . 0.657 ' HB2' HE22 ' A' ' 201' ' ' GLN . 76.9 mt -89.46 159.32 17.33 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.022 0.439 . . . . 0.0 111.409 -173.007 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 62.4 tttp . . . . . 0 C--O 1.246 0.917 0 CA-C-O 118.408 -0.806 . . . . 0.0 109.488 177.591 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 33.6 t30 . . . . . 0 N--CA 1.481 1.095 0 CA-C-O 120.859 0.361 . . . . 0.0 110.411 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 15.3 p -106.03 -14.23 15.24 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.057 0.456 . . . . 0.0 110.309 179.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -77.93 6.8 6.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.481 -177.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 22.7 t -75.59 -27.22 58.46 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 177.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 67.1 t30 59.04 32.18 22.0 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 121.458 0.646 . . . . 0.0 110.669 178.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 28.4 m -74.06 -25.84 60.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.88 0.847 . . . . 0.0 108.844 175.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 19.7 m -135.81 175.27 9.74 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 171.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . 0.45 ' HB ' ' HA ' ' A' ' 198' ' ' ALA . 4.9 m -62.68 114.72 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 C-N-CA 120.01 -0.676 . . . . 0.0 110.402 176.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . 0.468 HD21 ' O ' ' A' ' 196' ' ' LEU . 9.4 tt -55.38 94.74 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.665 177.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.595 ' HB2' HG23 ' A' ' 199' ' ' VAL . 7.7 mp 53.59 10.34 0.22 Allowed 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.164 -177.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.45 ' HA ' ' HB ' ' A' ' 195' ' ' VAL . . . 58.15 20.32 6.91 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 123.023 0.529 . . . . 0.0 111.21 -173.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.595 HG23 ' HB2' ' A' ' 197' ' ' LEU . 35.9 m -108.89 19.4 6.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.631 -175.245 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -77.09 30.67 0.14 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.005 0.431 . . . . 0.0 111.095 178.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . 0.667 ' HA ' ' CE2' ' A' ' 274' ' ' TYR . 49.3 mt-30 -80.4 127.57 32.56 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.281 -178.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 50.8 m -144.57 177.34 8.74 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.687 178.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -70.42 90.97 0.38 Allowed Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.806 -0.712 . . . . 0.0 111.858 178.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . 0.661 ' HB2' ' HB2' ' A' ' 207' ' ' ASN . . . -147.7 107.11 3.91 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.592 0.234 . . . . 0.0 110.824 -179.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' CYS . . . . . 0.473 ' HB3' HG12 ' A' ' 251' ' ' ILE . 25.5 p -98.44 145.87 26.31 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 174.235 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . 0.872 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 0.6 OUTLIER 57.54 6.21 0.39 Allowed 'General case' 0 C--O 1.219 -0.539 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -178.079 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . 0.661 ' HB2' ' HB2' ' A' ' 204' ' ' ALA . 6.5 m-20 -106.38 105.95 16.24 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 118.555 0.616 . . . . 0.0 111.442 -173.094 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.505 ' HB ' ' HB ' ' A' ' 246' ' ' VAL . 66.5 t -137.62 119.75 18.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.309 177.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -115.22 124.32 51.11 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.816 0.341 . . . . 0.0 110.469 -177.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.504 ' HG ' HG23 ' A' ' 272' ' ' ILE . 5.4 mp -107.31 129.44 54.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.275 177.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . 0.536 ' HA2' HG22 ' A' ' 243' ' ' ILE . . . -136.65 59.43 0.64 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.394 -0.908 . . . . 0.0 113.266 -178.268 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . 0.535 ' HB3' ' HA ' ' A' ' 270' ' ' ARG . 1.7 t30 177.03 43.53 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.027 0.442 . . . . 0.0 110.063 177.017 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.552 HD21 ' HG2' ' A' ' 270' ' ' ARG . 1.2 mt -87.01 164.09 37.8 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.041 -177.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.544 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 73.0 Cg_endo -76.51 169.03 22.65 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.365 2.043 . . . . 0.0 111.763 175.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 -78.5 130.17 35.7 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.897 179.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 91.48 3.78 68.79 Favored Glycine 0 C--N 1.317 -0.499 0 C-N-CA 120.732 -0.747 . . . . 0.0 113.188 177.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . 0.636 HG21 HG22 ' A' ' 237' ' ' ILE . 4.5 tp -58.82 128.55 19.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.34 0.591 . . . . 0.0 111.153 -178.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' THR . . . . . 0.463 ' CG2' ' HG3' ' A' ' 221' ' ' GLU . 14.5 t -111.91 156.17 22.49 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 121.367 0.603 . . . . 0.0 110.839 -178.248 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -62.41 -35.45 79.26 Favored 'General case' 0 C--O 1.209 -1.052 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.654 -177.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -48.89 -40.63 30.57 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.033 177.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . 0.463 ' HG3' ' CG2' ' A' ' 218' ' ' THR . 43.2 mt-10 -70.69 -56.01 7.38 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.751 -178.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . 0.455 ' O ' HD11 ' A' ' 226' ' ' LEU . 10.6 mt -61.41 -45.21 99.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.632 -178.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . 0.756 ' HG3' HD11 ' A' ' 235' ' ' ILE . 64.2 mtp180 -54.01 -62.46 1.64 Allowed 'General case' 0 CA--C 1.505 -0.786 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 176.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -55.68 -24.25 33.13 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.731 -177.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' ASP . . . . . 0.46 ' HB3' ' CZ2' ' A' ' 267' ' ' TRP . 8.9 m-20 -86.0 -32.14 21.65 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.955 -178.432 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.832 HD21 ' HZ ' ' A' ' 248' ' ' PHE . 7.3 mp -104.99 -15.1 15.21 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.959 -0.297 . . . . 0.0 111.669 -172.095 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . 0.621 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 42.7 mm-40 -61.46 -36.58 33.38 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -177.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . 0.621 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 97.5 Cg_endo -67.13 -27.03 42.18 Favored 'Trans proline' 0 C--N 1.358 1.03 0 C-N-CA 121.66 1.573 . . . . 0.0 112.377 -173.002 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . 0.513 ' CE1' ' HA ' ' A' ' 226' ' ' LEU . 2.9 p90 -110.78 -14.14 14.05 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.411 -0.516 . . . . 0.0 111.825 176.025 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . 0.475 ' CA ' ' HB3' ' A' ' 253' ' ' ALA . . . -164.08 97.73 0.15 Allowed Glycine 0 N--CA 1.44 -1.099 0 C-N-CA 120.479 -0.867 . . . . 0.0 112.05 -174.176 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -65.05 135.68 44.89 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 121.747 1.631 . . . . 0.0 111.136 178.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.666 HG21 HG12 ' A' ' 246' ' ' VAL . 2.4 mp -112.11 148.95 14.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.919 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . 0.442 ' OD2' HD23 ' A' ' 249' ' ' LEU . 8.8 m-20 -109.3 -24.66 10.97 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.111 0.481 . . . . 0.0 110.369 178.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . 0.568 ' HB3' ' HB2' ' A' ' 247' ' ' HIS . 22.9 tt0 -142.09 122.01 13.62 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.543 -174.318 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . 0.756 HD11 ' HG3' ' A' ' 223' ' ' ARG . 8.1 mt -135.52 105.52 5.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 121.512 0.672 . . . . 0.0 109.927 178.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -108.35 107.51 18.12 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.993 -177.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' ILE . . . . . 0.636 HG22 HG21 ' A' ' 217' ' ' ILE . 81.3 mt -101.19 125.43 55.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.947 -178.287 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.533 ' HB ' HG13 ' A' ' 243' ' ' ILE . 41.2 t -109.67 88.05 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 170.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 15.3 t -69.94 -12.34 61.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.356 -176.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -69.02 -35.26 76.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.311 176.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . 0.597 ' HB2' HG12 ' A' ' 243' ' ' ILE . 90.7 mtt180 -113.75 5.12 16.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.6 -178.238 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 68.06 24.84 7.66 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.381 176.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.597 HG12 ' HB2' ' A' ' 241' ' ' ARG . 1.5 pt -122.31 150.79 25.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.823 -173.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -144.13 137.78 27.73 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.243 179.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -107.19 110.98 23.18 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.539 177.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . 0.666 HG12 HG21 ' A' ' 232' ' ' ILE . 1.5 t -107.86 134.91 48.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.872 -177.01 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' HIS . . . . . 0.872 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 36.2 m170 -113.87 101.93 9.73 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.358 0.599 . . . . 0.0 111.382 177.528 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . 0.832 ' HZ ' HD21 ' A' ' 226' ' ' LEU . 35.1 m-85 -85.39 101.27 12.45 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.952 178.031 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.442 HD23 ' OD2' ' A' ' 233' ' ' ASP . 0.1 OUTLIER -43.96 -38.94 3.73 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 124.293 0.996 . . . . 0.0 112.881 -174.41 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . 0.452 ' HB2' ' HB1' ' A' ' 253' ' ' ALA . 2.6 m-20 -94.34 139.19 31.4 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 176.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . 0.584 ' O ' HG13 ' A' ' 255' ' ' ILE . 0.2 OUTLIER -62.71 -41.24 91.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.962 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -72.08 -28.66 63.45 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.741 -177.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . 0.475 ' HB3' ' CA ' ' A' ' 230' ' ' GLY . . . -61.34 -41.37 96.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.25 178.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . 0.506 ' HB1' ' HB2' ' A' ' 248' ' ' PHE . . . -68.7 -40.74 79.87 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.724 178.509 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.86 ' HA ' ' HH ' ' A' ' 274' ' ' TYR . 7.5 mt -56.14 -60.59 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.348 -178.247 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . 0.423 ' O ' ' HG2' ' A' ' 260' ' ' GLU . 9.9 ptmt -61.36 -41.49 97.16 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.513 -177.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -62.14 -49.81 74.39 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.693 0.283 . . . . 0.0 111.464 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . 0.423 HG13 HG12 ' A' ' 272' ' ' ILE . 41.2 t -64.84 -26.52 40.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.897 0.38 . . . . 0.0 111.121 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . 0.405 ' HG3' ' O ' ' A' ' 255' ' ' ILE . 53.3 mt-30 -84.64 -23.08 29.66 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 178.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . 0.423 ' HG2' ' O ' ' A' ' 256' ' ' LYS . 49.5 mm-40 -95.31 -32.48 12.95 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.611 0.243 . . . . 0.0 111.158 -176.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.777 HD13 ' CE3' ' A' ' 267' ' ' TRP . 0.6 OUTLIER -50.44 -49.92 74.63 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.549 179.506 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 262' ' ' PRO . . . . . 0.564 ' HD2' ' N ' ' A' ' 261' ' ' LEU . 40.4 Cg_endo -67.25 -17.14 49.84 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.416 2.078 . . . . 0.0 112.972 -178.422 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 55.2 mt -91.63 -3.56 56.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.248 0.547 . . . . 0.0 111.493 -178.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -106.64 148.82 37.53 Favored Pre-proline 0 C--N 1.314 -0.962 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.839 -175.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -65.41 -35.98 37.0 Favored 'Trans proline' 0 C--O 1.23 0.108 0 C-N-CA 123.557 2.838 . . . . 0.0 112.902 -169.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 9.7 mtpt -86.53 -45.08 11.42 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.671 0.748 . . . . 0.0 109.685 -177.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 267' ' ' TRP . . . . . 0.777 ' CE3' HD13 ' A' ' 261' ' ' LEU . 11.6 m0 -76.34 -29.35 57.21 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.87 -173.34 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 38.0 t -62.32 -21.98 65.69 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.822 0.344 . . . . 0.0 110.853 178.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -71.46 -16.59 62.38 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.106 0.479 . . . . 0.0 110.276 177.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 270' ' ' ARG . . . . . 0.552 ' HG2' HD21 ' A' ' 213' ' ' LEU . 0.0 OUTLIER -100.26 146.31 27.06 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.495 178.554 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 9.9 mmp_? -95.4 105.92 17.93 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 176.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . 0.606 HG22 HD23 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -115.86 141.87 31.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.546 0.688 . . . . 0.0 111.285 -177.952 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -151.69 169.24 22.65 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.354 -0.839 . . . . 0.0 108.966 172.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 274' ' ' TYR . . . . . 0.86 ' HH ' ' HA ' ' A' ' 255' ' ' ILE . 75.6 m-85 -58.68 116.16 3.53 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 173.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 275' ' ' GLY . . . . . 0.456 ' O ' ' HB3' ' A' ' 207' ' ' ASN . . . -68.94 147.82 46.96 Favored Glycine 0 N--CA 1.443 -0.89 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.783 -176.3 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' A' ' 276' ' ' ARG . 44.1 mtt180 -115.17 109.0 17.35 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.834 0.826 . . . . 0.0 110.101 177.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -173.98 147.3 1.28 Allowed 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 113.857 -1.52 . . . . 0.0 108.49 -172.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 278' ' ' ARG . . . . . . . . . . . . . 19.9 mmm180 -98.22 -1.58 41.7 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.681 0.277 . . . . 0.0 110.705 -172.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 279' ' ' CYS . . . . . . . . . . . . . 16.1 t 63.77 30.88 14.5 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.658 0.742 . . . . 0.0 109.874 -177.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -123.78 35.31 4.87 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.502 -177.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 7.7 p 40.48 83.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-O 122.32 1.057 . . . . 0.0 112.5 -175.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 125.41 139.51 5.2 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 114.915 -1.039 . . . . 0.0 111.967 178.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 84.3 mt -74.06 118.46 17.05 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.884 0.373 . . . . 0.0 110.435 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? . . . . . 0 C--O 1.247 0.935 0 CA-C-O 118.336 -0.84 . . . . 0.0 109.546 177.951 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 . . . . . 0 N--CA 1.48 1.051 0 CA-C-O 120.624 0.25 . . . . 0.0 110.361 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 33.0 p -105.95 126.38 52.12 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.898 -178.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -89.84 111.88 23.04 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.249 178.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 26.2 m -78.37 -7.73 57.64 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -173.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -68.81 -20.93 64.34 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 176.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 22.3 m -109.45 130.97 55.47 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.426 175.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 33.5 p -108.41 152.38 24.76 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.787 0.327 . . . . 0.0 110.867 -179.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 3.1 m -140.7 83.85 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.818 178.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . 0.539 ' HA ' HG22 ' A' ' 199' ' ' VAL . 66.7 mt -75.22 -20.66 59.13 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.526 0.679 . . . . 0.0 109.68 178.307 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 96.7 mt -68.03 -9.66 47.59 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.833 173.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -106.8 -9.28 16.45 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.304 178.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.539 HG22 ' HA ' ' A' ' 196' ' ' LEU . 16.0 m -105.12 2.37 10.41 Favored 'Isoleucine or valine' 0 C--O 1.231 0.084 0 C-N-CA 120.344 -0.542 . . . . 0.0 111.047 -178.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' GLN . . . . . 0.487 ' HB2' ' HA3' ' A' ' 203' ' ' GLY . 3.2 pt20 -104.07 77.5 1.44 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.493 0.663 . . . . 0.0 110.916 -179.155 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -70.03 -27.65 64.84 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.038 -179.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 27.0 p -97.72 13.32 30.74 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.93 174.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.487 ' HA3' ' HB2' ' A' ' 200' ' ' GLN . . . -101.1 -15.75 27.37 Favored Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.801 -176.409 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . 0.553 ' HB1' ' HB2' ' A' ' 207' ' ' ASN . . . -149.08 143.41 26.02 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.006 0.431 . . . . 0.0 111.151 -179.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' CYS . . . . . 0.711 ' HB3' HG12 ' A' ' 251' ' ' ILE . 5.9 p -127.92 145.7 50.87 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 172.152 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . 0.773 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 48.7 mtp180 52.73 12.33 0.25 Allowed 'General case' 0 C--O 1.221 -0.4 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -176.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . 0.553 ' HB2' ' HB1' ' A' ' 204' ' ' ALA . 0.9 OUTLIER -116.25 107.41 14.82 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.805 0.336 . . . . 0.0 111.19 -173.721 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.537 ' HB ' ' HB ' ' A' ' 246' ' ' VAL . 99.7 t -135.68 124.89 40.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.726 179.352 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' PHE . . . . . 0.405 ' O ' ' HA ' ' A' ' 272' ' ' ILE . 3.9 t80 -117.27 122.93 45.31 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.744 0.307 . . . . 0.0 110.446 -177.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.529 ' O ' ' HA ' ' A' ' 243' ' ' ILE . 5.5 mp -106.01 132.76 51.71 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.039 176.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . 0.542 ' HA2' HG21 ' A' ' 243' ' ' ILE . . . -140.75 59.32 0.57 Allowed Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.441 -0.885 . . . . 0.0 113.475 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . 0.53 ' HB3' ' HA ' ' A' ' 270' ' ' ARG . 57.5 t30 -179.17 33.4 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.328 0.585 . . . . 0.0 110.156 175.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.625 HD21 ' HG2' ' A' ' 270' ' ' ARG . 2.0 mt -76.27 161.13 76.13 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.113 -177.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.426 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 66.3 Cg_endo -73.98 162.18 39.62 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.253 1.969 . . . . 0.0 111.023 174.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -77.6 120.99 23.33 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 178.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 106.94 -1.58 35.7 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.193 -1.003 . . . . 0.0 113.046 -179.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . 0.659 HG22 HG21 ' A' ' 237' ' ' ILE . 4.5 tp -59.31 128.48 20.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.961 0.41 . . . . 0.0 110.803 179.036 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' THR . . . . . 0.449 HG23 ' HG3' ' A' ' 221' ' ' GLU . 9.8 t -113.56 158.84 20.27 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-O 121.296 0.569 . . . . 0.0 110.91 -178.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.46 ' CD ' ' H ' ' A' ' 219' ' ' GLU . 7.0 mp0 -62.39 -39.33 92.87 Favored 'General case' 0 C--O 1.21 -0.978 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.138 -174.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' ASP . . . . . 0.458 ' O ' ' HG2' ' A' ' 224' ' ' GLU . 16.3 t70 -54.22 -35.04 62.0 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 123.429 0.455 . . . . 0.0 110.987 -178.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . 0.449 ' HG3' HG23 ' A' ' 218' ' ' THR . 45.9 mt-10 -67.27 -57.2 7.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.325 178.22 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . 0.448 HD13 HD13 ' A' ' 237' ' ' ILE . 6.9 mt -60.28 -41.79 88.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.563 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . 0.716 ' HG3' HD13 ' A' ' 235' ' ' ILE . 64.0 mtp180 -53.19 -62.8 1.42 Allowed 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 174.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.458 ' HG2' ' O ' ' A' ' 220' ' ' ASP . 8.8 pt-20 -58.53 -23.51 58.4 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.849 -176.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -88.55 -31.75 18.51 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.697 -176.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.755 HD22 ' HZ ' ' A' ' 248' ' ' PHE . 8.0 mp -105.7 -19.31 13.8 Favored 'General case' 0 CA--C 1.517 -0.307 0 C-N-CA 120.684 -0.406 . . . . 0.0 112.085 -171.333 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . 0.648 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 33.9 mt-10 -64.82 -33.55 8.68 Favored Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -176.471 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . 0.648 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 75.8 Cg_endo -65.63 -29.16 52.2 Favored 'Trans proline' 0 C--N 1.358 1.05 0 C-N-CA 121.34 1.36 . . . . 0.0 112.014 -175.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . 0.526 ' CE1' ' HA ' ' A' ' 226' ' ' LEU . 4.4 p90 -111.16 3.97 18.91 Favored 'General case' 0 C--O 1.223 -0.338 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.366 174.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . 0.576 ' CA ' ' HB3' ' A' ' 253' ' ' ALA . . . 178.8 99.88 0.13 Allowed Glycine 0 N--CA 1.441 -1.007 0 C-N-CA 120.045 -1.074 . . . . 0.0 112.725 -177.168 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -66.34 134.98 38.03 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 121.833 1.689 . . . . 0.0 111.28 178.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.661 HG22 HG13 ' A' ' 246' ' ' VAL . 3.5 mp -106.48 151.96 8.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.28 178.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . 0.541 ' OD2' ' HB3' ' A' ' 249' ' ' LEU . 8.9 m-20 -104.54 -28.8 11.07 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.3 179.215 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -151.66 130.55 12.5 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.825 -173.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . 0.716 HD13 ' HG3' ' A' ' 223' ' ' ARG . 15.0 mt -136.7 110.26 8.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.923 -179.322 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.423 ' O ' ' HA ' ' A' ' 244' ' ' ALA . 84.9 tttt -111.29 112.42 24.17 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.131 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' ILE . . . . . 0.659 HG21 HG22 ' A' ' 217' ' ' ILE . 78.2 mt -104.79 118.06 51.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 121.084 0.468 . . . . 0.0 111.12 -179.529 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.575 ' HB ' HG13 ' A' ' 243' ' ' ILE . 46.8 t -99.2 87.81 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 171.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 9.5 t -64.94 -21.03 66.76 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.466 -175.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -58.13 -38.71 77.04 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.718 175.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . 0.681 ' HB2' HG12 ' A' ' 243' ' ' ILE . 72.4 mtp180 -112.41 3.0 16.66 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.39 -177.134 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 14.8 m120 66.07 28.87 10.24 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.877 0.37 . . . . 0.0 110.543 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.681 HG12 ' HB2' ' A' ' 241' ' ' ARG . 1.2 pt -121.35 150.34 24.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.312 -174.24 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . 0.476 ' HB2' ' HB2' ' A' ' 210' ' ' LEU . . . -144.75 140.7 28.7 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.674 -178.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -111.19 115.51 29.5 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.433 177.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . 0.661 HG13 HG22 ' A' ' 232' ' ' ILE . 1.6 t -113.48 139.63 37.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.312 -174.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' HIS . . . . . 0.773 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 59.4 m170 -111.38 101.93 10.35 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.459 176.478 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . 0.755 ' HZ ' HD22 ' A' ' 226' ' ' LEU . 39.6 m-85 -89.28 98.52 11.81 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.164 176.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.663 ' HA ' ' HE ' ' A' ' 206' ' ' ARG . 0.2 OUTLIER -47.58 -44.62 26.46 Favored 'General case' 0 N--CA 1.464 0.232 0 O-C-N 124.24 0.962 . . . . 0.0 112.618 -173.509 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . 0.426 ' HB2' ' HB2' ' A' ' 253' ' ' ALA . 12.5 m120 -85.81 135.78 33.58 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 176.373 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . 0.711 HG12 ' HB3' ' A' ' 205' ' ' CYS . 0.2 OUTLIER -62.63 -40.69 89.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 -177.411 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -70.78 -27.38 63.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.524 -177.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . 0.576 ' HB3' ' CA ' ' A' ' 230' ' ' GLY . . . -62.87 -41.36 99.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.106 -179.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . 0.538 ' HB3' ' HB2' ' A' ' 248' ' ' PHE . . . -69.13 -41.04 77.87 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.561 178.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.699 ' HA ' ' HH ' ' A' ' 274' ' ' TYR . 11.0 mt -56.05 -60.74 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.045 -178.398 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . 0.426 ' O ' ' HG2' ' A' ' 260' ' ' GLU . 13.5 ptmt -63.3 -39.78 95.52 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.496 -176.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -61.29 -48.16 82.67 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.71 0.29 . . . . 0.0 111.351 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . 0.504 HG12 HG12 ' A' ' 272' ' ' ILE . 54.9 t -66.76 -24.38 32.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.995 179.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 16.5 mm100 -84.52 -25.94 28.42 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 177.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . 0.426 ' HG2' ' O ' ' A' ' 256' ' ' LYS . 59.3 mm-40 -93.89 -33.96 13.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.634 0.254 . . . . 0.0 110.987 -175.243 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.722 HD11 ' CE3' ' A' ' 267' ' ' TRP . 0.8 OUTLIER -51.6 -51.32 70.78 Favored Pre-proline 0 CA--C 1.537 0.478 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.515 -179.619 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 262' ' ' PRO . . . . . 0.557 ' HD2' ' N ' ' A' ' 261' ' ' LEU . 43.1 Cg_endo -66.75 -17.57 52.41 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.381 2.054 . . . . 0.0 112.762 -177.496 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 62.9 mt -95.22 -1.19 52.16 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.274 0.559 . . . . 0.0 111.525 -176.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 264' ' ' ASN . . . . . 0.467 ' O ' ' HB2' ' A' ' 268' ' ' SER . 14.4 m-80 -105.62 148.69 36.84 Favored Pre-proline 0 C--N 1.317 -0.846 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.244 -178.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -63.05 -40.84 31.6 Favored 'Trans proline' 0 C--N 1.335 -0.143 0 C-N-CA 123.298 2.666 . . . . 0.0 112.74 -169.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 12.6 mtpt -86.2 -42.71 13.59 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.461 0.648 . . . . 0.0 110.133 -176.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 267' ' ' TRP . . . . . 0.722 ' CE3' HD11 ' A' ' 261' ' ' LEU . 17.1 m0 -73.98 -28.04 61.28 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.835 -176.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 268' ' ' SER . . . . . 0.467 ' HB2' ' O ' ' A' ' 264' ' ' ASN . 12.8 t -65.71 -18.32 65.25 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.186 0.517 . . . . 0.0 110.577 177.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -71.71 -9.04 57.68 Favored 'General case' 0 C--O 1.225 -0.224 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.105 174.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 270' ' ' ARG . . . . . 0.625 ' HG2' HD21 ' A' ' 213' ' ' LEU . 0.0 OUTLIER -112.86 143.17 44.57 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.392 -179.745 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 35.5 mmt180 -94.2 109.0 20.83 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.283 177.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . 0.605 HG23 HD23 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -121.91 140.91 44.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.418 0.628 . . . . 0.0 111.38 -178.627 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -152.26 169.86 21.45 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.372 174.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 274' ' ' TYR . . . . . 0.699 ' HH ' ' HA ' ' A' ' 255' ' ' ILE . 74.2 m-85 -64.5 119.99 11.47 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.224 0.535 . . . . 0.0 109.827 176.292 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -95.07 174.04 32.29 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 115.362 -0.835 . . . . 0.0 112.621 -173.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -110.5 109.4 19.73 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 122.001 0.905 . . . . 0.0 110.787 176.219 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -152.35 141.21 21.07 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 114.279 -1.328 . . . . 0.0 109.72 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 278' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 278' ' ' ARG . 32.7 mtp85 -103.99 13.35 32.82 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.405 -171.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 279' ' ' CYS . . . . . . . . . . . . . 55.6 m 61.62 24.97 14.97 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.353 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -162.2 125.89 3.09 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.146 -175.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 28.7 m -86.15 -33.46 7.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 120.855 0.36 . . . . 0.0 111.14 -178.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -124.06 24.06 6.4 Favored Glycine 0 N--CA 1.442 -0.923 0 C-N-CA 120.459 -0.877 . . . . 0.0 112.459 -175.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -124.93 97.64 5.35 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 178.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp . . . . . 0 C--O 1.247 0.944 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.533 -179.196 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 43.3 t30 . . . . . 0 N--CA 1.48 1.069 0 CA-C-O 120.491 0.186 . . . . 0.0 110.53 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 19.9 m -130.2 -2.96 4.47 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 121.069 -0.252 . . . . 0.0 111.165 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . 62.02 92.18 0.06 Allowed 'General case' 0 N--CA 1.462 0.149 0 O-C-N 123.714 0.634 . . . . 0.0 111.095 -178.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 23.7 m -68.63 -23.15 64.4 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.795 -177.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -137.55 137.79 38.95 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 177.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 50.9 m -65.54 147.93 52.59 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.896 0.379 . . . . 0.0 111.037 -179.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 17.2 m -71.78 113.38 8.76 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.973 -176.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . 0.502 HG23 ' CD2' ' A' ' 273' ' ' TYR . 3.3 m -104.62 76.57 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.416 0.627 . . . . 0.0 110.767 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . 0.48 ' O ' HG22 ' A' ' 199' ' ' VAL . 2.5 mm? -59.04 94.21 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.893 -175.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 8.3 mp 51.68 25.76 3.04 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.704 0.287 . . . . 0.0 111.31 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . 65.76 23.56 11.49 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.602 -178.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.48 HG22 ' O ' ' A' ' 196' ' ' LEU . 32.6 m -67.91 -15.8 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 O-C-N 121.688 -0.632 . . . . 0.0 110.178 174.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -69.27 -1.24 7.57 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.241 -0.89 . . . . 0.0 112.212 178.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -142.32 160.87 39.41 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.247 178.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 20.0 m -87.14 -34.35 19.1 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.898 0.38 . . . . 0.0 111.24 -178.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 173.7 136.86 2.29 Favored Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 -178.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . 0.837 ' HB2' ' HB2' ' A' ' 207' ' ' ASN . . . -126.79 111.2 13.94 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.988 0.423 . . . . 0.0 112.079 -175.081 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' CYS . . . . . 0.559 ' HB3' HG12 ' A' ' 251' ' ' ILE . 3.4 p -101.04 145.77 28.29 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 167.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . 0.775 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 29.8 mtm180 55.08 5.33 0.1 Allowed 'General case' 0 C--O 1.223 -0.339 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -175.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . 0.837 ' HB2' ' HB2' ' A' ' 204' ' ' ALA . 18.9 m-80 -108.18 106.19 16.26 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-O 121.232 0.539 . . . . 0.0 111.385 -173.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.461 ' HB ' ' HB ' ' A' ' 246' ' ' VAL . 61.1 t -134.56 111.93 14.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.012 177.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' PHE . . . . . 0.413 ' HE1' ' HB ' ' A' ' 243' ' ' ILE . 1.7 t80 -109.96 122.08 46.74 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.973 0.416 . . . . 0.0 110.361 -174.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.559 ' HG ' HG22 ' A' ' 272' ' ' ILE . 6.2 mp -106.81 133.93 50.73 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.613 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . 0.546 ' HA2' HG21 ' A' ' 243' ' ' ILE . . . -136.92 61.3 0.61 Allowed Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.548 -0.834 . . . . 0.0 113.097 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . 0.438 ' HB2' ' O ' ' A' ' 211' ' ' GLY . 2.3 t30 175.61 53.92 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.066 0.46 . . . . 0.0 110.612 175.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.613 HD21 ' HG2' ' A' ' 270' ' ' ARG . 0.7 OUTLIER -102.53 155.6 36.31 Favored Pre-proline 0 C--N 1.316 -0.862 0 N-CA-C 110.043 -0.355 . . . . 0.0 110.043 178.012 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -77.18 165.82 27.36 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.502 2.135 . . . . 0.0 112.163 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -75.94 118.82 19.12 Favored 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 177.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 109.51 2.59 30.93 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.255 -0.974 . . . . 0.0 112.56 -178.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . 0.626 HG23 HG22 ' A' ' 237' ' ' ILE . 6.3 tp -68.23 129.03 32.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.941 0.401 . . . . 0.0 110.36 175.306 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' THR . . . . . 0.464 ' CG2' ' HG3' ' A' ' 221' ' ' GLU . 10.6 t -113.65 156.84 23.0 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-O 121.397 0.618 . . . . 0.0 111.041 179.147 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.476 ' CD ' ' H ' ' A' ' 219' ' ' GLU . 5.1 mp0 -60.92 -35.98 78.11 Favored 'General case' 0 C--O 1.21 -0.986 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.615 -179.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -54.39 -35.69 63.12 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.845 -179.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . 0.464 ' HG3' ' CG2' ' A' ' 218' ' ' THR . 42.9 mt-10 -69.91 -57.65 4.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.565 178.426 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . 0.46 HD13 HD13 ' A' ' 237' ' ' ILE . 8.1 mt -59.49 -42.81 89.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.488 -178.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . 0.816 ' HG3' HD11 ' A' ' 235' ' ' ILE . 45.0 mtp85 -55.86 -61.92 2.04 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 176.197 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -57.19 -21.73 35.49 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.925 -178.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -89.67 -30.73 17.89 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 116.021 -0.536 . . . . 0.0 112.055 -178.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.705 HD21 ' HZ ' ' A' ' 248' ' ' PHE . 8.4 mp -106.41 -19.26 13.74 Favored 'General case' 0 C--O 1.225 -0.215 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -171.207 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . 0.656 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 41.4 mt-10 -66.87 -31.43 3.99 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -175.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . 0.656 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 71.7 Cg_endo -65.73 -28.13 51.99 Favored 'Trans proline' 0 C--N 1.357 1.013 0 C-N-CA 121.442 1.428 . . . . 0.0 112.16 -176.225 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . 0.478 ' CE1' ' HA ' ' A' ' 226' ' ' LEU . 3.8 p90 -111.04 -0.72 16.55 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.752 0.31 . . . . 0.0 111.399 173.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . 0.564 ' CA ' ' HB3' ' A' ' 253' ' ' ALA . . . -175.43 95.51 0.1 Allowed Glycine 0 N--CA 1.442 -0.914 0 C-N-CA 120.128 -1.034 . . . . 0.0 112.466 -176.248 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -62.45 130.47 30.19 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.12 1.88 . . . . 0.0 111.634 178.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.718 HG22 HG12 ' A' ' 246' ' ' VAL . 2.4 mp -109.47 148.26 13.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.315 178.166 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . 0.46 ' CG ' HD22 ' A' ' 249' ' ' LEU . 44.4 m-20 -110.18 -24.26 10.8 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.003 0.43 . . . . 0.0 110.704 179.106 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -142.8 122.13 13.08 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.548 -174.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . 0.816 HD11 ' HG3' ' A' ' 223' ' ' ARG . 10.5 mt -135.95 110.96 11.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.912 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.426 ' O ' ' HA ' ' A' ' 244' ' ' ALA . 62.4 tttp -113.31 110.55 20.54 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.541 -176.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' ILE . . . . . 0.626 HG22 HG23 ' A' ' 217' ' ' ILE . 76.2 mt -101.84 119.51 50.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.115 0.484 . . . . 0.0 111.041 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.554 ' HB ' HG13 ' A' ' 243' ' ' ILE . 43.6 t -103.98 88.24 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 173.395 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 10.0 t -62.48 -25.13 67.84 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.16 -177.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -55.59 -39.98 71.44 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 121.069 0.462 . . . . 0.0 110.392 176.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . 0.696 ' HB2' HG12 ' A' ' 243' ' ' ILE . 99.2 mtt180 -111.31 5.86 20.09 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.847 -178.296 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 16.6 m120 62.93 28.76 16.44 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.083 177.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.696 HG12 ' HB2' ' A' ' 241' ' ' ARG . 1.3 pt -121.28 154.22 25.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.104 -173.025 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . 0.426 ' HA ' ' O ' ' A' ' 236' ' ' LYS . . . -144.92 138.37 26.85 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.441 -178.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -107.09 114.17 28.08 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.394 177.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . 0.718 HG12 HG22 ' A' ' 232' ' ' ILE . 0.7 OUTLIER -109.83 127.82 66.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -179.229 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' HIS . . . . . 0.775 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 48.9 m170 -107.95 101.83 11.06 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.038 -0.665 . . . . 0.0 111.319 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . 0.705 ' HZ ' HD21 ' A' ' 226' ' ' LEU . 34.1 m-85 -87.49 99.18 11.84 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.149 178.322 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.46 HD22 ' CG ' ' A' ' 233' ' ' ASP . 0.1 OUTLIER -42.27 -43.3 3.39 Favored 'General case' 0 N--CA 1.467 0.375 0 O-C-N 124.564 1.165 . . . . 0.0 112.651 -177.612 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 57.1 m-20 -90.87 135.36 33.78 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 177.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . 0.559 HG12 ' HB3' ' A' ' 205' ' ' CYS . 0.2 OUTLIER -62.99 -40.96 91.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -178.69 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -69.06 -31.77 70.77 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 120.786 0.327 . . . . 0.0 110.662 -177.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . 0.564 ' HB3' ' CA ' ' A' ' 230' ' ' GLY . . . -59.53 -42.14 91.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.353 179.095 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . 0.531 ' HB3' ' HB2' ' A' ' 248' ' ' PHE . . . -68.24 -40.52 81.96 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.655 178.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.791 ' HA ' ' HH ' ' A' ' 274' ' ' TYR . 6.9 mt -56.49 -61.13 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.272 -178.305 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 12.8 ptmt -62.3 -39.23 92.32 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.439 -177.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -62.09 -48.88 78.2 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.639 0.257 . . . . 0.0 111.508 179.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . 0.517 HG12 HG12 ' A' ' 272' ' ' ILE . 70.1 t -66.3 -23.34 31.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.009 0.433 . . . . 0.0 111.05 179.062 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -85.06 -21.76 29.24 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 177.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -95.32 -36.75 11.27 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.895 0.379 . . . . 0.0 110.911 -177.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.716 HD12 ' CE3' ' A' ' 267' ' ' TRP . 1.1 mp -51.94 -47.74 90.22 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.956 -177.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 262' ' ' PRO . . . . . 0.558 ' HD2' ' N ' ' A' ' 261' ' ' LEU . 41.1 Cg_endo -67.49 -19.05 49.27 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.145 1.896 . . . . 0.0 112.711 -178.592 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 65.6 mt -95.53 -3.72 46.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.971 0.415 . . . . 0.0 111.811 -175.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 264' ' ' ASN . . . . . 0.474 ' O ' ' HB2' ' A' ' 268' ' ' SER . 14.1 m-80 -105.65 148.42 36.38 Favored Pre-proline 0 C--N 1.316 -0.878 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.761 -176.408 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -67.32 -32.97 31.65 Favored 'Trans proline' 0 N--CA 1.466 -0.098 0 C-N-CA 123.255 2.636 . . . . 0.0 112.652 -169.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.2 -45.13 12.3 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-O 121.825 0.821 . . . . 0.0 109.289 -178.31 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 267' ' ' TRP . . . . . 0.716 ' CE3' HD12 ' A' ' 261' ' ' LEU . 10.2 m0 -78.76 -25.23 44.43 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.947 -172.611 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 268' ' ' SER . . . . . 0.474 ' HB2' ' O ' ' A' ' 264' ' ' ASN . 12.5 t -66.8 -19.13 65.68 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.834 0.35 . . . . 0.0 110.782 178.199 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -71.7 -21.51 61.77 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 121.013 0.435 . . . . 0.0 110.239 175.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 270' ' ' ARG . . . . . 0.613 ' HG2' HD21 ' A' ' 213' ' ' LEU . 2.6 mpt_? -99.76 141.43 32.58 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.424 -178.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -94.13 106.2 18.18 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . 0.61 HG23 HD21 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -112.48 141.38 28.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.992 0.425 . . . . 0.0 111.207 -176.093 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 273' ' ' TYR . . . . . 0.502 ' CD2' HG23 ' A' ' 195' ' ' VAL . 7.8 p90 -152.6 168.86 24.2 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.158 171.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 274' ' ' TYR . . . . . 0.791 ' HH ' ' HA ' ' A' ' 255' ' ' ILE . 64.7 m-85 -65.11 133.9 52.6 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.81 0.338 . . . . 0.0 110.577 173.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -72.12 164.26 54.39 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.301 178.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 76.8 mtt85 -87.07 126.16 34.58 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -178.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -165.98 154.72 11.31 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.089 -174.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 278' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 278' ' ' ARG . 64.2 mtt-85 -93.37 14.76 17.45 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 111.52 0.193 . . . . 0.0 111.52 -174.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 279' ' ' CYS . . . . . . . . . . . . . 37.0 m 66.55 25.8 9.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.158 0.504 . . . . 0.0 110.385 178.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -117.39 108.98 16.22 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.432 0.634 . . . . 0.0 110.381 -176.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 7.3 p -92.66 -24.24 5.36 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.725 178.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -148.61 -91.6 0.1 OUTLIER Glycine 0 N--CA 1.446 -0.689 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.58 177.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -104.06 159.16 15.91 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 178.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . 0.461 ' NZ ' ' HB3' ' A' ' 284' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.877 0 CA-C-O 118.64 -0.695 . . . . 0.0 109.283 -179.04 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 49.4 t30 . . . . . 0 N--CA 1.48 1.067 0 N-CA-C 110.251 -0.277 . . . . 0.0 110.251 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 13.2 t 63.23 77.68 0.32 Allowed 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.475 0.655 . . . . 0.0 110.732 -179.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -76.01 135.71 39.97 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.31 178.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 10.6 m -80.4 109.14 14.62 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.492 -177.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -117.39 160.84 20.51 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -178.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 19.6 m -51.42 102.86 0.05 OUTLIER 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.941 0.401 . . . . 0.0 110.163 176.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 15.2 m -89.89 115.19 27.02 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.673 -169.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 1.1 m -137.16 17.79 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.707 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.664 174.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . 0.572 HD22 ' HG3' ' A' ' 200' ' ' GLN . 27.3 tp 64.68 34.76 9.44 Favored 'General case' 0 C--N 1.319 -0.735 0 O-C-N 124.028 0.83 . . . . 0.0 109.347 -175.384 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 66.3 mt 63.13 16.08 9.06 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.161 -174.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . 62.85 22.01 13.15 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.584 178.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.402 ' C ' ' H ' ' A' ' 201' ' ' GLN . 16.5 m -74.25 -2.98 4.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 121.205 0.526 . . . . 0.0 110.531 178.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' GLN . . . . . 0.572 ' HG3' HD22 ' A' ' 196' ' ' LEU . 51.7 mt-30 -77.99 39.13 0.29 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.614 177.331 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . 0.476 ' HA ' HD12 ' A' ' 255' ' ' ILE . 3.5 pt20 -63.86 -20.25 65.67 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.85 -176.266 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 35.0 m -135.52 16.22 3.39 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 171.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -92.16 -50.44 2.62 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 114.944 -1.025 . . . . 0.0 112.574 -174.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -122.79 93.48 3.98 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 121.174 0.511 . . . . 0.0 110.725 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' CYS . . . . . 0.556 ' HA ' HG12 ' A' ' 251' ' ' ILE . 3.3 m -88.44 146.93 24.95 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.192 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . 0.844 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 30.7 mtm180 55.29 6.05 0.14 Allowed 'General case' 0 C--O 1.22 -0.477 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 178.746 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -104.42 105.16 15.18 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 119.974 -0.691 . . . . 0.0 111.496 -171.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 61.9 t -136.14 116.33 17.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.384 177.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' PHE . . . . . 0.428 ' O ' ' HA ' ' A' ' 272' ' ' ILE . 3.4 t80 -113.5 126.52 55.4 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.447 -176.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.456 HD22 HD23 ' A' ' 213' ' ' LEU . 5.6 mp -110.65 131.37 55.11 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.553 178.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . 0.52 ' HA2' HG23 ' A' ' 243' ' ' ILE . . . -139.07 66.46 0.52 Allowed Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.621 -0.799 . . . . 0.0 113.396 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . 0.53 ' HB3' ' HA ' ' A' ' 270' ' ' ARG . 40.2 t30 177.08 36.47 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.183 0.516 . . . . 0.0 110.014 176.437 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.825 HD22 ' HG2' ' A' ' 270' ' ' ARG . 1.3 mt -89.16 158.27 46.9 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.466 -178.131 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -81.98 163.96 17.88 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.541 2.16 . . . . 0.0 111.42 176.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . 0.516 ' HA ' ' OG1' ' A' ' 239' ' ' THR . 14.8 m120 -78.42 127.89 32.84 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.104 178.334 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 108.76 -8.87 34.41 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.473 -177.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . 0.645 HG23 HG23 ' A' ' 237' ' ' ILE . 4.3 tp -61.41 126.85 20.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-O 121.146 0.498 . . . . 0.0 110.376 178.063 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' THR . . . . . 0.504 HG21 ' HG3' ' A' ' 221' ' ' GLU . 5.1 t -113.77 161.2 17.83 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 121.35 0.595 . . . . 0.0 110.999 -178.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.482 ' CD ' ' H ' ' A' ' 219' ' ' GLU . 7.7 mp0 -62.84 -41.7 99.45 Favored 'General case' 0 C--O 1.209 -1.035 0 CA-C-N 115.113 -0.948 . . . . 0.0 109.887 -175.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -50.33 -37.16 35.34 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 123.584 0.553 . . . . 0.0 111.175 -179.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . 0.504 ' HG3' HG21 ' A' ' 218' ' ' THR . 44.6 mt-10 -68.44 -56.23 9.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.553 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . 0.457 HD13 HD13 ' A' ' 237' ' ' ILE . 6.9 mt -62.17 -40.64 88.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.382 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . 0.608 ' HG3' HD11 ' A' ' 235' ' ' ILE . 25.6 mtp85 -53.15 -64.12 0.92 Allowed 'General case' 0 CA--C 1.509 -0.631 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 174.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -58.04 -21.02 43.44 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.855 -176.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -86.22 -33.31 20.79 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.703 -178.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.792 HD22 ' HZ ' ' A' ' 248' ' ' PHE . 7.5 mp -107.2 -14.44 14.9 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -171.173 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . 0.609 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 24.5 mm-40 -61.01 -37.68 46.87 Favored Pre-proline 0 C--N 1.328 -0.353 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -178.322 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . 0.609 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 97.2 Cg_endo -66.52 -27.51 46.25 Favored 'Trans proline' 0 C--N 1.36 1.134 0 C-N-CA 121.687 1.591 . . . . 0.0 112.295 -171.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . 0.53 ' CZ ' ' HA ' ' A' ' 226' ' ' LEU . 3.8 p90 -110.91 -7.05 14.6 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.686 176.308 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . 0.416 ' CA ' ' HB1' ' A' ' 253' ' ' ALA . . . -171.8 98.72 0.13 Allowed Glycine 0 N--CA 1.442 -0.906 0 C-N-CA 120.045 -1.074 . . . . 0.0 112.347 -175.643 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -63.9 133.17 37.59 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 121.904 1.736 . . . . 0.0 111.256 177.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.84 HG21 HG11 ' A' ' 246' ' ' VAL . 2.4 mp -109.54 147.7 13.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.905 178.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . 0.444 ' CG ' HD22 ' A' ' 249' ' ' LEU . 14.4 m-20 -108.89 -24.46 11.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.731 178.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . 0.57 ' HB3' ' HB2' ' A' ' 247' ' ' HIS . 21.4 tt0 -140.06 121.81 15.4 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.305 -173.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . 0.608 HD11 ' HG3' ' A' ' 223' ' ' ARG . 18.6 mt -136.83 111.14 9.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.111 0.481 . . . . 0.0 110.158 -178.357 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 22.1 ttmm -115.77 109.34 17.54 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.41 -179.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' ILE . . . . . 0.645 HG23 HG23 ' A' ' 217' ' ' ILE . 73.2 mt -99.72 118.24 46.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-O 121.043 0.449 . . . . 0.0 110.323 177.156 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.538 ' HB ' HG13 ' A' ' 243' ' ' ILE . 40.8 t -102.14 86.1 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 172.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' THR . . . . . 0.516 ' OG1' ' HA ' ' A' ' 215' ' ' ASN . 8.9 t -70.19 -19.02 63.2 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.274 -176.045 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -60.83 -33.62 73.31 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.951 174.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . 0.419 ' HB2' HG12 ' A' ' 243' ' ' ILE . 98.9 mtt180 -114.94 4.24 14.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.791 -179.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 17.3 m120 65.93 27.76 10.77 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.23 0.612 . . . . 0.0 111.419 176.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.538 HG13 ' HB ' ' A' ' 238' ' ' VAL . 1.4 pt -123.07 155.08 28.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.294 -175.48 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . 0.434 ' HB3' ' HB2' ' A' ' 210' ' ' LEU . . . -144.38 141.47 29.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.989 0.423 . . . . 0.0 111.569 179.284 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -112.73 115.41 28.49 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.64 176.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . 0.84 HG11 HG21 ' A' ' 232' ' ' ILE . 0.3 OUTLIER -111.48 129.41 66.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 -179.124 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 247' ' ' HIS . . . . . 0.844 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 32.4 m170 -107.79 102.78 11.96 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.006 -0.677 . . . . 0.0 111.357 178.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . 0.792 ' HZ ' HD22 ' A' ' 226' ' ' LEU . 33.2 m-85 -84.82 103.17 13.66 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.811 177.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.444 HD22 ' CG ' ' A' ' 233' ' ' ASP . 0.1 OUTLIER -43.29 -39.46 3.06 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 124.505 1.128 . . . . 0.0 113.068 -174.306 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -99.71 137.94 37.49 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 176.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . 0.592 ' O ' HG13 ' A' ' 255' ' ' ILE . 0.2 OUTLIER -58.51 -41.65 82.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.918 -179.289 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -69.22 -30.67 68.88 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 116.756 -0.202 . . . . 0.0 111.09 -176.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . 0.416 ' HB1' ' CA ' ' A' ' 230' ' ' GLY . . . -62.35 -39.14 92.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.221 178.523 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . 0.549 ' HB3' ' HB2' ' A' ' 248' ' ' PHE . . . -69.53 -41.79 75.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.799 178.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.592 HG13 ' O ' ' A' ' 251' ' ' ILE . 11.4 mt -56.11 -60.61 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.105 -178.049 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . 0.512 ' O ' ' HG2' ' A' ' 260' ' ' GLU . 12.3 ptmt -61.22 -39.73 91.34 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.515 -178.347 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -62.61 -47.9 81.75 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.628 0.252 . . . . 0.0 111.4 179.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . 0.455 HG13 HG12 ' A' ' 272' ' ' ILE . 53.7 t -66.63 -26.27 36.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.9 0.381 . . . . 0.0 111.221 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . 0.532 ' HA ' ' OE1' ' A' ' 259' ' ' GLN . 10.4 mm-40 -84.3 -28.71 26.94 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 177.469 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . 0.512 ' HG2' ' O ' ' A' ' 256' ' ' LYS . 37.1 mm-40 -92.91 -26.02 17.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.445 0.164 . . . . 0.0 111.423 -175.279 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.786 ' HA ' ' HE3' ' A' ' 267' ' ' TRP . 0.6 OUTLIER -54.23 -52.55 67.84 Favored Pre-proline 0 CA--C 1.537 0.465 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.981 176.412 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 262' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 261' ' ' LEU . 37.7 Cg_endo -67.18 -15.92 47.45 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.503 2.135 . . . . 0.0 112.828 -178.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 259' ' ' GLN . 46.1 mt -85.06 -9.07 58.36 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.126 0.489 . . . . 0.0 111.151 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 -105.15 148.7 36.64 Favored Pre-proline 0 C--N 1.316 -0.887 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.108 -175.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -66.38 -34.73 33.81 Favored 'Trans proline' 0 C--N 1.336 -0.085 0 C-N-CA 123.546 2.831 . . . . 0.0 112.689 -170.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 5.1 mtpt -86.25 -45.22 11.48 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 121.465 0.65 . . . . 0.0 109.714 -177.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 267' ' ' TRP . . . . . 0.786 ' HE3' ' HA ' ' A' ' 261' ' ' LEU . 14.3 m0 -75.97 -30.11 58.5 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.757 -173.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 29.5 t -65.9 -18.81 65.59 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.958 0.409 . . . . 0.0 110.749 178.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . 0.403 ' C ' ' HD2' ' A' ' 270' ' ' ARG . 96.8 mttt -77.3 -8.38 57.54 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 121.139 0.495 . . . . 0.0 110.206 176.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 270' ' ' ARG . . . . . 0.825 ' HG2' HD22 ' A' ' 213' ' ' LEU . 3.6 mpt_? -111.11 141.51 44.51 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 178.061 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 31.9 mmm180 -92.36 110.27 21.67 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 -176.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . 0.588 HG22 HD21 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -121.46 142.41 37.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.534 0.683 . . . . 0.0 111.571 -178.259 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -151.76 169.31 22.51 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.679 173.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -62.18 127.87 33.4 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 123.117 0.261 . . . . 0.0 110.301 175.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -59.65 153.42 33.06 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.936 -0.649 . . . . 0.0 111.743 176.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 8.2 mtp180 -85.71 130.71 34.49 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.17 0.509 . . . . 0.0 110.132 -176.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -159.68 152.35 21.43 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.987 -171.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 278' ' ' ARG . . . . . 0.559 ' HG3' ' O ' ' A' ' 283' ' ' LEU . 22.8 mmt180 -78.79 0.3 27.51 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -172.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 279' ' ' CYS . . . . . . . . . . . . . 86.1 m 64.98 26.24 12.72 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.808 0.813 . . . . 0.0 109.257 -175.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -167.89 123.56 1.04 Allowed 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 114.423 -1.262 . . . . 0.0 109.469 -176.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 6.1 p -82.93 80.16 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 122.254 1.026 . . . . 0.0 110.653 -178.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -155.64 -96.24 0.12 Allowed Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.759 177.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 283' ' ' LEU . . . . . 0.559 ' O ' ' HG3' ' A' ' 278' ' ' ARG . 4.5 mm? -79.37 94.33 5.49 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.852 0.358 . . . . 0.0 110.518 177.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.514 -0.755 . . . . 0.0 109.746 178.523 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 . . . . . 0 N--CA 1.481 1.113 0 CA-C-O 120.658 0.265 . . . . 0.0 110.472 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 45.0 m -78.35 103.85 8.56 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.963 0.411 . . . . 0.0 110.454 178.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -108.46 150.87 26.82 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.425 178.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 7.0 m -76.59 113.17 13.92 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.312 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 44.4 t-20 -60.55 113.32 2.37 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.327 0.584 . . . . 0.0 110.037 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' SER . . . . . 0.873 ' HA ' ' HB2' ' A' ' 262' ' ' PRO . 6.6 m -105.52 13.7 29.68 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.678 -175.342 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 29.1 m -98.98 106.64 18.92 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.342 0.591 . . . . 0.0 111.238 -177.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -124.9 68.13 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.574 176.513 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . 0.457 ' HG ' HG21 ' A' ' 199' ' ' VAL . 25.5 tp 60.8 14.72 5.34 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.635 0.731 . . . . 0.0 109.639 -174.148 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 9.2 mp 59.42 21.28 9.65 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.889 -174.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.476 ' HB2' ' CE2' ' A' ' 274' ' ' TYR . . . 57.03 27.64 13.62 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.921 177.375 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.457 HG21 ' HG ' ' A' ' 196' ' ' LEU . 33.2 m -79.27 -6.47 9.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.691 0.281 . . . . 0.0 111.631 -177.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -80.99 70.02 7.72 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.67 0.748 . . . . 0.0 110.126 176.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -144.26 130.96 20.13 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.89 -176.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 23.3 t -119.28 25.11 10.34 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 176.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 96.81 65.24 0.92 Allowed Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 110.429 -1.069 . . . . 0.0 110.429 -173.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . 0.635 ' HB3' ' HB2' ' A' ' 207' ' ' ASN . . . -99.2 102.13 13.68 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 120.92 0.391 . . . . 0.0 111.508 -172.565 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' CYS . . . . . 0.482 ' CA ' HG12 ' A' ' 251' ' ' ILE . 25.5 p -93.0 146.66 23.45 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 173.437 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . 0.826 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 59.6 mtm180 58.06 1.41 0.15 Allowed 'General case' 0 C--O 1.222 -0.383 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -179.53 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . 0.635 ' HB2' ' HB3' ' A' ' 204' ' ' ALA . 95.1 m-20 -100.08 104.66 16.24 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 119.743 -0.783 . . . . 0.0 111.213 -172.523 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 67.8 t -137.45 123.73 27.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.134 176.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' PHE . . . . . 0.414 ' HE1' ' HB ' ' A' ' 243' ' ' ILE . 4.2 t80 -121.38 125.41 46.89 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 120.752 0.311 . . . . 0.0 110.251 -177.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.533 ' HG ' HG23 ' A' ' 272' ' ' ILE . 4.6 mp -108.28 126.09 52.43 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.39 177.427 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . 0.564 ' HA2' HG22 ' A' ' 243' ' ' ILE . . . -129.76 57.52 0.72 Allowed Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.304 -0.951 . . . . 0.0 113.343 -178.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . 0.542 ' HB3' ' HA ' ' A' ' 270' ' ' ARG . 2.1 t30 178.19 45.12 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.045 0.45 . . . . 0.0 111.027 178.166 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.451 HD21 HD22 ' A' ' 210' ' ' LEU . 0.7 OUTLIER -92.94 160.99 32.72 Favored Pre-proline 0 C--N 1.317 -0.814 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 176.971 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.432 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 87.9 Cg_endo -80.17 165.23 21.58 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.527 2.151 . . . . 0.0 111.188 176.06 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . 0.506 ' HA ' ' OG1' ' A' ' 239' ' ' THR . 28.2 t-20 -78.72 128.19 33.09 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 106.6 -2.98 36.57 Favored Glycine 0 C--N 1.315 -0.622 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.589 -178.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . 0.71 HG22 HG22 ' A' ' 237' ' ' ILE . 4.5 tp -64.71 127.99 26.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.224 0.535 . . . . 0.0 110.71 177.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 14.1 t -113.92 155.75 25.24 Favored 'General case' 0 C--O 1.24 0.602 0 CA-C-O 121.328 0.585 . . . . 0.0 111.075 -178.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -61.25 -37.26 82.44 Favored 'General case' 0 C--O 1.209 -1.055 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.365 -177.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -51.71 -36.0 45.15 Favored 'General case' 0 C--N 1.321 -0.632 0 O-C-N 123.464 0.478 . . . . 0.0 111.064 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -73.58 -55.56 6.15 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.316 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . 0.458 HD11 HD12 ' A' ' 237' ' ' ILE . 11.1 mt -60.17 -43.66 93.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.63 -179.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . 0.648 ' HG3' HD12 ' A' ' 235' ' ' ILE . 51.2 mtp180 -52.19 -63.11 1.25 Allowed 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 175.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -60.13 -19.46 53.69 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.077 -177.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' ASP . . . . . 0.49 ' HB3' ' CZ2' ' A' ' 267' ' ' TRP . 19.6 m-20 -87.32 -33.18 19.3 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.569 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.781 HD23 ' HZ ' ' A' ' 248' ' ' PHE . 8.2 mp -106.73 -18.25 14.0 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -170.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . 0.661 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 40.6 mt-10 -71.16 -24.41 0.72 Allowed Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -175.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . 0.661 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 74.7 Cg_endo -67.73 -26.76 38.69 Favored 'Trans proline' 0 C--N 1.36 1.184 0 C-N-CA 121.286 1.324 . . . . 0.0 112.05 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . 0.518 ' CZ ' ' HA ' ' A' ' 226' ' ' LEU . 3.6 p90 -110.55 -12.82 14.32 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.674 174.217 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . 0.461 ' HA2' ' HB2' ' A' ' 253' ' ' ALA . . . -165.01 96.06 0.13 Allowed Glycine 0 N--CA 1.441 -1.021 0 C-N-CA 120.319 -0.943 . . . . 0.0 111.939 -175.13 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -63.36 130.55 28.85 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.157 1.905 . . . . 0.0 111.423 178.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.957 HG21 HG13 ' A' ' 246' ' ' VAL . 2.1 mp -109.8 146.3 15.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.387 178.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . 0.517 ' OD2' HD23 ' A' ' 249' ' ' LEU . 7.7 m-20 -109.92 -22.43 11.86 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.909 0.385 . . . . 0.0 110.755 177.282 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . 0.577 ' HB3' ' HB2' ' A' ' 247' ' ' HIS . 30.9 tt0 -135.23 119.5 17.78 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.404 -176.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . 0.648 HD12 ' HG3' ' A' ' 223' ' ' ARG . 15.2 mt -136.96 106.57 4.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.852 -179.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -112.46 108.55 17.73 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.37 -179.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' ILE . . . . . 0.71 HG22 HG22 ' A' ' 217' ' ' ILE . 66.3 mt -99.99 117.77 45.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.548 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.588 ' HB ' HG13 ' A' ' 243' ' ' ILE . 45.2 t -100.1 87.44 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 172.523 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' THR . . . . . 0.506 ' OG1' ' HA ' ' A' ' 215' ' ' ASN . 14.0 t -64.77 -20.68 66.5 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.647 -175.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -67.74 -28.32 67.54 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.896 178.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . 0.535 ' HB2' HG12 ' A' ' 243' ' ' ILE . 81.9 mtt180 -120.13 5.12 10.82 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.653 -176.609 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 18.2 m120 66.12 24.75 10.86 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.33 175.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.588 HG13 ' HB ' ' A' ' 238' ' ' VAL . 1.6 pt -122.01 149.45 25.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.51 -173.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . 0.407 ' HB3' ' HB2' ' A' ' 210' ' ' LEU . . . -141.58 135.31 29.93 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.187 179.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 245' ' ' PHE . . . . . 0.402 ' HE2' ' HB3' ' A' ' 279' ' ' CYS . 25.7 m-85 -107.06 112.87 26.0 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.579 177.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . 0.957 HG13 HG21 ' A' ' 232' ' ' ILE . 0.1 OUTLIER -112.5 128.81 68.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.876 -176.944 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 247' ' ' HIS . . . . . 0.826 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 27.4 m170 -109.57 104.04 13.01 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.362 0.601 . . . . 0.0 111.313 178.398 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . 0.781 ' HZ ' HD23 ' A' ' 226' ' ' LEU . 30.4 m-85 -86.49 99.99 12.06 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.669 178.473 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.517 HD23 ' OD2' ' A' ' 233' ' ' ASP . 0.0 OUTLIER -37.37 -49.3 0.98 Allowed 'General case' 0 N--CA 1.469 0.511 0 O-C-N 124.654 1.221 . . . . 0.0 113.334 -176.131 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -90.95 139.48 30.72 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.109 177.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . 0.513 ' O ' HG13 ' A' ' 255' ' ' ILE . 0.2 OUTLIER -59.55 -41.35 84.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.047 -176.795 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -71.99 -30.88 65.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.981 -175.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . 0.461 ' HB2' ' HA2' ' A' ' 230' ' ' GLY . . . -59.33 -39.58 83.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.391 178.06 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . 0.567 ' HB3' ' HB2' ' A' ' 248' ' ' PHE . . . -69.19 -41.91 76.53 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.693 178.229 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.516 ' HA ' ' OH ' ' A' ' 274' ' ' TYR . 8.4 mt -56.97 -60.85 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.247 -177.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . 0.478 ' O ' ' HG2' ' A' ' 260' ' ' GLU . 10.8 ptmt -61.17 -38.5 86.7 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.339 -177.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -61.95 -48.53 80.0 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.625 0.25 . . . . 0.0 111.344 178.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . 0.49 HG12 HG12 ' A' ' 272' ' ' ILE . 55.3 t -68.37 -24.02 29.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.878 0.371 . . . . 0.0 111.057 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -84.52 -23.78 29.63 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 177.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . 0.478 ' HG2' ' O ' ' A' ' 256' ' ' LYS . 68.7 mm-40 -95.83 -31.68 13.04 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.679 0.276 . . . . 0.0 110.972 -176.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.743 ' HA ' ' HE3' ' A' ' 267' ' ' TRP . 0.7 OUTLIER -52.46 -49.13 87.29 Favored Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.689 179.849 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 262' ' ' PRO . . . . . 0.873 ' HB2' ' HA ' ' A' ' 193' ' ' SER . 48.6 Cg_endo -67.75 -15.7 44.81 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.352 2.035 . . . . 0.0 112.81 -178.434 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 56.4 mt -87.45 -8.66 56.23 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.499 0.666 . . . . 0.0 111.072 -178.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 -106.77 149.64 38.7 Favored Pre-proline 0 C--N 1.311 -1.065 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.133 -171.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -65.36 -39.44 22.44 Favored 'Trans proline' 0 C--O 1.231 0.137 0 C-N-CA 123.424 2.749 . . . . 0.0 112.768 -168.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 10.1 mtpt -86.33 -44.42 12.1 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.385 0.612 . . . . 0.0 109.615 -176.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 267' ' ' TRP . . . . . 0.743 ' HE3' ' HA ' ' A' ' 261' ' ' LEU . 17.7 m0 -70.98 -32.34 69.16 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.008 -0.997 . . . . 0.0 110.869 -175.414 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 22.7 t -64.19 -24.26 67.61 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.739 0.305 . . . . 0.0 110.799 179.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -71.02 -15.6 62.57 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.239 0.543 . . . . 0.0 110.124 177.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 270' ' ' ARG . . . . . 0.542 ' HA ' ' HB3' ' A' ' 212' ' ' ASN . 1.6 mpt_? -93.84 156.03 16.87 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.13 174.17 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 6.1 mmp_? -103.82 105.54 15.78 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 173.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . 0.604 HG21 HD21 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -113.45 138.25 43.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.303 0.573 . . . . 0.0 110.667 -176.571 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -152.85 167.77 27.98 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.149 175.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 274' ' ' TYR . . . . . 0.516 ' OH ' ' HA ' ' A' ' 255' ' ' ILE . 80.6 m-85 -65.42 122.46 17.22 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.537 173.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -59.02 130.93 51.7 Favored Glycine 0 N--CA 1.441 -0.97 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.391 176.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' A' ' 276' ' ' ARG . 0.0 OUTLIER -95.06 146.51 24.23 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 177.986 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 277' ' ' ASP . . . . . 0.457 ' CG ' ' H ' ' A' ' 278' ' ' ARG . 23.2 t70 60.66 -168.48 0.17 Allowed 'General case' 0 CA--C 1.538 0.503 0 O-C-N 123.761 0.663 . . . . 0.0 109.302 -176.277 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 278' ' ' ARG . . . . . 0.457 ' H ' ' CG ' ' A' ' 277' ' ' ASP . 0.0 OUTLIER -88.63 11.05 18.47 Favored 'General case' 0 C--N 1.321 -0.64 0 O-C-N 121.656 -0.653 . . . . 0.0 110.579 179.4 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 279' ' ' CYS . . . . . 0.402 ' HB3' ' HE2' ' A' ' 245' ' ' PHE . 77.1 m 57.61 69.1 0.77 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.704 -1.135 . . . . 0.0 110.667 178.536 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . 0.632 ' HB2' ' HB2' ' A' ' 283' ' ' LEU . . . -153.19 127.05 8.9 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.395 -176.171 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 3.4 p -112.66 89.16 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-O 122.032 0.92 . . . . 0.0 109.479 177.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 110.38 -68.42 0.22 Allowed Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.081 -176.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 283' ' ' LEU . . . . . 0.632 ' HB2' ' HB2' ' A' ' 280' ' ' ALA . 0.4 OUTLIER 42.4 78.5 0.05 OUTLIER 'General case' 0 C--O 1.234 0.284 0 C-N-CA 123.863 0.865 . . . . 0.0 111.943 177.829 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 19.3 pttp . . . . . 0 C--O 1.249 1.049 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.157 179.884 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 . . . . . 0 N--CA 1.479 0.987 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 9.9 m -102.63 -10.87 18.88 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.759 -178.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -77.15 -41.06 43.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.296 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 47.8 m -80.58 160.57 25.09 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.333 177.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -86.35 119.86 27.08 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.157 179.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 15.8 m -113.52 90.83 3.45 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.063 0.459 . . . . 0.0 109.926 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' SER . . . . . 0.564 ' O ' HD21 ' A' ' 196' ' ' LEU . 23.3 t -176.18 -150.98 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -177.016 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 5.2 m -79.81 81.32 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.157 0.503 . . . . 0.0 111.41 177.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . 0.578 ' O ' HG22 ' A' ' 199' ' ' VAL . 2.0 mm? -59.79 98.32 0.05 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.054 179.308 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 90.4 mt 53.46 26.84 5.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.093 0.473 . . . . 0.0 110.168 -176.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . 63.17 29.32 16.07 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.055 -0.975 . . . . 0.0 112.389 -178.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.578 HG22 ' O ' ' A' ' 196' ' ' LEU . 20.6 m -84.4 -23.45 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.772 174.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' GLN . . . . . 0.465 ' HG2' HG23 ' A' ' 199' ' ' VAL . 17.0 mm-40 -104.01 78.86 1.57 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.408 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -172.91 156.7 3.43 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.642 177.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 37.3 m -151.25 19.74 0.75 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.837 0.351 . . . . 0.0 111.078 -179.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 79.18 33.42 36.06 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.671 -0.776 . . . . 0.0 111.358 -177.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -71.13 114.46 9.21 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.54 -0.33 . . . . 0.0 111.099 -176.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' CYS . . . . . 0.756 ' HB3' HG12 ' A' ' 251' ' ' ILE . 16.6 p -89.34 146.81 24.44 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 176.22 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . 0.827 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 44.0 mtp180 60.26 -10.7 0.05 OUTLIER 'General case' 0 C--O 1.219 -0.505 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 177.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -97.5 106.34 18.64 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 119.246 0.93 . . . . 0.0 112.146 -169.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.486 ' HB ' ' HB ' ' A' ' 246' ' ' VAL . 57.3 t -137.28 121.21 22.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.076 -0.966 . . . . 0.0 109.819 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' PHE . . . . . 0.437 ' O ' ' HA ' ' A' ' 272' ' ' ILE . 10.5 t80 -114.57 126.81 55.34 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.743 0.306 . . . . 0.0 110.906 -178.244 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.468 ' HG ' HG21 ' A' ' 272' ' ' ILE . 4.8 mp -110.3 128.07 55.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.372 175.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . 0.532 ' HA2' HG23 ' A' ' 243' ' ' ILE . . . -137.82 66.32 0.54 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.383 -0.913 . . . . 0.0 113.046 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . 0.562 ' HB3' ' HA ' ' A' ' 270' ' ' ARG . 3.4 t30 177.58 43.07 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.332 0.586 . . . . 0.0 110.004 176.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.648 HD22 ' HG2' ' A' ' 270' ' ' ARG . 1.1 mt -94.83 161.16 29.48 Favored Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.966 -179.474 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -83.05 167.9 13.9 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.458 2.105 . . . . 0.0 111.533 176.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . 0.475 ' HA ' ' OG1' ' A' ' 239' ' ' THR . 53.7 t30 -78.28 124.69 28.37 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.078 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 107.78 -4.38 34.32 Favored Glycine 0 C--N 1.314 -0.663 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.925 -177.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . 0.656 HG21 HG23 ' A' ' 237' ' ' ILE . 5.1 tp -60.75 126.74 19.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.05 0.453 . . . . 0.0 110.384 177.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' THR . . . . . 0.458 HG23 ' HG3' ' A' ' 221' ' ' GLU . 15.1 t -114.43 158.77 21.11 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.076 0.465 . . . . 0.0 111.077 -178.116 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.637 ' HB3' ' HD2' ' A' ' 223' ' ' ARG . 2.3 mp0 -57.88 -44.46 86.68 Favored 'General case' 0 C--O 1.205 -1.274 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.523 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -42.75 -39.69 2.54 Favored 'General case' 0 C--N 1.319 -0.728 0 O-C-N 123.959 0.787 . . . . 0.0 111.66 178.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . 0.458 ' HG3' HG23 ' A' ' 218' ' ' THR . 43.7 mt-10 -70.74 -60.54 2.19 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.876 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . 0.492 HD12 HD13 ' A' ' 237' ' ' ILE . 10.8 mt -62.64 -41.6 92.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.665 -176.393 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . 0.824 ' HG3' HD11 ' A' ' 235' ' ' ILE . 46.3 mtt-85 -54.85 -62.28 1.76 Allowed 'General case' 0 CA--C 1.507 -0.678 0 CA-C-N 116.21 -0.45 . . . . 0.0 112.162 176.163 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -56.03 -25.23 43.89 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.47 -178.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' ASP . . . . . 0.472 ' HB3' ' CZ2' ' A' ' 267' ' ' TRP . 19.3 m-20 -83.22 -33.3 26.14 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.615 -176.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.809 HD23 ' HZ ' ' A' ' 248' ' ' PHE . 7.2 mp -106.72 -12.16 15.61 Favored 'General case' 0 C--O 1.224 -0.242 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -171.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . 0.63 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 15.1 mm-40 -62.31 -37.23 34.81 Favored Pre-proline 0 C--N 1.327 -0.387 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.211 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . 0.63 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 71.7 Cg_endo -65.33 -30.3 53.93 Favored 'Trans proline' 0 C--N 1.358 1.046 0 C-N-CA 121.569 1.513 . . . . 0.0 112.248 -172.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . 0.507 ' CE1' ' HA ' ' A' ' 226' ' ' LEU . 3.5 p90 -110.53 -6.69 14.84 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.935 177.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . 0.492 ' CA ' ' HB2' ' A' ' 253' ' ' ALA . . . -170.2 96.19 0.11 Allowed Glycine 0 N--CA 1.441 -1.006 0 C-N-CA 119.849 -1.167 . . . . 0.0 112.395 -176.139 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . 0.427 ' HA ' ' OE2' ' A' ' 227' ' ' GLU . 17.9 Cg_endo -63.21 129.76 26.59 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 121.704 1.603 . . . . 0.0 111.41 178.557 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.687 HG22 HG12 ' A' ' 246' ' ' VAL . 2.3 mp -107.38 151.99 9.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.644 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -114.51 -21.77 10.15 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.645 177.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . 0.422 ' HB3' ' HB2' ' A' ' 247' ' ' HIS . 21.5 tt0 -141.19 120.42 12.99 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.648 -178.011 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . 0.824 HD11 ' HG3' ' A' ' 223' ' ' ARG . 6.1 mt -134.61 106.23 7.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.311 177.292 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.422 ' HE3' ' HB2' ' A' ' 236' ' ' LYS . 35.0 ttmt -106.58 107.46 18.48 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.981 -177.314 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' ILE . . . . . 0.656 HG23 HG21 ' A' ' 217' ' ' ILE . 87.9 mt -100.62 114.31 39.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-O 121.267 0.556 . . . . 0.0 110.52 -179.394 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.52 ' HB ' HG13 ' A' ' 243' ' ' ILE . 45.9 t -100.52 85.87 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 173.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 239' ' ' THR . . . . . 0.475 ' OG1' ' HA ' ' A' ' 215' ' ' ASN . 12.3 t -71.75 -13.04 61.59 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.075 -176.079 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -57.37 -41.83 80.95 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.804 170.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . 0.504 ' HB2' HG12 ' A' ' 243' ' ' ILE . 75.3 mtt180 -116.06 8.79 14.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.126 -177.271 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 68.7 25.9 6.3 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.298 174.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.532 HG23 ' HA2' ' A' ' 211' ' ' GLY . 2.1 pt -122.23 151.14 25.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.33 -173.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . 0.443 ' HB3' ' HB2' ' A' ' 210' ' ' LEU . . . -141.52 135.61 30.35 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.977 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -108.8 115.08 29.4 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.688 177.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . 0.687 HG12 HG22 ' A' ' 232' ' ' ILE . 1.5 t -108.71 141.02 25.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.612 -176.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 247' ' ' HIS . . . . . 0.827 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 11.5 m80 -122.39 101.94 7.8 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.584 0.707 . . . . 0.0 111.668 174.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . 0.809 ' HZ ' HD23 ' A' ' 226' ' ' LEU . 33.2 m-85 -84.87 101.95 12.7 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 114.581 -1.19 . . . . 0.0 110.896 178.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.402 HD23 ' H ' ' A' ' 249' ' ' LEU . 0.1 OUTLIER -43.62 -39.37 3.5 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 124.344 1.028 . . . . 0.0 112.882 -175.92 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . 0.408 ' HB2' ' HB3' ' A' ' 253' ' ' ALA . 37.5 m-20 -93.73 140.17 29.96 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.128 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . 0.756 HG12 ' HB3' ' A' ' 205' ' ' CYS . 0.2 OUTLIER -63.4 -43.95 98.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -178.75 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . 0.414 ' O ' ' HG2' ' A' ' 256' ' ' LYS . . . -70.16 -30.72 67.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.647 0.26 . . . . 0.0 110.617 -177.303 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . 0.492 ' HB2' ' CA ' ' A' ' 230' ' ' GLY . . . -58.14 -44.12 87.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.261 178.487 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . 0.541 ' HB1' ' HB2' ' A' ' 248' ' ' PHE . . . -68.56 -39.58 81.0 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.566 178.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.724 ' HA ' ' HH ' ' A' ' 274' ' ' TYR . 3.5 mt -57.37 -60.89 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.513 -179.219 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . 0.414 ' HG2' ' O ' ' A' ' 252' ' ' ALA . 13.2 ptmt -62.92 -38.67 91.9 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.184 -176.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -61.96 -49.95 74.08 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.514 0.19 . . . . 0.0 111.514 179.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . 0.483 HG13 HG12 ' A' ' 272' ' ' ILE . 53.0 t -64.21 -27.19 42.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.1 0.476 . . . . 0.0 110.998 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -84.53 -21.25 30.58 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 178.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . 0.405 ' HG2' ' O ' ' A' ' 256' ' ' LYS . 67.1 mm-40 -94.81 -33.27 12.93 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 122.677 0.391 . . . . 0.0 110.989 -177.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.754 ' HA ' ' HE3' ' A' ' 267' ' ' TRP . 0.7 OUTLIER -51.84 -50.67 76.58 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.666 -178.915 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 262' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 261' ' ' LEU . 37.1 Cg_endo -66.76 -17.12 51.99 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.442 2.094 . . . . 0.0 112.807 -178.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 54.0 mt -90.27 -5.82 55.88 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.138 0.494 . . . . 0.0 111.624 -177.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 17.1 m-80 -107.13 149.73 39.0 Favored Pre-proline 0 C--N 1.315 -0.922 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.507 -174.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -65.51 -37.57 29.15 Favored 'Trans proline' 0 N--CA 1.465 -0.16 0 C-N-CA 123.432 2.754 . . . . 0.0 112.825 -171.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.446 ' HE3' ' HB2' ' A' ' 266' ' ' LYS . 0.0 OUTLIER -82.8 -44.77 15.14 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 121.736 0.779 . . . . 0.0 109.251 -177.139 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 267' ' ' TRP . . . . . 0.754 ' HE3' ' HA ' ' A' ' 261' ' ' LEU . 10.4 m0 -77.29 -29.39 53.72 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.581 -1.19 . . . . 0.0 111.115 -172.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 19.4 t -66.4 -17.56 64.85 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.976 0.417 . . . . 0.0 110.406 178.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -78.02 -8.08 57.72 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.237 0.542 . . . . 0.0 110.182 176.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 270' ' ' ARG . . . . . 0.648 ' HG2' HD22 ' A' ' 213' ' ' LEU . 3.6 mpt_? -108.97 165.02 11.89 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.816 177.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -111.59 119.12 37.63 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 177.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . 0.588 HG23 HD23 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -128.97 143.25 41.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.139 0.495 . . . . 0.0 111.476 -179.276 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -151.69 169.5 22.01 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.942 170.414 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 274' ' ' TYR . . . . . 0.724 ' HH ' ' HA ' ' A' ' 255' ' ' ILE . 69.9 m-85 -67.54 117.53 9.61 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 172.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -165.95 160.27 33.7 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 119.921 -1.133 . . . . 0.0 113.077 -173.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . 0.455 ' N ' ' HD3' ' A' ' 276' ' ' ARG . 0.0 OUTLIER -138.83 -151.99 0.4 Allowed 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 -179.803 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 277' ' ' ASP . . . . . 0.464 ' C ' ' H ' ' A' ' 279' ' ' CYS . 20.8 t70 -50.85 143.41 10.04 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.717 0.294 . . . . 0.0 110.711 172.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 278' ' ' ARG . . . . . 0.44 ' CD ' ' HB3' ' A' ' 280' ' ' ALA . 0.3 OUTLIER -74.16 27.27 0.08 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -177.302 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 279' ' ' CYS . . . . . 0.464 ' H ' ' C ' ' A' ' 277' ' ' ASP . 79.7 m 58.07 47.25 14.96 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.643 0.735 . . . . 0.0 109.304 -176.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . 0.44 ' HB3' ' CD ' ' A' ' 278' ' ' ARG . . . -73.55 92.29 1.9 Allowed 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 114.711 -1.132 . . . . 0.0 110.951 -175.148 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 7.2 p -149.69 7.93 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.952 178.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -82.38 88.69 1.45 Allowed Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.322 -176.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 283' ' ' LEU . . . . . 0.451 ' C ' HD21 ' A' ' 283' ' ' LEU . 8.9 tt -64.72 122.19 16.3 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 175.338 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 63.7 tttp . . . . . 0 C--O 1.248 1.02 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -179.913 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 8.2 t30 . . . . . 0 N--CA 1.48 1.031 0 N-CA-C 109.946 -0.391 . . . . 0.0 109.946 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 36.1 t -114.58 152.34 31.97 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.27 109.11 2.12 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.816 0.341 . . . . 0.0 110.082 178.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 33.3 t -145.56 164.22 32.35 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.015 -175.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 55.2 m-80 -109.23 94.78 5.22 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.044 0.45 . . . . 0.0 110.333 178.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 49.2 m -93.09 25.97 3.04 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.465 178.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 7.4 m -72.04 163.27 28.17 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.406 175.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 4.2 m -81.57 83.52 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.412 0.625 . . . . 0.0 111.378 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . 0.584 ' O ' ' HG2' ' A' ' 200' ' ' GLN . 3.7 mm? -74.04 -20.79 60.19 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 176.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.592 HD23 ' HB2' ' A' ' 274' ' ' TYR . 25.0 tp -64.52 -22.67 67.03 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.61 177.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -78.11 -26.51 48.01 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.229 176.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.506 HG21 ' HA ' ' A' ' 196' ' ' LEU . 2.5 t -80.27 -20.86 11.74 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.662 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.649 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' GLN . . . . . 0.584 ' HG2' ' O ' ' A' ' 196' ' ' LEU . 13.5 mm100 -81.95 5.6 18.61 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.943 -174.398 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 59.02 23.22 11.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.391 -178.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 33.0 m -82.59 110.2 17.46 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 121.124 0.488 . . . . 0.0 109.896 177.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -82.65 72.22 2.86 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 121.019 -0.61 . . . . 0.0 111.588 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.95 101.62 1.14 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.085 0.469 . . . . 0.0 110.38 -179.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' CYS . . . . . 0.453 ' HA ' HG12 ' A' ' 251' ' ' ILE . 1.8 m -87.05 146.12 26.21 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -179.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . 0.78 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 19.0 mtm180 55.88 3.48 0.09 Allowed 'General case' 0 C--O 1.223 -0.33 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 179.048 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . 0.437 ' ND2' ' HB3' ' A' ' 277' ' ' ASP . 16.9 m-80 -105.93 105.64 15.77 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 118.816 0.734 . . . . 0.0 111.644 -172.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 61.5 t -134.36 109.16 11.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.035 176.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' PHE . . . . . 0.428 ' HE1' ' HB ' ' A' ' 243' ' ' ILE . 2.6 t80 -106.33 124.7 49.99 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.183 -175.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.532 ' HG ' HG23 ' A' ' 272' ' ' ILE . 6.1 mp -109.17 132.87 53.71 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.167 178.388 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . 0.552 ' HA2' HG22 ' A' ' 243' ' ' ILE . . . -138.05 60.7 0.59 Allowed Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.235 -0.983 . . . . 0.0 113.326 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . 0.533 ' HB3' ' HA ' ' A' ' 270' ' ' ARG . 2.5 t30 179.95 41.38 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.938 0.399 . . . . 0.0 110.67 177.103 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.436 HD21 HD21 ' A' ' 210' ' ' LEU . 1.4 mp -93.77 157.29 38.41 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.545 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.409 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 86.9 Cg_endo -77.72 169.87 20.06 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.764 2.31 . . . . 0.0 112.472 179.39 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . 0.578 ' HA ' ' OG1' ' A' ' 239' ' ' THR . 13.9 m120 -78.36 123.76 27.35 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.634 176.482 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 108.75 -8.75 34.36 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.358 -0.925 . . . . 0.0 112.865 179.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . 0.604 HG23 HG22 ' A' ' 237' ' ' ILE . 4.8 tp -58.99 128.69 20.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.889 0.345 . . . . 0.0 110.107 178.347 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' THR . . . . . 0.454 HG22 ' HG3' ' A' ' 221' ' ' GLU . 7.1 t -114.1 161.62 17.52 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.447 0.641 . . . . 0.0 111.235 -179.449 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.498 ' CD ' ' H ' ' A' ' 219' ' ' GLU . 1.6 mp0 -64.31 -40.4 95.84 Favored 'General case' 0 C--O 1.21 -0.99 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.849 -175.171 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' ASP . . . . . 0.527 ' O ' ' HG2' ' A' ' 224' ' ' GLU . 38.6 t70 -48.46 -41.44 29.54 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 123.803 0.689 . . . . 0.0 111.187 178.215 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . 0.454 ' HG3' HG22 ' A' ' 218' ' ' THR . 43.4 mt-10 -65.45 -56.81 10.43 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.332 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . 0.455 HD13 HD11 ' A' ' 237' ' ' ILE . 7.5 mt -61.07 -39.92 83.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.668 -179.117 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . 0.817 ' HG3' HD12 ' A' ' 235' ' ' ILE . 26.0 mtp180 -55.83 -62.77 1.47 Allowed 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 175.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.527 ' HG2' ' O ' ' A' ' 220' ' ' ASP . 9.1 pt-20 -60.92 -18.03 54.41 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.958 -178.057 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' ASP . . . . . 0.507 ' HB3' ' CZ2' ' A' ' 267' ' ' TRP . 44.0 m-20 -88.11 -35.2 17.6 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.288 -179.059 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.71 HD21 ' HZ ' ' A' ' 248' ' ' PHE . 8.0 mp -107.05 -17.63 14.12 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -169.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . 0.661 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 41.4 mt-10 -68.81 -27.27 1.33 Allowed Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -176.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . 0.661 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 71.6 Cg_endo -66.61 -27.83 45.33 Favored 'Trans proline' 0 C--N 1.36 1.171 0 C-N-CA 121.319 1.346 . . . . 0.0 111.94 -178.308 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . 0.531 ' CZ ' ' HA ' ' A' ' 226' ' ' LEU . 3.7 p90 -110.82 -7.6 14.6 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-O 120.734 0.302 . . . . 0.0 111.631 174.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . -170.09 95.55 0.11 Allowed Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.373 -0.918 . . . . 0.0 111.957 -175.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -60.94 132.43 42.15 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.016 1.811 . . . . 0.0 111.578 178.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.793 HG22 HG13 ' A' ' 246' ' ' VAL . 2.6 mp -109.99 149.92 12.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.766 178.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . 0.444 ' OD2' HD21 ' A' ' 249' ' ' LEU . 15.3 m-20 -115.63 -14.73 11.45 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.412 179.034 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . 0.471 ' HB3' ' HB2' ' A' ' 247' ' ' HIS . 29.7 tt0 -148.35 120.87 8.52 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.518 -179.293 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . 0.817 HD12 ' HG3' ' A' ' 223' ' ' ARG . 17.1 mt -134.32 107.94 10.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.001 179.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -112.73 115.72 28.97 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.582 -177.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 237' ' ' ILE . . . . . 0.604 HG22 HG23 ' A' ' 217' ' ' ILE . 68.8 mt -104.74 121.88 57.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.932 -178.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 45.1 t -110.57 86.82 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 171.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 239' ' ' THR . . . . . 0.578 ' OG1' ' HA ' ' A' ' 215' ' ' ASN . 8.2 t -68.16 -19.89 64.83 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.405 -175.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -56.19 -37.57 69.79 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.359 174.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . 0.45 ' HB2' HG12 ' A' ' 243' ' ' ILE . 98.8 mtt180 -107.05 0.25 23.45 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.776 179.215 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 242' ' ' ASN . . . . . 0.427 ' O ' HD11 ' A' ' 213' ' ' LEU . 18.7 m120 65.63 29.12 11.06 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.472 -179.284 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.552 HG22 ' HA2' ' A' ' 211' ' ' GLY . 1.7 pp -122.22 157.24 26.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.604 -174.255 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -149.13 141.05 23.73 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.034 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -109.81 113.77 26.78 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.851 177.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . 0.793 HG13 HG22 ' A' ' 232' ' ' ILE . 0.2 OUTLIER -107.47 126.33 63.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.434 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 247' ' ' HIS . . . . . 0.78 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 51.8 m170 -105.83 102.6 12.03 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.183 -0.607 . . . . 0.0 111.244 179.699 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . 0.71 ' HZ ' HD21 ' A' ' 226' ' ' LEU . 34.6 m-85 -87.38 102.37 14.47 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.887 -1.051 . . . . 0.0 111.274 178.581 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.444 HD21 ' OD2' ' A' ' 233' ' ' ASP . 0.0 OUTLIER -40.94 -47.21 2.96 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 124.512 1.132 . . . . 0.0 113.382 -174.881 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -93.84 144.68 25.21 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.252 177.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . 0.583 ' O ' HG13 ' A' ' 255' ' ' ILE . 0.2 OUTLIER -61.33 -41.82 91.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.328 -177.167 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -71.34 -30.39 66.13 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 120.58 0.228 . . . . 0.0 110.952 -175.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -57.27 -41.59 79.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.208 177.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . 0.515 ' HB2' ' HB2' ' A' ' 248' ' ' PHE . . . -69.77 -40.64 75.96 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.594 178.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.713 ' HA ' ' HH ' ' A' ' 274' ' ' TYR . 12.8 mt -57.38 -60.85 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.249 -178.367 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 10.6 ptmt -61.77 -38.12 86.84 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.552 -176.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -62.98 -49.38 74.91 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 111.556 0.206 . . . . 0.0 111.556 178.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . 0.4 HG11 HG12 ' A' ' 272' ' ' ILE . 52.3 t -65.21 -23.47 33.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.985 0.421 . . . . 0.0 110.86 179.251 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -83.75 -25.91 30.14 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 177.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -94.27 -33.09 13.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.842 0.353 . . . . 0.0 111.069 -175.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.705 HD13 ' CE3' ' A' ' 267' ' ' TRP . 0.7 OUTLIER -52.15 -49.63 83.51 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.483 -179.703 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 262' ' ' PRO . . . . . 0.545 ' HD2' ' N ' ' A' ' 261' ' ' LEU . 50.6 Cg_endo -68.63 -14.18 38.85 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.486 2.124 . . . . 0.0 112.863 -178.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 60.1 mt -91.19 -6.22 53.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.476 0.655 . . . . 0.0 111.207 -179.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -106.64 149.13 38.02 Favored Pre-proline 0 C--N 1.315 -0.93 0 CA-C-N 115.346 -0.843 . . . . 0.0 112.272 -174.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -66.46 -36.92 24.77 Favored 'Trans proline' 0 CA--C 1.527 0.136 0 C-N-CA 123.429 2.753 . . . . 0.0 112.919 -171.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -86.07 -44.28 12.41 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-O 121.579 0.704 . . . . 0.0 109.935 -178.27 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 267' ' ' TRP . . . . . 0.705 ' CE3' HD13 ' A' ' 261' ' ' LEU . 15.9 m0 -74.54 -27.97 60.75 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.873 -174.503 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 33.1 t -67.8 -18.11 64.74 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.889 0.376 . . . . 0.0 110.679 176.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -71.34 -19.3 62.32 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.394 0.616 . . . . 0.0 109.571 175.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 270' ' ' ARG . . . . . 0.533 ' HA ' ' HB3' ' A' ' 212' ' ' ASN . 5.0 mpt_? -95.09 156.11 16.45 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.537 177.484 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . 0.405 ' HA ' ' NE ' ' A' ' 271' ' ' ARG . 4.9 mmp_? -105.48 106.3 16.74 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 172.452 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . 0.597 HG21 HD22 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -115.62 138.42 46.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.401 0.619 . . . . 0.0 111.155 -175.407 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -151.6 169.11 22.92 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.857 174.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 274' ' ' TYR . . . . . 0.713 ' HH ' ' HA ' ' A' ' 255' ' ' ILE . 77.8 m-85 -65.21 126.95 29.74 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.862 0.363 . . . . 0.0 110.496 175.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -72.65 148.05 41.21 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 177.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 276' ' ' ARG . 10.2 ptt180 -72.12 111.31 7.23 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.709 0.766 . . . . 0.0 111.311 -178.566 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 277' ' ' ASP . . . . . 0.493 ' O ' ' HB2' ' A' ' 278' ' ' ARG . 24.3 t70 175.59 147.22 0.09 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 113.874 -1.512 . . . . 0.0 108.123 -178.131 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 278' ' ' ARG . . . . . 0.493 ' HB2' ' O ' ' A' ' 277' ' ' ASP . 23.4 mmm180 66.64 4.5 3.4 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 121.476 0.655 . . . . 0.0 109.786 -168.041 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 279' ' ' CYS . . . . . 0.457 ' H ' ' C ' ' A' ' 277' ' ' ASP . 58.2 m -84.86 -11.48 55.56 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.235 175.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -123.0 127.53 48.94 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 114.485 -1.234 . . . . 0.0 108.708 177.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 27.2 m -68.48 -22.7 27.35 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.408 -178.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 176.94 79.24 0.05 OUTLIER Glycine 0 N--CA 1.434 -1.48 0 C-N-CA 120.413 -0.899 . . . . 0.0 112.345 -178.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 30.9 tp -135.91 101.65 4.81 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.051 0.453 . . . . 0.0 110.652 179.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . 0.425 ' N ' ' HD3' ' A' ' 284' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.972 0 CA-C-O 118.446 -0.787 . . . . 0.0 109.91 178.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 46.1 t30 . . . . . 0 N--CA 1.479 1.007 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 20.7 m -74.1 -42.88 59.43 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.793 0.33 . . . . 0.0 110.602 -178.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -98.11 83.71 3.15 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.985 0.422 . . . . 0.0 110.13 178.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 24.6 m -76.74 -53.59 7.76 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.808 -179.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -156.73 128.54 7.22 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.58 177.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.8 p -103.64 116.89 33.18 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.324 176.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 33.5 t 67.45 -81.4 0.03 OUTLIER 'General case' 0 C--O 1.232 0.174 0 O-C-N 123.606 0.566 . . . . 0.0 109.895 -173.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -134.25 135.43 54.36 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.196 175.393 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . 0.449 ' O ' HG21 ' A' ' 199' ' ' VAL . 6.6 tt -61.84 96.03 0.06 Allowed 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 178.323 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 94.7 mt 54.78 19.94 2.79 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.427 -0.806 . . . . 0.0 112.318 179.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . 53.37 31.61 12.28 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.113 -0.494 . . . . 0.0 112.17 -179.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.449 HG21 ' O ' ' A' ' 196' ' ' LEU . 30.4 m -81.51 -7.36 10.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.04 0.448 . . . . 0.0 111.197 -179.033 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -117.69 93.17 4.05 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.713 179.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -129.69 -77.31 0.55 Allowed 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.234 178.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' SER . . . . . 0.636 ' HA ' HD12 ' A' ' 251' ' ' ILE . 17.5 m -77.32 -8.36 57.53 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.873 -178.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -68.89 -13.51 66.52 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 121.081 -0.581 . . . . 0.0 112.206 178.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . 0.44 ' HB3' ' HB3' ' A' ' 274' ' ' TYR . . . -142.41 98.33 3.29 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.994 0.426 . . . . 0.0 111.075 177.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' CYS . . . . . 0.793 ' HB3' HG12 ' A' ' 251' ' ' ILE . 14.3 p -96.57 147.41 23.89 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 175.358 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . 0.773 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 31.2 mtm180 57.53 2.66 0.15 Allowed 'General case' 0 C--O 1.223 -0.312 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -177.228 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . 0.403 ' HB2' ' HB2' ' A' ' 204' ' ' ALA . 6.3 m-20 -105.51 104.95 14.78 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.156 0.503 . . . . 0.0 111.472 -172.118 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.429 ' HB ' ' HB ' ' A' ' 246' ' ' VAL . 58.8 t -134.63 117.43 23.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.33 177.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' PHE . . . . . 0.4 ' HE1' ' HB ' ' A' ' 243' ' ' ILE . 3.1 t80 -114.46 123.97 50.75 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 120.951 0.405 . . . . 0.0 110.463 -177.024 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.534 ' HG ' HG22 ' A' ' 272' ' ' ILE . 6.1 mp -107.86 135.21 49.65 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.172 176.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . 0.536 ' HA2' HG22 ' A' ' 243' ' ' ILE . . . -142.9 61.74 0.52 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.229 -0.986 . . . . 0.0 113.249 179.247 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 37.7 t30 179.03 41.94 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.928 0.394 . . . . 0.0 110.253 178.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.462 HD12 ' O ' ' A' ' 242' ' ' ASN . 1.1 mp -92.51 159.93 35.72 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.392 -179.304 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.436 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 91.6 Cg_endo -79.63 162.84 24.34 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.541 2.161 . . . . 0.0 111.739 176.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -77.41 119.92 21.69 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.541 179.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 109.72 0.52 30.58 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.473 -0.87 . . . . 0.0 112.615 -177.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . 0.591 HG21 HG21 ' A' ' 237' ' ' ILE . 5.5 tp -64.49 129.01 27.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.863 0.364 . . . . 0.0 110.163 175.174 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' THR . . . . . 0.443 ' CG2' ' HG3' ' A' ' 221' ' ' GLU . 15.1 t -113.66 154.27 27.52 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 121.523 0.678 . . . . 0.0 110.917 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -62.78 -33.56 75.44 Favored 'General case' 0 C--O 1.206 -1.193 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.934 -178.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' ASP . . . . . 0.431 ' O ' ' HG2' ' A' ' 224' ' ' GLU . 15.7 t70 -49.48 -38.89 31.64 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.021 0.439 . . . . 0.0 110.811 176.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . 0.443 ' HG3' ' CG2' ' A' ' 218' ' ' THR . 42.1 mt-10 -70.77 -58.09 3.98 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.314 179.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . 0.46 HD12 HD13 ' A' ' 237' ' ' ILE . 8.6 mt -58.5 -41.79 82.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.815 -178.446 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . 0.652 ' CG ' HD11 ' A' ' 235' ' ' ILE . 49.4 mtp180 -57.61 -62.24 1.93 Allowed 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 177.585 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.431 ' HG2' ' O ' ' A' ' 220' ' ' ASP . 6.4 pt-20 -57.57 -24.23 55.07 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.731 -178.51 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -86.79 -31.42 20.9 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.854 -176.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.701 HD23 ' HZ ' ' A' ' 248' ' ' PHE . 8.0 mp -105.39 -20.21 13.56 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 120.609 -0.436 . . . . 0.0 112.167 -171.401 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . 0.662 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 36.6 mt-10 -68.99 -27.71 1.41 Allowed Pre-proline 0 C--N 1.325 -0.492 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -176.314 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . 0.662 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 71.5 Cg_endo -66.72 -28.77 43.66 Favored 'Trans proline' 0 C--N 1.359 1.081 0 C-N-CA 121.254 1.302 . . . . 0.0 112.07 -178.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . 0.502 ' CE1' ' HA ' ' A' ' 226' ' ' LEU . 3.9 p90 -111.15 4.13 19.06 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-O 120.69 0.281 . . . . 0.0 111.353 173.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . 0.499 ' CA ' ' HB2' ' A' ' 253' ' ' ALA . . . 177.25 98.9 0.11 Allowed Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 119.837 -1.173 . . . . 0.0 112.748 -177.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . 0.522 ' HA ' ' HG2' ' A' ' 227' ' ' GLU . 22.7 Cg_endo -63.38 134.29 44.32 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 121.904 1.736 . . . . 0.0 111.34 177.213 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.755 HG21 HG13 ' A' ' 246' ' ' VAL . 3.2 mp -107.7 151.06 9.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.642 178.208 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . 0.48 ' CG ' HD22 ' A' ' 249' ' ' LEU . 9.9 m-20 -106.84 -25.33 11.73 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.05 0.452 . . . . 0.0 110.319 178.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . 0.402 ' HB3' ' HB2' ' A' ' 247' ' ' HIS . 30.8 tt0 -145.15 122.85 11.84 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.862 -175.057 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . 0.652 HD11 ' CG ' ' A' ' 223' ' ' ARG . 13.5 mt -136.13 109.35 8.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.909 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -119.21 120.42 37.01 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.475 -178.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 237' ' ' ILE . . . . . 0.591 HG21 HG21 ' A' ' 217' ' ' ILE . 64.7 mt -106.19 117.46 51.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.596 179.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.566 ' HB ' HG13 ' A' ' 243' ' ' ILE . 42.4 t -97.7 86.52 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 173.327 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 3.8 t -64.44 -23.15 67.19 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.291 -177.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -59.48 -36.08 75.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.073 0.463 . . . . 0.0 110.396 176.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . 0.641 ' HB2' HG12 ' A' ' 243' ' ' ILE . 74.6 mtt180 -113.91 3.37 15.39 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.632 -176.425 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 242' ' ' ASN . . . . . 0.462 ' O ' HD12 ' A' ' 213' ' ' LEU . 14.1 m120 66.42 27.36 9.92 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.996 176.502 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.641 HG12 ' HB2' ' A' ' 241' ' ' ARG . 1.5 pt -122.28 153.25 26.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.088 -174.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . 0.418 ' HB3' ' HB2' ' A' ' 210' ' ' LEU . . . -143.78 140.45 29.92 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.012 0.434 . . . . 0.0 111.083 -179.11 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -110.57 117.89 34.75 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.788 178.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . 0.755 HG13 HG21 ' A' ' 232' ' ' ILE . 0.6 OUTLIER -113.41 129.25 69.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -179.594 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 247' ' ' HIS . . . . . 0.773 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 48.2 m170 -109.33 101.9 10.85 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.064 -0.654 . . . . 0.0 111.414 178.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . 0.701 ' HZ ' HD23 ' A' ' 226' ' ' LEU . 41.5 m-85 -87.14 100.88 12.98 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.18 178.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.48 HD22 ' CG ' ' A' ' 233' ' ' ASP . 0.1 OUTLIER -43.86 -45.77 7.64 Favored 'General case' 0 N--CA 1.463 0.217 0 O-C-N 124.464 1.102 . . . . 0.0 112.62 -176.174 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . 0.419 ' HB2' ' HB1' ' A' ' 253' ' ' ALA . 13.4 m120 -86.35 136.88 32.97 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 177.313 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . 0.793 HG12 ' HB3' ' A' ' 205' ' ' CYS . 0.2 OUTLIER -60.76 -43.17 94.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.272 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -69.23 -30.74 68.96 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.027 -177.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . 0.499 ' HB2' ' CA ' ' A' ' 230' ' ' GLY . . . -61.69 -39.98 93.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.384 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . 0.533 ' HB1' ' HB2' ' A' ' 248' ' ' PHE . . . -69.14 -41.91 76.7 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.59 178.678 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.58 HG13 ' O ' ' A' ' 251' ' ' ILE . 11.7 mt -55.89 -60.91 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.054 -177.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 13.7 ptmt -62.17 -38.12 87.85 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.607 -176.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -64.7 -48.63 73.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.587 0.232 . . . . 0.0 111.422 178.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 43.0 t -65.96 -23.27 31.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 120.865 0.365 . . . . 0.0 110.96 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . 0.553 ' HA ' ' OE1' ' A' ' 259' ' ' GLN . 9.9 mm-40 -84.83 -25.81 27.86 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 176.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 48.9 mm-40 -89.5 -36.44 15.39 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-O 120.791 0.329 . . . . 0.0 111.026 -177.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.734 HD13 ' CE3' ' A' ' 267' ' ' TRP . 0.8 OUTLIER -51.71 -48.3 87.69 Favored Pre-proline 0 CA--C 1.54 0.568 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.656 -178.808 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 262' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 261' ' ' LEU . 55.9 Cg_endo -69.67 -16.53 37.99 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.5 2.133 . . . . 0.0 112.926 -179.229 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 66.2 mt -92.8 -3.62 54.39 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.344 0.592 . . . . 0.0 111.162 -177.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -106.14 149.95 38.76 Favored Pre-proline 0 C--N 1.313 -1.002 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.376 -176.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -65.56 -41.47 15.02 Favored 'Trans proline' 0 C--N 1.34 0.124 0 C-N-CA 123.284 2.656 . . . . 0.0 112.774 -168.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 16.0 mtpt -86.89 -44.67 11.49 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.198 0.523 . . . . 0.0 109.799 -175.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 267' ' ' TRP . . . . . 0.734 ' CE3' HD13 ' A' ' 261' ' ' LEU . 24.4 m0 -67.81 -33.51 74.93 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.802 -176.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 29.1 t -63.94 -24.29 67.67 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.99 0.424 . . . . 0.0 111.014 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -71.78 -16.44 62.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.188 0.518 . . . . 0.0 110.134 177.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 270' ' ' ARG . . . . . 0.417 ' HB3' HD23 ' A' ' 210' ' ' LEU . 5.2 mpt_? -93.99 144.88 25.07 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 173.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . 0.476 ' O ' ' HA ' ' A' ' 210' ' ' LEU . 5.0 mmp_? -94.2 105.76 17.75 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 177.05 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . 0.6 HG23 HD22 ' A' ' 261' ' ' LEU . 0.1 OUTLIER -116.93 136.56 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 CA-C-O 121.634 0.73 . . . . 0.0 111.24 -177.665 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -152.07 167.99 26.68 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.826 173.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 274' ' ' TYR . . . . . 0.586 ' O ' ' HD3' ' A' ' 276' ' ' ARG . 90.9 m-85 -63.54 134.46 55.6 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.244 173.002 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -77.85 101.97 1.73 Allowed Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.274 -0.965 . . . . 0.0 111.704 177.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . 0.586 ' HD3' ' O ' ' A' ' 274' ' ' TYR . 0.0 OUTLIER -92.25 111.25 22.74 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.515 0.674 . . . . 0.0 110.514 -178.63 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 277' ' ' ASP . . . . . 0.623 ' C ' ' H ' ' A' ' 279' ' ' CYS . 18.9 t70 -144.47 125.31 14.29 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.505 -178.036 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 278' ' ' ARG . . . . . . . . . . . . . 57.5 mtm180 56.29 -7.82 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 O-C-N 124.382 1.051 . . . . 0.0 112.896 -173.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 279' ' ' CYS . . . . . 0.623 ' H ' ' C ' ' A' ' 277' ' ' ASP . 20.0 p -95.94 -9.33 31.5 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.322 0.582 . . . . 0.0 110.231 176.375 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -91.93 94.06 9.11 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.13 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 3.4 p -89.58 82.91 2.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 122.222 1.01 . . . . 0.0 110.3 -179.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -165.73 -116.33 0.36 Allowed Glycine 0 N--CA 1.449 -0.465 0 CA-C-N 114.588 -1.187 . . . . 0.0 111.407 178.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 283' ' ' LEU . . . . . 0.405 HD11 ' HA ' ' A' ' 283' ' ' LEU . 4.0 mm? -87.73 98.52 11.49 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 175.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . 0.798 ' HE2' ' HA ' ' A' ' 284' ' ' LYS . 0.4 OUTLIER . . . . . 0 C--O 1.244 0.806 0 CA-C-O 118.567 -0.73 . . . . 0.0 110.159 -176.342 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 206' ' ' ARG . . . . . 0.821 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 45.2 mtm180 . . . . . 0 C--O 1.222 -0.381 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -103.23 105.17 15.4 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 118.984 0.811 . . . . 0.0 111.759 -170.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.455 ' HB ' ' HB ' ' A' ' 246' ' ' VAL . 61.3 t -138.31 126.76 30.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.571 179.219 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 209' ' ' PHE . . . . . 0.575 ' O ' ' HA ' ' A' ' 272' ' ' ILE . 17.9 t80 -117.31 131.73 56.75 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.659 178.345 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.685 ' HG ' HG22 ' A' ' 272' ' ' ILE . 2.5 mp -112.85 115.18 28.06 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.46 175.179 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 211' ' ' GLY . . . . . 0.652 ' HA2' HG22 ' A' ' 243' ' ' ILE . . . -124.59 67.18 0.52 Allowed Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.664 -0.779 . . . . 0.0 113.227 -177.632 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 212' ' ' ASN . . . . . 0.61 ' HB2' ' HG3' ' A' ' 271' ' ' ARG . 2.5 t30 168.93 51.29 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.124 0.57 . . . . 0.0 110.039 172.139 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.503 HD21 HD22 ' A' ' 210' ' ' LEU . 1.0 OUTLIER -92.38 162.75 29.04 Favored Pre-proline 0 C--N 1.313 -0.983 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.108 -179.972 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.438 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 71.9 Cg_endo -79.66 156.09 24.37 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 122.109 1.872 . . . . 0.0 111.333 174.097 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 39.6 t-20 -70.61 128.01 34.63 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 178.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 106.07 -7.04 40.6 Favored Glycine 0 C--N 1.315 -0.606 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.88 -178.359 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 217' ' ' ILE . . . . . 0.624 HG23 HG21 ' A' ' 237' ' ' ILE . 5.2 tp -59.83 126.71 18.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.124 0.488 . . . . 0.0 110.649 178.36 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 218' ' ' THR . . . . . 0.547 HG22 ' HG3' ' A' ' 221' ' ' GLU . 6.9 t -112.43 154.87 25.16 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-O 121.251 0.548 . . . . 0.0 110.581 -179.088 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.458 ' H ' ' CD ' ' A' ' 219' ' ' GLU . 1.6 mp0 -58.88 -40.86 85.64 Favored 'General case' 0 C--O 1.21 -0.979 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.867 -176.285 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -50.74 -36.81 38.32 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 123.727 0.642 . . . . 0.0 111.262 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 221' ' ' GLU . . . . . 0.547 ' HG3' HG22 ' A' ' 218' ' ' THR . 42.2 mt-10 -68.47 -53.98 19.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.599 179.196 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 222' ' ' ILE . . . . . 0.589 HD12 HD11 ' A' ' 237' ' ' ILE . 7.2 mt -61.96 -40.86 88.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.429 179.186 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 223' ' ' ARG . . . . . 0.776 ' HG3' HD12 ' A' ' 235' ' ' ILE . 61.7 mtp180 -53.99 -62.07 1.89 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.976 0.417 . . . . 0.0 111.955 174.663 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -59.03 -22.76 61.2 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.27 -178.034 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -89.07 -31.3 18.1 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.864 -177.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.832 HD23 ' HZ ' ' A' ' 248' ' ' PHE . 8.6 mp -106.56 -19.54 13.64 Favored 'General case' 0 C--O 1.223 -0.298 0 N-CA-C 112.257 0.465 . . . . 0.0 112.257 -170.458 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 227' ' ' GLU . . . . . 0.683 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 38.7 mt-10 -70.82 -26.35 0.95 Allowed Pre-proline 0 C--N 1.323 -0.556 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -175.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 228' ' ' PRO . . . . . 0.683 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 74.1 Cg_endo -65.33 -25.86 56.43 Favored 'Trans proline' 0 C--N 1.36 1.139 0 C-N-CA 121.202 1.268 . . . . 0.0 111.908 -178.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 229' ' ' PHE . . . . . 0.483 ' CE1' ' HA ' ' A' ' 226' ' ' LEU . 2.7 p90 -111.01 -17.37 13.29 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.726 173.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . -162.33 93.49 0.12 Allowed Glycine 0 N--CA 1.442 -0.949 0 C-N-CA 120.397 -0.906 . . . . 0.0 111.897 -173.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 231' ' ' PRO . . . . . 0.542 ' HA ' ' HG2' ' A' ' 227' ' ' GLU . 17.5 Cg_endo -60.93 136.6 66.88 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.136 1.891 . . . . 0.0 111.677 178.769 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.76 HG21 HG12 ' A' ' 246' ' ' VAL . 2.8 mp -113.07 148.81 15.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.867 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 233' ' ' ASP . . . . . 0.429 ' CG ' HD22 ' A' ' 249' ' ' LEU . 11.5 m-20 -109.9 -20.2 12.84 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 120.894 0.378 . . . . 0.0 110.964 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 234' ' ' GLN . . . . . 0.564 ' HB3' ' HB2' ' A' ' 247' ' ' HIS . 31.3 tt0 -143.39 121.78 12.37 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.58 -176.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 235' ' ' ILE . . . . . 0.776 HD12 ' HG3' ' A' ' 223' ' ' ARG . 14.2 mt -137.7 107.48 4.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.601 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 54.7 tttp -113.33 112.53 23.84 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.442 -178.261 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 237' ' ' ILE . . . . . 0.624 HG21 HG23 ' A' ' 217' ' ' ILE . 86.3 mt -103.2 121.72 54.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.902 -178.486 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.578 ' HB ' HG13 ' A' ' 243' ' ' ILE . 41.5 t -101.84 86.71 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 170.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 13.8 t -64.87 -22.22 66.95 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.792 -176.168 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -62.82 -30.92 71.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.534 177.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 241' ' ' ARG . . . . . 0.615 ' HB2' HG12 ' A' ' 243' ' ' ILE . 83.2 mtt180 -117.45 3.75 12.48 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.732 -176.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 16.8 m120 67.14 27.24 8.6 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.086 175.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.652 HG22 ' HA2' ' A' ' 211' ' ' GLY . 1.4 pt -122.73 151.54 26.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.526 -175.026 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 244' ' ' ALA . . . . . 0.468 ' HB3' ' HB2' ' A' ' 210' ' ' LEU . . . -143.7 138.04 28.59 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.227 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -108.52 117.54 34.43 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.478 178.14 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 246' ' ' VAL . . . . . 0.76 HG12 HG21 ' A' ' 232' ' ' ILE . 0.4 OUTLIER -113.94 138.47 43.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -176.209 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 247' ' ' HIS . . . . . 0.821 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 55.1 m170 -118.39 102.95 9.33 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.337 0.589 . . . . 0.0 111.147 175.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 248' ' ' PHE . . . . . 0.832 ' HZ ' HD23 ' A' ' 226' ' ' LEU . 33.6 m-85 -85.5 105.38 16.06 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.215 178.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.506 HD23 ' H ' ' A' ' 249' ' ' LEU . 0.1 OUTLIER -44.15 -45.34 8.22 Favored 'General case' 0 N--CA 1.467 0.398 0 O-C-N 124.389 1.056 . . . . 0.0 113.108 -173.474 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -95.86 142.89 27.57 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.401 -0.52 . . . . 0.0 110.209 177.557 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 251' ' ' ILE . . . . . 0.608 ' O ' HG13 ' A' ' 255' ' ' ILE . 0.2 OUTLIER -61.2 -42.5 93.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 -178.045 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -70.7 -28.38 64.7 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.001 -176.498 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -61.32 -41.48 97.08 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.146 178.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 254' ' ' ALA . . . . . 0.574 ' HB2' ' HB2' ' A' ' 248' ' ' PHE . . . -68.51 -41.45 79.94 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.67 178.22 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.615 ' HA ' ' OH ' ' A' ' 274' ' ' TYR . 11.4 mt -56.41 -59.89 2.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.402 -177.448 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 256' ' ' LYS . . . . . 0.49 ' O ' ' HG2' ' A' ' 260' ' ' GLU . 12.2 ptmt -61.63 -40.47 95.0 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.254 -177.655 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -63.3 -48.86 76.3 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 111.686 0.254 . . . . 0.0 111.686 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 258' ' ' VAL . . . . . 0.409 HG13 HG12 ' A' ' 272' ' ' ILE . 50.5 t -66.45 -24.0 32.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.957 0.408 . . . . 0.0 111.114 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 19.3 mm-40 -83.8 -24.82 30.86 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 177.036 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 260' ' ' GLU . . . . . 0.49 ' HG2' ' O ' ' A' ' 256' ' ' LYS . 27.5 mm-40 -95.17 -31.43 13.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.611 0.243 . . . . 0.0 111.273 -176.296 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.818 ' HA ' ' HE3' ' A' ' 267' ' ' TRP . 0.7 OUTLIER -52.17 -50.92 76.3 Favored Pre-proline 0 CA--C 1.537 0.471 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.255 179.362 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 262' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' A' ' 261' ' ' LEU . 42.0 Cg_endo -67.47 -17.87 49.02 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.441 2.094 . . . . 0.0 112.97 -178.471 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 59.0 mt -91.57 -5.58 53.78 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.068 0.461 . . . . 0.0 111.561 -177.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 264' ' ' ASN . . . . . 0.434 ' O ' ' HB2' ' A' ' 268' ' ' SER . 13.7 m-80 -105.34 145.89 31.68 Favored Pre-proline 0 C--N 1.313 -1.017 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.712 -175.783 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 265' ' ' PRO . . . . . 0.403 ' O ' ' HE3' ' A' ' 269' ' ' LYS . 51.9 Cg_endo -68.18 -26.65 36.03 Favored 'Trans proline' 0 C--N 1.334 -0.229 0 C-N-CA 123.332 2.688 . . . . 0.0 112.583 -170.491 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 266' ' ' LYS . . . . . 0.463 ' HE3' ' NE1' ' A' ' 267' ' ' TRP . 0.0 OUTLIER -86.17 -46.3 10.53 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.958 0.885 . . . . 0.0 109.25 -178.837 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 267' ' ' TRP . . . . . 0.818 ' HE3' ' HA ' ' A' ' 261' ' ' LEU . 8.0 m0 -82.52 -24.12 34.25 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.478 -1.237 . . . . 0.0 110.6 -172.474 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 268' ' ' SER . . . . . 0.434 ' HB2' ' O ' ' A' ' 264' ' ' ASN . 22.4 t -65.58 -18.01 65.0 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.034 0.445 . . . . 0.0 110.581 176.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 269' ' ' LYS . . . . . 0.403 ' HE3' ' O ' ' A' ' 265' ' ' PRO . 94.3 mttt -73.65 -13.75 61.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.316 0.579 . . . . 0.0 109.879 176.734 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 270' ' ' ARG . . . . . 0.529 ' HA ' ' HB3' ' A' ' 212' ' ' ASN . 0.0 OUTLIER -109.95 147.4 33.51 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.742 -179.705 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 271' ' ' ARG . . . . . 0.61 ' HG3' ' HB2' ' A' ' 212' ' ' ASN . 40.6 mtm180 -98.06 106.15 18.4 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.106 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 272' ' ' ILE . . . . . 0.721 HG21 HD23 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -116.61 143.33 27.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.147 -177.451 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 273' ' ' TYR . . . . . 0.413 ' CZ ' ' HD2' ' A' ' 209' ' ' PHE . 1.5 p90 -150.57 167.75 26.32 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.4 172.541 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 274' ' ' TYR . . . . . 0.615 ' OH ' ' HA ' ' A' ' 255' ' ' ILE . 74.2 m-85 . . . . . 0 N--CA 1.449 -0.524 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.948 172.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 206' ' ' ARG . . . . . 0.832 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 7.7 mtp180 . . . . . 0 C--O 1.219 -0.549 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 70.5 m-20 -106.6 105.8 16.01 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 118.953 0.797 . . . . 0.0 111.9 -172.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.487 ' HB ' ' HB ' ' A' ' 246' ' ' VAL . 59.4 t -135.4 118.19 22.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.041 177.521 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 209' ' ' PHE . . . . . 0.44 ' HE1' ' HB ' ' A' ' 243' ' ' ILE . 2.3 t80 -116.92 125.13 51.01 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.263 -176.693 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.579 ' HG ' HG22 ' A' ' 272' ' ' ILE . 5.6 mp -107.65 132.19 53.58 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.265 178.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 211' ' ' GLY . . . . . 0.624 ' HA2' HG22 ' A' ' 243' ' ' ILE . . . -137.64 62.09 0.58 Allowed Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.309 -0.948 . . . . 0.0 113.326 -179.304 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 212' ' ' ASN . . . . . 0.579 ' HB2' ' HG2' ' A' ' 271' ' ' ARG . 38.8 t30 177.64 38.38 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.775 0.321 . . . . 0.0 110.598 175.292 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.531 HD21 HD22 ' A' ' 210' ' ' LEU . 1.0 OUTLIER -87.26 158.82 51.8 Favored Pre-proline 0 C--N 1.319 -0.74 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 178.828 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.409 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 83.8 Cg_endo -78.42 161.47 28.47 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.403 2.068 . . . . 0.0 110.994 176.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 215' ' ' ASN . . . . . 0.59 ' HA ' ' OG1' ' A' ' 239' ' ' THR . 9.1 t-20 -78.41 127.46 32.22 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -179.32 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 108.21 -6.27 34.33 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.485 -176.494 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 217' ' ' ILE . . . . . 0.639 HG23 HG21 ' A' ' 237' ' ' ILE . 4.5 tp -61.57 129.41 24.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.884 0.373 . . . . 0.0 110.309 177.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 218' ' ' THR . . . . . 0.475 ' CG2' ' HG3' ' A' ' 221' ' ' GLU . 15.2 t -112.83 155.9 23.84 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.4 0.619 . . . . 0.0 110.605 -179.414 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.494 ' H ' ' CD ' ' A' ' 219' ' ' GLU . 8.0 mp0 -63.95 -34.77 78.73 Favored 'General case' 0 C--O 1.206 -1.211 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.936 -176.222 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -54.69 -35.67 63.84 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 123.335 0.397 . . . . 0.0 110.591 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 221' ' ' GLU . . . . . 0.535 ' O ' ' HG2' ' A' ' 224' ' ' GLU . 46.1 mt-10 -67.03 -58.64 4.54 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.276 177.748 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 222' ' ' ILE . . . . . 0.654 HD12 HD11 ' A' ' 237' ' ' ILE . 7.8 mt -61.24 -38.48 79.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.63 -178.068 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 223' ' ' ARG . . . . . 0.725 ' HG3' HD12 ' A' ' 235' ' ' ILE . 51.2 mtp180 -54.17 -63.14 1.25 Allowed 'General case' 0 CA--C 1.508 -0.645 0 CA-C-O 121.125 0.488 . . . . 0.0 111.693 174.358 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.535 ' HG2' ' O ' ' A' ' 221' ' ' GLU . 17.7 pt-20 -60.48 -17.38 44.69 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.03 -177.712 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 225' ' ' ASP . . . . . 0.501 ' HB3' ' CZ2' ' A' ' 267' ' ' TRP . 13.7 m-20 -89.23 -33.76 16.87 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.371 -179.326 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.71 HD23 ' HZ ' ' A' ' 248' ' ' PHE . 7.7 mp -106.98 -11.48 15.67 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 111.979 0.362 . . . . 0.0 111.979 -171.277 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 227' ' ' GLU . . . . . 0.641 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 53.3 mm-40 -62.97 -36.0 22.19 Favored Pre-proline 0 C--N 1.325 -0.468 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -178.441 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 228' ' ' PRO . . . . . 0.641 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 85.7 Cg_endo -66.21 -31.1 45.31 Favored 'Trans proline' 0 C--N 1.358 1.071 0 C-N-CA 121.43 1.42 . . . . 0.0 112.163 -173.351 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 229' ' ' PHE . . . . . 0.508 ' CZ ' ' HA ' ' A' ' 226' ' ' LEU . 4.0 p90 -110.21 -0.73 17.7 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.628 177.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 230' ' ' GLY . . . . . 0.429 ' HA2' ' HD2' ' A' ' 231' ' ' PRO . . . -177.21 94.61 0.1 OUTLIER Glycine 0 N--CA 1.441 -1.002 0 C-N-CA 119.658 -1.258 . . . . 0.0 112.64 -178.095 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 231' ' ' PRO . . . . . 0.429 ' HD2' ' HA2' ' A' ' 230' ' ' GLY . 17.1 Cg_endo -59.53 131.54 40.98 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 121.877 1.718 . . . . 0.0 111.246 175.748 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.64 HG21 HG12 ' A' ' 246' ' ' VAL . 2.7 mp -106.86 151.9 8.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.423 178.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 233' ' ' ASP . . . . . 0.527 ' CG ' HD22 ' A' ' 249' ' ' LEU . 34.2 m-20 -109.93 -23.62 11.25 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.786 0.326 . . . . 0.0 110.223 179.062 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 234' ' ' GLN . . . . . 0.459 ' H ' HG22 ' A' ' 232' ' ' ILE . 13.7 tt0 -143.43 126.83 16.77 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.843 -177.64 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 235' ' ' ILE . . . . . 0.725 HD12 ' HG3' ' A' ' 223' ' ' ARG . 15.6 mt -139.52 113.49 6.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.903 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -121.12 116.67 25.43 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.33 -178.644 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 237' ' ' ILE . . . . . 0.654 HD11 HD12 ' A' ' 222' ' ' ILE . 86.7 mt -104.76 126.01 59.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.434 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.578 ' HB ' HG13 ' A' ' 243' ' ' ILE . 42.1 t -103.8 85.51 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.046 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 169.681 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 239' ' ' THR . . . . . 0.59 ' OG1' ' HA ' ' A' ' 215' ' ' ASN . 11.7 t -71.04 -16.56 62.61 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.637 -173.324 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -65.36 -33.0 74.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.117 174.258 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 241' ' ' ARG . . . . . 0.545 ' HB2' HG12 ' A' ' 243' ' ' ILE . 71.1 mtt180 -110.74 3.18 18.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.085 -178.063 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 242' ' ' ASN . . . . . 0.456 ' O ' HD12 ' A' ' 213' ' ' LEU . 89.4 m-20 68.35 23.7 7.55 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.108 177.192 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.624 HG22 ' HA2' ' A' ' 211' ' ' GLY . 1.5 pt -122.43 150.65 26.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.466 -174.282 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 244' ' ' ALA . . . . . 0.449 ' HB3' ' HB2' ' A' ' 210' ' ' LEU . . . -143.19 139.47 30.32 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.053 0.454 . . . . 0.0 111.668 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -109.3 115.78 30.63 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.765 178.093 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 246' ' ' VAL . . . . . 0.64 HG12 HG21 ' A' ' 232' ' ' ILE . 1.3 t -112.3 134.89 53.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -179.129 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 247' ' ' HIS . . . . . 0.832 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 33.5 m170 -112.98 101.7 9.72 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.016 -0.674 . . . . 0.0 111.309 177.378 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 248' ' ' PHE . . . . . 0.71 ' HZ ' HD23 ' A' ' 226' ' ' LEU . 34.5 m-85 -86.28 104.25 15.63 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-N 115.089 -0.96 . . . . 0.0 111.651 179.445 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.527 HD22 ' CG ' ' A' ' 233' ' ' ASP . 0.0 OUTLIER -42.85 -48.17 5.71 Favored 'General case' 0 N--CA 1.465 0.306 0 O-C-N 124.506 1.129 . . . . 0.0 112.975 -175.192 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -93.37 141.4 28.49 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.112 176.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 251' ' ' ILE . . . . . 0.642 ' O ' HG13 ' A' ' 255' ' ' ILE . 0.3 OUTLIER -61.71 -39.94 85.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.027 -178.549 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -68.64 -31.72 71.07 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.995 -176.303 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 253' ' ' ALA . . . . . 0.423 ' HB1' ' CA ' ' A' ' 230' ' ' GLY . . . -61.68 -41.81 98.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.298 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 254' ' ' ALA . . . . . 0.56 ' HB2' ' HB2' ' A' ' 248' ' ' PHE . . . -67.17 -41.72 85.47 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.409 178.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.642 HG13 ' O ' ' A' ' 251' ' ' ILE . 10.6 mt -57.37 -59.45 3.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.065 -178.385 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 256' ' ' LYS . . . . . 0.421 ' O ' ' HG2' ' A' ' 260' ' ' GLU . 13.9 ptmt -62.27 -40.33 95.86 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.305 -177.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -61.55 -48.93 78.74 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.668 0.271 . . . . 0.0 111.184 178.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 258' ' ' VAL . . . . . 0.514 HG13 HG12 ' A' ' 272' ' ' ILE . 53.5 t -65.86 -26.33 38.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.907 0.384 . . . . 0.0 111.107 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 28.7 mm-40 -84.94 -24.61 28.31 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 178.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 260' ' ' GLU . . . . . 0.421 ' HG2' ' O ' ' A' ' 256' ' ' LYS . 71.9 mm-40 -95.3 -31.42 13.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.595 0.236 . . . . 0.0 111.026 -176.408 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.707 HD12 ' CE3' ' A' ' 267' ' ' TRP . 0.4 OUTLIER -50.91 -51.04 70.78 Favored Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.266 178.727 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 262' ' ' PRO . . . . . 0.566 ' HD2' ' N ' ' A' ' 261' ' ' LEU . 43.3 Cg_endo -67.42 -14.62 43.16 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.465 2.11 . . . . 0.0 112.698 -177.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 52.6 mt -92.43 -4.69 53.34 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.175 0.512 . . . . 0.0 111.367 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 264' ' ' ASN . . . . . 0.433 ' O ' ' HB2' ' A' ' 268' ' ' SER . 10.9 m-80 -106.18 149.42 38.15 Favored Pre-proline 0 C--N 1.315 -0.929 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.998 -175.565 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -63.9 -38.58 37.74 Favored 'Trans proline' 0 N--CA 1.465 -0.171 0 C-N-CA 123.421 2.747 . . . . 0.0 112.534 -169.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 7.1 mtpt -84.62 -45.09 12.86 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 121.648 0.737 . . . . 0.0 109.376 -177.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 267' ' ' TRP . . . . . 0.707 ' CE3' HD12 ' A' ' 261' ' ' LEU . 12.9 m0 -77.37 -27.6 52.63 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.737 -1.12 . . . . 0.0 111.058 -171.078 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 268' ' ' SER . . . . . 0.451 ' HA ' ' HA ' ' A' ' 262' ' ' PRO . 12.0 t -65.47 -21.93 66.69 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.934 0.397 . . . . 0.0 110.547 178.604 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -72.7 -22.66 60.86 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.301 0.572 . . . . 0.0 110.069 177.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 270' ' ' ARG . . . . . 0.474 ' HA ' ' HB3' ' A' ' 212' ' ' ASN . 5.4 mpt_? -92.98 141.3 28.56 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 178.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 271' ' ' ARG . . . . . 0.579 ' HG2' ' HB2' ' A' ' 212' ' ' ASN . 37.5 mmt180 -93.02 105.93 17.96 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 178.376 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 272' ' ' ILE . . . . . 0.703 HG21 HD23 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -114.33 142.65 26.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.242 0.544 . . . . 0.0 111.42 -176.902 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -152.35 169.29 22.89 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.55 173.424 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 . . . . . 0 C--N 1.322 -0.592 0 CA-C-O 120.692 0.282 . . . . 0.0 110.41 173.607 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 206' ' ' ARG . . . . . 0.912 ' HE ' ' HA ' ' A' ' 249' ' ' LEU . 16.9 mtp180 . . . . . 0 C--O 1.22 -0.483 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -109.9 107.02 16.8 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-N 118.988 0.813 . . . . 0.0 112.493 -174.083 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.551 ' HB ' ' HB ' ' A' ' 246' ' ' VAL . 60.8 t -135.3 127.11 46.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 114.878 -1.055 . . . . 0.0 109.148 177.3 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 209' ' ' PHE . . . . . 0.446 ' O ' ' HA ' ' A' ' 272' ' ' ILE . 6.8 t80 -122.37 127.41 49.71 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-O 120.725 0.298 . . . . 0.0 110.307 -178.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.575 ' HG ' HG22 ' A' ' 272' ' ' ILE . 4.7 mp -109.77 126.03 53.32 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.335 176.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 211' ' ' GLY . . . . . 0.713 ' HA2' HG22 ' A' ' 243' ' ' ILE . . . -130.65 57.49 0.72 Allowed Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.265 -0.969 . . . . 0.0 113.373 -178.553 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 212' ' ' ASN . . . . . 0.498 ' HB3' ' HA ' ' A' ' 270' ' ' ARG . 2.8 t30 177.4 49.74 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.061 0.458 . . . . 0.0 110.509 177.245 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.556 HD21 HD22 ' A' ' 210' ' ' LEU . 1.0 OUTLIER -97.39 159.05 32.09 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.184 178.722 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.425 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 95.8 Cg_endo -79.85 154.46 23.09 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.326 2.017 . . . . 0.0 112.15 178.3 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 215' ' ' ASN . . . . . 0.545 ' HA ' ' OG1' ' A' ' 239' ' ' THR . 8.8 m120 -66.31 121.21 14.74 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.032 177.442 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 108.86 -1.97 31.86 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.451 -0.88 . . . . 0.0 112.876 -177.493 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 217' ' ' ILE . . . . . 0.583 HG23 HG21 ' A' ' 237' ' ' ILE . 5.7 tp -64.08 128.0 25.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.046 0.451 . . . . 0.0 110.525 175.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 218' ' ' THR . . . . . 0.55 HG22 ' HG3' ' A' ' 221' ' ' GLU . 4.9 t -114.22 157.55 22.54 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.119 0.485 . . . . 0.0 110.575 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.425 ' H ' ' CD ' ' A' ' 219' ' ' GLU . 3.3 mp0 -61.66 -40.31 94.48 Favored 'General case' 0 C--O 1.208 -1.11 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.41 -175.61 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -51.46 -35.81 41.44 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 123.514 0.509 . . . . 0.0 111.029 -179.164 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 221' ' ' GLU . . . . . 0.55 ' HG3' HG22 ' A' ' 218' ' ' THR . 43.4 mt-10 -67.65 -55.9 11.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.303 178.207 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 222' ' ' ILE . . . . . 0.572 HD12 HD11 ' A' ' 237' ' ' ILE . 8.0 mt -60.95 -41.21 88.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.537 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 223' ' ' ARG . . . . . 0.639 ' HG3' HD12 ' A' ' 235' ' ' ILE . 26.1 mtp180 -56.55 -61.81 2.16 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 175.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -57.16 -21.64 34.43 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.625 -178.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 225' ' ' ASP . . . . . 0.425 ' HB3' ' CZ2' ' A' ' 267' ' ' TRP . 12.8 m-20 -87.27 -33.98 19.07 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.746 -178.637 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.785 HD23 ' HZ ' ' A' ' 248' ' ' PHE . 7.7 mp -106.83 -18.01 14.05 Favored 'General case' 0 C--O 1.224 -0.247 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -170.008 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 227' ' ' GLU . . . . . 0.679 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 35.7 mt-10 -65.79 -31.58 4.95 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -175.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 228' ' ' PRO . . . . . 0.679 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 72.0 Cg_endo -65.94 -29.94 48.94 Favored 'Trans proline' 0 C--N 1.359 1.085 0 C-N-CA 121.459 1.439 . . . . 0.0 112.3 -176.317 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 229' ' ' PHE . . . . . 0.489 ' CE1' ' HA ' ' A' ' 226' ' ' LEU . 3.6 p90 -111.06 -4.22 15.18 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.579 176.134 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . -172.08 95.73 0.11 Allowed Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.127 -1.035 . . . . 0.0 112.478 -176.17 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -61.58 133.64 46.68 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.174 1.916 . . . . 0.0 111.43 177.521 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.698 HG21 HG12 ' A' ' 246' ' ' VAL . 2.5 mp -110.42 151.3 12.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.925 178.105 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 233' ' ' ASP . . . . . 0.462 ' OD2' HD22 ' A' ' 249' ' ' LEU . 6.7 m-20 -110.89 -25.49 9.82 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.92 177.606 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 234' ' ' GLN . . . . . 0.626 ' HB3' ' HB2' ' A' ' 247' ' ' HIS . 16.8 tt0 -138.82 120.57 15.3 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.551 -174.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 235' ' ' ILE . . . . . 0.639 HD12 ' HG3' ' A' ' 223' ' ' ARG . 11.1 mt -137.08 107.73 5.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.99 178.655 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 63.1 tttp -115.81 113.79 23.87 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.364 -177.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 237' ' ' ILE . . . . . 0.583 HG21 HG23 ' A' ' 217' ' ' ILE . 86.4 mt -102.13 125.71 56.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-O 121.134 0.492 . . . . 0.0 110.955 -179.18 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.552 ' HB ' HG13 ' A' ' 243' ' ' ILE . 57.7 t -108.81 87.31 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 171.155 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 239' ' ' THR . . . . . 0.545 ' OG1' ' HA ' ' A' ' 215' ' ' ASN . 14.4 t -68.91 -12.62 61.79 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.529 -177.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 18.6 mp0 -63.01 -35.48 80.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.986 175.097 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 241' ' ' ARG . . . . . 0.7 ' HB2' HG12 ' A' ' 243' ' ' ILE . 66.8 mtp180 -115.58 4.2 14.13 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.1 179.045 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 242' ' ' ASN . . . . . 0.446 ' O ' HD12 ' A' ' 213' ' ' LEU . 15.9 m120 65.85 30.56 9.93 Favored 'General case' 0 N--CA 1.465 0.278 0 O-C-N 123.446 0.466 . . . . 0.0 110.743 178.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.713 HG22 ' HA2' ' A' ' 211' ' ' GLY . 1.3 pt -122.06 149.72 25.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.158 -175.081 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -142.36 138.14 30.98 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.048 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -109.54 120.79 43.57 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.881 179.007 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 246' ' ' VAL . . . . . 0.698 HG12 HG21 ' A' ' 232' ' ' ILE . 0.5 OUTLIER -116.3 136.16 54.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.981 -176.385 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 247' ' ' HIS . . . . . 0.827 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 20.1 m170 -114.45 102.97 10.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.191 0.519 . . . . 0.0 111.23 175.62 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 248' ' ' PHE . . . . . 0.785 ' HZ ' HD23 ' A' ' 226' ' ' LEU . 29.7 m-85 -85.76 103.79 14.86 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.014 178.006 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.912 ' HA ' ' HE ' ' A' ' 206' ' ' ARG . 0.1 OUTLIER -44.64 -39.28 4.91 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 124.218 0.949 . . . . 0.0 113.311 -172.998 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 57.9 m-20 -100.17 144.71 28.88 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 178.132 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 251' ' ' ILE . . . . . 0.584 ' O ' HG13 ' A' ' 255' ' ' ILE . 0.3 OUTLIER -63.89 -43.3 97.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -176.618 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -68.63 -31.12 70.04 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.111 -177.458 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -58.25 -42.88 87.39 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.541 179.097 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 254' ' ' ALA . . . . . 0.596 ' HB2' ' HB2' ' A' ' 248' ' ' PHE . . . -68.52 -41.67 79.63 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.614 178.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.584 HG13 ' O ' ' A' ' 251' ' ' ILE . 8.4 mt -57.03 -58.47 5.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.456 -177.398 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 256' ' ' LYS . . . . . 0.414 ' O ' ' HG2' ' A' ' 260' ' ' GLU . 11.1 ptmt -63.81 -38.79 92.42 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.395 -177.201 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -63.19 -49.83 72.72 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.632 0.253 . . . . 0.0 111.297 178.316 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 258' ' ' VAL . . . . . 0.57 HG13 HG12 ' A' ' 272' ' ' ILE . 70.3 t -66.8 -22.9 30.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 120.883 0.373 . . . . 0.0 111.09 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 259' ' ' GLN . . . . . 0.423 ' HG3' ' O ' ' A' ' 255' ' ' ILE . 63.9 mt-30 -83.53 -24.1 31.8 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 176.166 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 260' ' ' GLU . . . . . 0.414 ' HG2' ' O ' ' A' ' 256' ' ' LYS . 42.4 mm-40 -94.75 -33.61 12.84 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.868 0.366 . . . . 0.0 110.893 -176.267 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.709 HD12 ' CE3' ' A' ' 267' ' ' TRP . 0.9 OUTLIER -51.57 -50.91 74.23 Favored Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.508 -179.777 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 262' ' ' PRO . . . . . 0.567 ' HD3' HD11 ' A' ' 272' ' ' ILE . 44.5 Cg_endo -67.5 -15.4 45.08 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.378 2.052 . . . . 0.0 112.679 -177.703 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 59.2 mt -96.66 0.55 49.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.062 0.458 . . . . 0.0 111.673 -177.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 -107.05 148.6 37.31 Favored Pre-proline 0 C--N 1.314 -0.94 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.34 -177.132 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -64.11 -35.28 54.19 Favored 'Trans proline' 0 C--O 1.23 0.092 0 C-N-CA 123.509 2.806 . . . . 0.0 112.411 -172.073 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 3.5 mtpt -86.11 -45.17 11.63 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 121.643 0.735 . . . . 0.0 109.738 -178.065 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 267' ' ' TRP . . . . . 0.709 ' CE3' HD12 ' A' ' 261' ' ' LEU . 15.4 m0 -78.03 -28.53 49.06 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 114.772 -1.104 . . . . 0.0 111.14 -172.222 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 23.0 t -68.51 -15.11 63.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.797 0.332 . . . . 0.0 110.812 178.154 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -73.76 -17.32 61.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.41 0.624 . . . . 0.0 109.631 174.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 270' ' ' ARG . . . . . 0.498 ' HA ' ' HB3' ' A' ' 212' ' ' ASN . 4.7 mpt_? -97.43 154.72 17.29 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.444 177.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 271' ' ' ARG . . . . . 0.421 HH11 ' HD3' ' A' ' 271' ' ' ARG . 39.5 mmt-85 -104.5 105.78 16.02 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 174.429 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 272' ' ' ILE . . . . . 0.657 HG21 HD23 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -115.65 141.14 34.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-O 121.306 0.574 . . . . 0.0 111.536 -177.09 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -152.37 169.8 21.65 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.363 171.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 274' ' ' TYR . . . . . 0.418 ' OH ' ' HA ' ' A' ' 255' ' ' ILE . 84.4 m-85 . . . . . 0 C--N 1.324 -0.531 0 CA-C-O 120.983 0.42 . . . . 0.0 110.755 176.443 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 206' ' ' ARG . . . . . 0.762 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 39.4 mtm180 . . . . . 0 N--CA 1.463 0.223 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -108.96 105.63 15.24 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 119.053 0.842 . . . . 0.0 111.824 -170.404 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 63.4 t -137.43 123.09 26.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 114.605 -1.179 . . . . 0.0 109.18 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 209' ' ' PHE . . . . . 0.444 ' CE1' ' HB ' ' A' ' 243' ' ' ILE . 4.0 t80 -120.0 128.18 53.3 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.723 0.297 . . . . 0.0 110.655 -178.13 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.665 ' HG ' HG22 ' A' ' 272' ' ' ILE . 4.8 mp -108.27 126.53 52.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.534 177.582 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 211' ' ' GLY . . . . . 0.69 ' HA2' HG22 ' A' ' 243' ' ' ILE . . . -132.92 59.96 0.68 Allowed Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.702 -0.761 . . . . 0.0 113.445 -178.496 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 212' ' ' ASN . . . . . 0.497 ' HB3' ' HA ' ' A' ' 270' ' ' ARG . 3.4 t30 178.22 42.11 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.279 0.561 . . . . 0.0 109.815 177.192 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.725 HD23 ' HG2' ' A' ' 270' ' ' ARG . 1.0 OUTLIER -89.57 163.52 32.86 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.098 -179.94 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.499 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 89.2 Cg_endo -81.62 161.65 19.23 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 122.383 2.055 . . . . 0.0 111.342 175.216 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -72.94 128.19 34.75 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.574 176.055 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 103.94 -5.56 46.65 Favored Glycine 0 C--N 1.313 -0.722 0 C-N-CA 120.446 -0.883 . . . . 0.0 113.039 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 217' ' ' ILE . . . . . 0.626 HG23 HG21 ' A' ' 237' ' ' ILE . 5.1 tp -58.56 128.36 19.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.973 0.416 . . . . 0.0 110.734 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 218' ' ' THR . . . . . 0.431 ' CG2' ' HG3' ' A' ' 221' ' ' GLU . 14.9 t -112.28 157.24 21.19 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-O 121.394 0.616 . . . . 0.0 110.975 -178.665 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.496 ' H ' ' CD ' ' A' ' 219' ' ' GLU . 3.9 mp0 -62.36 -36.7 83.09 Favored 'General case' 0 C--O 1.207 -1.16 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.591 -177.262 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 220' ' ' ASP . . . . . 0.45 ' O ' ' HG2' ' A' ' 224' ' ' GLU . 37.4 t70 -50.1 -40.14 44.89 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 123.745 0.653 . . . . 0.0 111.144 179.105 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 221' ' ' GLU . . . . . 0.431 ' HG3' ' CG2' ' A' ' 218' ' ' THR . 41.6 mt-10 -68.74 -56.96 6.41 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.326 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 222' ' ' ILE . . . . . 0.539 HD12 HD11 ' A' ' 237' ' ' ILE . 7.5 mt -60.05 -42.25 89.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.743 -179.123 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 223' ' ' ARG . . . . . 0.753 ' HG3' HD12 ' A' ' 235' ' ' ILE . 53.9 mtp85 -54.3 -63.56 1.11 Allowed 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 176.328 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.45 ' HG2' ' O ' ' A' ' 220' ' ' ASP . 14.4 pt-20 -60.52 -20.36 59.98 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.975 -176.768 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -88.69 -32.29 18.06 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.553 -177.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.696 HD23 ' HZ ' ' A' ' 248' ' ' PHE . 8.6 mp -107.32 -18.76 13.79 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -170.636 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 227' ' ' GLU . . . . . 0.687 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 31.5 mt-10 -71.48 -25.33 0.78 Allowed Pre-proline 0 C--N 1.324 -0.5 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -175.303 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 228' ' ' PRO . . . . . 0.687 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 74.2 Cg_endo -65.76 -28.84 51.35 Favored 'Trans proline' 0 C--N 1.359 1.102 0 CA-C-N 120.692 1.283 . . . . 0.0 112.019 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 229' ' ' PHE . . . . . 0.463 ' CE1' ' HA ' ' A' ' 226' ' ' LEU . 3.7 p90 -110.92 -2.08 16.17 Favored 'General case' 0 C--O 1.224 -0.249 0 C-N-CA 120.921 -0.311 . . . . 0.0 111.463 174.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 230' ' ' GLY . . . . . 0.452 ' CA ' ' HB1' ' A' ' 253' ' ' ALA . . . -174.21 94.31 0.1 OUTLIER Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 120.249 -0.977 . . . . 0.0 112.23 -177.257 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 231' ' ' PRO . . . . . 0.421 ' HA ' ' HG2' ' A' ' 227' ' ' GLU . 21.0 Cg_endo -62.74 130.14 28.59 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 121.975 1.784 . . . . 0.0 111.401 178.503 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.736 HG21 HG12 ' A' ' 246' ' ' VAL . 2.8 mp -106.4 152.33 8.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.442 178.12 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 233' ' ' ASP . . . . . 0.422 ' CG ' HD22 ' A' ' 249' ' ' LEU . 23.4 m-20 -111.29 -26.98 8.87 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.762 176.319 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 234' ' ' GLN . . . . . 0.44 ' HB3' ' HB2' ' A' ' 247' ' ' HIS . 20.4 tt0 -136.97 120.51 17.12 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.635 -175.397 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 235' ' ' ILE . . . . . 0.753 HD12 ' HG3' ' A' ' 223' ' ' ARG . 20.0 mt -134.99 105.8 6.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.675 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -111.58 109.45 19.37 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.321 -175.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 237' ' ' ILE . . . . . 0.626 HG21 HG23 ' A' ' 217' ' ' ILE . 87.4 mt -101.23 122.28 53.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 121.286 0.565 . . . . 0.0 111.155 -177.569 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.58 ' HB ' HG13 ' A' ' 243' ' ' ILE . 46.5 t -103.63 87.39 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 170.69 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 11.6 t -67.5 -19.31 65.31 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.463 -176.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -65.98 -29.56 69.97 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.696 176.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 241' ' ' ARG . . . . . 0.559 ' HB2' HG12 ' A' ' 243' ' ' ILE . 98.9 mtt180 -117.39 4.85 12.52 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.803 -179.59 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 15.9 m120 64.81 27.24 12.96 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.988 176.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.69 HG22 ' HA2' ' A' ' 211' ' ' GLY . 1.4 pt -122.4 148.9 25.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.165 -175.477 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -142.41 137.58 30.51 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.969 0.414 . . . . 0.0 111.556 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -105.51 120.31 41.31 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.894 177.307 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 246' ' ' VAL . . . . . 0.736 HG12 HG21 ' A' ' 232' ' ' ILE . 0.2 OUTLIER -115.11 132.15 65.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -178.558 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 247' ' ' HIS . . . . . 0.762 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 50.1 m170 -111.43 102.58 10.94 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.164 -0.614 . . . . 0.0 111.311 176.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 248' ' ' PHE . . . . . 0.696 ' HZ ' HD23 ' A' ' 226' ' ' LEU . 33.2 m-85 -86.04 103.28 14.58 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.068 178.681 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.486 HD23 ' H ' ' A' ' 249' ' ' LEU . 0.1 OUTLIER -43.7 -39.52 3.7 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 124.139 0.899 . . . . 0.0 113.342 -175.8 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -96.51 144.92 26.16 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.512 177.316 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 251' ' ' ILE . . . . . 0.566 ' O ' HG13 ' A' ' 255' ' ' ILE . 0.2 OUTLIER -64.06 -43.22 97.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.723 -178.83 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -72.03 -30.78 65.54 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.672 -176.18 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 253' ' ' ALA . . . . . 0.452 ' HB1' ' CA ' ' A' ' 230' ' ' GLY . . . -58.72 -41.93 87.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.217 178.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 254' ' ' ALA . . . . . 0.598 ' HB2' ' HB2' ' A' ' 248' ' ' PHE . . . -69.24 -40.61 77.81 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.821 178.482 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.566 HG13 ' O ' ' A' ' 251' ' ' ILE . 6.5 mt -57.84 -60.85 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.453 -177.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 256' ' ' LYS . . . . . 0.454 ' O ' ' HG2' ' A' ' 260' ' ' GLU . 11.8 ptmt -61.98 -38.45 88.62 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.396 -177.062 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -61.47 -48.51 80.78 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.617 0.246 . . . . 0.0 111.182 178.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 258' ' ' VAL . . . . . 0.548 HG13 HG12 ' A' ' 272' ' ' ILE . 69.7 t -66.92 -23.97 31.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.892 0.377 . . . . 0.0 110.972 179.152 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -83.42 -26.93 29.93 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 177.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 260' ' ' GLU . . . . . 0.454 ' HG2' ' O ' ' A' ' 256' ' ' LYS . 51.1 mm-40 -94.74 -30.97 14.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.72 0.295 . . . . 0.0 111.223 -174.386 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.741 HD23 HG21 ' A' ' 272' ' ' ILE . 0.6 OUTLIER -52.85 -50.74 79.78 Favored Pre-proline 0 CA--C 1.538 0.51 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.375 179.366 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 262' ' ' PRO . . . . . 0.558 ' HD2' ' N ' ' A' ' 261' ' ' LEU . 41.2 Cg_endo -67.47 -16.46 47.53 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.357 2.038 . . . . 0.0 112.667 -178.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 59.1 mt -89.77 -7.83 53.56 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.235 0.54 . . . . 0.0 111.574 -177.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 264' ' ' ASN . . . . . 0.4 ' O ' ' HB2' ' A' ' 268' ' ' SER . 14.1 m-80 -106.38 148.17 36.24 Favored Pre-proline 0 C--N 1.311 -1.068 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.897 -174.733 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -64.1 -36.4 48.05 Favored 'Trans proline' 0 C--N 1.334 -0.208 0 C-N-CA 123.512 2.808 . . . . 0.0 112.584 -169.596 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 8.2 mtpt -86.23 -44.58 12.04 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 121.558 0.694 . . . . 0.0 109.791 -176.4 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 267' ' ' TRP . . . . . 0.694 ' CE3' HD12 ' A' ' 261' ' ' LEU . 11.2 m0 -76.49 -28.57 56.51 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.519 -174.428 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 268' ' ' SER . . . . . 0.4 ' HB2' ' O ' ' A' ' 264' ' ' ASN . 22.9 t -64.18 -21.61 66.63 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.712 0.292 . . . . 0.0 110.532 177.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 64.2 mttm -70.53 -16.67 62.91 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-O 121.299 0.571 . . . . 0.0 110.087 176.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 270' ' ' ARG . . . . . 0.725 ' HG2' HD23 ' A' ' 213' ' ' LEU . 3.1 mpt_? -103.4 146.25 28.78 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.646 -179.076 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 271' ' ' ARG . . . . . 0.454 ' NE ' ' HA ' ' A' ' 271' ' ' ARG . 4.9 mmp_? -97.44 107.59 20.13 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 178.434 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 272' ' ' ILE . . . . . 0.741 HG21 HD23 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -116.15 142.22 30.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.141 0.496 . . . . 0.0 111.174 -176.967 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -150.93 167.68 26.83 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.661 172.565 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 274' ' ' TYR . . . . . 0.539 ' OH ' ' HA ' ' A' ' 255' ' ' ILE . 87.2 m-85 . . . . . 0 C--N 1.32 -0.691 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.072 173.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 206' ' ' ARG . . . . . 0.815 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 41.9 mtm180 . . . . . 0 C--O 1.221 -0.404 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -106.0 105.34 15.33 Favored 'General case' 0 CA--C 1.511 -0.542 0 C-N-CA 120.166 -0.614 . . . . 0.0 111.128 -171.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.46 ' HB ' ' HB ' ' A' ' 246' ' ' VAL . 64.6 t -137.24 115.25 13.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.361 177.612 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 209' ' ' PHE . . . . . 0.461 ' HE1' ' HB ' ' A' ' 243' ' ' ILE . 3.2 t80 -111.68 124.77 53.02 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.364 -175.746 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.702 ' HG ' HG22 ' A' ' 272' ' ' ILE . 5.6 mp -107.34 129.48 54.9 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.561 177.666 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 211' ' ' GLY . . . . . 0.663 ' HA2' HG22 ' A' ' 243' ' ' ILE . . . -138.26 63.28 0.56 Allowed Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.656 -0.783 . . . . 0.0 113.208 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 212' ' ' ASN . . . . . 0.546 ' HB3' ' HA ' ' A' ' 270' ' ' ARG . 3.5 t30 -179.01 34.86 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.355 0.597 . . . . 0.0 109.969 178.112 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.809 HD23 ' HG2' ' A' ' 270' ' ' ARG . 1.2 mt -87.77 163.73 37.12 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.868 -179.269 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.44 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 91.3 Cg_endo -81.98 165.83 17.14 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 122.261 1.974 . . . . 0.0 110.772 172.357 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -78.7 129.21 34.44 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 177.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 105.25 -6.29 42.46 Favored Glycine 0 C--N 1.315 -0.617 0 C-N-CA 120.557 -0.83 . . . . 0.0 113.211 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 217' ' ' ILE . . . . . 0.715 HG23 HG21 ' A' ' 237' ' ' ILE . 4.6 tp -58.88 131.19 23.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-O 120.929 0.395 . . . . 0.0 110.743 179.083 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 218' ' ' THR . . . . . 0.446 ' CG2' ' HG3' ' A' ' 221' ' ' GLU . 10.7 t -112.39 157.44 21.04 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-O 121.625 0.726 . . . . 0.0 111.206 -179.138 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.461 ' H ' ' CD ' ' A' ' 219' ' ' GLU . 4.2 mp0 -62.79 -34.72 77.85 Favored 'General case' 0 C--O 1.209 -1.075 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.987 -177.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -54.4 -36.19 63.68 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.924 0.392 . . . . 0.0 110.81 -179.315 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 221' ' ' GLU . . . . . 0.446 ' HG3' ' CG2' ' A' ' 218' ' ' THR . 44.4 mt-10 -70.56 -55.47 8.8 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.371 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 222' ' ' ILE . . . . . 0.537 HD12 HD11 ' A' ' 237' ' ' ILE . 6.7 mt -62.03 -40.56 87.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.693 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 223' ' ' ARG . . . . . 0.847 ' HG3' HD12 ' A' ' 235' ' ' ILE . 17.2 mtp180 -54.22 -62.34 1.72 Allowed 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 175.161 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -57.74 -21.31 40.42 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.962 -178.445 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 225' ' ' ASP . . . . . 0.454 ' CG ' ' HE1' ' A' ' 267' ' ' TRP . 24.9 m-20 -87.77 -33.02 18.81 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.978 -178.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.702 HD23 ' HZ ' ' A' ' 248' ' ' PHE . 8.1 mp -107.98 -17.83 13.95 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -169.631 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 227' ' ' GLU . . . . . 0.667 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 46.1 mt-10 -69.79 -26.03 1.01 Allowed Pre-proline 0 C--N 1.324 -0.517 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -175.353 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 228' ' ' PRO . . . . . 0.667 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 84.7 Cg_endo -67.64 -27.28 38.74 Favored 'Trans proline' 0 C--N 1.36 1.139 0 C-N-CA 121.359 1.373 . . . . 0.0 112.488 -178.781 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 229' ' ' PHE . . . . . 0.479 ' CZ ' ' HA ' ' A' ' 226' ' ' LEU . 2.6 p90 -110.64 -14.66 14.01 Favored 'General case' 0 C--O 1.222 -0.364 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.557 175.348 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 230' ' ' GLY . . . . . 0.413 ' HA2' ' HD2' ' A' ' 231' ' ' PRO . . . -161.27 91.97 0.11 Allowed Glycine 0 N--CA 1.438 -1.178 0 C-N-CA 120.441 -0.885 . . . . 0.0 111.223 -175.353 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 231' ' ' PRO . . . . . 0.413 ' HD2' ' HA2' ' A' ' 230' ' ' GLY . 13.4 Cg_endo -58.72 131.8 44.28 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 121.859 1.706 . . . . 0.0 111.155 178.579 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.594 HG21 HG12 ' A' ' 246' ' ' VAL . 2.7 mp -108.17 151.7 10.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.92 177.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 233' ' ' ASP . . . . . 0.498 ' CG ' HD22 ' A' ' 249' ' ' LEU . 15.6 m-20 -112.77 -23.06 10.37 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 120.915 0.388 . . . . 0.0 110.147 178.751 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 234' ' ' GLN . . . . . 0.58 ' HB3' ' HB2' ' A' ' 247' ' ' HIS . 36.1 tt0 -143.99 120.1 10.77 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.841 -176.076 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 235' ' ' ILE . . . . . 0.847 HD12 ' HG3' ' A' ' 223' ' ' ARG . 14.8 mt -131.52 115.63 29.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.92 178.718 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 65.9 tttp -120.81 113.66 20.48 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.37 -178.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 237' ' ' ILE . . . . . 0.715 HG21 HG23 ' A' ' 217' ' ' ILE . 80.8 mt -102.85 123.71 56.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.683 -179.062 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.559 ' HB ' HG13 ' A' ' 243' ' ' ILE . 39.9 t -102.06 87.09 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 172.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 13.9 t -65.33 -18.21 65.13 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.726 -177.062 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -64.93 -31.05 72.09 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.538 176.521 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 241' ' ' ARG . . . . . 0.778 ' HB2' HG12 ' A' ' 243' ' ' ILE . 48.7 mtt180 -116.29 3.53 13.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.944 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 66.91 27.28 9.0 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.81 177.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.778 HG12 ' HB2' ' A' ' 241' ' ' ARG . 1.7 pt -122.2 155.53 27.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.156 -173.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 244' ' ' ALA . . . . . 0.475 ' HB3' ' HB2' ' A' ' 210' ' ' LEU . . . -143.92 138.3 28.43 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.019 0.438 . . . . 0.0 111.579 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -107.68 109.11 20.63 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.702 176.438 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 246' ' ' VAL . . . . . 0.594 HG12 HG21 ' A' ' 232' ' ' ILE . 1.3 t -103.2 133.3 47.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 247' ' ' HIS . . . . . 0.815 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 40.9 m170 -112.49 101.56 9.72 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.496 0.665 . . . . 0.0 111.128 178.665 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 248' ' ' PHE . . . . . 0.702 ' HZ ' HD23 ' A' ' 226' ' ' LEU . 33.5 m-85 -85.87 102.92 14.14 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.744 -1.116 . . . . 0.0 111.429 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.498 HD22 ' CG ' ' A' ' 233' ' ' ASP . 0.1 OUTLIER -40.27 -46.45 2.29 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 124.422 1.076 . . . . 0.0 113.117 -174.835 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -97.39 139.54 33.18 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.858 0.361 . . . . 0.0 110.325 177.555 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 251' ' ' ILE . . . . . 0.663 ' O ' HG13 ' A' ' 255' ' ' ILE . 0.2 OUTLIER -57.53 -40.62 75.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.675 179.995 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -68.93 -33.15 73.27 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.183 -176.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -59.85 -40.28 88.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.483 179.162 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 254' ' ' ALA . . . . . 0.532 ' HB2' ' HB2' ' A' ' 248' ' ' PHE . . . -68.88 -41.58 78.14 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.757 178.483 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.663 HG13 ' O ' ' A' ' 251' ' ' ILE . 14.4 mt -56.06 -59.62 2.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.293 -177.559 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 256' ' ' LYS . . . . . 0.401 ' O ' ' HG2' ' A' ' 260' ' ' GLU . 12.6 ptmt -62.28 -40.19 95.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.422 -177.737 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -62.05 -49.28 76.63 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.586 0.231 . . . . 0.0 111.323 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 258' ' ' VAL . . . . . 0.467 HG13 HG12 ' A' ' 272' ' ' ILE . 53.7 t -64.89 -24.38 35.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.078 0.465 . . . . 0.0 110.892 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 71.6 mm-40 -84.83 -24.53 28.59 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 178.069 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 260' ' ' GLU . . . . . 0.401 ' HG2' ' O ' ' A' ' 256' ' ' LYS . 58.4 mm-40 -95.89 -33.89 12.03 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.769 0.319 . . . . 0.0 111.081 -175.599 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.749 HD23 HG21 ' A' ' 272' ' ' ILE . 0.6 OUTLIER -52.05 -49.54 83.69 Favored Pre-proline 0 CA--C 1.539 0.523 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.724 -179.013 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 262' ' ' PRO . . . . . 0.575 ' HD2' ' N ' ' A' ' 261' ' ' LEU . 43.6 Cg_endo -67.46 -15.25 44.85 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.446 2.097 . . . . 0.0 113.052 -178.329 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 54.3 mt -92.09 -4.99 53.61 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.269 0.557 . . . . 0.0 111.449 -178.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 -106.94 149.97 39.21 Favored Pre-proline 0 C--N 1.312 -1.029 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.367 -173.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.25 -37.66 30.56 Favored 'Trans proline' 0 N--CA 1.465 -0.159 0 C-N-CA 123.172 2.581 . . . . 0.0 112.79 -169.269 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 12.6 mtpt -86.63 -44.33 11.95 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 121.531 0.682 . . . . 0.0 109.788 -177.366 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 267' ' ' TRP . . . . . 0.742 ' CE3' HD12 ' A' ' 261' ' ' LEU . 10.6 m0 -75.34 -28.85 59.77 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.9 -173.634 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 34.7 t -65.02 -20.89 66.72 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.151 0.501 . . . . 0.0 110.555 176.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 269' ' ' LYS . . . . . 0.422 ' C ' ' HD2' ' A' ' 270' ' ' ARG . 97.6 mttt -76.84 -6.2 51.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.238 176.581 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 270' ' ' ARG . . . . . 0.809 ' HG2' HD23 ' A' ' 213' ' ' LEU . 3.3 mpt_? -114.97 141.64 47.7 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.021 177.69 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 271' ' ' ARG . . . . . 0.814 ' HA ' ' HE ' ' A' ' 271' ' ' ARG . 0.8 OUTLIER -93.05 108.36 19.96 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 -179.769 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 272' ' ' ILE . . . . . 0.749 HG21 HD23 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -117.31 140.91 38.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.361 0.6 . . . . 0.0 110.823 -178.556 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -152.42 170.15 20.81 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.55 173.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 . . . . . 0 C--N 1.33 -0.264 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 171.793 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 206' ' ' ARG . . . . . 0.756 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 46.3 mtp180 . . . . . 0 C--O 1.223 -0.337 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -110.93 106.34 15.43 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.1 0.476 . . . . 0.0 111.643 -171.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.478 ' HB ' ' HB ' ' A' ' 246' ' ' VAL . 57.7 t -136.87 117.97 18.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.552 179.102 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 209' ' ' PHE . . . . . 0.504 ' O ' ' HA ' ' A' ' 272' ' ' ILE . 5.8 t80 -113.28 125.35 54.2 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.463 -177.409 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.84 ' HG ' HG22 ' A' ' 272' ' ' ILE . 5.5 mp -107.8 130.09 55.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.595 177.74 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 211' ' ' GLY . . . . . 0.734 ' HA2' HG22 ' A' ' 243' ' ' ILE . . . -132.13 53.01 0.81 Allowed Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.503 -0.856 . . . . 0.0 113.951 -178.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 212' ' ' ASN . . . . . 0.441 ' HB3' ' HA ' ' A' ' 270' ' ' ARG . 36.3 t30 179.72 52.73 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.037 0.446 . . . . 0.0 111.288 174.487 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.585 HD21 HD22 ' A' ' 210' ' ' LEU . 1.0 OUTLIER -94.65 159.43 33.55 Favored Pre-proline 0 C--N 1.314 -0.96 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.444 177.509 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.462 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 87.1 Cg_endo -78.42 169.48 19.93 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 122.701 2.267 . . . . 0.0 111.638 178.109 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 215' ' ' ASN . . . . . 0.504 ' HA ' ' OG1' ' A' ' 239' ' ' THR . 3.9 p-10 -77.49 134.02 38.43 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 98.27 -6.27 61.41 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.398 -0.906 . . . . 0.0 112.857 178.019 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 217' ' ' ILE . . . . . 0.707 HG23 HG21 ' A' ' 237' ' ' ILE . 4.1 tp -58.15 126.11 15.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 CA-C-O 121.294 0.568 . . . . 0.0 110.724 -178.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 218' ' ' THR . . . . . 0.492 ' CG2' ' HG3' ' A' ' 221' ' ' GLU . 8.8 t -109.22 157.49 18.76 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 121.429 0.633 . . . . 0.0 110.847 -178.686 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.502 ' H ' ' CD ' ' A' ' 219' ' ' GLU . 2.6 mp0 -62.05 -36.24 81.03 Favored 'General case' 0 C--O 1.209 -1.028 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.455 -177.399 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 220' ' ' ASP . . . . . 0.536 ' O ' ' HG2' ' A' ' 224' ' ' GLU . 30.7 t70 -55.08 -37.56 66.96 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 123.741 0.651 . . . . 0.0 110.683 -178.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 221' ' ' GLU . . . . . 0.492 ' HG3' ' CG2' ' A' ' 218' ' ' THR . 45.9 mt-10 -65.97 -55.24 17.78 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.02 179.184 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 222' ' ' ILE . . . . . 0.486 HD12 HD11 ' A' ' 237' ' ' ILE . 6.7 mt -62.52 -38.84 82.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.656 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 223' ' ' ARG . . . . . 0.872 ' HG3' HD12 ' A' ' 235' ' ' ILE . 63.4 mtp180 -56.47 -62.53 1.66 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.981 0.42 . . . . 0.0 112.066 175.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.536 ' HG2' ' O ' ' A' ' 220' ' ' ASP . 7.0 pt-20 -58.73 -24.74 62.08 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.149 -178.306 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 225' ' ' ASP . . . . . 0.469 ' HB3' ' CZ2' ' A' ' 267' ' ' TRP . 8.0 m-20 -85.98 -32.5 21.5 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.596 -176.279 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.742 HD23 ' HZ ' ' A' ' 248' ' ' PHE . 8.4 mp -107.11 -17.49 14.15 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -170.353 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 227' ' ' GLU . . . . . 0.675 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 37.6 mt-10 -70.71 -27.96 1.2 Allowed Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -176.404 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 228' ' ' PRO . . . . . 0.675 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 74.4 Cg_endo -65.47 -27.09 54.58 Favored 'Trans proline' 0 C--N 1.359 1.089 0 C-N-CA 121.313 1.342 . . . . 0.0 111.818 -177.577 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 229' ' ' PHE . . . . . 0.475 ' CE1' ' HA ' ' A' ' 226' ' ' LEU . 3.2 p90 -111.01 -7.89 14.5 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.879 -0.328 . . . . 0.0 111.65 173.523 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 230' ' ' GLY . . . . . 0.482 ' CA ' ' HB1' ' A' ' 253' ' ' ALA . . . -169.69 93.8 0.1 Allowed Glycine 0 N--CA 1.442 -0.954 0 C-N-CA 120.104 -1.046 . . . . 0.0 112.454 -174.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 231' ' ' PRO . . . . . 0.461 ' HA ' ' HG2' ' A' ' 227' ' ' GLU . 15.3 Cg_endo -59.52 131.79 42.43 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 122.038 1.825 . . . . 0.0 111.759 178.633 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.603 HG21 HG12 ' A' ' 246' ' ' VAL . 2.8 mp -108.53 152.95 10.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.108 177.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 233' ' ' ASP . . . . . 0.455 ' OD2' HD22 ' A' ' 249' ' ' LEU . 16.3 m-20 -116.1 -18.39 10.63 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 120.708 0.289 . . . . 0.0 111.059 178.005 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 234' ' ' GLN . . . . . 0.49 ' H ' HG22 ' A' ' 232' ' ' ILE . 23.0 tt0 -145.57 121.69 10.78 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.033 -179.118 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 235' ' ' ILE . . . . . 0.872 HD12 ' HG3' ' A' ' 223' ' ' ARG . 13.6 mt -133.65 109.79 13.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.045 177.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -113.93 121.29 43.49 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.363 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 237' ' ' ILE . . . . . 0.707 HG21 HG23 ' A' ' 217' ' ' ILE . 53.7 mt -111.85 127.97 68.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.361 -177.221 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.577 ' HB ' HG13 ' A' ' 243' ' ' ILE . 44.8 t -109.58 88.07 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 170.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 239' ' ' THR . . . . . 0.504 ' OG1' ' HA ' ' A' ' 215' ' ' ASN . 12.4 t -64.0 -24.66 67.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.643 -175.548 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -61.8 -39.0 90.19 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.084 0.469 . . . . 0.0 110.647 178.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 241' ' ' ARG . . . . . 0.691 ' HB2' HG12 ' A' ' 243' ' ' ILE . 63.9 mtt180 -104.28 0.11 28.92 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.47 -177.678 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 69.01 25.7 5.85 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.054 177.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.734 HG22 ' HA2' ' A' ' 211' ' ' GLY . 1.4 pt -121.71 151.29 25.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-O 120.835 0.35 . . . . 0.0 111.579 -172.55 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -145.89 141.5 27.88 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.169 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -111.15 114.42 27.66 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.91 178.227 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 246' ' ' VAL . . . . . 0.603 HG12 HG21 ' A' ' 232' ' ' ILE . 1.4 t -108.67 138.35 36.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.665 -178.254 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 247' ' ' HIS . . . . . 0.756 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 27.1 m170 -115.89 102.15 9.42 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.113 -0.635 . . . . 0.0 111.182 177.016 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 248' ' ' PHE . . . . . 0.742 ' HZ ' HD23 ' A' ' 226' ' ' LEU . 35.3 m-85 -86.86 100.74 12.77 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.22 179.036 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.474 HD23 ' H ' ' A' ' 249' ' ' LEU . 0.1 OUTLIER -43.24 -41.55 3.92 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 124.533 1.146 . . . . 0.0 112.693 -175.841 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 250' ' ' ASN . . . . . 0.418 ' HB2' ' HB2' ' A' ' 253' ' ' ALA . 59.4 m-20 -94.6 137.89 33.14 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 251' ' ' ILE . . . . . 0.588 ' O ' HG13 ' A' ' 255' ' ' ILE . 0.2 OUTLIER -60.98 -43.51 96.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -178.933 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -71.32 -27.52 63.45 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.666 -176.513 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 253' ' ' ALA . . . . . 0.482 ' HB1' ' CA ' ' A' ' 230' ' ' GLY . . . -62.73 -42.37 99.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.204 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 254' ' ' ALA . . . . . 0.556 ' HB2' ' HB2' ' A' ' 248' ' ' PHE . . . -67.38 -41.89 84.26 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.614 178.588 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.588 HG13 ' O ' ' A' ' 251' ' ' ILE . 9.8 mt -56.17 -60.26 2.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.285 -177.395 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 12.7 ptmt -62.6 -36.22 82.06 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.553 -176.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -65.73 -49.41 68.55 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 122.981 0.176 . . . . 0.0 111.438 178.555 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 258' ' ' VAL . . . . . 0.581 HG13 HG12 ' A' ' 272' ' ' ILE . 60.9 t -63.5 -25.5 38.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.976 0.417 . . . . 0.0 110.838 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -83.96 -25.45 30.04 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.11 -0.495 . . . . 0.0 112.187 178.328 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 46.5 mm-40 -95.05 -30.88 13.85 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-O 120.665 0.269 . . . . 0.0 111.283 -175.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.826 HD23 HG21 ' A' ' 272' ' ' ILE . 1.0 OUTLIER -52.42 -50.45 79.83 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.251 179.625 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 262' ' ' PRO . . . . . 0.571 ' HD2' ' N ' ' A' ' 261' ' ' LEU . 43.2 Cg_endo -66.99 -14.48 43.81 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.399 2.066 . . . . 0.0 112.909 -178.424 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 55.6 mt -96.34 -3.91 42.96 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.899 0.381 . . . . 0.0 111.827 -178.484 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 264' ' ' ASN . . . . . 0.447 ' HB2' ' CE3' ' A' ' 267' ' ' TRP . 13.1 m-80 -106.72 149.78 38.85 Favored Pre-proline 0 C--N 1.317 -0.84 0 N-CA-C 112.662 0.615 . . . . 0.0 112.662 -174.711 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -63.22 -35.66 62.09 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 123.771 2.981 . . . . 0.0 113.189 -168.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 266' ' ' LYS . . . . . 0.463 ' HE3' ' HB2' ' A' ' 266' ' ' LYS . 0.0 OUTLIER -86.93 -45.74 10.53 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 121.791 0.805 . . . . 0.0 109.298 -179.616 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 267' ' ' TRP . . . . . 0.729 ' CE3' HD12 ' A' ' 261' ' ' LEU . 9.1 m0 -76.46 -29.29 56.86 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 114.362 -1.29 . . . . 0.0 111.309 -170.512 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 268' ' ' SER . . . . . 0.419 ' HA ' ' HA ' ' A' ' 262' ' ' PRO . 23.2 t -64.92 -16.54 63.42 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.742 0.306 . . . . 0.0 111.547 -179.043 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -87.17 -13.16 44.82 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.095 0.474 . . . . 0.0 110.183 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 270' ' ' ARG . . . . . 0.441 ' HA ' ' HB3' ' A' ' 212' ' ' ASN . 6.9 mpt_? -88.32 166.75 14.07 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 173.11 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 271' ' ' ARG . . . . . 0.462 ' HA ' ' HD3' ' A' ' 271' ' ' ARG . 45.1 mmt-85 -120.4 106.58 11.98 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 177.709 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 272' ' ' ILE . . . . . 0.84 HG22 ' HG ' ' A' ' 210' ' ' LEU . 0.2 OUTLIER -119.58 141.94 37.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.461 0.648 . . . . 0.0 111.903 -174.411 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -151.76 169.73 21.49 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.613 171.471 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 . . . . . 0 C--N 1.324 -0.521 0 CA-C-O 120.873 0.368 . . . . 0.0 110.49 176.615 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 206' ' ' ARG . . . . . 0.822 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 8.0 mtm180 . . . . . 0 C--O 1.221 -0.398 0 N-CA-C 114.579 1.325 . . . . 0.0 114.579 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -104.98 105.6 15.71 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 119.09 0.859 . . . . 0.0 112.161 -172.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.502 ' HB ' ' HB ' ' A' ' 246' ' ' VAL . 65.1 t -133.69 114.7 20.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 114.569 -1.196 . . . . 0.0 109.199 177.701 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 209' ' ' PHE . . . . . 0.449 ' HE1' ' HB ' ' A' ' 243' ' ' ILE . 1.5 t80 -113.6 122.64 47.83 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.061 -176.029 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.683 ' HG ' HG22 ' A' ' 272' ' ' ILE . 6.4 mp -105.35 136.95 43.95 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.463 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 211' ' ' GLY . . . . . 0.567 ' HA2' HG22 ' A' ' 243' ' ' ILE . . . -144.58 68.55 0.42 Allowed Glycine 0 N--CA 1.448 -0.567 0 C-N-CA 120.422 -0.894 . . . . 0.0 113.19 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 212' ' ' ASN . . . . . 0.554 ' HB3' ' HA ' ' A' ' 270' ' ' ARG . 20.5 t30 173.66 37.57 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.092 0.473 . . . . 0.0 109.992 176.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.795 HD23 ' HG2' ' A' ' 270' ' ' ARG . 0.9 OUTLIER -86.59 159.91 51.67 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.71 -176.758 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.489 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 98.6 Cg_endo -77.67 162.94 29.67 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.76 2.307 . . . . 0.0 112.046 178.486 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -76.04 117.68 18.0 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.771 178.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 109.02 -0.94 31.53 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.292 -0.956 . . . . 0.0 113.011 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 217' ' ' ILE . . . . . 0.712 HG23 HG21 ' A' ' 237' ' ' ILE . 6.2 tp -60.76 130.19 24.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.046 0.451 . . . . 0.0 110.852 177.801 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 218' ' ' THR . . . . . 0.436 ' CG2' ' HG3' ' A' ' 221' ' ' GLU . 12.1 t -114.07 156.24 24.51 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 121.722 0.772 . . . . 0.0 110.969 178.461 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -60.74 -35.31 76.06 Favored 'General case' 0 C--O 1.208 -1.089 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.093 -178.407 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -56.11 -35.68 67.35 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 123.433 0.458 . . . . 0.0 110.689 -178.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 221' ' ' GLU . . . . . 0.436 ' HG3' ' CG2' ' A' ' 218' ' ' THR . 43.6 mt-10 -68.44 -56.43 8.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.122 178.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 222' ' ' ILE . . . . . 0.523 HD12 HD11 ' A' ' 237' ' ' ILE . 7.6 mt -60.45 -39.66 81.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.434 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 223' ' ' ARG . . . . . 0.774 ' HG3' HD12 ' A' ' 235' ' ' ILE . 33.6 mtp180 -55.88 -63.1 1.29 Allowed 'General case' 0 CA--C 1.509 -0.627 0 CA-C-O 120.935 0.398 . . . . 0.0 112.05 175.758 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -58.04 -22.1 48.5 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.813 -177.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -86.44 -34.21 20.19 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.621 -177.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.699 HD23 ' HZ ' ' A' ' 248' ' ' PHE . 8.1 mp -105.98 -18.54 14.01 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -169.484 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 227' ' ' GLU . . . . . 0.662 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 53.7 mt-10 -67.52 -30.32 2.89 Favored Pre-proline 0 C--N 1.326 -0.432 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -176.229 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 228' ' ' PRO . . . . . 0.662 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 71.7 Cg_endo -65.29 -28.71 55.2 Favored 'Trans proline' 0 C--N 1.36 1.146 0 C-N-CA 121.147 1.231 . . . . 0.0 112.089 -176.731 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 229' ' ' PHE . . . . . 0.506 ' CE1' ' HA ' ' A' ' 226' ' ' LEU . 3.1 p90 -110.84 -4.7 15.13 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.737 0.303 . . . . 0.0 111.725 175.627 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 230' ' ' GLY . . . . . 0.431 ' CA ' ' HB1' ' A' ' 253' ' ' ALA . . . -171.95 97.83 0.12 Allowed Glycine 0 N--CA 1.443 -0.895 0 C-N-CA 120.274 -0.965 . . . . 0.0 112.311 -175.136 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -64.65 131.45 29.52 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 121.778 1.652 . . . . 0.0 111.527 178.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.617 HG21 HG12 ' A' ' 246' ' ' VAL . 2.7 mp -107.77 151.97 9.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.563 177.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 233' ' ' ASP . . . . . 0.448 ' CG ' HD22 ' A' ' 249' ' ' LEU . 10.6 m-20 -109.42 -28.56 8.87 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.122 0.487 . . . . 0.0 110.168 176.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 234' ' ' GLN . . . . . 0.623 ' HB3' ' HB2' ' A' ' 247' ' ' HIS . 26.6 tt0 -136.28 122.54 20.49 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.748 -174.082 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 235' ' ' ILE . . . . . 0.774 HD12 ' HG3' ' A' ' 223' ' ' ARG . 14.1 mt -138.45 112.99 8.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.763 178.51 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -125.35 118.23 25.47 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.41 -179.165 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 237' ' ' ILE . . . . . 0.712 HG21 HG23 ' A' ' 217' ' ' ILE . 44.9 mt -104.97 115.64 47.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.821 -178.137 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.547 ' HB ' HG13 ' A' ' 243' ' ' ILE . 21.9 t -94.08 87.77 2.22 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 173.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 11.1 t -64.28 -23.69 67.39 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.393 -176.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -64.27 -23.4 67.29 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.152 178.463 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 241' ' ' ARG . . . . . 0.729 ' HB2' HG12 ' A' ' 243' ' ' ILE . 97.1 mtt180 -120.21 -0.13 10.54 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.244 176.253 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 19.2 m120 63.55 29.65 15.24 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.137 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.729 HG12 ' HB2' ' A' ' 241' ' ' ARG . 1.2 pt -121.78 154.33 26.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.76 -175.675 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 244' ' ' ALA . . . . . 0.537 ' HB3' ' HB2' ' A' ' 210' ' ' LEU . . . -142.29 138.8 31.59 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.11 0.481 . . . . 0.0 111.788 -178.173 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -106.33 113.81 27.56 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.62 177.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 246' ' ' VAL . . . . . 0.617 HG12 HG21 ' A' ' 232' ' ' ILE . 1.0 OUTLIER -112.77 130.58 66.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -179.817 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 247' ' ' HIS . . . . . 0.822 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 28.0 m170 -111.19 102.44 10.87 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.024 -0.67 . . . . 0.0 111.373 177.356 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 248' ' ' PHE . . . . . 0.699 ' HZ ' HD23 ' A' ' 226' ' ' LEU . 36.9 m-85 -84.61 101.92 12.51 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.599 177.48 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.478 HD23 ' H ' ' A' ' 249' ' ' LEU . 0.1 OUTLIER -44.43 -39.12 4.49 Favored 'General case' 0 N--CA 1.465 0.294 0 O-C-N 124.568 1.167 . . . . 0.0 112.956 -174.875 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 50.5 m-20 -99.88 143.16 30.42 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.056 178.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 251' ' ' ILE . . . . . 0.628 ' O ' HG13 ' A' ' 255' ' ' ILE . 0.2 OUTLIER -63.76 -44.62 98.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.138 -176.56 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -68.35 -29.93 68.77 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 120.606 0.241 . . . . 0.0 110.768 -176.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 253' ' ' ALA . . . . . 0.431 ' HB1' ' CA ' ' A' ' 230' ' ' GLY . . . -61.25 -42.41 98.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.285 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 254' ' ' ALA . . . . . 0.572 ' HB2' ' HB2' ' A' ' 248' ' ' PHE . . . -67.33 -41.33 85.42 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.719 178.731 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.71 ' O ' ' HG2' ' A' ' 259' ' ' GLN . 15.1 mt -57.05 -62.41 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.096 -177.19 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 256' ' ' LYS . . . . . 0.484 ' O ' ' HG2' ' A' ' 260' ' ' GLU . 10.1 ptmt -59.81 -38.42 81.93 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.109 -176.766 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -63.19 -49.76 72.98 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.59 0.233 . . . . 0.0 111.428 178.57 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 258' ' ' VAL . . . . . 0.478 HG13 HG12 ' A' ' 272' ' ' ILE . 52.7 t -66.36 -24.43 33.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.048 0.451 . . . . 0.0 111.119 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 259' ' ' GLN . . . . . 0.71 ' HG2' ' O ' ' A' ' 255' ' ' ILE . 78.9 mm-40 -84.13 -26.87 28.56 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.933 178.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 260' ' ' GLU . . . . . 0.484 ' HG2' ' O ' ' A' ' 256' ' ' LYS . 53.3 mm-40 -95.52 -31.65 13.23 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 122.702 0.401 . . . . 0.0 111.532 -175.033 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.807 ' HA ' ' HE3' ' A' ' 267' ' ' TRP . 0.7 OUTLIER -50.81 -51.03 70.2 Favored Pre-proline 0 CA--C 1.537 0.445 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.501 178.888 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 262' ' ' PRO . . . . . 0.619 ' HD3' HD11 ' A' ' 272' ' ' ILE . 37.8 Cg_endo -66.11 -15.69 49.43 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.287 1.991 . . . . 0.0 112.538 -177.587 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 57.6 mt -88.66 -9.34 52.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.967 0.413 . . . . 0.0 111.745 -177.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -105.44 148.82 36.99 Favored Pre-proline 0 C--N 1.314 -0.968 0 N-CA-C 112.586 0.588 . . . . 0.0 112.586 -172.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -61.52 -36.11 78.47 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 123.711 2.941 . . . . 0.0 112.61 -171.094 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 7.6 mtpt -85.99 -45.07 11.81 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 121.542 0.687 . . . . 0.0 109.608 -176.457 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 267' ' ' TRP . . . . . 0.807 ' HE3' ' HA ' ' A' ' 261' ' ' LEU . 11.2 m0 -78.29 -28.16 47.49 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.686 -173.387 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 23.9 t -63.94 -17.96 63.77 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.802 0.334 . . . . 0.0 110.802 177.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -73.81 -21.71 60.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.23 0.538 . . . . 0.0 110.097 176.017 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 270' ' ' ARG . . . . . 0.795 ' HG2' HD23 ' A' ' 213' ' ' LEU . 3.1 mpt_? -102.19 141.7 34.61 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.913 -176.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 271' ' ' ARG . . . . . 0.477 ' HG2' ' HB2' ' A' ' 212' ' ' ASN . 26.5 mmt180 -93.17 109.45 20.95 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.237 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 272' ' ' ILE . . . . . 0.748 HG21 HD23 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -117.95 139.31 45.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.424 0.63 . . . . 0.0 111.012 -177.203 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 273' ' ' TYR . . . . . 0.448 ' CE1' ' HB3' ' A' ' 209' ' ' PHE . 6.0 p90 -151.78 168.79 23.97 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.73 176.477 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 274' ' ' TYR . . . . . 0.419 ' OH ' ' HA ' ' A' ' 255' ' ' ILE . 85.5 m-85 . . . . . 0 C--N 1.32 -0.686 0 CA-C-O 120.895 0.378 . . . . 0.0 110.523 174.519 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 206' ' ' ARG . . . . . 0.748 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 63.4 mtm180 . . . . . 0 C--O 1.223 -0.319 0 N-CA-C 114.579 1.325 . . . . 0.0 114.579 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -100.78 105.81 17.16 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 118.95 0.795 . . . . 0.0 111.528 -171.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.474 ' HB ' ' HB ' ' A' ' 246' ' ' VAL . 58.4 t -137.22 125.91 34.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.362 176.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 209' ' ' PHE . . . . . 0.474 ' HE1' ' HB ' ' A' ' 243' ' ' ILE . 3.3 t80 -125.61 121.37 33.36 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.75 -176.321 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.611 ' HG ' HG22 ' A' ' 272' ' ' ILE . 5.4 mp -103.79 134.67 46.7 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.298 177.49 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 211' ' ' GLY . . . . . 0.613 ' HA2' HG22 ' A' ' 243' ' ' ILE . . . -143.13 65.96 0.47 Allowed Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.493 -0.86 . . . . 0.0 112.908 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 212' ' ' ASN . . . . . 0.529 ' HB3' ' HA ' ' A' ' 270' ' ' ARG . 54.6 t30 174.83 39.54 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.252 0.549 . . . . 0.0 110.125 178.251 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.476 ' HB3' ' HD2' ' A' ' 214' ' ' PRO . 0.5 OUTLIER -89.96 162.82 34.33 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.985 -179.617 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.476 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 74.9 Cg_endo -83.8 169.27 12.0 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.739 2.293 . . . . 0.0 111.396 175.461 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -78.92 134.58 36.86 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 177.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 103.32 -9.78 53.89 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.468 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 217' ' ' ILE . . . . . 0.601 HG23 HG21 ' A' ' 237' ' ' ILE . 4.9 tp -59.85 128.08 20.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-O 121.071 0.462 . . . . 0.0 110.494 178.694 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 218' ' ' THR . . . . . 0.447 ' CG2' ' HG2' ' A' ' 221' ' ' GLU . 9.0 t -114.43 158.28 21.77 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-O 121.252 0.548 . . . . 0.0 110.575 179.242 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.458 ' H ' ' CD ' ' A' ' 219' ' ' GLU . 1.3 mp0 -62.3 -39.35 92.68 Favored 'General case' 0 C--O 1.21 -0.975 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.809 -175.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -52.33 -37.82 56.98 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 123.676 0.61 . . . . 0.0 111.234 -178.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 221' ' ' GLU . . . . . 0.447 ' HG2' ' CG2' ' A' ' 218' ' ' THR . 47.5 mm-40 -68.16 -53.57 24.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.367 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 222' ' ' ILE . . . . . 0.583 HD12 HD11 ' A' ' 237' ' ' ILE . 8.0 mt -62.0 -42.33 94.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.254 179.378 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 223' ' ' ARG . . . . . 0.705 ' HG3' HD12 ' A' ' 235' ' ' ILE . 66.4 mtp180 -53.27 -63.15 1.24 Allowed 'General case' 0 CA--C 1.507 -0.7 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 175.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -57.16 -23.91 50.72 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.782 -177.7 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -83.37 -33.1 25.88 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.592 -178.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.773 HD23 ' HZ ' ' A' ' 248' ' ' PHE . 7.7 mp -106.0 -15.51 14.88 Favored 'General case' 0 C--O 1.224 -0.253 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -171.655 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 227' ' ' GLU . . . . . 0.649 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 43.6 mm-40 -61.62 -37.62 42.67 Favored Pre-proline 0 C--N 1.328 -0.366 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -177.444 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 228' ' ' PRO . . . . . 0.649 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 85.1 Cg_endo -66.08 -29.07 48.6 Favored 'Trans proline' 0 C--N 1.358 1.039 0 C-N-CA 121.638 1.558 . . . . 0.0 112.414 -172.749 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 229' ' ' PHE . . . . . 0.52 ' CE1' ' HA ' ' A' ' 226' ' ' LEU . 3.5 p90 -110.56 -11.06 14.5 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.449 -0.5 . . . . 0.0 111.999 176.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 230' ' ' GLY . . . . . 0.415 ' CA ' ' HB1' ' A' ' 253' ' ' ALA . . . -164.93 92.4 0.11 Allowed Glycine 0 N--CA 1.44 -1.048 0 C-N-CA 120.282 -0.961 . . . . 0.0 112.01 -175.734 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -60.41 130.18 32.75 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.126 1.884 . . . . 0.0 111.319 178.054 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.784 HG21 HG12 ' A' ' 246' ' ' VAL . 2.3 mp -109.17 152.22 11.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.898 179.135 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 233' ' ' ASP . . . . . 0.421 ' CG ' HD22 ' A' ' 249' ' ' LEU . 27.7 m-20 -112.99 -23.47 10.04 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.985 0.421 . . . . 0.0 110.675 176.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 234' ' ' GLN . . . . . 0.554 ' HB3' ' HB2' ' A' ' 247' ' ' HIS . 35.1 tt0 -139.36 120.47 14.67 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.721 -175.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 235' ' ' ILE . . . . . 0.705 HD12 ' HG3' ' A' ' 223' ' ' ARG . 13.7 mt -136.61 112.3 11.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.037 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -120.32 110.74 16.91 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.57 -177.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 237' ' ' ILE . . . . . 0.601 HG21 HG23 ' A' ' 217' ' ' ILE . 72.6 mt -98.85 117.55 44.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.791 -178.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.609 ' HB ' HG13 ' A' ' 243' ' ' ILE . 24.3 t -97.97 88.29 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 174.044 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 8.8 t -65.04 -24.33 67.45 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.455 -175.645 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -66.93 -21.49 65.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.329 0.585 . . . . 0.0 110.339 178.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 241' ' ' ARG . . . . . 0.624 ' CB ' HG12 ' A' ' 243' ' ' ILE . 33.4 mmt180 -117.91 -2.73 11.26 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.906 -178.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 17.4 m120 66.35 25.33 10.41 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.73 178.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.624 HG12 ' CB ' ' A' ' 241' ' ' ARG . 2.8 pt -122.33 153.1 26.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.01 -173.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 244' ' ' ALA . . . . . 0.486 ' HB3' ' HB2' ' A' ' 210' ' ' LEU . . . -142.14 134.92 28.47 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.897 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -105.89 120.13 40.95 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.821 178.492 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 246' ' ' VAL . . . . . 0.784 HG12 HG21 ' A' ' 232' ' ' ILE . 0.2 OUTLIER -116.95 133.38 63.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -177.079 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 247' ' ' HIS . . . . . 0.748 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 41.3 m170 -115.05 102.81 10.29 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.067 -0.653 . . . . 0.0 111.195 177.631 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 248' ' ' PHE . . . . . 0.773 ' HZ ' HD23 ' A' ' 226' ' ' LEU . 28.2 m-85 -86.67 104.52 16.15 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.333 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.507 HD23 ' H ' ' A' ' 249' ' ' LEU . 0.1 OUTLIER -41.92 -46.44 4.05 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 124.405 1.066 . . . . 0.0 113.111 -175.766 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -94.02 145.64 24.51 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.296 178.092 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 251' ' ' ILE . . . . . 0.614 ' O ' HG13 ' A' ' 255' ' ' ILE . 0.2 OUTLIER -63.38 -41.72 93.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -179.705 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -70.69 -31.2 68.0 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 120.783 0.325 . . . . 0.0 110.57 -174.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 253' ' ' ALA . . . . . 0.415 ' HB1' ' CA ' ' A' ' 230' ' ' GLY . . . -59.5 -43.56 93.33 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.253 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 254' ' ' ALA . . . . . 0.594 ' HB2' ' HB2' ' A' ' 248' ' ' PHE . . . -68.44 -39.73 81.42 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.915 179.103 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.614 HG13 ' O ' ' A' ' 251' ' ' ILE . 7.9 mt -56.95 -61.97 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.21 -177.797 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 256' ' ' LYS . . . . . 0.511 ' O ' ' HG2' ' A' ' 260' ' ' GLU . 10.7 ptmt -61.43 -40.57 94.93 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.512 -176.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -60.44 -49.53 77.21 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.72 0.295 . . . . 0.0 111.365 178.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 258' ' ' VAL . . . . . 0.451 HG13 HG12 ' A' ' 272' ' ' ILE . 51.7 t -67.24 -23.34 30.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 120.98 0.419 . . . . 0.0 111.206 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 259' ' ' GLN . . . . . 0.518 ' HG3' ' O ' ' A' ' 255' ' ' ILE . 54.2 mt-30 -83.28 -27.39 29.86 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 122.193 -0.317 . . . . 0.0 111.54 177.549 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 260' ' ' GLU . . . . . 0.511 ' HG2' ' O ' ' A' ' 256' ' ' LYS . 30.2 mm-40 -95.62 -30.16 13.94 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.33 -173.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.714 ' HA ' ' HE3' ' A' ' 267' ' ' TRP . 0.7 OUTLIER -51.79 -51.41 70.61 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.382 178.096 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 262' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 261' ' ' LEU . 42.6 Cg_endo -67.07 -15.83 47.68 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.408 2.072 . . . . 0.0 112.84 -177.378 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 60.6 mt -94.94 -3.09 49.24 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.291 0.567 . . . . 0.0 111.832 -177.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 264' ' ' ASN . . . . . 0.486 ' O ' ' HB2' ' A' ' 268' ' ' SER . 13.3 m-80 -105.91 147.99 35.73 Favored Pre-proline 0 C--N 1.314 -0.947 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.321 -177.471 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -66.92 -32.87 34.71 Favored 'Trans proline' 0 C--N 1.334 -0.195 0 C-N-CA 123.35 2.7 . . . . 0.0 112.733 -168.381 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 3.8 mtpt -86.21 -44.53 12.1 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.517 0.675 . . . . 0.0 109.51 -178.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 267' ' ' TRP . . . . . 0.714 ' HE3' ' HA ' ' A' ' 261' ' ' LEU . 13.5 m0 -77.16 -28.15 54.02 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.874 -174.249 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 268' ' ' SER . . . . . 0.486 ' HB2' ' O ' ' A' ' 264' ' ' ASN . 8.0 t -68.68 -15.12 63.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.035 0.445 . . . . 0.0 110.504 178.692 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -74.65 -14.67 60.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.856 174.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 270' ' ' ARG . . . . . 0.529 ' HA ' ' HB3' ' A' ' 212' ' ' ASN . 4.1 mpt_? -99.37 162.65 12.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.838 178.698 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 271' ' ' ARG . . . . . 0.424 ' HG2' ' CB ' ' A' ' 212' ' ' ASN . 36.7 mmt180 -112.14 105.76 14.2 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 174.682 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 272' ' ' ILE . . . . . 0.693 HG21 HD23 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -116.87 140.91 37.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.373 0.606 . . . . 0.0 111.34 -175.817 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -151.66 167.99 26.41 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.805 172.46 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 274' ' ' TYR . . . . . 0.591 ' OH ' ' HA ' ' A' ' 255' ' ' ILE . 85.9 m-85 . . . . . 0 C--N 1.321 -0.65 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.402 174.599 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 206' ' ' ARG . . . . . 0.804 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 57.1 mtp180 . . . . . 0 C--O 1.224 -0.281 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -108.36 105.79 15.64 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 119.85 -0.74 . . . . 0.0 112.041 -175.204 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.449 ' HB ' ' HB ' ' A' ' 246' ' ' VAL . 67.9 t -133.49 113.48 18.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 114.691 -1.141 . . . . 0.0 109.153 176.199 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 209' ' ' PHE . . . . . 0.45 ' HE1' ' HB ' ' A' ' 243' ' ' ILE . 1.7 t80 -112.05 122.37 47.58 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.094 -175.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.641 ' HG ' HG22 ' A' ' 272' ' ' ILE . 5.4 mp -104.8 131.13 52.64 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.257 178.759 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 211' ' ' GLY . . . . . 0.654 ' HA2' HG22 ' A' ' 243' ' ' ILE . . . -137.16 64.1 0.57 Allowed Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.217 -0.992 . . . . 0.0 113.636 -178.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 212' ' ' ASN . . . . . 0.53 ' HB3' ' HA ' ' A' ' 270' ' ' ARG . 30.6 t30 175.81 37.15 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.055 0.455 . . . . 0.0 109.93 174.531 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.551 HD23 ' HG2' ' A' ' 270' ' ' ARG . 1.0 OUTLIER -81.8 158.26 68.17 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.849 -176.792 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.434 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 73.4 Cg_endo -74.89 152.47 41.38 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 122.351 2.034 . . . . 0.0 111.522 177.522 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -70.04 116.17 10.1 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.237 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 108.5 1.68 32.88 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.487 -0.863 . . . . 0.0 112.639 -177.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 217' ' ' ILE . . . . . 0.71 HG23 HG21 ' A' ' 237' ' ' ILE . 5.1 tp -60.66 130.54 24.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.0 0.428 . . . . 0.0 110.502 176.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 218' ' ' THR . . . . . 0.498 HG22 ' HG3' ' A' ' 221' ' ' GLU . 11.6 t -113.5 158.45 20.7 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.379 0.609 . . . . 0.0 110.949 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.541 ' H ' ' CD ' ' A' ' 219' ' ' GLU . 5.8 mp0 -61.85 -42.5 99.11 Favored 'General case' 0 C--O 1.21 -1.023 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.581 -176.355 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -48.18 -38.42 18.1 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 123.839 0.712 . . . . 0.0 111.547 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 221' ' ' GLU . . . . . 0.498 ' HG3' HG22 ' A' ' 218' ' ' THR . 42.3 mt-10 -66.22 -57.9 6.56 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.281 178.789 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 222' ' ' ILE . . . . . 0.585 HD12 HD11 ' A' ' 237' ' ' ILE . 8.4 mt -61.45 -41.3 89.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.602 -178.481 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 223' ' ' ARG . . . . . 0.754 ' HG3' HD12 ' A' ' 235' ' ' ILE . 48.7 mtp180 -53.63 -62.7 1.48 Allowed 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 175.793 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -58.27 -22.89 54.33 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.756 -177.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 225' ' ' ASP . . . . . 0.463 ' HB3' ' CZ2' ' A' ' 267' ' ' TRP . 10.7 m-20 -86.2 -32.26 21.3 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.844 -177.613 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.789 HD23 ' HZ ' ' A' ' 248' ' ' PHE . 7.7 mp -106.68 -15.31 14.79 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -170.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 227' ' ' GLU . . . . . 0.631 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 23.2 mm-40 -60.4 -38.38 57.16 Favored Pre-proline 0 C--N 1.327 -0.393 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -178.108 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 228' ' ' PRO . . . . . 0.631 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 96.1 Cg_endo -66.78 -26.47 45.12 Favored 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 121.587 1.525 . . . . 0.0 112.485 -171.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 229' ' ' PHE . . . . . 0.524 ' CZ ' ' HA ' ' A' ' 226' ' ' LEU . 3.6 p90 -111.21 -9.19 14.33 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.958 175.633 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 230' ' ' GLY . . . . . 0.434 ' CA ' ' HB1' ' A' ' 253' ' ' ALA . . . -169.05 99.1 0.15 Allowed Glycine 0 N--CA 1.442 -0.942 0 C-N-CA 120.033 -1.079 . . . . 0.0 112.268 -175.457 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 231' ' ' PRO . . . . . 0.441 ' HA ' ' OE2' ' A' ' 227' ' ' GLU . 18.5 Cg_endo -65.86 131.43 27.32 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 121.808 1.672 . . . . 0.0 111.532 178.643 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.709 HG21 HG12 ' A' ' 246' ' ' VAL . 2.1 mp -108.68 151.51 10.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.437 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 233' ' ' ASP . . . . . 0.458 ' CG ' HD22 ' A' ' 249' ' ' LEU . 38.0 m-20 -114.56 -19.89 10.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.848 0.356 . . . . 0.0 110.75 177.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 234' ' ' GLN . . . . . 0.492 ' HB3' ' HB2' ' A' ' 247' ' ' HIS . 9.4 tt0 -143.62 121.22 11.8 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.73 -177.501 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 235' ' ' ILE . . . . . 0.754 HD12 ' HG3' ' A' ' 223' ' ' ARG . 12.1 mt -135.09 108.52 9.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.964 -179.462 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 61.9 tttp -115.9 112.47 21.94 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.411 -178.306 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 237' ' ' ILE . . . . . 0.71 HG21 HG23 ' A' ' 217' ' ' ILE . 67.0 mt -102.35 124.1 56.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-O 121.017 0.436 . . . . 0.0 110.783 -179.544 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.532 ' HB ' HG13 ' A' ' 243' ' ' ILE . 61.2 t -105.23 87.68 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 171.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 13.2 t -69.84 -16.53 63.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.381 -177.084 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -62.06 -34.04 75.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.202 175.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 241' ' ' ARG . . . . . 0.774 ' HB2' HG12 ' A' ' 243' ' ' ILE . 77.0 mtt180 -112.88 -0.28 14.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.527 178.542 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 17.9 m120 67.46 29.64 7.2 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.847 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.774 HG12 ' HB2' ' A' ' 241' ' ' ARG . 1.3 pt -122.3 151.68 26.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.037 -175.498 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 244' ' ' ALA . . . . . 0.46 ' HB3' ' HB2' ' A' ' 210' ' ' LEU . . . -141.3 138.19 32.98 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.046 0.451 . . . . 0.0 111.849 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -107.27 108.05 19.28 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.836 177.656 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 246' ' ' VAL . . . . . 0.709 HG12 HG21 ' A' ' 232' ' ' ILE . 0.9 OUTLIER -106.12 133.57 50.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 -179.288 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 247' ' ' HIS . . . . . 0.804 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 41.8 m170 -112.27 101.97 10.16 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.486 0.66 . . . . 0.0 111.295 178.437 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 248' ' ' PHE . . . . . 0.789 ' HZ ' HD23 ' A' ' 226' ' ' LEU . 33.7 m-85 -86.65 101.28 13.11 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.99 -1.004 . . . . 0.0 111.33 179.216 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.483 HD23 ' H ' ' A' ' 249' ' ' LEU . 0.1 OUTLIER -42.26 -48.05 4.88 Favored 'General case' 0 N--CA 1.465 0.312 0 O-C-N 124.367 1.042 . . . . 0.0 112.583 -176.611 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 46.1 m-20 -84.95 138.18 32.65 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 178.387 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 251' ' ' ILE . . . . . 0.584 ' O ' HG13 ' A' ' 255' ' ' ILE . 0.2 OUTLIER -62.38 -43.69 98.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -179.609 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -68.98 -30.12 68.47 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.901 -177.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 253' ' ' ALA . . . . . 0.434 ' HB1' ' CA ' ' A' ' 230' ' ' GLY . . . -60.72 -41.74 95.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.32 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 254' ' ' ALA . . . . . 0.594 ' HB2' ' HB2' ' A' ' 248' ' ' PHE . . . -67.87 -41.29 83.08 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.591 178.38 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.584 HG13 ' O ' ' A' ' 251' ' ' ILE . 11.7 mt -56.05 -60.84 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.159 -178.634 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 10.0 ptmt -62.66 -38.84 91.92 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.622 -176.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -61.96 -47.97 82.46 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.557 0.218 . . . . 0.0 111.349 178.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 258' ' ' VAL . . . . . 0.557 HG13 HG12 ' A' ' 272' ' ' ILE . 54.6 t -65.15 -25.14 36.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.878 0.371 . . . . 0.0 110.931 178.297 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -83.71 -23.61 31.59 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 178.267 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -94.93 -34.93 12.21 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.826 0.345 . . . . 0.0 110.689 -175.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.732 ' HA ' ' HE3' ' A' ' 267' ' ' TRP . 0.7 OUTLIER -51.57 -50.48 76.73 Favored Pre-proline 0 CA--C 1.538 0.503 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.578 -178.296 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 262' ' ' PRO . . . . . 0.586 ' HD3' HD11 ' A' ' 272' ' ' ILE . 37.3 Cg_endo -66.35 -20.6 55.02 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.222 1.948 . . . . 0.0 112.544 -177.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 65.8 mt -90.65 -2.22 57.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.292 0.568 . . . . 0.0 111.551 -175.069 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 264' ' ' ASN . . . . . 0.403 ' O ' ' HB2' ' A' ' 268' ' ' SER . 12.2 m-80 -106.71 148.93 37.77 Favored Pre-proline 0 C--N 1.315 -0.916 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.938 -176.115 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -65.59 -34.2 42.82 Favored 'Trans proline' 0 C--O 1.23 0.11 0 C-N-CA 123.367 2.711 . . . . 0.0 112.604 -171.276 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 5.1 mtpt -86.05 -45.23 11.62 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 121.812 0.815 . . . . 0.0 109.747 -177.513 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 267' ' ' TRP . . . . . 0.732 ' HE3' ' HA ' ' A' ' 261' ' ' LEU . 11.3 m0 -78.75 -26.02 44.57 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.722 -172.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 268' ' ' SER . . . . . 0.403 ' HB2' ' O ' ' A' ' 264' ' ' ASN . 37.3 t -61.41 -22.15 64.75 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.758 0.313 . . . . 0.0 111.01 177.454 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -71.15 -18.08 62.52 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.242 0.544 . . . . 0.0 110.481 176.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 270' ' ' ARG . . . . . 0.551 ' HG2' HD23 ' A' ' 213' ' ' LEU . 0.0 OUTLIER -101.9 140.56 36.02 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.475 -179.932 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 271' ' ' ARG . . . . . 0.779 ' HA ' ' HE ' ' A' ' 271' ' ' ARG . 0.2 OUTLIER -95.62 105.77 17.8 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.777 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 272' ' ' ILE . . . . . 0.717 HG21 HD23 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -115.24 144.07 23.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.352 0.596 . . . . 0.0 111.285 -174.693 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -151.87 169.46 22.22 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.421 174.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 . . . . . 0 N--CA 1.449 -0.519 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 171.541 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 206' ' ' ARG . . . . . 0.82 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 24.7 mtp-105 . . . . . 0 C--O 1.222 -0.388 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -101.3 106.04 17.18 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 118.681 0.673 . . . . 0.0 111.562 -172.034 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.413 ' HB ' ' HB ' ' A' ' 246' ' ' VAL . 60.0 t -138.57 119.69 16.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.936 176.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 209' ' ' PHE . . . . . 0.437 ' O ' ' HA ' ' A' ' 272' ' ' ILE . 4.3 t80 -116.31 125.64 52.43 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.49 -177.637 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.625 ' HG ' HG22 ' A' ' 272' ' ' ILE . 6.2 mp -110.7 133.96 52.88 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.612 178.194 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 211' ' ' GLY . . . . . 0.569 ' HA2' HG22 ' A' ' 243' ' ' ILE . . . -138.94 65.9 0.53 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.591 -0.814 . . . . 0.0 113.351 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 212' ' ' ASN . . . . . 0.462 ' HB2' ' O ' ' A' ' 211' ' ' GLY . 25.1 t30 172.05 42.77 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.831 0.348 . . . . 0.0 110.617 177.725 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.473 HD21 HD22 ' A' ' 210' ' ' LEU . 1.2 mp -91.23 160.32 37.57 Favored Pre-proline 0 C--N 1.322 -0.591 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.268 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.413 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 92.7 Cg_endo -82.49 166.76 15.62 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 122.637 2.225 . . . . 0.0 112.202 177.464 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -73.36 125.87 28.83 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.324 0.583 . . . . 0.0 111.139 178.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 106.01 -8.78 42.6 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.839 178.175 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 217' ' ' ILE . . . . . 0.8 HG23 HG21 ' A' ' 237' ' ' ILE . 5.0 tp -57.99 125.92 14.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.338 0.59 . . . . 0.0 110.625 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 218' ' ' THR . . . . . 0.457 ' CG2' ' HG3' ' A' ' 221' ' ' GLU . 11.1 t -114.42 157.88 22.3 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.751 -178.403 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -61.34 -35.53 77.67 Favored 'General case' 0 C--O 1.209 -1.056 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.936 -177.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 220' ' ' ASP . . . . . 0.42 ' O ' ' HG2' ' A' ' 224' ' ' GLU . 29.5 t70 -51.32 -40.0 58.14 Favored 'General case' 0 C--N 1.32 -0.702 0 O-C-N 123.632 0.582 . . . . 0.0 111.109 178.639 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 221' ' ' GLU . . . . . 0.457 ' HG3' ' CG2' ' A' ' 218' ' ' THR . 44.4 mt-10 -70.01 -54.13 14.59 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.562 -179.32 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 222' ' ' ILE . . . . . 0.584 HD12 HD11 ' A' ' 237' ' ' ILE . 11.8 mt -60.98 -42.29 92.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.616 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 223' ' ' ARG . . . . . 0.831 ' HG3' HD12 ' A' ' 235' ' ' ILE . 38.9 mtp180 -53.87 -63.09 1.26 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 174.279 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.42 ' HG2' ' O ' ' A' ' 220' ' ' ASP . 15.4 pt-20 -57.7 -22.16 44.67 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.19 -177.338 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 225' ' ' ASP . . . . . 0.481 ' HB3' ' CZ2' ' A' ' 267' ' ' TRP . 27.0 m-20 -89.62 -31.88 17.34 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.973 -177.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.854 HD23 ' HZ ' ' A' ' 248' ' ' PHE . 8.3 mp -107.05 -17.46 14.17 Favored 'General case' 0 C--O 1.224 -0.282 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -169.765 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 227' ' ' GLU . . . . . 0.679 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 58.6 mt-10 -69.6 -26.91 1.15 Allowed Pre-proline 0 C--N 1.323 -0.568 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -175.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 228' ' ' PRO . . . . . 0.679 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 72.3 Cg_endo -66.25 -27.84 48.06 Favored 'Trans proline' 0 C--N 1.36 1.179 0 C-N-CA 121.247 1.298 . . . . 0.0 111.916 -178.659 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 229' ' ' PHE . . . . . 0.489 ' CZ ' ' HA ' ' A' ' 226' ' ' LEU . 3.6 p90 -110.6 -9.36 14.55 Favored 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.66 174.238 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 230' ' ' GLY . . . . . 0.404 ' HA2' ' HD2' ' A' ' 231' ' ' PRO . . . -168.35 93.77 0.11 Allowed Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 120.18 -1.01 . . . . 0.0 112.109 -175.336 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 231' ' ' PRO . . . . . 0.404 ' HD2' ' HA2' ' A' ' 230' ' ' GLY . 16.9 Cg_endo -59.76 133.59 52.08 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.214 1.943 . . . . 0.0 111.393 177.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.726 HG21 HG12 ' A' ' 246' ' ' VAL . 2.4 mp -111.4 151.59 13.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.309 177.519 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 233' ' ' ASP . . . . . 0.435 ' OD2' HD22 ' A' ' 249' ' ' LEU . 14.9 m-20 -115.51 -20.08 10.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.76 0.314 . . . . 0.0 111.227 177.626 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 234' ' ' GLN . . . . . 0.543 ' HB3' ' HB2' ' A' ' 247' ' ' HIS . 22.9 tt0 -142.77 120.48 11.86 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.279 -176.415 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 235' ' ' ILE . . . . . 0.831 HD12 ' HG3' ' A' ' 223' ' ' ARG . 17.2 mt -136.3 116.28 17.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.889 -179.446 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -122.2 116.11 23.58 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.849 0.357 . . . . 0.0 110.457 178.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 237' ' ' ILE . . . . . 0.8 HG21 HG23 ' A' ' 217' ' ' ILE . 33.4 mt -104.57 115.47 46.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.248 179.224 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.575 ' HB ' HG13 ' A' ' 243' ' ' ILE . 45.5 t -94.26 87.0 2.04 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.152 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 173.673 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 8.8 t -65.32 -22.29 66.81 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.482 -177.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -60.32 -29.12 68.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.565 176.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 241' ' ' ARG . . . . . 0.786 ' HB2' HG12 ' A' ' 243' ' ' ILE . 73.9 mtt180 -120.0 0.43 10.77 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.797 -179.436 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 242' ' ' ASN . . . . . 0.472 ' O ' HD12 ' A' ' 213' ' ' LEU . 92.1 m-20 66.16 29.72 9.66 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.194 179.764 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.786 HG12 ' HB2' ' A' ' 241' ' ' ARG . 1.3 pt -121.92 151.34 25.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.792 -176.569 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 244' ' ' ALA . . . . . 0.552 ' HB3' ' HB2' ' A' ' 210' ' ' LEU . . . -141.55 138.77 32.92 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.103 0.477 . . . . 0.0 111.55 -178.416 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -110.78 111.43 22.6 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.677 176.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 246' ' ' VAL . . . . . 0.726 HG12 HG21 ' A' ' 232' ' ' ILE . 0.8 OUTLIER -108.16 134.89 48.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -179.234 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 247' ' ' HIS . . . . . 0.82 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 46.1 m80 -116.06 101.72 9.0 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 119.995 -0.682 . . . . 0.0 111.457 178.623 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 248' ' ' PHE . . . . . 0.854 ' HZ ' HD23 ' A' ' 226' ' ' LEU . 29.9 m-85 -84.67 104.67 14.85 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.716 -1.129 . . . . 0.0 111.113 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.577 ' HA ' ' HE ' ' A' ' 206' ' ' ARG . 0.1 OUTLIER -42.82 -42.56 3.66 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 124.194 0.934 . . . . 0.0 113.058 -174.11 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 47.4 m-20 -95.51 143.8 26.53 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.23 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 251' ' ' ILE . . . . . 0.533 ' O ' HG13 ' A' ' 255' ' ' ILE . 0.2 OUTLIER -63.56 -45.0 98.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -177.594 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -70.79 -29.14 65.25 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-O 120.625 0.25 . . . . 0.0 110.791 -176.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -58.6 -42.7 88.71 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.36 178.326 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 254' ' ' ALA . . . . . 0.594 ' HB2' ' HB2' ' A' ' 248' ' ' PHE . . . -67.29 -42.0 84.49 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.626 178.025 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.533 HG13 ' O ' ' A' ' 251' ' ' ILE . 8.5 mt -56.95 -61.31 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.539 -177.292 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 256' ' ' LYS . . . . . 0.406 ' O ' ' HG2' ' A' ' 260' ' ' GLU . 12.3 ptmt -60.41 -38.52 84.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.271 -177.3 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -62.75 -47.91 81.47 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.741 0.305 . . . . 0.0 111.211 178.098 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 44.4 t -66.18 -23.54 32.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.011 0.434 . . . . 0.0 111.023 179.288 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 259' ' ' GLN . . . . . 0.484 ' HG3' ' O ' ' A' ' 255' ' ' ILE . 50.8 mt-30 -83.53 -27.8 29.09 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.825 177.507 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 260' ' ' GLU . . . . . 0.406 ' HG2' ' O ' ' A' ' 256' ' ' LYS . 50.9 mm-40 -96.02 -28.89 14.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.69 0.281 . . . . 0.0 111.59 -173.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.731 ' HA ' ' HE3' ' A' ' 267' ' ' TRP . 0.7 OUTLIER -54.1 -50.04 86.62 Favored Pre-proline 0 CA--C 1.536 0.437 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.516 179.252 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 262' ' ' PRO . . . . . 0.581 ' HD2' ' N ' ' A' ' 261' ' ' LEU . 41.2 Cg_endo -66.41 -13.76 41.27 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.271 1.981 . . . . 0.0 112.419 -179.271 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 60.8 mt -91.15 -8.0 49.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.929 0.395 . . . . 0.0 112.0 -178.069 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 264' ' ' ASN . . . . . 0.405 ' O ' ' HB2' ' A' ' 268' ' ' SER . 3.2 m-20 -106.11 149.8 38.57 Favored Pre-proline 0 C--O 1.211 -0.964 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.974 -177.196 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 265' ' ' PRO . . . . . 0.427 ' O ' ' HG3' ' A' ' 269' ' ' LYS . 47.3 Cg_endo -67.28 -33.28 30.98 Favored 'Trans proline' 0 C--O 1.224 -0.21 0 C-N-CA 123.325 2.684 . . . . 0.0 112.804 -171.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 266' ' ' LYS . . . . . 0.461 ' HB2' ' HE3' ' A' ' 266' ' ' LYS . 0.0 OUTLIER -83.35 -45.91 13.19 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 121.732 0.777 . . . . 0.0 109.224 -179.376 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 267' ' ' TRP . . . . . 0.731 ' HE3' ' HA ' ' A' ' 261' ' ' LEU . 14.3 m0 -76.49 -29.75 56.96 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.909 -172.621 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 268' ' ' SER . . . . . 0.405 ' HB2' ' O ' ' A' ' 264' ' ' ASN . 24.1 t -63.84 -23.12 67.23 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.896 0.379 . . . . 0.0 110.72 178.659 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 269' ' ' LYS . . . . . 0.427 ' HG3' ' O ' ' A' ' 265' ' ' PRO . 93.4 mttt -70.82 -19.08 62.7 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.283 0.563 . . . . 0.0 109.695 178.123 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 270' ' ' ARG . . . . . 0.432 ' HA ' ' HB3' ' A' ' 212' ' ' ASN . 4.7 mpt_? -93.25 146.49 23.66 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.476 176.2 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 6.6 mmp_? -99.33 106.07 18.13 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 173.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 272' ' ' ILE . . . . . 0.679 HG21 HD23 ' A' ' 261' ' ' LEU . 0.1 OUTLIER -117.73 142.34 32.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.336 0.589 . . . . 0.0 111.552 -176.673 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -150.61 168.87 23.0 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.254 170.716 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 . . . . . 0 C--N 1.324 -0.509 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 175.095 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 206' ' ' ARG . . . . . 0.748 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 15.0 mtm180 . . . . . 0 C--O 1.224 -0.256 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 19.3 m-80 -100.65 105.64 17.03 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 118.876 0.762 . . . . 0.0 111.332 -172.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.504 ' HB ' ' HB ' ' A' ' 246' ' ' VAL . 60.3 t -137.36 127.76 38.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.24 176.375 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 209' ' ' PHE . . . . . 0.591 ' HB3' ' CE1' ' A' ' 273' ' ' TYR . 1.8 t80 -127.44 128.18 45.33 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 -177.514 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.489 ' HG ' HG22 ' A' ' 272' ' ' ILE . 5.9 mp -111.02 134.0 52.96 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.505 179.032 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 211' ' ' GLY . . . . . 0.595 ' HA2' HG22 ' A' ' 243' ' ' ILE . . . -138.94 65.68 0.53 Allowed Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.098 -1.048 . . . . 0.0 113.328 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 212' ' ' ASN . . . . . 0.581 ' HB2' ' HG3' ' A' ' 271' ' ' ARG . 3.3 t30 174.83 40.92 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.24 0.543 . . . . 0.0 110.105 175.784 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.623 ' HA ' ' HG3' ' A' ' 270' ' ' ARG . 1.0 OUTLIER -85.81 155.85 58.53 Favored Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.811 -177.693 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -79.79 169.14 18.5 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.81 2.34 . . . . 0.0 112.059 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -78.69 124.05 27.79 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 108.52 -2.83 32.53 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.592 -0.814 . . . . 0.0 112.613 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 217' ' ' ILE . . . . . 0.403 HG23 HG21 ' A' ' 237' ' ' ILE . 6.0 tp -65.14 125.18 21.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-O 121.255 0.55 . . . . 0.0 111.194 179.001 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 218' ' ' THR . . . . . 0.465 HG22 ' HG3' ' A' ' 221' ' ' GLU . 15.0 t -114.4 161.05 18.45 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.561 177.502 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.449 ' H ' ' CD ' ' A' ' 219' ' ' GLU . 9.3 mp0 -62.81 -38.04 89.11 Favored 'General case' 0 C--O 1.208 -1.105 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.059 -178.411 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 220' ' ' ASP . . . . . 0.483 ' O ' ' HG2' ' A' ' 224' ' ' GLU . 26.2 t70 -51.63 -37.87 52.21 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 123.618 0.574 . . . . 0.0 110.813 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 221' ' ' GLU . . . . . 0.465 ' HG3' HG22 ' A' ' 218' ' ' THR . 41.9 mt-10 -67.49 -57.5 6.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.4 178.574 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 222' ' ' ILE . . . . . 0.533 HG23 HD22 ' A' ' 226' ' ' LEU . 6.9 mt -58.29 -41.67 81.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.351 -179.604 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 223' ' ' ARG . . . . . 0.729 ' HG3' HD12 ' A' ' 235' ' ' ILE . 37.3 mtp180 -57.12 -62.84 1.47 Allowed 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 175.82 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.483 ' HG2' ' O ' ' A' ' 220' ' ' ASP . 11.1 pt-20 -59.32 -20.8 57.49 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.083 -177.023 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 225' ' ' ASP . . . . . 0.462 ' HB3' ' CZ2' ' A' ' 267' ' ' TRP . 3.3 m-20 -90.58 -31.43 16.69 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.637 -177.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.681 HD23 ' HZ ' ' A' ' 248' ' ' PHE . 8.2 mp -107.45 -19.1 13.68 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -171.588 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 227' ' ' GLU . . . . . 0.693 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 48.1 mt-10 -73.34 -22.24 0.49 Allowed Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 113.264 0.839 . . . . 0.0 113.264 -175.591 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 228' ' ' PRO . . . . . 0.693 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 74.3 Cg_endo -66.59 -28.17 45.21 Favored 'Trans proline' 0 C--N 1.361 1.223 0 CA-C-N 120.747 1.302 . . . . 0.0 111.895 178.357 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 229' ' ' PHE . . . . . 0.482 ' CE1' ' HA ' ' A' ' 226' ' ' LEU . 2.9 p90 -110.71 -5.66 14.96 Favored 'General case' 0 C--O 1.225 -0.237 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.609 174.803 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 230' ' ' GLY . . . . . 0.482 ' CA ' ' HB1' ' A' ' 253' ' ' ALA . . . -174.6 95.59 0.1 Allowed Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 119.945 -1.121 . . . . 0.0 112.554 -175.695 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 231' ' ' PRO . . . . . 0.487 ' HA ' ' HG2' ' A' ' 227' ' ' GLU . 19.2 Cg_endo -60.75 135.69 61.7 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.264 1.976 . . . . 0.0 111.584 177.788 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.632 HG21 HG12 ' A' ' 246' ' ' VAL . 3.3 mp -108.6 151.31 10.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.488 178.166 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 233' ' ' ASP . . . . . 0.489 ' CG ' HD22 ' A' ' 249' ' ' LEU . 12.7 m-20 -107.07 -25.58 11.52 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.001 0.429 . . . . 0.0 110.831 178.657 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 234' ' ' GLN . . . . . 0.473 ' H ' HG22 ' A' ' 232' ' ' ILE . 12.9 tt0 -145.1 120.28 10.15 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.749 -173.774 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 235' ' ' ILE . . . . . 0.729 HD12 ' HG3' ' A' ' 223' ' ' ARG . 24.0 mt -133.04 107.59 11.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.8 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -113.75 110.58 20.38 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.605 -175.672 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 237' ' ' ILE . . . . . 0.485 HD11 HD12 ' A' ' 222' ' ' ILE . 89.3 mt -100.76 121.52 51.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.262 0.553 . . . . 0.0 111.188 -178.43 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.499 ' HB ' HG13 ' A' ' 243' ' ' ILE . 46.1 t -108.97 87.22 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 172.563 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 13.9 t -68.33 -20.36 64.73 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.193 -177.38 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -57.91 -30.84 66.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.154 175.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 241' ' ' ARG . . . . . 0.696 ' HB2' HG12 ' A' ' 243' ' ' ILE . 98.8 mtt180 -118.26 4.41 11.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.732 177.815 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 17.5 m120 64.71 29.14 12.95 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.224 178.393 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.696 HG12 ' HB2' ' A' ' 241' ' ' ARG . 1.3 pt -122.19 151.64 26.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.31 -174.448 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -142.02 135.9 29.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.005 0.431 . . . . 0.0 111.446 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -103.91 114.42 28.66 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.702 178.46 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 246' ' ' VAL . . . . . 0.632 HG12 HG21 ' A' ' 232' ' ' ILE . 0.4 OUTLIER -110.35 132.17 59.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -179.349 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 247' ' ' HIS . . . . . 0.748 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 28.1 m80 -114.81 102.76 10.3 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 119.96 -0.696 . . . . 0.0 111.348 177.781 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 248' ' ' PHE . . . . . 0.681 ' HZ ' HD23 ' A' ' 226' ' ' LEU . 37.4 m-85 -86.18 102.98 14.39 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 114.887 -1.051 . . . . 0.0 111.33 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.489 HD22 ' CG ' ' A' ' 233' ' ' ASP . 0.2 OUTLIER -46.28 -37.9 7.92 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 124.437 1.086 . . . . 0.0 112.797 -175.789 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 250' ' ' ASN . . . . . 0.432 ' HB2' ' HB2' ' A' ' 253' ' ' ALA . 55.0 m-20 -97.27 136.32 37.93 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 178.697 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 251' ' ' ILE . . . . . 0.612 ' O ' HG13 ' A' ' 255' ' ' ILE . 0.2 OUTLIER -60.62 -43.41 94.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -179.094 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -70.96 -27.82 64.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.903 -176.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 253' ' ' ALA . . . . . 0.482 ' HB1' ' CA ' ' A' ' 230' ' ' GLY . . . -62.5 -41.72 99.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.215 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 254' ' ' ALA . . . . . 0.577 ' HB2' ' HB2' ' A' ' 248' ' ' PHE . . . -67.41 -41.96 84.04 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.645 178.391 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.675 ' HA ' ' OH ' ' A' ' 274' ' ' TYR . 13.5 mt -55.9 -61.25 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.297 -177.725 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 13.3 ptmt -62.37 -38.23 88.77 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.425 -176.648 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -64.48 -49.98 69.26 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 111.512 0.189 . . . . 0.0 111.512 179.117 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 258' ' ' VAL . . . . . 0.484 HG13 HG12 ' A' ' 272' ' ' ILE . 53.3 t -66.47 -22.79 30.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.01 0.434 . . . . 0.0 111.081 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -84.44 -24.61 29.47 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 175.724 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -90.55 -35.63 14.94 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.884 0.373 . . . . 0.0 111.032 -178.149 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.769 HD12 ' CE3' ' A' ' 267' ' ' TRP . 0.9 OUTLIER -52.24 -47.17 93.25 Favored Pre-proline 0 CA--C 1.54 0.576 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.79 -178.252 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 262' ' ' PRO . . . . . 0.563 ' HD3' HD11 ' A' ' 272' ' ' ILE . 39.1 Cg_endo -69.38 -21.86 34.64 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.257 1.971 . . . . 0.0 112.74 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 57.0 mt -90.02 -0.35 57.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.4 0.619 . . . . 0.0 111.114 -176.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 264' ' ' ASN . . . . . 0.474 ' O ' ' HB2' ' A' ' 268' ' ' SER . 12.1 m-80 -107.0 148.92 37.89 Favored Pre-proline 0 C--N 1.316 -0.857 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.757 -178.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -67.54 -41.74 8.18 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 123.074 2.516 . . . . 0.0 112.474 -171.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 266' ' ' LYS . . . . . 0.433 ' HE2' ' HB2' ' A' ' 266' ' ' LYS . 2.6 mtpt -80.9 -45.1 17.29 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-O 121.615 0.722 . . . . 0.0 109.784 -175.437 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 267' ' ' TRP . . . . . 0.769 ' CE3' HD12 ' A' ' 261' ' ' LEU . 22.6 m0 -72.83 -28.79 62.76 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.549 -175.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 268' ' ' SER . . . . . 0.474 ' HB2' ' O ' ' A' ' 264' ' ' ASN . 23.1 t -66.57 -20.05 65.92 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 120.952 -0.299 . . . . 0.0 111.013 178.881 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -71.44 -15.73 62.35 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.336 0.589 . . . . 0.0 109.721 175.264 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 270' ' ' ARG . . . . . 0.623 ' HG3' ' HA ' ' A' ' 213' ' ' LEU . 0.0 OUTLIER -104.09 139.9 38.53 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.713 175.71 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 271' ' ' ARG . . . . . 0.581 ' HG3' ' HB2' ' A' ' 212' ' ' ASN . 15.3 mtm180 -93.22 105.36 17.45 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 272' ' ' ILE . . . . . 0.662 HG21 HD23 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -110.21 141.88 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-O 121.423 0.63 . . . . 0.0 110.857 -175.14 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 273' ' ' TYR . . . . . 0.591 ' CE1' ' HB3' ' A' ' 209' ' ' PHE . 4.6 p90 -152.78 167.75 27.98 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.83 174.136 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 274' ' ' TYR . . . . . 0.675 ' OH ' ' HA ' ' A' ' 255' ' ' ILE . 90.1 m-85 . . . . . 0 C--N 1.318 -0.795 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.266 172.323 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 206' ' ' ARG . . . . . 0.82 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 49.0 mtp180 . . . . . 0 CA--C 1.537 0.476 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 69.6 m-20 -100.86 106.13 17.47 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 119.125 0.875 . . . . 0.0 112.041 -173.313 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.5 ' HB ' ' HB ' ' A' ' 246' ' ' VAL . 59.5 t -136.02 117.6 19.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.607 178.094 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -115.47 123.38 48.42 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.752 0.31 . . . . 0.0 110.5 -177.244 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.74 ' HG ' HG22 ' A' ' 272' ' ' ILE . 5.9 mp -106.89 133.81 50.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.57 178.064 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 211' ' ' GLY . . . . . 0.557 ' HA2' HG22 ' A' ' 243' ' ' ILE . . . -143.39 65.78 0.47 Allowed Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.618 -0.801 . . . . 0.0 113.088 179.453 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 212' ' ' ASN . . . . . 0.52 ' HB3' ' HA ' ' A' ' 270' ' ' ARG . 50.5 t30 177.05 39.85 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.325 0.583 . . . . 0.0 109.733 177.315 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.764 HD23 ' HG2' ' A' ' 270' ' ' ARG . 1.2 mt -89.53 165.2 26.55 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.156 -179.269 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.496 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 78.5 Cg_endo -83.66 167.77 13.0 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 122.423 2.082 . . . . 0.0 111.14 174.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 215' ' ' ASN . . . . . 0.483 ' HA ' ' OG1' ' A' ' 239' ' ' THR . 40.9 t-20 -79.21 125.71 29.82 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 177.858 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 105.96 -3.92 38.7 Favored Glycine 0 C--N 1.314 -0.661 0 C-N-CA 120.458 -0.877 . . . . 0.0 113.082 -179.348 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 217' ' ' ILE . . . . . 0.696 HG23 HG21 ' A' ' 237' ' ' ILE . 5.0 tp -59.29 126.32 16.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.041 0.448 . . . . 0.0 110.436 178.815 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 218' ' ' THR . . . . . 0.477 ' CG2' ' HG3' ' A' ' 221' ' ' GLU . 10.6 t -111.11 156.81 20.8 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.321 0.582 . . . . 0.0 110.839 -178.041 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.508 ' H ' ' CD ' ' A' ' 219' ' ' GLU . 18.4 mp0 -62.28 -36.59 82.55 Favored 'General case' 0 C--O 1.21 -1.011 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.449 -177.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -50.98 -36.37 38.75 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.018 178.687 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 221' ' ' GLU . . . . . 0.477 ' HG3' ' CG2' ' A' ' 218' ' ' THR . 42.3 mt-10 -70.94 -59.46 2.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.798 178.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 222' ' ' ILE . . . . . 0.593 HD12 HD11 ' A' ' 237' ' ' ILE . 7.6 mt -60.21 -39.85 81.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.469 -178.189 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 223' ' ' ARG . . . . . 0.666 ' HG3' HD12 ' A' ' 235' ' ' ILE . 52.1 mtp180 -55.2 -62.27 1.78 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 174.088 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -55.71 -25.17 38.71 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.82 -178.281 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -86.3 -31.62 21.5 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.435 -176.355 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.78 HD23 ' HZ ' ' A' ' 248' ' ' PHE . 7.3 mp -108.43 -16.03 14.32 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -171.379 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 227' ' ' GLU . . . . . 0.639 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 34.8 mm-40 -61.55 -37.25 39.27 Favored Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -177.108 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 228' ' ' PRO . . . . . 0.639 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 96.7 Cg_endo -66.3 -30.57 45.13 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 121.5 1.467 . . . . 0.0 112.247 -172.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 229' ' ' PHE . . . . . 0.496 ' CE1' ' HA ' ' A' ' 226' ' ' LEU . 4.3 p90 -110.88 3.22 18.73 Favored 'General case' 0 C--O 1.221 -0.43 0 C-N-CA 120.591 -0.443 . . . . 0.0 111.346 176.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 230' ' ' GLY . . . . . 0.454 ' CA ' ' HB1' ' A' ' 253' ' ' ALA . . . -179.82 97.13 0.11 Allowed Glycine 0 N--CA 1.44 -1.041 0 C-N-CA 119.666 -1.254 . . . . 0.0 112.609 -178.061 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 231' ' ' PRO . . . . . 0.41 ' HD2' ' HA2' ' A' ' 230' ' ' GLY . 29.0 Cg_endo -64.17 134.31 41.91 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 121.772 1.648 . . . . 0.0 111.031 177.368 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.638 HG21 HG12 ' A' ' 246' ' ' VAL . 2.9 mp -108.59 150.65 11.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.97 178.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 233' ' ' ASP . . . . . 0.519 ' CG ' HD22 ' A' ' 249' ' ' LEU . 20.7 m-20 -107.44 -26.96 10.72 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.153 0.502 . . . . 0.0 110.446 178.731 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 234' ' ' GLN . . . . . 0.52 ' HB3' ' HB2' ' A' ' 247' ' ' HIS . 29.5 tt0 -142.24 120.31 12.13 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.612 -173.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 235' ' ' ILE . . . . . 0.666 HD12 ' HG3' ' A' ' 223' ' ' ARG . 13.5 mt -134.17 111.89 15.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.001 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 35.2 ttmt -115.66 112.61 22.36 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.349 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 237' ' ' ILE . . . . . 0.696 HG21 HG23 ' A' ' 217' ' ' ILE . 85.3 mt -102.13 121.62 53.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-O 121.1 0.476 . . . . 0.0 110.841 178.667 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.557 ' HB ' HG13 ' A' ' 243' ' ' ILE . 39.2 t -104.46 87.07 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 172.513 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 239' ' ' THR . . . . . 0.483 ' OG1' ' HA ' ' A' ' 215' ' ' ASN . 9.6 t -70.04 -15.33 62.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.222 -175.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -66.7 -32.73 74.23 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.133 175.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 241' ' ' ARG . . . . . 0.573 ' HB2' HG12 ' A' ' 243' ' ' ILE . 81.1 mtt180 -114.98 3.25 14.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.859 -178.366 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 67.66 24.87 8.32 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.288 176.739 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.573 HG12 ' HB2' ' A' ' 241' ' ' ARG . 1.8 pt -122.33 153.27 26.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.293 -175.009 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 244' ' ' ALA . . . . . 0.471 ' HB3' ' HB2' ' A' ' 210' ' ' LEU . . . -143.7 140.05 29.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.119 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -111.03 115.13 28.93 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.757 177.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 246' ' ' VAL . . . . . 0.638 HG12 HG21 ' A' ' 232' ' ' ILE . 1.1 t -111.81 136.05 49.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 -178.007 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 247' ' ' HIS . . . . . 0.82 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 44.0 m80 -117.41 102.62 9.37 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.594 0.711 . . . . 0.0 111.287 176.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 248' ' ' PHE . . . . . 0.78 ' HZ ' HD23 ' A' ' 226' ' ' LEU . 34.7 m-85 -85.38 104.61 15.35 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.634 -1.166 . . . . 0.0 111.516 -179.435 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.519 HD22 ' CG ' ' A' ' 233' ' ' ASP . 0.2 OUTLIER -46.57 -39.5 11.17 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 124.41 1.069 . . . . 0.0 112.929 -174.526 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 250' ' ' ASN . . . . . 0.424 ' HB2' ' HB2' ' A' ' 253' ' ' ALA . 47.5 m-80 -92.93 141.51 28.33 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 177.045 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 251' ' ' ILE . . . . . 0.597 ' O ' HG13 ' A' ' 255' ' ' ILE . 0.1 OUTLIER -62.84 -44.05 99.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.316 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -70.1 -29.8 66.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.91 -176.408 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 253' ' ' ALA . . . . . 0.454 ' HB1' ' CA ' ' A' ' 230' ' ' GLY . . . -60.36 -42.84 96.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.135 179.512 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 254' ' ' ALA . . . . . 0.56 ' HB2' ' HB2' ' A' ' 248' ' ' PHE . . . -67.96 -41.68 82.05 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.479 179.23 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.597 HG13 ' O ' ' A' ' 251' ' ' ILE . 11.2 mt -56.69 -60.78 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.108 -177.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 256' ' ' LYS . . . . . 0.496 ' HE2' ' HB2' ' A' ' 229' ' ' PHE . 15.0 ptmt -62.25 -38.74 90.43 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.406 -177.275 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -62.9 -49.99 72.63 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.661 0.267 . . . . 0.0 111.45 178.806 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 258' ' ' VAL . . . . . 0.514 HG13 HG12 ' A' ' 272' ' ' ILE . 55.6 t -65.07 -26.48 40.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.805 0.336 . . . . 0.0 110.994 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 16.9 mm-40 -84.64 -23.04 29.68 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 178.457 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 260' ' ' GLU . . . . . 0.406 ' HG2' ' O ' ' A' ' 256' ' ' LYS . 62.1 mm-40 -94.7 -32.03 13.54 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.813 0.34 . . . . 0.0 111.158 -176.589 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.796 HD23 HG21 ' A' ' 272' ' ' ILE . 0.8 OUTLIER -52.49 -49.54 85.15 Favored Pre-proline 0 CA--C 1.541 0.614 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.511 179.769 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 262' ' ' PRO . . . . . 0.611 ' HD3' HD11 ' A' ' 272' ' ' ILE . 53.3 Cg_endo -69.16 -11.0 30.56 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.512 2.142 . . . . 0.0 112.565 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 43.5 mt -92.07 -9.09 43.94 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.037 0.446 . . . . 0.0 111.555 -179.524 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 264' ' ' ASN . . . . . 0.421 ' HB2' ' CE3' ' A' ' 267' ' ' TRP . 3.5 m-20 -106.9 149.7 38.85 Favored Pre-proline 0 C--N 1.314 -0.942 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.258 -176.315 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 265' ' ' PRO . . . . . 0.402 ' O ' ' HG3' ' A' ' 269' ' ' LYS . 54.8 Cg_endo -67.73 -32.04 31.0 Favored 'Trans proline' 0 CA--C 1.521 -0.129 0 C-N-CA 123.383 2.722 . . . . 0.0 112.738 -171.167 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 266' ' ' LYS . . . . . 0.432 ' HE3' ' HB2' ' A' ' 266' ' ' LYS . 0.0 OUTLIER -84.77 -45.64 12.18 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 121.574 0.702 . . . . 0.0 109.24 -179.113 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 267' ' ' TRP . . . . . 0.743 ' HE3' ' HA ' ' A' ' 261' ' ' LEU . 12.6 m0 -76.88 -31.07 56.51 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.934 -172.382 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 17.7 t -68.3 -15.96 63.77 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.617 179.542 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 269' ' ' LYS . . . . . 0.402 ' HG3' ' O ' ' A' ' 265' ' ' PRO . 89.6 mttt -77.05 -7.71 56.16 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.218 0.533 . . . . 0.0 109.953 174.36 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 270' ' ' ARG . . . . . 0.764 ' HG2' HD23 ' A' ' 213' ' ' LEU . 3.7 mpt_? -110.82 143.89 40.69 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.92 178.303 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 36.0 mmt180 -91.99 106.42 18.44 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 110.021 -0.362 . . . . 0.0 110.021 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 272' ' ' ILE . . . . . 0.796 HG21 HD23 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -118.27 140.35 42.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.377 0.608 . . . . 0.0 110.718 179.701 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -152.39 168.96 23.77 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.38 173.489 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 . . . . . 0 C--N 1.324 -0.532 0 CA-C-O 120.713 0.292 . . . . 0.0 110.257 174.127 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 206' ' ' ARG . . . . . 0.879 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 0.6 OUTLIER . . . . . 0 C--O 1.219 -0.539 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -106.38 105.95 16.24 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 118.555 0.616 . . . . 0.0 111.442 -173.094 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.526 ' HB ' ' HB ' ' A' ' 246' ' ' VAL . 66.5 t -137.62 119.75 18.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.309 177.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -115.22 124.32 51.11 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.816 0.341 . . . . 0.0 110.469 -177.087 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.687 ' HG ' HG22 ' A' ' 272' ' ' ILE . 5.4 mp -107.31 129.44 54.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.275 177.838 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 211' ' ' GLY . . . . . 0.623 ' HA2' HG22 ' A' ' 243' ' ' ILE . . . -136.65 59.43 0.64 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.394 -0.908 . . . . 0.0 113.266 -178.268 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 212' ' ' ASN . . . . . 0.551 ' HB3' ' HA ' ' A' ' 270' ' ' ARG . 1.7 t30 177.03 43.53 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.027 0.442 . . . . 0.0 110.063 177.017 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.576 ' HA ' ' HG3' ' A' ' 270' ' ' ARG . 1.2 mt -87.01 164.09 37.8 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.041 -177.666 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.54 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 73.0 Cg_endo -76.51 169.03 22.65 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.365 2.043 . . . . 0.0 111.763 175.829 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 -78.5 130.17 35.7 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.897 179.115 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 91.48 3.78 68.79 Favored Glycine 0 C--N 1.317 -0.499 0 C-N-CA 120.732 -0.747 . . . . 0.0 113.188 177.239 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 217' ' ' ILE . . . . . 0.65 HG23 HG21 ' A' ' 237' ' ' ILE . 4.5 tp -58.82 128.55 19.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.34 0.591 . . . . 0.0 111.153 -178.73 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 218' ' ' THR . . . . . 0.465 ' CG2' ' HG3' ' A' ' 221' ' ' GLU . 14.5 t -111.91 156.17 22.49 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 121.367 0.603 . . . . 0.0 110.839 -178.248 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -62.41 -35.45 79.26 Favored 'General case' 0 C--O 1.209 -1.052 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.654 -177.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -48.89 -40.63 30.57 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.033 177.619 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 221' ' ' GLU . . . . . 0.465 ' HG3' ' CG2' ' A' ' 218' ' ' THR . 43.2 mt-10 -70.69 -56.01 7.38 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.751 -178.668 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 222' ' ' ILE . . . . . 0.59 HD12 HD11 ' A' ' 237' ' ' ILE . 10.6 mt -61.41 -45.21 99.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.632 -178.84 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 223' ' ' ARG . . . . . 0.784 ' HG3' HD12 ' A' ' 235' ' ' ILE . 64.2 mtp180 -54.01 -62.46 1.64 Allowed 'General case' 0 CA--C 1.505 -0.786 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 176.481 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -55.68 -24.25 33.13 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.731 -177.64 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 225' ' ' ASP . . . . . 0.446 ' HB3' ' CZ2' ' A' ' 267' ' ' TRP . 8.9 m-20 -86.0 -32.14 21.65 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.955 -178.432 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.838 HD23 ' HZ ' ' A' ' 248' ' ' PHE . 7.3 mp -104.99 -15.1 15.21 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.959 -0.297 . . . . 0.0 111.669 -172.095 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 227' ' ' GLU . . . . . 0.638 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 42.7 mm-40 -61.46 -36.58 33.38 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -177.376 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 228' ' ' PRO . . . . . 0.638 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 97.5 Cg_endo -67.13 -27.03 42.18 Favored 'Trans proline' 0 C--N 1.358 1.03 0 C-N-CA 121.66 1.573 . . . . 0.0 112.377 -173.002 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 229' ' ' PHE . . . . . 0.519 ' CE1' ' HA ' ' A' ' 226' ' ' LEU . 2.9 p90 -110.78 -14.14 14.05 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.411 -0.516 . . . . 0.0 111.825 176.025 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 230' ' ' GLY . . . . . 0.469 ' CA ' ' HB1' ' A' ' 253' ' ' ALA . . . -164.08 97.73 0.15 Allowed Glycine 0 N--CA 1.44 -1.099 0 C-N-CA 120.479 -0.867 . . . . 0.0 112.05 -174.176 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -65.05 135.68 44.89 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 121.747 1.631 . . . . 0.0 111.136 178.72 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.596 HG21 HG12 ' A' ' 246' ' ' VAL . 2.4 mp -112.11 148.95 14.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.919 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 233' ' ' ASP . . . . . 0.487 ' OD2' HD22 ' A' ' 249' ' ' LEU . 8.8 m-20 -109.3 -24.66 10.97 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.111 0.481 . . . . 0.0 110.369 178.871 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 234' ' ' GLN . . . . . 0.594 ' HB3' ' HB2' ' A' ' 247' ' ' HIS . 22.9 tt0 -142.09 122.01 13.62 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.543 -174.318 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 235' ' ' ILE . . . . . 0.784 HD12 ' HG3' ' A' ' 223' ' ' ARG . 8.1 mt -135.52 105.52 5.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 121.512 0.672 . . . . 0.0 109.927 178.579 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -108.35 107.51 18.12 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.993 -177.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 237' ' ' ILE . . . . . 0.65 HG21 HG23 ' A' ' 217' ' ' ILE . 81.3 mt -101.19 125.43 55.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.947 -178.287 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.545 ' HB ' HG13 ' A' ' 243' ' ' ILE . 41.2 t -109.67 88.05 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 170.776 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 15.3 t -69.94 -12.34 61.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.356 -176.057 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -69.02 -35.26 76.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.311 176.523 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 241' ' ' ARG . . . . . 0.626 ' HB2' HG12 ' A' ' 243' ' ' ILE . 90.7 mtt180 -113.75 5.12 16.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.6 -178.238 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 68.06 24.84 7.66 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.381 176.535 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.626 HG12 ' HB2' ' A' ' 241' ' ' ARG . 1.5 pt -122.31 150.79 25.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.823 -173.655 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 244' ' ' ALA . . . . . 0.424 ' HB3' ' HB2' ' A' ' 210' ' ' LEU . . . -144.13 137.78 27.73 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.243 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -107.19 110.98 23.18 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.539 177.489 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 246' ' ' VAL . . . . . 0.596 HG12 HG21 ' A' ' 232' ' ' ILE . 1.5 t -107.86 134.91 48.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.872 -177.01 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 247' ' ' HIS . . . . . 0.879 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 36.2 m170 -113.87 101.93 9.73 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.358 0.599 . . . . 0.0 111.382 177.528 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 248' ' ' PHE . . . . . 0.838 ' HZ ' HD23 ' A' ' 226' ' ' LEU . 35.1 m-85 -85.39 101.27 12.45 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.952 178.031 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.514 HD23 ' H ' ' A' ' 249' ' ' LEU . 0.1 OUTLIER -43.96 -38.94 3.73 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 124.293 0.996 . . . . 0.0 112.881 -174.41 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 250' ' ' ASN . . . . . 0.43 ' HB2' ' HB2' ' A' ' 253' ' ' ALA . 2.6 m-20 -94.34 139.19 31.4 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 176.789 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 251' ' ' ILE . . . . . 0.6 ' O ' HG13 ' A' ' 255' ' ' ILE . 0.2 OUTLIER -62.71 -41.24 91.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.962 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -72.08 -28.66 63.45 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.741 -177.573 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 253' ' ' ALA . . . . . 0.469 ' HB1' ' CA ' ' A' ' 230' ' ' GLY . . . -61.34 -41.37 96.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.25 178.7 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 254' ' ' ALA . . . . . 0.545 ' HB2' ' HB2' ' A' ' 248' ' ' PHE . . . -68.7 -40.74 79.87 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.724 178.509 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.6 HG13 ' O ' ' A' ' 251' ' ' ILE . 7.5 mt -56.14 -60.59 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.348 -178.247 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 256' ' ' LYS . . . . . 0.43 ' O ' ' HG2' ' A' ' 260' ' ' GLU . 9.9 ptmt -61.36 -41.49 97.16 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.513 -177.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -62.14 -49.81 74.39 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.693 0.283 . . . . 0.0 111.464 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 258' ' ' VAL . . . . . 0.453 HG13 HG12 ' A' ' 272' ' ' ILE . 41.2 t -64.84 -26.52 40.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.897 0.38 . . . . 0.0 111.121 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 259' ' ' GLN . . . . . 0.401 ' HG3' ' O ' ' A' ' 255' ' ' ILE . 53.3 mt-30 -84.64 -23.08 29.66 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 178.599 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 260' ' ' GLU . . . . . 0.43 ' HG2' ' O ' ' A' ' 256' ' ' LYS . 49.5 mm-40 -95.31 -32.48 12.95 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.611 0.243 . . . . 0.0 111.158 -176.719 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.782 HD12 ' CE3' ' A' ' 267' ' ' TRP . 0.6 OUTLIER -50.44 -49.92 74.63 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.549 179.506 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 262' ' ' PRO . . . . . 0.579 ' HD2' ' N ' ' A' ' 261' ' ' LEU . 40.4 Cg_endo -67.25 -17.14 49.84 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.416 2.078 . . . . 0.0 112.972 -178.422 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 55.2 mt -91.63 -3.56 56.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.248 0.547 . . . . 0.0 111.493 -178.17 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -106.64 148.82 37.53 Favored Pre-proline 0 C--N 1.314 -0.962 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.839 -175.24 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -65.41 -35.98 37.0 Favored 'Trans proline' 0 C--O 1.23 0.108 0 C-N-CA 123.557 2.838 . . . . 0.0 112.902 -169.562 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 9.7 mtpt -86.53 -45.08 11.42 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.671 0.748 . . . . 0.0 109.685 -177.358 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 267' ' ' TRP . . . . . 0.782 ' CE3' HD12 ' A' ' 261' ' ' LEU . 11.6 m0 -76.34 -29.35 57.21 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.87 -173.34 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 38.0 t -62.32 -21.98 65.69 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.822 0.344 . . . . 0.0 110.853 178.215 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -71.46 -16.59 62.38 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.106 0.479 . . . . 0.0 110.276 177.765 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 270' ' ' ARG . . . . . 0.576 ' HG3' ' HA ' ' A' ' 213' ' ' LEU . 0.0 OUTLIER -100.26 146.31 27.06 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.495 178.554 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 271' ' ' ARG . . . . . 0.407 ' HG2' ' HB2' ' A' ' 212' ' ' ASN . 9.9 mmp_? -95.4 105.92 17.93 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 176.106 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 272' ' ' ILE . . . . . 0.721 HG21 HD23 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -115.86 141.87 31.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.546 0.688 . . . . 0.0 111.285 -177.952 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -151.69 169.24 22.65 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.354 -0.839 . . . . 0.0 108.966 172.015 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 274' ' ' TYR . . . . . 0.466 ' OH ' ' HA ' ' A' ' 255' ' ' ILE . 75.6 m-85 . . . . . 0 C--N 1.323 -0.586 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 173.639 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 206' ' ' ARG . . . . . 0.774 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 48.7 mtp180 . . . . . 0 C--O 1.221 -0.4 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -116.25 107.41 14.82 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.805 0.336 . . . . 0.0 111.19 -173.721 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.555 ' HB ' ' HB ' ' A' ' 246' ' ' VAL . 99.7 t -135.68 124.89 40.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.726 179.352 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 209' ' ' PHE . . . . . 0.406 ' O ' ' HA ' ' A' ' 272' ' ' ILE . 3.9 t80 -117.27 122.93 45.31 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.744 0.307 . . . . 0.0 110.446 -177.497 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.701 ' HG ' HG22 ' A' ' 272' ' ' ILE . 5.5 mp -106.01 132.76 51.71 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.039 176.811 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 211' ' ' GLY . . . . . 0.68 ' HA2' HG22 ' A' ' 243' ' ' ILE . . . -140.75 59.32 0.57 Allowed Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.441 -0.885 . . . . 0.0 113.475 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 212' ' ' ASN . . . . . 0.552 ' HB3' ' HA ' ' A' ' 270' ' ' ARG . 57.5 t30 -179.17 33.4 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.328 0.585 . . . . 0.0 110.156 175.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.612 HD23 ' HG2' ' A' ' 270' ' ' ARG . 2.0 mt -76.27 161.13 76.13 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.113 -177.78 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.424 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 66.3 Cg_endo -73.98 162.18 39.62 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.253 1.969 . . . . 0.0 111.023 174.354 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -77.6 120.99 23.33 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 178.442 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 106.94 -1.58 35.7 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.193 -1.003 . . . . 0.0 113.046 -179.573 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 217' ' ' ILE . . . . . 0.675 HG23 HG21 ' A' ' 237' ' ' ILE . 4.5 tp -59.31 128.48 20.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.961 0.41 . . . . 0.0 110.803 179.036 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 218' ' ' THR . . . . . 0.476 HG22 ' HG3' ' A' ' 221' ' ' GLU . 9.8 t -113.56 158.84 20.27 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-O 121.296 0.569 . . . . 0.0 110.91 -178.824 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.533 ' H ' ' CD ' ' A' ' 219' ' ' GLU . 7.0 mp0 -62.39 -39.33 92.87 Favored 'General case' 0 C--O 1.21 -0.978 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.138 -174.636 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 220' ' ' ASP . . . . . 0.455 ' O ' ' HG2' ' A' ' 224' ' ' GLU . 16.3 t70 -54.22 -35.04 62.0 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 123.429 0.455 . . . . 0.0 110.987 -178.518 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 221' ' ' GLU . . . . . 0.476 ' HG3' HG22 ' A' ' 218' ' ' THR . 45.9 mt-10 -67.27 -57.2 7.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.325 178.22 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 222' ' ' ILE . . . . . 0.564 HD12 HD11 ' A' ' 237' ' ' ILE . 6.9 mt -60.28 -41.79 88.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.563 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 223' ' ' ARG . . . . . 0.751 ' HG3' HD12 ' A' ' 235' ' ' ILE . 64.0 mtp180 -53.19 -62.8 1.42 Allowed 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 174.653 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.455 ' HG2' ' O ' ' A' ' 220' ' ' ASP . 8.8 pt-20 -58.53 -23.51 58.4 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.849 -176.764 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -88.55 -31.75 18.51 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.697 -176.718 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.775 HD23 ' HZ ' ' A' ' 248' ' ' PHE . 8.0 mp -105.7 -19.31 13.8 Favored 'General case' 0 CA--C 1.517 -0.307 0 C-N-CA 120.684 -0.406 . . . . 0.0 112.085 -171.333 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 227' ' ' GLU . . . . . 0.662 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 33.9 mt-10 -64.82 -33.55 8.68 Favored Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -176.471 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 228' ' ' PRO . . . . . 0.662 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 75.8 Cg_endo -65.63 -29.16 52.2 Favored 'Trans proline' 0 C--N 1.358 1.05 0 C-N-CA 121.34 1.36 . . . . 0.0 112.014 -175.518 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 229' ' ' PHE . . . . . 0.526 ' CE1' ' HA ' ' A' ' 226' ' ' LEU . 4.4 p90 -111.16 3.97 18.91 Favored 'General case' 0 C--O 1.223 -0.338 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.366 174.887 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 230' ' ' GLY . . . . . 0.573 ' CA ' ' HB1' ' A' ' 253' ' ' ALA . . . 178.8 99.88 0.13 Allowed Glycine 0 N--CA 1.441 -1.007 0 C-N-CA 120.045 -1.074 . . . . 0.0 112.725 -177.168 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -66.34 134.98 38.03 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 121.833 1.689 . . . . 0.0 111.28 178.461 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.634 HG21 HG12 ' A' ' 235' ' ' ILE . 3.5 mp -106.48 151.96 8.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.28 178.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 233' ' ' ASP . . . . . 0.552 ' OD2' ' HB3' ' A' ' 249' ' ' LEU . 8.9 m-20 -104.54 -28.8 11.07 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.3 179.215 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 234' ' ' GLN . . . . . 0.494 ' H ' HG22 ' A' ' 232' ' ' ILE . 13.1 tt0 -151.66 130.55 12.5 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.825 -173.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 235' ' ' ILE . . . . . 0.751 HD12 ' HG3' ' A' ' 223' ' ' ARG . 15.0 mt -136.7 110.26 8.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.923 -179.322 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.421 ' O ' ' HA ' ' A' ' 244' ' ' ALA . 84.9 tttt -111.29 112.42 24.17 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.131 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 237' ' ' ILE . . . . . 0.675 HG21 HG23 ' A' ' 217' ' ' ILE . 78.2 mt -104.79 118.06 51.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 121.084 0.468 . . . . 0.0 111.12 -179.529 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.589 ' HB ' HG13 ' A' ' 243' ' ' ILE . 46.8 t -99.2 87.81 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 171.854 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 9.5 t -64.94 -21.03 66.76 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.466 -175.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -58.13 -38.71 77.04 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.718 175.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 241' ' ' ARG . . . . . 0.72 ' HB2' HG12 ' A' ' 243' ' ' ILE . 72.4 mtp180 -112.41 3.0 16.66 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.39 -177.134 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 66.07 28.87 10.24 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.877 0.37 . . . . 0.0 110.543 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.72 HG12 ' HB2' ' A' ' 241' ' ' ARG . 1.2 pt -121.35 150.34 24.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.312 -174.24 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 244' ' ' ALA . . . . . 0.522 ' HB3' ' HB2' ' A' ' 210' ' ' LEU . . . -144.75 140.7 28.7 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.674 -178.63 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -111.19 115.51 29.5 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.433 177.036 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 246' ' ' VAL . . . . . 0.57 HG13 HG12 ' A' ' 235' ' ' ILE . 1.6 t -113.48 139.63 37.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.312 -174.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 247' ' ' HIS . . . . . 0.774 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 59.4 m170 -111.38 101.93 10.35 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.459 176.478 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 248' ' ' PHE . . . . . 0.775 ' HZ ' HD23 ' A' ' 226' ' ' LEU . 39.6 m-85 -89.28 98.52 11.81 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.164 176.761 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.661 ' HA ' ' HE ' ' A' ' 206' ' ' ARG . 0.2 OUTLIER -47.58 -44.62 26.46 Favored 'General case' 0 N--CA 1.464 0.232 0 O-C-N 124.24 0.962 . . . . 0.0 112.618 -173.509 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 250' ' ' ASN . . . . . 0.425 ' HB2' ' HB2' ' A' ' 253' ' ' ALA . 67.7 m-20 -85.81 135.78 33.58 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 176.373 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 251' ' ' ILE . . . . . 0.598 ' O ' HG13 ' A' ' 255' ' ' ILE . 0.2 OUTLIER -62.63 -40.69 89.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 -177.411 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -70.78 -27.38 63.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.524 -177.761 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 253' ' ' ALA . . . . . 0.573 ' HB1' ' CA ' ' A' ' 230' ' ' GLY . . . -62.87 -41.36 99.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.106 -179.599 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 254' ' ' ALA . . . . . 0.59 ' HB2' ' HB2' ' A' ' 248' ' ' PHE . . . -69.13 -41.04 77.87 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.561 178.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.598 HG13 ' O ' ' A' ' 251' ' ' ILE . 11.0 mt -56.05 -60.74 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.045 -178.398 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 256' ' ' LYS . . . . . 0.454 ' HE2' ' HB2' ' A' ' 229' ' ' PHE . 13.5 ptmt -63.3 -39.78 95.52 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.496 -176.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -61.29 -48.16 82.67 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.71 0.29 . . . . 0.0 111.351 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 258' ' ' VAL . . . . . 0.532 HG13 HG12 ' A' ' 272' ' ' ILE . 54.9 t -66.76 -24.38 32.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.995 179.603 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 16.5 mm100 -84.52 -25.94 28.42 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 177.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 260' ' ' GLU . . . . . 0.438 ' HG2' ' O ' ' A' ' 256' ' ' LYS . 59.3 mm-40 -93.89 -33.96 13.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.634 0.254 . . . . 0.0 110.987 -175.243 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.807 HD23 HG21 ' A' ' 272' ' ' ILE . 0.8 OUTLIER -51.6 -51.32 70.78 Favored Pre-proline 0 CA--C 1.537 0.478 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.515 -179.619 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 262' ' ' PRO . . . . . 0.595 ' HD3' HD11 ' A' ' 272' ' ' ILE . 43.1 Cg_endo -66.75 -17.57 52.41 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.381 2.054 . . . . 0.0 112.762 -177.496 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 62.9 mt -95.22 -1.19 52.16 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.274 0.559 . . . . 0.0 111.525 -176.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 264' ' ' ASN . . . . . 0.489 ' O ' ' HB2' ' A' ' 268' ' ' SER . 14.4 m-80 -105.62 148.69 36.84 Favored Pre-proline 0 C--N 1.317 -0.846 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.244 -178.76 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -63.05 -40.84 31.6 Favored 'Trans proline' 0 C--N 1.335 -0.143 0 C-N-CA 123.298 2.666 . . . . 0.0 112.74 -169.129 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 12.6 mtpt -86.2 -42.71 13.59 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.461 0.648 . . . . 0.0 110.133 -176.106 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 267' ' ' TRP . . . . . 0.726 ' CE3' HD12 ' A' ' 261' ' ' LEU . 17.1 m0 -73.98 -28.04 61.28 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.835 -176.781 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 268' ' ' SER . . . . . 0.489 ' HB2' ' O ' ' A' ' 264' ' ' ASN . 12.8 t -65.71 -18.32 65.25 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.186 0.517 . . . . 0.0 110.577 177.48 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -71.71 -9.04 57.68 Favored 'General case' 0 C--O 1.225 -0.224 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.105 174.691 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 270' ' ' ARG . . . . . 0.612 ' HG2' HD23 ' A' ' 213' ' ' LEU . 0.0 OUTLIER -112.86 143.17 44.57 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.392 -179.745 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 35.5 mmt180 -94.2 109.0 20.83 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.283 177.565 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 272' ' ' ILE . . . . . 0.807 HG21 HD23 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -121.91 140.91 44.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.418 0.628 . . . . 0.0 111.38 -178.627 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -152.26 169.86 21.45 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.372 174.04 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 274' ' ' TYR . . . . . 0.488 ' OH ' ' HA ' ' A' ' 255' ' ' ILE . 74.2 m-85 . . . . . 0 C--N 1.321 -0.662 0 CA-C-O 121.224 0.535 . . . . 0.0 109.827 176.292 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 206' ' ' ARG . . . . . 0.789 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 29.8 mtm180 . . . . . 0 C--O 1.223 -0.339 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 18.9 m-80 -108.18 106.19 16.26 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-O 121.232 0.539 . . . . 0.0 111.385 -173.644 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.481 ' HB ' ' HB ' ' A' ' 246' ' ' VAL . 61.1 t -134.56 111.93 14.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.012 177.406 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 209' ' ' PHE . . . . . 0.427 ' HE1' ' HB ' ' A' ' 243' ' ' ILE . 1.7 t80 -109.96 122.08 46.74 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.973 0.416 . . . . 0.0 110.361 -174.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.53 ' HG ' HG22 ' A' ' 272' ' ' ILE . 6.2 mp -106.81 133.93 50.73 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.613 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 211' ' ' GLY . . . . . 0.643 ' HA2' HG22 ' A' ' 243' ' ' ILE . . . -136.92 61.3 0.61 Allowed Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.548 -0.834 . . . . 0.0 113.097 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 212' ' ' ASN . . . . . 0.425 ' HB2' ' O ' ' A' ' 211' ' ' GLY . 2.3 t30 175.61 53.92 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.066 0.46 . . . . 0.0 110.612 175.709 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.625 HD23 ' HG2' ' A' ' 270' ' ' ARG . 0.7 OUTLIER -102.53 155.6 36.31 Favored Pre-proline 0 C--N 1.316 -0.862 0 N-CA-C 110.043 -0.355 . . . . 0.0 110.043 178.012 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -77.18 165.82 27.36 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.502 2.135 . . . . 0.0 112.163 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -75.94 118.82 19.12 Favored 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 177.176 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 109.51 2.59 30.93 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.255 -0.974 . . . . 0.0 112.56 -178.309 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 217' ' ' ILE . . . . . 0.652 HG23 HG21 ' A' ' 237' ' ' ILE . 6.3 tp -68.23 129.03 32.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.941 0.401 . . . . 0.0 110.36 175.306 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 218' ' ' THR . . . . . 0.465 ' CG2' ' HG3' ' A' ' 221' ' ' GLU . 10.6 t -113.65 156.84 23.0 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-O 121.397 0.618 . . . . 0.0 111.041 179.147 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.561 ' H ' ' CD ' ' A' ' 219' ' ' GLU . 5.1 mp0 -60.92 -35.98 78.11 Favored 'General case' 0 C--O 1.21 -0.986 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.615 -179.044 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -54.39 -35.69 63.12 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.845 -179.006 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 221' ' ' GLU . . . . . 0.465 ' HG3' ' CG2' ' A' ' 218' ' ' THR . 42.9 mt-10 -69.91 -57.65 4.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.565 178.426 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 222' ' ' ILE . . . . . 0.532 HD12 HD11 ' A' ' 237' ' ' ILE . 8.1 mt -59.49 -42.81 89.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.488 -178.888 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 223' ' ' ARG . . . . . 0.839 ' HG3' HD12 ' A' ' 235' ' ' ILE . 45.0 mtp85 -55.86 -61.92 2.04 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 176.197 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -57.19 -21.73 35.49 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.925 -178.123 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -89.67 -30.73 17.89 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 116.021 -0.536 . . . . 0.0 112.055 -178.794 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.713 HD23 ' HZ ' ' A' ' 248' ' ' PHE . 8.4 mp -106.41 -19.26 13.74 Favored 'General case' 0 C--O 1.225 -0.215 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -171.207 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 227' ' ' GLU . . . . . 0.669 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 41.4 mt-10 -66.87 -31.43 3.99 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -175.844 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 228' ' ' PRO . . . . . 0.669 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 71.7 Cg_endo -65.73 -28.13 51.99 Favored 'Trans proline' 0 C--N 1.357 1.013 0 C-N-CA 121.442 1.428 . . . . 0.0 112.16 -176.225 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 229' ' ' PHE . . . . . 0.48 ' CE1' ' HA ' ' A' ' 226' ' ' LEU . 3.8 p90 -111.04 -0.72 16.55 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.752 0.31 . . . . 0.0 111.399 173.842 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 230' ' ' GLY . . . . . 0.568 ' CA ' ' HB1' ' A' ' 253' ' ' ALA . . . -175.43 95.51 0.1 Allowed Glycine 0 N--CA 1.442 -0.914 0 C-N-CA 120.128 -1.034 . . . . 0.0 112.466 -176.248 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -62.45 130.47 30.19 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.12 1.88 . . . . 0.0 111.634 178.726 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.656 HG21 HG12 ' A' ' 246' ' ' VAL . 2.4 mp -109.47 148.26 13.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.315 178.166 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 233' ' ' ASP . . . . . 0.487 ' CG ' HD22 ' A' ' 249' ' ' LEU . 44.4 m-20 -110.18 -24.26 10.8 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.003 0.43 . . . . 0.0 110.704 179.106 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 234' ' ' GLN . . . . . 0.43 ' H ' HG22 ' A' ' 232' ' ' ILE . 15.7 tt0 -142.8 122.13 13.08 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.548 -174.547 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 235' ' ' ILE . . . . . 0.839 HD12 ' HG3' ' A' ' 223' ' ' ARG . 10.5 mt -135.95 110.96 11.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.912 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.428 ' O ' ' HA ' ' A' ' 244' ' ' ALA . 62.4 tttp -113.31 110.55 20.54 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.541 -176.637 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 237' ' ' ILE . . . . . 0.652 HG21 HG23 ' A' ' 217' ' ' ILE . 76.2 mt -101.84 119.51 50.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.115 0.484 . . . . 0.0 111.041 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.57 ' HB ' HG13 ' A' ' 243' ' ' ILE . 43.6 t -103.98 88.24 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 173.395 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 10.0 t -62.48 -25.13 67.84 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.16 -177.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -55.59 -39.98 71.44 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 121.069 0.462 . . . . 0.0 110.392 176.368 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 241' ' ' ARG . . . . . 0.737 ' HB2' HG12 ' A' ' 243' ' ' ILE . 99.2 mtt180 -111.31 5.86 20.09 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.847 -178.296 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 62.93 28.76 16.44 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.083 177.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.737 HG12 ' HB2' ' A' ' 241' ' ' ARG . 1.3 pt -121.28 154.22 25.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.104 -173.025 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 244' ' ' ALA . . . . . 0.444 ' HB3' ' HB2' ' A' ' 210' ' ' LEU . . . -144.92 138.37 26.85 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.441 -178.856 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -107.09 114.17 28.08 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.394 177.089 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 246' ' ' VAL . . . . . 0.656 HG12 HG21 ' A' ' 232' ' ' ILE . 0.7 OUTLIER -109.83 127.82 66.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -179.229 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 247' ' ' HIS . . . . . 0.789 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 48.9 m170 -107.95 101.83 11.06 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.038 -0.665 . . . . 0.0 111.319 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 248' ' ' PHE . . . . . 0.713 ' HZ ' HD23 ' A' ' 226' ' ' LEU . 34.1 m-85 -87.49 99.18 11.84 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.149 178.322 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.501 HD23 ' H ' ' A' ' 249' ' ' LEU . 0.1 OUTLIER -42.27 -43.3 3.39 Favored 'General case' 0 N--CA 1.467 0.375 0 O-C-N 124.564 1.165 . . . . 0.0 112.651 -177.612 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 57.1 m-20 -90.87 135.36 33.78 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 177.408 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 251' ' ' ILE . . . . . 0.561 ' O ' HG13 ' A' ' 255' ' ' ILE . 0.2 OUTLIER -62.99 -40.96 91.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -178.69 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -69.06 -31.77 70.77 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 120.786 0.327 . . . . 0.0 110.662 -177.432 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 253' ' ' ALA . . . . . 0.568 ' HB1' ' CA ' ' A' ' 230' ' ' GLY . . . -59.53 -42.14 91.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.353 179.095 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 254' ' ' ALA . . . . . 0.587 ' HB2' ' HB2' ' A' ' 248' ' ' PHE . . . -68.24 -40.52 81.96 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.655 178.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.561 HG13 ' O ' ' A' ' 251' ' ' ILE . 6.9 mt -56.49 -61.13 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.272 -178.305 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 12.8 ptmt -62.3 -39.23 92.32 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.439 -177.237 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -62.09 -48.88 78.2 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.639 0.257 . . . . 0.0 111.508 179.172 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 258' ' ' VAL . . . . . 0.546 HG13 HG12 ' A' ' 272' ' ' ILE . 70.1 t -66.3 -23.34 31.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.009 0.433 . . . . 0.0 111.05 179.062 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -85.06 -21.76 29.24 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 177.11 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -95.32 -36.75 11.27 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.895 0.379 . . . . 0.0 110.911 -177.312 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.749 HD23 HG21 ' A' ' 272' ' ' ILE . 1.1 mp -51.94 -47.74 90.22 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.956 -177.812 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 262' ' ' PRO . . . . . 0.575 ' HD2' ' N ' ' A' ' 261' ' ' LEU . 41.1 Cg_endo -67.49 -19.05 49.27 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.145 1.896 . . . . 0.0 112.711 -178.592 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 65.6 mt -95.53 -3.72 46.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.971 0.415 . . . . 0.0 111.811 -175.056 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 264' ' ' ASN . . . . . 0.494 ' O ' ' HB2' ' A' ' 268' ' ' SER . 14.1 m-80 -105.65 148.42 36.38 Favored Pre-proline 0 C--N 1.316 -0.878 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.761 -176.408 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -67.32 -32.97 31.65 Favored 'Trans proline' 0 N--CA 1.466 -0.098 0 C-N-CA 123.255 2.636 . . . . 0.0 112.652 -169.416 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.2 -45.13 12.3 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-O 121.825 0.821 . . . . 0.0 109.289 -178.31 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 267' ' ' TRP . . . . . 0.727 ' CE3' HD12 ' A' ' 261' ' ' LEU . 10.2 m0 -78.76 -25.23 44.43 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.947 -172.611 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 268' ' ' SER . . . . . 0.494 ' HB2' ' O ' ' A' ' 264' ' ' ASN . 12.5 t -66.8 -19.13 65.68 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.834 0.35 . . . . 0.0 110.782 178.199 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -71.7 -21.51 61.77 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 121.013 0.435 . . . . 0.0 110.239 175.65 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 270' ' ' ARG . . . . . 0.625 ' HG2' HD23 ' A' ' 213' ' ' LEU . 2.6 mpt_? -99.76 141.43 32.58 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.424 -178.876 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 271' ' ' ARG . . . . . 0.412 ' HD3' ' HA ' ' A' ' 271' ' ' ARG . 26.7 mmt180 -94.13 106.2 18.18 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 179.707 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 272' ' ' ILE . . . . . 0.749 HG21 HD23 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -112.48 141.38 28.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.992 0.425 . . . . 0.0 111.207 -176.093 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -152.6 168.86 24.2 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.158 171.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 274' ' ' TYR . . . . . 0.541 ' OH ' ' HA ' ' A' ' 255' ' ' ILE . 64.7 m-85 . . . . . 0 C--N 1.325 -0.473 0 CA-C-O 120.81 0.338 . . . . 0.0 110.577 173.632 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 206' ' ' ARG . . . . . 0.851 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 30.7 mtm180 . . . . . 0 C--O 1.22 -0.477 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -104.42 105.16 15.18 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 119.974 -0.691 . . . . 0.0 111.496 -171.292 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 61.9 t -136.14 116.33 17.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.384 177.64 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 209' ' ' PHE . . . . . 0.429 ' O ' ' HA ' ' A' ' 272' ' ' ILE . 3.4 t80 -113.5 126.52 55.4 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.447 -176.679 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.742 ' HG ' HG22 ' A' ' 272' ' ' ILE . 5.6 mp -110.65 131.37 55.11 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.553 178.537 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 211' ' ' GLY . . . . . 0.593 ' HA2' HG22 ' A' ' 243' ' ' ILE . . . -139.07 66.46 0.52 Allowed Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.621 -0.799 . . . . 0.0 113.396 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 212' ' ' ASN . . . . . 0.556 ' HB3' ' HA ' ' A' ' 270' ' ' ARG . 40.2 t30 177.08 36.47 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.183 0.516 . . . . 0.0 110.014 176.437 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.842 HD23 ' HG2' ' A' ' 270' ' ' ARG . 1.3 mt -89.16 158.27 46.9 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.466 -178.131 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -81.98 163.96 17.88 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.541 2.16 . . . . 0.0 111.42 176.509 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 215' ' ' ASN . . . . . 0.532 ' HA ' ' OG1' ' A' ' 239' ' ' THR . 14.8 m120 -78.42 127.89 32.84 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.104 178.334 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 108.76 -8.87 34.41 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.473 -177.577 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 217' ' ' ILE . . . . . 0.668 HG23 HG21 ' A' ' 237' ' ' ILE . 4.3 tp -61.41 126.85 20.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-O 121.146 0.498 . . . . 0.0 110.376 178.063 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 218' ' ' THR . . . . . 0.562 HG22 ' HG3' ' A' ' 221' ' ' GLU . 5.1 t -113.77 161.2 17.83 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 121.35 0.595 . . . . 0.0 110.999 -178.724 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.554 ' H ' ' CD ' ' A' ' 219' ' ' GLU . 7.7 mp0 -62.84 -41.7 99.45 Favored 'General case' 0 C--O 1.209 -1.035 0 CA-C-N 115.113 -0.948 . . . . 0.0 109.887 -175.528 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -50.33 -37.16 35.34 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 123.584 0.553 . . . . 0.0 111.175 -179.173 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 221' ' ' GLU . . . . . 0.562 ' HG3' HG22 ' A' ' 218' ' ' THR . 44.6 mt-10 -68.44 -56.23 9.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.553 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 222' ' ' ILE . . . . . 0.543 HD12 HD11 ' A' ' 237' ' ' ILE . 6.9 mt -62.17 -40.64 88.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.382 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 223' ' ' ARG . . . . . 0.634 ' HG3' HD12 ' A' ' 235' ' ' ILE . 25.6 mtp85 -53.15 -64.12 0.92 Allowed 'General case' 0 CA--C 1.509 -0.631 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 174.77 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -58.04 -21.02 43.44 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.855 -176.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -86.22 -33.31 20.79 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.703 -178.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.786 HD23 ' HZ ' ' A' ' 248' ' ' PHE . 7.5 mp -107.2 -14.44 14.9 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -171.173 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 227' ' ' GLU . . . . . 0.628 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 24.5 mm-40 -61.01 -37.68 46.87 Favored Pre-proline 0 C--N 1.328 -0.353 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -178.322 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 228' ' ' PRO . . . . . 0.628 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 97.2 Cg_endo -66.52 -27.51 46.25 Favored 'Trans proline' 0 C--N 1.36 1.134 0 C-N-CA 121.687 1.591 . . . . 0.0 112.295 -171.723 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 229' ' ' PHE . . . . . 0.54 ' CZ ' ' HA ' ' A' ' 226' ' ' LEU . 3.8 p90 -110.91 -7.05 14.6 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.686 176.308 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 230' ' ' GLY . . . . . 0.411 ' CA ' ' HB1' ' A' ' 253' ' ' ALA . . . -171.8 98.72 0.13 Allowed Glycine 0 N--CA 1.442 -0.906 0 C-N-CA 120.045 -1.074 . . . . 0.0 112.347 -175.643 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 231' ' ' PRO . . . . . 0.403 ' HD2' ' HA2' ' A' ' 230' ' ' GLY . 18.2 Cg_endo -63.9 133.17 37.59 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 121.904 1.736 . . . . 0.0 111.256 177.452 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.811 HG21 HG12 ' A' ' 246' ' ' VAL . 2.4 mp -109.54 147.7 13.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.905 178.802 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 233' ' ' ASP . . . . . 0.476 ' CG ' HD22 ' A' ' 249' ' ' LEU . 14.4 m-20 -108.89 -24.46 11.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.731 178.59 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 234' ' ' GLN . . . . . 0.597 ' HB3' ' HB2' ' A' ' 247' ' ' HIS . 21.4 tt0 -140.06 121.81 15.4 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.305 -173.837 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 235' ' ' ILE . . . . . 0.634 HD12 ' HG3' ' A' ' 223' ' ' ARG . 18.6 mt -136.83 111.14 9.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.111 0.481 . . . . 0.0 110.158 -178.357 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 22.1 ttmm -115.77 109.34 17.54 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.41 -179.501 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 237' ' ' ILE . . . . . 0.668 HG21 HG23 ' A' ' 217' ' ' ILE . 73.2 mt -99.72 118.24 46.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-O 121.043 0.449 . . . . 0.0 110.323 177.156 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.552 ' HB ' HG13 ' A' ' 243' ' ' ILE . 40.8 t -102.14 86.1 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 172.594 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 239' ' ' THR . . . . . 0.532 ' OG1' ' HA ' ' A' ' 215' ' ' ASN . 8.9 t -70.19 -19.02 63.2 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.274 -176.045 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -60.83 -33.62 73.31 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.951 174.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 241' ' ' ARG . . . . . 0.46 ' HB2' HG12 ' A' ' 243' ' ' ILE . 98.9 mtt180 -114.94 4.24 14.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.791 -179.521 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 17.3 m120 65.93 27.76 10.77 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.23 0.612 . . . . 0.0 111.419 176.005 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.593 HG22 ' HA2' ' A' ' 211' ' ' GLY . 1.4 pt -123.07 155.08 28.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.294 -175.48 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 244' ' ' ALA . . . . . 0.475 ' HB3' ' HB2' ' A' ' 210' ' ' LEU . . . -144.38 141.47 29.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.989 0.423 . . . . 0.0 111.569 179.284 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -112.73 115.41 28.49 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.64 176.194 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 246' ' ' VAL . . . . . 0.811 HG12 HG21 ' A' ' 232' ' ' ILE . 0.3 OUTLIER -111.48 129.41 66.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 -179.124 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 247' ' ' HIS . . . . . 0.851 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 32.4 m170 -107.79 102.78 11.96 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.006 -0.677 . . . . 0.0 111.357 178.644 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 248' ' ' PHE . . . . . 0.786 ' HZ ' HD23 ' A' ' 226' ' ' LEU . 33.2 m-85 -84.82 103.17 13.66 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.811 177.775 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.476 HD22 ' CG ' ' A' ' 233' ' ' ASP . 0.1 OUTLIER -43.29 -39.46 3.06 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 124.505 1.128 . . . . 0.0 113.068 -174.306 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -99.71 137.94 37.49 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 176.611 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 251' ' ' ILE . . . . . 0.605 ' O ' HG13 ' A' ' 255' ' ' ILE . 0.2 OUTLIER -58.51 -41.65 82.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.918 -179.289 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -69.22 -30.67 68.88 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 116.756 -0.202 . . . . 0.0 111.09 -176.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 253' ' ' ALA . . . . . 0.411 ' HB1' ' CA ' ' A' ' 230' ' ' GLY . . . -62.35 -39.14 92.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.221 178.523 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 254' ' ' ALA . . . . . 0.6 ' HB2' ' HB2' ' A' ' 248' ' ' PHE . . . -69.53 -41.79 75.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.799 178.851 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.605 HG13 ' O ' ' A' ' 251' ' ' ILE . 11.4 mt -56.11 -60.61 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.105 -178.049 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 256' ' ' LYS . . . . . 0.521 ' O ' ' HG2' ' A' ' 260' ' ' GLU . 12.3 ptmt -61.22 -39.73 91.34 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.515 -178.347 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -62.61 -47.9 81.75 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.628 0.252 . . . . 0.0 111.4 179.246 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 258' ' ' VAL . . . . . 0.484 HG13 HG12 ' A' ' 272' ' ' ILE . 53.7 t -66.63 -26.27 36.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.9 0.381 . . . . 0.0 111.221 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 259' ' ' GLN . . . . . 0.523 ' HA ' ' OE1' ' A' ' 259' ' ' GLN . 10.4 mm-40 -84.3 -28.71 26.94 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 177.469 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 260' ' ' GLU . . . . . 0.521 ' HG2' ' O ' ' A' ' 256' ' ' LYS . 37.1 mm-40 -92.91 -26.02 17.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.445 0.164 . . . . 0.0 111.423 -175.279 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.803 HD23 HG21 ' A' ' 272' ' ' ILE . 0.6 OUTLIER -54.23 -52.55 67.84 Favored Pre-proline 0 CA--C 1.537 0.465 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.981 176.412 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 262' ' ' PRO . . . . . 0.554 ' HD2' ' N ' ' A' ' 261' ' ' LEU . 37.7 Cg_endo -67.18 -15.92 47.45 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.503 2.135 . . . . 0.0 112.828 -178.627 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 263' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' A' ' 259' ' ' GLN . 46.1 mt -85.06 -9.07 58.36 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.126 0.489 . . . . 0.0 111.151 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 -105.15 148.7 36.64 Favored Pre-proline 0 C--N 1.316 -0.887 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.108 -175.49 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -66.38 -34.73 33.81 Favored 'Trans proline' 0 C--N 1.336 -0.085 0 C-N-CA 123.546 2.831 . . . . 0.0 112.689 -170.822 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 5.1 mtpt -86.25 -45.22 11.48 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 121.465 0.65 . . . . 0.0 109.714 -177.185 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 267' ' ' TRP . . . . . 0.795 ' HE3' ' HA ' ' A' ' 261' ' ' LEU . 14.3 m0 -75.97 -30.11 58.5 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.757 -173.863 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 29.5 t -65.9 -18.81 65.59 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.958 0.409 . . . . 0.0 110.749 178.812 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 269' ' ' LYS . . . . . 0.408 ' C ' ' HD2' ' A' ' 270' ' ' ARG . 96.8 mttt -77.3 -8.38 57.54 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 121.139 0.495 . . . . 0.0 110.206 176.542 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 270' ' ' ARG . . . . . 0.842 ' HG2' HD23 ' A' ' 213' ' ' LEU . 3.6 mpt_? -111.11 141.51 44.51 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 178.061 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 31.9 mmm180 -92.36 110.27 21.67 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 -176.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 272' ' ' ILE . . . . . 0.803 HG21 HD23 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -121.46 142.41 37.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.534 0.683 . . . . 0.0 111.571 -178.259 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -151.76 169.31 22.51 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.679 173.099 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 . . . . . 0 C--N 1.324 -0.533 0 O-C-N 123.117 0.261 . . . . 0.0 110.301 175.221 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 206' ' ' ARG . . . . . 0.832 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 59.6 mtm180 . . . . . 0 C--O 1.222 -0.383 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -100.08 104.66 16.24 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 119.743 -0.783 . . . . 0.0 111.213 -172.523 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 67.8 t -137.45 123.73 27.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.134 176.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 209' ' ' PHE . . . . . 0.43 ' HE1' ' HB ' ' A' ' 243' ' ' ILE . 4.2 t80 -121.38 125.41 46.89 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 120.752 0.311 . . . . 0.0 110.251 -177.756 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.484 HD22 HD21 ' A' ' 213' ' ' LEU . 4.6 mp -108.28 126.09 52.43 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.39 177.427 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 211' ' ' GLY . . . . . 0.628 ' HA2' HG22 ' A' ' 243' ' ' ILE . . . -129.76 57.52 0.72 Allowed Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.304 -0.951 . . . . 0.0 113.343 -178.519 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 212' ' ' ASN . . . . . 0.542 ' HB3' ' HA ' ' A' ' 270' ' ' ARG . 2.1 t30 178.19 45.12 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.045 0.45 . . . . 0.0 111.027 178.166 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.484 HD21 HD22 ' A' ' 210' ' ' LEU . 0.7 OUTLIER -92.94 160.99 32.72 Favored Pre-proline 0 C--N 1.317 -0.814 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 176.971 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.444 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 87.9 Cg_endo -80.17 165.23 21.58 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.527 2.151 . . . . 0.0 111.188 176.06 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 215' ' ' ASN . . . . . 0.519 ' HA ' ' OG1' ' A' ' 239' ' ' THR . 28.2 t-20 -78.72 128.19 33.09 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 106.6 -2.98 36.57 Favored Glycine 0 C--N 1.315 -0.622 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.589 -178.076 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 217' ' ' ILE . . . . . 0.73 HG23 HG21 ' A' ' 237' ' ' ILE . 4.5 tp -64.71 127.99 26.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.224 0.535 . . . . 0.0 110.71 177.532 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 14.1 t -113.92 155.75 25.24 Favored 'General case' 0 C--O 1.24 0.602 0 CA-C-O 121.328 0.585 . . . . 0.0 111.075 -178.553 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.428 ' H ' ' CD ' ' A' ' 219' ' ' GLU . 1.5 mp0 -61.25 -37.26 82.44 Favored 'General case' 0 C--O 1.209 -1.055 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.365 -177.152 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -51.71 -36.0 45.15 Favored 'General case' 0 C--N 1.321 -0.632 0 O-C-N 123.464 0.478 . . . . 0.0 111.064 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -73.58 -55.56 6.15 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.316 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 222' ' ' ILE . . . . . 0.584 HD12 HD11 ' A' ' 237' ' ' ILE . 11.1 mt -60.17 -43.66 93.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.63 -179.528 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 223' ' ' ARG . . . . . 0.673 ' HG3' HD12 ' A' ' 235' ' ' ILE . 51.2 mtp180 -52.19 -63.11 1.25 Allowed 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 175.689 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -60.13 -19.46 53.69 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.077 -177.499 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 225' ' ' ASP . . . . . 0.478 ' HB3' ' CZ2' ' A' ' 267' ' ' TRP . 19.6 m-20 -87.32 -33.18 19.3 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.569 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.787 HD23 ' HZ ' ' A' ' 248' ' ' PHE . 8.2 mp -106.73 -18.25 14.0 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -170.625 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 227' ' ' GLU . . . . . 0.676 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 40.6 mt-10 -71.16 -24.41 0.72 Allowed Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -175.628 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 228' ' ' PRO . . . . . 0.676 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 74.7 Cg_endo -67.73 -26.76 38.69 Favored 'Trans proline' 0 C--N 1.36 1.184 0 C-N-CA 121.286 1.324 . . . . 0.0 112.05 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 229' ' ' PHE . . . . . 0.527 ' CZ ' ' HA ' ' A' ' 226' ' ' LEU . 3.6 p90 -110.55 -12.82 14.32 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.674 174.217 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 230' ' ' GLY . . . . . 0.448 ' HA2' ' HB1' ' A' ' 253' ' ' ALA . . . -165.01 96.06 0.13 Allowed Glycine 0 N--CA 1.441 -1.021 0 C-N-CA 120.319 -0.943 . . . . 0.0 111.939 -175.13 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 231' ' ' PRO . . . . . 0.4 ' HD2' ' HA2' ' A' ' 230' ' ' GLY . 18.9 Cg_endo -63.36 130.55 28.85 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.157 1.905 . . . . 0.0 111.423 178.519 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.934 HG21 HG12 ' A' ' 246' ' ' VAL . 2.1 mp -109.8 146.3 15.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.387 178.791 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 233' ' ' ASP . . . . . 0.541 ' OD2' HD22 ' A' ' 249' ' ' LEU . 7.7 m-20 -109.92 -22.43 11.86 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.909 0.385 . . . . 0.0 110.755 177.282 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 234' ' ' GLN . . . . . 0.617 ' HB3' ' HB2' ' A' ' 247' ' ' HIS . 30.9 tt0 -135.23 119.5 17.78 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.404 -176.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 235' ' ' ILE . . . . . 0.673 HD12 ' HG3' ' A' ' 223' ' ' ARG . 15.2 mt -136.96 106.57 4.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.852 -179.636 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -112.46 108.55 17.73 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.37 -179.05 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 237' ' ' ILE . . . . . 0.73 HG21 HG23 ' A' ' 217' ' ' ILE . 66.3 mt -99.99 117.77 45.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.548 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.607 ' HB ' HG13 ' A' ' 243' ' ' ILE . 45.2 t -100.1 87.44 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 172.523 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 239' ' ' THR . . . . . 0.519 ' OG1' ' HA ' ' A' ' 215' ' ' ASN . 14.0 t -64.77 -20.68 66.5 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.647 -175.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -67.74 -28.32 67.54 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.896 178.168 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 241' ' ' ARG . . . . . 0.578 ' HB2' HG12 ' A' ' 243' ' ' ILE . 81.9 mtt180 -120.13 5.12 10.82 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.653 -176.609 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 18.2 m120 66.12 24.75 10.86 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.33 175.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.628 HG22 ' HA2' ' A' ' 211' ' ' GLY . 1.6 pt -122.01 149.45 25.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.51 -173.827 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 244' ' ' ALA . . . . . 0.45 ' HB3' ' HB2' ' A' ' 210' ' ' LEU . . . -141.58 135.31 29.93 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.187 179.648 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -107.06 112.87 26.0 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.579 177.732 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 246' ' ' VAL . . . . . 0.934 HG12 HG21 ' A' ' 232' ' ' ILE . 0.1 OUTLIER -112.5 128.81 68.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.876 -176.944 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 247' ' ' HIS . . . . . 0.832 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 27.4 m170 -109.57 104.04 13.01 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.362 0.601 . . . . 0.0 111.313 178.398 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 248' ' ' PHE . . . . . 0.787 ' HZ ' HD23 ' A' ' 226' ' ' LEU . 30.4 m-85 -86.49 99.99 12.06 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.669 178.473 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.541 HD22 ' OD2' ' A' ' 233' ' ' ASP . 0.0 OUTLIER -37.37 -49.3 0.98 Allowed 'General case' 0 N--CA 1.469 0.511 0 O-C-N 124.654 1.221 . . . . 0.0 113.334 -176.131 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -90.95 139.48 30.72 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.109 177.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 251' ' ' ILE . . . . . 0.527 ' O ' HG13 ' A' ' 255' ' ' ILE . 0.2 OUTLIER -59.55 -41.35 84.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.047 -176.795 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -71.99 -30.88 65.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.981 -175.687 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 253' ' ' ALA . . . . . 0.448 ' HB1' ' HA2' ' A' ' 230' ' ' GLY . . . -59.33 -39.58 83.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.391 178.06 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 254' ' ' ALA . . . . . 0.621 ' HB2' ' HB2' ' A' ' 248' ' ' PHE . . . -69.19 -41.91 76.53 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.693 178.229 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.527 HG13 ' O ' ' A' ' 251' ' ' ILE . 8.4 mt -56.97 -60.85 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.247 -177.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 256' ' ' LYS . . . . . 0.488 ' O ' ' HG2' ' A' ' 260' ' ' GLU . 10.8 ptmt -61.17 -38.5 86.7 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.339 -177.196 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -61.95 -48.53 80.0 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.625 0.25 . . . . 0.0 111.344 178.66 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 258' ' ' VAL . . . . . 0.519 HG13 HG12 ' A' ' 272' ' ' ILE . 55.3 t -68.37 -24.02 29.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.878 0.371 . . . . 0.0 111.057 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -84.52 -23.78 29.63 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 177.207 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 260' ' ' GLU . . . . . 0.488 ' HG2' ' O ' ' A' ' 256' ' ' LYS . 68.7 mm-40 -95.83 -31.68 13.04 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.679 0.276 . . . . 0.0 110.972 -176.863 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.755 ' HA ' ' HE3' ' A' ' 267' ' ' TRP . 0.7 OUTLIER -52.46 -49.13 87.29 Favored Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.689 179.849 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 262' ' ' PRO . . . . . 0.577 ' HD2' ' N ' ' A' ' 261' ' ' LEU . 48.6 Cg_endo -67.75 -15.7 44.81 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.352 2.035 . . . . 0.0 112.81 -178.434 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 56.4 mt -87.45 -8.66 56.23 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.499 0.666 . . . . 0.0 111.072 -178.242 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 -106.77 149.64 38.7 Favored Pre-proline 0 C--N 1.311 -1.065 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.133 -171.698 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -65.36 -39.44 22.44 Favored 'Trans proline' 0 C--O 1.231 0.137 0 C-N-CA 123.424 2.749 . . . . 0.0 112.768 -168.769 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 10.1 mtpt -86.33 -44.42 12.1 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.385 0.612 . . . . 0.0 109.615 -176.709 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 267' ' ' TRP . . . . . 0.755 ' HE3' ' HA ' ' A' ' 261' ' ' LEU . 17.7 m0 -70.98 -32.34 69.16 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.008 -0.997 . . . . 0.0 110.869 -175.414 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 22.7 t -64.19 -24.26 67.61 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.739 0.305 . . . . 0.0 110.799 179.276 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -71.02 -15.6 62.57 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.239 0.543 . . . . 0.0 110.124 177.63 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 270' ' ' ARG . . . . . 0.542 ' HA ' ' HB3' ' A' ' 212' ' ' ASN . 1.6 mpt_? -93.84 156.03 16.87 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.13 174.17 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 6.1 mmp_? -103.82 105.54 15.78 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 173.383 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 272' ' ' ILE . . . . . 0.714 HG21 HD23 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -113.45 138.25 43.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.303 0.573 . . . . 0.0 110.667 -176.571 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -152.85 167.77 27.98 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.149 175.624 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 274' ' ' TYR . . . . . 0.512 ' OH ' ' HA ' ' A' ' 255' ' ' ILE . 80.6 m-85 . . . . . 0 C--N 1.321 -0.645 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.537 173.674 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 206' ' ' ARG . . . . . 0.839 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 44.0 mtp180 . . . . . 0 C--O 1.219 -0.505 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -97.5 106.34 18.64 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 119.246 0.93 . . . . 0.0 112.146 -169.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.505 ' HB ' ' HB ' ' A' ' 246' ' ' VAL . 57.3 t -137.28 121.21 22.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.076 -0.966 . . . . 0.0 109.819 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 209' ' ' PHE . . . . . 0.43 ' O ' ' HA ' ' A' ' 272' ' ' ILE . 10.5 t80 -114.57 126.81 55.34 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.743 0.306 . . . . 0.0 110.906 -178.244 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.738 ' HG ' HG22 ' A' ' 272' ' ' ILE . 4.8 mp -110.3 128.07 55.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.372 175.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 211' ' ' GLY . . . . . 0.596 ' HA2' HG22 ' A' ' 243' ' ' ILE . . . -137.82 66.32 0.54 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.383 -0.913 . . . . 0.0 113.046 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 212' ' ' ASN . . . . . 0.59 ' HB3' ' HA ' ' A' ' 270' ' ' ARG . 3.4 t30 177.58 43.07 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.332 0.586 . . . . 0.0 110.004 176.847 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.688 HD23 ' HG2' ' A' ' 270' ' ' ARG . 1.1 mt -94.83 161.16 29.48 Favored Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.966 -179.474 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -83.05 167.9 13.9 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.458 2.105 . . . . 0.0 111.533 176.309 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 215' ' ' ASN . . . . . 0.484 ' HA ' ' OG1' ' A' ' 239' ' ' THR . 53.7 t30 -78.28 124.69 28.37 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.078 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 107.78 -4.38 34.32 Favored Glycine 0 C--N 1.314 -0.663 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.925 -177.697 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 217' ' ' ILE . . . . . 0.676 HG23 HG21 ' A' ' 237' ' ' ILE . 5.1 tp -60.75 126.74 19.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.05 0.453 . . . . 0.0 110.384 177.748 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 218' ' ' THR . . . . . 0.488 HG22 ' HG3' ' A' ' 221' ' ' GLU . 15.1 t -114.43 158.77 21.11 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.076 0.465 . . . . 0.0 111.077 -178.116 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.627 ' HB3' ' HD2' ' A' ' 223' ' ' ARG . 2.3 mp0 -57.88 -44.46 86.68 Favored 'General case' 0 C--O 1.205 -1.274 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.523 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -42.75 -39.69 2.54 Favored 'General case' 0 C--N 1.319 -0.728 0 O-C-N 123.959 0.787 . . . . 0.0 111.66 178.585 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 221' ' ' GLU . . . . . 0.488 ' HG3' HG22 ' A' ' 218' ' ' THR . 43.7 mt-10 -70.74 -60.54 2.19 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.876 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 222' ' ' ILE . . . . . 0.644 HD12 HD11 ' A' ' 237' ' ' ILE . 10.8 mt -62.64 -41.6 92.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.665 -176.393 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 223' ' ' ARG . . . . . 0.854 ' HG3' HD12 ' A' ' 235' ' ' ILE . 46.3 mtt-85 -54.85 -62.28 1.76 Allowed 'General case' 0 CA--C 1.507 -0.678 0 CA-C-N 116.21 -0.45 . . . . 0.0 112.162 176.163 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -56.03 -25.23 43.89 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.47 -178.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 225' ' ' ASP . . . . . 0.466 ' HB3' ' CZ2' ' A' ' 267' ' ' TRP . 19.3 m-20 -83.22 -33.3 26.14 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.615 -176.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.808 HD23 ' HZ ' ' A' ' 248' ' ' PHE . 7.2 mp -106.72 -12.16 15.61 Favored 'General case' 0 C--O 1.224 -0.242 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -171.769 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 227' ' ' GLU . . . . . 0.65 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 15.1 mm-40 -62.31 -37.23 34.81 Favored Pre-proline 0 C--N 1.327 -0.387 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.211 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 228' ' ' PRO . . . . . 0.65 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 71.7 Cg_endo -65.33 -30.3 53.93 Favored 'Trans proline' 0 C--N 1.358 1.046 0 C-N-CA 121.569 1.513 . . . . 0.0 112.248 -172.567 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 229' ' ' PHE . . . . . 0.512 ' CE1' ' HA ' ' A' ' 226' ' ' LEU . 3.5 p90 -110.53 -6.69 14.84 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.935 177.767 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 230' ' ' GLY . . . . . 0.493 ' CA ' ' HB1' ' A' ' 253' ' ' ALA . . . -170.2 96.19 0.11 Allowed Glycine 0 N--CA 1.441 -1.006 0 C-N-CA 119.849 -1.167 . . . . 0.0 112.395 -176.139 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 231' ' ' PRO . . . . . 0.458 ' HA ' ' OE2' ' A' ' 227' ' ' GLU . 17.9 Cg_endo -63.21 129.76 26.59 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 121.704 1.603 . . . . 0.0 111.41 178.557 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.586 HG21 HG12 ' A' ' 246' ' ' VAL . 2.3 mp -107.38 151.99 9.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.644 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 233' ' ' ASP . . . . . 0.423 ' CG ' HD22 ' A' ' 249' ' ' LEU . 26.2 m-20 -114.51 -21.77 10.15 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.645 177.823 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 234' ' ' GLN . . . . . 0.458 ' H ' HG22 ' A' ' 232' ' ' ILE . 21.5 tt0 -141.19 120.42 12.99 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.648 -178.011 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 235' ' ' ILE . . . . . 0.854 HD12 ' HG3' ' A' ' 223' ' ' ARG . 6.1 mt -134.61 106.23 7.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.311 177.292 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.423 ' O ' ' HA ' ' A' ' 244' ' ' ALA . 35.0 ttmt -106.58 107.46 18.48 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.981 -177.314 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 237' ' ' ILE . . . . . 0.676 HG21 HG23 ' A' ' 217' ' ' ILE . 87.9 mt -100.62 114.31 39.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-O 121.267 0.556 . . . . 0.0 110.52 -179.394 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.532 ' HB ' HG13 ' A' ' 243' ' ' ILE . 45.9 t -100.52 85.87 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 173.5 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 239' ' ' THR . . . . . 0.484 ' OG1' ' HA ' ' A' ' 215' ' ' ASN . 12.3 t -71.75 -13.04 61.59 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.075 -176.079 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -57.37 -41.83 80.95 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.804 170.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 241' ' ' ARG . . . . . 0.537 ' HB2' HG12 ' A' ' 243' ' ' ILE . 75.3 mtt180 -116.06 8.79 14.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.126 -177.271 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 68.7 25.9 6.3 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.298 174.023 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.596 HG22 ' HA2' ' A' ' 211' ' ' GLY . 2.1 pt -122.23 151.14 25.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.33 -173.841 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 244' ' ' ALA . . . . . 0.47 ' HB3' ' HB2' ' A' ' 210' ' ' LEU . . . -141.52 135.61 30.35 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.977 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -108.8 115.08 29.4 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.688 177.39 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 246' ' ' VAL . . . . . 0.586 HG12 HG21 ' A' ' 232' ' ' ILE . 1.5 t -108.71 141.02 25.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.612 -176.582 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 247' ' ' HIS . . . . . 0.839 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 11.5 m80 -122.39 101.94 7.8 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.584 0.707 . . . . 0.0 111.668 174.787 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 248' ' ' PHE . . . . . 0.808 ' HZ ' HD23 ' A' ' 226' ' ' LEU . 33.2 m-85 -84.87 101.95 12.7 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 114.581 -1.19 . . . . 0.0 110.896 178.739 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.485 HD23 ' H ' ' A' ' 249' ' ' LEU . 0.1 OUTLIER -43.62 -39.37 3.5 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 124.344 1.028 . . . . 0.0 112.882 -175.92 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 250' ' ' ASN . . . . . 0.413 ' HB2' ' HB2' ' A' ' 253' ' ' ALA . 37.5 m-20 -93.73 140.17 29.96 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.128 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 251' ' ' ILE . . . . . 0.547 ' O ' HG13 ' A' ' 255' ' ' ILE . 0.2 OUTLIER -63.4 -43.95 98.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -178.75 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 252' ' ' ALA . . . . . 0.41 ' O ' ' HG2' ' A' ' 256' ' ' LYS . . . -70.16 -30.72 67.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.647 0.26 . . . . 0.0 110.617 -177.303 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 253' ' ' ALA . . . . . 0.493 ' HB1' ' CA ' ' A' ' 230' ' ' GLY . . . -58.14 -44.12 87.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.261 178.487 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 254' ' ' ALA . . . . . 0.573 ' HB2' ' HB2' ' A' ' 248' ' ' PHE . . . -68.56 -39.58 81.0 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.566 178.738 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.699 ' HA ' ' OH ' ' A' ' 274' ' ' TYR . 3.5 mt -57.37 -60.89 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.513 -179.219 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 256' ' ' LYS . . . . . 0.417 ' O ' ' HG2' ' A' ' 260' ' ' GLU . 13.2 ptmt -62.92 -38.67 91.9 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.184 -176.848 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -61.96 -49.95 74.08 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.514 0.19 . . . . 0.0 111.514 179.601 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 258' ' ' VAL . . . . . 0.508 HG13 HG12 ' A' ' 272' ' ' ILE . 53.0 t -64.21 -27.19 42.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.1 0.476 . . . . 0.0 110.998 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -84.53 -21.25 30.58 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 178.775 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 260' ' ' GLU . . . . . 0.417 ' HG2' ' O ' ' A' ' 256' ' ' LYS . 67.1 mm-40 -94.81 -33.27 12.93 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 122.677 0.391 . . . . 0.0 110.989 -177.742 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.876 HD23 HG21 ' A' ' 272' ' ' ILE . 0.7 OUTLIER -51.84 -50.67 76.58 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.666 -178.915 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 262' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 261' ' ' LEU . 37.1 Cg_endo -66.76 -17.12 51.99 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.442 2.094 . . . . 0.0 112.807 -178.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 54.0 mt -90.27 -5.82 55.88 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.138 0.494 . . . . 0.0 111.624 -177.701 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 264' ' ' ASN . . . . . 0.417 ' HB2' ' CE3' ' A' ' 267' ' ' TRP . 17.1 m-80 -107.13 149.73 39.0 Favored Pre-proline 0 C--N 1.315 -0.922 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.507 -174.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -65.51 -37.57 29.15 Favored 'Trans proline' 0 N--CA 1.465 -0.16 0 C-N-CA 123.432 2.754 . . . . 0.0 112.825 -171.088 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 266' ' ' LYS . . . . . 0.435 ' HE3' ' HB2' ' A' ' 266' ' ' LYS . 0.0 OUTLIER -82.8 -44.77 15.14 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 121.736 0.779 . . . . 0.0 109.251 -177.139 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 267' ' ' TRP . . . . . 0.758 ' HE3' ' HA ' ' A' ' 261' ' ' LEU . 10.4 m0 -77.29 -29.39 53.72 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.581 -1.19 . . . . 0.0 111.115 -172.547 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 19.4 t -66.4 -17.56 64.85 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.976 0.417 . . . . 0.0 110.406 178.012 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -78.02 -8.08 57.72 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.237 0.542 . . . . 0.0 110.182 176.356 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 270' ' ' ARG . . . . . 0.688 ' HG2' HD23 ' A' ' 213' ' ' LEU . 3.6 mpt_? -108.97 165.02 11.89 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.816 177.596 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -111.59 119.12 37.63 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 177.585 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 272' ' ' ILE . . . . . 0.876 HG21 HD23 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -128.97 143.25 41.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.139 0.495 . . . . 0.0 111.476 -179.276 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -151.69 169.5 22.01 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.942 170.414 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 274' ' ' TYR . . . . . 0.699 ' OH ' ' HA ' ' A' ' 255' ' ' ILE . 69.9 m-85 . . . . . 0 C--N 1.324 -0.53 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 172.298 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 206' ' ' ARG . . . . . 0.79 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 19.0 mtm180 . . . . . 0 C--O 1.223 -0.33 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 16.9 m-80 -105.93 105.64 15.77 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 118.816 0.734 . . . . 0.0 111.644 -172.677 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 61.5 t -134.36 109.16 11.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.035 176.665 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 209' ' ' PHE . . . . . 0.451 ' HE1' ' HB ' ' A' ' 243' ' ' ILE . 2.6 t80 -106.33 124.7 49.99 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.183 -175.861 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.565 ' HG ' HG22 ' A' ' 272' ' ' ILE . 6.1 mp -109.17 132.87 53.71 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.167 178.388 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 211' ' ' GLY . . . . . 0.676 ' HA2' HG22 ' A' ' 243' ' ' ILE . . . -138.05 60.7 0.59 Allowed Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.235 -0.983 . . . . 0.0 113.326 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 212' ' ' ASN . . . . . 0.536 ' HB3' ' HA ' ' A' ' 270' ' ' ARG . 2.5 t30 179.95 41.38 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.938 0.399 . . . . 0.0 110.67 177.103 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.464 HD21 HD22 ' A' ' 210' ' ' LEU . 1.4 mp -93.77 157.29 38.41 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.545 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.415 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 86.9 Cg_endo -77.72 169.87 20.06 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.764 2.31 . . . . 0.0 112.472 179.39 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 215' ' ' ASN . . . . . 0.589 ' HA ' ' OG1' ' A' ' 239' ' ' THR . 13.9 m120 -78.36 123.76 27.35 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.634 176.482 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 108.75 -8.75 34.36 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.358 -0.925 . . . . 0.0 112.865 179.306 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 217' ' ' ILE . . . . . 0.627 HG23 HG21 ' A' ' 237' ' ' ILE . 4.8 tp -58.99 128.69 20.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.889 0.345 . . . . 0.0 110.107 178.347 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 218' ' ' THR . . . . . 0.461 HG22 ' HG3' ' A' ' 221' ' ' GLU . 7.1 t -114.1 161.62 17.52 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.447 0.641 . . . . 0.0 111.235 -179.449 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.564 ' H ' ' CD ' ' A' ' 219' ' ' GLU . 1.6 mp0 -64.31 -40.4 95.84 Favored 'General case' 0 C--O 1.21 -0.99 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.849 -175.171 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 220' ' ' ASP . . . . . 0.529 ' O ' ' HG2' ' A' ' 224' ' ' GLU . 38.6 t70 -48.46 -41.44 29.54 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 123.803 0.689 . . . . 0.0 111.187 178.215 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 221' ' ' GLU . . . . . 0.461 ' HG3' HG22 ' A' ' 218' ' ' THR . 43.4 mt-10 -65.45 -56.81 10.43 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.332 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 222' ' ' ILE . . . . . 0.51 HD12 HD11 ' A' ' 237' ' ' ILE . 7.5 mt -61.07 -39.92 83.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.668 -179.117 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 223' ' ' ARG . . . . . 0.856 ' HG3' HD12 ' A' ' 235' ' ' ILE . 26.0 mtp180 -55.83 -62.77 1.47 Allowed 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 175.843 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.529 ' HG2' ' O ' ' A' ' 220' ' ' ASP . 9.1 pt-20 -60.92 -18.03 54.41 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.958 -178.057 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 225' ' ' ASP . . . . . 0.501 ' HB3' ' CZ2' ' A' ' 267' ' ' TRP . 44.0 m-20 -88.11 -35.2 17.6 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.288 -179.059 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.707 HD23 ' HZ ' ' A' ' 248' ' ' PHE . 8.0 mp -107.05 -17.63 14.12 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -169.746 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 227' ' ' GLU . . . . . 0.676 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 41.4 mt-10 -68.81 -27.27 1.33 Allowed Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -176.477 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 228' ' ' PRO . . . . . 0.676 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 71.6 Cg_endo -66.61 -27.83 45.33 Favored 'Trans proline' 0 C--N 1.36 1.171 0 C-N-CA 121.319 1.346 . . . . 0.0 111.94 -178.308 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 229' ' ' PHE . . . . . 0.541 ' CZ ' ' HA ' ' A' ' 226' ' ' LEU . 3.7 p90 -110.82 -7.6 14.6 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-O 120.734 0.302 . . . . 0.0 111.631 174.822 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . -170.09 95.55 0.11 Allowed Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.373 -0.918 . . . . 0.0 111.957 -175.744 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -60.94 132.43 42.15 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.016 1.811 . . . . 0.0 111.578 178.342 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.72 HG21 HG12 ' A' ' 246' ' ' VAL . 2.6 mp -109.99 149.92 12.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.766 178.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 233' ' ' ASP . . . . . 0.468 ' OD2' HD22 ' A' ' 249' ' ' LEU . 15.3 m-20 -115.63 -14.73 11.45 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.412 179.034 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 234' ' ' GLN . . . . . 0.497 ' H ' HG22 ' A' ' 232' ' ' ILE . 29.7 tt0 -148.35 120.87 8.52 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.518 -179.293 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 235' ' ' ILE . . . . . 0.856 HD12 ' HG3' ' A' ' 223' ' ' ARG . 17.1 mt -134.32 107.94 10.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.001 179.383 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -112.73 115.72 28.97 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.582 -177.676 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 237' ' ' ILE . . . . . 0.627 HG21 HG23 ' A' ' 217' ' ' ILE . 68.8 mt -104.74 121.88 57.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.932 -178.764 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 45.1 t -110.57 86.82 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 171.505 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 239' ' ' THR . . . . . 0.589 ' OG1' ' HA ' ' A' ' 215' ' ' ASN . 8.2 t -68.16 -19.89 64.83 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.405 -175.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -56.19 -37.57 69.79 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.359 174.341 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 241' ' ' ARG . . . . . 0.493 ' HB2' HG12 ' A' ' 243' ' ' ILE . 98.8 mtt180 -107.05 0.25 23.45 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.776 179.215 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 242' ' ' ASN . . . . . 0.439 ' O ' HD12 ' A' ' 213' ' ' LEU . 18.7 m120 65.63 29.12 11.06 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.472 -179.284 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.676 HG22 ' HA2' ' A' ' 211' ' ' GLY . 1.7 pp -122.22 157.24 26.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.604 -174.255 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -149.13 141.05 23.73 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.034 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -109.81 113.77 26.78 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.851 177.503 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 246' ' ' VAL . . . . . 0.72 HG12 HG21 ' A' ' 232' ' ' ILE . 0.2 OUTLIER -107.47 126.33 63.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.434 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 247' ' ' HIS . . . . . 0.79 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 51.8 m170 -105.83 102.6 12.03 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.183 -0.607 . . . . 0.0 111.244 179.699 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 248' ' ' PHE . . . . . 0.707 ' HZ ' HD23 ' A' ' 226' ' ' LEU . 34.6 m-85 -87.38 102.37 14.47 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.887 -1.051 . . . . 0.0 111.274 178.581 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.508 HD23 ' H ' ' A' ' 249' ' ' LEU . 0.0 OUTLIER -40.94 -47.21 2.96 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 124.512 1.132 . . . . 0.0 113.382 -174.881 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -93.84 144.68 25.21 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.252 177.368 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 251' ' ' ILE . . . . . 0.596 ' O ' HG13 ' A' ' 255' ' ' ILE . 0.2 OUTLIER -61.33 -41.82 91.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.328 -177.167 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -71.34 -30.39 66.13 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 120.58 0.228 . . . . 0.0 110.952 -175.597 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -57.27 -41.59 79.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.208 177.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 254' ' ' ALA . . . . . 0.546 ' HB2' ' HB2' ' A' ' 248' ' ' PHE . . . -69.77 -40.64 75.96 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.594 178.85 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.596 HG13 ' O ' ' A' ' 251' ' ' ILE . 12.8 mt -57.38 -60.85 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.249 -178.367 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 10.6 ptmt -61.77 -38.12 86.84 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.552 -176.737 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -62.98 -49.38 74.91 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 111.556 0.206 . . . . 0.0 111.556 178.393 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 258' ' ' VAL . . . . . 0.436 HG13 HG12 ' A' ' 272' ' ' ILE . 52.3 t -65.21 -23.47 33.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.985 0.421 . . . . 0.0 110.86 179.251 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -83.75 -25.91 30.14 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 177.484 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -94.27 -33.09 13.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.842 0.353 . . . . 0.0 111.069 -175.25 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.706 HD12 ' CE3' ' A' ' 267' ' ' TRP . 0.7 OUTLIER -52.15 -49.63 83.51 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.483 -179.703 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 262' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 261' ' ' LEU . 50.6 Cg_endo -68.63 -14.18 38.85 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.486 2.124 . . . . 0.0 112.863 -178.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 60.1 mt -91.19 -6.22 53.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.476 0.655 . . . . 0.0 111.207 -179.159 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -106.64 149.13 38.02 Favored Pre-proline 0 C--N 1.315 -0.93 0 CA-C-N 115.346 -0.843 . . . . 0.0 112.272 -174.015 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -66.46 -36.92 24.77 Favored 'Trans proline' 0 CA--C 1.527 0.136 0 C-N-CA 123.429 2.753 . . . . 0.0 112.919 -171.187 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -86.07 -44.28 12.41 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-O 121.579 0.704 . . . . 0.0 109.935 -178.27 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 267' ' ' TRP . . . . . 0.706 ' CE3' HD12 ' A' ' 261' ' ' LEU . 15.9 m0 -74.54 -27.97 60.75 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.873 -174.503 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 33.1 t -67.8 -18.11 64.74 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.889 0.376 . . . . 0.0 110.679 176.201 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -71.34 -19.3 62.32 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.394 0.616 . . . . 0.0 109.571 175.545 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 270' ' ' ARG . . . . . 0.536 ' HA ' ' HB3' ' A' ' 212' ' ' ASN . 5.0 mpt_? -95.09 156.11 16.45 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.537 177.484 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 271' ' ' ARG . . . . . 0.431 ' NE ' ' HA ' ' A' ' 271' ' ' ARG . 4.9 mmp_? -105.48 106.3 16.74 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 172.452 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 272' ' ' ILE . . . . . 0.667 HG21 HD23 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -115.62 138.42 46.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.401 0.619 . . . . 0.0 111.155 -175.407 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -151.6 169.11 22.92 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.857 174.244 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 274' ' ' TYR . . . . . 0.468 ' OH ' ' HA ' ' A' ' 255' ' ' ILE . 77.8 m-85 . . . . . 0 C--N 1.321 -0.652 0 CA-C-O 120.862 0.363 . . . . 0.0 110.496 175.705 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 206' ' ' ARG . . . . . 0.788 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 31.2 mtm180 . . . . . 0 C--O 1.223 -0.312 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -105.51 104.95 14.78 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.156 0.503 . . . . 0.0 111.472 -172.118 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.451 ' HB ' ' HB ' ' A' ' 246' ' ' VAL . 58.8 t -134.63 117.43 23.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.33 177.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 209' ' ' PHE . . . . . 0.414 ' HE1' ' HB ' ' A' ' 243' ' ' ILE . 3.1 t80 -114.46 123.97 50.75 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 120.951 0.405 . . . . 0.0 110.463 -177.024 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.549 ' HG ' HG22 ' A' ' 272' ' ' ILE . 6.1 mp -107.86 135.21 49.65 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.172 176.878 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 211' ' ' GLY . . . . . 0.624 ' HA2' HG22 ' A' ' 243' ' ' ILE . . . -142.9 61.74 0.52 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.229 -0.986 . . . . 0.0 113.249 179.247 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 37.7 t30 179.03 41.94 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.928 0.394 . . . . 0.0 110.253 178.334 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.475 HD12 ' O ' ' A' ' 242' ' ' ASN . 1.1 mp -92.51 159.93 35.72 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.392 -179.304 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.44 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 91.6 Cg_endo -79.63 162.84 24.34 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.541 2.161 . . . . 0.0 111.739 176.757 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -77.41 119.92 21.69 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.541 179.487 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 109.72 0.52 30.58 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.473 -0.87 . . . . 0.0 112.615 -177.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 217' ' ' ILE . . . . . 0.608 HG23 HG21 ' A' ' 237' ' ' ILE . 5.5 tp -64.49 129.01 27.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.863 0.364 . . . . 0.0 110.163 175.174 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 218' ' ' THR . . . . . 0.446 ' CG2' ' HG3' ' A' ' 221' ' ' GLU . 15.1 t -113.66 154.27 27.52 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 121.523 0.678 . . . . 0.0 110.917 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.475 ' H ' ' CD ' ' A' ' 219' ' ' GLU . 2.1 mp0 -62.78 -33.56 75.44 Favored 'General case' 0 C--O 1.206 -1.193 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.934 -178.319 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 220' ' ' ASP . . . . . 0.43 ' O ' ' HG2' ' A' ' 224' ' ' GLU . 15.7 t70 -49.48 -38.89 31.64 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.021 0.439 . . . . 0.0 110.811 176.84 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 221' ' ' GLU . . . . . 0.446 ' HG3' ' CG2' ' A' ' 218' ' ' THR . 42.1 mt-10 -70.77 -58.09 3.98 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.314 179.694 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 222' ' ' ILE . . . . . 0.509 HD12 HD11 ' A' ' 237' ' ' ILE . 8.6 mt -58.5 -41.79 82.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.815 -178.446 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 223' ' ' ARG . . . . . 0.671 ' HG3' HD12 ' A' ' 235' ' ' ILE . 49.4 mtp180 -57.61 -62.24 1.93 Allowed 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 177.585 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.43 ' HG2' ' O ' ' A' ' 220' ' ' ASP . 6.4 pt-20 -57.57 -24.23 55.07 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.731 -178.51 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -86.79 -31.42 20.9 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.854 -176.638 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.708 HD23 ' HZ ' ' A' ' 248' ' ' PHE . 8.0 mp -105.39 -20.21 13.56 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 120.609 -0.436 . . . . 0.0 112.167 -171.401 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 227' ' ' GLU . . . . . 0.677 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 36.6 mt-10 -68.99 -27.71 1.41 Allowed Pre-proline 0 C--N 1.325 -0.492 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -176.314 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 228' ' ' PRO . . . . . 0.677 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 71.5 Cg_endo -66.72 -28.77 43.66 Favored 'Trans proline' 0 C--N 1.359 1.081 0 C-N-CA 121.254 1.302 . . . . 0.0 112.07 -178.819 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 229' ' ' PHE . . . . . 0.501 ' CE1' ' HA ' ' A' ' 226' ' ' LEU . 3.9 p90 -111.15 4.13 19.06 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-O 120.69 0.281 . . . . 0.0 111.353 173.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 230' ' ' GLY . . . . . 0.488 ' CA ' ' HB1' ' A' ' 253' ' ' ALA . . . 177.25 98.9 0.11 Allowed Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 119.837 -1.173 . . . . 0.0 112.748 -177.876 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 231' ' ' PRO . . . . . 0.557 ' HA ' ' HG2' ' A' ' 227' ' ' GLU . 22.7 Cg_endo -63.38 134.29 44.32 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 121.904 1.736 . . . . 0.0 111.34 177.213 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.642 HG21 HG12 ' A' ' 246' ' ' VAL . 3.2 mp -107.7 151.06 9.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.642 178.208 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 233' ' ' ASP . . . . . 0.532 ' CG ' HD22 ' A' ' 249' ' ' LEU . 9.9 m-20 -106.84 -25.33 11.73 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.05 0.452 . . . . 0.0 110.319 178.863 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 234' ' ' GLN . . . . . 0.471 ' H ' HG22 ' A' ' 232' ' ' ILE . 30.8 tt0 -145.15 122.85 11.84 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.862 -175.057 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 235' ' ' ILE . . . . . 0.671 HD12 ' HG3' ' A' ' 223' ' ' ARG . 13.5 mt -136.13 109.35 8.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.909 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -119.21 120.42 37.01 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.475 -178.435 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 237' ' ' ILE . . . . . 0.608 HG21 HG23 ' A' ' 217' ' ' ILE . 64.7 mt -106.19 117.46 51.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.596 179.738 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.582 ' HB ' HG13 ' A' ' 243' ' ' ILE . 42.4 t -97.7 86.52 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 173.327 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 3.8 t -64.44 -23.15 67.19 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.291 -177.195 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -59.48 -36.08 75.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.073 0.463 . . . . 0.0 110.396 176.361 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 241' ' ' ARG . . . . . 0.684 ' HB2' HG12 ' A' ' 243' ' ' ILE . 74.6 mtt180 -113.91 3.37 15.39 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.632 -176.425 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 242' ' ' ASN . . . . . 0.475 ' O ' HD12 ' A' ' 213' ' ' LEU . 75.4 m-20 66.42 27.36 9.92 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.996 176.502 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.684 HG12 ' HB2' ' A' ' 241' ' ' ARG . 1.5 pt -122.28 153.25 26.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.088 -174.645 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 244' ' ' ALA . . . . . 0.446 ' HB3' ' HB2' ' A' ' 210' ' ' LEU . . . -143.78 140.45 29.92 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.012 0.434 . . . . 0.0 111.083 -179.11 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -110.57 117.89 34.75 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.788 178.324 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 246' ' ' VAL . . . . . 0.642 HG12 HG21 ' A' ' 232' ' ' ILE . 0.6 OUTLIER -113.41 129.25 69.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -179.594 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 247' ' ' HIS . . . . . 0.788 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 48.2 m170 -109.33 101.9 10.85 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.064 -0.654 . . . . 0.0 111.414 178.536 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 248' ' ' PHE . . . . . 0.708 ' HZ ' HD23 ' A' ' 226' ' ' LEU . 41.5 m-85 -87.14 100.88 12.98 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.18 178.825 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.556 HD23 ' H ' ' A' ' 249' ' ' LEU . 0.1 OUTLIER -43.86 -45.77 7.64 Favored 'General case' 0 N--CA 1.463 0.217 0 O-C-N 124.464 1.102 . . . . 0.0 112.62 -176.174 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 250' ' ' ASN . . . . . 0.401 ' HB2' ' HB2' ' A' ' 253' ' ' ALA . 13.4 m120 -86.35 136.88 32.97 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 177.313 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 251' ' ' ILE . . . . . 0.589 ' O ' HG13 ' A' ' 255' ' ' ILE . 0.2 OUTLIER -60.76 -43.17 94.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.272 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -69.23 -30.74 68.96 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.027 -177.203 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 253' ' ' ALA . . . . . 0.488 ' HB1' ' CA ' ' A' ' 230' ' ' GLY . . . -61.69 -39.98 93.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.384 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 254' ' ' ALA . . . . . 0.61 ' HB2' ' HB2' ' A' ' 248' ' ' PHE . . . -69.14 -41.91 76.7 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.59 178.678 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.589 HG13 ' O ' ' A' ' 251' ' ' ILE . 11.7 mt -55.89 -60.91 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.054 -177.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 13.7 ptmt -62.17 -38.12 87.85 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.607 -176.491 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -64.7 -48.63 73.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.587 0.232 . . . . 0.0 111.422 178.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 258' ' ' VAL . . . . . 0.421 HG13 HG12 ' A' ' 272' ' ' ILE . 43.0 t -65.96 -23.27 31.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 120.865 0.365 . . . . 0.0 110.96 179.558 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 259' ' ' GLN . . . . . 0.547 ' HA ' ' OE1' ' A' ' 259' ' ' GLN . 9.9 mm-40 -84.83 -25.81 27.86 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 176.503 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 48.9 mm-40 -89.5 -36.44 15.39 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-O 120.791 0.329 . . . . 0.0 111.026 -177.368 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.739 HD12 ' CE3' ' A' ' 267' ' ' TRP . 0.8 OUTLIER -51.71 -48.3 87.69 Favored Pre-proline 0 CA--C 1.54 0.568 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.656 -178.808 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 262' ' ' PRO . . . . . 0.611 ' HD3' HD11 ' A' ' 272' ' ' ILE . 55.9 Cg_endo -69.67 -16.53 37.99 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.5 2.133 . . . . 0.0 112.926 -179.229 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 66.2 mt -92.8 -3.62 54.39 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.344 0.592 . . . . 0.0 111.162 -177.695 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -106.14 149.95 38.76 Favored Pre-proline 0 C--N 1.313 -1.002 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.376 -176.71 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -65.56 -41.47 15.02 Favored 'Trans proline' 0 C--N 1.34 0.124 0 C-N-CA 123.284 2.656 . . . . 0.0 112.774 -168.448 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 16.0 mtpt -86.89 -44.67 11.49 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.198 0.523 . . . . 0.0 109.799 -175.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 267' ' ' TRP . . . . . 0.739 ' CE3' HD12 ' A' ' 261' ' ' LEU . 24.4 m0 -67.81 -33.51 74.93 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.802 -176.531 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 29.1 t -63.94 -24.29 67.67 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.99 0.424 . . . . 0.0 111.014 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -71.78 -16.44 62.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.188 0.518 . . . . 0.0 110.134 177.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 270' ' ' ARG . . . . . 0.439 ' HB3' HD23 ' A' ' 210' ' ' LEU . 5.2 mpt_? -93.99 144.88 25.07 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 173.899 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 271' ' ' ARG . . . . . 0.486 ' NE ' ' HA ' ' A' ' 271' ' ' ARG . 5.0 mmp_? -94.2 105.76 17.75 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 177.05 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 272' ' ' ILE . . . . . 0.701 HG21 HD23 ' A' ' 261' ' ' LEU . 0.1 OUTLIER -116.93 136.56 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 CA-C-O 121.634 0.73 . . . . 0.0 111.24 -177.665 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -152.07 167.99 26.68 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.826 173.367 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 274' ' ' TYR . . . . . 0.541 ' OH ' ' HA ' ' A' ' 255' ' ' ILE . 90.9 m-85 . . . . . 0 C--N 1.319 -0.735 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.244 173.002 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 56.8 m-80 . . . . . 0 N--CA 1.48 1.052 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 21.8 t -139.84 94.44 2.77 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -149.4 -179.49 7.11 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.989 -176.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' SER . . . . . 0.585 ' HA ' HD23 ' A' ' 196' ' ' LEU . 20.8 m -76.2 -51.94 11.07 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.804 -179.353 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 64.86 -88.64 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.016 0.526 . . . . 0.0 110.508 -177.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 5.1 p -127.38 6.86 6.37 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.395 0.617 . . . . 0.0 109.98 175.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' SER . . . . . 0.449 ' O ' ' HB3' ' A' ' 191' ' ' SER . 6.2 m -100.03 138.02 37.68 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.628 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 3.3 m -86.37 90.37 3.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-O 121.523 0.678 . . . . 0.0 112.166 -179.016 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.603 ' O ' HG22 ' A' ' 199' ' ' VAL . 4.1 mm? -78.53 -16.05 57.91 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.497 0.665 . . . . 0.0 109.522 174.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 63.2 tp -64.85 -18.31 65.03 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.273 173.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -91.17 -27.96 18.17 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.307 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.603 HG22 ' O ' ' A' ' 196' ' ' LEU . 4.3 m -76.86 -11.27 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.119 0 CA-C-O 121.171 0.51 . . . . 0.0 110.643 -174.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 14.7 mm-40 -99.81 14.67 29.52 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.539 -179.08 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' GLN . . . . . 0.49 ' HB2' ' HD2' ' A' ' 274' ' ' TYR . 26.1 mm-40 -112.3 162.78 15.14 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.2 -177.651 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 7.8 t -167.32 -173.71 2.35 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 177.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 74.32 49.82 11.29 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.787 178.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -156.29 107.32 2.44 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.671 0.272 . . . . 0.0 110.424 178.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' CYS . . . . . 0.565 ' HB3' HG12 ' A' ' 251' ' ' ILE . 19.2 p -87.68 146.47 25.68 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 178.239 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 206' ' ' ARG . . . . . 0.821 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 45.2 mtm180 56.59 0.69 0.07 Allowed 'General case' 0 C--O 1.222 -0.381 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 177.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -103.23 105.17 15.4 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 118.984 0.811 . . . . 0.0 111.759 -170.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.455 ' HB ' ' HB ' ' A' ' 246' ' ' VAL . 61.3 t -138.31 126.76 30.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.571 179.219 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 209' ' ' PHE . . . . . 0.575 ' O ' ' HA ' ' A' ' 272' ' ' ILE . 17.9 t80 -117.31 131.73 56.75 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.659 178.345 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.685 ' HG ' HG22 ' A' ' 272' ' ' ILE . 2.5 mp -112.85 115.18 28.06 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.46 175.179 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 211' ' ' GLY . . . . . 0.652 ' HA2' HG22 ' A' ' 243' ' ' ILE . . . -124.59 67.18 0.52 Allowed Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.664 -0.779 . . . . 0.0 113.227 -177.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 212' ' ' ASN . . . . . 0.61 ' HB2' ' HG3' ' A' ' 271' ' ' ARG . 2.5 t30 168.93 51.29 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.124 0.57 . . . . 0.0 110.039 172.139 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.503 HD21 HD22 ' A' ' 210' ' ' LEU . 1.0 OUTLIER -92.38 162.75 29.04 Favored Pre-proline 0 C--N 1.313 -0.983 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.108 -179.972 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.438 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 71.9 Cg_endo -79.66 156.09 24.37 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 122.109 1.872 . . . . 0.0 111.333 174.097 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 39.6 t-20 -70.61 128.01 34.63 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 178.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 106.07 -7.04 40.6 Favored Glycine 0 C--N 1.315 -0.606 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.88 -178.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' ILE . . . . . 0.624 HG23 HG21 ' A' ' 237' ' ' ILE . 5.2 tp -59.83 126.71 18.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.124 0.488 . . . . 0.0 110.649 178.36 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 218' ' ' THR . . . . . 0.547 HG22 ' HG3' ' A' ' 221' ' ' GLU . 6.9 t -112.43 154.87 25.16 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-O 121.251 0.548 . . . . 0.0 110.581 -179.088 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.458 ' H ' ' CD ' ' A' ' 219' ' ' GLU . 1.6 mp0 -58.88 -40.86 85.64 Favored 'General case' 0 C--O 1.21 -0.979 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.867 -176.285 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -50.74 -36.81 38.32 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 123.727 0.642 . . . . 0.0 111.262 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' GLU . . . . . 0.547 ' HG3' HG22 ' A' ' 218' ' ' THR . 42.2 mt-10 -68.47 -53.98 19.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.599 179.196 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.589 HD12 HD11 ' A' ' 237' ' ' ILE . 7.2 mt -61.96 -40.86 88.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.429 179.186 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 223' ' ' ARG . . . . . 0.776 ' HG3' HD12 ' A' ' 235' ' ' ILE . 61.7 mtp180 -53.99 -62.07 1.89 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.976 0.417 . . . . 0.0 111.955 174.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -59.03 -22.76 61.2 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.27 -178.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -89.07 -31.3 18.1 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.864 -177.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.832 HD23 ' HZ ' ' A' ' 248' ' ' PHE . 8.6 mp -106.56 -19.54 13.64 Favored 'General case' 0 C--O 1.223 -0.298 0 N-CA-C 112.257 0.465 . . . . 0.0 112.257 -170.458 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 227' ' ' GLU . . . . . 0.683 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 38.7 mt-10 -70.82 -26.35 0.95 Allowed Pre-proline 0 C--N 1.323 -0.556 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -175.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 228' ' ' PRO . . . . . 0.683 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 74.1 Cg_endo -65.33 -25.86 56.43 Favored 'Trans proline' 0 C--N 1.36 1.139 0 C-N-CA 121.202 1.268 . . . . 0.0 111.908 -178.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 229' ' ' PHE . . . . . 0.483 ' CE1' ' HA ' ' A' ' 226' ' ' LEU . 2.7 p90 -111.01 -17.37 13.29 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.726 173.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . -162.33 93.49 0.12 Allowed Glycine 0 N--CA 1.442 -0.949 0 C-N-CA 120.397 -0.906 . . . . 0.0 111.897 -173.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.542 ' HA ' ' HG2' ' A' ' 227' ' ' GLU . 17.5 Cg_endo -60.93 136.6 66.88 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.136 1.891 . . . . 0.0 111.677 178.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.76 HG21 HG12 ' A' ' 246' ' ' VAL . 2.8 mp -113.07 148.81 15.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.867 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 233' ' ' ASP . . . . . 0.429 ' CG ' HD22 ' A' ' 249' ' ' LEU . 11.5 m-20 -109.9 -20.2 12.84 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 120.894 0.378 . . . . 0.0 110.964 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 234' ' ' GLN . . . . . 0.564 ' HB3' ' HB2' ' A' ' 247' ' ' HIS . 31.3 tt0 -143.39 121.78 12.37 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.58 -176.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.776 HD12 ' HG3' ' A' ' 223' ' ' ARG . 14.2 mt -137.7 107.48 4.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.601 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 54.7 tttp -113.33 112.53 23.84 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.442 -178.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 237' ' ' ILE . . . . . 0.624 HG21 HG23 ' A' ' 217' ' ' ILE . 86.3 mt -103.2 121.72 54.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.902 -178.486 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.578 ' HB ' HG13 ' A' ' 243' ' ' ILE . 41.5 t -101.84 86.71 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 170.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 13.8 t -64.87 -22.22 66.95 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.792 -176.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -62.82 -30.92 71.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.534 177.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 241' ' ' ARG . . . . . 0.615 ' HB2' HG12 ' A' ' 243' ' ' ILE . 83.2 mtt180 -117.45 3.75 12.48 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.732 -176.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 16.8 m120 67.14 27.24 8.6 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.086 175.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.652 HG22 ' HA2' ' A' ' 211' ' ' GLY . 1.4 pt -122.73 151.54 26.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.526 -175.026 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 244' ' ' ALA . . . . . 0.468 ' HB3' ' HB2' ' A' ' 210' ' ' LEU . . . -143.7 138.04 28.59 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.227 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 245' ' ' PHE . . . . . 0.782 ' HZ ' ' HB ' ' A' ' 281' ' ' VAL . 21.5 m-85 -108.52 117.54 34.43 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.478 178.14 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.76 HG12 HG21 ' A' ' 232' ' ' ILE . 0.4 OUTLIER -113.94 138.47 43.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -176.209 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 247' ' ' HIS . . . . . 0.821 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 55.1 m170 -118.39 102.95 9.33 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.337 0.589 . . . . 0.0 111.147 175.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 248' ' ' PHE . . . . . 0.832 ' HZ ' HD23 ' A' ' 226' ' ' LEU . 33.6 m-85 -85.5 105.38 16.06 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.215 178.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.506 HD23 ' H ' ' A' ' 249' ' ' LEU . 0.1 OUTLIER -44.15 -45.34 8.22 Favored 'General case' 0 N--CA 1.467 0.398 0 O-C-N 124.389 1.056 . . . . 0.0 113.108 -173.474 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -95.86 142.89 27.57 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.401 -0.52 . . . . 0.0 110.209 177.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 251' ' ' ILE . . . . . 0.608 ' O ' HG13 ' A' ' 255' ' ' ILE . 0.2 OUTLIER -61.2 -42.5 93.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 -178.045 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -70.7 -28.38 64.7 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.001 -176.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -61.32 -41.48 97.08 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.146 178.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 254' ' ' ALA . . . . . 0.574 ' HB2' ' HB2' ' A' ' 248' ' ' PHE . . . -68.51 -41.45 79.94 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.67 178.22 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.615 ' HA ' ' OH ' ' A' ' 274' ' ' TYR . 11.4 mt -56.41 -59.89 2.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.402 -177.448 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 256' ' ' LYS . . . . . 0.49 ' O ' ' HG2' ' A' ' 260' ' ' GLU . 12.2 ptmt -61.63 -40.47 95.0 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.254 -177.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -63.3 -48.86 76.3 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 111.686 0.254 . . . . 0.0 111.686 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 258' ' ' VAL . . . . . 0.409 HG13 HG12 ' A' ' 272' ' ' ILE . 50.5 t -66.45 -24.0 32.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.957 0.408 . . . . 0.0 111.114 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 19.3 mm-40 -83.8 -24.82 30.86 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 177.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 260' ' ' GLU . . . . . 0.49 ' HG2' ' O ' ' A' ' 256' ' ' LYS . 27.5 mm-40 -95.17 -31.43 13.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.611 0.243 . . . . 0.0 111.273 -176.296 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.818 ' HA ' ' HE3' ' A' ' 267' ' ' TRP . 0.7 OUTLIER -52.17 -50.92 76.3 Favored Pre-proline 0 CA--C 1.537 0.471 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.255 179.362 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 262' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' A' ' 261' ' ' LEU . 42.0 Cg_endo -67.47 -17.87 49.02 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.441 2.094 . . . . 0.0 112.97 -178.471 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 59.0 mt -91.57 -5.58 53.78 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.068 0.461 . . . . 0.0 111.561 -177.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 264' ' ' ASN . . . . . 0.434 ' O ' ' HB2' ' A' ' 268' ' ' SER . 13.7 m-80 -105.34 145.89 31.68 Favored Pre-proline 0 C--N 1.313 -1.017 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.712 -175.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 265' ' ' PRO . . . . . 0.403 ' O ' ' HE3' ' A' ' 269' ' ' LYS . 51.9 Cg_endo -68.18 -26.65 36.03 Favored 'Trans proline' 0 C--N 1.334 -0.229 0 C-N-CA 123.332 2.688 . . . . 0.0 112.583 -170.491 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.463 ' HE3' ' NE1' ' A' ' 267' ' ' TRP . 0.0 OUTLIER -86.17 -46.3 10.53 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.958 0.885 . . . . 0.0 109.25 -178.837 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 267' ' ' TRP . . . . . 0.818 ' HE3' ' HA ' ' A' ' 261' ' ' LEU . 8.0 m0 -82.52 -24.12 34.25 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.478 -1.237 . . . . 0.0 110.6 -172.474 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 268' ' ' SER . . . . . 0.434 ' HB2' ' O ' ' A' ' 264' ' ' ASN . 22.4 t -65.58 -18.01 65.0 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.034 0.445 . . . . 0.0 110.581 176.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 269' ' ' LYS . . . . . 0.403 ' HE3' ' O ' ' A' ' 265' ' ' PRO . 94.3 mttt -73.65 -13.75 61.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.316 0.579 . . . . 0.0 109.879 176.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 270' ' ' ARG . . . . . 0.529 ' HA ' ' HB3' ' A' ' 212' ' ' ASN . 0.0 OUTLIER -109.95 147.4 33.51 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.742 -179.705 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 271' ' ' ARG . . . . . 0.61 ' HG3' ' HB2' ' A' ' 212' ' ' ASN . 40.6 mtm180 -98.06 106.15 18.4 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.106 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 272' ' ' ILE . . . . . 0.721 HG21 HD23 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -116.61 143.33 27.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.147 -177.451 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 273' ' ' TYR . . . . . 0.413 ' CZ ' ' HD2' ' A' ' 209' ' ' PHE . 1.5 p90 -150.57 167.75 26.32 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.4 172.541 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 274' ' ' TYR . . . . . 0.615 ' OH ' ' HA ' ' A' ' 255' ' ' ILE . 74.2 m-85 -66.66 118.53 10.35 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.948 172.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -73.64 115.36 5.0 Favored Glycine 0 N--CA 1.44 -1.077 0 C-N-CA 120.334 -0.936 . . . . 0.0 112.205 -177.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 276' ' ' ARG . . . . . 0.718 ' HB2' ' HB2' ' A' ' 284' ' ' LYS . 38.8 mmt180 -77.27 133.04 38.94 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 174.267 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 277' ' ' ASP . . . . . 0.584 ' CG ' ' H ' ' A' ' 278' ' ' ARG . 30.0 t70 59.56 -164.96 0.2 Allowed 'General case' 0 CA--C 1.539 0.553 0 O-C-N 123.7 0.625 . . . . 0.0 109.761 -174.167 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 278' ' ' ARG . . . . . 0.584 ' H ' ' CG ' ' A' ' 277' ' ' ASP . 3.8 mpt_? -99.26 -19.94 16.83 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.264 0.555 . . . . 0.0 109.662 -177.298 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 279' ' ' CYS . . . . . . . . . . . . . 24.1 m -95.44 31.15 2.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.142 -175.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -74.45 82.23 1.95 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.777 -178.063 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 281' ' ' VAL . . . . . 0.782 ' HB ' ' HZ ' ' A' ' 245' ' ' PHE . 11.7 p -126.94 -26.32 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.149 173.549 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -152.82 -50.33 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 177.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 91.7 mt -107.62 101.47 10.79 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 175.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 284' ' ' LYS . . . . . 0.718 ' HB2' ' HB2' ' A' ' 276' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.662 -0.685 . . . . 0.0 110.285 -177.29 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 . . . . . 0 N--CA 1.479 0.979 0 CA-C-O 121.017 0.436 . . . . 0.0 110.471 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 40.9 m -114.65 -18.25 11.45 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.792 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.545 ' HB3' HD23 ' A' ' 263' ' ' LEU . . . -155.89 -179.28 7.98 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.573 -178.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 43.8 m -98.61 -42.36 7.3 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.887 0.375 . . . . 0.0 110.121 177.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -159.1 -56.25 0.06 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.048 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 71.5 m 62.89 81.92 0.19 Allowed 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.528 0.68 . . . . 0.0 109.463 -170.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 16.1 m -73.54 179.33 4.14 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.346 -174.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' VAL . . . . . 0.795 HG21 ' HE2' ' A' ' 274' ' ' TYR . 0.0 OUTLIER -127.78 51.12 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.397 -178.734 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 26.4 tp 60.9 29.47 19.03 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.645 0.736 . . . . 0.0 109.67 -179.013 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 9.2 mp 65.03 14.58 9.46 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 114.752 -1.113 . . . . 0.0 111.204 -177.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . 60.41 24.12 13.68 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.665 179.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.482 HG23 ' HG3' ' A' ' 200' ' ' GLN . 31.5 m -65.41 -22.71 31.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.767 0.318 . . . . 0.0 111.624 -178.477 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 200' ' ' GLN . . . . . 0.482 ' HG3' HG23 ' A' ' 199' ' ' VAL . 49.7 mt-30 -117.98 13.49 13.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.105 0.479 . . . . 0.0 110.122 176.56 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 -145.72 31.96 1.05 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.557 -173.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 17.5 m -69.49 -37.87 77.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.135 -176.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.405 ' HA3' ' NH1' ' A' ' 278' ' ' ARG . . . -118.76 39.97 2.4 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 120.366 -0.921 . . . . 0.0 112.429 -175.714 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -87.19 88.62 7.74 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 121.164 0.507 . . . . 0.0 109.645 178.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' CYS . . . . . 0.561 ' HA ' HG12 ' A' ' 251' ' ' ILE . 5.4 m -87.05 145.56 26.43 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.222 -176.265 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 206' ' ' ARG . . . . . 0.832 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 7.7 mtp180 55.15 6.65 0.15 Allowed 'General case' 0 C--O 1.219 -0.549 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 70.5 m-20 -106.6 105.8 16.01 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 118.953 0.797 . . . . 0.0 111.9 -172.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.487 ' HB ' ' HB ' ' A' ' 246' ' ' VAL . 59.4 t -135.4 118.19 22.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.041 177.521 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 209' ' ' PHE . . . . . 0.44 ' HE1' ' HB ' ' A' ' 243' ' ' ILE . 2.3 t80 -116.92 125.13 51.01 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.263 -176.693 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.579 ' HG ' HG22 ' A' ' 272' ' ' ILE . 5.6 mp -107.65 132.19 53.58 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.265 178.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 211' ' ' GLY . . . . . 0.624 ' HA2' HG22 ' A' ' 243' ' ' ILE . . . -137.64 62.09 0.58 Allowed Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.309 -0.948 . . . . 0.0 113.326 -179.304 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 212' ' ' ASN . . . . . 0.579 ' HB2' ' HG2' ' A' ' 271' ' ' ARG . 38.8 t30 177.64 38.38 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.775 0.321 . . . . 0.0 110.598 175.292 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.531 HD21 HD22 ' A' ' 210' ' ' LEU . 1.0 OUTLIER -87.26 158.82 51.8 Favored Pre-proline 0 C--N 1.319 -0.74 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 178.828 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.409 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 83.8 Cg_endo -78.42 161.47 28.47 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.403 2.068 . . . . 0.0 110.994 176.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 215' ' ' ASN . . . . . 0.59 ' HA ' ' OG1' ' A' ' 239' ' ' THR . 9.1 t-20 -78.41 127.46 32.22 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -179.32 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 108.21 -6.27 34.33 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.485 -176.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' ILE . . . . . 0.639 HG23 HG21 ' A' ' 237' ' ' ILE . 4.5 tp -61.57 129.41 24.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.884 0.373 . . . . 0.0 110.309 177.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 218' ' ' THR . . . . . 0.475 ' CG2' ' HG3' ' A' ' 221' ' ' GLU . 15.2 t -112.83 155.9 23.84 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.4 0.619 . . . . 0.0 110.605 -179.414 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.494 ' H ' ' CD ' ' A' ' 219' ' ' GLU . 8.0 mp0 -63.95 -34.77 78.73 Favored 'General case' 0 C--O 1.206 -1.211 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.936 -176.222 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -54.69 -35.67 63.84 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 123.335 0.397 . . . . 0.0 110.591 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' GLU . . . . . 0.535 ' O ' ' HG2' ' A' ' 224' ' ' GLU . 46.1 mt-10 -67.03 -58.64 4.54 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.276 177.748 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.654 HD12 HD11 ' A' ' 237' ' ' ILE . 7.8 mt -61.24 -38.48 79.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.63 -178.068 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 223' ' ' ARG . . . . . 0.725 ' HG3' HD12 ' A' ' 235' ' ' ILE . 51.2 mtp180 -54.17 -63.14 1.25 Allowed 'General case' 0 CA--C 1.508 -0.645 0 CA-C-O 121.125 0.488 . . . . 0.0 111.693 174.358 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.535 ' HG2' ' O ' ' A' ' 221' ' ' GLU . 17.7 pt-20 -60.48 -17.38 44.69 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.03 -177.712 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 225' ' ' ASP . . . . . 0.501 ' HB3' ' CZ2' ' A' ' 267' ' ' TRP . 13.7 m-20 -89.23 -33.76 16.87 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.371 -179.326 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.71 HD23 ' HZ ' ' A' ' 248' ' ' PHE . 7.7 mp -106.98 -11.48 15.67 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 111.979 0.362 . . . . 0.0 111.979 -171.277 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 227' ' ' GLU . . . . . 0.641 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 53.3 mm-40 -62.97 -36.0 22.19 Favored Pre-proline 0 C--N 1.325 -0.468 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -178.441 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 228' ' ' PRO . . . . . 0.641 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 85.7 Cg_endo -66.21 -31.1 45.31 Favored 'Trans proline' 0 C--N 1.358 1.071 0 C-N-CA 121.43 1.42 . . . . 0.0 112.163 -173.351 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 229' ' ' PHE . . . . . 0.508 ' CZ ' ' HA ' ' A' ' 226' ' ' LEU . 4.0 p90 -110.21 -0.73 17.7 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.628 177.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 230' ' ' GLY . . . . . 0.429 ' HA2' ' HD2' ' A' ' 231' ' ' PRO . . . -177.21 94.61 0.1 OUTLIER Glycine 0 N--CA 1.441 -1.002 0 C-N-CA 119.658 -1.258 . . . . 0.0 112.64 -178.095 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.429 ' HD2' ' HA2' ' A' ' 230' ' ' GLY . 17.1 Cg_endo -59.53 131.54 40.98 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 121.877 1.718 . . . . 0.0 111.246 175.748 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.64 HG21 HG12 ' A' ' 246' ' ' VAL . 2.7 mp -106.86 151.9 8.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.423 178.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 233' ' ' ASP . . . . . 0.527 ' CG ' HD22 ' A' ' 249' ' ' LEU . 34.2 m-20 -109.93 -23.62 11.25 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.786 0.326 . . . . 0.0 110.223 179.062 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 234' ' ' GLN . . . . . 0.459 ' H ' HG22 ' A' ' 232' ' ' ILE . 13.7 tt0 -143.43 126.83 16.77 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.843 -177.64 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.725 HD12 ' HG3' ' A' ' 223' ' ' ARG . 15.6 mt -139.52 113.49 6.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.903 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -121.12 116.67 25.43 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.33 -178.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 237' ' ' ILE . . . . . 0.654 HD11 HD12 ' A' ' 222' ' ' ILE . 86.7 mt -104.76 126.01 59.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.434 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.578 ' HB ' HG13 ' A' ' 243' ' ' ILE . 42.1 t -103.8 85.51 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.046 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 169.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 239' ' ' THR . . . . . 0.59 ' OG1' ' HA ' ' A' ' 215' ' ' ASN . 11.7 t -71.04 -16.56 62.61 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.637 -173.324 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -65.36 -33.0 74.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.117 174.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 241' ' ' ARG . . . . . 0.545 ' HB2' HG12 ' A' ' 243' ' ' ILE . 71.1 mtt180 -110.74 3.18 18.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.085 -178.063 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 242' ' ' ASN . . . . . 0.456 ' O ' HD12 ' A' ' 213' ' ' LEU . 89.4 m-20 68.35 23.7 7.55 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.108 177.192 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.624 HG22 ' HA2' ' A' ' 211' ' ' GLY . 1.5 pt -122.43 150.65 26.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.466 -174.282 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 244' ' ' ALA . . . . . 0.449 ' HB3' ' HB2' ' A' ' 210' ' ' LEU . . . -143.19 139.47 30.32 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.053 0.454 . . . . 0.0 111.668 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -109.3 115.78 30.63 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.765 178.093 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.64 HG12 HG21 ' A' ' 232' ' ' ILE . 1.3 t -112.3 134.89 53.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -179.129 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 247' ' ' HIS . . . . . 0.832 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 33.5 m170 -112.98 101.7 9.72 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.016 -0.674 . . . . 0.0 111.309 177.378 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 248' ' ' PHE . . . . . 0.71 ' HZ ' HD23 ' A' ' 226' ' ' LEU . 34.5 m-85 -86.28 104.25 15.63 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-N 115.089 -0.96 . . . . 0.0 111.651 179.445 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.527 HD22 ' CG ' ' A' ' 233' ' ' ASP . 0.0 OUTLIER -42.85 -48.17 5.71 Favored 'General case' 0 N--CA 1.465 0.306 0 O-C-N 124.506 1.129 . . . . 0.0 112.975 -175.192 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -93.37 141.4 28.49 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.112 176.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 251' ' ' ILE . . . . . 0.642 ' O ' HG13 ' A' ' 255' ' ' ILE . 0.3 OUTLIER -61.71 -39.94 85.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.027 -178.549 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -68.64 -31.72 71.07 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.995 -176.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 253' ' ' ALA . . . . . 0.423 ' HB1' ' CA ' ' A' ' 230' ' ' GLY . . . -61.68 -41.81 98.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.298 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 254' ' ' ALA . . . . . 0.56 ' HB2' ' HB2' ' A' ' 248' ' ' PHE . . . -67.17 -41.72 85.47 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.409 178.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.642 HG13 ' O ' ' A' ' 251' ' ' ILE . 10.6 mt -57.37 -59.45 3.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.065 -178.385 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 256' ' ' LYS . . . . . 0.421 ' O ' ' HG2' ' A' ' 260' ' ' GLU . 13.9 ptmt -62.27 -40.33 95.86 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.305 -177.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -61.55 -48.93 78.74 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.668 0.271 . . . . 0.0 111.184 178.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 258' ' ' VAL . . . . . 0.514 HG13 HG12 ' A' ' 272' ' ' ILE . 53.5 t -65.86 -26.33 38.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.907 0.384 . . . . 0.0 111.107 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 28.7 mm-40 -84.94 -24.61 28.31 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 178.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 260' ' ' GLU . . . . . 0.421 ' HG2' ' O ' ' A' ' 256' ' ' LYS . 71.9 mm-40 -95.3 -31.42 13.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.595 0.236 . . . . 0.0 111.026 -176.408 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.707 HD12 ' CE3' ' A' ' 267' ' ' TRP . 0.4 OUTLIER -50.91 -51.04 70.78 Favored Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.266 178.727 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 262' ' ' PRO . . . . . 0.566 ' HD2' ' N ' ' A' ' 261' ' ' LEU . 43.3 Cg_endo -67.42 -14.62 43.16 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.465 2.11 . . . . 0.0 112.698 -177.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 263' ' ' LEU . . . . . 0.545 HD23 ' HB3' ' A' ' 190' ' ' ALA . 52.6 mt -92.43 -4.69 53.34 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.175 0.512 . . . . 0.0 111.367 -179.278 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 264' ' ' ASN . . . . . 0.433 ' O ' ' HB2' ' A' ' 268' ' ' SER . 10.9 m-80 -106.18 149.42 38.15 Favored Pre-proline 0 C--N 1.315 -0.929 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.998 -175.565 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -63.9 -38.58 37.74 Favored 'Trans proline' 0 N--CA 1.465 -0.171 0 C-N-CA 123.421 2.747 . . . . 0.0 112.534 -169.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 7.1 mtpt -84.62 -45.09 12.86 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 121.648 0.737 . . . . 0.0 109.376 -177.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 267' ' ' TRP . . . . . 0.707 ' CE3' HD12 ' A' ' 261' ' ' LEU . 12.9 m0 -77.37 -27.6 52.63 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.737 -1.12 . . . . 0.0 111.058 -171.078 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 268' ' ' SER . . . . . 0.451 ' HA ' ' HA ' ' A' ' 262' ' ' PRO . 12.0 t -65.47 -21.93 66.69 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.934 0.397 . . . . 0.0 110.547 178.604 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -72.7 -22.66 60.86 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.301 0.572 . . . . 0.0 110.069 177.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 270' ' ' ARG . . . . . 0.474 ' HA ' ' HB3' ' A' ' 212' ' ' ASN . 5.4 mpt_? -92.98 141.3 28.56 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 178.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 271' ' ' ARG . . . . . 0.579 ' HG2' ' HB2' ' A' ' 212' ' ' ASN . 37.5 mmt180 -93.02 105.93 17.96 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 178.376 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 272' ' ' ILE . . . . . 0.703 HG21 HD23 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -114.33 142.65 26.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.242 0.544 . . . . 0.0 111.42 -176.902 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -152.35 169.29 22.89 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.55 173.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 274' ' ' TYR . . . . . 0.795 ' HE2' HG21 ' A' ' 195' ' ' VAL . 85.2 m-85 -64.3 136.93 57.62 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.692 0.282 . . . . 0.0 110.41 173.607 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -65.93 171.46 26.96 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.053 176.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 276' ' ' ARG . . . . . 0.472 ' O ' ' HB3' ' A' ' 277' ' ' ASP . 16.5 mmt180 -87.49 152.67 22.03 Favored 'General case' 0 C--N 1.32 -0.702 0 O-C-N 122.735 -0.273 . . . . 0.0 110.335 -177.319 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 277' ' ' ASP . . . . . 0.472 ' HB3' ' O ' ' A' ' 276' ' ' ARG . 8.9 t70 68.55 150.07 0.07 Allowed 'General case' 0 CA--C 1.533 0.326 0 O-C-N 124.106 0.879 . . . . 0.0 110.678 -173.619 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 278' ' ' ARG . . . . . 0.405 ' NH1' ' HA3' ' A' ' 203' ' ' GLY . 60.9 mtt-85 -73.78 -35.08 64.92 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 122.082 -0.386 . . . . 0.0 111.626 -177.172 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 279' ' ' CYS . . . . . . . . . . . . . 73.1 m 59.71 25.15 14.09 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.299 0.571 . . . . 0.0 110.769 -175.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -110.5 18.8 19.4 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.144 -179.05 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 9.2 p -88.86 -19.16 7.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.655 -177.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -135.96 63.94 0.58 Allowed Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.118 178.252 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 83.4 mt -103.78 130.48 51.32 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.844 0.354 . . . . 0.0 110.552 178.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 284' ' ' LYS . . . . . 0.789 ' HE2' ' HA ' ' A' ' 284' ' ' LYS . 0.5 OUTLIER . . . . . 0 C--O 1.247 0.947 0 CA-C-O 118.511 -0.756 . . . . 0.0 109.941 178.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 . . . . . 0 N--CA 1.482 1.163 0 CA-C-O 120.734 0.302 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 17.0 p -87.33 -41.52 13.57 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.308 0.575 . . . . 0.0 110.119 176.409 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -118.47 -179.13 3.7 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.844 177.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 25.1 m 66.83 17.72 10.58 Favored 'General case' 0 N--CA 1.463 0.186 0 O-C-N 123.552 0.533 . . . . 0.0 110.682 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -93.6 160.37 14.81 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 178.117 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 13.3 m -73.41 92.56 1.86 Allowed 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.409 178.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 17.5 m -70.43 95.49 1.05 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 176.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 16.5 m -134.94 139.84 46.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.149 -175.017 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 89.0 mt -80.33 -4.0 51.71 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 167.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 56.9 tp -64.77 -23.37 67.22 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.742 -1.117 . . . . 0.0 109.165 169.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -64.34 -32.59 74.25 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.364 177.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 33.2 m -103.51 12.32 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 177.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 47.66 30.03 1.66 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.937 1.295 . . . . 0.0 113.203 177.226 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -139.33 124.89 19.34 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.17 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 48.7 m -159.42 127.88 5.09 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.375 -179.212 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.404 ' O ' HG12 ' A' ' 281' ' ' VAL . . . -82.87 48.17 3.96 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.939 -0.648 . . . . 0.0 111.986 177.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 204' ' ' ALA . . . . . 0.745 ' HA ' ' HA ' ' A' ' 280' ' ' ALA . . . -111.67 101.61 9.97 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 -179.293 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 205' ' ' CYS . . . . . 0.522 ' HA ' HG12 ' A' ' 251' ' ' ILE . 2.4 m -87.27 145.58 26.31 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -177.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 206' ' ' ARG . . . . . 0.912 ' HE ' ' HA ' ' A' ' 249' ' ' LEU . 16.9 mtp180 54.2 9.14 0.21 Allowed 'General case' 0 C--O 1.22 -0.483 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 176.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 207' ' ' ASN . . . . . 0.644 HD21 ' HB2' ' A' ' 277' ' ' ASP . 11.0 m120 -109.9 107.02 16.8 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-N 118.988 0.813 . . . . 0.0 112.493 -174.083 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.551 ' HB ' ' HB ' ' A' ' 246' ' ' VAL . 60.8 t -135.3 127.11 46.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 114.878 -1.055 . . . . 0.0 109.148 177.3 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 209' ' ' PHE . . . . . 0.446 ' O ' ' HA ' ' A' ' 272' ' ' ILE . 6.8 t80 -122.37 127.41 49.71 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-O 120.725 0.298 . . . . 0.0 110.307 -178.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.575 ' HG ' HG22 ' A' ' 272' ' ' ILE . 4.7 mp -109.77 126.03 53.32 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.335 176.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 211' ' ' GLY . . . . . 0.713 ' HA2' HG22 ' A' ' 243' ' ' ILE . . . -130.65 57.49 0.72 Allowed Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.265 -0.969 . . . . 0.0 113.373 -178.553 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 212' ' ' ASN . . . . . 0.498 ' HB3' ' HA ' ' A' ' 270' ' ' ARG . 2.8 t30 177.4 49.74 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.061 0.458 . . . . 0.0 110.509 177.245 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.556 HD21 HD22 ' A' ' 210' ' ' LEU . 1.0 OUTLIER -97.39 159.05 32.09 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.184 178.722 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.425 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 95.8 Cg_endo -79.85 154.46 23.09 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.326 2.017 . . . . 0.0 112.15 178.3 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 215' ' ' ASN . . . . . 0.545 ' HA ' ' OG1' ' A' ' 239' ' ' THR . 8.8 m120 -66.31 121.21 14.74 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.032 177.442 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 108.86 -1.97 31.86 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.451 -0.88 . . . . 0.0 112.876 -177.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' ILE . . . . . 0.583 HG23 HG21 ' A' ' 237' ' ' ILE . 5.7 tp -64.08 128.0 25.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.046 0.451 . . . . 0.0 110.525 175.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 218' ' ' THR . . . . . 0.55 HG22 ' HG3' ' A' ' 221' ' ' GLU . 4.9 t -114.22 157.55 22.54 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.119 0.485 . . . . 0.0 110.575 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.425 ' H ' ' CD ' ' A' ' 219' ' ' GLU . 3.3 mp0 -61.66 -40.31 94.48 Favored 'General case' 0 C--O 1.208 -1.11 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.41 -175.61 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -51.46 -35.81 41.44 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 123.514 0.509 . . . . 0.0 111.029 -179.164 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' GLU . . . . . 0.55 ' HG3' HG22 ' A' ' 218' ' ' THR . 43.4 mt-10 -67.65 -55.9 11.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.303 178.207 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.572 HD12 HD11 ' A' ' 237' ' ' ILE . 8.0 mt -60.95 -41.21 88.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.537 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 223' ' ' ARG . . . . . 0.639 ' HG3' HD12 ' A' ' 235' ' ' ILE . 26.1 mtp180 -56.55 -61.81 2.16 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 175.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -57.16 -21.64 34.43 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.625 -178.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 225' ' ' ASP . . . . . 0.425 ' HB3' ' CZ2' ' A' ' 267' ' ' TRP . 12.8 m-20 -87.27 -33.98 19.07 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.746 -178.637 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.785 HD23 ' HZ ' ' A' ' 248' ' ' PHE . 7.7 mp -106.83 -18.01 14.05 Favored 'General case' 0 C--O 1.224 -0.247 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -170.008 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 227' ' ' GLU . . . . . 0.679 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 35.7 mt-10 -65.79 -31.58 4.95 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -175.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 228' ' ' PRO . . . . . 0.679 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 72.0 Cg_endo -65.94 -29.94 48.94 Favored 'Trans proline' 0 C--N 1.359 1.085 0 C-N-CA 121.459 1.439 . . . . 0.0 112.3 -176.317 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 229' ' ' PHE . . . . . 0.489 ' CE1' ' HA ' ' A' ' 226' ' ' LEU . 3.6 p90 -111.06 -4.22 15.18 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.579 176.134 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . -172.08 95.73 0.11 Allowed Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.127 -1.035 . . . . 0.0 112.478 -176.17 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -61.58 133.64 46.68 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.174 1.916 . . . . 0.0 111.43 177.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.698 HG21 HG12 ' A' ' 246' ' ' VAL . 2.5 mp -110.42 151.3 12.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.925 178.105 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 233' ' ' ASP . . . . . 0.462 ' OD2' HD22 ' A' ' 249' ' ' LEU . 6.7 m-20 -110.89 -25.49 9.82 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.92 177.606 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 234' ' ' GLN . . . . . 0.626 ' HB3' ' HB2' ' A' ' 247' ' ' HIS . 16.8 tt0 -138.82 120.57 15.3 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.551 -174.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.639 HD12 ' HG3' ' A' ' 223' ' ' ARG . 11.1 mt -137.08 107.73 5.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.99 178.655 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 63.1 tttp -115.81 113.79 23.87 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.364 -177.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 237' ' ' ILE . . . . . 0.583 HG21 HG23 ' A' ' 217' ' ' ILE . 86.4 mt -102.13 125.71 56.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-O 121.134 0.492 . . . . 0.0 110.955 -179.18 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.552 ' HB ' HG13 ' A' ' 243' ' ' ILE . 57.7 t -108.81 87.31 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 171.155 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 239' ' ' THR . . . . . 0.545 ' OG1' ' HA ' ' A' ' 215' ' ' ASN . 14.4 t -68.91 -12.62 61.79 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.529 -177.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 18.6 mp0 -63.01 -35.48 80.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.986 175.097 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 241' ' ' ARG . . . . . 0.7 ' HB2' HG12 ' A' ' 243' ' ' ILE . 66.8 mtp180 -115.58 4.2 14.13 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.1 179.045 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 242' ' ' ASN . . . . . 0.446 ' O ' HD12 ' A' ' 213' ' ' LEU . 15.9 m120 65.85 30.56 9.93 Favored 'General case' 0 N--CA 1.465 0.278 0 O-C-N 123.446 0.466 . . . . 0.0 110.743 178.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.713 HG22 ' HA2' ' A' ' 211' ' ' GLY . 1.3 pt -122.06 149.72 25.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.158 -175.081 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -142.36 138.14 30.98 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.048 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -109.54 120.79 43.57 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.881 179.007 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.698 HG12 HG21 ' A' ' 232' ' ' ILE . 0.5 OUTLIER -116.3 136.16 54.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.981 -176.385 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 247' ' ' HIS . . . . . 0.827 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 20.1 m170 -114.45 102.97 10.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.191 0.519 . . . . 0.0 111.23 175.62 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 248' ' ' PHE . . . . . 0.785 ' HZ ' HD23 ' A' ' 226' ' ' LEU . 29.7 m-85 -85.76 103.79 14.86 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.014 178.006 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.912 ' HA ' ' HE ' ' A' ' 206' ' ' ARG . 0.1 OUTLIER -44.64 -39.28 4.91 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 124.218 0.949 . . . . 0.0 113.311 -172.998 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 57.9 m-20 -100.17 144.71 28.88 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 178.132 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 251' ' ' ILE . . . . . 0.584 ' O ' HG13 ' A' ' 255' ' ' ILE . 0.3 OUTLIER -63.89 -43.3 97.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -176.618 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -68.63 -31.12 70.04 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.111 -177.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -58.25 -42.88 87.39 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.541 179.097 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 254' ' ' ALA . . . . . 0.596 ' HB2' ' HB2' ' A' ' 248' ' ' PHE . . . -68.52 -41.67 79.63 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.614 178.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.584 HG13 ' O ' ' A' ' 251' ' ' ILE . 8.4 mt -57.03 -58.47 5.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.456 -177.398 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 256' ' ' LYS . . . . . 0.414 ' O ' ' HG2' ' A' ' 260' ' ' GLU . 11.1 ptmt -63.81 -38.79 92.42 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.395 -177.201 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -63.19 -49.83 72.72 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.632 0.253 . . . . 0.0 111.297 178.316 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 258' ' ' VAL . . . . . 0.57 HG13 HG12 ' A' ' 272' ' ' ILE . 70.3 t -66.8 -22.9 30.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 120.883 0.373 . . . . 0.0 111.09 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 259' ' ' GLN . . . . . 0.423 ' HG3' ' O ' ' A' ' 255' ' ' ILE . 63.9 mt-30 -83.53 -24.1 31.8 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 176.166 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 260' ' ' GLU . . . . . 0.414 ' HG2' ' O ' ' A' ' 256' ' ' LYS . 42.4 mm-40 -94.75 -33.61 12.84 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.868 0.366 . . . . 0.0 110.893 -176.267 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.709 HD12 ' CE3' ' A' ' 267' ' ' TRP . 0.9 OUTLIER -51.57 -50.91 74.23 Favored Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.508 -179.777 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 262' ' ' PRO . . . . . 0.567 ' HD3' HD11 ' A' ' 272' ' ' ILE . 44.5 Cg_endo -67.5 -15.4 45.08 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.378 2.052 . . . . 0.0 112.679 -177.703 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 59.2 mt -96.66 0.55 49.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.062 0.458 . . . . 0.0 111.673 -177.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 -107.05 148.6 37.31 Favored Pre-proline 0 C--N 1.314 -0.94 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.34 -177.132 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -64.11 -35.28 54.19 Favored 'Trans proline' 0 C--O 1.23 0.092 0 C-N-CA 123.509 2.806 . . . . 0.0 112.411 -172.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 3.5 mtpt -86.11 -45.17 11.63 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 121.643 0.735 . . . . 0.0 109.738 -178.065 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 267' ' ' TRP . . . . . 0.709 ' CE3' HD12 ' A' ' 261' ' ' LEU . 15.4 m0 -78.03 -28.53 49.06 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 114.772 -1.104 . . . . 0.0 111.14 -172.222 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 23.0 t -68.51 -15.11 63.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.797 0.332 . . . . 0.0 110.812 178.154 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -73.76 -17.32 61.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.41 0.624 . . . . 0.0 109.631 174.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 270' ' ' ARG . . . . . 0.498 ' HA ' ' HB3' ' A' ' 212' ' ' ASN . 4.7 mpt_? -97.43 154.72 17.29 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.444 177.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 271' ' ' ARG . . . . . 0.421 HH11 ' HD3' ' A' ' 271' ' ' ARG . 39.5 mmt-85 -104.5 105.78 16.02 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 174.429 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 272' ' ' ILE . . . . . 0.657 HG21 HD23 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -115.65 141.14 34.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-O 121.306 0.574 . . . . 0.0 111.536 -177.09 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -152.37 169.8 21.65 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.363 171.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 274' ' ' TYR . . . . . 0.418 ' OH ' ' HA ' ' A' ' 255' ' ' ILE . 84.4 m-85 -63.5 124.71 22.03 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.983 0.42 . . . . 0.0 110.755 176.443 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -76.28 -175.02 39.09 Favored Glycine 0 CA--C 1.518 0.221 0 CA-C-N 115.62 -0.718 . . . . 0.0 113.726 -172.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 276' ' ' ARG . . . . . 0.487 ' HG2' HD22 ' A' ' 283' ' ' LEU . 49.9 mtm180 -103.21 131.53 50.17 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.681 0.277 . . . . 0.0 111.094 -176.645 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 277' ' ' ASP . . . . . 0.644 ' HB2' HD21 ' A' ' 207' ' ' ASN . 26.3 t70 -172.4 165.66 5.77 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.833 -179.026 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 278' ' ' ARG . . . . . 0.481 ' HD2' ' N ' ' A' ' 279' ' ' CYS . 7.1 ppt_? -69.87 -20.09 63.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.323 179.015 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 279' ' ' CYS . . . . . 0.481 ' N ' ' HD2' ' A' ' 278' ' ' ARG . 35.2 t -101.51 21.55 14.1 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.532 0.682 . . . . 0.0 109.826 178.219 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 280' ' ' ALA . . . . . 0.745 ' HA ' ' HA ' ' A' ' 204' ' ' ALA . . . -125.83 93.06 3.73 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.785 -178.385 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 281' ' ' VAL . . . . . 0.404 HG12 ' O ' ' A' ' 203' ' ' GLY . 7.8 p -88.62 17.45 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 122.097 0.951 . . . . 0.0 109.727 178.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -85.83 -1.56 87.03 Favored Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.021 173.321 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 283' ' ' LEU . . . . . 0.487 HD22 ' HG2' ' A' ' 276' ' ' ARG . 33.4 tp -100.29 88.25 3.64 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.053 -0.573 . . . . 0.0 109.93 179.373 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 61.8 tttm . . . . . 0 C--O 1.247 0.943 0 CA-C-O 118.254 -0.879 . . . . 0.0 109.94 -178.008 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 . . . . . 0 N--CA 1.479 0.986 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 189' ' ' SER . . . . . 0.43 ' HB3' ' HB2' ' A' ' 192' ' ' ASN . 12.7 m -55.27 -64.14 0.94 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.359 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . 68.88 -59.34 0.47 Allowed 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.474 0.71 . . . . 0.0 111.485 -176.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 17.0 m -90.8 30.1 1.24 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.6 0.238 . . . . 0.0 111.48 -177.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' ASN . . . . . 0.43 ' HB2' ' HB3' ' A' ' 189' ' ' SER . 4.5 t30 -121.63 -45.51 2.29 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.445 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 17.2 m 69.5 -84.28 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.058 175.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 11.5 m -64.06 149.65 47.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.61 0.243 . . . . 0.0 111.217 -174.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' VAL . . . . . 0.652 HG13 ' HB2' ' A' ' 273' ' ' TYR . 3.5 m -101.55 -3.23 9.44 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.612 0 CA-C-O 120.827 0.346 . . . . 0.0 111.516 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.494 HD23 ' O ' ' A' ' 196' ' ' LEU . 2.4 tt 51.79 71.22 0.47 Allowed 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.911 -176.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 27.7 tp 61.26 9.83 2.72 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.812 -178.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.563 ' HA ' ' HB ' ' A' ' 195' ' ' VAL . . . 63.74 20.16 12.09 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 123.065 0.546 . . . . 0.0 111.657 178.494 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.438 HG22 ' O ' ' A' ' 196' ' ' LEU . 31.3 m -98.68 22.99 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.086 0.469 . . . . 0.0 110.968 -178.457 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 25.9 mm-40 -115.01 28.82 8.45 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.185 -178.281 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 50.95 76.81 0.14 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-O 121.254 0.549 . . . . 0.0 111.137 -176.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 20.3 m -127.04 21.81 6.76 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.278 -177.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -59.25 94.52 0.06 OUTLIER Glycine 0 C--N 1.334 0.419 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.986 -175.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -103.01 149.49 24.49 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.565 -0.317 . . . . 0.0 110.161 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' CYS . . . . . 0.689 ' HB2' HG12 ' A' ' 251' ' ' ILE . 35.7 t -91.16 145.61 24.53 Favored 'General case' 0 CA--C 1.508 -0.666 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.13 -178.136 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 206' ' ' ARG . . . . . 0.762 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 39.4 mtm180 48.97 1.13 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -108.96 105.63 15.24 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 119.053 0.842 . . . . 0.0 111.824 -170.404 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 63.4 t -137.43 123.09 26.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 114.605 -1.179 . . . . 0.0 109.18 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' PHE . . . . . 0.444 ' CE1' ' HB ' ' A' ' 243' ' ' ILE . 4.0 t80 -120.0 128.18 53.3 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.723 0.297 . . . . 0.0 110.655 -178.13 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.665 ' HG ' HG22 ' A' ' 272' ' ' ILE . 4.8 mp -108.27 126.53 52.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.534 177.582 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 211' ' ' GLY . . . . . 0.69 ' HA2' HG22 ' A' ' 243' ' ' ILE . . . -132.92 59.96 0.68 Allowed Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.702 -0.761 . . . . 0.0 113.445 -178.496 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 212' ' ' ASN . . . . . 0.497 ' HB3' ' HA ' ' A' ' 270' ' ' ARG . 3.4 t30 178.22 42.11 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.279 0.561 . . . . 0.0 109.815 177.192 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.725 HD23 ' HG2' ' A' ' 270' ' ' ARG . 1.0 OUTLIER -89.57 163.52 32.86 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.098 -179.94 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.499 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 89.2 Cg_endo -81.62 161.65 19.23 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 122.383 2.055 . . . . 0.0 111.342 175.216 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -72.94 128.19 34.75 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.574 176.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 103.94 -5.56 46.65 Favored Glycine 0 C--N 1.313 -0.722 0 C-N-CA 120.446 -0.883 . . . . 0.0 113.039 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' ILE . . . . . 0.626 HG23 HG21 ' A' ' 237' ' ' ILE . 5.1 tp -58.56 128.36 19.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.973 0.416 . . . . 0.0 110.734 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 218' ' ' THR . . . . . 0.431 ' CG2' ' HG3' ' A' ' 221' ' ' GLU . 14.9 t -112.28 157.24 21.19 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-O 121.394 0.616 . . . . 0.0 110.975 -178.665 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.496 ' H ' ' CD ' ' A' ' 219' ' ' GLU . 3.9 mp0 -62.36 -36.7 83.09 Favored 'General case' 0 C--O 1.207 -1.16 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.591 -177.262 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 220' ' ' ASP . . . . . 0.45 ' O ' ' HG2' ' A' ' 224' ' ' GLU . 37.4 t70 -50.1 -40.14 44.89 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 123.745 0.653 . . . . 0.0 111.144 179.105 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 221' ' ' GLU . . . . . 0.431 ' HG3' ' CG2' ' A' ' 218' ' ' THR . 41.6 mt-10 -68.74 -56.96 6.41 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.326 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.539 HD12 HD11 ' A' ' 237' ' ' ILE . 7.5 mt -60.05 -42.25 89.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.743 -179.123 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 223' ' ' ARG . . . . . 0.753 ' HG3' HD12 ' A' ' 235' ' ' ILE . 53.9 mtp85 -54.3 -63.56 1.11 Allowed 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 176.328 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.45 ' HG2' ' O ' ' A' ' 220' ' ' ASP . 14.4 pt-20 -60.52 -20.36 59.98 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.975 -176.768 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -88.69 -32.29 18.06 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.553 -177.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.696 HD23 ' HZ ' ' A' ' 248' ' ' PHE . 8.6 mp -107.32 -18.76 13.79 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -170.636 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 227' ' ' GLU . . . . . 0.687 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 31.5 mt-10 -71.48 -25.33 0.78 Allowed Pre-proline 0 C--N 1.324 -0.5 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -175.303 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 228' ' ' PRO . . . . . 0.687 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 74.2 Cg_endo -65.76 -28.84 51.35 Favored 'Trans proline' 0 C--N 1.359 1.102 0 CA-C-N 120.692 1.283 . . . . 0.0 112.019 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 229' ' ' PHE . . . . . 0.463 ' CE1' ' HA ' ' A' ' 226' ' ' LEU . 3.7 p90 -110.92 -2.08 16.17 Favored 'General case' 0 C--O 1.224 -0.249 0 C-N-CA 120.921 -0.311 . . . . 0.0 111.463 174.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 230' ' ' GLY . . . . . 0.452 ' CA ' ' HB1' ' A' ' 253' ' ' ALA . . . -174.21 94.31 0.1 OUTLIER Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 120.249 -0.977 . . . . 0.0 112.23 -177.257 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.421 ' HA ' ' HG2' ' A' ' 227' ' ' GLU . 21.0 Cg_endo -62.74 130.14 28.59 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 121.975 1.784 . . . . 0.0 111.401 178.503 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.736 HG21 HG12 ' A' ' 246' ' ' VAL . 2.8 mp -106.4 152.33 8.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.442 178.12 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 233' ' ' ASP . . . . . 0.422 ' CG ' HD22 ' A' ' 249' ' ' LEU . 23.4 m-20 -111.29 -26.98 8.87 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.762 176.319 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 234' ' ' GLN . . . . . 0.44 ' HB3' ' HB2' ' A' ' 247' ' ' HIS . 20.4 tt0 -136.97 120.51 17.12 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.635 -175.397 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.753 HD12 ' HG3' ' A' ' 223' ' ' ARG . 20.0 mt -134.99 105.8 6.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.675 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.411 ' HE2' HD21 ' A' ' 283' ' ' LEU . 86.8 tttt -111.58 109.45 19.37 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.321 -175.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 237' ' ' ILE . . . . . 0.626 HG21 HG23 ' A' ' 217' ' ' ILE . 87.4 mt -101.23 122.28 53.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 121.286 0.565 . . . . 0.0 111.155 -177.569 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.58 ' HB ' HG13 ' A' ' 243' ' ' ILE . 46.5 t -103.63 87.39 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 170.69 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 11.6 t -67.5 -19.31 65.31 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.463 -176.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -65.98 -29.56 69.97 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.696 176.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 241' ' ' ARG . . . . . 0.559 ' HB2' HG12 ' A' ' 243' ' ' ILE . 98.9 mtt180 -117.39 4.85 12.52 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.803 -179.59 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 15.9 m120 64.81 27.24 12.96 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.988 176.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.69 HG22 ' HA2' ' A' ' 211' ' ' GLY . 1.4 pt -122.4 148.9 25.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.165 -175.477 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -142.41 137.58 30.51 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.969 0.414 . . . . 0.0 111.556 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 245' ' ' PHE . . . . . 0.45 ' HE2' ' HB1' ' A' ' 280' ' ' ALA . 34.1 m-85 -105.51 120.31 41.31 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.894 177.307 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.736 HG12 HG21 ' A' ' 232' ' ' ILE . 0.2 OUTLIER -115.11 132.15 65.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -178.558 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 247' ' ' HIS . . . . . 0.762 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 50.1 m170 -111.43 102.58 10.94 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.164 -0.614 . . . . 0.0 111.311 176.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 248' ' ' PHE . . . . . 0.696 ' HZ ' HD23 ' A' ' 226' ' ' LEU . 33.2 m-85 -86.04 103.28 14.58 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.068 178.681 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.486 HD23 ' H ' ' A' ' 249' ' ' LEU . 0.1 OUTLIER -43.7 -39.52 3.7 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 124.139 0.899 . . . . 0.0 113.342 -175.8 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -96.51 144.92 26.16 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.512 177.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 251' ' ' ILE . . . . . 0.689 HG12 ' HB2' ' A' ' 205' ' ' CYS . 0.2 OUTLIER -64.06 -43.22 97.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.723 -178.83 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -72.03 -30.78 65.54 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.672 -176.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 253' ' ' ALA . . . . . 0.452 ' HB1' ' CA ' ' A' ' 230' ' ' GLY . . . -58.72 -41.93 87.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.217 178.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 254' ' ' ALA . . . . . 0.598 ' HB2' ' HB2' ' A' ' 248' ' ' PHE . . . -69.24 -40.61 77.81 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.821 178.482 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.566 HG13 ' O ' ' A' ' 251' ' ' ILE . 6.5 mt -57.84 -60.85 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.453 -177.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 256' ' ' LYS . . . . . 0.454 ' O ' ' HG2' ' A' ' 260' ' ' GLU . 11.8 ptmt -61.98 -38.45 88.62 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.396 -177.062 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -61.47 -48.51 80.78 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.617 0.246 . . . . 0.0 111.182 178.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 258' ' ' VAL . . . . . 0.548 HG13 HG12 ' A' ' 272' ' ' ILE . 69.7 t -66.92 -23.97 31.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.892 0.377 . . . . 0.0 110.972 179.152 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -83.42 -26.93 29.93 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 177.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 260' ' ' GLU . . . . . 0.454 ' HG2' ' O ' ' A' ' 256' ' ' LYS . 51.1 mm-40 -94.74 -30.97 14.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.72 0.295 . . . . 0.0 111.223 -174.386 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.741 HD23 HG21 ' A' ' 272' ' ' ILE . 0.6 OUTLIER -52.85 -50.74 79.78 Favored Pre-proline 0 CA--C 1.538 0.51 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.375 179.366 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 262' ' ' PRO . . . . . 0.558 ' HD2' ' N ' ' A' ' 261' ' ' LEU . 41.2 Cg_endo -67.47 -16.46 47.53 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.357 2.038 . . . . 0.0 112.667 -178.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 59.1 mt -89.77 -7.83 53.56 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.235 0.54 . . . . 0.0 111.574 -177.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 264' ' ' ASN . . . . . 0.4 ' O ' ' HB2' ' A' ' 268' ' ' SER . 14.1 m-80 -106.38 148.17 36.24 Favored Pre-proline 0 C--N 1.311 -1.068 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.897 -174.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -64.1 -36.4 48.05 Favored 'Trans proline' 0 C--N 1.334 -0.208 0 C-N-CA 123.512 2.808 . . . . 0.0 112.584 -169.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 8.2 mtpt -86.23 -44.58 12.04 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 121.558 0.694 . . . . 0.0 109.791 -176.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 267' ' ' TRP . . . . . 0.694 ' CE3' HD12 ' A' ' 261' ' ' LEU . 11.2 m0 -76.49 -28.57 56.51 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.519 -174.428 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 268' ' ' SER . . . . . 0.4 ' HB2' ' O ' ' A' ' 264' ' ' ASN . 22.9 t -64.18 -21.61 66.63 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.712 0.292 . . . . 0.0 110.532 177.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 64.2 mttm -70.53 -16.67 62.91 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-O 121.299 0.571 . . . . 0.0 110.087 176.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 270' ' ' ARG . . . . . 0.725 ' HG2' HD23 ' A' ' 213' ' ' LEU . 3.1 mpt_? -103.4 146.25 28.78 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.646 -179.076 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 271' ' ' ARG . . . . . 0.454 ' NE ' ' HA ' ' A' ' 271' ' ' ARG . 4.9 mmp_? -97.44 107.59 20.13 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 178.434 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 272' ' ' ILE . . . . . 0.741 HG21 HD23 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -116.15 142.22 30.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.141 0.496 . . . . 0.0 111.174 -176.967 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 273' ' ' TYR . . . . . 0.652 ' HB2' HG13 ' A' ' 195' ' ' VAL . 3.0 p90 -150.93 167.68 26.83 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.661 172.565 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 274' ' ' TYR . . . . . 0.539 ' OH ' ' HA ' ' A' ' 255' ' ' ILE . 87.2 m-85 -67.35 138.78 57.02 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.072 173.746 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -88.4 107.55 3.35 Favored Glycine 0 N--CA 1.441 -0.968 0 C-N-CA 120.172 -1.013 . . . . 0.0 112.34 -178.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 276' ' ' ARG . . . . . 0.418 ' HD3' ' N ' ' A' ' 276' ' ' ARG . 0.0 OUTLIER -123.42 101.06 7.14 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.689 0.757 . . . . 0.0 110.254 175.834 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 26.2 t70 179.28 144.37 0.15 Allowed 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.363 -1.289 . . . . 0.0 109.442 -173.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 278' ' ' ARG . . . . . . . . . . . . . 34.6 ptt85 -89.58 -13.6 36.89 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -175.072 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 279' ' ' CYS . . . . . . . . . . . . . 68.7 m -97.22 -2.41 42.86 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.441 0.639 . . . . 0.0 110.031 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 280' ' ' ALA . . . . . 0.45 ' HB1' ' HE2' ' A' ' 245' ' ' PHE . . . -86.84 13.87 8.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.935 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 14.7 p -88.4 -18.62 7.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.39 176.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -160.2 100.82 0.19 Allowed Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.835 178.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 283' ' ' LEU . . . . . 0.411 HD21 ' HE2' ' A' ' 236' ' ' LYS . 3.9 pp -73.05 153.08 41.0 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.053 0.454 . . . . 0.0 111.309 -173.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.245 0.866 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.443 179.168 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 . . . . . 0 N--CA 1.479 1.007 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 21.6 m -98.3 115.23 27.97 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.985 0.421 . . . . 0.0 110.698 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -88.27 -16.45 33.12 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.028 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 47.4 m -116.97 163.68 15.85 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.386 178.127 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -96.39 131.75 42.62 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.171 -178.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 17.0 m -109.71 133.34 53.24 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.143 177.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 73.2 m 59.43 -171.03 0.13 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.513 -176.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' VAL . . . . . 0.483 HG11 ' HG3' ' A' ' 262' ' ' PRO . 3.3 m -126.94 78.35 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 121.61 0.719 . . . . 0.0 111.777 176.096 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.582 ' O ' HG22 ' A' ' 199' ' ' VAL . 65.9 mt -77.51 -13.97 59.79 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 122.089 0.947 . . . . 0.0 108.836 174.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 1.046 ' HB3' ' HB3' ' A' ' 273' ' ' TYR . 98.3 mt -70.5 -13.49 62.13 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.327 -1.306 . . . . 0.0 109.531 172.48 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -111.43 -3.79 15.09 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.353 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.582 HG22 ' O ' ' A' ' 196' ' ' LEU . 13.6 m -86.53 -11.1 11.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.052 178.246 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -81.01 66.3 6.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.856 0.836 . . . . 0.0 109.813 175.122 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -79.1 95.04 5.45 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.147 -177.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 16.9 m -105.9 28.06 7.94 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.805 179.277 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 68.25 48.25 53.59 Favored Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.357 -176.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' ALA . . . . . 0.653 ' HB1' ' HB2' ' A' ' 207' ' ' ASN . . . -91.0 89.34 7.39 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 121.208 0.528 . . . . 0.0 111.322 -175.464 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 205' ' ' CYS . . . . . 0.523 ' HB3' HG12 ' A' ' 251' ' ' ILE . 10.1 p -88.02 146.98 25.22 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 173.317 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 206' ' ' ARG . . . . . 0.815 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 41.9 mtm180 56.81 5.03 0.19 Allowed 'General case' 0 C--O 1.221 -0.404 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -178.613 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 207' ' ' ASN . . . . . 0.653 ' HB2' ' HB1' ' A' ' 204' ' ' ALA . 8.3 m120 -106.0 105.34 15.33 Favored 'General case' 0 CA--C 1.511 -0.542 0 C-N-CA 120.166 -0.614 . . . . 0.0 111.128 -171.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.46 ' HB ' ' HB ' ' A' ' 246' ' ' VAL . 64.6 t -137.24 115.25 13.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.361 177.612 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 209' ' ' PHE . . . . . 0.537 ' HB2' ' HA2' ' A' ' 275' ' ' GLY . 3.2 t80 -111.68 124.77 53.02 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.364 -175.746 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.702 ' HG ' HG22 ' A' ' 272' ' ' ILE . 5.6 mp -107.34 129.48 54.9 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.561 177.666 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 211' ' ' GLY . . . . . 0.663 ' HA2' HG22 ' A' ' 243' ' ' ILE . . . -138.26 63.28 0.56 Allowed Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.656 -0.783 . . . . 0.0 113.208 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 212' ' ' ASN . . . . . 0.546 ' HB3' ' HA ' ' A' ' 270' ' ' ARG . 3.5 t30 -179.01 34.86 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.355 0.597 . . . . 0.0 109.969 178.112 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.809 HD23 ' HG2' ' A' ' 270' ' ' ARG . 1.2 mt -87.77 163.73 37.12 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.868 -179.269 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.44 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 91.3 Cg_endo -81.98 165.83 17.14 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 122.261 1.974 . . . . 0.0 110.772 172.357 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -78.7 129.21 34.44 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 177.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 105.25 -6.29 42.46 Favored Glycine 0 C--N 1.315 -0.617 0 C-N-CA 120.557 -0.83 . . . . 0.0 113.211 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' ILE . . . . . 0.715 HG23 HG21 ' A' ' 237' ' ' ILE . 4.6 tp -58.88 131.19 23.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-O 120.929 0.395 . . . . 0.0 110.743 179.083 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 218' ' ' THR . . . . . 0.446 ' CG2' ' HG3' ' A' ' 221' ' ' GLU . 10.7 t -112.39 157.44 21.04 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-O 121.625 0.726 . . . . 0.0 111.206 -179.138 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.461 ' H ' ' CD ' ' A' ' 219' ' ' GLU . 4.2 mp0 -62.79 -34.72 77.85 Favored 'General case' 0 C--O 1.209 -1.075 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.987 -177.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -54.4 -36.19 63.68 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.924 0.392 . . . . 0.0 110.81 -179.315 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' GLU . . . . . 0.446 ' HG3' ' CG2' ' A' ' 218' ' ' THR . 44.4 mt-10 -70.56 -55.47 8.8 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.371 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.537 HD12 HD11 ' A' ' 237' ' ' ILE . 6.7 mt -62.03 -40.56 87.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.693 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 223' ' ' ARG . . . . . 0.847 ' HG3' HD12 ' A' ' 235' ' ' ILE . 17.2 mtp180 -54.22 -62.34 1.72 Allowed 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 175.161 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -57.74 -21.31 40.42 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.962 -178.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 225' ' ' ASP . . . . . 0.454 ' CG ' ' HE1' ' A' ' 267' ' ' TRP . 24.9 m-20 -87.77 -33.02 18.81 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.978 -178.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.702 HD23 ' HZ ' ' A' ' 248' ' ' PHE . 8.1 mp -107.98 -17.83 13.95 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -169.631 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 227' ' ' GLU . . . . . 0.667 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 46.1 mt-10 -69.79 -26.03 1.01 Allowed Pre-proline 0 C--N 1.324 -0.517 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -175.353 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 228' ' ' PRO . . . . . 0.667 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 84.7 Cg_endo -67.64 -27.28 38.74 Favored 'Trans proline' 0 C--N 1.36 1.139 0 C-N-CA 121.359 1.373 . . . . 0.0 112.488 -178.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 229' ' ' PHE . . . . . 0.479 ' CZ ' ' HA ' ' A' ' 226' ' ' LEU . 2.6 p90 -110.64 -14.66 14.01 Favored 'General case' 0 C--O 1.222 -0.364 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.557 175.348 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 230' ' ' GLY . . . . . 0.413 ' HA2' ' HD2' ' A' ' 231' ' ' PRO . . . -161.27 91.97 0.11 Allowed Glycine 0 N--CA 1.438 -1.178 0 C-N-CA 120.441 -0.885 . . . . 0.0 111.223 -175.353 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.413 ' HD2' ' HA2' ' A' ' 230' ' ' GLY . 13.4 Cg_endo -58.72 131.8 44.28 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 121.859 1.706 . . . . 0.0 111.155 178.579 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.594 HG21 HG12 ' A' ' 246' ' ' VAL . 2.7 mp -108.17 151.7 10.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.92 177.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 233' ' ' ASP . . . . . 0.498 ' CG ' HD22 ' A' ' 249' ' ' LEU . 15.6 m-20 -112.77 -23.06 10.37 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 120.915 0.388 . . . . 0.0 110.147 178.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 234' ' ' GLN . . . . . 0.58 ' HB3' ' HB2' ' A' ' 247' ' ' HIS . 36.1 tt0 -143.99 120.1 10.77 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.841 -176.076 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.847 HD12 ' HG3' ' A' ' 223' ' ' ARG . 14.8 mt -131.52 115.63 29.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.92 178.718 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 65.9 tttp -120.81 113.66 20.48 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.37 -178.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 237' ' ' ILE . . . . . 0.715 HG21 HG23 ' A' ' 217' ' ' ILE . 80.8 mt -102.85 123.71 56.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.683 -179.062 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.559 ' HB ' HG13 ' A' ' 243' ' ' ILE . 39.9 t -102.06 87.09 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 172.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 13.9 t -65.33 -18.21 65.13 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.726 -177.062 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -64.93 -31.05 72.09 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.538 176.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 241' ' ' ARG . . . . . 0.778 ' HB2' HG12 ' A' ' 243' ' ' ILE . 48.7 mtt180 -116.29 3.53 13.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.944 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 66.91 27.28 9.0 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.81 177.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.778 HG12 ' HB2' ' A' ' 241' ' ' ARG . 1.7 pt -122.2 155.53 27.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.156 -173.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 244' ' ' ALA . . . . . 0.475 ' HB3' ' HB2' ' A' ' 210' ' ' LEU . . . -143.92 138.3 28.43 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.019 0.438 . . . . 0.0 111.579 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -107.68 109.11 20.63 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.702 176.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.594 HG12 HG21 ' A' ' 232' ' ' ILE . 1.3 t -103.2 133.3 47.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 247' ' ' HIS . . . . . 0.815 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 40.9 m170 -112.49 101.56 9.72 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.496 0.665 . . . . 0.0 111.128 178.665 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 248' ' ' PHE . . . . . 0.702 ' HZ ' HD23 ' A' ' 226' ' ' LEU . 33.5 m-85 -85.87 102.92 14.14 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.744 -1.116 . . . . 0.0 111.429 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.498 HD22 ' CG ' ' A' ' 233' ' ' ASP . 0.1 OUTLIER -40.27 -46.45 2.29 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 124.422 1.076 . . . . 0.0 113.117 -174.835 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -97.39 139.54 33.18 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.858 0.361 . . . . 0.0 110.325 177.555 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 251' ' ' ILE . . . . . 0.663 ' O ' HG13 ' A' ' 255' ' ' ILE . 0.2 OUTLIER -57.53 -40.62 75.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.675 179.995 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -68.93 -33.15 73.27 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.183 -176.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -59.85 -40.28 88.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.483 179.162 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 254' ' ' ALA . . . . . 0.532 ' HB2' ' HB2' ' A' ' 248' ' ' PHE . . . -68.88 -41.58 78.14 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.757 178.483 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.663 HG13 ' O ' ' A' ' 251' ' ' ILE . 14.4 mt -56.06 -59.62 2.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.293 -177.559 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 256' ' ' LYS . . . . . 0.401 ' O ' ' HG2' ' A' ' 260' ' ' GLU . 12.6 ptmt -62.28 -40.19 95.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.422 -177.737 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -62.05 -49.28 76.63 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.586 0.231 . . . . 0.0 111.323 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 258' ' ' VAL . . . . . 0.467 HG13 HG12 ' A' ' 272' ' ' ILE . 53.7 t -64.89 -24.38 35.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.078 0.465 . . . . 0.0 110.892 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 71.6 mm-40 -84.83 -24.53 28.59 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 178.069 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 260' ' ' GLU . . . . . 0.401 ' HG2' ' O ' ' A' ' 256' ' ' LYS . 58.4 mm-40 -95.89 -33.89 12.03 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.769 0.319 . . . . 0.0 111.081 -175.599 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.749 HD23 HG21 ' A' ' 272' ' ' ILE . 0.6 OUTLIER -52.05 -49.54 83.69 Favored Pre-proline 0 CA--C 1.539 0.523 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.724 -179.013 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 262' ' ' PRO . . . . . 0.575 ' HD2' ' N ' ' A' ' 261' ' ' LEU . 43.6 Cg_endo -67.46 -15.25 44.85 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.446 2.097 . . . . 0.0 113.052 -178.329 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 54.3 mt -92.09 -4.99 53.61 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.269 0.557 . . . . 0.0 111.449 -178.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 -106.94 149.97 39.21 Favored Pre-proline 0 C--N 1.312 -1.029 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.367 -173.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.25 -37.66 30.56 Favored 'Trans proline' 0 N--CA 1.465 -0.159 0 C-N-CA 123.172 2.581 . . . . 0.0 112.79 -169.269 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 12.6 mtpt -86.63 -44.33 11.95 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 121.531 0.682 . . . . 0.0 109.788 -177.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 267' ' ' TRP . . . . . 0.742 ' CE3' HD12 ' A' ' 261' ' ' LEU . 10.6 m0 -75.34 -28.85 59.77 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.9 -173.634 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 34.7 t -65.02 -20.89 66.72 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.151 0.501 . . . . 0.0 110.555 176.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 269' ' ' LYS . . . . . 0.422 ' C ' ' HD2' ' A' ' 270' ' ' ARG . 97.6 mttt -76.84 -6.2 51.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.238 176.581 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 270' ' ' ARG . . . . . 0.809 ' HG2' HD23 ' A' ' 213' ' ' LEU . 3.3 mpt_? -114.97 141.64 47.7 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.021 177.69 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 271' ' ' ARG . . . . . 0.814 ' HA ' ' HE ' ' A' ' 271' ' ' ARG . 0.8 OUTLIER -93.05 108.36 19.96 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 -179.769 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 272' ' ' ILE . . . . . 0.749 HG21 HD23 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -117.31 140.91 38.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.361 0.6 . . . . 0.0 110.823 -178.556 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 273' ' ' TYR . . . . . 1.046 ' HB3' ' HB3' ' A' ' 197' ' ' LEU . 5.2 p90 -152.42 170.15 20.81 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.55 173.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -53.32 115.54 1.96 Allowed 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 171.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 275' ' ' GLY . . . . . 0.537 ' HA2' ' HB2' ' A' ' 209' ' ' PHE . . . -52.83 129.35 38.4 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.363 -0.835 . . . . 0.0 113.439 -173.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 65.2 mtt180 -94.92 121.66 36.75 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 178.047 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -159.02 136.18 9.78 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.131 -178.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 278' ' ' ARG . . . . . 0.486 ' HD3' ' SG ' ' A' ' 279' ' ' CYS . 0.1 OUTLIER -80.37 -7.19 58.99 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.407 -172.272 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 279' ' ' CYS . . . . . 0.486 ' SG ' ' HD3' ' A' ' 278' ' ' ARG . 80.9 m -105.18 -4.64 21.53 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.103 0.478 . . . . 0.0 110.599 177.639 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -102.18 90.46 3.94 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.365 -177.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 3.3 m -86.25 -44.31 16.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.225 177.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 166.07 -141.83 7.25 Favored Glycine 0 N--CA 1.431 -1.662 0 C-N-CA 120.653 -0.784 . . . . 0.0 111.627 -178.107 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 96.5 mt -86.95 85.42 7.26 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.134 0.492 . . . . 0.0 110.634 -178.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 284' ' ' LYS . . . . . 0.41 ' HB3' ' HE3' ' A' ' 284' ' ' LYS . 1.3 tmmt? . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.193 -0.908 . . . . 0.0 109.144 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' ASN . . . . . 0.584 HD21 ' N ' ' A' ' 188' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.113 0 N-CA-C 111.053 0.02 . . . . 0.0 111.053 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 50.7 m 57.46 87.2 0.07 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.418 0.628 . . . . 0.0 111.014 -177.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -97.72 10.81 39.1 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.824 -177.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 75.5 m 66.34 178.49 0.21 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.26 -178.537 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -133.16 107.77 8.39 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 177.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' SER . . . . . 0.985 ' HB2' ' HB3' ' A' ' 271' ' ' ARG . 45.1 m -152.7 95.0 1.95 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.281 0.562 . . . . 0.0 110.492 -175.383 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 194' ' ' SER . . . . . 0.466 ' HA ' ' O ' ' A' ' 272' ' ' ILE . 55.6 m -156.31 -165.04 1.81 Allowed 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 177.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 195' ' ' VAL . . . . . 0.516 ' HB ' ' HA ' ' A' ' 198' ' ' ALA . 3.7 m -73.31 89.46 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 C-N-CA 120.53 -0.468 . . . . 0.0 109.743 172.62 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.626 ' H ' HD22 ' A' ' 196' ' ' LEU . 1.7 mm? -53.76 93.95 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.455 -176.189 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 6.4 mp 51.62 25.05 2.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.273 0.559 . . . . 0.0 110.317 -174.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.516 ' HA ' ' HB ' ' A' ' 195' ' ' VAL . . . 65.03 25.11 12.62 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 114.901 -1.045 . . . . 0.0 112.567 -178.434 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.523 HG22 ' O ' ' A' ' 196' ' ' LEU . 22.6 m -75.46 -24.21 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.987 177.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 200' ' ' GLN . . . . . 0.445 ' HG3' HG23 ' A' ' 199' ' ' VAL . 46.6 mt-30 -124.77 92.1 3.58 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.328 177.661 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -101.23 -36.72 8.82 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.279 174.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 46.5 m 67.59 -5.44 0.78 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.559 176.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 60.25 49.47 78.23 Favored Glycine 0 C--N 1.333 0.365 0 N-CA-C 111.639 -0.584 . . . . 0.0 111.639 -177.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' ALA . . . . . 0.852 ' HB1' ' HB2' ' A' ' 207' ' ' ASN . . . -92.07 130.56 37.77 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -172.216 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 205' ' ' CYS . . . . . 0.87 ' HB3' HG12 ' A' ' 251' ' ' ILE . 9.8 p -108.33 147.65 31.19 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 169.593 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 206' ' ' ARG . . . . . 0.756 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 46.3 mtp180 57.65 5.04 0.29 Allowed 'General case' 0 C--O 1.223 -0.337 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -179.208 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 207' ' ' ASN . . . . . 0.852 ' HB2' ' HB1' ' A' ' 204' ' ' ALA . 84.6 m-20 -110.93 106.34 15.43 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.1 0.476 . . . . 0.0 111.643 -171.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.478 ' HB ' ' HB ' ' A' ' 246' ' ' VAL . 57.7 t -136.87 117.97 18.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.552 179.102 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 209' ' ' PHE . . . . . 0.504 ' O ' ' HA ' ' A' ' 272' ' ' ILE . 5.8 t80 -113.28 125.35 54.2 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.463 -177.409 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.84 ' HG ' HG22 ' A' ' 272' ' ' ILE . 5.5 mp -107.8 130.09 55.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.595 177.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 211' ' ' GLY . . . . . 0.734 ' HA2' HG22 ' A' ' 243' ' ' ILE . . . -132.13 53.01 0.81 Allowed Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.503 -0.856 . . . . 0.0 113.951 -178.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 212' ' ' ASN . . . . . 0.441 ' HB3' ' HA ' ' A' ' 270' ' ' ARG . 36.3 t30 179.72 52.73 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.037 0.446 . . . . 0.0 111.288 174.487 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.585 HD21 HD22 ' A' ' 210' ' ' LEU . 1.0 OUTLIER -94.65 159.43 33.55 Favored Pre-proline 0 C--N 1.314 -0.96 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.444 177.509 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.462 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 87.1 Cg_endo -78.42 169.48 19.93 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 122.701 2.267 . . . . 0.0 111.638 178.109 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 215' ' ' ASN . . . . . 0.504 ' HA ' ' OG1' ' A' ' 239' ' ' THR . 3.9 p-10 -77.49 134.02 38.43 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 98.27 -6.27 61.41 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.398 -0.906 . . . . 0.0 112.857 178.019 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' ILE . . . . . 0.707 HG23 HG21 ' A' ' 237' ' ' ILE . 4.1 tp -58.15 126.11 15.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 CA-C-O 121.294 0.568 . . . . 0.0 110.724 -178.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 218' ' ' THR . . . . . 0.492 ' CG2' ' HG3' ' A' ' 221' ' ' GLU . 8.8 t -109.22 157.49 18.76 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 121.429 0.633 . . . . 0.0 110.847 -178.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.502 ' H ' ' CD ' ' A' ' 219' ' ' GLU . 2.6 mp0 -62.05 -36.24 81.03 Favored 'General case' 0 C--O 1.209 -1.028 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.455 -177.399 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 220' ' ' ASP . . . . . 0.536 ' O ' ' HG2' ' A' ' 224' ' ' GLU . 30.7 t70 -55.08 -37.56 66.96 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 123.741 0.651 . . . . 0.0 110.683 -178.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 221' ' ' GLU . . . . . 0.492 ' HG3' ' CG2' ' A' ' 218' ' ' THR . 45.9 mt-10 -65.97 -55.24 17.78 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.02 179.184 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.486 HD12 HD11 ' A' ' 237' ' ' ILE . 6.7 mt -62.52 -38.84 82.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.656 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 223' ' ' ARG . . . . . 0.872 ' HG3' HD12 ' A' ' 235' ' ' ILE . 63.4 mtp180 -56.47 -62.53 1.66 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.981 0.42 . . . . 0.0 112.066 175.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.536 ' HG2' ' O ' ' A' ' 220' ' ' ASP . 7.0 pt-20 -58.73 -24.74 62.08 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.149 -178.306 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 225' ' ' ASP . . . . . 0.469 ' HB3' ' CZ2' ' A' ' 267' ' ' TRP . 8.0 m-20 -85.98 -32.5 21.5 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.596 -176.279 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.742 HD23 ' HZ ' ' A' ' 248' ' ' PHE . 8.4 mp -107.11 -17.49 14.15 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -170.353 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 227' ' ' GLU . . . . . 0.675 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 37.6 mt-10 -70.71 -27.96 1.2 Allowed Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -176.404 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 228' ' ' PRO . . . . . 0.675 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 74.4 Cg_endo -65.47 -27.09 54.58 Favored 'Trans proline' 0 C--N 1.359 1.089 0 C-N-CA 121.313 1.342 . . . . 0.0 111.818 -177.577 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 229' ' ' PHE . . . . . 0.475 ' CE1' ' HA ' ' A' ' 226' ' ' LEU . 3.2 p90 -111.01 -7.89 14.5 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.879 -0.328 . . . . 0.0 111.65 173.523 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 230' ' ' GLY . . . . . 0.482 ' CA ' ' HB1' ' A' ' 253' ' ' ALA . . . -169.69 93.8 0.1 Allowed Glycine 0 N--CA 1.442 -0.954 0 C-N-CA 120.104 -1.046 . . . . 0.0 112.454 -174.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.461 ' HA ' ' HG2' ' A' ' 227' ' ' GLU . 15.3 Cg_endo -59.52 131.79 42.43 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 122.038 1.825 . . . . 0.0 111.759 178.633 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.603 HG21 HG12 ' A' ' 246' ' ' VAL . 2.8 mp -108.53 152.95 10.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.108 177.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 233' ' ' ASP . . . . . 0.455 ' OD2' HD22 ' A' ' 249' ' ' LEU . 16.3 m-20 -116.1 -18.39 10.63 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 120.708 0.289 . . . . 0.0 111.059 178.005 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 234' ' ' GLN . . . . . 0.49 ' H ' HG22 ' A' ' 232' ' ' ILE . 23.0 tt0 -145.57 121.69 10.78 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.033 -179.118 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.872 HD12 ' HG3' ' A' ' 223' ' ' ARG . 13.6 mt -133.65 109.79 13.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.045 177.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -113.93 121.29 43.49 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.363 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 237' ' ' ILE . . . . . 0.707 HG21 HG23 ' A' ' 217' ' ' ILE . 53.7 mt -111.85 127.97 68.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.361 -177.221 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.577 ' HB ' HG13 ' A' ' 243' ' ' ILE . 44.8 t -109.58 88.07 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 170.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 239' ' ' THR . . . . . 0.504 ' OG1' ' HA ' ' A' ' 215' ' ' ASN . 12.4 t -64.0 -24.66 67.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.643 -175.548 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -61.8 -39.0 90.19 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.084 0.469 . . . . 0.0 110.647 178.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 241' ' ' ARG . . . . . 0.691 ' HB2' HG12 ' A' ' 243' ' ' ILE . 63.9 mtt180 -104.28 0.11 28.92 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.47 -177.678 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 69.01 25.7 5.85 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.054 177.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.734 HG22 ' HA2' ' A' ' 211' ' ' GLY . 1.4 pt -121.71 151.29 25.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-O 120.835 0.35 . . . . 0.0 111.579 -172.55 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -145.89 141.5 27.88 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.169 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -111.15 114.42 27.66 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.91 178.227 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.603 HG12 HG21 ' A' ' 232' ' ' ILE . 1.4 t -108.67 138.35 36.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.665 -178.254 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 247' ' ' HIS . . . . . 0.756 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 27.1 m170 -115.89 102.15 9.42 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.113 -0.635 . . . . 0.0 111.182 177.016 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 248' ' ' PHE . . . . . 0.742 ' HZ ' HD23 ' A' ' 226' ' ' LEU . 35.3 m-85 -86.86 100.74 12.77 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.22 179.036 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.474 HD23 ' H ' ' A' ' 249' ' ' LEU . 0.1 OUTLIER -43.24 -41.55 3.92 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 124.533 1.146 . . . . 0.0 112.693 -175.841 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 250' ' ' ASN . . . . . 0.418 ' HB2' ' HB2' ' A' ' 253' ' ' ALA . 59.4 m-20 -94.6 137.89 33.14 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 251' ' ' ILE . . . . . 0.87 HG12 ' HB3' ' A' ' 205' ' ' CYS . 0.2 OUTLIER -60.98 -43.51 96.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -178.933 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -71.32 -27.52 63.45 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.666 -176.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 253' ' ' ALA . . . . . 0.482 ' HB1' ' CA ' ' A' ' 230' ' ' GLY . . . -62.73 -42.37 99.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.204 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 254' ' ' ALA . . . . . 0.556 ' HB2' ' HB2' ' A' ' 248' ' ' PHE . . . -67.38 -41.89 84.26 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.614 178.588 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.588 HG13 ' O ' ' A' ' 251' ' ' ILE . 9.8 mt -56.17 -60.26 2.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.285 -177.395 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 12.7 ptmt -62.6 -36.22 82.06 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.553 -176.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -65.73 -49.41 68.55 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 122.981 0.176 . . . . 0.0 111.438 178.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 258' ' ' VAL . . . . . 0.581 HG13 HG12 ' A' ' 272' ' ' ILE . 60.9 t -63.5 -25.5 38.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.976 0.417 . . . . 0.0 110.838 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -83.96 -25.45 30.04 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.11 -0.495 . . . . 0.0 112.187 178.328 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 46.5 mm-40 -95.05 -30.88 13.85 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-O 120.665 0.269 . . . . 0.0 111.283 -175.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.826 HD23 HG21 ' A' ' 272' ' ' ILE . 1.0 OUTLIER -52.42 -50.45 79.83 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.251 179.625 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 262' ' ' PRO . . . . . 0.571 ' HD2' ' N ' ' A' ' 261' ' ' LEU . 43.2 Cg_endo -66.99 -14.48 43.81 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.399 2.066 . . . . 0.0 112.909 -178.424 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 55.6 mt -96.34 -3.91 42.96 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.899 0.381 . . . . 0.0 111.827 -178.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 264' ' ' ASN . . . . . 0.447 ' HB2' ' CE3' ' A' ' 267' ' ' TRP . 13.1 m-80 -106.72 149.78 38.85 Favored Pre-proline 0 C--N 1.317 -0.84 0 N-CA-C 112.662 0.615 . . . . 0.0 112.662 -174.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -63.22 -35.66 62.09 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 123.771 2.981 . . . . 0.0 113.189 -168.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.463 ' HE3' ' HB2' ' A' ' 266' ' ' LYS . 0.0 OUTLIER -86.93 -45.74 10.53 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 121.791 0.805 . . . . 0.0 109.298 -179.616 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 267' ' ' TRP . . . . . 0.729 ' CE3' HD12 ' A' ' 261' ' ' LEU . 9.1 m0 -76.46 -29.29 56.86 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 114.362 -1.29 . . . . 0.0 111.309 -170.512 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 268' ' ' SER . . . . . 0.419 ' HA ' ' HA ' ' A' ' 262' ' ' PRO . 23.2 t -64.92 -16.54 63.42 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.742 0.306 . . . . 0.0 111.547 -179.043 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -87.17 -13.16 44.82 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.095 0.474 . . . . 0.0 110.183 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 270' ' ' ARG . . . . . 0.441 ' HA ' ' HB3' ' A' ' 212' ' ' ASN . 6.9 mpt_? -88.32 166.75 14.07 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 173.11 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 271' ' ' ARG . . . . . 0.985 ' HB3' ' HB2' ' A' ' 193' ' ' SER . 45.1 mmt-85 -120.4 106.58 11.98 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 177.709 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 272' ' ' ILE . . . . . 0.84 HG22 ' HG ' ' A' ' 210' ' ' LEU . 0.2 OUTLIER -119.58 141.94 37.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.461 0.648 . . . . 0.0 111.903 -174.411 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -151.76 169.73 21.49 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.613 171.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 274' ' ' TYR . . . . . 0.655 ' HB3' ' HB3' ' A' ' 204' ' ' ALA . 72.0 m-85 -63.23 127.74 32.65 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.873 0.368 . . . . 0.0 110.49 176.615 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -82.13 159.06 38.97 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.997 -0.621 . . . . 0.0 113.22 -175.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 58.7 mtt180 -98.18 6.1 47.83 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 122.162 0.982 . . . . 0.0 109.746 177.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -68.35 174.94 3.61 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 113.35 -1.75 . . . . 0.0 109.886 176.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 278' ' ' ARG . . . . . . . . . . . . . 13.7 ptt180 -147.45 8.5 0.91 Allowed 'General case' 0 C--N 1.327 -0.402 0 O-C-N 121.9 -0.5 . . . . 0.0 111.653 177.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 279' ' ' CYS . . . . . . . . . . . . . 22.7 t 64.43 21.97 12.61 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.664 177.198 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 280' ' ' ALA . . . . . 0.679 ' HB1' HD11 ' A' ' 283' ' ' LEU . . . -163.28 98.06 0.91 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.685 -175.267 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 281' ' ' VAL . . . . . 0.401 ' O ' HG13 ' A' ' 281' ' ' VAL . 6.1 p -136.35 99.73 2.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 121.756 0.788 . . . . 0.0 110.137 178.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 79.85 80.18 0.81 Allowed Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.535 -0.84 . . . . 0.0 111.217 -176.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 283' ' ' LEU . . . . . 0.679 HD11 ' HB1' ' A' ' 280' ' ' ALA . 5.4 mp -98.48 13.6 31.18 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.653 0.74 . . . . 0.0 109.992 -177.543 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 284' ' ' LYS . . . . . 0.404 ' HB3' ' NZ ' ' A' ' 284' ' ' LYS . 6.6 ttpm? . . . . . 0 C--N 1.315 -0.907 0 CA-C-N 114.743 -1.117 . . . . 0.0 108.899 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 47.6 t30 . . . . . 0 N--CA 1.479 1.019 0 CA-C-O 120.653 0.263 . . . . 0.0 110.503 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 11.6 p -90.76 164.74 13.99 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 175.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -80.83 99.13 8.14 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.831 0.348 . . . . 0.0 110.789 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 51.2 m -89.32 108.51 19.67 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.133 178.032 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -163.06 172.19 15.33 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.639 -175.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 12.9 t -74.58 -173.79 1.89 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 176.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 18.3 m -84.68 39.13 0.73 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.63 0.729 . . . . 0.0 110.93 -178.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 1.7 m -101.92 137.46 29.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.252 -178.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.483 ' O ' HG22 ' A' ' 199' ' ' VAL . 7.4 tt -59.29 95.36 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 O-C-N 123.725 0.641 . . . . 0.0 109.426 177.508 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 4.0 mm? 55.11 20.24 3.22 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.339 -0.846 . . . . 0.0 112.608 178.532 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . 57.26 16.69 3.21 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.483 HG22 ' O ' ' A' ' 196' ' ' LEU . 35.5 m -95.89 4.54 8.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.173 0.511 . . . . 0.0 110.366 -179.445 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -107.01 87.58 2.54 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-O 121.756 0.789 . . . . 0.0 110.249 177.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -116.35 -7.82 11.7 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.109 -0.95 . . . . 0.0 108.896 173.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 8.6 t -159.0 177.12 11.47 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 114.305 -1.316 . . . . 0.0 107.676 177.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 91.68 -53.37 3.03 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.388 -0.911 . . . . 0.0 112.807 178.324 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -64.09 114.1 3.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.899 0.38 . . . . 0.0 110.838 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' CYS . . . . . 0.688 ' SG ' ' HG3' ' A' ' 206' ' ' ARG . 40.4 t -97.7 150.32 21.33 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.873 -176.458 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 206' ' ' ARG . . . . . 0.822 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 8.0 mtm180 55.43 -0.61 0.04 OUTLIER 'General case' 0 C--O 1.221 -0.398 0 N-CA-C 114.579 1.325 . . . . 0.0 114.579 177.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 207' ' ' ASN . . . . . 0.408 ' ND2' ' HB2' ' A' ' 277' ' ' ASP . 13.3 m-80 -104.98 105.6 15.71 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 119.09 0.859 . . . . 0.0 112.161 -172.498 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.502 ' HB ' ' HB ' ' A' ' 246' ' ' VAL . 65.1 t -133.69 114.7 20.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 114.569 -1.196 . . . . 0.0 109.199 177.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 209' ' ' PHE . . . . . 0.449 ' HE1' ' HB ' ' A' ' 243' ' ' ILE . 1.5 t80 -113.6 122.64 47.83 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.061 -176.029 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.683 ' HG ' HG22 ' A' ' 272' ' ' ILE . 6.4 mp -105.35 136.95 43.95 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.463 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 211' ' ' GLY . . . . . 0.567 ' HA2' HG22 ' A' ' 243' ' ' ILE . . . -144.58 68.55 0.42 Allowed Glycine 0 N--CA 1.448 -0.567 0 C-N-CA 120.422 -0.894 . . . . 0.0 113.19 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 212' ' ' ASN . . . . . 0.554 ' HB3' ' HA ' ' A' ' 270' ' ' ARG . 20.5 t30 173.66 37.57 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.092 0.473 . . . . 0.0 109.992 176.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.795 HD23 ' HG2' ' A' ' 270' ' ' ARG . 0.9 OUTLIER -86.59 159.91 51.67 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.71 -176.758 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.489 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 98.6 Cg_endo -77.67 162.94 29.67 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.76 2.307 . . . . 0.0 112.046 178.486 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -76.04 117.68 18.0 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.771 178.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 109.02 -0.94 31.53 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.292 -0.956 . . . . 0.0 113.011 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' ILE . . . . . 0.712 HG23 HG21 ' A' ' 237' ' ' ILE . 6.2 tp -60.76 130.19 24.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.046 0.451 . . . . 0.0 110.852 177.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 218' ' ' THR . . . . . 0.436 ' CG2' ' HG3' ' A' ' 221' ' ' GLU . 12.1 t -114.07 156.24 24.51 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 121.722 0.772 . . . . 0.0 110.969 178.461 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -60.74 -35.31 76.06 Favored 'General case' 0 C--O 1.208 -1.089 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.093 -178.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -56.11 -35.68 67.35 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 123.433 0.458 . . . . 0.0 110.689 -178.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' GLU . . . . . 0.436 ' HG3' ' CG2' ' A' ' 218' ' ' THR . 43.6 mt-10 -68.44 -56.43 8.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.122 178.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.523 HD12 HD11 ' A' ' 237' ' ' ILE . 7.6 mt -60.45 -39.66 81.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.434 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 223' ' ' ARG . . . . . 0.774 ' HG3' HD12 ' A' ' 235' ' ' ILE . 33.6 mtp180 -55.88 -63.1 1.29 Allowed 'General case' 0 CA--C 1.509 -0.627 0 CA-C-O 120.935 0.398 . . . . 0.0 112.05 175.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -58.04 -22.1 48.5 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.813 -177.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -86.44 -34.21 20.19 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.621 -177.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.699 HD23 ' HZ ' ' A' ' 248' ' ' PHE . 8.1 mp -105.98 -18.54 14.01 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -169.484 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 227' ' ' GLU . . . . . 0.662 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 53.7 mt-10 -67.52 -30.32 2.89 Favored Pre-proline 0 C--N 1.326 -0.432 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -176.229 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 228' ' ' PRO . . . . . 0.662 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 71.7 Cg_endo -65.29 -28.71 55.2 Favored 'Trans proline' 0 C--N 1.36 1.146 0 C-N-CA 121.147 1.231 . . . . 0.0 112.089 -176.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 229' ' ' PHE . . . . . 0.506 ' CE1' ' HA ' ' A' ' 226' ' ' LEU . 3.1 p90 -110.84 -4.7 15.13 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.737 0.303 . . . . 0.0 111.725 175.627 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 230' ' ' GLY . . . . . 0.431 ' CA ' ' HB1' ' A' ' 253' ' ' ALA . . . -171.95 97.83 0.12 Allowed Glycine 0 N--CA 1.443 -0.895 0 C-N-CA 120.274 -0.965 . . . . 0.0 112.311 -175.136 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -64.65 131.45 29.52 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 121.778 1.652 . . . . 0.0 111.527 178.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.617 HG21 HG12 ' A' ' 246' ' ' VAL . 2.7 mp -107.77 151.97 9.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.563 177.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 233' ' ' ASP . . . . . 0.448 ' CG ' HD22 ' A' ' 249' ' ' LEU . 10.6 m-20 -109.42 -28.56 8.87 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.122 0.487 . . . . 0.0 110.168 176.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 234' ' ' GLN . . . . . 0.623 ' HB3' ' HB2' ' A' ' 247' ' ' HIS . 26.6 tt0 -136.28 122.54 20.49 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.748 -174.082 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.774 HD12 ' HG3' ' A' ' 223' ' ' ARG . 14.1 mt -138.45 112.99 8.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.763 178.51 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -125.35 118.23 25.47 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.41 -179.165 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 237' ' ' ILE . . . . . 0.712 HG21 HG23 ' A' ' 217' ' ' ILE . 44.9 mt -104.97 115.64 47.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.821 -178.137 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.547 ' HB ' HG13 ' A' ' 243' ' ' ILE . 21.9 t -94.08 87.77 2.22 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 173.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 11.1 t -64.28 -23.69 67.39 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.393 -176.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -64.27 -23.4 67.29 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.152 178.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 241' ' ' ARG . . . . . 0.729 ' HB2' HG12 ' A' ' 243' ' ' ILE . 97.1 mtt180 -120.21 -0.13 10.54 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.244 176.253 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 19.2 m120 63.55 29.65 15.24 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.137 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.729 HG12 ' HB2' ' A' ' 241' ' ' ARG . 1.2 pt -121.78 154.33 26.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.76 -175.675 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 244' ' ' ALA . . . . . 0.537 ' HB3' ' HB2' ' A' ' 210' ' ' LEU . . . -142.29 138.8 31.59 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.11 0.481 . . . . 0.0 111.788 -178.173 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -106.33 113.81 27.56 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.62 177.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.617 HG12 HG21 ' A' ' 232' ' ' ILE . 1.0 OUTLIER -112.77 130.58 66.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -179.817 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 247' ' ' HIS . . . . . 0.822 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 28.0 m170 -111.19 102.44 10.87 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.024 -0.67 . . . . 0.0 111.373 177.356 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 248' ' ' PHE . . . . . 0.699 ' HZ ' HD23 ' A' ' 226' ' ' LEU . 36.9 m-85 -84.61 101.92 12.51 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.599 177.48 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.478 HD23 ' H ' ' A' ' 249' ' ' LEU . 0.1 OUTLIER -44.43 -39.12 4.49 Favored 'General case' 0 N--CA 1.465 0.294 0 O-C-N 124.568 1.167 . . . . 0.0 112.956 -174.875 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 50.5 m-20 -99.88 143.16 30.42 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.056 178.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 251' ' ' ILE . . . . . 0.628 ' O ' HG13 ' A' ' 255' ' ' ILE . 0.2 OUTLIER -63.76 -44.62 98.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.138 -176.56 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -68.35 -29.93 68.77 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 120.606 0.241 . . . . 0.0 110.768 -176.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 253' ' ' ALA . . . . . 0.431 ' HB1' ' CA ' ' A' ' 230' ' ' GLY . . . -61.25 -42.41 98.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.285 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 254' ' ' ALA . . . . . 0.572 ' HB2' ' HB2' ' A' ' 248' ' ' PHE . . . -67.33 -41.33 85.42 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.719 178.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.71 ' O ' ' HG2' ' A' ' 259' ' ' GLN . 15.1 mt -57.05 -62.41 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.096 -177.19 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 256' ' ' LYS . . . . . 0.484 ' O ' ' HG2' ' A' ' 260' ' ' GLU . 10.1 ptmt -59.81 -38.42 81.93 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.109 -176.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -63.19 -49.76 72.98 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.59 0.233 . . . . 0.0 111.428 178.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 258' ' ' VAL . . . . . 0.478 HG13 HG12 ' A' ' 272' ' ' ILE . 52.7 t -66.36 -24.43 33.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.048 0.451 . . . . 0.0 111.119 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 259' ' ' GLN . . . . . 0.71 ' HG2' ' O ' ' A' ' 255' ' ' ILE . 78.9 mm-40 -84.13 -26.87 28.56 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.933 178.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 260' ' ' GLU . . . . . 0.484 ' HG2' ' O ' ' A' ' 256' ' ' LYS . 53.3 mm-40 -95.52 -31.65 13.23 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 122.702 0.401 . . . . 0.0 111.532 -175.033 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.807 ' HA ' ' HE3' ' A' ' 267' ' ' TRP . 0.7 OUTLIER -50.81 -51.03 70.2 Favored Pre-proline 0 CA--C 1.537 0.445 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.501 178.888 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 262' ' ' PRO . . . . . 0.619 ' HD3' HD11 ' A' ' 272' ' ' ILE . 37.8 Cg_endo -66.11 -15.69 49.43 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.287 1.991 . . . . 0.0 112.538 -177.587 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 57.6 mt -88.66 -9.34 52.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.967 0.413 . . . . 0.0 111.745 -177.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -105.44 148.82 36.99 Favored Pre-proline 0 C--N 1.314 -0.968 0 N-CA-C 112.586 0.588 . . . . 0.0 112.586 -172.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -61.52 -36.11 78.47 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 123.711 2.941 . . . . 0.0 112.61 -171.094 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 7.6 mtpt -85.99 -45.07 11.81 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 121.542 0.687 . . . . 0.0 109.608 -176.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 267' ' ' TRP . . . . . 0.807 ' HE3' ' HA ' ' A' ' 261' ' ' LEU . 11.2 m0 -78.29 -28.16 47.49 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.686 -173.387 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 23.9 t -63.94 -17.96 63.77 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.802 0.334 . . . . 0.0 110.802 177.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -73.81 -21.71 60.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.23 0.538 . . . . 0.0 110.097 176.017 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 270' ' ' ARG . . . . . 0.795 ' HG2' HD23 ' A' ' 213' ' ' LEU . 3.1 mpt_? -102.19 141.7 34.61 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.913 -176.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 271' ' ' ARG . . . . . 0.477 ' HG2' ' HB2' ' A' ' 212' ' ' ASN . 26.5 mmt180 -93.17 109.45 20.95 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.237 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 272' ' ' ILE . . . . . 0.748 HG21 HD23 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -117.95 139.31 45.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.424 0.63 . . . . 0.0 111.012 -177.203 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 273' ' ' TYR . . . . . 0.448 ' CE1' ' HB3' ' A' ' 209' ' ' PHE . 6.0 p90 -151.78 168.79 23.97 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.73 176.477 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 274' ' ' TYR . . . . . 0.419 ' OH ' ' HA ' ' A' ' 255' ' ' ILE . 85.5 m-85 -68.09 135.96 53.01 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.895 0.378 . . . . 0.0 110.523 174.519 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -79.37 -137.94 1.56 Allowed Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.908 -0.663 . . . . 0.0 111.536 176.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 73.5 mmt-85 -124.76 118.68 26.96 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 179.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 277' ' ' ASP . . . . . 0.408 ' HB2' ' ND2' ' A' ' 207' ' ' ASN . 9.4 t0 -115.79 138.91 50.68 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.765 -168.151 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 278' ' ' ARG . . . . . 0.53 ' HA ' HD11 ' A' ' 283' ' ' LEU . 54.4 mtm180 -103.66 -11.85 17.4 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.584 -176.432 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 279' ' ' CYS . . . . . 0.556 ' SG ' ' HB3' ' A' ' 205' ' ' CYS . 29.4 p -87.98 36.34 0.77 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.453 0.644 . . . . 0.0 110.458 -177.478 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -142.49 159.13 42.84 Favored 'General case' 0 N--CA 1.429 -1.521 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 3.7 p -70.47 76.91 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-O 122.277 1.037 . . . . 0.0 111.054 179.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -144.34 15.03 2.07 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.202 175.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 283' ' ' LEU . . . . . 0.53 HD11 ' HA ' ' A' ' 278' ' ' ARG . 9.3 mp -115.36 95.69 5.29 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.329 -0.435 . . . . 0.0 109.94 -178.511 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 284' ' ' LYS . . . . . 0.582 ' HB3' ' NZ ' ' A' ' 284' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.869 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -178.521 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 . . . . . 0 N--CA 1.482 1.142 0 CA-C-O 120.892 0.377 . . . . 0.0 111.028 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 189' ' ' SER . . . . . 0.406 ' HB3' HD21 ' A' ' 263' ' ' LEU . 53.7 m -125.16 -32.7 2.96 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.181 175.601 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -139.19 178.57 7.08 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.362 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 17.2 m -62.97 -40.6 98.2 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.068 0.461 . . . . 0.0 110.18 177.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 -153.47 119.64 5.45 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.354 178.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 64.4 m -81.58 10.37 6.07 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -178.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 42.5 m 69.89 13.77 7.96 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 122.789 0.436 . . . . 0.0 112.035 175.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' VAL . . . . . 0.428 ' HB ' ' HA ' ' A' ' 198' ' ' ALA . 4.8 m -112.31 116.11 51.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.142 0.496 . . . . 0.0 111.536 178.36 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.468 ' O ' HG22 ' A' ' 199' ' ' VAL . 10.0 tt -60.46 101.57 0.14 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.669 175.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 8.3 mp 53.03 23.56 3.0 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.842 178.215 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.428 ' HA ' ' HB ' ' A' ' 195' ' ' VAL . . . 56.51 31.04 18.22 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.108 -179.531 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.468 HG22 ' O ' ' A' ' 196' ' ' LEU . 29.0 m -77.37 6.48 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 121.157 0.503 . . . . 0.0 111.34 179.08 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 200' ' ' GLN . . . . . 0.424 ' HA ' ' OE1' ' A' ' 200' ' ' GLN . 11.2 mm-40 -96.47 105.13 17.17 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 176.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 201' ' ' GLN . . . . . 0.481 ' OE1' ' HG3' ' A' ' 278' ' ' ARG . 96.1 mt-30 -28.72 105.58 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 O-C-N 125.34 1.65 . . . . 0.0 112.268 179.053 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 61.8 p -65.57 -34.13 77.53 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 121.231 0.538 . . . . 0.0 110.114 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -90.01 53.15 3.6 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.523 177.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -106.74 122.0 45.5 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 178.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' CYS . . . . . 0.64 ' HB3' HG12 ' A' ' 251' ' ' ILE . 7.6 p -86.78 146.35 26.28 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.673 -0.411 . . . . 0.0 109.979 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 206' ' ' ARG . . . . . 0.748 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 63.4 mtm180 56.71 -3.73 0.04 OUTLIER 'General case' 0 C--O 1.223 -0.319 0 N-CA-C 114.579 1.325 . . . . 0.0 114.579 176.143 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 207' ' ' ASN . . . . . 0.429 ' ND2' ' HA ' ' A' ' 278' ' ' ARG . 77.4 m-20 -100.78 105.81 17.16 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 118.95 0.795 . . . . 0.0 111.528 -171.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.474 ' HB ' ' HB ' ' A' ' 246' ' ' VAL . 58.4 t -137.22 125.91 34.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.362 176.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 209' ' ' PHE . . . . . 0.474 ' HE1' ' HB ' ' A' ' 243' ' ' ILE . 3.3 t80 -125.61 121.37 33.36 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.75 -176.321 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.611 ' HG ' HG22 ' A' ' 272' ' ' ILE . 5.4 mp -103.79 134.67 46.7 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.298 177.49 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 211' ' ' GLY . . . . . 0.613 ' HA2' HG22 ' A' ' 243' ' ' ILE . . . -143.13 65.96 0.47 Allowed Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.493 -0.86 . . . . 0.0 112.908 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 212' ' ' ASN . . . . . 0.529 ' HB3' ' HA ' ' A' ' 270' ' ' ARG . 54.6 t30 174.83 39.54 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.252 0.549 . . . . 0.0 110.125 178.251 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.476 ' HB3' ' HD2' ' A' ' 214' ' ' PRO . 0.5 OUTLIER -89.96 162.82 34.33 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.985 -179.617 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.476 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 74.9 Cg_endo -83.8 169.27 12.0 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.739 2.293 . . . . 0.0 111.396 175.461 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -78.92 134.58 36.86 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 177.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 103.32 -9.78 53.89 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.468 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' ILE . . . . . 0.601 HG23 HG21 ' A' ' 237' ' ' ILE . 4.9 tp -59.85 128.08 20.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-O 121.071 0.462 . . . . 0.0 110.494 178.694 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 218' ' ' THR . . . . . 0.447 ' CG2' ' HG2' ' A' ' 221' ' ' GLU . 9.0 t -114.43 158.28 21.77 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-O 121.252 0.548 . . . . 0.0 110.575 179.242 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.458 ' H ' ' CD ' ' A' ' 219' ' ' GLU . 1.3 mp0 -62.3 -39.35 92.68 Favored 'General case' 0 C--O 1.21 -0.975 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.809 -175.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -52.33 -37.82 56.98 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 123.676 0.61 . . . . 0.0 111.234 -178.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' GLU . . . . . 0.447 ' HG2' ' CG2' ' A' ' 218' ' ' THR . 47.5 mm-40 -68.16 -53.57 24.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.367 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.583 HD12 HD11 ' A' ' 237' ' ' ILE . 8.0 mt -62.0 -42.33 94.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.254 179.378 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 223' ' ' ARG . . . . . 0.705 ' HG3' HD12 ' A' ' 235' ' ' ILE . 66.4 mtp180 -53.27 -63.15 1.24 Allowed 'General case' 0 CA--C 1.507 -0.7 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 175.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -57.16 -23.91 50.72 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.782 -177.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -83.37 -33.1 25.88 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.592 -178.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.773 HD23 ' HZ ' ' A' ' 248' ' ' PHE . 7.7 mp -106.0 -15.51 14.88 Favored 'General case' 0 C--O 1.224 -0.253 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -171.655 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 227' ' ' GLU . . . . . 0.649 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 43.6 mm-40 -61.62 -37.62 42.67 Favored Pre-proline 0 C--N 1.328 -0.366 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -177.444 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 228' ' ' PRO . . . . . 0.649 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 85.1 Cg_endo -66.08 -29.07 48.6 Favored 'Trans proline' 0 C--N 1.358 1.039 0 C-N-CA 121.638 1.558 . . . . 0.0 112.414 -172.749 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 229' ' ' PHE . . . . . 0.52 ' CE1' ' HA ' ' A' ' 226' ' ' LEU . 3.5 p90 -110.56 -11.06 14.5 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.449 -0.5 . . . . 0.0 111.999 176.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 230' ' ' GLY . . . . . 0.415 ' CA ' ' HB1' ' A' ' 253' ' ' ALA . . . -164.93 92.4 0.11 Allowed Glycine 0 N--CA 1.44 -1.048 0 C-N-CA 120.282 -0.961 . . . . 0.0 112.01 -175.734 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -60.41 130.18 32.75 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.126 1.884 . . . . 0.0 111.319 178.054 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.784 HG21 HG12 ' A' ' 246' ' ' VAL . 2.3 mp -109.17 152.22 11.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.898 179.135 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 233' ' ' ASP . . . . . 0.421 ' CG ' HD22 ' A' ' 249' ' ' LEU . 27.7 m-20 -112.99 -23.47 10.04 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.985 0.421 . . . . 0.0 110.675 176.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 234' ' ' GLN . . . . . 0.554 ' HB3' ' HB2' ' A' ' 247' ' ' HIS . 35.1 tt0 -139.36 120.47 14.67 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.721 -175.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.705 HD12 ' HG3' ' A' ' 223' ' ' ARG . 13.7 mt -136.61 112.3 11.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.037 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -120.32 110.74 16.91 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.57 -177.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 237' ' ' ILE . . . . . 0.601 HG21 HG23 ' A' ' 217' ' ' ILE . 72.6 mt -98.85 117.55 44.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.791 -178.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.609 ' HB ' HG13 ' A' ' 243' ' ' ILE . 24.3 t -97.97 88.29 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 174.044 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 8.8 t -65.04 -24.33 67.45 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.455 -175.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -66.93 -21.49 65.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.329 0.585 . . . . 0.0 110.339 178.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 241' ' ' ARG . . . . . 0.624 ' CB ' HG12 ' A' ' 243' ' ' ILE . 33.4 mmt180 -117.91 -2.73 11.26 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.906 -178.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 17.4 m120 66.35 25.33 10.41 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.73 178.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.624 HG12 ' CB ' ' A' ' 241' ' ' ARG . 2.8 pt -122.33 153.1 26.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.01 -173.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 244' ' ' ALA . . . . . 0.486 ' HB3' ' HB2' ' A' ' 210' ' ' LEU . . . -142.14 134.92 28.47 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.897 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -105.89 120.13 40.95 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.821 178.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.784 HG12 HG21 ' A' ' 232' ' ' ILE . 0.2 OUTLIER -116.95 133.38 63.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -177.079 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 247' ' ' HIS . . . . . 0.748 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 41.3 m170 -115.05 102.81 10.29 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.067 -0.653 . . . . 0.0 111.195 177.631 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 248' ' ' PHE . . . . . 0.773 ' HZ ' HD23 ' A' ' 226' ' ' LEU . 28.2 m-85 -86.67 104.52 16.15 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.333 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.507 HD23 ' H ' ' A' ' 249' ' ' LEU . 0.1 OUTLIER -41.92 -46.44 4.05 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 124.405 1.066 . . . . 0.0 113.111 -175.766 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -94.02 145.64 24.51 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.296 178.092 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 251' ' ' ILE . . . . . 0.64 HG12 ' HB3' ' A' ' 205' ' ' CYS . 0.2 OUTLIER -63.38 -41.72 93.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -179.705 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -70.69 -31.2 68.0 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 120.783 0.325 . . . . 0.0 110.57 -174.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 253' ' ' ALA . . . . . 0.415 ' HB1' ' CA ' ' A' ' 230' ' ' GLY . . . -59.5 -43.56 93.33 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.253 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 254' ' ' ALA . . . . . 0.594 ' HB2' ' HB2' ' A' ' 248' ' ' PHE . . . -68.44 -39.73 81.42 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.915 179.103 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.614 HG13 ' O ' ' A' ' 251' ' ' ILE . 7.9 mt -56.95 -61.97 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.21 -177.797 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 256' ' ' LYS . . . . . 0.511 ' O ' ' HG2' ' A' ' 260' ' ' GLU . 10.7 ptmt -61.43 -40.57 94.93 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.512 -176.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -60.44 -49.53 77.21 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.72 0.295 . . . . 0.0 111.365 178.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 258' ' ' VAL . . . . . 0.451 HG13 HG12 ' A' ' 272' ' ' ILE . 51.7 t -67.24 -23.34 30.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 120.98 0.419 . . . . 0.0 111.206 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 259' ' ' GLN . . . . . 0.518 ' HG3' ' O ' ' A' ' 255' ' ' ILE . 54.2 mt-30 -83.28 -27.39 29.86 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 122.193 -0.317 . . . . 0.0 111.54 177.549 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 260' ' ' GLU . . . . . 0.511 ' HG2' ' O ' ' A' ' 256' ' ' LYS . 30.2 mm-40 -95.62 -30.16 13.94 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.33 -173.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.714 ' HA ' ' HE3' ' A' ' 267' ' ' TRP . 0.7 OUTLIER -51.79 -51.41 70.61 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.382 178.096 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 262' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 261' ' ' LEU . 42.6 Cg_endo -67.07 -15.83 47.68 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.408 2.072 . . . . 0.0 112.84 -177.378 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 263' ' ' LEU . . . . . 0.406 HD21 ' HB3' ' A' ' 189' ' ' SER . 60.6 mt -94.94 -3.09 49.24 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.291 0.567 . . . . 0.0 111.832 -177.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 264' ' ' ASN . . . . . 0.486 ' O ' ' HB2' ' A' ' 268' ' ' SER . 13.3 m-80 -105.91 147.99 35.73 Favored Pre-proline 0 C--N 1.314 -0.947 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.321 -177.471 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -66.92 -32.87 34.71 Favored 'Trans proline' 0 C--N 1.334 -0.195 0 C-N-CA 123.35 2.7 . . . . 0.0 112.733 -168.381 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 3.8 mtpt -86.21 -44.53 12.1 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.517 0.675 . . . . 0.0 109.51 -178.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 267' ' ' TRP . . . . . 0.714 ' HE3' ' HA ' ' A' ' 261' ' ' LEU . 13.5 m0 -77.16 -28.15 54.02 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.874 -174.249 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 268' ' ' SER . . . . . 0.486 ' HB2' ' O ' ' A' ' 264' ' ' ASN . 8.0 t -68.68 -15.12 63.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.035 0.445 . . . . 0.0 110.504 178.692 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -74.65 -14.67 60.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.856 174.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 270' ' ' ARG . . . . . 0.529 ' HA ' ' HB3' ' A' ' 212' ' ' ASN . 4.1 mpt_? -99.37 162.65 12.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.838 178.698 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 271' ' ' ARG . . . . . 0.424 ' HG2' ' CB ' ' A' ' 212' ' ' ASN . 36.7 mmt180 -112.14 105.76 14.2 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 174.682 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 272' ' ' ILE . . . . . 0.693 HG21 HD23 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -116.87 140.91 37.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.373 0.606 . . . . 0.0 111.34 -175.817 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 273' ' ' TYR . . . . . 0.406 ' HB2' ' HG3' ' A' ' 200' ' ' GLN . 2.0 p90 -151.66 167.99 26.41 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.805 172.46 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 274' ' ' TYR . . . . . 0.591 ' OH ' ' HA ' ' A' ' 255' ' ' ILE . 85.9 m-85 -67.09 138.0 56.79 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.402 174.599 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 275' ' ' GLY . . . . . 0.416 ' H ' ' HB3' ' A' ' 207' ' ' ASN . . . -60.44 118.13 13.78 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.724 -0.75 . . . . 0.0 111.593 178.084 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 276' ' ' ARG . . . . . 0.463 ' HD3' ' N ' ' A' ' 276' ' ' ARG . 0.1 OUTLIER -52.25 126.86 20.21 Favored 'General case' 0 C--O 1.238 0.46 0 O-C-N 123.915 0.421 . . . . 0.0 111.069 -178.295 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 12.0 t70 67.4 122.95 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 O-C-N 124.307 1.004 . . . . 0.0 111.459 -176.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 278' ' ' ARG . . . . . 0.481 ' HG3' ' OE1' ' A' ' 201' ' ' GLN . 25.2 mtp180 -67.48 -18.65 65.15 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.653 -174.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 279' ' ' CYS . . . . . . . . . . . . . 11.4 m -91.51 20.75 5.08 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.85 0.357 . . . . 0.0 110.396 -179.043 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -67.01 91.97 0.22 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.789 178.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 11.0 p -124.65 -8.37 6.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.759 -178.332 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -84.44 67.08 3.76 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.383 -177.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 82.8 mt -105.74 79.79 1.48 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.087 0.47 . . . . 0.0 110.648 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.622 -0.704 . . . . 0.0 110.111 178.974 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 . . . . . 0 N--CA 1.48 1.056 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 47.4 t -167.32 111.84 0.71 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.92 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -86.8 109.2 19.11 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.032 177.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 8.1 p -98.89 129.62 45.25 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.797 -179.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -74.93 132.75 41.66 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.967 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 14.9 m -84.19 64.94 8.53 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.728 0.299 . . . . 0.0 110.724 -177.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' SER . . . . . 0.771 ' HA ' ' HD2' ' A' ' 273' ' ' TYR . 7.4 m 60.86 -168.53 0.17 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.108 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 195' ' ' VAL . . . . . 0.526 HG12 ' HG3' ' A' ' 200' ' ' GLN . 3.8 m -86.31 123.58 39.74 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.453 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.187 173.404 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 9.0 tt -62.48 99.13 0.13 Allowed 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 176.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 81.5 mt 55.39 24.87 7.03 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.382 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.489 ' HA ' ' HB ' ' A' ' 195' ' ' VAL . . . 57.1 35.04 25.8 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.778 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 29.8 m -69.46 -24.25 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-O 120.754 0.312 . . . . 0.0 111.245 178.208 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' GLN . . . . . 0.526 ' HG3' HG12 ' A' ' 195' ' ' VAL . 7.4 pt20 -108.35 82.02 1.56 Allowed 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 121.449 0.642 . . . . 0.0 110.999 176.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 201' ' ' GLN . . . . . 0.44 ' HG3' ' O ' ' A' ' 198' ' ' ALA . 25.6 mt-30 -103.14 40.16 1.44 Allowed 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 174.66 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 20.8 m -58.09 150.01 22.17 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.812 -177.259 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -74.4 72.66 1.43 Allowed Glycine 0 N--CA 1.449 -0.462 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.599 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -91.55 122.54 34.22 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 175.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' CYS . . . . . 0.702 ' HB3' HG12 ' A' ' 251' ' ' ILE . 15.6 p -87.15 145.96 26.21 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.644 -177.081 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 206' ' ' ARG . . . . . 0.804 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 57.1 mtp180 56.25 3.97 0.12 Allowed 'General case' 0 C--O 1.224 -0.281 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 175.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 207' ' ' ASN . . . . . 0.497 HD21 ' HB3' ' A' ' 277' ' ' ASP . 4.4 m-20 -108.36 105.79 15.64 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 119.85 -0.74 . . . . 0.0 112.041 -175.204 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.449 ' HB ' ' HB ' ' A' ' 246' ' ' VAL . 67.9 t -133.49 113.48 18.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 114.691 -1.141 . . . . 0.0 109.153 176.199 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 209' ' ' PHE . . . . . 0.45 ' HE1' ' HB ' ' A' ' 243' ' ' ILE . 1.7 t80 -112.05 122.37 47.58 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.094 -175.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.641 ' HG ' HG22 ' A' ' 272' ' ' ILE . 5.4 mp -104.8 131.13 52.64 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.257 178.759 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 211' ' ' GLY . . . . . 0.654 ' HA2' HG22 ' A' ' 243' ' ' ILE . . . -137.16 64.1 0.57 Allowed Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.217 -0.992 . . . . 0.0 113.636 -178.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 212' ' ' ASN . . . . . 0.53 ' HB3' ' HA ' ' A' ' 270' ' ' ARG . 30.6 t30 175.81 37.15 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.055 0.455 . . . . 0.0 109.93 174.531 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.551 HD23 ' HG2' ' A' ' 270' ' ' ARG . 1.0 OUTLIER -81.8 158.26 68.17 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.849 -176.792 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.434 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 73.4 Cg_endo -74.89 152.47 41.38 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 122.351 2.034 . . . . 0.0 111.522 177.522 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -70.04 116.17 10.1 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.237 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 108.5 1.68 32.88 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.487 -0.863 . . . . 0.0 112.639 -177.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' ILE . . . . . 0.71 HG23 HG21 ' A' ' 237' ' ' ILE . 5.1 tp -60.66 130.54 24.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.0 0.428 . . . . 0.0 110.502 176.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 218' ' ' THR . . . . . 0.498 HG22 ' HG3' ' A' ' 221' ' ' GLU . 11.6 t -113.5 158.45 20.7 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.379 0.609 . . . . 0.0 110.949 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.541 ' H ' ' CD ' ' A' ' 219' ' ' GLU . 5.8 mp0 -61.85 -42.5 99.11 Favored 'General case' 0 C--O 1.21 -1.023 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.581 -176.355 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -48.18 -38.42 18.1 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 123.839 0.712 . . . . 0.0 111.547 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 221' ' ' GLU . . . . . 0.498 ' HG3' HG22 ' A' ' 218' ' ' THR . 42.3 mt-10 -66.22 -57.9 6.56 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.281 178.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.585 HD12 HD11 ' A' ' 237' ' ' ILE . 8.4 mt -61.45 -41.3 89.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.602 -178.481 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 223' ' ' ARG . . . . . 0.754 ' HG3' HD12 ' A' ' 235' ' ' ILE . 48.7 mtp180 -53.63 -62.7 1.48 Allowed 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 175.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -58.27 -22.89 54.33 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.756 -177.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 225' ' ' ASP . . . . . 0.463 ' HB3' ' CZ2' ' A' ' 267' ' ' TRP . 10.7 m-20 -86.2 -32.26 21.3 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.844 -177.613 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.789 HD23 ' HZ ' ' A' ' 248' ' ' PHE . 7.7 mp -106.68 -15.31 14.79 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -170.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 227' ' ' GLU . . . . . 0.631 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 23.2 mm-40 -60.4 -38.38 57.16 Favored Pre-proline 0 C--N 1.327 -0.393 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -178.108 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 228' ' ' PRO . . . . . 0.631 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 96.1 Cg_endo -66.78 -26.47 45.12 Favored 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 121.587 1.525 . . . . 0.0 112.485 -171.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 229' ' ' PHE . . . . . 0.524 ' CZ ' ' HA ' ' A' ' 226' ' ' LEU . 3.6 p90 -111.21 -9.19 14.33 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.958 175.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 230' ' ' GLY . . . . . 0.434 ' CA ' ' HB1' ' A' ' 253' ' ' ALA . . . -169.05 99.1 0.15 Allowed Glycine 0 N--CA 1.442 -0.942 0 C-N-CA 120.033 -1.079 . . . . 0.0 112.268 -175.457 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.441 ' HA ' ' OE2' ' A' ' 227' ' ' GLU . 18.5 Cg_endo -65.86 131.43 27.32 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 121.808 1.672 . . . . 0.0 111.532 178.643 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.709 HG21 HG12 ' A' ' 246' ' ' VAL . 2.1 mp -108.68 151.51 10.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.437 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 233' ' ' ASP . . . . . 0.458 ' CG ' HD22 ' A' ' 249' ' ' LEU . 38.0 m-20 -114.56 -19.89 10.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.848 0.356 . . . . 0.0 110.75 177.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 234' ' ' GLN . . . . . 0.492 ' HB3' ' HB2' ' A' ' 247' ' ' HIS . 9.4 tt0 -143.62 121.22 11.8 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.73 -177.501 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.754 HD12 ' HG3' ' A' ' 223' ' ' ARG . 12.1 mt -135.09 108.52 9.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.964 -179.462 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 61.9 tttp -115.9 112.47 21.94 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.411 -178.306 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 237' ' ' ILE . . . . . 0.71 HG21 HG23 ' A' ' 217' ' ' ILE . 67.0 mt -102.35 124.1 56.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-O 121.017 0.436 . . . . 0.0 110.783 -179.544 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.532 ' HB ' HG13 ' A' ' 243' ' ' ILE . 61.2 t -105.23 87.68 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 171.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 13.2 t -69.84 -16.53 63.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.381 -177.084 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -62.06 -34.04 75.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.202 175.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 241' ' ' ARG . . . . . 0.774 ' HB2' HG12 ' A' ' 243' ' ' ILE . 77.0 mtt180 -112.88 -0.28 14.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.527 178.542 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 17.9 m120 67.46 29.64 7.2 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.847 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.774 HG12 ' HB2' ' A' ' 241' ' ' ARG . 1.3 pt -122.3 151.68 26.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.037 -175.498 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 244' ' ' ALA . . . . . 0.46 ' HB3' ' HB2' ' A' ' 210' ' ' LEU . . . -141.3 138.19 32.98 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.046 0.451 . . . . 0.0 111.849 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -107.27 108.05 19.28 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.836 177.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.709 HG12 HG21 ' A' ' 232' ' ' ILE . 0.9 OUTLIER -106.12 133.57 50.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 -179.288 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 247' ' ' HIS . . . . . 0.804 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 41.8 m170 -112.27 101.97 10.16 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.486 0.66 . . . . 0.0 111.295 178.437 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 248' ' ' PHE . . . . . 0.789 ' HZ ' HD23 ' A' ' 226' ' ' LEU . 33.7 m-85 -86.65 101.28 13.11 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.99 -1.004 . . . . 0.0 111.33 179.216 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.483 HD23 ' H ' ' A' ' 249' ' ' LEU . 0.1 OUTLIER -42.26 -48.05 4.88 Favored 'General case' 0 N--CA 1.465 0.312 0 O-C-N 124.367 1.042 . . . . 0.0 112.583 -176.611 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 46.1 m-20 -84.95 138.18 32.65 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 178.387 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 251' ' ' ILE . . . . . 0.702 HG12 ' HB3' ' A' ' 205' ' ' CYS . 0.2 OUTLIER -62.38 -43.69 98.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -179.609 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -68.98 -30.12 68.47 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.901 -177.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 253' ' ' ALA . . . . . 0.434 ' HB1' ' CA ' ' A' ' 230' ' ' GLY . . . -60.72 -41.74 95.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.32 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 254' ' ' ALA . . . . . 0.594 ' HB2' ' HB2' ' A' ' 248' ' ' PHE . . . -67.87 -41.29 83.08 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.591 178.38 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.584 HG13 ' O ' ' A' ' 251' ' ' ILE . 11.7 mt -56.05 -60.84 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.159 -178.634 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 10.0 ptmt -62.66 -38.84 91.92 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.622 -176.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -61.96 -47.97 82.46 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.557 0.218 . . . . 0.0 111.349 178.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 258' ' ' VAL . . . . . 0.557 HG13 HG12 ' A' ' 272' ' ' ILE . 54.6 t -65.15 -25.14 36.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.878 0.371 . . . . 0.0 110.931 178.297 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -83.71 -23.61 31.59 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 178.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -94.93 -34.93 12.21 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.826 0.345 . . . . 0.0 110.689 -175.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.732 ' HA ' ' HE3' ' A' ' 267' ' ' TRP . 0.7 OUTLIER -51.57 -50.48 76.73 Favored Pre-proline 0 CA--C 1.538 0.503 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.578 -178.296 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 262' ' ' PRO . . . . . 0.586 ' HD3' HD11 ' A' ' 272' ' ' ILE . 37.3 Cg_endo -66.35 -20.6 55.02 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.222 1.948 . . . . 0.0 112.544 -177.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 65.8 mt -90.65 -2.22 57.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.292 0.568 . . . . 0.0 111.551 -175.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 264' ' ' ASN . . . . . 0.403 ' O ' ' HB2' ' A' ' 268' ' ' SER . 12.2 m-80 -106.71 148.93 37.77 Favored Pre-proline 0 C--N 1.315 -0.916 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.938 -176.115 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -65.59 -34.2 42.82 Favored 'Trans proline' 0 C--O 1.23 0.11 0 C-N-CA 123.367 2.711 . . . . 0.0 112.604 -171.276 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 5.1 mtpt -86.05 -45.23 11.62 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 121.812 0.815 . . . . 0.0 109.747 -177.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 267' ' ' TRP . . . . . 0.732 ' HE3' ' HA ' ' A' ' 261' ' ' LEU . 11.3 m0 -78.75 -26.02 44.57 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.722 -172.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 268' ' ' SER . . . . . 0.403 ' HB2' ' O ' ' A' ' 264' ' ' ASN . 37.3 t -61.41 -22.15 64.75 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.758 0.313 . . . . 0.0 111.01 177.454 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -71.15 -18.08 62.52 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.242 0.544 . . . . 0.0 110.481 176.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 270' ' ' ARG . . . . . 0.551 ' HG2' HD23 ' A' ' 213' ' ' LEU . 0.0 OUTLIER -101.9 140.56 36.02 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.475 -179.932 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 271' ' ' ARG . . . . . 0.779 ' HA ' ' HE ' ' A' ' 271' ' ' ARG . 0.2 OUTLIER -95.62 105.77 17.8 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.777 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 272' ' ' ILE . . . . . 0.717 HG21 HD23 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -115.24 144.07 23.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.352 0.596 . . . . 0.0 111.285 -174.693 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 273' ' ' TYR . . . . . 0.771 ' HD2' ' HA ' ' A' ' 194' ' ' SER . 5.0 p90 -151.87 169.46 22.22 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.421 174.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -62.34 115.0 3.81 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 171.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -83.13 169.15 47.69 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.717 -0.754 . . . . 0.0 113.111 -170.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 24.7 ptt180 -110.24 141.45 43.19 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 176.224 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 277' ' ' ASP . . . . . 0.497 ' HB3' HD21 ' A' ' 207' ' ' ASN . 21.9 t70 -159.21 164.27 35.21 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.822 0.344 . . . . 0.0 110.93 -170.602 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 278' ' ' ARG . . . . . . . . . . . . . 21.5 ptt180 -56.55 -33.71 66.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.386 -0.825 . . . . 0.0 112.21 179.153 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 279' ' ' CYS . . . . . . . . . . . . . 42.7 t -110.17 67.19 0.64 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -176.66 -171.91 0.41 Allowed 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.408 -176.299 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 2.9 p -151.39 110.06 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 115.025 -0.988 . . . . 0.0 110.055 178.358 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -75.8 -76.75 0.77 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.805 178.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 32.5 tp -140.09 90.56 2.38 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 177.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 60.7 tttm . . . . . 0 C--O 1.247 0.941 0 CA-C-O 118.376 -0.821 . . . . 0.0 109.832 -175.462 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 15.6 m120 . . . . . 0 N--CA 1.479 1.018 0 CA-C-O 120.806 0.336 . . . . 0.0 110.582 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 9.0 t -150.79 100.76 2.85 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 176.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -100.74 -21.24 15.25 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.925 -173.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 50.7 p 50.71 -84.43 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.976 0.91 . . . . 0.0 112.119 -176.196 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 63.0 t30 70.57 -70.11 0.16 Allowed 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.836 0.855 . . . . 0.0 111.981 176.136 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 5.6 p -80.31 -1.76 42.37 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.093 0.473 . . . . 0.0 111.14 -178.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 3.9 m -109.56 74.7 0.91 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.888 177.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' VAL . . . . . 0.536 ' HB ' ' HA ' ' A' ' 198' ' ' ALA . 13.9 m 35.27 100.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 -177.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.549 ' O ' HG22 ' A' ' 199' ' ' VAL . 8.3 tt -55.32 102.81 0.08 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.596 174.226 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 94.7 mt 54.27 16.24 1.17 Allowed 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.407 0.683 . . . . 0.0 112.364 178.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.536 ' HA ' ' HB ' ' A' ' 195' ' ' VAL . . . 57.62 17.71 4.19 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.055 0.542 . . . . 0.0 112.042 -176.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.549 HG22 ' O ' ' A' ' 196' ' ' LEU . 33.7 m -84.17 -21.56 8.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.298 0.571 . . . . 0.0 110.465 -179.304 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -92.53 75.0 5.14 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.475 0.655 . . . . 0.0 110.65 -179.236 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -124.39 111.08 15.35 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.744 178.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' SER . . . . . 0.552 ' HA ' ' HA ' ' A' ' 281' ' ' VAL . 15.0 m -85.25 -56.21 3.65 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 174.323 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.535 ' HA3' ' HG ' ' A' ' 283' ' ' LEU . . . 160.35 51.75 0.01 OUTLIER Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.642 -179.516 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.3 101.72 1.26 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.015 0.436 . . . . 0.0 110.404 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' CYS . . . . . 0.462 ' SG ' HG12 ' A' ' 251' ' ' ILE . 2.5 m -87.48 146.16 25.94 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.984 -0.746 . . . . 0.0 108.984 -178.533 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 206' ' ' ARG . . . . . 0.82 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 24.7 mtp-105 55.52 4.98 0.11 Allowed 'General case' 0 C--O 1.222 -0.388 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 177.474 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -101.3 106.04 17.18 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 118.681 0.673 . . . . 0.0 111.562 -172.034 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.413 ' HB ' ' HB ' ' A' ' 246' ' ' VAL . 60.0 t -138.57 119.69 16.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.936 176.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 209' ' ' PHE . . . . . 0.437 ' O ' ' HA ' ' A' ' 272' ' ' ILE . 4.3 t80 -116.31 125.64 52.43 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.49 -177.637 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.625 ' HG ' HG22 ' A' ' 272' ' ' ILE . 6.2 mp -110.7 133.96 52.88 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.612 178.194 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 211' ' ' GLY . . . . . 0.569 ' HA2' HG22 ' A' ' 243' ' ' ILE . . . -138.94 65.9 0.53 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.591 -0.814 . . . . 0.0 113.351 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 212' ' ' ASN . . . . . 0.462 ' HB2' ' O ' ' A' ' 211' ' ' GLY . 25.1 t30 172.05 42.77 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.831 0.348 . . . . 0.0 110.617 177.725 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.473 HD21 HD22 ' A' ' 210' ' ' LEU . 1.2 mp -91.23 160.32 37.57 Favored Pre-proline 0 C--N 1.322 -0.591 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.268 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.413 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 92.7 Cg_endo -82.49 166.76 15.62 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 122.637 2.225 . . . . 0.0 112.202 177.464 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -73.36 125.87 28.83 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.324 0.583 . . . . 0.0 111.139 178.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 106.01 -8.78 42.6 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.839 178.175 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' ILE . . . . . 0.8 HG23 HG21 ' A' ' 237' ' ' ILE . 5.0 tp -57.99 125.92 14.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.338 0.59 . . . . 0.0 110.625 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 218' ' ' THR . . . . . 0.457 ' CG2' ' HG3' ' A' ' 221' ' ' GLU . 11.1 t -114.42 157.88 22.3 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.751 -178.403 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -61.34 -35.53 77.67 Favored 'General case' 0 C--O 1.209 -1.056 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.936 -177.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 220' ' ' ASP . . . . . 0.42 ' O ' ' HG2' ' A' ' 224' ' ' GLU . 29.5 t70 -51.32 -40.0 58.14 Favored 'General case' 0 C--N 1.32 -0.702 0 O-C-N 123.632 0.582 . . . . 0.0 111.109 178.639 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 221' ' ' GLU . . . . . 0.457 ' HG3' ' CG2' ' A' ' 218' ' ' THR . 44.4 mt-10 -70.01 -54.13 14.59 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.562 -179.32 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.584 HD12 HD11 ' A' ' 237' ' ' ILE . 11.8 mt -60.98 -42.29 92.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.616 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 223' ' ' ARG . . . . . 0.831 ' HG3' HD12 ' A' ' 235' ' ' ILE . 38.9 mtp180 -53.87 -63.09 1.26 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 174.279 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.42 ' HG2' ' O ' ' A' ' 220' ' ' ASP . 15.4 pt-20 -57.7 -22.16 44.67 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.19 -177.338 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 225' ' ' ASP . . . . . 0.481 ' HB3' ' CZ2' ' A' ' 267' ' ' TRP . 27.0 m-20 -89.62 -31.88 17.34 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.973 -177.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.854 HD23 ' HZ ' ' A' ' 248' ' ' PHE . 8.3 mp -107.05 -17.46 14.17 Favored 'General case' 0 C--O 1.224 -0.282 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -169.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 227' ' ' GLU . . . . . 0.679 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 58.6 mt-10 -69.6 -26.91 1.15 Allowed Pre-proline 0 C--N 1.323 -0.568 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -175.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 228' ' ' PRO . . . . . 0.679 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 72.3 Cg_endo -66.25 -27.84 48.06 Favored 'Trans proline' 0 C--N 1.36 1.179 0 C-N-CA 121.247 1.298 . . . . 0.0 111.916 -178.659 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 229' ' ' PHE . . . . . 0.489 ' CZ ' ' HA ' ' A' ' 226' ' ' LEU . 3.6 p90 -110.6 -9.36 14.55 Favored 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.66 174.238 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 230' ' ' GLY . . . . . 0.404 ' HA2' ' HD2' ' A' ' 231' ' ' PRO . . . -168.35 93.77 0.11 Allowed Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 120.18 -1.01 . . . . 0.0 112.109 -175.336 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.404 ' HD2' ' HA2' ' A' ' 230' ' ' GLY . 16.9 Cg_endo -59.76 133.59 52.08 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.214 1.943 . . . . 0.0 111.393 177.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.726 HG21 HG12 ' A' ' 246' ' ' VAL . 2.4 mp -111.4 151.59 13.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.309 177.519 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 233' ' ' ASP . . . . . 0.435 ' OD2' HD22 ' A' ' 249' ' ' LEU . 14.9 m-20 -115.51 -20.08 10.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.76 0.314 . . . . 0.0 111.227 177.626 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 234' ' ' GLN . . . . . 0.543 ' HB3' ' HB2' ' A' ' 247' ' ' HIS . 22.9 tt0 -142.77 120.48 11.86 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.279 -176.415 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.831 HD12 ' HG3' ' A' ' 223' ' ' ARG . 17.2 mt -136.3 116.28 17.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.889 -179.446 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -122.2 116.11 23.58 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.849 0.357 . . . . 0.0 110.457 178.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 237' ' ' ILE . . . . . 0.8 HG21 HG23 ' A' ' 217' ' ' ILE . 33.4 mt -104.57 115.47 46.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.248 179.224 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.575 ' HB ' HG13 ' A' ' 243' ' ' ILE . 45.5 t -94.26 87.0 2.04 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.152 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 173.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 8.8 t -65.32 -22.29 66.81 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.482 -177.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -60.32 -29.12 68.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.565 176.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 241' ' ' ARG . . . . . 0.786 ' HB2' HG12 ' A' ' 243' ' ' ILE . 73.9 mtt180 -120.0 0.43 10.77 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.797 -179.436 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 242' ' ' ASN . . . . . 0.472 ' O ' HD12 ' A' ' 213' ' ' LEU . 92.1 m-20 66.16 29.72 9.66 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.194 179.764 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.786 HG12 ' HB2' ' A' ' 241' ' ' ARG . 1.3 pt -121.92 151.34 25.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.792 -176.569 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 244' ' ' ALA . . . . . 0.552 ' HB3' ' HB2' ' A' ' 210' ' ' LEU . . . -141.55 138.77 32.92 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.103 0.477 . . . . 0.0 111.55 -178.416 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -110.78 111.43 22.6 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.677 176.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.726 HG12 HG21 ' A' ' 232' ' ' ILE . 0.8 OUTLIER -108.16 134.89 48.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -179.234 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 247' ' ' HIS . . . . . 0.82 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 46.1 m80 -116.06 101.72 9.0 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 119.995 -0.682 . . . . 0.0 111.457 178.623 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 248' ' ' PHE . . . . . 0.854 ' HZ ' HD23 ' A' ' 226' ' ' LEU . 29.9 m-85 -84.67 104.67 14.85 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.716 -1.129 . . . . 0.0 111.113 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.577 ' HA ' ' HE ' ' A' ' 206' ' ' ARG . 0.1 OUTLIER -42.82 -42.56 3.66 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 124.194 0.934 . . . . 0.0 113.058 -174.11 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 47.4 m-20 -95.51 143.8 26.53 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.23 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 251' ' ' ILE . . . . . 0.533 ' O ' HG13 ' A' ' 255' ' ' ILE . 0.2 OUTLIER -63.56 -45.0 98.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -177.594 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -70.79 -29.14 65.25 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-O 120.625 0.25 . . . . 0.0 110.791 -176.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -58.6 -42.7 88.71 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.36 178.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 254' ' ' ALA . . . . . 0.594 ' HB2' ' HB2' ' A' ' 248' ' ' PHE . . . -67.29 -42.0 84.49 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.626 178.025 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.533 HG13 ' O ' ' A' ' 251' ' ' ILE . 8.5 mt -56.95 -61.31 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.539 -177.292 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 256' ' ' LYS . . . . . 0.406 ' O ' ' HG2' ' A' ' 260' ' ' GLU . 12.3 ptmt -60.41 -38.52 84.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.271 -177.3 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -62.75 -47.91 81.47 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.741 0.305 . . . . 0.0 111.211 178.098 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 44.4 t -66.18 -23.54 32.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.011 0.434 . . . . 0.0 111.023 179.288 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 259' ' ' GLN . . . . . 0.484 ' HG3' ' O ' ' A' ' 255' ' ' ILE . 50.8 mt-30 -83.53 -27.8 29.09 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.825 177.507 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 260' ' ' GLU . . . . . 0.406 ' HG2' ' O ' ' A' ' 256' ' ' LYS . 50.9 mm-40 -96.02 -28.89 14.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.69 0.281 . . . . 0.0 111.59 -173.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.731 ' HA ' ' HE3' ' A' ' 267' ' ' TRP . 0.7 OUTLIER -54.1 -50.04 86.62 Favored Pre-proline 0 CA--C 1.536 0.437 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.516 179.252 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 262' ' ' PRO . . . . . 0.581 ' HD2' ' N ' ' A' ' 261' ' ' LEU . 41.2 Cg_endo -66.41 -13.76 41.27 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.271 1.981 . . . . 0.0 112.419 -179.271 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 60.8 mt -91.15 -8.0 49.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.929 0.395 . . . . 0.0 112.0 -178.069 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 264' ' ' ASN . . . . . 0.405 ' O ' ' HB2' ' A' ' 268' ' ' SER . 3.2 m-20 -106.11 149.8 38.57 Favored Pre-proline 0 C--O 1.211 -0.964 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.974 -177.196 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 265' ' ' PRO . . . . . 0.427 ' O ' ' HG3' ' A' ' 269' ' ' LYS . 47.3 Cg_endo -67.28 -33.28 30.98 Favored 'Trans proline' 0 C--O 1.224 -0.21 0 C-N-CA 123.325 2.684 . . . . 0.0 112.804 -171.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.461 ' HB2' ' HE3' ' A' ' 266' ' ' LYS . 0.0 OUTLIER -83.35 -45.91 13.19 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 121.732 0.777 . . . . 0.0 109.224 -179.376 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 267' ' ' TRP . . . . . 0.731 ' HE3' ' HA ' ' A' ' 261' ' ' LEU . 14.3 m0 -76.49 -29.75 56.96 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.909 -172.621 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 268' ' ' SER . . . . . 0.405 ' HB2' ' O ' ' A' ' 264' ' ' ASN . 24.1 t -63.84 -23.12 67.23 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.896 0.379 . . . . 0.0 110.72 178.659 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 269' ' ' LYS . . . . . 0.427 ' HG3' ' O ' ' A' ' 265' ' ' PRO . 93.4 mttt -70.82 -19.08 62.7 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.283 0.563 . . . . 0.0 109.695 178.123 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 270' ' ' ARG . . . . . 0.432 ' HA ' ' HB3' ' A' ' 212' ' ' ASN . 4.7 mpt_? -93.25 146.49 23.66 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.476 176.2 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 6.6 mmp_? -99.33 106.07 18.13 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 173.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 272' ' ' ILE . . . . . 0.679 HG21 HD23 ' A' ' 261' ' ' LEU . 0.1 OUTLIER -117.73 142.34 32.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.336 0.589 . . . . 0.0 111.552 -176.673 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -150.61 168.87 23.0 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.254 170.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -58.74 132.59 54.35 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 175.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -72.89 78.22 0.77 Allowed Glycine 0 CA--C 1.507 -0.459 0 C-N-CA 121.173 -0.537 . . . . 0.0 112.131 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 76.9 mtp180 64.41 135.54 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.874 0 C-N-CA 124.4 1.08 . . . . 0.0 113.207 -176.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -141.96 151.64 42.74 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.172 -1.376 . . . . 0.0 108.638 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 278' ' ' ARG . . . . . . . . . . . . . 65.0 mtp180 -64.5 -24.85 67.75 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 111.614 0.228 . . . . 0.0 111.614 -175.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 279' ' ' CYS . . . . . . . . . . . . . 77.5 m 52.31 45.88 27.67 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.384 0.611 . . . . 0.0 110.288 -175.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -141.11 24.19 2.16 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.308 -177.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 281' ' ' VAL . . . . . 0.552 ' HA ' ' HA ' ' A' ' 202' ' ' SER . 7.6 p 38.29 86.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 124.325 1.05 . . . . 0.0 113.045 -177.229 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 178.16 131.14 1.5 Allowed Glycine 0 N--CA 1.447 -0.567 0 CA-C-N 115.131 -0.94 . . . . 0.0 111.248 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 283' ' ' LEU . . . . . 0.535 ' HG ' ' HA3' ' A' ' 203' ' ' GLY . 5.1 mp -93.51 -170.58 2.4 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.862 0.331 . . . . 0.0 110.461 -176.026 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 10.8 ptmm? . . . . . 0 C--O 1.247 0.929 0 CA-C-O 118.296 -0.859 . . . . 0.0 110.883 178.578 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 9.7 t30 . . . . . 0 N--CA 1.479 1.007 0 CA-C-O 120.896 0.379 . . . . 0.0 110.758 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 189' ' ' SER . . . . . 0.511 ' HB3' ' HA ' ' A' ' 192' ' ' ASN . 17.3 m -109.05 93.7 4.65 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 175.832 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -66.07 -63.68 1.03 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.643 -178.501 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 39.7 t -84.16 -25.86 29.28 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 177.008 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 192' ' ' ASN . . . . . 0.511 ' HA ' ' HB3' ' A' ' 189' ' ' SER . 49.5 t30 63.89 91.53 0.07 Allowed 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.419 -175.244 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 33.8 m -85.55 6.75 25.78 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.981 -178.118 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 15.4 m 60.9 30.58 19.72 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.604 174.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 195' ' ' VAL . . . . . 0.548 ' CG2' ' HA ' ' A' ' 198' ' ' ALA . 0.3 OUTLIER -125.79 150.28 31.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.396 -176.77 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.638 ' O ' HG22 ' A' ' 199' ' ' VAL . 5.5 tt -60.85 97.13 0.05 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 176.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 98.4 mt 52.21 25.11 3.13 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.212 -0.904 . . . . 0.0 112.682 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.548 ' HA ' ' CG2' ' A' ' 195' ' ' VAL . . . 59.01 18.17 6.06 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 179.18 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.638 HG22 ' O ' ' A' ' 196' ' ' LEU . 21.3 m -91.54 -7.84 10.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.351 0.596 . . . . 0.0 110.16 177.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -83.86 78.66 9.68 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.347 178.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 201' ' ' GLN . . . . . 0.428 ' HA ' ' OE1' ' A' ' 201' ' ' GLN . 15.4 mm-40 -92.05 -4.19 54.76 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.644 0.735 . . . . 0.0 109.625 174.227 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 28.1 m -150.89 168.92 23.03 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.032 -0.986 . . . . 0.0 109.24 176.287 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.448 ' C ' ' HA ' ' A' ' 279' ' ' CYS . . . 98.11 -48.33 1.44 Allowed Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.811 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 204' ' ' ALA . . . . . 0.53 ' HA ' ' OD2' ' A' ' 277' ' ' ASP . . . -67.19 102.89 1.11 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.95 0.405 . . . . 0.0 110.49 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 205' ' ' CYS . . . . . 0.575 ' SG ' ' HG3' ' A' ' 206' ' ' ARG . 35.2 t -88.48 148.27 24.25 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.74 -176.331 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 206' ' ' ARG . . . . . 0.748 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 15.0 mtm180 51.86 -0.7 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 179.182 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 19.3 m-80 -100.65 105.64 17.03 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 118.876 0.762 . . . . 0.0 111.332 -172.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.504 ' HB ' ' HB ' ' A' ' 246' ' ' VAL . 60.3 t -137.36 127.76 38.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.24 176.375 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 209' ' ' PHE . . . . . 0.591 ' HB3' ' CE1' ' A' ' 273' ' ' TYR . 1.8 t80 -127.44 128.18 45.33 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 -177.514 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.489 ' HG ' HG22 ' A' ' 272' ' ' ILE . 5.9 mp -111.02 134.0 52.96 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.505 179.032 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 211' ' ' GLY . . . . . 0.595 ' HA2' HG22 ' A' ' 243' ' ' ILE . . . -138.94 65.68 0.53 Allowed Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.098 -1.048 . . . . 0.0 113.328 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 212' ' ' ASN . . . . . 0.581 ' HB2' ' HG3' ' A' ' 271' ' ' ARG . 3.3 t30 174.83 40.92 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.24 0.543 . . . . 0.0 110.105 175.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.623 ' HA ' ' HG3' ' A' ' 270' ' ' ARG . 1.0 OUTLIER -85.81 155.85 58.53 Favored Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.811 -177.693 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -79.79 169.14 18.5 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.81 2.34 . . . . 0.0 112.059 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -78.69 124.05 27.79 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 108.52 -2.83 32.53 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.592 -0.814 . . . . 0.0 112.613 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 217' ' ' ILE . . . . . 0.403 HG23 HG21 ' A' ' 237' ' ' ILE . 6.0 tp -65.14 125.18 21.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-O 121.255 0.55 . . . . 0.0 111.194 179.001 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 218' ' ' THR . . . . . 0.465 HG22 ' HG3' ' A' ' 221' ' ' GLU . 15.0 t -114.4 161.05 18.45 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.561 177.502 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.449 ' H ' ' CD ' ' A' ' 219' ' ' GLU . 9.3 mp0 -62.81 -38.04 89.11 Favored 'General case' 0 C--O 1.208 -1.105 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.059 -178.411 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 220' ' ' ASP . . . . . 0.483 ' O ' ' HG2' ' A' ' 224' ' ' GLU . 26.2 t70 -51.63 -37.87 52.21 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 123.618 0.574 . . . . 0.0 110.813 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 221' ' ' GLU . . . . . 0.465 ' HG3' HG22 ' A' ' 218' ' ' THR . 41.9 mt-10 -67.49 -57.5 6.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.4 178.574 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.533 HG23 HD22 ' A' ' 226' ' ' LEU . 6.9 mt -58.29 -41.67 81.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.351 -179.604 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 223' ' ' ARG . . . . . 0.729 ' HG3' HD12 ' A' ' 235' ' ' ILE . 37.3 mtp180 -57.12 -62.84 1.47 Allowed 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 175.82 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.483 ' HG2' ' O ' ' A' ' 220' ' ' ASP . 11.1 pt-20 -59.32 -20.8 57.49 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.083 -177.023 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 225' ' ' ASP . . . . . 0.462 ' HB3' ' CZ2' ' A' ' 267' ' ' TRP . 3.3 m-20 -90.58 -31.43 16.69 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.637 -177.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.681 HD23 ' HZ ' ' A' ' 248' ' ' PHE . 8.2 mp -107.45 -19.1 13.68 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -171.588 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 227' ' ' GLU . . . . . 0.693 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 48.1 mt-10 -73.34 -22.24 0.49 Allowed Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 113.264 0.839 . . . . 0.0 113.264 -175.591 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 228' ' ' PRO . . . . . 0.693 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 74.3 Cg_endo -66.59 -28.17 45.21 Favored 'Trans proline' 0 C--N 1.361 1.223 0 CA-C-N 120.747 1.302 . . . . 0.0 111.895 178.357 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 229' ' ' PHE . . . . . 0.482 ' CE1' ' HA ' ' A' ' 226' ' ' LEU . 2.9 p90 -110.71 -5.66 14.96 Favored 'General case' 0 C--O 1.225 -0.237 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.609 174.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 230' ' ' GLY . . . . . 0.482 ' CA ' ' HB1' ' A' ' 253' ' ' ALA . . . -174.6 95.59 0.1 Allowed Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 119.945 -1.121 . . . . 0.0 112.554 -175.695 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.487 ' HA ' ' HG2' ' A' ' 227' ' ' GLU . 19.2 Cg_endo -60.75 135.69 61.7 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.264 1.976 . . . . 0.0 111.584 177.788 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.632 HG21 HG12 ' A' ' 246' ' ' VAL . 3.3 mp -108.6 151.31 10.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.488 178.166 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 233' ' ' ASP . . . . . 0.489 ' CG ' HD22 ' A' ' 249' ' ' LEU . 12.7 m-20 -107.07 -25.58 11.52 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.001 0.429 . . . . 0.0 110.831 178.657 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 234' ' ' GLN . . . . . 0.473 ' H ' HG22 ' A' ' 232' ' ' ILE . 12.9 tt0 -145.1 120.28 10.15 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.749 -173.774 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.729 HD12 ' HG3' ' A' ' 223' ' ' ARG . 24.0 mt -133.04 107.59 11.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.8 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -113.75 110.58 20.38 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.605 -175.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 237' ' ' ILE . . . . . 0.485 HD11 HD12 ' A' ' 222' ' ' ILE . 89.3 mt -100.76 121.52 51.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.262 0.553 . . . . 0.0 111.188 -178.43 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.499 ' HB ' HG13 ' A' ' 243' ' ' ILE . 46.1 t -108.97 87.22 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 172.563 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 13.9 t -68.33 -20.36 64.73 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.193 -177.38 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -57.91 -30.84 66.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.154 175.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 241' ' ' ARG . . . . . 0.696 ' HB2' HG12 ' A' ' 243' ' ' ILE . 98.8 mtt180 -118.26 4.41 11.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.732 177.815 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 17.5 m120 64.71 29.14 12.95 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.224 178.393 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.696 HG12 ' HB2' ' A' ' 241' ' ' ARG . 1.3 pt -122.19 151.64 26.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.31 -174.448 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -142.02 135.9 29.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.005 0.431 . . . . 0.0 111.446 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -103.91 114.42 28.66 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.702 178.46 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.632 HG12 HG21 ' A' ' 232' ' ' ILE . 0.4 OUTLIER -110.35 132.17 59.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -179.349 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 247' ' ' HIS . . . . . 0.748 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 28.1 m80 -114.81 102.76 10.3 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 119.96 -0.696 . . . . 0.0 111.348 177.781 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 248' ' ' PHE . . . . . 0.681 ' HZ ' HD23 ' A' ' 226' ' ' LEU . 37.4 m-85 -86.18 102.98 14.39 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 114.887 -1.051 . . . . 0.0 111.33 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.489 HD22 ' CG ' ' A' ' 233' ' ' ASP . 0.2 OUTLIER -46.28 -37.9 7.92 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 124.437 1.086 . . . . 0.0 112.797 -175.789 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 250' ' ' ASN . . . . . 0.432 ' HB2' ' HB2' ' A' ' 253' ' ' ALA . 55.0 m-20 -97.27 136.32 37.93 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 178.697 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 251' ' ' ILE . . . . . 0.612 ' O ' HG13 ' A' ' 255' ' ' ILE . 0.2 OUTLIER -60.62 -43.41 94.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -179.094 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -70.96 -27.82 64.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.903 -176.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 253' ' ' ALA . . . . . 0.482 ' HB1' ' CA ' ' A' ' 230' ' ' GLY . . . -62.5 -41.72 99.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.215 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 254' ' ' ALA . . . . . 0.577 ' HB2' ' HB2' ' A' ' 248' ' ' PHE . . . -67.41 -41.96 84.04 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.645 178.391 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.675 ' HA ' ' OH ' ' A' ' 274' ' ' TYR . 13.5 mt -55.9 -61.25 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.297 -177.725 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 13.3 ptmt -62.37 -38.23 88.77 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.425 -176.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -64.48 -49.98 69.26 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 111.512 0.189 . . . . 0.0 111.512 179.117 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 258' ' ' VAL . . . . . 0.484 HG13 HG12 ' A' ' 272' ' ' ILE . 53.3 t -66.47 -22.79 30.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.01 0.434 . . . . 0.0 111.081 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -84.44 -24.61 29.47 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 175.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -90.55 -35.63 14.94 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.884 0.373 . . . . 0.0 111.032 -178.149 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.769 HD12 ' CE3' ' A' ' 267' ' ' TRP . 0.9 OUTLIER -52.24 -47.17 93.25 Favored Pre-proline 0 CA--C 1.54 0.576 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.79 -178.252 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 262' ' ' PRO . . . . . 0.563 ' HD3' HD11 ' A' ' 272' ' ' ILE . 39.1 Cg_endo -69.38 -21.86 34.64 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.257 1.971 . . . . 0.0 112.74 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 57.0 mt -90.02 -0.35 57.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.4 0.619 . . . . 0.0 111.114 -176.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 264' ' ' ASN . . . . . 0.474 ' O ' ' HB2' ' A' ' 268' ' ' SER . 12.1 m-80 -107.0 148.92 37.89 Favored Pre-proline 0 C--N 1.316 -0.857 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.757 -178.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -67.54 -41.74 8.18 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 123.074 2.516 . . . . 0.0 112.474 -171.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.433 ' HE2' ' HB2' ' A' ' 266' ' ' LYS . 2.6 mtpt -80.9 -45.1 17.29 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-O 121.615 0.722 . . . . 0.0 109.784 -175.437 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 267' ' ' TRP . . . . . 0.769 ' CE3' HD12 ' A' ' 261' ' ' LEU . 22.6 m0 -72.83 -28.79 62.76 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.549 -175.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 268' ' ' SER . . . . . 0.474 ' HB2' ' O ' ' A' ' 264' ' ' ASN . 23.1 t -66.57 -20.05 65.92 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 120.952 -0.299 . . . . 0.0 111.013 178.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -71.44 -15.73 62.35 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.336 0.589 . . . . 0.0 109.721 175.264 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 270' ' ' ARG . . . . . 0.623 ' HG3' ' HA ' ' A' ' 213' ' ' LEU . 0.0 OUTLIER -104.09 139.9 38.53 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.713 175.71 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 271' ' ' ARG . . . . . 0.581 ' HG3' ' HB2' ' A' ' 212' ' ' ASN . 15.3 mtm180 -93.22 105.36 17.45 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 272' ' ' ILE . . . . . 0.662 HG21 HD23 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -110.21 141.88 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-O 121.423 0.63 . . . . 0.0 110.857 -175.14 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 273' ' ' TYR . . . . . 0.591 ' CE1' ' HB3' ' A' ' 209' ' ' PHE . 4.6 p90 -152.78 167.75 27.98 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.83 174.136 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 274' ' ' TYR . . . . . 0.675 ' OH ' ' HA ' ' A' ' 255' ' ' ILE . 90.1 m-85 -69.38 136.49 51.75 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.266 172.323 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -67.99 -177.71 12.57 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.815 -0.707 . . . . 0.0 111.628 176.045 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 17.6 ptt180 -78.16 111.38 14.04 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.954 0.883 . . . . 0.0 110.81 -177.031 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 277' ' ' ASP . . . . . 0.53 ' OD2' ' HA ' ' A' ' 204' ' ' ALA . 31.3 t70 -157.59 146.68 19.75 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 114.475 -1.238 . . . . 0.0 109.205 -177.095 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 278' ' ' ARG . . . . . . . . . . . . . 74.5 mtt180 -104.26 50.56 0.79 Allowed 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.451 0.644 . . . . 0.0 110.424 -177.299 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 279' ' ' CYS . . . . . 0.448 ' HA ' ' C ' ' A' ' 203' ' ' GLY . 81.1 m 56.5 58.65 4.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.602 179.572 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -114.78 94.91 4.98 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.989 -177.552 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 6.4 p -90.72 -32.55 5.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.115 178.236 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -142.26 -119.86 1.52 Allowed Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.567 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 3.6 tt -136.24 95.62 3.22 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.181 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 63.9 tttm . . . . . 0 C--O 1.247 0.931 0 CA-C-O 118.43 -0.795 . . . . 0.0 109.774 -177.235 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 . . . . . 0 N--CA 1.48 1.049 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 43.9 m -76.63 -32.25 57.89 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.958 0.409 . . . . 0.0 110.443 178.319 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -83.46 -177.23 6.66 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.338 177.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 22.2 m -54.85 122.48 10.89 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.352 176.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -79.83 77.84 6.46 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.698 0.285 . . . . 0.0 110.593 -178.148 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' SER . . . . . 0.453 ' HA ' ' OE1' ' A' ' 259' ' ' GLN . 6.7 p -156.53 140.59 16.37 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.729 179.48 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 194' ' ' SER . . . . . 0.498 ' HB3' ' HG3' ' A' ' 262' ' ' PRO . 12.9 p -100.18 -0.7 38.28 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.311 0.577 . . . . 0.0 110.928 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 3.1 m -111.69 128.34 68.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.62 -177.189 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 7.1 tt -56.77 95.96 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.539 175.244 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 9.8 mp 53.48 18.08 1.29 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.632 179.379 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . 50.64 36.83 14.84 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 120.906 0.384 . . . . 0.0 111.158 -177.168 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 27.0 m -63.55 -22.38 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -175.423 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -78.49 72.38 5.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.841 0.353 . . . . 0.0 111.396 -179.345 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 54.46 33.03 17.86 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.377 -0.829 . . . . 0.0 112.139 175.174 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 37.2 t 71.12 -67.87 0.24 Allowed 'General case' 0 N--CA 1.465 0.29 0 O-C-N 123.843 0.715 . . . . 0.0 111.606 177.551 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -154.93 132.32 3.42 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.299 -176.615 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -102.49 145.59 29.35 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 110.008 -0.368 . . . . 0.0 110.008 178.302 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 205' ' ' CYS . . . . . 0.916 ' HB3' HG12 ' A' ' 251' ' ' ILE . 26.1 p -87.63 145.82 26.01 Favored 'General case' 0 CA--C 1.51 -0.567 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 177.289 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 206' ' ' ARG . . . . . 0.82 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 49.0 mtp180 57.04 -5.99 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 177.241 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 69.6 m-20 -100.86 106.13 17.47 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 119.125 0.875 . . . . 0.0 112.041 -173.313 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.5 ' HB ' ' HB ' ' A' ' 246' ' ' VAL . 59.5 t -136.02 117.6 19.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.607 178.094 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -115.47 123.38 48.42 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.752 0.31 . . . . 0.0 110.5 -177.244 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.74 ' HG ' HG22 ' A' ' 272' ' ' ILE . 5.9 mp -106.89 133.81 50.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.57 178.064 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 211' ' ' GLY . . . . . 0.557 ' HA2' HG22 ' A' ' 243' ' ' ILE . . . -143.39 65.78 0.47 Allowed Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.618 -0.801 . . . . 0.0 113.088 179.453 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 212' ' ' ASN . . . . . 0.52 ' HB3' ' HA ' ' A' ' 270' ' ' ARG . 50.5 t30 177.05 39.85 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.325 0.583 . . . . 0.0 109.733 177.315 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.764 HD23 ' HG2' ' A' ' 270' ' ' ARG . 1.2 mt -89.53 165.2 26.55 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.156 -179.269 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.496 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 78.5 Cg_endo -83.66 167.77 13.0 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 122.423 2.082 . . . . 0.0 111.14 174.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 215' ' ' ASN . . . . . 0.483 ' HA ' ' OG1' ' A' ' 239' ' ' THR . 40.9 t-20 -79.21 125.71 29.82 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 177.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 105.96 -3.92 38.7 Favored Glycine 0 C--N 1.314 -0.661 0 C-N-CA 120.458 -0.877 . . . . 0.0 113.082 -179.348 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 217' ' ' ILE . . . . . 0.696 HG23 HG21 ' A' ' 237' ' ' ILE . 5.0 tp -59.29 126.32 16.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.041 0.448 . . . . 0.0 110.436 178.815 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 218' ' ' THR . . . . . 0.477 ' CG2' ' HG3' ' A' ' 221' ' ' GLU . 10.6 t -111.11 156.81 20.8 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.321 0.582 . . . . 0.0 110.839 -178.041 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.508 ' H ' ' CD ' ' A' ' 219' ' ' GLU . 18.4 mp0 -62.28 -36.59 82.55 Favored 'General case' 0 C--O 1.21 -1.011 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.449 -177.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -50.98 -36.37 38.75 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.018 178.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 221' ' ' GLU . . . . . 0.477 ' HG3' ' CG2' ' A' ' 218' ' ' THR . 42.3 mt-10 -70.94 -59.46 2.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.798 178.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.593 HD12 HD11 ' A' ' 237' ' ' ILE . 7.6 mt -60.21 -39.85 81.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.469 -178.189 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 223' ' ' ARG . . . . . 0.666 ' HG3' HD12 ' A' ' 235' ' ' ILE . 52.1 mtp180 -55.2 -62.27 1.78 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 174.088 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -55.71 -25.17 38.71 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.82 -178.281 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -86.3 -31.62 21.5 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.435 -176.355 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.78 HD23 ' HZ ' ' A' ' 248' ' ' PHE . 7.3 mp -108.43 -16.03 14.32 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -171.379 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 227' ' ' GLU . . . . . 0.639 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 34.8 mm-40 -61.55 -37.25 39.27 Favored Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -177.108 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 228' ' ' PRO . . . . . 0.639 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 96.7 Cg_endo -66.3 -30.57 45.13 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 121.5 1.467 . . . . 0.0 112.247 -172.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 229' ' ' PHE . . . . . 0.496 ' CE1' ' HA ' ' A' ' 226' ' ' LEU . 4.3 p90 -110.88 3.22 18.73 Favored 'General case' 0 C--O 1.221 -0.43 0 C-N-CA 120.591 -0.443 . . . . 0.0 111.346 176.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 230' ' ' GLY . . . . . 0.454 ' CA ' ' HB1' ' A' ' 253' ' ' ALA . . . -179.82 97.13 0.11 Allowed Glycine 0 N--CA 1.44 -1.041 0 C-N-CA 119.666 -1.254 . . . . 0.0 112.609 -178.061 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.41 ' HD2' ' HA2' ' A' ' 230' ' ' GLY . 29.0 Cg_endo -64.17 134.31 41.91 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 121.772 1.648 . . . . 0.0 111.031 177.368 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.638 HG21 HG12 ' A' ' 246' ' ' VAL . 2.9 mp -108.59 150.65 11.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.97 178.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 233' ' ' ASP . . . . . 0.519 ' CG ' HD22 ' A' ' 249' ' ' LEU . 20.7 m-20 -107.44 -26.96 10.72 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.153 0.502 . . . . 0.0 110.446 178.731 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 234' ' ' GLN . . . . . 0.52 ' HB3' ' HB2' ' A' ' 247' ' ' HIS . 29.5 tt0 -142.24 120.31 12.13 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.612 -173.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.666 HD12 ' HG3' ' A' ' 223' ' ' ARG . 13.5 mt -134.17 111.89 15.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.001 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 35.2 ttmt -115.66 112.61 22.36 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.349 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 237' ' ' ILE . . . . . 0.696 HG21 HG23 ' A' ' 217' ' ' ILE . 85.3 mt -102.13 121.62 53.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-O 121.1 0.476 . . . . 0.0 110.841 178.667 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.557 ' HB ' HG13 ' A' ' 243' ' ' ILE . 39.2 t -104.46 87.07 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 172.513 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 239' ' ' THR . . . . . 0.483 ' OG1' ' HA ' ' A' ' 215' ' ' ASN . 9.6 t -70.04 -15.33 62.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.222 -175.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -66.7 -32.73 74.23 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.133 175.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 241' ' ' ARG . . . . . 0.573 ' HB2' HG12 ' A' ' 243' ' ' ILE . 81.1 mtt180 -114.98 3.25 14.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.859 -178.366 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 67.66 24.87 8.32 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.288 176.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.573 HG12 ' HB2' ' A' ' 241' ' ' ARG . 1.8 pt -122.33 153.27 26.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.293 -175.009 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 244' ' ' ALA . . . . . 0.471 ' HB3' ' HB2' ' A' ' 210' ' ' LEU . . . -143.7 140.05 29.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.119 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -111.03 115.13 28.93 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.757 177.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.638 HG12 HG21 ' A' ' 232' ' ' ILE . 1.1 t -111.81 136.05 49.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 -178.007 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 247' ' ' HIS . . . . . 0.82 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 44.0 m80 -117.41 102.62 9.37 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.594 0.711 . . . . 0.0 111.287 176.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 248' ' ' PHE . . . . . 0.78 ' HZ ' HD23 ' A' ' 226' ' ' LEU . 34.7 m-85 -85.38 104.61 15.35 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.634 -1.166 . . . . 0.0 111.516 -179.435 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.519 HD22 ' CG ' ' A' ' 233' ' ' ASP . 0.2 OUTLIER -46.57 -39.5 11.17 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 124.41 1.069 . . . . 0.0 112.929 -174.526 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 250' ' ' ASN . . . . . 0.424 ' HB2' ' HB2' ' A' ' 253' ' ' ALA . 47.5 m-80 -92.93 141.51 28.33 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 177.045 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 251' ' ' ILE . . . . . 0.916 HG12 ' HB3' ' A' ' 205' ' ' CYS . 0.1 OUTLIER -62.84 -44.05 99.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.316 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -70.1 -29.8 66.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.91 -176.408 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 253' ' ' ALA . . . . . 0.454 ' HB1' ' CA ' ' A' ' 230' ' ' GLY . . . -60.36 -42.84 96.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.135 179.512 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 254' ' ' ALA . . . . . 0.56 ' HB2' ' HB2' ' A' ' 248' ' ' PHE . . . -67.96 -41.68 82.05 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.479 179.23 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.597 HG13 ' O ' ' A' ' 251' ' ' ILE . 11.2 mt -56.69 -60.78 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.108 -177.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 256' ' ' LYS . . . . . 0.496 ' HE2' ' HB2' ' A' ' 229' ' ' PHE . 15.0 ptmt -62.25 -38.74 90.43 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.406 -177.275 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -62.9 -49.99 72.63 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.661 0.267 . . . . 0.0 111.45 178.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 258' ' ' VAL . . . . . 0.514 HG13 HG12 ' A' ' 272' ' ' ILE . 55.6 t -65.07 -26.48 40.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.805 0.336 . . . . 0.0 110.994 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 259' ' ' GLN . . . . . 0.453 ' OE1' ' HA ' ' A' ' 193' ' ' SER . 16.9 mm-40 -84.64 -23.04 29.68 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 178.457 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 260' ' ' GLU . . . . . 0.406 ' HG2' ' O ' ' A' ' 256' ' ' LYS . 62.1 mm-40 -94.7 -32.03 13.54 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.813 0.34 . . . . 0.0 111.158 -176.589 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.796 HD23 HG21 ' A' ' 272' ' ' ILE . 0.8 OUTLIER -52.49 -49.54 85.15 Favored Pre-proline 0 CA--C 1.541 0.614 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.511 179.769 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 262' ' ' PRO . . . . . 0.611 ' HD3' HD11 ' A' ' 272' ' ' ILE . 53.3 Cg_endo -69.16 -11.0 30.56 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.512 2.142 . . . . 0.0 112.565 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 43.5 mt -92.07 -9.09 43.94 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.037 0.446 . . . . 0.0 111.555 -179.524 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 264' ' ' ASN . . . . . 0.421 ' HB2' ' CE3' ' A' ' 267' ' ' TRP . 3.5 m-20 -106.9 149.7 38.85 Favored Pre-proline 0 C--N 1.314 -0.942 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.258 -176.315 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 265' ' ' PRO . . . . . 0.402 ' O ' ' HG3' ' A' ' 269' ' ' LYS . 54.8 Cg_endo -67.73 -32.04 31.0 Favored 'Trans proline' 0 CA--C 1.521 -0.129 0 C-N-CA 123.383 2.722 . . . . 0.0 112.738 -171.167 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.432 ' HE3' ' HB2' ' A' ' 266' ' ' LYS . 0.0 OUTLIER -84.77 -45.64 12.18 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 121.574 0.702 . . . . 0.0 109.24 -179.113 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 267' ' ' TRP . . . . . 0.743 ' HE3' ' HA ' ' A' ' 261' ' ' LEU . 12.6 m0 -76.88 -31.07 56.51 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.934 -172.382 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 17.7 t -68.3 -15.96 63.77 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.617 179.542 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 269' ' ' LYS . . . . . 0.402 ' HG3' ' O ' ' A' ' 265' ' ' PRO . 89.6 mttt -77.05 -7.71 56.16 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.218 0.533 . . . . 0.0 109.953 174.36 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 270' ' ' ARG . . . . . 0.764 ' HG2' HD23 ' A' ' 213' ' ' LEU . 3.7 mpt_? -110.82 143.89 40.69 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.92 178.303 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 36.0 mmt180 -91.99 106.42 18.44 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 110.021 -0.362 . . . . 0.0 110.021 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 272' ' ' ILE . . . . . 0.796 HG21 HD23 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -118.27 140.35 42.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.377 0.608 . . . . 0.0 110.718 179.701 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -152.39 168.96 23.77 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.38 173.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -61.13 119.63 8.75 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.713 0.292 . . . . 0.0 110.257 174.127 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -84.16 -173.27 49.69 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.864 -0.684 . . . . 0.0 111.906 178.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 276' ' ' ARG . . . . . 0.604 ' O ' ' HD2' ' A' ' 276' ' ' ARG . 0.2 OUTLIER -124.62 143.69 50.58 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.052 0.453 . . . . 0.0 111.081 -178.821 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -172.3 140.5 1.13 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.516 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 278' ' ' ARG . . . . . 0.56 ' HD2' ' N ' ' A' ' 278' ' ' ARG . 6.6 mpt_? -90.01 -2.76 58.19 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.257 -170.518 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 279' ' ' CYS . . . . . . . . . . . . . 63.5 m -104.92 0.04 27.46 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.307 0.575 . . . . 0.0 109.913 175.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -130.88 29.23 4.75 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.676 -177.413 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 281' ' ' VAL . . . . . 0.423 ' O ' HG22 ' A' ' 281' ' ' VAL . 14.5 p 37.34 44.62 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-O 122.499 1.142 . . . . 0.0 112.359 -177.557 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -115.12 85.98 0.4 Allowed Glycine 0 N--CA 1.444 -0.788 0 N-CA-C 110.244 -1.142 . . . . 0.0 110.244 175.083 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 76.9 mt -89.46 159.32 17.33 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.022 0.439 . . . . 0.0 111.409 -173.007 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 62.4 tttp . . . . . 0 C--O 1.246 0.917 0 CA-C-O 118.408 -0.806 . . . . 0.0 109.488 177.591 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 33.6 t30 . . . . . 0 N--CA 1.481 1.095 0 CA-C-O 120.859 0.361 . . . . 0.0 110.411 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 15.3 p -106.03 -14.23 15.24 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.057 0.456 . . . . 0.0 110.309 179.072 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -77.93 6.8 6.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.481 -177.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 22.7 t -75.59 -27.22 58.46 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 177.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 67.1 t30 59.04 32.18 22.0 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 121.458 0.646 . . . . 0.0 110.669 178.255 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 28.4 m -74.06 -25.84 60.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.88 0.847 . . . . 0.0 108.844 175.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 19.7 m -135.81 175.27 9.74 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 171.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 195' ' ' VAL . . . . . 0.455 ' HB ' ' HA ' ' A' ' 198' ' ' ALA . 4.9 m -62.68 114.72 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 C-N-CA 120.01 -0.676 . . . . 0.0 110.402 176.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 9.4 tt -55.38 94.74 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.665 177.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.612 ' HB2' HG22 ' A' ' 199' ' ' VAL . 7.7 mp 53.59 10.34 0.22 Allowed 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.164 -177.738 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.455 ' HA ' ' HB ' ' A' ' 195' ' ' VAL . . . 58.15 20.32 6.91 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 123.023 0.529 . . . . 0.0 111.21 -173.78 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.612 HG22 ' HB2' ' A' ' 197' ' ' LEU . 35.9 m -108.89 19.4 6.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.631 -175.245 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -77.09 30.67 0.14 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.005 0.431 . . . . 0.0 111.095 178.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 201' ' ' GLN . . . . . 0.678 ' HA ' ' CE2' ' A' ' 274' ' ' TYR . 49.3 mt-30 -80.4 127.57 32.56 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.281 -178.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 50.8 m -144.57 177.34 8.74 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.687 178.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -70.42 90.97 0.38 Allowed Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.806 -0.712 . . . . 0.0 111.858 178.28 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 204' ' ' ALA . . . . . 0.694 ' HB1' ' HB2' ' A' ' 207' ' ' ASN . . . -147.7 107.11 3.91 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.592 0.234 . . . . 0.0 110.824 -179.63 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 205' ' ' CYS . . . . . 0.513 ' HB3' HG12 ' A' ' 251' ' ' ILE . 25.5 p -98.44 145.87 26.31 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 174.235 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 206' ' ' ARG . . . . . 0.879 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 0.6 OUTLIER 57.54 6.21 0.39 Allowed 'General case' 0 C--O 1.219 -0.539 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -178.079 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 207' ' ' ASN . . . . . 0.694 ' HB2' ' HB1' ' A' ' 204' ' ' ALA . 6.5 m-20 -106.38 105.95 16.24 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 118.555 0.616 . . . . 0.0 111.442 -173.094 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.526 ' HB ' ' HB ' ' A' ' 246' ' ' VAL . 66.5 t -137.62 119.75 18.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.309 177.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -115.22 124.32 51.11 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.816 0.341 . . . . 0.0 110.469 -177.087 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.687 ' HG ' HG22 ' A' ' 272' ' ' ILE . 5.4 mp -107.31 129.44 54.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.275 177.838 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 211' ' ' GLY . . . . . 0.623 ' HA2' HG22 ' A' ' 243' ' ' ILE . . . -136.65 59.43 0.64 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.394 -0.908 . . . . 0.0 113.266 -178.268 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 212' ' ' ASN . . . . . 0.551 ' HB3' ' HA ' ' A' ' 270' ' ' ARG . 1.7 t30 177.03 43.53 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.027 0.442 . . . . 0.0 110.063 177.017 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.576 ' HA ' ' HG3' ' A' ' 270' ' ' ARG . 1.2 mt -87.01 164.09 37.8 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.041 -177.666 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.54 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 73.0 Cg_endo -76.51 169.03 22.65 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.365 2.043 . . . . 0.0 111.763 175.829 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 -78.5 130.17 35.7 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.897 179.115 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 91.48 3.78 68.79 Favored Glycine 0 C--N 1.317 -0.499 0 C-N-CA 120.732 -0.747 . . . . 0.0 113.188 177.239 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 217' ' ' ILE . . . . . 0.65 HG23 HG21 ' A' ' 237' ' ' ILE . 4.5 tp -58.82 128.55 19.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.34 0.591 . . . . 0.0 111.153 -178.73 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 218' ' ' THR . . . . . 0.465 ' CG2' ' HG3' ' A' ' 221' ' ' GLU . 14.5 t -111.91 156.17 22.49 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 121.367 0.603 . . . . 0.0 110.839 -178.248 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -62.41 -35.45 79.26 Favored 'General case' 0 C--O 1.209 -1.052 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.654 -177.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -48.89 -40.63 30.57 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.033 177.619 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 221' ' ' GLU . . . . . 0.465 ' HG3' ' CG2' ' A' ' 218' ' ' THR . 43.2 mt-10 -70.69 -56.01 7.38 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.751 -178.668 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.59 HD12 HD11 ' A' ' 237' ' ' ILE . 10.6 mt -61.41 -45.21 99.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.632 -178.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 223' ' ' ARG . . . . . 0.784 ' HG3' HD12 ' A' ' 235' ' ' ILE . 64.2 mtp180 -54.01 -62.46 1.64 Allowed 'General case' 0 CA--C 1.505 -0.786 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 176.481 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -55.68 -24.25 33.13 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.731 -177.64 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 225' ' ' ASP . . . . . 0.446 ' HB3' ' CZ2' ' A' ' 267' ' ' TRP . 8.9 m-20 -86.0 -32.14 21.65 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.955 -178.432 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.838 HD23 ' HZ ' ' A' ' 248' ' ' PHE . 7.3 mp -104.99 -15.1 15.21 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.959 -0.297 . . . . 0.0 111.669 -172.095 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 227' ' ' GLU . . . . . 0.638 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 42.7 mm-40 -61.46 -36.58 33.38 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -177.376 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 228' ' ' PRO . . . . . 0.638 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 97.5 Cg_endo -67.13 -27.03 42.18 Favored 'Trans proline' 0 C--N 1.358 1.03 0 C-N-CA 121.66 1.573 . . . . 0.0 112.377 -173.002 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 229' ' ' PHE . . . . . 0.519 ' CE1' ' HA ' ' A' ' 226' ' ' LEU . 2.9 p90 -110.78 -14.14 14.05 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.411 -0.516 . . . . 0.0 111.825 176.025 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 230' ' ' GLY . . . . . 0.469 ' CA ' ' HB1' ' A' ' 253' ' ' ALA . . . -164.08 97.73 0.15 Allowed Glycine 0 N--CA 1.44 -1.099 0 C-N-CA 120.479 -0.867 . . . . 0.0 112.05 -174.176 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -65.05 135.68 44.89 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 121.747 1.631 . . . . 0.0 111.136 178.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.596 HG21 HG12 ' A' ' 246' ' ' VAL . 2.4 mp -112.11 148.95 14.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.919 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 233' ' ' ASP . . . . . 0.487 ' OD2' HD22 ' A' ' 249' ' ' LEU . 8.8 m-20 -109.3 -24.66 10.97 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.111 0.481 . . . . 0.0 110.369 178.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 234' ' ' GLN . . . . . 0.594 ' HB3' ' HB2' ' A' ' 247' ' ' HIS . 22.9 tt0 -142.09 122.01 13.62 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.543 -174.318 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.784 HD12 ' HG3' ' A' ' 223' ' ' ARG . 8.1 mt -135.52 105.52 5.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 121.512 0.672 . . . . 0.0 109.927 178.579 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -108.35 107.51 18.12 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.993 -177.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 237' ' ' ILE . . . . . 0.65 HG21 HG23 ' A' ' 217' ' ' ILE . 81.3 mt -101.19 125.43 55.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.947 -178.287 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.545 ' HB ' HG13 ' A' ' 243' ' ' ILE . 41.2 t -109.67 88.05 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 170.776 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 15.3 t -69.94 -12.34 61.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.356 -176.057 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -69.02 -35.26 76.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.311 176.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 241' ' ' ARG . . . . . 0.626 ' HB2' HG12 ' A' ' 243' ' ' ILE . 90.7 mtt180 -113.75 5.12 16.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.6 -178.238 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 68.06 24.84 7.66 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.381 176.535 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.626 HG12 ' HB2' ' A' ' 241' ' ' ARG . 1.5 pt -122.31 150.79 25.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.823 -173.655 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 244' ' ' ALA . . . . . 0.424 ' HB3' ' HB2' ' A' ' 210' ' ' LEU . . . -144.13 137.78 27.73 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.243 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -107.19 110.98 23.18 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.539 177.489 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.596 HG12 HG21 ' A' ' 232' ' ' ILE . 1.5 t -107.86 134.91 48.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.872 -177.01 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 247' ' ' HIS . . . . . 0.879 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 1.9 m-70 -113.87 101.93 9.73 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.358 0.599 . . . . 0.0 111.382 177.528 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 248' ' ' PHE . . . . . 0.838 ' HZ ' HD23 ' A' ' 226' ' ' LEU . 35.1 m-85 -85.39 101.27 12.45 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.952 178.031 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.514 HD23 ' H ' ' A' ' 249' ' ' LEU . 0.1 OUTLIER -43.96 -38.94 3.73 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 124.293 0.996 . . . . 0.0 112.881 -174.41 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 250' ' ' ASN . . . . . 0.43 ' HB2' ' HB2' ' A' ' 253' ' ' ALA . 2.6 m-20 -94.34 139.19 31.4 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 176.789 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 251' ' ' ILE . . . . . 0.6 ' O ' HG13 ' A' ' 255' ' ' ILE . 0.2 OUTLIER -62.71 -41.24 91.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.962 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -72.08 -28.66 63.45 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.741 -177.573 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 253' ' ' ALA . . . . . 0.469 ' HB1' ' CA ' ' A' ' 230' ' ' GLY . . . -61.34 -41.37 96.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.25 178.7 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 254' ' ' ALA . . . . . 0.545 ' HB2' ' HB2' ' A' ' 248' ' ' PHE . . . -68.7 -40.74 79.87 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.724 178.509 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.6 HG13 ' O ' ' A' ' 251' ' ' ILE . 7.5 mt -56.14 -60.59 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.348 -178.247 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 256' ' ' LYS . . . . . 0.43 ' O ' ' HG2' ' A' ' 260' ' ' GLU . 9.9 ptmt -61.36 -41.49 97.16 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.513 -177.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -62.14 -49.81 74.39 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.693 0.283 . . . . 0.0 111.464 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 258' ' ' VAL . . . . . 0.453 HG13 HG12 ' A' ' 272' ' ' ILE . 41.2 t -64.84 -26.52 40.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.897 0.38 . . . . 0.0 111.121 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 259' ' ' GLN . . . . . 0.401 ' HG3' ' O ' ' A' ' 255' ' ' ILE . 53.3 mt-30 -84.64 -23.08 29.66 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 178.599 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 260' ' ' GLU . . . . . 0.43 ' HG2' ' O ' ' A' ' 256' ' ' LYS . 49.5 mm-40 -95.31 -32.48 12.95 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.611 0.243 . . . . 0.0 111.158 -176.719 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.782 HD12 ' CE3' ' A' ' 267' ' ' TRP . 0.6 OUTLIER -50.44 -49.92 74.63 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.549 179.506 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 262' ' ' PRO . . . . . 0.579 ' HD2' ' N ' ' A' ' 261' ' ' LEU . 40.4 Cg_endo -67.25 -17.14 49.84 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.416 2.078 . . . . 0.0 112.972 -178.422 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 55.2 mt -91.63 -3.56 56.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.248 0.547 . . . . 0.0 111.493 -178.17 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -106.64 148.82 37.53 Favored Pre-proline 0 C--N 1.314 -0.962 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.839 -175.24 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -65.41 -35.98 37.0 Favored 'Trans proline' 0 C--O 1.23 0.108 0 C-N-CA 123.557 2.838 . . . . 0.0 112.902 -169.562 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 9.7 mtpt -86.53 -45.08 11.42 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.671 0.748 . . . . 0.0 109.685 -177.358 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 267' ' ' TRP . . . . . 0.782 ' CE3' HD12 ' A' ' 261' ' ' LEU . 11.6 m0 -76.34 -29.35 57.21 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.87 -173.34 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 38.0 t -62.32 -21.98 65.69 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.822 0.344 . . . . 0.0 110.853 178.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -71.46 -16.59 62.38 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.106 0.479 . . . . 0.0 110.276 177.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 270' ' ' ARG . . . . . 0.576 ' HG3' ' HA ' ' A' ' 213' ' ' LEU . 0.0 OUTLIER -100.26 146.31 27.06 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.495 178.554 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 271' ' ' ARG . . . . . 0.407 ' HG2' ' HB2' ' A' ' 212' ' ' ASN . 9.9 mmp_? -95.4 105.92 17.93 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 176.106 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 272' ' ' ILE . . . . . 0.721 HG21 HD23 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -115.86 141.87 31.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.546 0.688 . . . . 0.0 111.285 -177.952 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -151.69 169.24 22.65 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.354 -0.839 . . . . 0.0 108.966 172.015 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 274' ' ' TYR . . . . . 0.678 ' CE2' ' HA ' ' A' ' 201' ' ' GLN . 75.6 m-85 -58.68 116.16 3.53 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 173.639 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 275' ' ' GLY . . . . . 0.463 ' O ' ' HB3' ' A' ' 207' ' ' ASN . . . -68.94 147.82 46.96 Favored Glycine 0 N--CA 1.443 -0.89 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.783 -176.3 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 276' ' ' ARG . . . . . 0.422 HH11 ' HD3' ' A' ' 276' ' ' ARG . 44.1 mtt180 -115.17 109.0 17.35 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.834 0.826 . . . . 0.0 110.101 177.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -173.98 147.3 1.28 Allowed 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 113.857 -1.52 . . . . 0.0 108.49 -172.333 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 278' ' ' ARG . . . . . . . . . . . . . 19.9 mmm180 -98.22 -1.58 41.7 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.681 0.277 . . . . 0.0 110.705 -172.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 279' ' ' CYS . . . . . . . . . . . . . 16.1 t 63.77 30.88 14.5 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.658 0.742 . . . . 0.0 109.874 -177.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -123.78 35.31 4.87 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.502 -177.416 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 7.7 p 40.48 83.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-O 122.32 1.057 . . . . 0.0 112.5 -175.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 125.41 139.51 5.2 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 114.915 -1.039 . . . . 0.0 111.967 178.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 84.3 mt -74.06 118.46 17.05 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.884 0.373 . . . . 0.0 110.435 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? . . . . . 0 C--O 1.247 0.935 0 CA-C-O 118.336 -0.84 . . . . 0.0 109.546 177.951 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 188' ' ' ASN . . . . . 0.568 HD21 ' N ' ' A' ' 188' ' ' ASN . 0.7 OUTLIER . . . . . 0 N--CA 1.48 1.051 0 CA-C-O 120.624 0.25 . . . . 0.0 110.361 . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 33.0 p -105.95 126.38 52.12 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.898 -178.203 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -89.84 111.88 23.04 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.249 178.243 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 26.2 m -78.37 -7.73 57.64 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -173.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -68.81 -20.93 64.34 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 176.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 22.3 m -109.45 130.97 55.47 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.426 175.221 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 33.5 p -108.41 152.38 24.76 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.787 0.327 . . . . 0.0 110.867 -179.023 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 3.1 m -140.7 83.85 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.818 178.066 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.607 ' HA ' HG22 ' A' ' 199' ' ' VAL . 66.7 mt -75.22 -20.66 59.13 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.526 0.679 . . . . 0.0 109.68 178.307 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 96.7 mt -68.03 -9.66 47.59 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.833 173.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -106.8 -9.28 16.45 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.304 178.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.607 HG22 ' HA ' ' A' ' 196' ' ' LEU . 16.0 m -105.12 2.37 10.41 Favored 'Isoleucine or valine' 0 C--O 1.231 0.084 0 C-N-CA 120.344 -0.542 . . . . 0.0 111.047 -178.662 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 200' ' ' GLN . . . . . 0.492 ' HB2' ' HA3' ' A' ' 203' ' ' GLY . 13.3 pt20 -104.07 77.5 1.44 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.493 0.663 . . . . 0.0 110.916 -179.155 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -70.03 -27.65 64.84 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.038 -179.399 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 27.0 p -97.72 13.32 30.74 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.93 174.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.492 ' HA3' ' HB2' ' A' ' 200' ' ' GLN . . . -101.1 -15.75 27.37 Favored Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.801 -176.409 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 204' ' ' ALA . . . . . 0.58 ' HB1' ' HB2' ' A' ' 207' ' ' ASN . . . -149.08 143.41 26.02 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.006 0.431 . . . . 0.0 111.151 -179.519 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 205' ' ' CYS . . . . . 0.758 ' HB3' HG12 ' A' ' 251' ' ' ILE . 5.9 p -127.92 145.7 50.87 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 172.152 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 206' ' ' ARG . . . . . 0.774 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 48.7 mtp180 52.73 12.33 0.25 Allowed 'General case' 0 C--O 1.221 -0.4 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -176.82 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 207' ' ' ASN . . . . . 0.58 ' HB2' ' HB1' ' A' ' 204' ' ' ALA . 0.9 OUTLIER -116.25 107.41 14.82 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.805 0.336 . . . . 0.0 111.19 -173.721 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.555 ' HB ' ' HB ' ' A' ' 246' ' ' VAL . 99.7 t -135.68 124.89 40.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.726 179.352 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 209' ' ' PHE . . . . . 0.406 ' O ' ' HA ' ' A' ' 272' ' ' ILE . 3.9 t80 -117.27 122.93 45.31 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.744 0.307 . . . . 0.0 110.446 -177.497 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.701 ' HG ' HG22 ' A' ' 272' ' ' ILE . 5.5 mp -106.01 132.76 51.71 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.039 176.811 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 211' ' ' GLY . . . . . 0.68 ' HA2' HG22 ' A' ' 243' ' ' ILE . . . -140.75 59.32 0.57 Allowed Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.441 -0.885 . . . . 0.0 113.475 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 212' ' ' ASN . . . . . 0.552 ' HB3' ' HA ' ' A' ' 270' ' ' ARG . 57.5 t30 -179.17 33.4 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.328 0.585 . . . . 0.0 110.156 175.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.612 HD23 ' HG2' ' A' ' 270' ' ' ARG . 2.0 mt -76.27 161.13 76.13 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.113 -177.78 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.424 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 66.3 Cg_endo -73.98 162.18 39.62 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.253 1.969 . . . . 0.0 111.023 174.354 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -77.6 120.99 23.33 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 178.442 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 106.94 -1.58 35.7 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.193 -1.003 . . . . 0.0 113.046 -179.573 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 217' ' ' ILE . . . . . 0.675 HG23 HG21 ' A' ' 237' ' ' ILE . 4.5 tp -59.31 128.48 20.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.961 0.41 . . . . 0.0 110.803 179.036 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 218' ' ' THR . . . . . 0.476 HG22 ' HG3' ' A' ' 221' ' ' GLU . 9.8 t -113.56 158.84 20.27 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-O 121.296 0.569 . . . . 0.0 110.91 -178.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.533 ' H ' ' CD ' ' A' ' 219' ' ' GLU . 7.0 mp0 -62.39 -39.33 92.87 Favored 'General case' 0 C--O 1.21 -0.978 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.138 -174.636 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 220' ' ' ASP . . . . . 0.455 ' O ' ' HG2' ' A' ' 224' ' ' GLU . 16.3 t70 -54.22 -35.04 62.0 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 123.429 0.455 . . . . 0.0 110.987 -178.518 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 221' ' ' GLU . . . . . 0.476 ' HG3' HG22 ' A' ' 218' ' ' THR . 45.9 mt-10 -67.27 -57.2 7.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.325 178.22 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.564 HD12 HD11 ' A' ' 237' ' ' ILE . 6.9 mt -60.28 -41.79 88.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.563 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 223' ' ' ARG . . . . . 0.751 ' HG3' HD12 ' A' ' 235' ' ' ILE . 64.0 mtp180 -53.19 -62.8 1.42 Allowed 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 174.653 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.455 ' HG2' ' O ' ' A' ' 220' ' ' ASP . 8.8 pt-20 -58.53 -23.51 58.4 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.849 -176.764 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -88.55 -31.75 18.51 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.697 -176.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.775 HD23 ' HZ ' ' A' ' 248' ' ' PHE . 8.0 mp -105.7 -19.31 13.8 Favored 'General case' 0 CA--C 1.517 -0.307 0 C-N-CA 120.684 -0.406 . . . . 0.0 112.085 -171.333 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 227' ' ' GLU . . . . . 0.662 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 33.9 mt-10 -64.82 -33.55 8.68 Favored Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -176.471 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 228' ' ' PRO . . . . . 0.662 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 75.8 Cg_endo -65.63 -29.16 52.2 Favored 'Trans proline' 0 C--N 1.358 1.05 0 C-N-CA 121.34 1.36 . . . . 0.0 112.014 -175.518 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 229' ' ' PHE . . . . . 0.526 ' CE1' ' HA ' ' A' ' 226' ' ' LEU . 4.4 p90 -111.16 3.97 18.91 Favored 'General case' 0 C--O 1.223 -0.338 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.366 174.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 230' ' ' GLY . . . . . 0.573 ' CA ' ' HB1' ' A' ' 253' ' ' ALA . . . 178.8 99.88 0.13 Allowed Glycine 0 N--CA 1.441 -1.007 0 C-N-CA 120.045 -1.074 . . . . 0.0 112.725 -177.168 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -66.34 134.98 38.03 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 121.833 1.689 . . . . 0.0 111.28 178.461 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.634 HG21 HG12 ' A' ' 235' ' ' ILE . 3.5 mp -106.48 151.96 8.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.28 178.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 233' ' ' ASP . . . . . 0.552 ' OD2' ' HB3' ' A' ' 249' ' ' LEU . 8.9 m-20 -104.54 -28.8 11.07 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.3 179.215 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 234' ' ' GLN . . . . . 0.494 ' H ' HG22 ' A' ' 232' ' ' ILE . 13.1 tt0 -151.66 130.55 12.5 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.825 -173.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.751 HD12 ' HG3' ' A' ' 223' ' ' ARG . 15.0 mt -136.7 110.26 8.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.923 -179.322 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.421 ' O ' ' HA ' ' A' ' 244' ' ' ALA . 84.9 tttt -111.29 112.42 24.17 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.131 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 237' ' ' ILE . . . . . 0.675 HG21 HG23 ' A' ' 217' ' ' ILE . 78.2 mt -104.79 118.06 51.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 121.084 0.468 . . . . 0.0 111.12 -179.529 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.589 ' HB ' HG13 ' A' ' 243' ' ' ILE . 46.8 t -99.2 87.81 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 171.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 9.5 t -64.94 -21.03 66.76 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.466 -175.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -58.13 -38.71 77.04 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.718 175.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 241' ' ' ARG . . . . . 0.72 ' HB2' HG12 ' A' ' 243' ' ' ILE . 72.4 mtp180 -112.41 3.0 16.66 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.39 -177.134 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 66.07 28.87 10.24 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.877 0.37 . . . . 0.0 110.543 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.72 HG12 ' HB2' ' A' ' 241' ' ' ARG . 1.2 pt -121.35 150.34 24.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.312 -174.24 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 244' ' ' ALA . . . . . 0.522 ' HB3' ' HB2' ' A' ' 210' ' ' LEU . . . -144.75 140.7 28.7 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.674 -178.63 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -111.19 115.51 29.5 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.433 177.036 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.57 HG13 HG12 ' A' ' 235' ' ' ILE . 1.6 t -113.48 139.63 37.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.312 -174.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 247' ' ' HIS . . . . . 0.774 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 59.4 m170 -111.38 101.93 10.35 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.459 176.478 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 248' ' ' PHE . . . . . 0.775 ' HZ ' HD23 ' A' ' 226' ' ' LEU . 39.6 m-85 -89.28 98.52 11.81 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.164 176.761 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.661 ' HA ' ' HE ' ' A' ' 206' ' ' ARG . 0.2 OUTLIER -47.58 -44.62 26.46 Favored 'General case' 0 N--CA 1.464 0.232 0 O-C-N 124.24 0.962 . . . . 0.0 112.618 -173.509 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 250' ' ' ASN . . . . . 0.425 ' HB2' ' HB2' ' A' ' 253' ' ' ALA . 67.7 m-20 -85.81 135.78 33.58 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 176.373 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 251' ' ' ILE . . . . . 0.758 HG12 ' HB3' ' A' ' 205' ' ' CYS . 0.2 OUTLIER -62.63 -40.69 89.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 -177.411 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -70.78 -27.38 63.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.524 -177.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 253' ' ' ALA . . . . . 0.573 ' HB1' ' CA ' ' A' ' 230' ' ' GLY . . . -62.87 -41.36 99.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.106 -179.599 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 254' ' ' ALA . . . . . 0.59 ' HB2' ' HB2' ' A' ' 248' ' ' PHE . . . -69.13 -41.04 77.87 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.561 178.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.598 HG13 ' O ' ' A' ' 251' ' ' ILE . 11.0 mt -56.05 -60.74 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.045 -178.398 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 256' ' ' LYS . . . . . 0.454 ' HE2' ' HB2' ' A' ' 229' ' ' PHE . 13.5 ptmt -63.3 -39.78 95.52 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.496 -176.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -61.29 -48.16 82.67 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.71 0.29 . . . . 0.0 111.351 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 258' ' ' VAL . . . . . 0.532 HG13 HG12 ' A' ' 272' ' ' ILE . 54.9 t -66.76 -24.38 32.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.995 179.603 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 16.5 mm100 -84.52 -25.94 28.42 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 177.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 260' ' ' GLU . . . . . 0.438 ' HG2' ' O ' ' A' ' 256' ' ' LYS . 59.3 mm-40 -93.89 -33.96 13.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.634 0.254 . . . . 0.0 110.987 -175.243 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.807 HD23 HG21 ' A' ' 272' ' ' ILE . 0.8 OUTLIER -51.6 -51.32 70.78 Favored Pre-proline 0 CA--C 1.537 0.478 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.515 -179.619 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 262' ' ' PRO . . . . . 0.595 ' HD3' HD11 ' A' ' 272' ' ' ILE . 43.1 Cg_endo -66.75 -17.57 52.41 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.381 2.054 . . . . 0.0 112.762 -177.496 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 62.9 mt -95.22 -1.19 52.16 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.274 0.559 . . . . 0.0 111.525 -176.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 264' ' ' ASN . . . . . 0.489 ' O ' ' HB2' ' A' ' 268' ' ' SER . 14.4 m-80 -105.62 148.69 36.84 Favored Pre-proline 0 C--N 1.317 -0.846 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.244 -178.76 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -63.05 -40.84 31.6 Favored 'Trans proline' 0 C--N 1.335 -0.143 0 C-N-CA 123.298 2.666 . . . . 0.0 112.74 -169.129 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 12.6 mtpt -86.2 -42.71 13.59 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.461 0.648 . . . . 0.0 110.133 -176.106 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 267' ' ' TRP . . . . . 0.726 ' CE3' HD12 ' A' ' 261' ' ' LEU . 17.1 m0 -73.98 -28.04 61.28 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.835 -176.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 268' ' ' SER . . . . . 0.489 ' HB2' ' O ' ' A' ' 264' ' ' ASN . 12.8 t -65.71 -18.32 65.25 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.186 0.517 . . . . 0.0 110.577 177.48 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -71.71 -9.04 57.68 Favored 'General case' 0 C--O 1.225 -0.224 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.105 174.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 270' ' ' ARG . . . . . 0.612 ' HG2' HD23 ' A' ' 213' ' ' LEU . 0.0 OUTLIER -112.86 143.17 44.57 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.392 -179.745 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 35.5 mmt180 -94.2 109.0 20.83 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.283 177.565 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 272' ' ' ILE . . . . . 0.807 HG21 HD23 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -121.91 140.91 44.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.418 0.628 . . . . 0.0 111.38 -178.627 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -152.26 169.86 21.45 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.372 174.04 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 274' ' ' TYR . . . . . 0.571 ' HB3' ' HB3' ' A' ' 204' ' ' ALA . 74.2 m-85 -64.5 119.99 11.47 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.224 0.535 . . . . 0.0 109.827 176.292 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -95.07 174.04 32.29 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 115.362 -0.835 . . . . 0.0 112.621 -173.404 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -110.5 109.4 19.73 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 122.001 0.905 . . . . 0.0 110.787 176.219 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -152.35 141.21 21.07 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 114.279 -1.328 . . . . 0.0 109.72 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 278' ' ' ARG . . . . . 0.419 HH11 ' HD2' ' A' ' 278' ' ' ARG . 32.7 mtp85 -103.99 13.35 32.82 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.405 -171.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 279' ' ' CYS . . . . . . . . . . . . . 55.6 m 61.62 24.97 14.97 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.353 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 280' ' ' ALA . . . . . 0.412 ' HB1' ' HB3' ' A' ' 283' ' ' LEU . . . -162.2 125.89 3.09 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.146 -175.349 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 28.7 m -86.15 -33.46 7.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 120.855 0.36 . . . . 0.0 111.14 -178.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -124.06 24.06 6.4 Favored Glycine 0 N--CA 1.442 -0.923 0 C-N-CA 120.459 -0.877 . . . . 0.0 112.459 -175.038 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 283' ' ' LEU . . . . . 0.412 ' HB3' ' HB1' ' A' ' 280' ' ' ALA . 1.7 tm? -124.93 97.64 5.35 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 178.72 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp . . . . . 0 C--O 1.247 0.944 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.533 -179.196 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 43.3 t30 . . . . . 0 N--CA 1.48 1.069 0 CA-C-O 120.491 0.186 . . . . 0.0 110.53 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 19.9 m -130.2 -2.96 4.47 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 121.069 -0.252 . . . . 0.0 111.165 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . 62.02 92.18 0.06 Allowed 'General case' 0 N--CA 1.462 0.149 0 O-C-N 123.714 0.634 . . . . 0.0 111.095 -178.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 23.7 m -68.63 -23.15 64.4 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.795 -177.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -137.55 137.79 38.95 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 177.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 50.9 m -65.54 147.93 52.59 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.896 0.379 . . . . 0.0 111.037 -179.065 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 17.2 m -71.78 113.38 8.76 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.973 -176.619 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 195' ' ' VAL . . . . . 0.498 HG21 ' CD2' ' A' ' 273' ' ' TYR . 3.3 m -104.62 76.57 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.416 0.627 . . . . 0.0 110.767 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.536 ' H ' HD22 ' A' ' 196' ' ' LEU . 2.5 mm? -59.04 94.21 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.893 -175.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 8.3 mp 51.68 25.76 3.04 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.704 0.287 . . . . 0.0 111.31 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . 65.76 23.56 11.49 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.602 -178.388 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.485 HG22 ' HB2' ' A' ' 196' ' ' LEU . 32.6 m -67.91 -15.8 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 O-C-N 121.688 -0.632 . . . . 0.0 110.178 174.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -69.27 -1.24 7.57 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.241 -0.89 . . . . 0.0 112.212 178.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -142.32 160.87 39.41 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.247 178.531 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 20.0 m -87.14 -34.35 19.1 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.898 0.38 . . . . 0.0 111.24 -178.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 173.7 136.86 2.29 Favored Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 -178.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 204' ' ' ALA . . . . . 0.866 ' HB1' ' HB2' ' A' ' 207' ' ' ASN . . . -126.79 111.2 13.94 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.988 0.423 . . . . 0.0 112.079 -175.081 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 205' ' ' CYS . . . . . 0.603 ' HB3' HG12 ' A' ' 251' ' ' ILE . 3.4 p -101.04 145.77 28.29 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 167.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 206' ' ' ARG . . . . . 0.789 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 29.8 mtm180 55.08 5.33 0.1 Allowed 'General case' 0 C--O 1.223 -0.339 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -175.792 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 207' ' ' ASN . . . . . 0.866 ' HB2' ' HB1' ' A' ' 204' ' ' ALA . 18.9 m-80 -108.18 106.19 16.26 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-O 121.232 0.539 . . . . 0.0 111.385 -173.644 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.481 ' HB ' ' HB ' ' A' ' 246' ' ' VAL . 61.1 t -134.56 111.93 14.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.012 177.406 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 209' ' ' PHE . . . . . 0.427 ' HE1' ' HB ' ' A' ' 243' ' ' ILE . 1.7 t80 -109.96 122.08 46.74 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.973 0.416 . . . . 0.0 110.361 -174.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.53 ' HG ' HG22 ' A' ' 272' ' ' ILE . 6.2 mp -106.81 133.93 50.73 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.613 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 211' ' ' GLY . . . . . 0.643 ' HA2' HG22 ' A' ' 243' ' ' ILE . . . -136.92 61.3 0.61 Allowed Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.548 -0.834 . . . . 0.0 113.097 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 212' ' ' ASN . . . . . 0.425 ' HB2' ' O ' ' A' ' 211' ' ' GLY . 2.3 t30 175.61 53.92 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.066 0.46 . . . . 0.0 110.612 175.709 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.625 HD23 ' HG2' ' A' ' 270' ' ' ARG . 0.7 OUTLIER -102.53 155.6 36.31 Favored Pre-proline 0 C--N 1.316 -0.862 0 N-CA-C 110.043 -0.355 . . . . 0.0 110.043 178.012 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -77.18 165.82 27.36 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.502 2.135 . . . . 0.0 112.163 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -75.94 118.82 19.12 Favored 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 177.176 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 109.51 2.59 30.93 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.255 -0.974 . . . . 0.0 112.56 -178.309 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 217' ' ' ILE . . . . . 0.652 HG23 HG21 ' A' ' 237' ' ' ILE . 6.3 tp -68.23 129.03 32.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.941 0.401 . . . . 0.0 110.36 175.306 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 218' ' ' THR . . . . . 0.465 ' CG2' ' HG3' ' A' ' 221' ' ' GLU . 10.6 t -113.65 156.84 23.0 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-O 121.397 0.618 . . . . 0.0 111.041 179.147 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.561 ' H ' ' CD ' ' A' ' 219' ' ' GLU . 5.1 mp0 -60.92 -35.98 78.11 Favored 'General case' 0 C--O 1.21 -0.986 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.615 -179.044 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -54.39 -35.69 63.12 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.845 -179.006 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 221' ' ' GLU . . . . . 0.465 ' HG3' ' CG2' ' A' ' 218' ' ' THR . 42.9 mt-10 -69.91 -57.65 4.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.565 178.426 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.532 HD12 HD11 ' A' ' 237' ' ' ILE . 8.1 mt -59.49 -42.81 89.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.488 -178.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 223' ' ' ARG . . . . . 0.839 ' HG3' HD12 ' A' ' 235' ' ' ILE . 45.0 mtp85 -55.86 -61.92 2.04 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 176.197 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -57.19 -21.73 35.49 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.925 -178.123 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -89.67 -30.73 17.89 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 116.021 -0.536 . . . . 0.0 112.055 -178.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.713 HD23 ' HZ ' ' A' ' 248' ' ' PHE . 8.4 mp -106.41 -19.26 13.74 Favored 'General case' 0 C--O 1.225 -0.215 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -171.207 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 227' ' ' GLU . . . . . 0.669 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 41.4 mt-10 -66.87 -31.43 3.99 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -175.844 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 228' ' ' PRO . . . . . 0.669 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 71.7 Cg_endo -65.73 -28.13 51.99 Favored 'Trans proline' 0 C--N 1.357 1.013 0 C-N-CA 121.442 1.428 . . . . 0.0 112.16 -176.225 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 229' ' ' PHE . . . . . 0.48 ' CE1' ' HA ' ' A' ' 226' ' ' LEU . 3.8 p90 -111.04 -0.72 16.55 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.752 0.31 . . . . 0.0 111.399 173.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 230' ' ' GLY . . . . . 0.568 ' CA ' ' HB1' ' A' ' 253' ' ' ALA . . . -175.43 95.51 0.1 Allowed Glycine 0 N--CA 1.442 -0.914 0 C-N-CA 120.128 -1.034 . . . . 0.0 112.466 -176.248 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -62.45 130.47 30.19 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.12 1.88 . . . . 0.0 111.634 178.726 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.656 HG21 HG12 ' A' ' 246' ' ' VAL . 2.4 mp -109.47 148.26 13.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.315 178.166 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 233' ' ' ASP . . . . . 0.487 ' CG ' HD22 ' A' ' 249' ' ' LEU . 44.4 m-20 -110.18 -24.26 10.8 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.003 0.43 . . . . 0.0 110.704 179.106 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 234' ' ' GLN . . . . . 0.43 ' H ' HG22 ' A' ' 232' ' ' ILE . 15.7 tt0 -142.8 122.13 13.08 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.548 -174.547 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.839 HD12 ' HG3' ' A' ' 223' ' ' ARG . 10.5 mt -135.95 110.96 11.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.912 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.428 ' O ' ' HA ' ' A' ' 244' ' ' ALA . 62.4 tttp -113.31 110.55 20.54 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.541 -176.637 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 237' ' ' ILE . . . . . 0.652 HG21 HG23 ' A' ' 217' ' ' ILE . 76.2 mt -101.84 119.51 50.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.115 0.484 . . . . 0.0 111.041 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.57 ' HB ' HG13 ' A' ' 243' ' ' ILE . 43.6 t -103.98 88.24 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 173.395 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 10.0 t -62.48 -25.13 67.84 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.16 -177.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -55.59 -39.98 71.44 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 121.069 0.462 . . . . 0.0 110.392 176.368 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 241' ' ' ARG . . . . . 0.737 ' HB2' HG12 ' A' ' 243' ' ' ILE . 99.2 mtt180 -111.31 5.86 20.09 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.847 -178.296 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 62.93 28.76 16.44 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.083 177.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.737 HG12 ' HB2' ' A' ' 241' ' ' ARG . 1.3 pt -121.28 154.22 25.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.104 -173.025 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 244' ' ' ALA . . . . . 0.444 ' HB3' ' HB2' ' A' ' 210' ' ' LEU . . . -144.92 138.37 26.85 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.441 -178.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -107.09 114.17 28.08 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.394 177.089 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.656 HG12 HG21 ' A' ' 232' ' ' ILE . 0.7 OUTLIER -109.83 127.82 66.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -179.229 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 247' ' ' HIS . . . . . 0.789 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 48.9 m170 -107.95 101.83 11.06 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.038 -0.665 . . . . 0.0 111.319 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 248' ' ' PHE . . . . . 0.713 ' HZ ' HD23 ' A' ' 226' ' ' LEU . 34.1 m-85 -87.49 99.18 11.84 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.149 178.322 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.501 HD23 ' H ' ' A' ' 249' ' ' LEU . 0.1 OUTLIER -42.27 -43.3 3.39 Favored 'General case' 0 N--CA 1.467 0.375 0 O-C-N 124.564 1.165 . . . . 0.0 112.651 -177.612 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 57.1 m-20 -90.87 135.36 33.78 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 177.408 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 251' ' ' ILE . . . . . 0.603 HG12 ' HB3' ' A' ' 205' ' ' CYS . 0.2 OUTLIER -62.99 -40.96 91.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -178.69 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -69.06 -31.77 70.77 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 120.786 0.327 . . . . 0.0 110.662 -177.432 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 253' ' ' ALA . . . . . 0.568 ' HB1' ' CA ' ' A' ' 230' ' ' GLY . . . -59.53 -42.14 91.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.353 179.095 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 254' ' ' ALA . . . . . 0.587 ' HB2' ' HB2' ' A' ' 248' ' ' PHE . . . -68.24 -40.52 81.96 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.655 178.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.561 HG13 ' O ' ' A' ' 251' ' ' ILE . 6.9 mt -56.49 -61.13 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.272 -178.305 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 12.8 ptmt -62.3 -39.23 92.32 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.439 -177.237 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -62.09 -48.88 78.2 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.639 0.257 . . . . 0.0 111.508 179.172 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 258' ' ' VAL . . . . . 0.546 HG13 HG12 ' A' ' 272' ' ' ILE . 70.1 t -66.3 -23.34 31.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.009 0.433 . . . . 0.0 111.05 179.062 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -85.06 -21.76 29.24 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 177.11 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -95.32 -36.75 11.27 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.895 0.379 . . . . 0.0 110.911 -177.312 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.749 HD23 HG21 ' A' ' 272' ' ' ILE . 1.1 mp -51.94 -47.74 90.22 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.956 -177.812 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 262' ' ' PRO . . . . . 0.575 ' HD2' ' N ' ' A' ' 261' ' ' LEU . 41.1 Cg_endo -67.49 -19.05 49.27 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.145 1.896 . . . . 0.0 112.711 -178.592 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 65.6 mt -95.53 -3.72 46.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.971 0.415 . . . . 0.0 111.811 -175.056 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 264' ' ' ASN . . . . . 0.494 ' O ' ' HB2' ' A' ' 268' ' ' SER . 14.1 m-80 -105.65 148.42 36.38 Favored Pre-proline 0 C--N 1.316 -0.878 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.761 -176.408 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -67.32 -32.97 31.65 Favored 'Trans proline' 0 N--CA 1.466 -0.098 0 C-N-CA 123.255 2.636 . . . . 0.0 112.652 -169.416 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.2 -45.13 12.3 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-O 121.825 0.821 . . . . 0.0 109.289 -178.31 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 267' ' ' TRP . . . . . 0.727 ' CE3' HD12 ' A' ' 261' ' ' LEU . 10.2 m0 -78.76 -25.23 44.43 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.947 -172.611 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 268' ' ' SER . . . . . 0.494 ' HB2' ' O ' ' A' ' 264' ' ' ASN . 12.5 t -66.8 -19.13 65.68 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.834 0.35 . . . . 0.0 110.782 178.199 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -71.7 -21.51 61.77 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 121.013 0.435 . . . . 0.0 110.239 175.65 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 270' ' ' ARG . . . . . 0.625 ' HG2' HD23 ' A' ' 213' ' ' LEU . 2.6 mpt_? -99.76 141.43 32.58 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.424 -178.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 271' ' ' ARG . . . . . 0.412 ' HD3' ' HA ' ' A' ' 271' ' ' ARG . 26.7 mmt180 -94.13 106.2 18.18 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 179.707 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 272' ' ' ILE . . . . . 0.749 HG21 HD23 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -112.48 141.38 28.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.992 0.425 . . . . 0.0 111.207 -176.093 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 273' ' ' TYR . . . . . 0.498 ' CD2' HG21 ' A' ' 195' ' ' VAL . 7.8 p90 -152.6 168.86 24.2 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.158 171.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 274' ' ' TYR . . . . . 0.541 ' OH ' ' HA ' ' A' ' 255' ' ' ILE . 64.7 m-85 -65.11 133.9 52.6 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.81 0.338 . . . . 0.0 110.577 173.632 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -72.12 164.26 54.39 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.301 178.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 76.8 mtt85 -87.07 126.16 34.58 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -178.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -165.98 154.72 11.31 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.089 -174.6 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 278' ' ' ARG . . . . . 0.414 HH11 ' HD3' ' A' ' 278' ' ' ARG . 64.2 mtt-85 -93.37 14.76 17.45 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 111.52 0.193 . . . . 0.0 111.52 -174.793 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 279' ' ' CYS . . . . . . . . . . . . . 37.0 m 66.55 25.8 9.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.158 0.504 . . . . 0.0 110.385 178.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -117.39 108.98 16.22 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.432 0.634 . . . . 0.0 110.381 -176.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 7.3 p -92.66 -24.24 5.36 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.725 178.156 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -148.61 -91.6 0.1 OUTLIER Glycine 0 N--CA 1.446 -0.689 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.58 177.356 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -104.06 159.16 15.91 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 178.336 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 284' ' ' LYS . . . . . 0.453 ' HB3' ' NZ ' ' A' ' 284' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.877 0 CA-C-O 118.64 -0.695 . . . . 0.0 109.283 -179.04 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 49.4 t30 . . . . . 0 N--CA 1.48 1.067 0 N-CA-C 110.251 -0.277 . . . . 0.0 110.251 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 13.2 t 63.23 77.68 0.32 Allowed 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.475 0.655 . . . . 0.0 110.732 -179.615 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -76.01 135.71 39.97 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.31 178.438 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 10.6 m -80.4 109.14 14.62 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.492 -177.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -117.39 160.84 20.51 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -178.726 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 19.6 m -51.42 102.86 0.05 OUTLIER 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.941 0.401 . . . . 0.0 110.163 176.267 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 15.2 m -89.89 115.19 27.02 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.673 -169.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 1.1 m -137.16 17.79 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.707 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.664 174.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.549 HD23 ' HG3' ' A' ' 200' ' ' GLN . 27.3 tp 64.68 34.76 9.44 Favored 'General case' 0 C--N 1.319 -0.735 0 O-C-N 124.028 0.83 . . . . 0.0 109.347 -175.384 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 66.3 mt 63.13 16.08 9.06 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.161 -174.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . 62.85 22.01 13.15 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.584 178.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.407 HG22 ' O ' ' A' ' 196' ' ' LEU . 16.5 m -74.25 -2.98 4.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 121.205 0.526 . . . . 0.0 110.531 178.815 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 200' ' ' GLN . . . . . 0.549 ' HG3' HD23 ' A' ' 196' ' ' LEU . 51.7 mt-30 -77.99 39.13 0.29 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.614 177.331 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 201' ' ' GLN . . . . . 0.476 ' HA ' HD11 ' A' ' 255' ' ' ILE . 12.6 pt20 -63.86 -20.25 65.67 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.85 -176.266 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 35.0 m -135.52 16.22 3.39 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 171.216 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -92.16 -50.44 2.62 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 114.944 -1.025 . . . . 0.0 112.574 -174.09 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -122.79 93.48 3.98 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 121.174 0.511 . . . . 0.0 110.725 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 205' ' ' CYS . . . . . 0.569 ' HA ' HG12 ' A' ' 251' ' ' ILE . 3.3 m -88.44 146.93 24.95 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.192 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 206' ' ' ARG . . . . . 0.851 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 30.7 mtm180 55.29 6.05 0.14 Allowed 'General case' 0 C--O 1.22 -0.477 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 178.746 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -104.42 105.16 15.18 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 119.974 -0.691 . . . . 0.0 111.496 -171.292 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 61.9 t -136.14 116.33 17.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.384 177.64 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 209' ' ' PHE . . . . . 0.429 ' O ' ' HA ' ' A' ' 272' ' ' ILE . 3.4 t80 -113.5 126.52 55.4 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.447 -176.679 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.742 ' HG ' HG22 ' A' ' 272' ' ' ILE . 5.6 mp -110.65 131.37 55.11 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.553 178.537 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 211' ' ' GLY . . . . . 0.593 ' HA2' HG22 ' A' ' 243' ' ' ILE . . . -139.07 66.46 0.52 Allowed Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.621 -0.799 . . . . 0.0 113.396 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 212' ' ' ASN . . . . . 0.556 ' HB3' ' HA ' ' A' ' 270' ' ' ARG . 40.2 t30 177.08 36.47 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.183 0.516 . . . . 0.0 110.014 176.437 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.842 HD23 ' HG2' ' A' ' 270' ' ' ARG . 1.3 mt -89.16 158.27 46.9 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.466 -178.131 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -81.98 163.96 17.88 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.541 2.16 . . . . 0.0 111.42 176.509 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 215' ' ' ASN . . . . . 0.532 ' HA ' ' OG1' ' A' ' 239' ' ' THR . 14.8 m120 -78.42 127.89 32.84 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.104 178.334 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 108.76 -8.87 34.41 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.473 -177.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 217' ' ' ILE . . . . . 0.668 HG23 HG21 ' A' ' 237' ' ' ILE . 4.3 tp -61.41 126.85 20.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-O 121.146 0.498 . . . . 0.0 110.376 178.063 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 218' ' ' THR . . . . . 0.562 HG22 ' HG3' ' A' ' 221' ' ' GLU . 5.1 t -113.77 161.2 17.83 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 121.35 0.595 . . . . 0.0 110.999 -178.724 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.554 ' H ' ' CD ' ' A' ' 219' ' ' GLU . 7.7 mp0 -62.84 -41.7 99.45 Favored 'General case' 0 C--O 1.209 -1.035 0 CA-C-N 115.113 -0.948 . . . . 0.0 109.887 -175.528 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -50.33 -37.16 35.34 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 123.584 0.553 . . . . 0.0 111.175 -179.173 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 221' ' ' GLU . . . . . 0.562 ' HG3' HG22 ' A' ' 218' ' ' THR . 44.6 mt-10 -68.44 -56.23 9.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.553 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.543 HD12 HD11 ' A' ' 237' ' ' ILE . 6.9 mt -62.17 -40.64 88.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.382 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 223' ' ' ARG . . . . . 0.634 ' HG3' HD12 ' A' ' 235' ' ' ILE . 25.6 mtp85 -53.15 -64.12 0.92 Allowed 'General case' 0 CA--C 1.509 -0.631 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 174.77 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -58.04 -21.02 43.44 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.855 -176.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -86.22 -33.31 20.79 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.703 -178.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.786 HD23 ' HZ ' ' A' ' 248' ' ' PHE . 7.5 mp -107.2 -14.44 14.9 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -171.173 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 227' ' ' GLU . . . . . 0.628 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 24.5 mm-40 -61.01 -37.68 46.87 Favored Pre-proline 0 C--N 1.328 -0.353 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -178.322 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 228' ' ' PRO . . . . . 0.628 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 97.2 Cg_endo -66.52 -27.51 46.25 Favored 'Trans proline' 0 C--N 1.36 1.134 0 C-N-CA 121.687 1.591 . . . . 0.0 112.295 -171.723 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 229' ' ' PHE . . . . . 0.54 ' CZ ' ' HA ' ' A' ' 226' ' ' LEU . 3.8 p90 -110.91 -7.05 14.6 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.686 176.308 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 230' ' ' GLY . . . . . 0.411 ' CA ' ' HB1' ' A' ' 253' ' ' ALA . . . -171.8 98.72 0.13 Allowed Glycine 0 N--CA 1.442 -0.906 0 C-N-CA 120.045 -1.074 . . . . 0.0 112.347 -175.643 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.403 ' HD2' ' HA2' ' A' ' 230' ' ' GLY . 18.2 Cg_endo -63.9 133.17 37.59 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 121.904 1.736 . . . . 0.0 111.256 177.452 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.811 HG21 HG12 ' A' ' 246' ' ' VAL . 2.4 mp -109.54 147.7 13.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.905 178.802 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 233' ' ' ASP . . . . . 0.476 ' CG ' HD22 ' A' ' 249' ' ' LEU . 14.4 m-20 -108.89 -24.46 11.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.731 178.59 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 234' ' ' GLN . . . . . 0.597 ' HB3' ' HB2' ' A' ' 247' ' ' HIS . 21.4 tt0 -140.06 121.81 15.4 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.305 -173.837 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.634 HD12 ' HG3' ' A' ' 223' ' ' ARG . 18.6 mt -136.83 111.14 9.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.111 0.481 . . . . 0.0 110.158 -178.357 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 22.1 ttmm -115.77 109.34 17.54 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.41 -179.501 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 237' ' ' ILE . . . . . 0.668 HG21 HG23 ' A' ' 217' ' ' ILE . 73.2 mt -99.72 118.24 46.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-O 121.043 0.449 . . . . 0.0 110.323 177.156 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.552 ' HB ' HG13 ' A' ' 243' ' ' ILE . 40.8 t -102.14 86.1 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 172.594 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 239' ' ' THR . . . . . 0.532 ' OG1' ' HA ' ' A' ' 215' ' ' ASN . 8.9 t -70.19 -19.02 63.2 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.274 -176.045 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -60.83 -33.62 73.31 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.951 174.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 241' ' ' ARG . . . . . 0.46 ' HB2' HG12 ' A' ' 243' ' ' ILE . 98.9 mtt180 -114.94 4.24 14.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.791 -179.521 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 17.3 m120 65.93 27.76 10.77 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.23 0.612 . . . . 0.0 111.419 176.005 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.593 HG22 ' HA2' ' A' ' 211' ' ' GLY . 1.4 pt -123.07 155.08 28.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.294 -175.48 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 244' ' ' ALA . . . . . 0.475 ' HB3' ' HB2' ' A' ' 210' ' ' LEU . . . -144.38 141.47 29.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.989 0.423 . . . . 0.0 111.569 179.284 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -112.73 115.41 28.49 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.64 176.194 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.811 HG12 HG21 ' A' ' 232' ' ' ILE . 0.3 OUTLIER -111.48 129.41 66.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 -179.124 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 247' ' ' HIS . . . . . 0.851 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 32.4 m170 -107.79 102.78 11.96 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.006 -0.677 . . . . 0.0 111.357 178.644 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 248' ' ' PHE . . . . . 0.786 ' HZ ' HD23 ' A' ' 226' ' ' LEU . 33.2 m-85 -84.82 103.17 13.66 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.811 177.775 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.476 HD22 ' CG ' ' A' ' 233' ' ' ASP . 0.1 OUTLIER -43.29 -39.46 3.06 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 124.505 1.128 . . . . 0.0 113.068 -174.306 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -99.71 137.94 37.49 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 176.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 251' ' ' ILE . . . . . 0.605 ' O ' HG13 ' A' ' 255' ' ' ILE . 0.2 OUTLIER -58.51 -41.65 82.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.918 -179.289 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -69.22 -30.67 68.88 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 116.756 -0.202 . . . . 0.0 111.09 -176.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 253' ' ' ALA . . . . . 0.411 ' HB1' ' CA ' ' A' ' 230' ' ' GLY . . . -62.35 -39.14 92.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.221 178.523 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 254' ' ' ALA . . . . . 0.6 ' HB2' ' HB2' ' A' ' 248' ' ' PHE . . . -69.53 -41.79 75.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.799 178.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.605 HG13 ' O ' ' A' ' 251' ' ' ILE . 11.4 mt -56.11 -60.61 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.105 -178.049 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 256' ' ' LYS . . . . . 0.521 ' O ' ' HG2' ' A' ' 260' ' ' GLU . 12.3 ptmt -61.22 -39.73 91.34 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.515 -178.347 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -62.61 -47.9 81.75 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.628 0.252 . . . . 0.0 111.4 179.246 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 258' ' ' VAL . . . . . 0.484 HG13 HG12 ' A' ' 272' ' ' ILE . 53.7 t -66.63 -26.27 36.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.9 0.381 . . . . 0.0 111.221 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 259' ' ' GLN . . . . . 0.523 ' HA ' ' OE1' ' A' ' 259' ' ' GLN . 10.4 mm-40 -84.3 -28.71 26.94 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 177.469 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 260' ' ' GLU . . . . . 0.521 ' HG2' ' O ' ' A' ' 256' ' ' LYS . 37.1 mm-40 -92.91 -26.02 17.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.445 0.164 . . . . 0.0 111.423 -175.279 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.803 HD23 HG21 ' A' ' 272' ' ' ILE . 0.6 OUTLIER -54.23 -52.55 67.84 Favored Pre-proline 0 CA--C 1.537 0.465 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.981 176.412 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 262' ' ' PRO . . . . . 0.554 ' HD2' ' N ' ' A' ' 261' ' ' LEU . 37.7 Cg_endo -67.18 -15.92 47.45 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.503 2.135 . . . . 0.0 112.828 -178.627 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 263' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' A' ' 259' ' ' GLN . 46.1 mt -85.06 -9.07 58.36 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.126 0.489 . . . . 0.0 111.151 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 -105.15 148.7 36.64 Favored Pre-proline 0 C--N 1.316 -0.887 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.108 -175.49 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -66.38 -34.73 33.81 Favored 'Trans proline' 0 C--N 1.336 -0.085 0 C-N-CA 123.546 2.831 . . . . 0.0 112.689 -170.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 5.1 mtpt -86.25 -45.22 11.48 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 121.465 0.65 . . . . 0.0 109.714 -177.185 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 267' ' ' TRP . . . . . 0.795 ' HE3' ' HA ' ' A' ' 261' ' ' LEU . 14.3 m0 -75.97 -30.11 58.5 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.757 -173.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 29.5 t -65.9 -18.81 65.59 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.958 0.409 . . . . 0.0 110.749 178.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 269' ' ' LYS . . . . . 0.408 ' C ' ' HD2' ' A' ' 270' ' ' ARG . 96.8 mttt -77.3 -8.38 57.54 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 121.139 0.495 . . . . 0.0 110.206 176.542 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 270' ' ' ARG . . . . . 0.842 ' HG2' HD23 ' A' ' 213' ' ' LEU . 3.6 mpt_? -111.11 141.51 44.51 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 178.061 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 31.9 mmm180 -92.36 110.27 21.67 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 -176.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 272' ' ' ILE . . . . . 0.803 HG21 HD23 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -121.46 142.41 37.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.534 0.683 . . . . 0.0 111.571 -178.259 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -151.76 169.31 22.51 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.679 173.099 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -62.18 127.87 33.4 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 123.117 0.261 . . . . 0.0 110.301 175.221 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -59.65 153.42 33.06 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.936 -0.649 . . . . 0.0 111.743 176.546 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 8.2 mtp180 -85.71 130.71 34.49 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.17 0.509 . . . . 0.0 110.132 -176.095 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -159.68 152.35 21.43 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.987 -171.357 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 278' ' ' ARG . . . . . 0.565 ' HG3' ' O ' ' A' ' 283' ' ' LEU . 22.8 mmt180 -78.79 0.3 27.51 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -172.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 279' ' ' CYS . . . . . . . . . . . . . 86.1 m 64.98 26.24 12.72 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.808 0.813 . . . . 0.0 109.257 -175.745 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -167.89 123.56 1.04 Allowed 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 114.423 -1.262 . . . . 0.0 109.469 -176.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 6.1 p -82.93 80.16 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 122.254 1.026 . . . . 0.0 110.653 -178.597 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -155.64 -96.24 0.12 Allowed Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.759 177.524 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 283' ' ' LEU . . . . . 0.565 ' O ' ' HG3' ' A' ' 278' ' ' ARG . 4.5 mm? -79.37 94.33 5.49 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.852 0.358 . . . . 0.0 110.518 177.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.514 -0.755 . . . . 0.0 109.746 178.523 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 . . . . . 0 N--CA 1.481 1.113 0 CA-C-O 120.658 0.265 . . . . 0.0 110.472 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 45.0 m -78.35 103.85 8.56 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.963 0.411 . . . . 0.0 110.454 178.219 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -108.46 150.87 26.82 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.425 178.386 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 7.0 m -76.59 113.17 13.92 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.312 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 44.4 t-20 -60.55 113.32 2.37 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.327 0.584 . . . . 0.0 110.037 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 193' ' ' SER . . . . . 0.9 ' HA ' ' HB2' ' A' ' 262' ' ' PRO . 6.6 m -105.52 13.7 29.68 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.678 -175.342 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 29.1 m -98.98 106.64 18.92 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.342 0.591 . . . . 0.0 111.238 -177.675 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -124.9 68.13 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.574 176.513 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.472 ' HG ' HG22 ' A' ' 199' ' ' VAL . 25.5 tp 60.8 14.72 5.34 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.635 0.731 . . . . 0.0 109.639 -174.148 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 9.2 mp 59.42 21.28 9.65 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.889 -174.216 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.494 ' HB1' ' CE2' ' A' ' 274' ' ' TYR . . . 57.03 27.64 13.62 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.921 177.375 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.472 HG22 ' HG ' ' A' ' 196' ' ' LEU . 33.2 m -79.27 -6.47 9.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.691 0.281 . . . . 0.0 111.631 -177.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -80.99 70.02 7.72 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.67 0.748 . . . . 0.0 110.126 176.55 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -144.26 130.96 20.13 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.89 -176.256 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 23.3 t -119.28 25.11 10.34 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 176.301 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 96.81 65.24 0.92 Allowed Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 110.429 -1.069 . . . . 0.0 110.429 -173.042 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 204' ' ' ALA . . . . . 0.662 ' HB1' ' HB2' ' A' ' 207' ' ' ASN . . . -99.2 102.13 13.68 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 120.92 0.391 . . . . 0.0 111.508 -172.565 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 205' ' ' CYS . . . . . 0.523 ' HB3' HG12 ' A' ' 251' ' ' ILE . 25.5 p -93.0 146.66 23.45 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 173.437 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 206' ' ' ARG . . . . . 0.832 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 59.6 mtm180 58.06 1.41 0.15 Allowed 'General case' 0 C--O 1.222 -0.383 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -179.53 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 207' ' ' ASN . . . . . 0.662 ' HB2' ' HB1' ' A' ' 204' ' ' ALA . 95.1 m-20 -100.08 104.66 16.24 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 119.743 -0.783 . . . . 0.0 111.213 -172.523 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 67.8 t -137.45 123.73 27.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.134 176.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 209' ' ' PHE . . . . . 0.43 ' HE1' ' HB ' ' A' ' 243' ' ' ILE . 4.2 t80 -121.38 125.41 46.89 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 120.752 0.311 . . . . 0.0 110.251 -177.756 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.484 HD22 HD21 ' A' ' 213' ' ' LEU . 4.6 mp -108.28 126.09 52.43 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.39 177.427 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 211' ' ' GLY . . . . . 0.628 ' HA2' HG22 ' A' ' 243' ' ' ILE . . . -129.76 57.52 0.72 Allowed Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.304 -0.951 . . . . 0.0 113.343 -178.519 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 212' ' ' ASN . . . . . 0.542 ' HB3' ' HA ' ' A' ' 270' ' ' ARG . 2.1 t30 178.19 45.12 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.045 0.45 . . . . 0.0 111.027 178.166 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.484 HD21 HD22 ' A' ' 210' ' ' LEU . 0.7 OUTLIER -92.94 160.99 32.72 Favored Pre-proline 0 C--N 1.317 -0.814 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 176.971 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.444 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 87.9 Cg_endo -80.17 165.23 21.58 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.527 2.151 . . . . 0.0 111.188 176.06 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 215' ' ' ASN . . . . . 0.519 ' HA ' ' OG1' ' A' ' 239' ' ' THR . 28.2 t-20 -78.72 128.19 33.09 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 106.6 -2.98 36.57 Favored Glycine 0 C--N 1.315 -0.622 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.589 -178.076 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 217' ' ' ILE . . . . . 0.73 HG23 HG21 ' A' ' 237' ' ' ILE . 4.5 tp -64.71 127.99 26.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.224 0.535 . . . . 0.0 110.71 177.532 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 14.1 t -113.92 155.75 25.24 Favored 'General case' 0 C--O 1.24 0.602 0 CA-C-O 121.328 0.585 . . . . 0.0 111.075 -178.553 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.428 ' H ' ' CD ' ' A' ' 219' ' ' GLU . 1.5 mp0 -61.25 -37.26 82.44 Favored 'General case' 0 C--O 1.209 -1.055 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.365 -177.152 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -51.71 -36.0 45.15 Favored 'General case' 0 C--N 1.321 -0.632 0 O-C-N 123.464 0.478 . . . . 0.0 111.064 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -73.58 -55.56 6.15 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.316 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.584 HD12 HD11 ' A' ' 237' ' ' ILE . 11.1 mt -60.17 -43.66 93.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.63 -179.528 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 223' ' ' ARG . . . . . 0.673 ' HG3' HD12 ' A' ' 235' ' ' ILE . 51.2 mtp180 -52.19 -63.11 1.25 Allowed 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 175.689 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -60.13 -19.46 53.69 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.077 -177.499 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 225' ' ' ASP . . . . . 0.478 ' HB3' ' CZ2' ' A' ' 267' ' ' TRP . 19.6 m-20 -87.32 -33.18 19.3 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.569 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.787 HD23 ' HZ ' ' A' ' 248' ' ' PHE . 8.2 mp -106.73 -18.25 14.0 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -170.625 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 227' ' ' GLU . . . . . 0.676 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 40.6 mt-10 -71.16 -24.41 0.72 Allowed Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -175.628 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 228' ' ' PRO . . . . . 0.676 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 74.7 Cg_endo -67.73 -26.76 38.69 Favored 'Trans proline' 0 C--N 1.36 1.184 0 C-N-CA 121.286 1.324 . . . . 0.0 112.05 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 229' ' ' PHE . . . . . 0.527 ' CZ ' ' HA ' ' A' ' 226' ' ' LEU . 3.6 p90 -110.55 -12.82 14.32 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.674 174.217 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 230' ' ' GLY . . . . . 0.448 ' HA2' ' HB1' ' A' ' 253' ' ' ALA . . . -165.01 96.06 0.13 Allowed Glycine 0 N--CA 1.441 -1.021 0 C-N-CA 120.319 -0.943 . . . . 0.0 111.939 -175.13 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.4 ' HD2' ' HA2' ' A' ' 230' ' ' GLY . 18.9 Cg_endo -63.36 130.55 28.85 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.157 1.905 . . . . 0.0 111.423 178.519 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.934 HG21 HG12 ' A' ' 246' ' ' VAL . 2.1 mp -109.8 146.3 15.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.387 178.791 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 233' ' ' ASP . . . . . 0.541 ' OD2' HD22 ' A' ' 249' ' ' LEU . 7.7 m-20 -109.92 -22.43 11.86 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.909 0.385 . . . . 0.0 110.755 177.282 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 234' ' ' GLN . . . . . 0.617 ' HB3' ' HB2' ' A' ' 247' ' ' HIS . 30.9 tt0 -135.23 119.5 17.78 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.404 -176.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.673 HD12 ' HG3' ' A' ' 223' ' ' ARG . 15.2 mt -136.96 106.57 4.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.852 -179.636 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -112.46 108.55 17.73 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.37 -179.05 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 237' ' ' ILE . . . . . 0.73 HG21 HG23 ' A' ' 217' ' ' ILE . 66.3 mt -99.99 117.77 45.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.548 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.607 ' HB ' HG13 ' A' ' 243' ' ' ILE . 45.2 t -100.1 87.44 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 172.523 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 239' ' ' THR . . . . . 0.519 ' OG1' ' HA ' ' A' ' 215' ' ' ASN . 14.0 t -64.77 -20.68 66.5 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.647 -175.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -67.74 -28.32 67.54 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.896 178.168 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 241' ' ' ARG . . . . . 0.578 ' HB2' HG12 ' A' ' 243' ' ' ILE . 81.9 mtt180 -120.13 5.12 10.82 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.653 -176.609 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 18.2 m120 66.12 24.75 10.86 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.33 175.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.628 HG22 ' HA2' ' A' ' 211' ' ' GLY . 1.6 pt -122.01 149.45 25.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.51 -173.827 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 244' ' ' ALA . . . . . 0.45 ' HB3' ' HB2' ' A' ' 210' ' ' LEU . . . -141.58 135.31 29.93 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.187 179.648 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 245' ' ' PHE . . . . . 0.406 ' HE2' ' HB3' ' A' ' 279' ' ' CYS . 25.7 m-85 -107.06 112.87 26.0 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.579 177.732 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.934 HG12 HG21 ' A' ' 232' ' ' ILE . 0.1 OUTLIER -112.5 128.81 68.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.876 -176.944 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 247' ' ' HIS . . . . . 0.832 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 27.4 m170 -109.57 104.04 13.01 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.362 0.601 . . . . 0.0 111.313 178.398 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 248' ' ' PHE . . . . . 0.787 ' HZ ' HD23 ' A' ' 226' ' ' LEU . 30.4 m-85 -86.49 99.99 12.06 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.669 178.473 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.541 HD22 ' OD2' ' A' ' 233' ' ' ASP . 0.0 OUTLIER -37.37 -49.3 0.98 Allowed 'General case' 0 N--CA 1.469 0.511 0 O-C-N 124.654 1.221 . . . . 0.0 113.334 -176.131 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -90.95 139.48 30.72 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.109 177.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 251' ' ' ILE . . . . . 0.527 ' O ' HG13 ' A' ' 255' ' ' ILE . 0.2 OUTLIER -59.55 -41.35 84.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.047 -176.795 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -71.99 -30.88 65.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.981 -175.687 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 253' ' ' ALA . . . . . 0.448 ' HB1' ' HA2' ' A' ' 230' ' ' GLY . . . -59.33 -39.58 83.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.391 178.06 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 254' ' ' ALA . . . . . 0.621 ' HB2' ' HB2' ' A' ' 248' ' ' PHE . . . -69.19 -41.91 76.53 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.693 178.229 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.527 HG13 ' O ' ' A' ' 251' ' ' ILE . 8.4 mt -56.97 -60.85 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.247 -177.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 256' ' ' LYS . . . . . 0.488 ' O ' ' HG2' ' A' ' 260' ' ' GLU . 10.8 ptmt -61.17 -38.5 86.7 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.339 -177.196 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -61.95 -48.53 80.0 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.625 0.25 . . . . 0.0 111.344 178.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 258' ' ' VAL . . . . . 0.519 HG13 HG12 ' A' ' 272' ' ' ILE . 55.3 t -68.37 -24.02 29.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.878 0.371 . . . . 0.0 111.057 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -84.52 -23.78 29.63 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 177.207 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 260' ' ' GLU . . . . . 0.488 ' HG2' ' O ' ' A' ' 256' ' ' LYS . 68.7 mm-40 -95.83 -31.68 13.04 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.679 0.276 . . . . 0.0 110.972 -176.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.755 ' HA ' ' HE3' ' A' ' 267' ' ' TRP . 0.7 OUTLIER -52.46 -49.13 87.29 Favored Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.689 179.849 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 262' ' ' PRO . . . . . 0.9 ' HB2' ' HA ' ' A' ' 193' ' ' SER . 48.6 Cg_endo -67.75 -15.7 44.81 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.352 2.035 . . . . 0.0 112.81 -178.434 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 56.4 mt -87.45 -8.66 56.23 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.499 0.666 . . . . 0.0 111.072 -178.242 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 -106.77 149.64 38.7 Favored Pre-proline 0 C--N 1.311 -1.065 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.133 -171.698 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -65.36 -39.44 22.44 Favored 'Trans proline' 0 C--O 1.231 0.137 0 C-N-CA 123.424 2.749 . . . . 0.0 112.768 -168.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 10.1 mtpt -86.33 -44.42 12.1 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.385 0.612 . . . . 0.0 109.615 -176.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 267' ' ' TRP . . . . . 0.755 ' HE3' ' HA ' ' A' ' 261' ' ' LEU . 17.7 m0 -70.98 -32.34 69.16 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.008 -0.997 . . . . 0.0 110.869 -175.414 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 22.7 t -64.19 -24.26 67.61 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.739 0.305 . . . . 0.0 110.799 179.276 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -71.02 -15.6 62.57 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.239 0.543 . . . . 0.0 110.124 177.63 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 270' ' ' ARG . . . . . 0.542 ' HA ' ' HB3' ' A' ' 212' ' ' ASN . 1.6 mpt_? -93.84 156.03 16.87 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.13 174.17 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 6.1 mmp_? -103.82 105.54 15.78 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 173.383 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 272' ' ' ILE . . . . . 0.714 HG21 HD23 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -113.45 138.25 43.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.303 0.573 . . . . 0.0 110.667 -176.571 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -152.85 167.77 27.98 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.149 175.624 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 274' ' ' TYR . . . . . 0.512 ' OH ' ' HA ' ' A' ' 255' ' ' ILE . 80.6 m-85 -65.42 122.46 17.22 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.537 173.674 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -59.02 130.93 51.7 Favored Glycine 0 N--CA 1.441 -0.97 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.391 176.516 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 276' ' ' ARG . . . . . 0.431 HH11 ' HD2' ' A' ' 276' ' ' ARG . 0.0 OUTLIER -95.06 146.51 24.23 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 177.986 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 277' ' ' ASP . . . . . 0.411 ' CG ' ' H ' ' A' ' 278' ' ' ARG . 23.2 t70 60.66 -168.48 0.17 Allowed 'General case' 0 CA--C 1.538 0.503 0 O-C-N 123.761 0.663 . . . . 0.0 109.302 -176.277 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 278' ' ' ARG . . . . . 0.411 ' H ' ' CG ' ' A' ' 277' ' ' ASP . 0.0 OUTLIER -88.63 11.05 18.47 Favored 'General case' 0 C--N 1.321 -0.64 0 O-C-N 121.656 -0.653 . . . . 0.0 110.579 179.4 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 279' ' ' CYS . . . . . 0.406 ' HB3' ' HE2' ' A' ' 245' ' ' PHE . 77.1 m 57.61 69.1 0.77 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.704 -1.135 . . . . 0.0 110.667 178.536 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 280' ' ' ALA . . . . . 0.659 ' HB1' ' HB2' ' A' ' 283' ' ' LEU . . . -153.19 127.05 8.9 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.395 -176.171 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 3.4 p -112.66 89.16 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-O 122.032 0.92 . . . . 0.0 109.479 177.383 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 110.38 -68.42 0.22 Allowed Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.081 -176.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 283' ' ' LEU . . . . . 0.659 ' HB2' ' HB1' ' A' ' 280' ' ' ALA . 0.4 OUTLIER 42.4 78.5 0.05 OUTLIER 'General case' 0 C--O 1.234 0.284 0 C-N-CA 123.863 0.865 . . . . 0.0 111.943 177.829 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 19.3 pttp . . . . . 0 C--O 1.249 1.049 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.157 179.884 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 . . . . . 0 N--CA 1.479 0.987 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 9.9 m -102.63 -10.87 18.88 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.759 -178.059 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -77.15 -41.06 43.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.296 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 47.8 m -80.58 160.57 25.09 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.333 177.171 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -86.35 119.86 27.08 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.157 179.484 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 15.8 m -113.52 90.83 3.45 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.063 0.459 . . . . 0.0 109.926 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 194' ' ' SER . . . . . 0.568 ' O ' HD22 ' A' ' 196' ' ' LEU . 23.3 t -176.18 -150.98 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -177.016 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 5.2 m -79.81 81.32 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.157 0.503 . . . . 0.0 111.41 177.496 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.581 ' O ' HG22 ' A' ' 199' ' ' VAL . 2.0 mm? -59.79 98.32 0.05 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.054 179.308 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 90.4 mt 53.46 26.84 5.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.093 0.473 . . . . 0.0 110.168 -176.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . 63.17 29.32 16.07 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.055 -0.975 . . . . 0.0 112.389 -178.011 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.581 HG22 ' O ' ' A' ' 196' ' ' LEU . 20.6 m -84.4 -23.45 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.772 174.806 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 200' ' ' GLN . . . . . 0.469 ' HG2' HG23 ' A' ' 199' ' ' VAL . 17.0 mm-40 -104.01 78.86 1.57 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.408 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -172.91 156.7 3.43 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.642 177.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 37.3 m -151.25 19.74 0.75 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.837 0.351 . . . . 0.0 111.078 -179.198 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 79.18 33.42 36.06 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.671 -0.776 . . . . 0.0 111.358 -177.73 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -71.13 114.46 9.21 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.54 -0.33 . . . . 0.0 111.099 -176.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 205' ' ' CYS . . . . . 0.8 ' HB3' HG12 ' A' ' 251' ' ' ILE . 16.6 p -89.34 146.81 24.44 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 176.22 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 206' ' ' ARG . . . . . 0.839 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 44.0 mtp180 60.26 -10.7 0.05 OUTLIER 'General case' 0 C--O 1.219 -0.505 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 177.778 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -97.5 106.34 18.64 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 119.246 0.93 . . . . 0.0 112.146 -169.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.505 ' HB ' ' HB ' ' A' ' 246' ' ' VAL . 57.3 t -137.28 121.21 22.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.076 -0.966 . . . . 0.0 109.819 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 209' ' ' PHE . . . . . 0.43 ' O ' ' HA ' ' A' ' 272' ' ' ILE . 10.5 t80 -114.57 126.81 55.34 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.743 0.306 . . . . 0.0 110.906 -178.244 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.738 ' HG ' HG22 ' A' ' 272' ' ' ILE . 4.8 mp -110.3 128.07 55.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.372 175.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 211' ' ' GLY . . . . . 0.596 ' HA2' HG22 ' A' ' 243' ' ' ILE . . . -137.82 66.32 0.54 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.383 -0.913 . . . . 0.0 113.046 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 212' ' ' ASN . . . . . 0.59 ' HB3' ' HA ' ' A' ' 270' ' ' ARG . 3.4 t30 177.58 43.07 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.332 0.586 . . . . 0.0 110.004 176.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.688 HD23 ' HG2' ' A' ' 270' ' ' ARG . 1.1 mt -94.83 161.16 29.48 Favored Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.966 -179.474 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -83.05 167.9 13.9 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.458 2.105 . . . . 0.0 111.533 176.309 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 215' ' ' ASN . . . . . 0.484 ' HA ' ' OG1' ' A' ' 239' ' ' THR . 53.7 t30 -78.28 124.69 28.37 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.078 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 107.78 -4.38 34.32 Favored Glycine 0 C--N 1.314 -0.663 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.925 -177.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 217' ' ' ILE . . . . . 0.676 HG23 HG21 ' A' ' 237' ' ' ILE . 5.1 tp -60.75 126.74 19.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.05 0.453 . . . . 0.0 110.384 177.748 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 218' ' ' THR . . . . . 0.488 HG22 ' HG3' ' A' ' 221' ' ' GLU . 15.1 t -114.43 158.77 21.11 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.076 0.465 . . . . 0.0 111.077 -178.116 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.627 ' HB3' ' HD2' ' A' ' 223' ' ' ARG . 2.3 mp0 -57.88 -44.46 86.68 Favored 'General case' 0 C--O 1.205 -1.274 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.523 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -42.75 -39.69 2.54 Favored 'General case' 0 C--N 1.319 -0.728 0 O-C-N 123.959 0.787 . . . . 0.0 111.66 178.585 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 221' ' ' GLU . . . . . 0.488 ' HG3' HG22 ' A' ' 218' ' ' THR . 43.7 mt-10 -70.74 -60.54 2.19 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.876 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.644 HD12 HD11 ' A' ' 237' ' ' ILE . 10.8 mt -62.64 -41.6 92.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.665 -176.393 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 223' ' ' ARG . . . . . 0.854 ' HG3' HD12 ' A' ' 235' ' ' ILE . 46.3 mtt-85 -54.85 -62.28 1.76 Allowed 'General case' 0 CA--C 1.507 -0.678 0 CA-C-N 116.21 -0.45 . . . . 0.0 112.162 176.163 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -56.03 -25.23 43.89 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.47 -178.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 225' ' ' ASP . . . . . 0.466 ' HB3' ' CZ2' ' A' ' 267' ' ' TRP . 19.3 m-20 -83.22 -33.3 26.14 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.615 -176.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.808 HD23 ' HZ ' ' A' ' 248' ' ' PHE . 7.2 mp -106.72 -12.16 15.61 Favored 'General case' 0 C--O 1.224 -0.242 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -171.769 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 227' ' ' GLU . . . . . 0.65 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 15.1 mm-40 -62.31 -37.23 34.81 Favored Pre-proline 0 C--N 1.327 -0.387 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.211 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 228' ' ' PRO . . . . . 0.65 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 71.7 Cg_endo -65.33 -30.3 53.93 Favored 'Trans proline' 0 C--N 1.358 1.046 0 C-N-CA 121.569 1.513 . . . . 0.0 112.248 -172.567 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 229' ' ' PHE . . . . . 0.512 ' CE1' ' HA ' ' A' ' 226' ' ' LEU . 3.5 p90 -110.53 -6.69 14.84 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.935 177.767 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 230' ' ' GLY . . . . . 0.493 ' CA ' ' HB1' ' A' ' 253' ' ' ALA . . . -170.2 96.19 0.11 Allowed Glycine 0 N--CA 1.441 -1.006 0 C-N-CA 119.849 -1.167 . . . . 0.0 112.395 -176.139 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.458 ' HA ' ' OE2' ' A' ' 227' ' ' GLU . 17.9 Cg_endo -63.21 129.76 26.59 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 121.704 1.603 . . . . 0.0 111.41 178.557 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.586 HG21 HG12 ' A' ' 246' ' ' VAL . 2.3 mp -107.38 151.99 9.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.644 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 233' ' ' ASP . . . . . 0.423 ' CG ' HD22 ' A' ' 249' ' ' LEU . 26.2 m-20 -114.51 -21.77 10.15 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.645 177.823 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 234' ' ' GLN . . . . . 0.458 ' H ' HG22 ' A' ' 232' ' ' ILE . 21.5 tt0 -141.19 120.42 12.99 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.648 -178.011 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.854 HD12 ' HG3' ' A' ' 223' ' ' ARG . 6.1 mt -134.61 106.23 7.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.311 177.292 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.423 ' O ' ' HA ' ' A' ' 244' ' ' ALA . 35.0 ttmt -106.58 107.46 18.48 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.981 -177.314 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 237' ' ' ILE . . . . . 0.676 HG21 HG23 ' A' ' 217' ' ' ILE . 87.9 mt -100.62 114.31 39.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-O 121.267 0.556 . . . . 0.0 110.52 -179.394 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.532 ' HB ' HG13 ' A' ' 243' ' ' ILE . 45.9 t -100.52 85.87 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 173.5 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 239' ' ' THR . . . . . 0.484 ' OG1' ' HA ' ' A' ' 215' ' ' ASN . 12.3 t -71.75 -13.04 61.59 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.075 -176.079 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -57.37 -41.83 80.95 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.804 170.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 241' ' ' ARG . . . . . 0.537 ' HB2' HG12 ' A' ' 243' ' ' ILE . 75.3 mtt180 -116.06 8.79 14.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.126 -177.271 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 68.7 25.9 6.3 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.298 174.023 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.596 HG22 ' HA2' ' A' ' 211' ' ' GLY . 2.1 pt -122.23 151.14 25.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.33 -173.841 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 244' ' ' ALA . . . . . 0.47 ' HB3' ' HB2' ' A' ' 210' ' ' LEU . . . -141.52 135.61 30.35 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.977 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -108.8 115.08 29.4 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.688 177.39 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.586 HG12 HG21 ' A' ' 232' ' ' ILE . 1.5 t -108.71 141.02 25.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.612 -176.582 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 247' ' ' HIS . . . . . 0.839 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 11.5 m80 -122.39 101.94 7.8 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.584 0.707 . . . . 0.0 111.668 174.787 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 248' ' ' PHE . . . . . 0.808 ' HZ ' HD23 ' A' ' 226' ' ' LEU . 33.2 m-85 -84.87 101.95 12.7 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 114.581 -1.19 . . . . 0.0 110.896 178.739 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.485 HD23 ' H ' ' A' ' 249' ' ' LEU . 0.1 OUTLIER -43.62 -39.37 3.5 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 124.344 1.028 . . . . 0.0 112.882 -175.92 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 250' ' ' ASN . . . . . 0.413 ' HB2' ' HB2' ' A' ' 253' ' ' ALA . 37.5 m-20 -93.73 140.17 29.96 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.128 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 251' ' ' ILE . . . . . 0.8 HG12 ' HB3' ' A' ' 205' ' ' CYS . 0.2 OUTLIER -63.4 -43.95 98.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -178.75 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 252' ' ' ALA . . . . . 0.41 ' O ' ' HG2' ' A' ' 256' ' ' LYS . . . -70.16 -30.72 67.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.647 0.26 . . . . 0.0 110.617 -177.303 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 253' ' ' ALA . . . . . 0.493 ' HB1' ' CA ' ' A' ' 230' ' ' GLY . . . -58.14 -44.12 87.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.261 178.487 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 254' ' ' ALA . . . . . 0.573 ' HB2' ' HB2' ' A' ' 248' ' ' PHE . . . -68.56 -39.58 81.0 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.566 178.738 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.699 ' HA ' ' OH ' ' A' ' 274' ' ' TYR . 3.5 mt -57.37 -60.89 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.513 -179.219 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 256' ' ' LYS . . . . . 0.417 ' O ' ' HG2' ' A' ' 260' ' ' GLU . 13.2 ptmt -62.92 -38.67 91.9 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.184 -176.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -61.96 -49.95 74.08 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.514 0.19 . . . . 0.0 111.514 179.601 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 258' ' ' VAL . . . . . 0.508 HG13 HG12 ' A' ' 272' ' ' ILE . 53.0 t -64.21 -27.19 42.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.1 0.476 . . . . 0.0 110.998 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -84.53 -21.25 30.58 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 178.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 260' ' ' GLU . . . . . 0.417 ' HG2' ' O ' ' A' ' 256' ' ' LYS . 67.1 mm-40 -94.81 -33.27 12.93 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 122.677 0.391 . . . . 0.0 110.989 -177.742 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.876 HD23 HG21 ' A' ' 272' ' ' ILE . 0.7 OUTLIER -51.84 -50.67 76.58 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.666 -178.915 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 262' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 261' ' ' LEU . 37.1 Cg_endo -66.76 -17.12 51.99 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.442 2.094 . . . . 0.0 112.807 -178.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 54.0 mt -90.27 -5.82 55.88 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.138 0.494 . . . . 0.0 111.624 -177.701 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 264' ' ' ASN . . . . . 0.417 ' HB2' ' CE3' ' A' ' 267' ' ' TRP . 17.1 m-80 -107.13 149.73 39.0 Favored Pre-proline 0 C--N 1.315 -0.922 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.507 -174.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -65.51 -37.57 29.15 Favored 'Trans proline' 0 N--CA 1.465 -0.16 0 C-N-CA 123.432 2.754 . . . . 0.0 112.825 -171.088 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.435 ' HE3' ' HB2' ' A' ' 266' ' ' LYS . 0.0 OUTLIER -82.8 -44.77 15.14 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 121.736 0.779 . . . . 0.0 109.251 -177.139 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 267' ' ' TRP . . . . . 0.758 ' HE3' ' HA ' ' A' ' 261' ' ' LEU . 10.4 m0 -77.29 -29.39 53.72 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.581 -1.19 . . . . 0.0 111.115 -172.547 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 19.4 t -66.4 -17.56 64.85 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.976 0.417 . . . . 0.0 110.406 178.012 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -78.02 -8.08 57.72 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.237 0.542 . . . . 0.0 110.182 176.356 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 270' ' ' ARG . . . . . 0.688 ' HG2' HD23 ' A' ' 213' ' ' LEU . 3.6 mpt_? -108.97 165.02 11.89 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.816 177.596 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -111.59 119.12 37.63 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 177.585 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 272' ' ' ILE . . . . . 0.876 HG21 HD23 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -128.97 143.25 41.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.139 0.495 . . . . 0.0 111.476 -179.276 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -151.69 169.5 22.01 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.942 170.414 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 274' ' ' TYR . . . . . 0.699 ' OH ' ' HA ' ' A' ' 255' ' ' ILE . 69.9 m-85 -67.54 117.53 9.61 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 172.298 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -165.95 160.27 33.7 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 119.921 -1.133 . . . . 0.0 113.077 -173.743 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 276' ' ' ARG . . . . . 0.451 ' HD3' ' N ' ' A' ' 276' ' ' ARG . 0.0 OUTLIER -138.83 -151.99 0.4 Allowed 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 -179.803 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 277' ' ' ASP . . . . . 0.434 ' C ' ' H ' ' A' ' 279' ' ' CYS . 20.8 t70 -50.85 143.41 10.04 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.717 0.294 . . . . 0.0 110.711 172.599 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 278' ' ' ARG . . . . . 0.473 ' HD2' ' H ' ' A' ' 278' ' ' ARG . 0.3 OUTLIER -74.16 27.27 0.08 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -177.302 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 279' ' ' CYS . . . . . 0.434 ' H ' ' C ' ' A' ' 277' ' ' ASP . 79.7 m 58.07 47.25 14.96 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.643 0.735 . . . . 0.0 109.304 -176.786 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 280' ' ' ALA . . . . . 0.435 ' HB2' ' HD3' ' A' ' 278' ' ' ARG . . . -73.55 92.29 1.9 Allowed 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 114.711 -1.132 . . . . 0.0 110.951 -175.148 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 7.2 p -149.69 7.93 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.952 178.099 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -82.38 88.69 1.45 Allowed Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.322 -176.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 283' ' ' LEU . . . . . 0.436 HD23 ' C ' ' A' ' 283' ' ' LEU . 8.9 tt -64.72 122.19 16.3 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 175.338 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 63.7 tttp . . . . . 0 C--O 1.248 1.02 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -179.913 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 8.2 t30 . . . . . 0 N--CA 1.48 1.031 0 N-CA-C 109.946 -0.391 . . . . 0.0 109.946 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 36.1 t -114.58 152.34 31.97 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.65 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.27 109.11 2.12 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.816 0.341 . . . . 0.0 110.082 178.034 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 33.3 t -145.56 164.22 32.35 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.015 -175.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 55.2 m-80 -109.23 94.78 5.22 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.044 0.45 . . . . 0.0 110.333 178.178 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 49.2 m -93.09 25.97 3.04 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.465 178.491 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 7.4 m -72.04 163.27 28.17 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.406 175.504 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 4.2 m -81.57 83.52 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.412 0.625 . . . . 0.0 111.378 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.591 ' O ' ' HG2' ' A' ' 200' ' ' GLN . 3.7 mm? -74.04 -20.79 60.19 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 176.681 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.631 HD23 ' HB2' ' A' ' 274' ' ' TYR . 25.0 tp -64.52 -22.67 67.03 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.61 177.722 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -78.11 -26.51 48.01 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.229 176.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.526 HG23 ' HA ' ' A' ' 196' ' ' LEU . 2.5 t -80.27 -20.86 11.74 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.662 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.649 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 200' ' ' GLN . . . . . 0.591 ' HG2' ' O ' ' A' ' 196' ' ' LEU . 13.5 mm100 -81.95 5.6 18.61 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.943 -174.398 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 59.02 23.22 11.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.391 -178.486 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 33.0 m -82.59 110.2 17.46 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 121.124 0.488 . . . . 0.0 109.896 177.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -82.65 72.22 2.86 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 121.019 -0.61 . . . . 0.0 111.588 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.95 101.62 1.14 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.085 0.469 . . . . 0.0 110.38 -179.263 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 205' ' ' CYS . . . . . 0.458 ' HA ' HG12 ' A' ' 251' ' ' ILE . 1.8 m -87.05 146.12 26.21 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -179.543 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 206' ' ' ARG . . . . . 0.79 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 19.0 mtm180 55.88 3.48 0.09 Allowed 'General case' 0 C--O 1.223 -0.33 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 179.048 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 207' ' ' ASN . . . . . 0.438 ' ND2' ' HB3' ' A' ' 277' ' ' ASP . 16.9 m-80 -105.93 105.64 15.77 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 118.816 0.734 . . . . 0.0 111.644 -172.677 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 61.5 t -134.36 109.16 11.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.035 176.665 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 209' ' ' PHE . . . . . 0.451 ' HE1' ' HB ' ' A' ' 243' ' ' ILE . 2.6 t80 -106.33 124.7 49.99 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.183 -175.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.565 ' HG ' HG22 ' A' ' 272' ' ' ILE . 6.1 mp -109.17 132.87 53.71 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.167 178.388 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 211' ' ' GLY . . . . . 0.676 ' HA2' HG22 ' A' ' 243' ' ' ILE . . . -138.05 60.7 0.59 Allowed Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.235 -0.983 . . . . 0.0 113.326 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 212' ' ' ASN . . . . . 0.536 ' HB3' ' HA ' ' A' ' 270' ' ' ARG . 2.5 t30 179.95 41.38 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.938 0.399 . . . . 0.0 110.67 177.103 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.464 HD21 HD22 ' A' ' 210' ' ' LEU . 1.4 mp -93.77 157.29 38.41 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.545 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.415 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 86.9 Cg_endo -77.72 169.87 20.06 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.764 2.31 . . . . 0.0 112.472 179.39 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 215' ' ' ASN . . . . . 0.589 ' HA ' ' OG1' ' A' ' 239' ' ' THR . 13.9 m120 -78.36 123.76 27.35 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.634 176.482 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 108.75 -8.75 34.36 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.358 -0.925 . . . . 0.0 112.865 179.306 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 217' ' ' ILE . . . . . 0.627 HG23 HG21 ' A' ' 237' ' ' ILE . 4.8 tp -58.99 128.69 20.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.889 0.345 . . . . 0.0 110.107 178.347 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 218' ' ' THR . . . . . 0.461 HG22 ' HG3' ' A' ' 221' ' ' GLU . 7.1 t -114.1 161.62 17.52 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.447 0.641 . . . . 0.0 111.235 -179.449 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.564 ' H ' ' CD ' ' A' ' 219' ' ' GLU . 1.6 mp0 -64.31 -40.4 95.84 Favored 'General case' 0 C--O 1.21 -0.99 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.849 -175.171 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 220' ' ' ASP . . . . . 0.529 ' O ' ' HG2' ' A' ' 224' ' ' GLU . 38.6 t70 -48.46 -41.44 29.54 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 123.803 0.689 . . . . 0.0 111.187 178.215 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 221' ' ' GLU . . . . . 0.461 ' HG3' HG22 ' A' ' 218' ' ' THR . 43.4 mt-10 -65.45 -56.81 10.43 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.332 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.51 HD12 HD11 ' A' ' 237' ' ' ILE . 7.5 mt -61.07 -39.92 83.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.668 -179.117 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 223' ' ' ARG . . . . . 0.856 ' HG3' HD12 ' A' ' 235' ' ' ILE . 26.0 mtp180 -55.83 -62.77 1.47 Allowed 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 175.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.529 ' HG2' ' O ' ' A' ' 220' ' ' ASP . 9.1 pt-20 -60.92 -18.03 54.41 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.958 -178.057 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 225' ' ' ASP . . . . . 0.501 ' HB3' ' CZ2' ' A' ' 267' ' ' TRP . 44.0 m-20 -88.11 -35.2 17.6 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.288 -179.059 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.707 HD23 ' HZ ' ' A' ' 248' ' ' PHE . 8.0 mp -107.05 -17.63 14.12 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -169.746 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 227' ' ' GLU . . . . . 0.676 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 41.4 mt-10 -68.81 -27.27 1.33 Allowed Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -176.477 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 228' ' ' PRO . . . . . 0.676 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 71.6 Cg_endo -66.61 -27.83 45.33 Favored 'Trans proline' 0 C--N 1.36 1.171 0 C-N-CA 121.319 1.346 . . . . 0.0 111.94 -178.308 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 229' ' ' PHE . . . . . 0.541 ' CZ ' ' HA ' ' A' ' 226' ' ' LEU . 3.7 p90 -110.82 -7.6 14.6 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-O 120.734 0.302 . . . . 0.0 111.631 174.822 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . -170.09 95.55 0.11 Allowed Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.373 -0.918 . . . . 0.0 111.957 -175.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -60.94 132.43 42.15 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.016 1.811 . . . . 0.0 111.578 178.342 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.72 HG21 HG12 ' A' ' 246' ' ' VAL . 2.6 mp -109.99 149.92 12.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.766 178.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 233' ' ' ASP . . . . . 0.468 ' OD2' HD22 ' A' ' 249' ' ' LEU . 15.3 m-20 -115.63 -14.73 11.45 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.412 179.034 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 234' ' ' GLN . . . . . 0.497 ' H ' HG22 ' A' ' 232' ' ' ILE . 29.7 tt0 -148.35 120.87 8.52 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.518 -179.293 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.856 HD12 ' HG3' ' A' ' 223' ' ' ARG . 17.1 mt -134.32 107.94 10.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.001 179.383 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -112.73 115.72 28.97 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.582 -177.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 237' ' ' ILE . . . . . 0.627 HG21 HG23 ' A' ' 217' ' ' ILE . 68.8 mt -104.74 121.88 57.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.932 -178.764 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 45.1 t -110.57 86.82 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 171.505 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 239' ' ' THR . . . . . 0.589 ' OG1' ' HA ' ' A' ' 215' ' ' ASN . 8.2 t -68.16 -19.89 64.83 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.405 -175.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -56.19 -37.57 69.79 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.359 174.341 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 241' ' ' ARG . . . . . 0.493 ' HB2' HG12 ' A' ' 243' ' ' ILE . 98.8 mtt180 -107.05 0.25 23.45 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.776 179.215 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 242' ' ' ASN . . . . . 0.439 ' O ' HD12 ' A' ' 213' ' ' LEU . 18.7 m120 65.63 29.12 11.06 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.472 -179.284 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.676 HG22 ' HA2' ' A' ' 211' ' ' GLY . 1.7 pp -122.22 157.24 26.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.604 -174.255 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -149.13 141.05 23.73 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.034 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -109.81 113.77 26.78 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.851 177.503 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.72 HG12 HG21 ' A' ' 232' ' ' ILE . 0.2 OUTLIER -107.47 126.33 63.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.434 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 247' ' ' HIS . . . . . 0.79 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 51.8 m170 -105.83 102.6 12.03 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.183 -0.607 . . . . 0.0 111.244 179.699 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 248' ' ' PHE . . . . . 0.707 ' HZ ' HD23 ' A' ' 226' ' ' LEU . 34.6 m-85 -87.38 102.37 14.47 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.887 -1.051 . . . . 0.0 111.274 178.581 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.508 HD23 ' H ' ' A' ' 249' ' ' LEU . 0.0 OUTLIER -40.94 -47.21 2.96 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 124.512 1.132 . . . . 0.0 113.382 -174.881 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -93.84 144.68 25.21 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.252 177.368 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 251' ' ' ILE . . . . . 0.596 ' O ' HG13 ' A' ' 255' ' ' ILE . 0.2 OUTLIER -61.33 -41.82 91.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.328 -177.167 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -71.34 -30.39 66.13 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 120.58 0.228 . . . . 0.0 110.952 -175.597 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -57.27 -41.59 79.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.208 177.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 254' ' ' ALA . . . . . 0.546 ' HB2' ' HB2' ' A' ' 248' ' ' PHE . . . -69.77 -40.64 75.96 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.594 178.85 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.596 HG13 ' O ' ' A' ' 251' ' ' ILE . 12.8 mt -57.38 -60.85 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.249 -178.367 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 10.6 ptmt -61.77 -38.12 86.84 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.552 -176.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -62.98 -49.38 74.91 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 111.556 0.206 . . . . 0.0 111.556 178.393 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 258' ' ' VAL . . . . . 0.436 HG13 HG12 ' A' ' 272' ' ' ILE . 52.3 t -65.21 -23.47 33.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.985 0.421 . . . . 0.0 110.86 179.251 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -83.75 -25.91 30.14 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 177.484 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -94.27 -33.09 13.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.842 0.353 . . . . 0.0 111.069 -175.25 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.706 HD12 ' CE3' ' A' ' 267' ' ' TRP . 0.7 OUTLIER -52.15 -49.63 83.51 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.483 -179.703 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 262' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 261' ' ' LEU . 50.6 Cg_endo -68.63 -14.18 38.85 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.486 2.124 . . . . 0.0 112.863 -178.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 60.1 mt -91.19 -6.22 53.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.476 0.655 . . . . 0.0 111.207 -179.159 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -106.64 149.13 38.02 Favored Pre-proline 0 C--N 1.315 -0.93 0 CA-C-N 115.346 -0.843 . . . . 0.0 112.272 -174.015 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -66.46 -36.92 24.77 Favored 'Trans proline' 0 CA--C 1.527 0.136 0 C-N-CA 123.429 2.753 . . . . 0.0 112.919 -171.187 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -86.07 -44.28 12.41 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-O 121.579 0.704 . . . . 0.0 109.935 -178.27 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 267' ' ' TRP . . . . . 0.706 ' CE3' HD12 ' A' ' 261' ' ' LEU . 15.9 m0 -74.54 -27.97 60.75 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.873 -174.503 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 33.1 t -67.8 -18.11 64.74 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.889 0.376 . . . . 0.0 110.679 176.201 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -71.34 -19.3 62.32 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.394 0.616 . . . . 0.0 109.571 175.545 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 270' ' ' ARG . . . . . 0.536 ' HA ' ' HB3' ' A' ' 212' ' ' ASN . 5.0 mpt_? -95.09 156.11 16.45 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.537 177.484 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 271' ' ' ARG . . . . . 0.431 ' NE ' ' HA ' ' A' ' 271' ' ' ARG . 4.9 mmp_? -105.48 106.3 16.74 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 172.452 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 272' ' ' ILE . . . . . 0.667 HG21 HD23 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -115.62 138.42 46.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.401 0.619 . . . . 0.0 111.155 -175.407 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -151.6 169.11 22.92 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.857 174.244 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 274' ' ' TYR . . . . . 0.631 ' HB2' HD23 ' A' ' 197' ' ' LEU . 77.8 m-85 -65.21 126.95 29.74 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.862 0.363 . . . . 0.0 110.496 175.705 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -72.65 148.05 41.21 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 177.397 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 276' ' ' ARG . . . . . 0.423 HH11 ' HD3' ' A' ' 276' ' ' ARG . 10.2 ptt180 -72.12 111.31 7.23 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.709 0.766 . . . . 0.0 111.311 -178.566 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 277' ' ' ASP . . . . . 0.501 ' O ' ' HB2' ' A' ' 278' ' ' ARG . 24.3 t70 175.59 147.22 0.09 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 113.874 -1.512 . . . . 0.0 108.123 -178.131 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 278' ' ' ARG . . . . . 0.501 ' HB2' ' O ' ' A' ' 277' ' ' ASP . 23.4 mmm180 66.64 4.5 3.4 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 121.476 0.655 . . . . 0.0 109.786 -168.041 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 279' ' ' CYS . . . . . 0.403 ' H ' ' C ' ' A' ' 277' ' ' ASP . 58.2 m -84.86 -11.48 55.56 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.235 175.776 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -123.0 127.53 48.94 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 114.485 -1.234 . . . . 0.0 108.708 177.219 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 27.2 m -68.48 -22.7 27.35 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.408 -178.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 176.94 79.24 0.05 OUTLIER Glycine 0 N--CA 1.434 -1.48 0 C-N-CA 120.413 -0.899 . . . . 0.0 112.345 -178.105 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 30.9 tp -135.91 101.65 4.81 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.051 0.453 . . . . 0.0 110.652 179.1 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 284' ' ' LYS . . . . . 0.429 ' HD3' ' N ' ' A' ' 284' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.972 0 CA-C-O 118.446 -0.787 . . . . 0.0 109.91 178.795 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 46.1 t30 . . . . . 0 N--CA 1.479 1.007 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 20.7 m -74.1 -42.88 59.43 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.793 0.33 . . . . 0.0 110.602 -178.272 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -98.11 83.71 3.15 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.985 0.422 . . . . 0.0 110.13 178.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 24.6 m -76.74 -53.59 7.76 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.808 -179.554 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -156.73 128.54 7.22 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.58 177.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.8 p -103.64 116.89 33.18 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.324 176.415 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 33.5 t 67.45 -81.4 0.03 OUTLIER 'General case' 0 C--O 1.232 0.174 0 O-C-N 123.606 0.566 . . . . 0.0 109.895 -173.551 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -134.25 135.43 54.36 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.196 175.393 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.46 ' O ' HG22 ' A' ' 199' ' ' VAL . 6.6 tt -61.84 96.03 0.06 Allowed 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 178.323 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 94.7 mt 54.78 19.94 2.79 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.427 -0.806 . . . . 0.0 112.318 179.328 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . 53.37 31.61 12.28 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.113 -0.494 . . . . 0.0 112.17 -179.423 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.46 HG22 ' O ' ' A' ' 196' ' ' LEU . 30.4 m -81.51 -7.36 10.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.04 0.448 . . . . 0.0 111.197 -179.033 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -117.69 93.17 4.05 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.713 179.209 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -129.69 -77.31 0.55 Allowed 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.234 178.014 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 202' ' ' SER . . . . . 0.631 ' HA ' HD11 ' A' ' 251' ' ' ILE . 17.5 m -77.32 -8.36 57.53 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.873 -178.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -68.89 -13.51 66.52 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 121.081 -0.581 . . . . 0.0 112.206 178.003 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 204' ' ' ALA . . . . . 0.455 ' HB3' ' HB3' ' A' ' 274' ' ' TYR . . . -142.41 98.33 3.29 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.994 0.426 . . . . 0.0 111.075 177.632 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 205' ' ' CYS . . . . . 0.832 ' HB3' HG12 ' A' ' 251' ' ' ILE . 14.3 p -96.57 147.41 23.89 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 175.358 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 206' ' ' ARG . . . . . 0.788 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 31.2 mtm180 57.53 2.66 0.15 Allowed 'General case' 0 C--O 1.223 -0.312 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -177.228 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 207' ' ' ASN . . . . . 0.441 ' HB2' ' HB1' ' A' ' 204' ' ' ALA . 6.3 m-20 -105.51 104.95 14.78 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.156 0.503 . . . . 0.0 111.472 -172.118 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.451 ' HB ' ' HB ' ' A' ' 246' ' ' VAL . 58.8 t -134.63 117.43 23.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.33 177.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 209' ' ' PHE . . . . . 0.414 ' HE1' ' HB ' ' A' ' 243' ' ' ILE . 3.1 t80 -114.46 123.97 50.75 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 120.951 0.405 . . . . 0.0 110.463 -177.024 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.549 ' HG ' HG22 ' A' ' 272' ' ' ILE . 6.1 mp -107.86 135.21 49.65 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.172 176.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 211' ' ' GLY . . . . . 0.624 ' HA2' HG22 ' A' ' 243' ' ' ILE . . . -142.9 61.74 0.52 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.229 -0.986 . . . . 0.0 113.249 179.247 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 37.7 t30 179.03 41.94 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.928 0.394 . . . . 0.0 110.253 178.334 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.475 HD12 ' O ' ' A' ' 242' ' ' ASN . 1.1 mp -92.51 159.93 35.72 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.392 -179.304 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.44 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 91.6 Cg_endo -79.63 162.84 24.34 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.541 2.161 . . . . 0.0 111.739 176.757 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -77.41 119.92 21.69 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.541 179.487 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 109.72 0.52 30.58 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.473 -0.87 . . . . 0.0 112.615 -177.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 217' ' ' ILE . . . . . 0.608 HG23 HG21 ' A' ' 237' ' ' ILE . 5.5 tp -64.49 129.01 27.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.863 0.364 . . . . 0.0 110.163 175.174 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 218' ' ' THR . . . . . 0.446 ' CG2' ' HG3' ' A' ' 221' ' ' GLU . 15.1 t -113.66 154.27 27.52 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 121.523 0.678 . . . . 0.0 110.917 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.475 ' H ' ' CD ' ' A' ' 219' ' ' GLU . 2.1 mp0 -62.78 -33.56 75.44 Favored 'General case' 0 C--O 1.206 -1.193 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.934 -178.319 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 220' ' ' ASP . . . . . 0.43 ' O ' ' HG2' ' A' ' 224' ' ' GLU . 15.7 t70 -49.48 -38.89 31.64 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.021 0.439 . . . . 0.0 110.811 176.84 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 221' ' ' GLU . . . . . 0.446 ' HG3' ' CG2' ' A' ' 218' ' ' THR . 42.1 mt-10 -70.77 -58.09 3.98 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.314 179.694 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.509 HD12 HD11 ' A' ' 237' ' ' ILE . 8.6 mt -58.5 -41.79 82.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.815 -178.446 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 223' ' ' ARG . . . . . 0.671 ' HG3' HD12 ' A' ' 235' ' ' ILE . 49.4 mtp180 -57.61 -62.24 1.93 Allowed 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 177.585 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.43 ' HG2' ' O ' ' A' ' 220' ' ' ASP . 6.4 pt-20 -57.57 -24.23 55.07 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.731 -178.51 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -86.79 -31.42 20.9 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.854 -176.638 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.708 HD23 ' HZ ' ' A' ' 248' ' ' PHE . 8.0 mp -105.39 -20.21 13.56 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 120.609 -0.436 . . . . 0.0 112.167 -171.401 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 227' ' ' GLU . . . . . 0.677 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 36.6 mt-10 -68.99 -27.71 1.41 Allowed Pre-proline 0 C--N 1.325 -0.492 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -176.314 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 228' ' ' PRO . . . . . 0.677 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 71.5 Cg_endo -66.72 -28.77 43.66 Favored 'Trans proline' 0 C--N 1.359 1.081 0 C-N-CA 121.254 1.302 . . . . 0.0 112.07 -178.819 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 229' ' ' PHE . . . . . 0.501 ' CE1' ' HA ' ' A' ' 226' ' ' LEU . 3.9 p90 -111.15 4.13 19.06 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-O 120.69 0.281 . . . . 0.0 111.353 173.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 230' ' ' GLY . . . . . 0.488 ' CA ' ' HB1' ' A' ' 253' ' ' ALA . . . 177.25 98.9 0.11 Allowed Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 119.837 -1.173 . . . . 0.0 112.748 -177.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.557 ' HA ' ' HG2' ' A' ' 227' ' ' GLU . 22.7 Cg_endo -63.38 134.29 44.32 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 121.904 1.736 . . . . 0.0 111.34 177.213 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.642 HG21 HG12 ' A' ' 246' ' ' VAL . 3.2 mp -107.7 151.06 9.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.642 178.208 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 233' ' ' ASP . . . . . 0.532 ' CG ' HD22 ' A' ' 249' ' ' LEU . 9.9 m-20 -106.84 -25.33 11.73 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.05 0.452 . . . . 0.0 110.319 178.863 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 234' ' ' GLN . . . . . 0.471 ' H ' HG22 ' A' ' 232' ' ' ILE . 30.8 tt0 -145.15 122.85 11.84 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.862 -175.057 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.671 HD12 ' HG3' ' A' ' 223' ' ' ARG . 13.5 mt -136.13 109.35 8.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.909 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -119.21 120.42 37.01 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.475 -178.435 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 237' ' ' ILE . . . . . 0.608 HG21 HG23 ' A' ' 217' ' ' ILE . 64.7 mt -106.19 117.46 51.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.596 179.738 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.582 ' HB ' HG13 ' A' ' 243' ' ' ILE . 42.4 t -97.7 86.52 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 173.327 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 3.8 t -64.44 -23.15 67.19 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.291 -177.195 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -59.48 -36.08 75.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.073 0.463 . . . . 0.0 110.396 176.361 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 241' ' ' ARG . . . . . 0.684 ' HB2' HG12 ' A' ' 243' ' ' ILE . 74.6 mtt180 -113.91 3.37 15.39 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.632 -176.425 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 242' ' ' ASN . . . . . 0.475 ' O ' HD12 ' A' ' 213' ' ' LEU . 75.4 m-20 66.42 27.36 9.92 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.996 176.502 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.684 HG12 ' HB2' ' A' ' 241' ' ' ARG . 1.5 pt -122.28 153.25 26.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.088 -174.645 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 244' ' ' ALA . . . . . 0.446 ' HB3' ' HB2' ' A' ' 210' ' ' LEU . . . -143.78 140.45 29.92 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.012 0.434 . . . . 0.0 111.083 -179.11 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -110.57 117.89 34.75 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.788 178.324 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.642 HG12 HG21 ' A' ' 232' ' ' ILE . 0.6 OUTLIER -113.41 129.25 69.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -179.594 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 247' ' ' HIS . . . . . 0.788 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 48.2 m170 -109.33 101.9 10.85 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.064 -0.654 . . . . 0.0 111.414 178.536 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 248' ' ' PHE . . . . . 0.708 ' HZ ' HD23 ' A' ' 226' ' ' LEU . 41.5 m-85 -87.14 100.88 12.98 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.18 178.825 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.556 HD23 ' H ' ' A' ' 249' ' ' LEU . 0.1 OUTLIER -43.86 -45.77 7.64 Favored 'General case' 0 N--CA 1.463 0.217 0 O-C-N 124.464 1.102 . . . . 0.0 112.62 -176.174 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 250' ' ' ASN . . . . . 0.401 ' HB2' ' HB2' ' A' ' 253' ' ' ALA . 13.4 m120 -86.35 136.88 32.97 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 177.313 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 251' ' ' ILE . . . . . 0.832 HG12 ' HB3' ' A' ' 205' ' ' CYS . 0.2 OUTLIER -60.76 -43.17 94.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.272 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -69.23 -30.74 68.96 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.027 -177.203 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 253' ' ' ALA . . . . . 0.488 ' HB1' ' CA ' ' A' ' 230' ' ' GLY . . . -61.69 -39.98 93.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.384 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 254' ' ' ALA . . . . . 0.61 ' HB2' ' HB2' ' A' ' 248' ' ' PHE . . . -69.14 -41.91 76.7 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.59 178.678 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.589 HG13 ' O ' ' A' ' 251' ' ' ILE . 11.7 mt -55.89 -60.91 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.054 -177.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 13.7 ptmt -62.17 -38.12 87.85 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.607 -176.491 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -64.7 -48.63 73.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.587 0.232 . . . . 0.0 111.422 178.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 258' ' ' VAL . . . . . 0.421 HG13 HG12 ' A' ' 272' ' ' ILE . 43.0 t -65.96 -23.27 31.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 120.865 0.365 . . . . 0.0 110.96 179.558 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 259' ' ' GLN . . . . . 0.547 ' HA ' ' OE1' ' A' ' 259' ' ' GLN . 9.9 mm-40 -84.83 -25.81 27.86 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 176.503 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 48.9 mm-40 -89.5 -36.44 15.39 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-O 120.791 0.329 . . . . 0.0 111.026 -177.368 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.739 HD12 ' CE3' ' A' ' 267' ' ' TRP . 0.8 OUTLIER -51.71 -48.3 87.69 Favored Pre-proline 0 CA--C 1.54 0.568 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.656 -178.808 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 262' ' ' PRO . . . . . 0.611 ' HD3' HD11 ' A' ' 272' ' ' ILE . 55.9 Cg_endo -69.67 -16.53 37.99 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.5 2.133 . . . . 0.0 112.926 -179.229 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 66.2 mt -92.8 -3.62 54.39 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.344 0.592 . . . . 0.0 111.162 -177.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -106.14 149.95 38.76 Favored Pre-proline 0 C--N 1.313 -1.002 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.376 -176.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -65.56 -41.47 15.02 Favored 'Trans proline' 0 C--N 1.34 0.124 0 C-N-CA 123.284 2.656 . . . . 0.0 112.774 -168.448 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 16.0 mtpt -86.89 -44.67 11.49 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.198 0.523 . . . . 0.0 109.799 -175.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 267' ' ' TRP . . . . . 0.739 ' CE3' HD12 ' A' ' 261' ' ' LEU . 24.4 m0 -67.81 -33.51 74.93 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.802 -176.531 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 29.1 t -63.94 -24.29 67.67 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.99 0.424 . . . . 0.0 111.014 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -71.78 -16.44 62.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.188 0.518 . . . . 0.0 110.134 177.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 270' ' ' ARG . . . . . 0.439 ' HB3' HD23 ' A' ' 210' ' ' LEU . 5.2 mpt_? -93.99 144.88 25.07 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 173.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 271' ' ' ARG . . . . . 0.486 ' NE ' ' HA ' ' A' ' 271' ' ' ARG . 5.0 mmp_? -94.2 105.76 17.75 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 177.05 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 272' ' ' ILE . . . . . 0.701 HG21 HD23 ' A' ' 261' ' ' LEU . 0.1 OUTLIER -116.93 136.56 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 CA-C-O 121.634 0.73 . . . . 0.0 111.24 -177.665 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -152.07 167.99 26.68 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.826 173.367 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 274' ' ' TYR . . . . . 0.591 ' O ' ' HD3' ' A' ' 276' ' ' ARG . 90.9 m-85 -63.54 134.46 55.6 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.244 173.002 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -77.85 101.97 1.73 Allowed Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.274 -0.965 . . . . 0.0 111.704 177.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 276' ' ' ARG . . . . . 0.591 ' HD3' ' O ' ' A' ' 274' ' ' TYR . 0.0 OUTLIER -92.25 111.25 22.74 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.515 0.674 . . . . 0.0 110.514 -178.63 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 277' ' ' ASP . . . . . 0.577 ' C ' ' H ' ' A' ' 279' ' ' CYS . 18.9 t70 -144.47 125.31 14.29 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.505 -178.036 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 278' ' ' ARG . . . . . . . . . . . . . 57.5 mtm180 56.29 -7.82 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 O-C-N 124.382 1.051 . . . . 0.0 112.896 -173.204 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 279' ' ' CYS . . . . . 0.577 ' H ' ' C ' ' A' ' 277' ' ' ASP . 20.0 p -95.94 -9.33 31.5 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.322 0.582 . . . . 0.0 110.231 176.375 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -91.93 94.06 9.11 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.13 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 3.4 p -89.58 82.91 2.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 122.222 1.01 . . . . 0.0 110.3 -179.093 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -165.73 -116.33 0.36 Allowed Glycine 0 N--CA 1.449 -0.465 0 CA-C-N 114.588 -1.187 . . . . 0.0 111.407 178.564 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 283' ' ' LEU . . . . . 0.413 HD13 ' HA ' ' A' ' 283' ' ' LEU . 4.0 mm? -87.73 98.52 11.49 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 175.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 284' ' ' LYS . . . . . 0.808 ' HE2' ' HA ' ' A' ' 284' ' ' LYS . 0.4 OUTLIER . . . . . 0 C--O 1.244 0.806 0 CA-C-O 118.567 -0.73 . . . . 0.0 110.159 -176.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' ARG . . . . . 0.821 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 45.2 mtm180 . . . . . 0 C--O 1.222 -0.381 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -103.23 105.17 15.4 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 118.984 0.811 . . . . 0.0 111.759 -170.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.455 ' HB ' ' HB ' ' A' ' 246' ' ' VAL . 61.3 t -138.31 126.76 30.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.571 179.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' PHE . . . . . 0.575 ' O ' ' HA ' ' A' ' 272' ' ' ILE . 17.9 t80 -117.31 131.73 56.75 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.659 178.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.685 ' HG ' HG22 ' A' ' 272' ' ' ILE . 2.5 mp -112.85 115.18 28.06 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.46 175.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . 0.652 ' HA2' HG22 ' A' ' 243' ' ' ILE . . . -124.59 67.18 0.52 Allowed Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.664 -0.779 . . . . 0.0 113.227 -177.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . 0.61 ' HB2' ' HG3' ' A' ' 271' ' ' ARG . 2.5 t30 168.93 51.29 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.124 0.57 . . . . 0.0 110.039 172.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.503 HD21 HD22 ' A' ' 210' ' ' LEU . 1.0 OUTLIER -92.38 162.75 29.04 Favored Pre-proline 0 C--N 1.313 -0.983 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.108 -179.972 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.438 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 71.9 Cg_endo -79.66 156.09 24.37 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 122.109 1.872 . . . . 0.0 111.333 174.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 39.6 t-20 -70.61 128.01 34.63 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 178.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 106.07 -7.04 40.6 Favored Glycine 0 C--N 1.315 -0.606 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.88 -178.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' ILE . . . . . 0.624 HG23 HG21 ' A' ' 237' ' ' ILE . 5.2 tp -59.83 126.71 18.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.124 0.488 . . . . 0.0 110.649 178.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . 0.547 HG22 ' HG3' ' A' ' 221' ' ' GLU . 6.9 t -112.43 154.87 25.16 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-O 121.251 0.548 . . . . 0.0 110.581 -179.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.458 ' CD ' ' H ' ' A' ' 219' ' ' GLU . 1.6 mp0 -58.88 -40.86 85.64 Favored 'General case' 0 C--O 1.21 -0.979 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.867 -176.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -50.74 -36.81 38.32 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 123.727 0.642 . . . . 0.0 111.262 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . 0.547 ' HG3' HG22 ' A' ' 218' ' ' THR . 42.2 mt-10 -68.47 -53.98 19.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.599 179.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . 0.589 HD12 HD11 ' A' ' 237' ' ' ILE . 7.2 mt -61.96 -40.86 88.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.429 179.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' ARG . . . . . 0.776 ' HG3' HD12 ' A' ' 235' ' ' ILE . 61.7 mtp180 -53.99 -62.07 1.89 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.976 0.417 . . . . 0.0 111.955 174.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -59.03 -22.76 61.2 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.27 -178.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -89.07 -31.3 18.1 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.864 -177.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.832 HD23 ' HZ ' ' A' ' 248' ' ' PHE . 8.6 mp -106.56 -19.54 13.64 Favored 'General case' 0 C--O 1.223 -0.298 0 N-CA-C 112.257 0.465 . . . . 0.0 112.257 -170.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' GLU . . . . . 0.683 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 38.7 mt-10 -70.82 -26.35 0.95 Allowed Pre-proline 0 C--N 1.323 -0.556 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -175.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' PRO . . . . . 0.683 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 74.1 Cg_endo -65.33 -25.86 56.43 Favored 'Trans proline' 0 C--N 1.36 1.139 0 C-N-CA 121.202 1.268 . . . . 0.0 111.908 -178.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . 0.483 ' CE1' ' HA ' ' A' ' 226' ' ' LEU . 2.7 p90 -111.01 -17.37 13.29 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.726 173.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . -162.33 93.49 0.12 Allowed Glycine 0 N--CA 1.442 -0.949 0 C-N-CA 120.397 -0.906 . . . . 0.0 111.897 -173.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . 0.542 ' HA ' ' HG2' ' A' ' 227' ' ' GLU . 17.5 Cg_endo -60.93 136.6 66.88 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.136 1.891 . . . . 0.0 111.677 178.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.76 HG21 HG12 ' A' ' 246' ' ' VAL . 2.8 mp -113.07 148.81 15.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.867 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' ASP . . . . . 0.429 ' CG ' HD22 ' A' ' 249' ' ' LEU . 11.5 m-20 -109.9 -20.2 12.84 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 120.894 0.378 . . . . 0.0 110.964 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . 0.564 ' HB3' ' HB2' ' A' ' 247' ' ' HIS . 31.3 tt0 -143.39 121.78 12.37 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.58 -176.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . 0.776 HD12 ' HG3' ' A' ' 223' ' ' ARG . 14.2 mt -137.7 107.48 4.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.601 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 54.7 tttp -113.33 112.53 23.84 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.442 -178.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' ILE . . . . . 0.624 HG21 HG23 ' A' ' 217' ' ' ILE . 86.3 mt -103.2 121.72 54.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.902 -178.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.578 ' HB ' HG13 ' A' ' 243' ' ' ILE . 41.5 t -101.84 86.71 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 170.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 13.8 t -64.87 -22.22 66.95 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.792 -176.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -62.82 -30.92 71.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.534 177.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . 0.615 ' HB2' HG12 ' A' ' 243' ' ' ILE . 83.2 mtt180 -117.45 3.75 12.48 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.732 -176.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 16.8 m120 67.14 27.24 8.6 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.086 175.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.652 HG22 ' HA2' ' A' ' 211' ' ' GLY . 1.4 pt -122.73 151.54 26.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.526 -175.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . 0.468 ' HB3' ' HB2' ' A' ' 210' ' ' LEU . . . -143.7 138.04 28.59 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.227 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -108.52 117.54 34.43 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.478 178.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . 0.76 HG12 HG21 ' A' ' 232' ' ' ILE . 0.4 OUTLIER -113.94 138.47 43.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -176.209 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' HIS . . . . . 0.821 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 55.1 m170 -118.39 102.95 9.33 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.337 0.589 . . . . 0.0 111.147 175.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . 0.832 ' HZ ' HD23 ' A' ' 226' ' ' LEU . 33.6 m-85 -85.5 105.38 16.06 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.215 178.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.506 ' H ' HD23 ' A' ' 249' ' ' LEU . 0.1 OUTLIER -44.15 -45.34 8.22 Favored 'General case' 0 N--CA 1.467 0.398 0 O-C-N 124.389 1.056 . . . . 0.0 113.108 -173.474 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -95.86 142.89 27.57 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.401 -0.52 . . . . 0.0 110.209 177.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' ILE . . . . . 0.608 ' O ' HG13 ' A' ' 255' ' ' ILE . 0.2 OUTLIER -61.2 -42.5 93.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 -178.045 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -70.7 -28.38 64.7 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.001 -176.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -61.32 -41.48 97.08 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.146 178.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' ALA . . . . . 0.574 ' HB2' ' HB2' ' A' ' 248' ' ' PHE . . . -68.51 -41.45 79.94 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.67 178.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.615 ' HA ' ' OH ' ' A' ' 274' ' ' TYR . 11.4 mt -56.41 -59.89 2.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.402 -177.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . 0.49 ' O ' ' HG2' ' A' ' 260' ' ' GLU . 12.2 ptmt -61.63 -40.47 95.0 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.254 -177.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -63.3 -48.86 76.3 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 111.686 0.254 . . . . 0.0 111.686 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . 0.409 HG13 HG12 ' A' ' 272' ' ' ILE . 50.5 t -66.45 -24.0 32.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.957 0.408 . . . . 0.0 111.114 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 19.3 mm-40 -83.8 -24.82 30.86 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 177.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . 0.49 ' HG2' ' O ' ' A' ' 256' ' ' LYS . 27.5 mm-40 -95.17 -31.43 13.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.611 0.243 . . . . 0.0 111.273 -176.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.818 ' HA ' ' HE3' ' A' ' 267' ' ' TRP . 0.7 OUTLIER -52.17 -50.92 76.3 Favored Pre-proline 0 CA--C 1.537 0.471 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.255 179.362 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 262' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' A' ' 261' ' ' LEU . 42.0 Cg_endo -67.47 -17.87 49.02 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.441 2.094 . . . . 0.0 112.97 -178.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 59.0 mt -91.57 -5.58 53.78 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.068 0.461 . . . . 0.0 111.561 -177.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 264' ' ' ASN . . . . . 0.434 ' O ' ' HB2' ' A' ' 268' ' ' SER . 13.7 m-80 -105.34 145.89 31.68 Favored Pre-proline 0 C--N 1.313 -1.017 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.712 -175.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 265' ' ' PRO . . . . . 0.403 ' O ' ' HE3' ' A' ' 269' ' ' LYS . 51.9 Cg_endo -68.18 -26.65 36.03 Favored 'Trans proline' 0 C--N 1.334 -0.229 0 C-N-CA 123.332 2.688 . . . . 0.0 112.583 -170.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . 0.463 ' HE3' ' NE1' ' A' ' 267' ' ' TRP . 0.0 OUTLIER -86.17 -46.3 10.53 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.958 0.885 . . . . 0.0 109.25 -178.837 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 267' ' ' TRP . . . . . 0.818 ' HE3' ' HA ' ' A' ' 261' ' ' LEU . 8.0 m0 -82.52 -24.12 34.25 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.478 -1.237 . . . . 0.0 110.6 -172.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . 0.434 ' HB2' ' O ' ' A' ' 264' ' ' ASN . 22.4 t -65.58 -18.01 65.0 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.034 0.445 . . . . 0.0 110.581 176.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . 0.403 ' HE3' ' O ' ' A' ' 265' ' ' PRO . 94.3 mttt -73.65 -13.75 61.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.316 0.579 . . . . 0.0 109.879 176.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 270' ' ' ARG . . . . . 0.529 ' HA ' ' HB3' ' A' ' 212' ' ' ASN . 0.0 OUTLIER -109.95 147.4 33.51 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.742 -179.705 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . 0.61 ' HG3' ' HB2' ' A' ' 212' ' ' ASN . 40.6 mtm180 -98.06 106.15 18.4 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.106 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . 0.721 HG21 HD23 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -116.61 143.33 27.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.147 -177.451 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 273' ' ' TYR . . . . . 0.413 ' CZ ' ' HD2' ' A' ' 209' ' ' PHE . 1.5 p90 -150.57 167.75 26.32 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.4 172.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 274' ' ' TYR . . . . . 0.615 ' OH ' ' HA ' ' A' ' 255' ' ' ILE . 74.2 m-85 . . . . . 0 N--CA 1.449 -0.524 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.948 172.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' ARG . . . . . 0.832 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 7.7 mtp180 . . . . . 0 C--O 1.219 -0.549 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 70.5 m-20 -106.6 105.8 16.01 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 118.953 0.797 . . . . 0.0 111.9 -172.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.487 ' HB ' ' HB ' ' A' ' 246' ' ' VAL . 59.4 t -135.4 118.19 22.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.041 177.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' PHE . . . . . 0.44 ' HE1' ' HB ' ' A' ' 243' ' ' ILE . 2.3 t80 -116.92 125.13 51.01 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.263 -176.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.579 ' HG ' HG22 ' A' ' 272' ' ' ILE . 5.6 mp -107.65 132.19 53.58 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.265 178.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . 0.624 ' HA2' HG22 ' A' ' 243' ' ' ILE . . . -137.64 62.09 0.58 Allowed Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.309 -0.948 . . . . 0.0 113.326 -179.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . 0.579 ' HB2' ' HG2' ' A' ' 271' ' ' ARG . 38.8 t30 177.64 38.38 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.775 0.321 . . . . 0.0 110.598 175.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.531 HD21 HD22 ' A' ' 210' ' ' LEU . 1.0 OUTLIER -87.26 158.82 51.8 Favored Pre-proline 0 C--N 1.319 -0.74 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 178.828 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.409 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 83.8 Cg_endo -78.42 161.47 28.47 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.403 2.068 . . . . 0.0 110.994 176.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . 0.59 ' HA ' ' OG1' ' A' ' 239' ' ' THR . 9.1 t-20 -78.41 127.46 32.22 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -179.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 108.21 -6.27 34.33 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.485 -176.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' ILE . . . . . 0.639 HG23 HG21 ' A' ' 237' ' ' ILE . 4.5 tp -61.57 129.41 24.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.884 0.373 . . . . 0.0 110.309 177.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . 0.475 ' CG2' ' HG3' ' A' ' 221' ' ' GLU . 15.2 t -112.83 155.9 23.84 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.4 0.619 . . . . 0.0 110.605 -179.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.494 ' CD ' ' H ' ' A' ' 219' ' ' GLU . 8.0 mp0 -63.95 -34.77 78.73 Favored 'General case' 0 C--O 1.206 -1.211 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.936 -176.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -54.69 -35.67 63.84 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 123.335 0.397 . . . . 0.0 110.591 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . 0.535 ' O ' ' HG2' ' A' ' 224' ' ' GLU . 46.1 mt-10 -67.03 -58.64 4.54 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.276 177.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . 0.654 HD12 HD11 ' A' ' 237' ' ' ILE . 7.8 mt -61.24 -38.48 79.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.63 -178.068 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' ARG . . . . . 0.725 ' HG3' HD12 ' A' ' 235' ' ' ILE . 51.2 mtp180 -54.17 -63.14 1.25 Allowed 'General case' 0 CA--C 1.508 -0.645 0 CA-C-O 121.125 0.488 . . . . 0.0 111.693 174.358 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.535 ' HG2' ' O ' ' A' ' 221' ' ' GLU . 17.7 pt-20 -60.48 -17.38 44.69 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.03 -177.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' ASP . . . . . 0.501 ' HB3' ' CZ2' ' A' ' 267' ' ' TRP . 13.7 m-20 -89.23 -33.76 16.87 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.371 -179.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.71 HD23 ' HZ ' ' A' ' 248' ' ' PHE . 7.7 mp -106.98 -11.48 15.67 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 111.979 0.362 . . . . 0.0 111.979 -171.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' GLU . . . . . 0.641 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 53.3 mm-40 -62.97 -36.0 22.19 Favored Pre-proline 0 C--N 1.325 -0.468 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -178.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' PRO . . . . . 0.641 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 85.7 Cg_endo -66.21 -31.1 45.31 Favored 'Trans proline' 0 C--N 1.358 1.071 0 C-N-CA 121.43 1.42 . . . . 0.0 112.163 -173.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . 0.508 ' CZ ' ' HA ' ' A' ' 226' ' ' LEU . 4.0 p90 -110.21 -0.73 17.7 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.628 177.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . 0.429 ' HA2' ' HD2' ' A' ' 231' ' ' PRO . . . -177.21 94.61 0.1 OUTLIER Glycine 0 N--CA 1.441 -1.002 0 C-N-CA 119.658 -1.258 . . . . 0.0 112.64 -178.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . 0.429 ' HD2' ' HA2' ' A' ' 230' ' ' GLY . 17.1 Cg_endo -59.53 131.54 40.98 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 121.877 1.718 . . . . 0.0 111.246 175.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.64 HG21 HG12 ' A' ' 246' ' ' VAL . 2.7 mp -106.86 151.9 8.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.423 178.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' ASP . . . . . 0.527 ' CG ' HD22 ' A' ' 249' ' ' LEU . 34.2 m-20 -109.93 -23.62 11.25 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.786 0.326 . . . . 0.0 110.223 179.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . 0.459 ' H ' HG22 ' A' ' 232' ' ' ILE . 13.7 tt0 -143.43 126.83 16.77 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.843 -177.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . 0.725 HD12 ' HG3' ' A' ' 223' ' ' ARG . 15.6 mt -139.52 113.49 6.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.903 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -121.12 116.67 25.43 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.33 -178.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' ILE . . . . . 0.654 HD11 HD12 ' A' ' 222' ' ' ILE . 86.7 mt -104.76 126.01 59.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.434 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.578 ' HB ' HG13 ' A' ' 243' ' ' ILE . 42.1 t -103.8 85.51 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.046 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 169.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . 0.59 ' OG1' ' HA ' ' A' ' 215' ' ' ASN . 11.7 t -71.04 -16.56 62.61 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.637 -173.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -65.36 -33.0 74.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.117 174.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . 0.545 ' HB2' HG12 ' A' ' 243' ' ' ILE . 71.1 mtt180 -110.74 3.18 18.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.085 -178.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' ASN . . . . . 0.456 ' O ' HD12 ' A' ' 213' ' ' LEU . 16.1 m120 68.35 23.7 7.55 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.108 177.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.624 HG22 ' HA2' ' A' ' 211' ' ' GLY . 1.5 pt -122.43 150.65 26.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.466 -174.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . 0.449 ' HB3' ' HB2' ' A' ' 210' ' ' LEU . . . -143.19 139.47 30.32 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.053 0.454 . . . . 0.0 111.668 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -109.3 115.78 30.63 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.765 178.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . 0.64 HG12 HG21 ' A' ' 232' ' ' ILE . 1.3 t -112.3 134.89 53.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -179.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' HIS . . . . . 0.832 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 33.5 m170 -112.98 101.7 9.72 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.016 -0.674 . . . . 0.0 111.309 177.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . 0.71 ' HZ ' HD23 ' A' ' 226' ' ' LEU . 34.5 m-85 -86.28 104.25 15.63 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-N 115.089 -0.96 . . . . 0.0 111.651 179.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.527 HD22 ' CG ' ' A' ' 233' ' ' ASP . 0.0 OUTLIER -42.85 -48.17 5.71 Favored 'General case' 0 N--CA 1.465 0.306 0 O-C-N 124.506 1.129 . . . . 0.0 112.975 -175.192 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 -93.37 141.4 28.49 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.112 176.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' ILE . . . . . 0.642 ' O ' HG13 ' A' ' 255' ' ' ILE . 0.3 OUTLIER -61.71 -39.94 85.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.027 -178.549 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -68.64 -31.72 71.07 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.995 -176.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . 0.423 ' HB1' ' CA ' ' A' ' 230' ' ' GLY . . . -61.68 -41.81 98.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.298 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' ALA . . . . . 0.56 ' HB2' ' HB2' ' A' ' 248' ' ' PHE . . . -67.17 -41.72 85.47 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.409 178.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.642 HG13 ' O ' ' A' ' 251' ' ' ILE . 10.6 mt -57.37 -59.45 3.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.065 -178.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . 0.421 ' O ' ' HG2' ' A' ' 260' ' ' GLU . 13.9 ptmt -62.27 -40.33 95.86 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.305 -177.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -61.55 -48.93 78.74 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.668 0.271 . . . . 0.0 111.184 178.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . 0.514 HG13 HG12 ' A' ' 272' ' ' ILE . 53.5 t -65.86 -26.33 38.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.907 0.384 . . . . 0.0 111.107 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 28.7 mm-40 -84.94 -24.61 28.31 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 178.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . 0.421 ' HG2' ' O ' ' A' ' 256' ' ' LYS . 71.9 mm-40 -95.3 -31.42 13.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.595 0.236 . . . . 0.0 111.026 -176.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.707 HD12 ' CE3' ' A' ' 267' ' ' TRP . 0.4 OUTLIER -50.91 -51.04 70.78 Favored Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.266 178.727 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 262' ' ' PRO . . . . . 0.566 ' HD2' ' N ' ' A' ' 261' ' ' LEU . 43.3 Cg_endo -67.42 -14.62 43.16 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.465 2.11 . . . . 0.0 112.698 -177.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 52.6 mt -92.43 -4.69 53.34 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.175 0.512 . . . . 0.0 111.367 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 264' ' ' ASN . . . . . 0.433 ' O ' ' HB2' ' A' ' 268' ' ' SER . 10.9 m-80 -106.18 149.42 38.15 Favored Pre-proline 0 C--N 1.315 -0.929 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.998 -175.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -63.9 -38.58 37.74 Favored 'Trans proline' 0 N--CA 1.465 -0.171 0 C-N-CA 123.421 2.747 . . . . 0.0 112.534 -169.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 7.1 mtpt -84.62 -45.09 12.86 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 121.648 0.737 . . . . 0.0 109.376 -177.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 267' ' ' TRP . . . . . 0.707 ' CE3' HD12 ' A' ' 261' ' ' LEU . 12.9 m0 -77.37 -27.6 52.63 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.737 -1.12 . . . . 0.0 111.058 -171.078 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . 0.451 ' HA ' ' HA ' ' A' ' 262' ' ' PRO . 12.0 t -65.47 -21.93 66.69 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.934 0.397 . . . . 0.0 110.547 178.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -72.7 -22.66 60.86 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.301 0.572 . . . . 0.0 110.069 177.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 270' ' ' ARG . . . . . 0.474 ' HA ' ' HB3' ' A' ' 212' ' ' ASN . 5.4 mpt_? -92.98 141.3 28.56 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 178.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . 0.579 ' HG2' ' HB2' ' A' ' 212' ' ' ASN . 37.5 mmt180 -93.02 105.93 17.96 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 178.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . 0.703 HG21 HD23 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -114.33 142.65 26.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.242 0.544 . . . . 0.0 111.42 -176.902 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -152.35 169.29 22.89 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.55 173.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 . . . . . 0 C--N 1.322 -0.592 0 CA-C-O 120.692 0.282 . . . . 0.0 110.41 173.607 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' ARG . . . . . 0.912 ' HE ' ' HA ' ' A' ' 249' ' ' LEU . 16.9 mtp180 . . . . . 0 C--O 1.22 -0.483 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -109.9 107.02 16.8 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-N 118.988 0.813 . . . . 0.0 112.493 -174.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.551 ' HB ' ' HB ' ' A' ' 246' ' ' VAL . 60.8 t -135.3 127.11 46.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 114.878 -1.055 . . . . 0.0 109.148 177.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' PHE . . . . . 0.446 ' O ' ' HA ' ' A' ' 272' ' ' ILE . 6.8 t80 -122.37 127.41 49.71 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-O 120.725 0.298 . . . . 0.0 110.307 -178.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.575 ' HG ' HG22 ' A' ' 272' ' ' ILE . 4.7 mp -109.77 126.03 53.32 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.335 176.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . 0.713 ' HA2' HG22 ' A' ' 243' ' ' ILE . . . -130.65 57.49 0.72 Allowed Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.265 -0.969 . . . . 0.0 113.373 -178.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . 0.498 ' HB3' ' HA ' ' A' ' 270' ' ' ARG . 2.8 t30 177.4 49.74 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.061 0.458 . . . . 0.0 110.509 177.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.556 HD21 HD22 ' A' ' 210' ' ' LEU . 1.0 OUTLIER -97.39 159.05 32.09 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.184 178.722 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.425 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 95.8 Cg_endo -79.85 154.46 23.09 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.326 2.017 . . . . 0.0 112.15 178.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . 0.545 ' HA ' ' OG1' ' A' ' 239' ' ' THR . 8.8 m120 -66.31 121.21 14.74 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.032 177.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 108.86 -1.97 31.86 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.451 -0.88 . . . . 0.0 112.876 -177.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' ILE . . . . . 0.583 HG23 HG21 ' A' ' 237' ' ' ILE . 5.7 tp -64.08 128.0 25.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.046 0.451 . . . . 0.0 110.525 175.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . 0.55 HG22 ' HG3' ' A' ' 221' ' ' GLU . 4.9 t -114.22 157.55 22.54 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.119 0.485 . . . . 0.0 110.575 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.425 ' CD ' ' H ' ' A' ' 219' ' ' GLU . 3.3 mp0 -61.66 -40.31 94.48 Favored 'General case' 0 C--O 1.208 -1.11 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.41 -175.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -51.46 -35.81 41.44 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 123.514 0.509 . . . . 0.0 111.029 -179.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . 0.55 ' HG3' HG22 ' A' ' 218' ' ' THR . 43.4 mt-10 -67.65 -55.9 11.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.303 178.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . 0.572 HD12 HD11 ' A' ' 237' ' ' ILE . 8.0 mt -60.95 -41.21 88.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.537 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' ARG . . . . . 0.639 ' HG3' HD12 ' A' ' 235' ' ' ILE . 26.1 mtp180 -56.55 -61.81 2.16 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 175.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -57.16 -21.64 34.43 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.625 -178.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' ASP . . . . . 0.425 ' HB3' ' CZ2' ' A' ' 267' ' ' TRP . 12.8 m-20 -87.27 -33.98 19.07 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.746 -178.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.785 HD23 ' HZ ' ' A' ' 248' ' ' PHE . 7.7 mp -106.83 -18.01 14.05 Favored 'General case' 0 C--O 1.224 -0.247 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -170.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' GLU . . . . . 0.679 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 35.7 mt-10 -65.79 -31.58 4.95 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -175.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' PRO . . . . . 0.679 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 72.0 Cg_endo -65.94 -29.94 48.94 Favored 'Trans proline' 0 C--N 1.359 1.085 0 C-N-CA 121.459 1.439 . . . . 0.0 112.3 -176.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . 0.489 ' CE1' ' HA ' ' A' ' 226' ' ' LEU . 3.6 p90 -111.06 -4.22 15.18 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.579 176.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . -172.08 95.73 0.11 Allowed Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.127 -1.035 . . . . 0.0 112.478 -176.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -61.58 133.64 46.68 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.174 1.916 . . . . 0.0 111.43 177.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.698 HG21 HG12 ' A' ' 246' ' ' VAL . 2.5 mp -110.42 151.3 12.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.925 178.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' ASP . . . . . 0.462 ' OD2' HD22 ' A' ' 249' ' ' LEU . 6.7 m-20 -110.89 -25.49 9.82 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.92 177.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . 0.626 ' HB3' ' HB2' ' A' ' 247' ' ' HIS . 16.8 tt0 -138.82 120.57 15.3 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.551 -174.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . 0.639 HD12 ' HG3' ' A' ' 223' ' ' ARG . 11.1 mt -137.08 107.73 5.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.99 178.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 63.1 tttp -115.81 113.79 23.87 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.364 -177.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' ILE . . . . . 0.583 HG21 HG23 ' A' ' 217' ' ' ILE . 86.4 mt -102.13 125.71 56.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-O 121.134 0.492 . . . . 0.0 110.955 -179.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.552 ' HB ' HG13 ' A' ' 243' ' ' ILE . 57.7 t -108.81 87.31 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 171.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . 0.545 ' OG1' ' HA ' ' A' ' 215' ' ' ASN . 14.4 t -68.91 -12.62 61.79 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.529 -177.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 18.6 mp0 -63.01 -35.48 80.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.986 175.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . 0.7 ' HB2' HG12 ' A' ' 243' ' ' ILE . 66.8 mtp180 -115.58 4.2 14.13 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.1 179.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' ASN . . . . . 0.446 ' O ' HD12 ' A' ' 213' ' ' LEU . 15.9 m120 65.85 30.56 9.93 Favored 'General case' 0 N--CA 1.465 0.278 0 O-C-N 123.446 0.466 . . . . 0.0 110.743 178.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.713 HG22 ' HA2' ' A' ' 211' ' ' GLY . 1.3 pt -122.06 149.72 25.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.158 -175.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -142.36 138.14 30.98 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.048 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -109.54 120.79 43.57 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.881 179.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . 0.698 HG12 HG21 ' A' ' 232' ' ' ILE . 0.5 OUTLIER -116.3 136.16 54.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.981 -176.385 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' HIS . . . . . 0.827 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 20.1 m170 -114.45 102.97 10.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.191 0.519 . . . . 0.0 111.23 175.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . 0.785 ' HZ ' HD23 ' A' ' 226' ' ' LEU . 29.7 m-85 -85.76 103.79 14.86 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.014 178.006 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.912 ' HA ' ' HE ' ' A' ' 206' ' ' ARG . 0.1 OUTLIER -44.64 -39.28 4.91 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 124.218 0.949 . . . . 0.0 113.311 -172.998 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 57.9 m-20 -100.17 144.71 28.88 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 178.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' ILE . . . . . 0.584 ' O ' HG13 ' A' ' 255' ' ' ILE . 0.3 OUTLIER -63.89 -43.3 97.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -176.618 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -68.63 -31.12 70.04 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.111 -177.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -58.25 -42.88 87.39 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.541 179.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' ALA . . . . . 0.596 ' HB2' ' HB2' ' A' ' 248' ' ' PHE . . . -68.52 -41.67 79.63 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.614 178.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.584 HG13 ' O ' ' A' ' 251' ' ' ILE . 8.4 mt -57.03 -58.47 5.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.456 -177.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . 0.414 ' O ' ' HG2' ' A' ' 260' ' ' GLU . 11.1 ptmt -63.81 -38.79 92.42 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.395 -177.201 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -63.19 -49.83 72.72 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.632 0.253 . . . . 0.0 111.297 178.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . 0.57 HG13 HG12 ' A' ' 272' ' ' ILE . 70.3 t -66.8 -22.9 30.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 120.883 0.373 . . . . 0.0 111.09 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . 0.423 ' HG3' ' O ' ' A' ' 255' ' ' ILE . 63.9 mt-30 -83.53 -24.1 31.8 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 176.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . 0.414 ' HG2' ' O ' ' A' ' 256' ' ' LYS . 42.4 mm-40 -94.75 -33.61 12.84 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.868 0.366 . . . . 0.0 110.893 -176.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.709 HD12 ' CE3' ' A' ' 267' ' ' TRP . 0.9 OUTLIER -51.57 -50.91 74.23 Favored Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.508 -179.777 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 262' ' ' PRO . . . . . 0.567 ' HD3' HD11 ' A' ' 272' ' ' ILE . 44.5 Cg_endo -67.5 -15.4 45.08 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.378 2.052 . . . . 0.0 112.679 -177.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 59.2 mt -96.66 0.55 49.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.062 0.458 . . . . 0.0 111.673 -177.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 -107.05 148.6 37.31 Favored Pre-proline 0 C--N 1.314 -0.94 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.34 -177.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -64.11 -35.28 54.19 Favored 'Trans proline' 0 C--O 1.23 0.092 0 C-N-CA 123.509 2.806 . . . . 0.0 112.411 -172.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 3.5 mtpt -86.11 -45.17 11.63 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 121.643 0.735 . . . . 0.0 109.738 -178.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 267' ' ' TRP . . . . . 0.709 ' CE3' HD12 ' A' ' 261' ' ' LEU . 15.4 m0 -78.03 -28.53 49.06 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 114.772 -1.104 . . . . 0.0 111.14 -172.222 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 23.0 t -68.51 -15.11 63.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.797 0.332 . . . . 0.0 110.812 178.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -73.76 -17.32 61.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.41 0.624 . . . . 0.0 109.631 174.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 270' ' ' ARG . . . . . 0.498 ' HA ' ' HB3' ' A' ' 212' ' ' ASN . 4.7 mpt_? -97.43 154.72 17.29 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.444 177.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . 0.421 HH11 ' HD3' ' A' ' 271' ' ' ARG . 39.5 mmt-85 -104.5 105.78 16.02 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 174.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . 0.657 HG21 HD23 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -115.65 141.14 34.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-O 121.306 0.574 . . . . 0.0 111.536 -177.09 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -152.37 169.8 21.65 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.363 171.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 274' ' ' TYR . . . . . 0.418 ' OH ' ' HA ' ' A' ' 255' ' ' ILE . 84.4 m-85 . . . . . 0 C--N 1.324 -0.531 0 CA-C-O 120.983 0.42 . . . . 0.0 110.755 176.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' ARG . . . . . 0.762 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 39.4 mtm180 . . . . . 0 N--CA 1.463 0.223 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -108.96 105.63 15.24 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 119.053 0.842 . . . . 0.0 111.824 -170.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 63.4 t -137.43 123.09 26.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 114.605 -1.179 . . . . 0.0 109.18 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' PHE . . . . . 0.444 ' CE1' ' HB ' ' A' ' 243' ' ' ILE . 4.0 t80 -120.0 128.18 53.3 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.723 0.297 . . . . 0.0 110.655 -178.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.665 ' HG ' HG22 ' A' ' 272' ' ' ILE . 4.8 mp -108.27 126.53 52.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.534 177.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . 0.69 ' HA2' HG22 ' A' ' 243' ' ' ILE . . . -132.92 59.96 0.68 Allowed Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.702 -0.761 . . . . 0.0 113.445 -178.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . 0.497 ' HB3' ' HA ' ' A' ' 270' ' ' ARG . 3.4 t30 178.22 42.11 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.279 0.561 . . . . 0.0 109.815 177.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.725 HD23 ' HG2' ' A' ' 270' ' ' ARG . 1.0 OUTLIER -89.57 163.52 32.86 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.098 -179.94 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.499 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 89.2 Cg_endo -81.62 161.65 19.23 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 122.383 2.055 . . . . 0.0 111.342 175.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -72.94 128.19 34.75 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.574 176.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 103.94 -5.56 46.65 Favored Glycine 0 C--N 1.313 -0.722 0 C-N-CA 120.446 -0.883 . . . . 0.0 113.039 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' ILE . . . . . 0.626 HG23 HG21 ' A' ' 237' ' ' ILE . 5.1 tp -58.56 128.36 19.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.973 0.416 . . . . 0.0 110.734 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . 0.431 ' CG2' ' HG3' ' A' ' 221' ' ' GLU . 14.9 t -112.28 157.24 21.19 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-O 121.394 0.616 . . . . 0.0 110.975 -178.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.496 ' CD ' ' H ' ' A' ' 219' ' ' GLU . 3.9 mp0 -62.36 -36.7 83.09 Favored 'General case' 0 C--O 1.207 -1.16 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.591 -177.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' ASP . . . . . 0.45 ' O ' ' HG2' ' A' ' 224' ' ' GLU . 37.4 t70 -50.1 -40.14 44.89 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 123.745 0.653 . . . . 0.0 111.144 179.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . 0.431 ' HG3' ' CG2' ' A' ' 218' ' ' THR . 41.6 mt-10 -68.74 -56.96 6.41 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.326 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . 0.539 HD12 HD11 ' A' ' 237' ' ' ILE . 7.5 mt -60.05 -42.25 89.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.743 -179.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' ARG . . . . . 0.753 ' HG3' HD12 ' A' ' 235' ' ' ILE . 53.9 mtp85 -54.3 -63.56 1.11 Allowed 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 176.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.45 ' HG2' ' O ' ' A' ' 220' ' ' ASP . 14.4 pt-20 -60.52 -20.36 59.98 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.975 -176.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -88.69 -32.29 18.06 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.553 -177.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.696 HD23 ' HZ ' ' A' ' 248' ' ' PHE . 8.6 mp -107.32 -18.76 13.79 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -170.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' GLU . . . . . 0.687 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 31.5 mt-10 -71.48 -25.33 0.78 Allowed Pre-proline 0 C--N 1.324 -0.5 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -175.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' PRO . . . . . 0.687 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 74.2 Cg_endo -65.76 -28.84 51.35 Favored 'Trans proline' 0 C--N 1.359 1.102 0 CA-C-N 120.692 1.283 . . . . 0.0 112.019 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . 0.463 ' CE1' ' HA ' ' A' ' 226' ' ' LEU . 3.7 p90 -110.92 -2.08 16.17 Favored 'General case' 0 C--O 1.224 -0.249 0 C-N-CA 120.921 -0.311 . . . . 0.0 111.463 174.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . 0.452 ' O ' ' HA ' ' A' ' 227' ' ' GLU . . . -174.21 94.31 0.1 OUTLIER Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 120.249 -0.977 . . . . 0.0 112.23 -177.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . 0.421 ' HA ' ' HG2' ' A' ' 227' ' ' GLU . 21.0 Cg_endo -62.74 130.14 28.59 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 121.975 1.784 . . . . 0.0 111.401 178.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.736 HG21 HG12 ' A' ' 246' ' ' VAL . 2.8 mp -106.4 152.33 8.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.442 178.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' ASP . . . . . 0.422 ' CG ' HD22 ' A' ' 249' ' ' LEU . 23.4 m-20 -111.29 -26.98 8.87 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.762 176.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . 0.44 ' HB3' ' HB2' ' A' ' 247' ' ' HIS . 20.4 tt0 -136.97 120.51 17.12 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.635 -175.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . 0.753 HD12 ' HG3' ' A' ' 223' ' ' ARG . 20.0 mt -134.99 105.8 6.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.675 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -111.58 109.45 19.37 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.321 -175.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' ILE . . . . . 0.626 HG21 HG23 ' A' ' 217' ' ' ILE . 87.4 mt -101.23 122.28 53.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 121.286 0.565 . . . . 0.0 111.155 -177.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.58 ' HB ' HG13 ' A' ' 243' ' ' ILE . 46.5 t -103.63 87.39 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 170.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 11.6 t -67.5 -19.31 65.31 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.463 -176.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -65.98 -29.56 69.97 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.696 176.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . 0.559 ' HB2' HG12 ' A' ' 243' ' ' ILE . 98.9 mtt180 -117.39 4.85 12.52 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.803 -179.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 15.9 m120 64.81 27.24 12.96 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.988 176.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.69 HG22 ' HA2' ' A' ' 211' ' ' GLY . 1.4 pt -122.4 148.9 25.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.165 -175.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -142.41 137.58 30.51 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.969 0.414 . . . . 0.0 111.556 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -105.51 120.31 41.31 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.894 177.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . 0.736 HG12 HG21 ' A' ' 232' ' ' ILE . 0.2 OUTLIER -115.11 132.15 65.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -178.558 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' HIS . . . . . 0.762 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 50.1 m170 -111.43 102.58 10.94 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.164 -0.614 . . . . 0.0 111.311 176.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . 0.696 ' HZ ' HD23 ' A' ' 226' ' ' LEU . 33.2 m-85 -86.04 103.28 14.58 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.068 178.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.486 ' H ' HD23 ' A' ' 249' ' ' LEU . 0.1 OUTLIER -43.7 -39.52 3.7 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 124.139 0.899 . . . . 0.0 113.342 -175.8 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -96.51 144.92 26.16 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.512 177.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' ILE . . . . . 0.566 ' O ' HG13 ' A' ' 255' ' ' ILE . 0.2 OUTLIER -64.06 -43.22 97.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.723 -178.83 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -72.03 -30.78 65.54 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.672 -176.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . 0.452 ' HB1' ' CA ' ' A' ' 230' ' ' GLY . . . -58.72 -41.93 87.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.217 178.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' ALA . . . . . 0.598 ' HB2' ' HB2' ' A' ' 248' ' ' PHE . . . -69.24 -40.61 77.81 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.821 178.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.566 HG13 ' O ' ' A' ' 251' ' ' ILE . 6.5 mt -57.84 -60.85 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.453 -177.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . 0.454 ' O ' ' HG2' ' A' ' 260' ' ' GLU . 11.8 ptmt -61.98 -38.45 88.62 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.396 -177.062 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -61.47 -48.51 80.78 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.617 0.246 . . . . 0.0 111.182 178.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . 0.548 HG13 HG12 ' A' ' 272' ' ' ILE . 69.7 t -66.92 -23.97 31.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.892 0.377 . . . . 0.0 110.972 179.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -83.42 -26.93 29.93 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 177.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . 0.454 ' HG2' ' O ' ' A' ' 256' ' ' LYS . 51.1 mm-40 -94.74 -30.97 14.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.72 0.295 . . . . 0.0 111.223 -174.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.741 HD23 HG21 ' A' ' 272' ' ' ILE . 0.6 OUTLIER -52.85 -50.74 79.78 Favored Pre-proline 0 CA--C 1.538 0.51 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.375 179.366 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 262' ' ' PRO . . . . . 0.558 ' HD2' ' N ' ' A' ' 261' ' ' LEU . 41.2 Cg_endo -67.47 -16.46 47.53 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.357 2.038 . . . . 0.0 112.667 -178.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 59.1 mt -89.77 -7.83 53.56 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.235 0.54 . . . . 0.0 111.574 -177.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 264' ' ' ASN . . . . . 0.4 ' O ' ' HB2' ' A' ' 268' ' ' SER . 14.1 m-80 -106.38 148.17 36.24 Favored Pre-proline 0 C--N 1.311 -1.068 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.897 -174.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -64.1 -36.4 48.05 Favored 'Trans proline' 0 C--N 1.334 -0.208 0 C-N-CA 123.512 2.808 . . . . 0.0 112.584 -169.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 8.2 mtpt -86.23 -44.58 12.04 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 121.558 0.694 . . . . 0.0 109.791 -176.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 267' ' ' TRP . . . . . 0.694 ' CE3' HD12 ' A' ' 261' ' ' LEU . 11.2 m0 -76.49 -28.57 56.51 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.519 -174.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . 0.4 ' HB2' ' O ' ' A' ' 264' ' ' ASN . 22.9 t -64.18 -21.61 66.63 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.712 0.292 . . . . 0.0 110.532 177.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 64.2 mttm -70.53 -16.67 62.91 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-O 121.299 0.571 . . . . 0.0 110.087 176.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 270' ' ' ARG . . . . . 0.725 ' HG2' HD23 ' A' ' 213' ' ' LEU . 3.1 mpt_? -103.4 146.25 28.78 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.646 -179.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . 0.454 ' NE ' ' HA ' ' A' ' 271' ' ' ARG . 4.9 mmp_? -97.44 107.59 20.13 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 178.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . 0.741 HG21 HD23 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -116.15 142.22 30.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.141 0.496 . . . . 0.0 111.174 -176.967 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -150.93 167.68 26.83 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.661 172.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 274' ' ' TYR . . . . . 0.539 ' OH ' ' HA ' ' A' ' 255' ' ' ILE . 87.2 m-85 . . . . . 0 C--N 1.32 -0.691 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.072 173.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' ARG . . . . . 0.815 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 41.9 mtm180 . . . . . 0 C--O 1.221 -0.404 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -106.0 105.34 15.33 Favored 'General case' 0 CA--C 1.511 -0.542 0 C-N-CA 120.166 -0.614 . . . . 0.0 111.128 -171.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.46 ' HB ' ' HB ' ' A' ' 246' ' ' VAL . 64.6 t -137.24 115.25 13.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.361 177.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' PHE . . . . . 0.461 ' HE1' ' HB ' ' A' ' 243' ' ' ILE . 3.2 t80 -111.68 124.77 53.02 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.364 -175.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.702 ' HG ' HG22 ' A' ' 272' ' ' ILE . 5.6 mp -107.34 129.48 54.9 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.561 177.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . 0.663 ' HA2' HG22 ' A' ' 243' ' ' ILE . . . -138.26 63.28 0.56 Allowed Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.656 -0.783 . . . . 0.0 113.208 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . 0.546 ' HB3' ' HA ' ' A' ' 270' ' ' ARG . 3.5 t30 -179.01 34.86 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.355 0.597 . . . . 0.0 109.969 178.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.809 HD23 ' HG2' ' A' ' 270' ' ' ARG . 1.2 mt -87.77 163.73 37.12 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.868 -179.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.44 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 91.3 Cg_endo -81.98 165.83 17.14 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 122.261 1.974 . . . . 0.0 110.772 172.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -78.7 129.21 34.44 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 177.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 105.25 -6.29 42.46 Favored Glycine 0 C--N 1.315 -0.617 0 C-N-CA 120.557 -0.83 . . . . 0.0 113.211 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' ILE . . . . . 0.715 HG23 HG21 ' A' ' 237' ' ' ILE . 4.6 tp -58.88 131.19 23.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-O 120.929 0.395 . . . . 0.0 110.743 179.083 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . 0.446 ' CG2' ' HG3' ' A' ' 221' ' ' GLU . 10.7 t -112.39 157.44 21.04 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-O 121.625 0.726 . . . . 0.0 111.206 -179.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.461 ' CD ' ' H ' ' A' ' 219' ' ' GLU . 4.2 mp0 -62.79 -34.72 77.85 Favored 'General case' 0 C--O 1.209 -1.075 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.987 -177.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -54.4 -36.19 63.68 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.924 0.392 . . . . 0.0 110.81 -179.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . 0.446 ' HG3' ' CG2' ' A' ' 218' ' ' THR . 44.4 mt-10 -70.56 -55.47 8.8 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.371 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . 0.537 HD12 HD11 ' A' ' 237' ' ' ILE . 6.7 mt -62.03 -40.56 87.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.693 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' ARG . . . . . 0.847 ' HG3' HD12 ' A' ' 235' ' ' ILE . 17.2 mtp180 -54.22 -62.34 1.72 Allowed 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 175.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -57.74 -21.31 40.42 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.962 -178.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' ASP . . . . . 0.454 ' CG ' ' HE1' ' A' ' 267' ' ' TRP . 24.9 m-20 -87.77 -33.02 18.81 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.978 -178.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.702 HD23 ' HZ ' ' A' ' 248' ' ' PHE . 8.1 mp -107.98 -17.83 13.95 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -169.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' GLU . . . . . 0.667 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 46.1 mt-10 -69.79 -26.03 1.01 Allowed Pre-proline 0 C--N 1.324 -0.517 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -175.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' PRO . . . . . 0.667 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 84.7 Cg_endo -67.64 -27.28 38.74 Favored 'Trans proline' 0 C--N 1.36 1.139 0 C-N-CA 121.359 1.373 . . . . 0.0 112.488 -178.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . 0.479 ' CZ ' ' HA ' ' A' ' 226' ' ' LEU . 2.6 p90 -110.64 -14.66 14.01 Favored 'General case' 0 C--O 1.222 -0.364 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.557 175.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . 0.413 ' HA2' ' HD2' ' A' ' 231' ' ' PRO . . . -161.27 91.97 0.11 Allowed Glycine 0 N--CA 1.438 -1.178 0 C-N-CA 120.441 -0.885 . . . . 0.0 111.223 -175.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . 0.413 ' HD2' ' HA2' ' A' ' 230' ' ' GLY . 13.4 Cg_endo -58.72 131.8 44.28 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 121.859 1.706 . . . . 0.0 111.155 178.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.594 HG21 HG12 ' A' ' 246' ' ' VAL . 2.7 mp -108.17 151.7 10.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.92 177.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' ASP . . . . . 0.498 ' CG ' HD22 ' A' ' 249' ' ' LEU . 15.6 m-20 -112.77 -23.06 10.37 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 120.915 0.388 . . . . 0.0 110.147 178.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . 0.58 ' HB3' ' HB2' ' A' ' 247' ' ' HIS . 36.1 tt0 -143.99 120.1 10.77 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.841 -176.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . 0.847 HD12 ' HG3' ' A' ' 223' ' ' ARG . 14.8 mt -131.52 115.63 29.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.92 178.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 65.9 tttp -120.81 113.66 20.48 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.37 -178.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' ILE . . . . . 0.715 HG21 HG23 ' A' ' 217' ' ' ILE . 80.8 mt -102.85 123.71 56.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.683 -179.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.559 ' HB ' HG13 ' A' ' 243' ' ' ILE . 39.9 t -102.06 87.09 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 172.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 13.9 t -65.33 -18.21 65.13 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.726 -177.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -64.93 -31.05 72.09 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.538 176.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . 0.778 ' HB2' HG12 ' A' ' 243' ' ' ILE . 48.7 mtt180 -116.29 3.53 13.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.944 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 13.3 m120 66.91 27.28 9.0 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.81 177.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.778 HG12 ' HB2' ' A' ' 241' ' ' ARG . 1.7 pt -122.2 155.53 27.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.156 -173.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . 0.475 ' HB3' ' HB2' ' A' ' 210' ' ' LEU . . . -143.92 138.3 28.43 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.019 0.438 . . . . 0.0 111.579 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -107.68 109.11 20.63 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.702 176.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . 0.594 HG12 HG21 ' A' ' 232' ' ' ILE . 1.3 t -103.2 133.3 47.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' HIS . . . . . 0.815 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 40.9 m170 -112.49 101.56 9.72 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.496 0.665 . . . . 0.0 111.128 178.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . 0.702 ' HZ ' HD23 ' A' ' 226' ' ' LEU . 33.5 m-85 -85.87 102.92 14.14 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.744 -1.116 . . . . 0.0 111.429 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.498 HD22 ' CG ' ' A' ' 233' ' ' ASP . 0.1 OUTLIER -40.27 -46.45 2.29 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 124.422 1.076 . . . . 0.0 113.117 -174.835 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -97.39 139.54 33.18 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.858 0.361 . . . . 0.0 110.325 177.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' ILE . . . . . 0.663 ' O ' HG13 ' A' ' 255' ' ' ILE . 0.2 OUTLIER -57.53 -40.62 75.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.675 179.995 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -68.93 -33.15 73.27 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.183 -176.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -59.85 -40.28 88.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.483 179.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 254' ' ' ALA . . . . . 0.532 ' HB2' ' HB2' ' A' ' 248' ' ' PHE . . . -68.88 -41.58 78.14 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.757 178.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.663 HG13 ' O ' ' A' ' 251' ' ' ILE . 14.4 mt -56.06 -59.62 2.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.293 -177.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . 0.401 ' O ' ' HG2' ' A' ' 260' ' ' GLU . 12.6 ptmt -62.28 -40.19 95.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.422 -177.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -62.05 -49.28 76.63 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.586 0.231 . . . . 0.0 111.323 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . 0.467 HG13 HG12 ' A' ' 272' ' ' ILE . 53.7 t -64.89 -24.38 35.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.078 0.465 . . . . 0.0 110.892 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 71.6 mm-40 -84.83 -24.53 28.59 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 178.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . 0.401 ' HG2' ' O ' ' A' ' 256' ' ' LYS . 58.4 mm-40 -95.89 -33.89 12.03 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.769 0.319 . . . . 0.0 111.081 -175.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.749 HD23 HG21 ' A' ' 272' ' ' ILE . 0.6 OUTLIER -52.05 -49.54 83.69 Favored Pre-proline 0 CA--C 1.539 0.523 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.724 -179.013 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 262' ' ' PRO . . . . . 0.575 ' HD2' ' N ' ' A' ' 261' ' ' LEU . 43.6 Cg_endo -67.46 -15.25 44.85 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.446 2.097 . . . . 0.0 113.052 -178.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 54.3 mt -92.09 -4.99 53.61 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.269 0.557 . . . . 0.0 111.449 -178.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 -106.94 149.97 39.21 Favored Pre-proline 0 C--N 1.312 -1.029 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.367 -173.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.25 -37.66 30.56 Favored 'Trans proline' 0 N--CA 1.465 -0.159 0 C-N-CA 123.172 2.581 . . . . 0.0 112.79 -169.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 12.6 mtpt -86.63 -44.33 11.95 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 121.531 0.682 . . . . 0.0 109.788 -177.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 267' ' ' TRP . . . . . 0.742 ' CE3' HD12 ' A' ' 261' ' ' LEU . 10.6 m0 -75.34 -28.85 59.77 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.9 -173.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 34.7 t -65.02 -20.89 66.72 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.151 0.501 . . . . 0.0 110.555 176.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . 0.422 ' C ' ' HD2' ' A' ' 270' ' ' ARG . 97.6 mttt -76.84 -6.2 51.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.238 176.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 270' ' ' ARG . . . . . 0.809 ' HG2' HD23 ' A' ' 213' ' ' LEU . 3.3 mpt_? -114.97 141.64 47.7 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.021 177.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . 0.814 ' HE ' ' HA ' ' A' ' 271' ' ' ARG . 0.8 OUTLIER -93.05 108.36 19.96 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 -179.769 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . 0.749 HG21 HD23 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -117.31 140.91 38.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.361 0.6 . . . . 0.0 110.823 -178.556 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -152.42 170.15 20.81 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.55 173.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 . . . . . 0 C--N 1.33 -0.264 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 171.793 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' ARG . . . . . 0.756 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 46.3 mtp180 . . . . . 0 C--O 1.223 -0.337 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -110.93 106.34 15.43 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.1 0.476 . . . . 0.0 111.643 -171.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.478 ' HB ' ' HB ' ' A' ' 246' ' ' VAL . 57.7 t -136.87 117.97 18.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.552 179.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' PHE . . . . . 0.504 ' O ' ' HA ' ' A' ' 272' ' ' ILE . 5.8 t80 -113.28 125.35 54.2 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.463 -177.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.84 ' HG ' HG22 ' A' ' 272' ' ' ILE . 5.5 mp -107.8 130.09 55.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.595 177.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . 0.734 ' HA2' HG22 ' A' ' 243' ' ' ILE . . . -132.13 53.01 0.81 Allowed Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.503 -0.856 . . . . 0.0 113.951 -178.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . 0.441 ' HB3' ' HA ' ' A' ' 270' ' ' ARG . 36.3 t30 179.72 52.73 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.037 0.446 . . . . 0.0 111.288 174.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.585 HD21 HD22 ' A' ' 210' ' ' LEU . 1.0 OUTLIER -94.65 159.43 33.55 Favored Pre-proline 0 C--N 1.314 -0.96 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.444 177.509 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.462 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 87.1 Cg_endo -78.42 169.48 19.93 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 122.701 2.267 . . . . 0.0 111.638 178.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . 0.504 ' HA ' ' OG1' ' A' ' 239' ' ' THR . 3.9 p-10 -77.49 134.02 38.43 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 98.27 -6.27 61.41 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.398 -0.906 . . . . 0.0 112.857 178.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' ILE . . . . . 0.707 HG23 HG21 ' A' ' 237' ' ' ILE . 4.1 tp -58.15 126.11 15.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 CA-C-O 121.294 0.568 . . . . 0.0 110.724 -178.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . 0.492 ' CG2' ' HG3' ' A' ' 221' ' ' GLU . 8.8 t -109.22 157.49 18.76 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 121.429 0.633 . . . . 0.0 110.847 -178.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.502 ' CD ' ' H ' ' A' ' 219' ' ' GLU . 2.6 mp0 -62.05 -36.24 81.03 Favored 'General case' 0 C--O 1.209 -1.028 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.455 -177.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' ASP . . . . . 0.536 ' O ' ' HG2' ' A' ' 224' ' ' GLU . 30.7 t70 -55.08 -37.56 66.96 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 123.741 0.651 . . . . 0.0 110.683 -178.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . 0.492 ' HG3' ' CG2' ' A' ' 218' ' ' THR . 45.9 mt-10 -65.97 -55.24 17.78 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.02 179.184 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . 0.486 HD12 HD11 ' A' ' 237' ' ' ILE . 6.7 mt -62.52 -38.84 82.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.656 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' ARG . . . . . 0.872 ' HG3' HD12 ' A' ' 235' ' ' ILE . 63.4 mtp180 -56.47 -62.53 1.66 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.981 0.42 . . . . 0.0 112.066 175.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.536 ' HG2' ' O ' ' A' ' 220' ' ' ASP . 7.0 pt-20 -58.73 -24.74 62.08 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.149 -178.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' ASP . . . . . 0.469 ' HB3' ' CZ2' ' A' ' 267' ' ' TRP . 8.0 m-20 -85.98 -32.5 21.5 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.596 -176.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.742 HD23 ' HZ ' ' A' ' 248' ' ' PHE . 8.4 mp -107.11 -17.49 14.15 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -170.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' GLU . . . . . 0.675 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 37.6 mt-10 -70.71 -27.96 1.2 Allowed Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -176.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' PRO . . . . . 0.675 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 74.4 Cg_endo -65.47 -27.09 54.58 Favored 'Trans proline' 0 C--N 1.359 1.089 0 C-N-CA 121.313 1.342 . . . . 0.0 111.818 -177.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . 0.475 ' CE1' ' HA ' ' A' ' 226' ' ' LEU . 3.2 p90 -111.01 -7.89 14.5 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.879 -0.328 . . . . 0.0 111.65 173.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . 0.482 ' CA ' ' HB1' ' A' ' 253' ' ' ALA . . . -169.69 93.8 0.1 Allowed Glycine 0 N--CA 1.442 -0.954 0 C-N-CA 120.104 -1.046 . . . . 0.0 112.454 -174.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . 0.461 ' HA ' ' HG2' ' A' ' 227' ' ' GLU . 15.3 Cg_endo -59.52 131.79 42.43 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 122.038 1.825 . . . . 0.0 111.759 178.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.603 HG21 HG12 ' A' ' 246' ' ' VAL . 2.8 mp -108.53 152.95 10.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.108 177.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' ASP . . . . . 0.455 ' OD2' HD22 ' A' ' 249' ' ' LEU . 16.3 m-20 -116.1 -18.39 10.63 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 120.708 0.289 . . . . 0.0 111.059 178.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . 0.49 ' H ' HG22 ' A' ' 232' ' ' ILE . 23.0 tt0 -145.57 121.69 10.78 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.033 -179.118 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . 0.872 HD12 ' HG3' ' A' ' 223' ' ' ARG . 13.6 mt -133.65 109.79 13.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.045 177.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -113.93 121.29 43.49 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.363 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' ILE . . . . . 0.707 HG21 HG23 ' A' ' 217' ' ' ILE . 53.7 mt -111.85 127.97 68.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.361 -177.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.577 ' HB ' HG13 ' A' ' 243' ' ' ILE . 44.8 t -109.58 88.07 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 170.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . 0.504 ' OG1' ' HA ' ' A' ' 215' ' ' ASN . 12.4 t -64.0 -24.66 67.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.643 -175.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -61.8 -39.0 90.19 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.084 0.469 . . . . 0.0 110.647 178.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . 0.691 ' HB2' HG12 ' A' ' 243' ' ' ILE . 63.9 mtt180 -104.28 0.11 28.92 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.47 -177.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 69.01 25.7 5.85 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.054 177.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.734 HG22 ' HA2' ' A' ' 211' ' ' GLY . 1.4 pt -121.71 151.29 25.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-O 120.835 0.35 . . . . 0.0 111.579 -172.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -145.89 141.5 27.88 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.169 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -111.15 114.42 27.66 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.91 178.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . 0.603 HG12 HG21 ' A' ' 232' ' ' ILE . 1.4 t -108.67 138.35 36.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.665 -178.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' HIS . . . . . 0.756 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 27.1 m170 -115.89 102.15 9.42 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.113 -0.635 . . . . 0.0 111.182 177.016 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . 0.742 ' HZ ' HD23 ' A' ' 226' ' ' LEU . 35.3 m-85 -86.86 100.74 12.77 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.22 179.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.474 ' H ' HD23 ' A' ' 249' ' ' LEU . 0.1 OUTLIER -43.24 -41.55 3.92 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 124.533 1.146 . . . . 0.0 112.693 -175.841 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 250' ' ' ASN . . . . . 0.418 ' HB2' ' HB2' ' A' ' 253' ' ' ALA . 59.4 m-20 -94.6 137.89 33.14 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 251' ' ' ILE . . . . . 0.588 ' O ' HG13 ' A' ' 255' ' ' ILE . 0.2 OUTLIER -60.98 -43.51 96.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -178.933 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -71.32 -27.52 63.45 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.666 -176.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . 0.482 ' HB1' ' CA ' ' A' ' 230' ' ' GLY . . . -62.73 -42.37 99.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.204 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 254' ' ' ALA . . . . . 0.556 ' HB2' ' HB2' ' A' ' 248' ' ' PHE . . . -67.38 -41.89 84.26 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.614 178.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.588 HG13 ' O ' ' A' ' 251' ' ' ILE . 9.8 mt -56.17 -60.26 2.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.285 -177.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 12.7 ptmt -62.6 -36.22 82.06 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.553 -176.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -65.73 -49.41 68.55 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 122.981 0.176 . . . . 0.0 111.438 178.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . 0.581 HG13 HG12 ' A' ' 272' ' ' ILE . 60.9 t -63.5 -25.5 38.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.976 0.417 . . . . 0.0 110.838 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -83.96 -25.45 30.04 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.11 -0.495 . . . . 0.0 112.187 178.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 46.5 mm-40 -95.05 -30.88 13.85 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-O 120.665 0.269 . . . . 0.0 111.283 -175.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.826 HD23 HG21 ' A' ' 272' ' ' ILE . 1.0 OUTLIER -52.42 -50.45 79.83 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.251 179.625 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 262' ' ' PRO . . . . . 0.571 ' HD2' ' N ' ' A' ' 261' ' ' LEU . 43.2 Cg_endo -66.99 -14.48 43.81 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.399 2.066 . . . . 0.0 112.909 -178.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 55.6 mt -96.34 -3.91 42.96 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.899 0.381 . . . . 0.0 111.827 -178.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 264' ' ' ASN . . . . . 0.447 ' HB2' ' CE3' ' A' ' 267' ' ' TRP . 13.1 m-80 -106.72 149.78 38.85 Favored Pre-proline 0 C--N 1.317 -0.84 0 N-CA-C 112.662 0.615 . . . . 0.0 112.662 -174.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -63.22 -35.66 62.09 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 123.771 2.981 . . . . 0.0 113.189 -168.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . 0.463 ' HE3' ' HB2' ' A' ' 266' ' ' LYS . 0.0 OUTLIER -86.93 -45.74 10.53 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 121.791 0.805 . . . . 0.0 109.298 -179.616 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 267' ' ' TRP . . . . . 0.729 ' CE3' HD12 ' A' ' 261' ' ' LEU . 9.1 m0 -76.46 -29.29 56.86 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 114.362 -1.29 . . . . 0.0 111.309 -170.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . 0.419 ' HA ' ' HA ' ' A' ' 262' ' ' PRO . 23.2 t -64.92 -16.54 63.42 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.742 0.306 . . . . 0.0 111.547 -179.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -87.17 -13.16 44.82 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.095 0.474 . . . . 0.0 110.183 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 270' ' ' ARG . . . . . 0.441 ' HA ' ' HB3' ' A' ' 212' ' ' ASN . 6.9 mpt_? -88.32 166.75 14.07 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 173.11 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . 0.462 ' HD3' ' HA ' ' A' ' 271' ' ' ARG . 45.1 mmt-85 -120.4 106.58 11.98 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 177.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . 0.84 HG22 ' HG ' ' A' ' 210' ' ' LEU . 0.2 OUTLIER -119.58 141.94 37.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.461 0.648 . . . . 0.0 111.903 -174.411 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -151.76 169.73 21.49 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.613 171.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 . . . . . 0 C--N 1.324 -0.521 0 CA-C-O 120.873 0.368 . . . . 0.0 110.49 176.615 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' ARG . . . . . 0.822 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 8.0 mtm180 . . . . . 0 C--O 1.221 -0.398 0 N-CA-C 114.579 1.325 . . . . 0.0 114.579 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -104.98 105.6 15.71 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 119.09 0.859 . . . . 0.0 112.161 -172.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.502 ' HB ' ' HB ' ' A' ' 246' ' ' VAL . 65.1 t -133.69 114.7 20.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 114.569 -1.196 . . . . 0.0 109.199 177.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' PHE . . . . . 0.449 ' HE1' ' HB ' ' A' ' 243' ' ' ILE . 1.5 t80 -113.6 122.64 47.83 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.061 -176.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.683 ' HG ' HG22 ' A' ' 272' ' ' ILE . 6.4 mp -105.35 136.95 43.95 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.463 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . 0.567 ' HA2' HG22 ' A' ' 243' ' ' ILE . . . -144.58 68.55 0.42 Allowed Glycine 0 N--CA 1.448 -0.567 0 C-N-CA 120.422 -0.894 . . . . 0.0 113.19 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . 0.554 ' HB3' ' HA ' ' A' ' 270' ' ' ARG . 20.5 t30 173.66 37.57 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.092 0.473 . . . . 0.0 109.992 176.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.795 HD23 ' HG2' ' A' ' 270' ' ' ARG . 0.9 OUTLIER -86.59 159.91 51.67 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.71 -176.758 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.489 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 98.6 Cg_endo -77.67 162.94 29.67 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.76 2.307 . . . . 0.0 112.046 178.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -76.04 117.68 18.0 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.771 178.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 109.02 -0.94 31.53 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.292 -0.956 . . . . 0.0 113.011 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' ILE . . . . . 0.712 HG23 HG21 ' A' ' 237' ' ' ILE . 6.2 tp -60.76 130.19 24.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.046 0.451 . . . . 0.0 110.852 177.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . 0.436 ' CG2' ' HG3' ' A' ' 221' ' ' GLU . 12.1 t -114.07 156.24 24.51 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 121.722 0.772 . . . . 0.0 110.969 178.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -60.74 -35.31 76.06 Favored 'General case' 0 C--O 1.208 -1.089 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.093 -178.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -56.11 -35.68 67.35 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 123.433 0.458 . . . . 0.0 110.689 -178.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . 0.436 ' HG3' ' CG2' ' A' ' 218' ' ' THR . 43.6 mt-10 -68.44 -56.43 8.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.122 178.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . 0.523 HD12 HD11 ' A' ' 237' ' ' ILE . 7.6 mt -60.45 -39.66 81.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.434 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' ARG . . . . . 0.774 ' HG3' HD12 ' A' ' 235' ' ' ILE . 33.6 mtp180 -55.88 -63.1 1.29 Allowed 'General case' 0 CA--C 1.509 -0.627 0 CA-C-O 120.935 0.398 . . . . 0.0 112.05 175.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -58.04 -22.1 48.5 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.813 -177.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -86.44 -34.21 20.19 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.621 -177.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.699 HD23 ' HZ ' ' A' ' 248' ' ' PHE . 8.1 mp -105.98 -18.54 14.01 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -169.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' GLU . . . . . 0.662 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 53.7 mt-10 -67.52 -30.32 2.89 Favored Pre-proline 0 C--N 1.326 -0.432 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -176.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' PRO . . . . . 0.662 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 71.7 Cg_endo -65.29 -28.71 55.2 Favored 'Trans proline' 0 C--N 1.36 1.146 0 C-N-CA 121.147 1.231 . . . . 0.0 112.089 -176.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . 0.506 ' CE1' ' HA ' ' A' ' 226' ' ' LEU . 3.1 p90 -110.84 -4.7 15.13 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.737 0.303 . . . . 0.0 111.725 175.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . 0.431 ' CA ' ' HB1' ' A' ' 253' ' ' ALA . . . -171.95 97.83 0.12 Allowed Glycine 0 N--CA 1.443 -0.895 0 C-N-CA 120.274 -0.965 . . . . 0.0 112.311 -175.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -64.65 131.45 29.52 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 121.778 1.652 . . . . 0.0 111.527 178.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.617 HG21 HG12 ' A' ' 246' ' ' VAL . 2.7 mp -107.77 151.97 9.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.563 177.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' ASP . . . . . 0.448 ' CG ' HD22 ' A' ' 249' ' ' LEU . 10.6 m-20 -109.42 -28.56 8.87 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.122 0.487 . . . . 0.0 110.168 176.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . 0.623 ' HB3' ' HB2' ' A' ' 247' ' ' HIS . 26.6 tt0 -136.28 122.54 20.49 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.748 -174.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . 0.774 HD12 ' HG3' ' A' ' 223' ' ' ARG . 14.1 mt -138.45 112.99 8.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.763 178.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -125.35 118.23 25.47 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.41 -179.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' ILE . . . . . 0.712 HG21 HG23 ' A' ' 217' ' ' ILE . 44.9 mt -104.97 115.64 47.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.821 -178.137 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.547 ' HB ' HG13 ' A' ' 243' ' ' ILE . 21.9 t -94.08 87.77 2.22 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 173.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 11.1 t -64.28 -23.69 67.39 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.393 -176.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -64.27 -23.4 67.29 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.152 178.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . 0.729 ' HB2' HG12 ' A' ' 243' ' ' ILE . 97.1 mtt180 -120.21 -0.13 10.54 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.244 176.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 19.2 m120 63.55 29.65 15.24 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.137 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.729 HG12 ' HB2' ' A' ' 241' ' ' ARG . 1.2 pt -121.78 154.33 26.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.76 -175.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . 0.537 ' HB3' ' HB2' ' A' ' 210' ' ' LEU . . . -142.29 138.8 31.59 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.11 0.481 . . . . 0.0 111.788 -178.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -106.33 113.81 27.56 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.62 177.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . 0.617 HG12 HG21 ' A' ' 232' ' ' ILE . 1.0 OUTLIER -112.77 130.58 66.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -179.817 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' HIS . . . . . 0.822 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 28.0 m170 -111.19 102.44 10.87 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.024 -0.67 . . . . 0.0 111.373 177.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . 0.699 ' HZ ' HD23 ' A' ' 226' ' ' LEU . 36.9 m-85 -84.61 101.92 12.51 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.599 177.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.478 ' H ' HD23 ' A' ' 249' ' ' LEU . 0.1 OUTLIER -44.43 -39.12 4.49 Favored 'General case' 0 N--CA 1.465 0.294 0 O-C-N 124.568 1.167 . . . . 0.0 112.956 -174.875 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 50.5 m-20 -99.88 143.16 30.42 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.056 178.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 251' ' ' ILE . . . . . 0.628 ' O ' HG13 ' A' ' 255' ' ' ILE . 0.2 OUTLIER -63.76 -44.62 98.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.138 -176.56 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -68.35 -29.93 68.77 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 120.606 0.241 . . . . 0.0 110.768 -176.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . 0.431 ' HB1' ' CA ' ' A' ' 230' ' ' GLY . . . -61.25 -42.41 98.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.285 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 254' ' ' ALA . . . . . 0.572 ' HB2' ' HB2' ' A' ' 248' ' ' PHE . . . -67.33 -41.33 85.42 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.719 178.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.71 ' O ' ' HG2' ' A' ' 259' ' ' GLN . 15.1 mt -57.05 -62.41 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.096 -177.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . 0.484 ' O ' ' HG2' ' A' ' 260' ' ' GLU . 10.1 ptmt -59.81 -38.42 81.93 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.109 -176.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -63.19 -49.76 72.98 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.59 0.233 . . . . 0.0 111.428 178.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . 0.478 HG13 HG12 ' A' ' 272' ' ' ILE . 52.7 t -66.36 -24.43 33.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.048 0.451 . . . . 0.0 111.119 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . 0.71 ' HG2' ' O ' ' A' ' 255' ' ' ILE . 78.9 mm-40 -84.13 -26.87 28.56 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.933 178.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . 0.484 ' HG2' ' O ' ' A' ' 256' ' ' LYS . 53.3 mm-40 -95.52 -31.65 13.23 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 122.702 0.401 . . . . 0.0 111.532 -175.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.807 ' HA ' ' HE3' ' A' ' 267' ' ' TRP . 0.7 OUTLIER -50.81 -51.03 70.2 Favored Pre-proline 0 CA--C 1.537 0.445 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.501 178.888 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 262' ' ' PRO . . . . . 0.619 ' HD3' HD11 ' A' ' 272' ' ' ILE . 37.8 Cg_endo -66.11 -15.69 49.43 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.287 1.991 . . . . 0.0 112.538 -177.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 57.6 mt -88.66 -9.34 52.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.967 0.413 . . . . 0.0 111.745 -177.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -105.44 148.82 36.99 Favored Pre-proline 0 C--N 1.314 -0.968 0 N-CA-C 112.586 0.588 . . . . 0.0 112.586 -172.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -61.52 -36.11 78.47 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 123.711 2.941 . . . . 0.0 112.61 -171.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 7.6 mtpt -85.99 -45.07 11.81 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 121.542 0.687 . . . . 0.0 109.608 -176.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 267' ' ' TRP . . . . . 0.807 ' HE3' ' HA ' ' A' ' 261' ' ' LEU . 11.2 m0 -78.29 -28.16 47.49 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.686 -173.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 23.9 t -63.94 -17.96 63.77 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.802 0.334 . . . . 0.0 110.802 177.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -73.81 -21.71 60.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.23 0.538 . . . . 0.0 110.097 176.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 270' ' ' ARG . . . . . 0.795 ' HG2' HD23 ' A' ' 213' ' ' LEU . 3.1 mpt_? -102.19 141.7 34.61 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.913 -176.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . 0.477 ' HG2' ' HB2' ' A' ' 212' ' ' ASN . 26.5 mmt180 -93.17 109.45 20.95 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . 0.748 HG21 HD23 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -117.95 139.31 45.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.424 0.63 . . . . 0.0 111.012 -177.203 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 273' ' ' TYR . . . . . 0.448 ' CE1' ' HB3' ' A' ' 209' ' ' PHE . 6.0 p90 -151.78 168.79 23.97 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.73 176.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 274' ' ' TYR . . . . . 0.419 ' OH ' ' HA ' ' A' ' 255' ' ' ILE . 85.5 m-85 . . . . . 0 C--N 1.32 -0.686 0 CA-C-O 120.895 0.378 . . . . 0.0 110.523 174.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' ARG . . . . . 0.748 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 63.4 mtm180 . . . . . 0 C--O 1.223 -0.319 0 N-CA-C 114.579 1.325 . . . . 0.0 114.579 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -100.78 105.81 17.16 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 118.95 0.795 . . . . 0.0 111.528 -171.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.474 ' HB ' ' HB ' ' A' ' 246' ' ' VAL . 58.4 t -137.22 125.91 34.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.362 176.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' PHE . . . . . 0.474 ' HE1' ' HB ' ' A' ' 243' ' ' ILE . 3.3 t80 -125.61 121.37 33.36 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.75 -176.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.611 ' HG ' HG22 ' A' ' 272' ' ' ILE . 5.4 mp -103.79 134.67 46.7 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.298 177.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . 0.613 ' HA2' HG22 ' A' ' 243' ' ' ILE . . . -143.13 65.96 0.47 Allowed Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.493 -0.86 . . . . 0.0 112.908 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . 0.529 ' HB3' ' HA ' ' A' ' 270' ' ' ARG . 1.6 t-20 174.83 39.54 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.252 0.549 . . . . 0.0 110.125 178.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.476 ' HB3' ' HD2' ' A' ' 214' ' ' PRO . 0.5 OUTLIER -89.96 162.82 34.33 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.985 -179.617 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.476 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 74.9 Cg_endo -83.8 169.27 12.0 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.739 2.293 . . . . 0.0 111.396 175.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -78.92 134.58 36.86 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 177.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 103.32 -9.78 53.89 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.468 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' ILE . . . . . 0.601 HG23 HG21 ' A' ' 237' ' ' ILE . 4.9 tp -59.85 128.08 20.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-O 121.071 0.462 . . . . 0.0 110.494 178.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . 0.447 ' CG2' ' HG2' ' A' ' 221' ' ' GLU . 9.0 t -114.43 158.28 21.77 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-O 121.252 0.548 . . . . 0.0 110.575 179.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.458 ' CD ' ' H ' ' A' ' 219' ' ' GLU . 1.3 mp0 -62.3 -39.35 92.68 Favored 'General case' 0 C--O 1.21 -0.975 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.809 -175.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -52.33 -37.82 56.98 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 123.676 0.61 . . . . 0.0 111.234 -178.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . 0.447 ' HG2' ' CG2' ' A' ' 218' ' ' THR . 47.5 mm-40 -68.16 -53.57 24.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.367 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . 0.583 HD12 HD11 ' A' ' 237' ' ' ILE . 8.0 mt -62.0 -42.33 94.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.254 179.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' ARG . . . . . 0.705 ' HG3' HD12 ' A' ' 235' ' ' ILE . 66.4 mtp180 -53.27 -63.15 1.24 Allowed 'General case' 0 CA--C 1.507 -0.7 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 175.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -57.16 -23.91 50.72 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.782 -177.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -83.37 -33.1 25.88 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.592 -178.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.773 HD23 ' HZ ' ' A' ' 248' ' ' PHE . 7.7 mp -106.0 -15.51 14.88 Favored 'General case' 0 C--O 1.224 -0.253 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -171.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' GLU . . . . . 0.649 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 43.6 mm-40 -61.62 -37.62 42.67 Favored Pre-proline 0 C--N 1.328 -0.366 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -177.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' PRO . . . . . 0.649 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 85.1 Cg_endo -66.08 -29.07 48.6 Favored 'Trans proline' 0 C--N 1.358 1.039 0 C-N-CA 121.638 1.558 . . . . 0.0 112.414 -172.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . 0.52 ' CE1' ' HA ' ' A' ' 226' ' ' LEU . 3.5 p90 -110.56 -11.06 14.5 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.449 -0.5 . . . . 0.0 111.999 176.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . 0.415 ' CA ' ' HB1' ' A' ' 253' ' ' ALA . . . -164.93 92.4 0.11 Allowed Glycine 0 N--CA 1.44 -1.048 0 C-N-CA 120.282 -0.961 . . . . 0.0 112.01 -175.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -60.41 130.18 32.75 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.126 1.884 . . . . 0.0 111.319 178.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.784 HG21 HG12 ' A' ' 246' ' ' VAL . 2.3 mp -109.17 152.22 11.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.898 179.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' ASP . . . . . 0.421 ' CG ' HD22 ' A' ' 249' ' ' LEU . 27.7 m-20 -112.99 -23.47 10.04 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.985 0.421 . . . . 0.0 110.675 176.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . 0.554 ' HB3' ' HB2' ' A' ' 247' ' ' HIS . 35.1 tt0 -139.36 120.47 14.67 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.721 -175.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . 0.705 HD12 ' HG3' ' A' ' 223' ' ' ARG . 13.7 mt -136.61 112.3 11.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.037 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -120.32 110.74 16.91 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.57 -177.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' ILE . . . . . 0.601 HG21 HG23 ' A' ' 217' ' ' ILE . 72.6 mt -98.85 117.55 44.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.791 -178.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.609 ' HB ' HG13 ' A' ' 243' ' ' ILE . 24.3 t -97.97 88.29 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 174.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 8.8 t -65.04 -24.33 67.45 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.455 -175.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -66.93 -21.49 65.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.329 0.585 . . . . 0.0 110.339 178.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . 0.624 ' CB ' HG12 ' A' ' 243' ' ' ILE . 33.4 mmt180 -117.91 -2.73 11.26 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.906 -178.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 17.4 m120 66.35 25.33 10.41 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.73 178.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.624 HG12 ' CB ' ' A' ' 241' ' ' ARG . 2.8 pt -122.33 153.1 26.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.01 -173.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . 0.486 ' HB3' ' HB2' ' A' ' 210' ' ' LEU . . . -142.14 134.92 28.47 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.897 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -105.89 120.13 40.95 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.821 178.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . 0.784 HG12 HG21 ' A' ' 232' ' ' ILE . 0.2 OUTLIER -116.95 133.38 63.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -177.079 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' HIS . . . . . 0.748 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 41.3 m170 -115.05 102.81 10.29 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.067 -0.653 . . . . 0.0 111.195 177.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . 0.773 ' HZ ' HD23 ' A' ' 226' ' ' LEU . 28.2 m-85 -86.67 104.52 16.15 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.333 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.507 ' H ' HD23 ' A' ' 249' ' ' LEU . 0.1 OUTLIER -41.92 -46.44 4.05 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 124.405 1.066 . . . . 0.0 113.111 -175.766 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 250' ' ' ASN . . . . . 0.412 HD22 ' N ' ' A' ' 250' ' ' ASN . 0.9 OUTLIER -94.02 145.64 24.51 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.296 178.092 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 251' ' ' ILE . . . . . 0.614 ' O ' HG13 ' A' ' 255' ' ' ILE . 0.2 OUTLIER -63.38 -41.72 93.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -179.705 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -70.69 -31.2 68.0 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 120.783 0.325 . . . . 0.0 110.57 -174.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . 0.415 ' HB1' ' CA ' ' A' ' 230' ' ' GLY . . . -59.5 -43.56 93.33 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.253 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 254' ' ' ALA . . . . . 0.594 ' HB2' ' HB2' ' A' ' 248' ' ' PHE . . . -68.44 -39.73 81.42 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.915 179.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.614 HG13 ' O ' ' A' ' 251' ' ' ILE . 7.9 mt -56.95 -61.97 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.21 -177.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . 0.511 ' O ' ' HG2' ' A' ' 260' ' ' GLU . 10.7 ptmt -61.43 -40.57 94.93 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.512 -176.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -60.44 -49.53 77.21 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.72 0.295 . . . . 0.0 111.365 178.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . 0.451 HG13 HG12 ' A' ' 272' ' ' ILE . 51.7 t -67.24 -23.34 30.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 120.98 0.419 . . . . 0.0 111.206 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . 0.518 ' HG3' ' O ' ' A' ' 255' ' ' ILE . 54.2 mt-30 -83.28 -27.39 29.86 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 122.193 -0.317 . . . . 0.0 111.54 177.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . 0.511 ' HG2' ' O ' ' A' ' 256' ' ' LYS . 30.2 mm-40 -95.62 -30.16 13.94 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.33 -173.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.714 ' HA ' ' HE3' ' A' ' 267' ' ' TRP . 0.7 OUTLIER -51.79 -51.41 70.61 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.382 178.096 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 262' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 261' ' ' LEU . 42.6 Cg_endo -67.07 -15.83 47.68 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.408 2.072 . . . . 0.0 112.84 -177.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 60.6 mt -94.94 -3.09 49.24 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.291 0.567 . . . . 0.0 111.832 -177.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 264' ' ' ASN . . . . . 0.486 ' O ' ' HB2' ' A' ' 268' ' ' SER . 13.3 m-80 -105.91 147.99 35.73 Favored Pre-proline 0 C--N 1.314 -0.947 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.321 -177.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -66.92 -32.87 34.71 Favored 'Trans proline' 0 C--N 1.334 -0.195 0 C-N-CA 123.35 2.7 . . . . 0.0 112.733 -168.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 3.8 mtpt -86.21 -44.53 12.1 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.517 0.675 . . . . 0.0 109.51 -178.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 267' ' ' TRP . . . . . 0.714 ' HE3' ' HA ' ' A' ' 261' ' ' LEU . 13.5 m0 -77.16 -28.15 54.02 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.874 -174.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . 0.486 ' HB2' ' O ' ' A' ' 264' ' ' ASN . 8.0 t -68.68 -15.12 63.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.035 0.445 . . . . 0.0 110.504 178.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -74.65 -14.67 60.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.856 174.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 270' ' ' ARG . . . . . 0.529 ' HA ' ' HB3' ' A' ' 212' ' ' ASN . 4.1 mpt_? -99.37 162.65 12.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.838 178.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . 0.424 ' HG2' ' CB ' ' A' ' 212' ' ' ASN . 36.7 mmt180 -112.14 105.76 14.2 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 174.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . 0.693 HG21 HD23 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -116.87 140.91 37.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.373 0.606 . . . . 0.0 111.34 -175.817 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -151.66 167.99 26.41 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.805 172.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 274' ' ' TYR . . . . . 0.591 ' OH ' ' HA ' ' A' ' 255' ' ' ILE . 85.9 m-85 . . . . . 0 C--N 1.321 -0.65 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.402 174.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' ARG . . . . . 0.804 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 57.1 mtp180 . . . . . 0 C--O 1.224 -0.281 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -108.36 105.79 15.64 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 119.85 -0.74 . . . . 0.0 112.041 -175.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.449 ' HB ' ' HB ' ' A' ' 246' ' ' VAL . 67.9 t -133.49 113.48 18.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 114.691 -1.141 . . . . 0.0 109.153 176.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' PHE . . . . . 0.45 ' HE1' ' HB ' ' A' ' 243' ' ' ILE . 1.7 t80 -112.05 122.37 47.58 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.094 -175.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.641 ' HG ' HG22 ' A' ' 272' ' ' ILE . 5.4 mp -104.8 131.13 52.64 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.257 178.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . 0.654 ' HA2' HG22 ' A' ' 243' ' ' ILE . . . -137.16 64.1 0.57 Allowed Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.217 -0.992 . . . . 0.0 113.636 -178.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . 0.53 ' HB3' ' HA ' ' A' ' 270' ' ' ARG . 30.6 t30 175.81 37.15 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.055 0.455 . . . . 0.0 109.93 174.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.551 HD23 ' HG2' ' A' ' 270' ' ' ARG . 1.0 OUTLIER -81.8 158.26 68.17 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.849 -176.792 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.434 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 73.4 Cg_endo -74.89 152.47 41.38 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 122.351 2.034 . . . . 0.0 111.522 177.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -70.04 116.17 10.1 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.237 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 108.5 1.68 32.88 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.487 -0.863 . . . . 0.0 112.639 -177.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' ILE . . . . . 0.71 HG23 HG21 ' A' ' 237' ' ' ILE . 5.1 tp -60.66 130.54 24.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.0 0.428 . . . . 0.0 110.502 176.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . 0.498 HG22 ' HG3' ' A' ' 221' ' ' GLU . 11.6 t -113.5 158.45 20.7 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.379 0.609 . . . . 0.0 110.949 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.541 ' CD ' ' H ' ' A' ' 219' ' ' GLU . 5.8 mp0 -61.85 -42.5 99.11 Favored 'General case' 0 C--O 1.21 -1.023 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.581 -176.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -48.18 -38.42 18.1 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 123.839 0.712 . . . . 0.0 111.547 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . 0.498 ' HG3' HG22 ' A' ' 218' ' ' THR . 42.3 mt-10 -66.22 -57.9 6.56 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.281 178.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . 0.585 HD12 HD11 ' A' ' 237' ' ' ILE . 8.4 mt -61.45 -41.3 89.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.602 -178.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' ARG . . . . . 0.754 ' HG3' HD12 ' A' ' 235' ' ' ILE . 48.7 mtp180 -53.63 -62.7 1.48 Allowed 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 175.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -58.27 -22.89 54.33 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.756 -177.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' ASP . . . . . 0.463 ' HB3' ' CZ2' ' A' ' 267' ' ' TRP . 10.7 m-20 -86.2 -32.26 21.3 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.844 -177.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.789 HD23 ' HZ ' ' A' ' 248' ' ' PHE . 7.7 mp -106.68 -15.31 14.79 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -170.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' GLU . . . . . 0.631 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 23.2 mm-40 -60.4 -38.38 57.16 Favored Pre-proline 0 C--N 1.327 -0.393 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -178.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' PRO . . . . . 0.631 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 96.1 Cg_endo -66.78 -26.47 45.12 Favored 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 121.587 1.525 . . . . 0.0 112.485 -171.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . 0.524 ' CZ ' ' HA ' ' A' ' 226' ' ' LEU . 3.6 p90 -111.21 -9.19 14.33 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.958 175.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . 0.434 ' CA ' ' HB1' ' A' ' 253' ' ' ALA . . . -169.05 99.1 0.15 Allowed Glycine 0 N--CA 1.442 -0.942 0 C-N-CA 120.033 -1.079 . . . . 0.0 112.268 -175.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . 0.441 ' HA ' ' OE2' ' A' ' 227' ' ' GLU . 18.5 Cg_endo -65.86 131.43 27.32 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 121.808 1.672 . . . . 0.0 111.532 178.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.709 HG21 HG12 ' A' ' 246' ' ' VAL . 2.1 mp -108.68 151.51 10.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.437 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' ASP . . . . . 0.458 ' CG ' HD22 ' A' ' 249' ' ' LEU . 38.0 m-20 -114.56 -19.89 10.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.848 0.356 . . . . 0.0 110.75 177.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . 0.492 ' HB3' ' HB2' ' A' ' 247' ' ' HIS . 9.4 tt0 -143.62 121.22 11.8 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.73 -177.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . 0.754 HD12 ' HG3' ' A' ' 223' ' ' ARG . 12.1 mt -135.09 108.52 9.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.964 -179.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 61.9 tttp -115.9 112.47 21.94 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.411 -178.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' ILE . . . . . 0.71 HG21 HG23 ' A' ' 217' ' ' ILE . 67.0 mt -102.35 124.1 56.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-O 121.017 0.436 . . . . 0.0 110.783 -179.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.532 ' HB ' HG13 ' A' ' 243' ' ' ILE . 61.2 t -105.23 87.68 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 171.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 13.2 t -69.84 -16.53 63.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.381 -177.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -62.06 -34.04 75.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.202 175.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . 0.774 ' HB2' HG12 ' A' ' 243' ' ' ILE . 77.0 mtt180 -112.88 -0.28 14.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.527 178.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 17.9 m120 67.46 29.64 7.2 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.847 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.774 HG12 ' HB2' ' A' ' 241' ' ' ARG . 1.3 pt -122.3 151.68 26.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.037 -175.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . 0.46 ' HB3' ' HB2' ' A' ' 210' ' ' LEU . . . -141.3 138.19 32.98 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.046 0.451 . . . . 0.0 111.849 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -107.27 108.05 19.28 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.836 177.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . 0.709 HG12 HG21 ' A' ' 232' ' ' ILE . 0.9 OUTLIER -106.12 133.57 50.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 -179.288 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' HIS . . . . . 0.804 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 41.8 m170 -112.27 101.97 10.16 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.486 0.66 . . . . 0.0 111.295 178.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . 0.789 ' HZ ' HD23 ' A' ' 226' ' ' LEU . 33.7 m-85 -86.65 101.28 13.11 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.99 -1.004 . . . . 0.0 111.33 179.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.483 ' H ' HD23 ' A' ' 249' ' ' LEU . 0.1 OUTLIER -42.26 -48.05 4.88 Favored 'General case' 0 N--CA 1.465 0.312 0 O-C-N 124.367 1.042 . . . . 0.0 112.583 -176.611 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -84.95 138.18 32.65 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 178.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 251' ' ' ILE . . . . . 0.584 ' O ' HG13 ' A' ' 255' ' ' ILE . 0.2 OUTLIER -62.38 -43.69 98.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -179.609 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -68.98 -30.12 68.47 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.901 -177.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . 0.434 ' HB1' ' CA ' ' A' ' 230' ' ' GLY . . . -60.72 -41.74 95.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.32 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 254' ' ' ALA . . . . . 0.594 ' HB2' ' HB2' ' A' ' 248' ' ' PHE . . . -67.87 -41.29 83.08 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.591 178.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.584 HG13 ' O ' ' A' ' 251' ' ' ILE . 11.7 mt -56.05 -60.84 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.159 -178.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 10.0 ptmt -62.66 -38.84 91.92 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.622 -176.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -61.96 -47.97 82.46 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.557 0.218 . . . . 0.0 111.349 178.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . 0.557 HG13 HG12 ' A' ' 272' ' ' ILE . 54.6 t -65.15 -25.14 36.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.878 0.371 . . . . 0.0 110.931 178.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -83.71 -23.61 31.59 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 178.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -94.93 -34.93 12.21 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.826 0.345 . . . . 0.0 110.689 -175.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.732 ' HA ' ' HE3' ' A' ' 267' ' ' TRP . 0.7 OUTLIER -51.57 -50.48 76.73 Favored Pre-proline 0 CA--C 1.538 0.503 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.578 -178.296 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 262' ' ' PRO . . . . . 0.586 ' HD3' HD11 ' A' ' 272' ' ' ILE . 37.3 Cg_endo -66.35 -20.6 55.02 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.222 1.948 . . . . 0.0 112.544 -177.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 65.8 mt -90.65 -2.22 57.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.292 0.568 . . . . 0.0 111.551 -175.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 264' ' ' ASN . . . . . 0.403 ' O ' ' HB2' ' A' ' 268' ' ' SER . 12.2 m-80 -106.71 148.93 37.77 Favored Pre-proline 0 C--N 1.315 -0.916 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.938 -176.115 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -65.59 -34.2 42.82 Favored 'Trans proline' 0 C--O 1.23 0.11 0 C-N-CA 123.367 2.711 . . . . 0.0 112.604 -171.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 5.1 mtpt -86.05 -45.23 11.62 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 121.812 0.815 . . . . 0.0 109.747 -177.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 267' ' ' TRP . . . . . 0.732 ' HE3' ' HA ' ' A' ' 261' ' ' LEU . 11.3 m0 -78.75 -26.02 44.57 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.722 -172.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . 0.403 ' HB2' ' O ' ' A' ' 264' ' ' ASN . 37.3 t -61.41 -22.15 64.75 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.758 0.313 . . . . 0.0 111.01 177.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -71.15 -18.08 62.52 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.242 0.544 . . . . 0.0 110.481 176.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 270' ' ' ARG . . . . . 0.551 ' HG2' HD23 ' A' ' 213' ' ' LEU . 0.0 OUTLIER -101.9 140.56 36.02 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.475 -179.932 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . 0.779 ' HE ' ' HA ' ' A' ' 271' ' ' ARG . 0.2 OUTLIER -95.62 105.77 17.8 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.777 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . 0.717 HG21 HD23 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -115.24 144.07 23.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.352 0.596 . . . . 0.0 111.285 -174.693 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -151.87 169.46 22.22 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.421 174.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 . . . . . 0 N--CA 1.449 -0.519 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 171.541 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' ARG . . . . . 0.82 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 24.7 mtp-105 . . . . . 0 C--O 1.222 -0.388 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -101.3 106.04 17.18 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 118.681 0.673 . . . . 0.0 111.562 -172.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.413 ' HB ' ' HB ' ' A' ' 246' ' ' VAL . 60.0 t -138.57 119.69 16.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.936 176.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' PHE . . . . . 0.437 ' O ' ' HA ' ' A' ' 272' ' ' ILE . 4.3 t80 -116.31 125.64 52.43 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.49 -177.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.625 ' HG ' HG22 ' A' ' 272' ' ' ILE . 6.2 mp -110.7 133.96 52.88 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.612 178.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . 0.569 ' HA2' HG22 ' A' ' 243' ' ' ILE . . . -138.94 65.9 0.53 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.591 -0.814 . . . . 0.0 113.351 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . 0.462 ' HB2' ' O ' ' A' ' 211' ' ' GLY . 25.1 t30 172.05 42.77 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.831 0.348 . . . . 0.0 110.617 177.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.473 HD21 HD22 ' A' ' 210' ' ' LEU . 1.2 mp -91.23 160.32 37.57 Favored Pre-proline 0 C--N 1.322 -0.591 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.268 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.413 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 92.7 Cg_endo -82.49 166.76 15.62 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 122.637 2.225 . . . . 0.0 112.202 177.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -73.36 125.87 28.83 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.324 0.583 . . . . 0.0 111.139 178.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 106.01 -8.78 42.6 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.839 178.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' ILE . . . . . 0.8 HG23 HG21 ' A' ' 237' ' ' ILE . 5.0 tp -57.99 125.92 14.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.338 0.59 . . . . 0.0 110.625 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . 0.457 ' CG2' ' HG3' ' A' ' 221' ' ' GLU . 11.1 t -114.42 157.88 22.3 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.751 -178.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -61.34 -35.53 77.67 Favored 'General case' 0 C--O 1.209 -1.056 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.936 -177.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' ASP . . . . . 0.42 ' O ' ' HG2' ' A' ' 224' ' ' GLU . 29.5 t70 -51.32 -40.0 58.14 Favored 'General case' 0 C--N 1.32 -0.702 0 O-C-N 123.632 0.582 . . . . 0.0 111.109 178.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . 0.457 ' HG3' ' CG2' ' A' ' 218' ' ' THR . 44.4 mt-10 -70.01 -54.13 14.59 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.562 -179.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . 0.584 HD12 HD11 ' A' ' 237' ' ' ILE . 11.8 mt -60.98 -42.29 92.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.616 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' ARG . . . . . 0.831 ' HG3' HD12 ' A' ' 235' ' ' ILE . 38.9 mtp180 -53.87 -63.09 1.26 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 174.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.42 ' HG2' ' O ' ' A' ' 220' ' ' ASP . 15.4 pt-20 -57.7 -22.16 44.67 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.19 -177.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' ASP . . . . . 0.481 ' HB3' ' CZ2' ' A' ' 267' ' ' TRP . 27.0 m-20 -89.62 -31.88 17.34 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.973 -177.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.854 HD23 ' HZ ' ' A' ' 248' ' ' PHE . 8.3 mp -107.05 -17.46 14.17 Favored 'General case' 0 C--O 1.224 -0.282 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -169.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' GLU . . . . . 0.679 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 58.6 mt-10 -69.6 -26.91 1.15 Allowed Pre-proline 0 C--N 1.323 -0.568 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -175.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' PRO . . . . . 0.679 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 72.3 Cg_endo -66.25 -27.84 48.06 Favored 'Trans proline' 0 C--N 1.36 1.179 0 C-N-CA 121.247 1.298 . . . . 0.0 111.916 -178.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . 0.489 ' CZ ' ' HA ' ' A' ' 226' ' ' LEU . 3.6 p90 -110.6 -9.36 14.55 Favored 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.66 174.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . 0.404 ' HA2' ' HD2' ' A' ' 231' ' ' PRO . . . -168.35 93.77 0.11 Allowed Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 120.18 -1.01 . . . . 0.0 112.109 -175.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . 0.404 ' HD2' ' HA2' ' A' ' 230' ' ' GLY . 16.9 Cg_endo -59.76 133.59 52.08 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.214 1.943 . . . . 0.0 111.393 177.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.726 HG21 HG12 ' A' ' 246' ' ' VAL . 2.4 mp -111.4 151.59 13.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.309 177.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' ASP . . . . . 0.435 ' OD2' HD22 ' A' ' 249' ' ' LEU . 14.9 m-20 -115.51 -20.08 10.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.76 0.314 . . . . 0.0 111.227 177.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . 0.543 ' HB3' ' HB2' ' A' ' 247' ' ' HIS . 22.9 tt0 -142.77 120.48 11.86 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.279 -176.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . 0.831 HD12 ' HG3' ' A' ' 223' ' ' ARG . 17.2 mt -136.3 116.28 17.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.889 -179.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -122.2 116.11 23.58 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.849 0.357 . . . . 0.0 110.457 178.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' ILE . . . . . 0.8 HG21 HG23 ' A' ' 217' ' ' ILE . 33.4 mt -104.57 115.47 46.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.248 179.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.575 ' HB ' HG13 ' A' ' 243' ' ' ILE . 45.5 t -94.26 87.0 2.04 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.152 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 173.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 8.8 t -65.32 -22.29 66.81 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.482 -177.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -60.32 -29.12 68.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.565 176.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . 0.786 ' HB2' HG12 ' A' ' 243' ' ' ILE . 73.9 mtt180 -120.0 0.43 10.77 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.797 -179.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' ASN . . . . . 0.472 ' O ' HD12 ' A' ' 213' ' ' LEU . 92.1 m-20 66.16 29.72 9.66 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.194 179.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.786 HG12 ' HB2' ' A' ' 241' ' ' ARG . 1.3 pt -121.92 151.34 25.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.792 -176.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . 0.552 ' HB3' ' HB2' ' A' ' 210' ' ' LEU . . . -141.55 138.77 32.92 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.103 0.477 . . . . 0.0 111.55 -178.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -110.78 111.43 22.6 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.677 176.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . 0.726 HG12 HG21 ' A' ' 232' ' ' ILE . 0.8 OUTLIER -108.16 134.89 48.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -179.234 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 247' ' ' HIS . . . . . 0.82 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 46.1 m80 -116.06 101.72 9.0 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 119.995 -0.682 . . . . 0.0 111.457 178.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . 0.854 ' HZ ' HD23 ' A' ' 226' ' ' LEU . 29.9 m-85 -84.67 104.67 14.85 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.716 -1.129 . . . . 0.0 111.113 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.577 ' HA ' ' HE ' ' A' ' 206' ' ' ARG . 0.1 OUTLIER -42.82 -42.56 3.66 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 124.194 0.934 . . . . 0.0 113.058 -174.11 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 47.4 m-20 -95.51 143.8 26.53 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 251' ' ' ILE . . . . . 0.533 ' O ' HG13 ' A' ' 255' ' ' ILE . 0.2 OUTLIER -63.56 -45.0 98.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -177.594 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -70.79 -29.14 65.25 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-O 120.625 0.25 . . . . 0.0 110.791 -176.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -58.6 -42.7 88.71 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.36 178.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 254' ' ' ALA . . . . . 0.594 ' HB2' ' HB2' ' A' ' 248' ' ' PHE . . . -67.29 -42.0 84.49 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.626 178.025 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.533 HG13 ' O ' ' A' ' 251' ' ' ILE . 8.5 mt -56.95 -61.31 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.539 -177.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . 0.406 ' O ' ' HG2' ' A' ' 260' ' ' GLU . 12.3 ptmt -60.41 -38.52 84.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.271 -177.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -62.75 -47.91 81.47 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.741 0.305 . . . . 0.0 111.211 178.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 44.4 t -66.18 -23.54 32.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.011 0.434 . . . . 0.0 111.023 179.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . 0.484 ' HG3' ' O ' ' A' ' 255' ' ' ILE . 50.8 mt-30 -83.53 -27.8 29.09 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.825 177.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . 0.406 ' HG2' ' O ' ' A' ' 256' ' ' LYS . 50.9 mm-40 -96.02 -28.89 14.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.69 0.281 . . . . 0.0 111.59 -173.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.731 ' HA ' ' HE3' ' A' ' 267' ' ' TRP . 0.7 OUTLIER -54.1 -50.04 86.62 Favored Pre-proline 0 CA--C 1.536 0.437 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.516 179.252 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 262' ' ' PRO . . . . . 0.581 ' HD2' ' N ' ' A' ' 261' ' ' LEU . 41.2 Cg_endo -66.41 -13.76 41.27 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.271 1.981 . . . . 0.0 112.419 -179.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 60.8 mt -91.15 -8.0 49.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.929 0.395 . . . . 0.0 112.0 -178.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 264' ' ' ASN . . . . . 0.405 ' O ' ' HB2' ' A' ' 268' ' ' SER . 3.2 m-20 -106.11 149.8 38.57 Favored Pre-proline 0 C--O 1.211 -0.964 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.974 -177.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 265' ' ' PRO . . . . . 0.427 ' O ' ' HG3' ' A' ' 269' ' ' LYS . 47.3 Cg_endo -67.28 -33.28 30.98 Favored 'Trans proline' 0 C--O 1.224 -0.21 0 C-N-CA 123.325 2.684 . . . . 0.0 112.804 -171.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . 0.461 ' HB2' ' HE3' ' A' ' 266' ' ' LYS . 0.0 OUTLIER -83.35 -45.91 13.19 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 121.732 0.777 . . . . 0.0 109.224 -179.376 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 267' ' ' TRP . . . . . 0.731 ' HE3' ' HA ' ' A' ' 261' ' ' LEU . 14.3 m0 -76.49 -29.75 56.96 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.909 -172.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . 0.405 ' HB2' ' O ' ' A' ' 264' ' ' ASN . 24.1 t -63.84 -23.12 67.23 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.896 0.379 . . . . 0.0 110.72 178.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . 0.427 ' HG3' ' O ' ' A' ' 265' ' ' PRO . 93.4 mttt -70.82 -19.08 62.7 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.283 0.563 . . . . 0.0 109.695 178.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 270' ' ' ARG . . . . . 0.432 ' HA ' ' HB3' ' A' ' 212' ' ' ASN . 4.7 mpt_? -93.25 146.49 23.66 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.476 176.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 6.6 mmp_? -99.33 106.07 18.13 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 173.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . 0.679 HG21 HD23 ' A' ' 261' ' ' LEU . 0.1 OUTLIER -117.73 142.34 32.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.336 0.589 . . . . 0.0 111.552 -176.673 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -150.61 168.87 23.0 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.254 170.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 . . . . . 0 C--N 1.324 -0.509 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 175.095 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' ARG . . . . . 0.748 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 15.0 mtm180 . . . . . 0 C--O 1.224 -0.256 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 19.3 m-80 -100.65 105.64 17.03 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 118.876 0.762 . . . . 0.0 111.332 -172.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.504 ' HB ' ' HB ' ' A' ' 246' ' ' VAL . 60.3 t -137.36 127.76 38.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.24 176.375 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' PHE . . . . . 0.591 ' HB3' ' CE1' ' A' ' 273' ' ' TYR . 1.8 t80 -127.44 128.18 45.33 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 -177.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.489 ' HG ' HG22 ' A' ' 272' ' ' ILE . 5.9 mp -111.02 134.0 52.96 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.505 179.032 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . 0.595 ' HA2' HG22 ' A' ' 243' ' ' ILE . . . -138.94 65.68 0.53 Allowed Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.098 -1.048 . . . . 0.0 113.328 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . 0.581 ' HB2' ' HG3' ' A' ' 271' ' ' ARG . 3.3 t30 174.83 40.92 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.24 0.543 . . . . 0.0 110.105 175.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.623 ' HA ' ' HG3' ' A' ' 270' ' ' ARG . 1.0 OUTLIER -85.81 155.85 58.53 Favored Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.811 -177.693 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -79.79 169.14 18.5 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.81 2.34 . . . . 0.0 112.059 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -78.69 124.05 27.79 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 108.52 -2.83 32.53 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.592 -0.814 . . . . 0.0 112.613 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' ILE . . . . . 0.403 HG23 HG21 ' A' ' 237' ' ' ILE . 6.0 tp -65.14 125.18 21.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-O 121.255 0.55 . . . . 0.0 111.194 179.001 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . 0.465 HG22 ' HG3' ' A' ' 221' ' ' GLU . 15.0 t -114.4 161.05 18.45 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.561 177.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.449 ' CD ' ' H ' ' A' ' 219' ' ' GLU . 9.3 mp0 -62.81 -38.04 89.11 Favored 'General case' 0 C--O 1.208 -1.105 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.059 -178.411 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' ASP . . . . . 0.483 ' O ' ' HG2' ' A' ' 224' ' ' GLU . 26.2 t70 -51.63 -37.87 52.21 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 123.618 0.574 . . . . 0.0 110.813 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . 0.465 ' HG3' HG22 ' A' ' 218' ' ' THR . 41.9 mt-10 -67.49 -57.5 6.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.4 178.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . 0.533 HG23 HD22 ' A' ' 226' ' ' LEU . 6.9 mt -58.29 -41.67 81.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.351 -179.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' ARG . . . . . 0.729 ' HG3' HD12 ' A' ' 235' ' ' ILE . 37.3 mtp180 -57.12 -62.84 1.47 Allowed 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 175.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.483 ' HG2' ' O ' ' A' ' 220' ' ' ASP . 11.1 pt-20 -59.32 -20.8 57.49 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.083 -177.023 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' ASP . . . . . 0.462 ' HB3' ' CZ2' ' A' ' 267' ' ' TRP . 3.3 m-20 -90.58 -31.43 16.69 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.637 -177.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.681 HD23 ' HZ ' ' A' ' 248' ' ' PHE . 8.2 mp -107.45 -19.1 13.68 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -171.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 227' ' ' GLU . . . . . 0.693 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 48.1 mt-10 -73.34 -22.24 0.49 Allowed Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 113.264 0.839 . . . . 0.0 113.264 -175.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 228' ' ' PRO . . . . . 0.693 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 74.3 Cg_endo -66.59 -28.17 45.21 Favored 'Trans proline' 0 C--N 1.361 1.223 0 CA-C-N 120.747 1.302 . . . . 0.0 111.895 178.357 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . 0.482 ' CE1' ' HA ' ' A' ' 226' ' ' LEU . 2.9 p90 -110.71 -5.66 14.96 Favored 'General case' 0 C--O 1.225 -0.237 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.609 174.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . 0.482 ' CA ' ' HB1' ' A' ' 253' ' ' ALA . . . -174.6 95.59 0.1 Allowed Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 119.945 -1.121 . . . . 0.0 112.554 -175.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . 0.487 ' HA ' ' HG2' ' A' ' 227' ' ' GLU . 19.2 Cg_endo -60.75 135.69 61.7 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.264 1.976 . . . . 0.0 111.584 177.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.632 HG21 HG12 ' A' ' 246' ' ' VAL . 3.3 mp -108.6 151.31 10.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.488 178.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 233' ' ' ASP . . . . . 0.489 ' CG ' HD22 ' A' ' 249' ' ' LEU . 12.7 m-20 -107.07 -25.58 11.52 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.001 0.429 . . . . 0.0 110.831 178.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . 0.473 ' H ' HG22 ' A' ' 232' ' ' ILE . 12.9 tt0 -145.1 120.28 10.15 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.749 -173.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . 0.729 HD12 ' HG3' ' A' ' 223' ' ' ARG . 24.0 mt -133.04 107.59 11.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.8 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -113.75 110.58 20.38 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.605 -175.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 237' ' ' ILE . . . . . 0.485 HD11 HD12 ' A' ' 222' ' ' ILE . 89.3 mt -100.76 121.52 51.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.262 0.553 . . . . 0.0 111.188 -178.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.499 ' HB ' HG13 ' A' ' 243' ' ' ILE . 46.1 t -108.97 87.22 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 172.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 13.9 t -68.33 -20.36 64.73 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.193 -177.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -57.91 -30.84 66.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.154 175.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . 0.696 ' HB2' HG12 ' A' ' 243' ' ' ILE . 98.8 mtt180 -118.26 4.41 11.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.732 177.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 17.5 m120 64.71 29.14 12.95 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.224 178.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.696 HG12 ' HB2' ' A' ' 241' ' ' ARG . 1.3 pt -122.19 151.64 26.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.31 -174.448 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -142.02 135.9 29.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.005 0.431 . . . . 0.0 111.446 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -103.91 114.42 28.66 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.702 178.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . 0.632 HG12 HG21 ' A' ' 232' ' ' ILE . 0.4 OUTLIER -110.35 132.17 59.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -179.349 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 247' ' ' HIS . . . . . 0.748 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 28.1 m80 -114.81 102.76 10.3 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 119.96 -0.696 . . . . 0.0 111.348 177.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . 0.681 ' HZ ' HD23 ' A' ' 226' ' ' LEU . 37.4 m-85 -86.18 102.98 14.39 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 114.887 -1.051 . . . . 0.0 111.33 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.489 HD22 ' CG ' ' A' ' 233' ' ' ASP . 0.2 OUTLIER -46.28 -37.9 7.92 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 124.437 1.086 . . . . 0.0 112.797 -175.789 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 250' ' ' ASN . . . . . 0.432 ' HB2' ' HB2' ' A' ' 253' ' ' ALA . 55.0 m-20 -97.27 136.32 37.93 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 178.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 251' ' ' ILE . . . . . 0.612 ' O ' HG13 ' A' ' 255' ' ' ILE . 0.2 OUTLIER -60.62 -43.41 94.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -179.094 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -70.96 -27.82 64.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.903 -176.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . 0.482 ' HB1' ' CA ' ' A' ' 230' ' ' GLY . . . -62.5 -41.72 99.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.215 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 254' ' ' ALA . . . . . 0.577 ' HB2' ' HB2' ' A' ' 248' ' ' PHE . . . -67.41 -41.96 84.04 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.645 178.391 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.675 ' HA ' ' OH ' ' A' ' 274' ' ' TYR . 13.5 mt -55.9 -61.25 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.297 -177.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 13.3 ptmt -62.37 -38.23 88.77 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.425 -176.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -64.48 -49.98 69.26 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 111.512 0.189 . . . . 0.0 111.512 179.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . 0.484 HG13 HG12 ' A' ' 272' ' ' ILE . 53.3 t -66.47 -22.79 30.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.01 0.434 . . . . 0.0 111.081 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -84.44 -24.61 29.47 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 175.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -90.55 -35.63 14.94 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.884 0.373 . . . . 0.0 111.032 -178.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.769 HD12 ' CE3' ' A' ' 267' ' ' TRP . 0.9 OUTLIER -52.24 -47.17 93.25 Favored Pre-proline 0 CA--C 1.54 0.576 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.79 -178.252 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 262' ' ' PRO . . . . . 0.563 ' HD3' HD11 ' A' ' 272' ' ' ILE . 39.1 Cg_endo -69.38 -21.86 34.64 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.257 1.971 . . . . 0.0 112.74 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 57.0 mt -90.02 -0.35 57.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.4 0.619 . . . . 0.0 111.114 -176.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 264' ' ' ASN . . . . . 0.474 ' O ' ' HB2' ' A' ' 268' ' ' SER . 12.1 m-80 -107.0 148.92 37.89 Favored Pre-proline 0 C--N 1.316 -0.857 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.757 -178.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -67.54 -41.74 8.18 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 123.074 2.516 . . . . 0.0 112.474 -171.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . 0.433 ' HE2' ' HB2' ' A' ' 266' ' ' LYS . 2.6 mtpt -80.9 -45.1 17.29 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-O 121.615 0.722 . . . . 0.0 109.784 -175.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 267' ' ' TRP . . . . . 0.769 ' CE3' HD12 ' A' ' 261' ' ' LEU . 22.6 m0 -72.83 -28.79 62.76 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.549 -175.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . 0.474 ' HB2' ' O ' ' A' ' 264' ' ' ASN . 23.1 t -66.57 -20.05 65.92 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 120.952 -0.299 . . . . 0.0 111.013 178.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -71.44 -15.73 62.35 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.336 0.589 . . . . 0.0 109.721 175.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 270' ' ' ARG . . . . . 0.623 ' HG3' ' HA ' ' A' ' 213' ' ' LEU . 0.0 OUTLIER -104.09 139.9 38.53 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.713 175.71 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . 0.581 ' HG3' ' HB2' ' A' ' 212' ' ' ASN . 15.3 mtm180 -93.22 105.36 17.45 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . 0.662 HG21 HD23 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -110.21 141.88 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-O 121.423 0.63 . . . . 0.0 110.857 -175.14 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 273' ' ' TYR . . . . . 0.591 ' CE1' ' HB3' ' A' ' 209' ' ' PHE . 4.6 p90 -152.78 167.75 27.98 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.83 174.136 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 274' ' ' TYR . . . . . 0.675 ' OH ' ' HA ' ' A' ' 255' ' ' ILE . 90.1 m-85 . . . . . 0 C--N 1.318 -0.795 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.266 172.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' ARG . . . . . 0.82 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 49.0 mtp180 . . . . . 0 CA--C 1.537 0.476 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 69.6 m-20 -100.86 106.13 17.47 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 119.125 0.875 . . . . 0.0 112.041 -173.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.5 ' HB ' ' HB ' ' A' ' 246' ' ' VAL . 59.5 t -136.02 117.6 19.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.607 178.094 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -115.47 123.38 48.42 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.752 0.31 . . . . 0.0 110.5 -177.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.74 ' HG ' HG22 ' A' ' 272' ' ' ILE . 5.9 mp -106.89 133.81 50.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.57 178.064 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . 0.557 ' HA2' HG22 ' A' ' 243' ' ' ILE . . . -143.39 65.78 0.47 Allowed Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.618 -0.801 . . . . 0.0 113.088 179.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . 0.52 ' HB3' ' HA ' ' A' ' 270' ' ' ARG . 50.5 t30 177.05 39.85 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.325 0.583 . . . . 0.0 109.733 177.315 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.764 HD23 ' HG2' ' A' ' 270' ' ' ARG . 1.2 mt -89.53 165.2 26.55 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.156 -179.269 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.496 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 78.5 Cg_endo -83.66 167.77 13.0 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 122.423 2.082 . . . . 0.0 111.14 174.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . 0.483 ' HA ' ' OG1' ' A' ' 239' ' ' THR . 40.9 t-20 -79.21 125.71 29.82 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 177.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 105.96 -3.92 38.7 Favored Glycine 0 C--N 1.314 -0.661 0 C-N-CA 120.458 -0.877 . . . . 0.0 113.082 -179.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' ILE . . . . . 0.696 HG23 HG21 ' A' ' 237' ' ' ILE . 5.0 tp -59.29 126.32 16.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.041 0.448 . . . . 0.0 110.436 178.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . 0.477 ' CG2' ' HG3' ' A' ' 221' ' ' GLU . 10.6 t -111.11 156.81 20.8 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.321 0.582 . . . . 0.0 110.839 -178.041 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.508 ' CD ' ' H ' ' A' ' 219' ' ' GLU . 18.4 mp0 -62.28 -36.59 82.55 Favored 'General case' 0 C--O 1.21 -1.011 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.449 -177.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -50.98 -36.37 38.75 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.018 178.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . 0.477 ' HG3' ' CG2' ' A' ' 218' ' ' THR . 42.3 mt-10 -70.94 -59.46 2.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.798 178.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . 0.593 HD12 HD11 ' A' ' 237' ' ' ILE . 7.6 mt -60.21 -39.85 81.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.469 -178.189 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' ARG . . . . . 0.666 ' HG3' HD12 ' A' ' 235' ' ' ILE . 52.1 mtp180 -55.2 -62.27 1.78 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 174.088 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -55.71 -25.17 38.71 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.82 -178.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -86.3 -31.62 21.5 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.435 -176.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.78 HD23 ' HZ ' ' A' ' 248' ' ' PHE . 7.3 mp -108.43 -16.03 14.32 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -171.379 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 227' ' ' GLU . . . . . 0.639 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 34.8 mm-40 -61.55 -37.25 39.27 Favored Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -177.108 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 228' ' ' PRO . . . . . 0.639 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 96.7 Cg_endo -66.3 -30.57 45.13 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 121.5 1.467 . . . . 0.0 112.247 -172.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . 0.496 ' CE1' ' HA ' ' A' ' 226' ' ' LEU . 4.3 p90 -110.88 3.22 18.73 Favored 'General case' 0 C--O 1.221 -0.43 0 C-N-CA 120.591 -0.443 . . . . 0.0 111.346 176.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . 0.454 ' CA ' ' HB1' ' A' ' 253' ' ' ALA . . . -179.82 97.13 0.11 Allowed Glycine 0 N--CA 1.44 -1.041 0 C-N-CA 119.666 -1.254 . . . . 0.0 112.609 -178.061 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . 0.41 ' HD2' ' HA2' ' A' ' 230' ' ' GLY . 29.0 Cg_endo -64.17 134.31 41.91 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 121.772 1.648 . . . . 0.0 111.031 177.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.638 HG21 HG12 ' A' ' 246' ' ' VAL . 2.9 mp -108.59 150.65 11.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.97 178.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 233' ' ' ASP . . . . . 0.519 ' CG ' HD22 ' A' ' 249' ' ' LEU . 20.7 m-20 -107.44 -26.96 10.72 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.153 0.502 . . . . 0.0 110.446 178.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . 0.52 ' HB3' ' HB2' ' A' ' 247' ' ' HIS . 29.5 tt0 -142.24 120.31 12.13 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.612 -173.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . 0.666 HD12 ' HG3' ' A' ' 223' ' ' ARG . 13.5 mt -134.17 111.89 15.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.001 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 35.2 ttmt -115.66 112.61 22.36 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.349 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 237' ' ' ILE . . . . . 0.696 HG21 HG23 ' A' ' 217' ' ' ILE . 85.3 mt -102.13 121.62 53.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-O 121.1 0.476 . . . . 0.0 110.841 178.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.557 ' HB ' HG13 ' A' ' 243' ' ' ILE . 39.2 t -104.46 87.07 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 172.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . 0.483 ' OG1' ' HA ' ' A' ' 215' ' ' ASN . 9.6 t -70.04 -15.33 62.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.222 -175.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -66.7 -32.73 74.23 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.133 175.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . 0.573 ' HB2' HG12 ' A' ' 243' ' ' ILE . 81.1 mtt180 -114.98 3.25 14.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.859 -178.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 67.66 24.87 8.32 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.288 176.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.573 HG12 ' HB2' ' A' ' 241' ' ' ARG . 1.8 pt -122.33 153.27 26.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.293 -175.009 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . 0.471 ' HB3' ' HB2' ' A' ' 210' ' ' LEU . . . -143.7 140.05 29.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.119 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -111.03 115.13 28.93 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.757 177.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . 0.638 HG12 HG21 ' A' ' 232' ' ' ILE . 1.1 t -111.81 136.05 49.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 -178.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 247' ' ' HIS . . . . . 0.82 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 44.0 m80 -117.41 102.62 9.37 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.594 0.711 . . . . 0.0 111.287 176.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . 0.78 ' HZ ' HD23 ' A' ' 226' ' ' LEU . 34.7 m-85 -85.38 104.61 15.35 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.634 -1.166 . . . . 0.0 111.516 -179.435 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.519 HD22 ' CG ' ' A' ' 233' ' ' ASP . 0.2 OUTLIER -46.57 -39.5 11.17 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 124.41 1.069 . . . . 0.0 112.929 -174.526 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 250' ' ' ASN . . . . . 0.424 ' HB2' ' HB2' ' A' ' 253' ' ' ALA . 47.5 m-80 -92.93 141.51 28.33 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 177.045 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 251' ' ' ILE . . . . . 0.597 ' O ' HG13 ' A' ' 255' ' ' ILE . 0.1 OUTLIER -62.84 -44.05 99.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.316 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -70.1 -29.8 66.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.91 -176.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . 0.454 ' HB1' ' CA ' ' A' ' 230' ' ' GLY . . . -60.36 -42.84 96.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.135 179.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 254' ' ' ALA . . . . . 0.56 ' HB2' ' HB2' ' A' ' 248' ' ' PHE . . . -67.96 -41.68 82.05 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.479 179.23 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.597 HG13 ' O ' ' A' ' 251' ' ' ILE . 11.2 mt -56.69 -60.78 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.108 -177.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . 0.496 ' HE2' ' HB2' ' A' ' 229' ' ' PHE . 15.0 ptmt -62.25 -38.74 90.43 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.406 -177.275 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -62.9 -49.99 72.63 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.661 0.267 . . . . 0.0 111.45 178.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . 0.514 HG13 HG12 ' A' ' 272' ' ' ILE . 55.6 t -65.07 -26.48 40.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.805 0.336 . . . . 0.0 110.994 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 16.9 mm-40 -84.64 -23.04 29.68 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 178.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . 0.406 ' HG2' ' O ' ' A' ' 256' ' ' LYS . 62.1 mm-40 -94.7 -32.03 13.54 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.813 0.34 . . . . 0.0 111.158 -176.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.796 HD23 HG21 ' A' ' 272' ' ' ILE . 0.8 OUTLIER -52.49 -49.54 85.15 Favored Pre-proline 0 CA--C 1.541 0.614 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.511 179.769 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 262' ' ' PRO . . . . . 0.611 ' HD3' HD11 ' A' ' 272' ' ' ILE . 53.3 Cg_endo -69.16 -11.0 30.56 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.512 2.142 . . . . 0.0 112.565 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 43.5 mt -92.07 -9.09 43.94 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.037 0.446 . . . . 0.0 111.555 -179.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 264' ' ' ASN . . . . . 0.421 ' HB2' ' CE3' ' A' ' 267' ' ' TRP . 3.5 m-20 -106.9 149.7 38.85 Favored Pre-proline 0 C--N 1.314 -0.942 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.258 -176.315 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 265' ' ' PRO . . . . . 0.402 ' O ' ' HG3' ' A' ' 269' ' ' LYS . 54.8 Cg_endo -67.73 -32.04 31.0 Favored 'Trans proline' 0 CA--C 1.521 -0.129 0 C-N-CA 123.383 2.722 . . . . 0.0 112.738 -171.167 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . 0.432 ' HE3' ' HB2' ' A' ' 266' ' ' LYS . 0.0 OUTLIER -84.77 -45.64 12.18 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 121.574 0.702 . . . . 0.0 109.24 -179.113 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 267' ' ' TRP . . . . . 0.743 ' HE3' ' HA ' ' A' ' 261' ' ' LEU . 12.6 m0 -76.88 -31.07 56.51 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.934 -172.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 17.7 t -68.3 -15.96 63.77 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.617 179.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . 0.402 ' HG3' ' O ' ' A' ' 265' ' ' PRO . 89.6 mttt -77.05 -7.71 56.16 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.218 0.533 . . . . 0.0 109.953 174.36 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 270' ' ' ARG . . . . . 0.764 ' HG2' HD23 ' A' ' 213' ' ' LEU . 3.7 mpt_? -110.82 143.89 40.69 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.92 178.303 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 36.0 mmt180 -91.99 106.42 18.44 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 110.021 -0.362 . . . . 0.0 110.021 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . 0.796 HG21 HD23 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -118.27 140.35 42.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.377 0.608 . . . . 0.0 110.718 179.701 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -152.39 168.96 23.77 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.38 173.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 . . . . . 0 C--N 1.324 -0.532 0 CA-C-O 120.713 0.292 . . . . 0.0 110.257 174.127 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' ARG . . . . . 0.879 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 0.6 OUTLIER . . . . . 0 C--O 1.219 -0.539 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -106.38 105.95 16.24 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 118.555 0.616 . . . . 0.0 111.442 -173.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.526 ' HB ' ' HB ' ' A' ' 246' ' ' VAL . 66.5 t -137.62 119.75 18.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.309 177.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -115.22 124.32 51.11 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.816 0.341 . . . . 0.0 110.469 -177.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.687 ' HG ' HG22 ' A' ' 272' ' ' ILE . 5.4 mp -107.31 129.44 54.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.275 177.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . 0.623 ' HA2' HG22 ' A' ' 243' ' ' ILE . . . -136.65 59.43 0.64 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.394 -0.908 . . . . 0.0 113.266 -178.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . 0.551 ' HB3' ' HA ' ' A' ' 270' ' ' ARG . 1.7 t30 177.03 43.53 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.027 0.442 . . . . 0.0 110.063 177.017 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.576 ' HA ' ' HG3' ' A' ' 270' ' ' ARG . 1.2 mt -87.01 164.09 37.8 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.041 -177.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.54 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 73.0 Cg_endo -76.51 169.03 22.65 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.365 2.043 . . . . 0.0 111.763 175.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 -78.5 130.17 35.7 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.897 179.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 91.48 3.78 68.79 Favored Glycine 0 C--N 1.317 -0.499 0 C-N-CA 120.732 -0.747 . . . . 0.0 113.188 177.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' ILE . . . . . 0.65 HG23 HG21 ' A' ' 237' ' ' ILE . 4.5 tp -58.82 128.55 19.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.34 0.591 . . . . 0.0 111.153 -178.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . 0.465 ' CG2' ' HG3' ' A' ' 221' ' ' GLU . 14.5 t -111.91 156.17 22.49 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 121.367 0.603 . . . . 0.0 110.839 -178.248 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -62.41 -35.45 79.26 Favored 'General case' 0 C--O 1.209 -1.052 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.654 -177.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -48.89 -40.63 30.57 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.033 177.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . 0.465 ' HG3' ' CG2' ' A' ' 218' ' ' THR . 43.2 mt-10 -70.69 -56.01 7.38 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.751 -178.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . 0.59 HD12 HD11 ' A' ' 237' ' ' ILE . 10.6 mt -61.41 -45.21 99.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.632 -178.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' ARG . . . . . 0.784 ' HG3' HD12 ' A' ' 235' ' ' ILE . 64.2 mtp180 -54.01 -62.46 1.64 Allowed 'General case' 0 CA--C 1.505 -0.786 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 176.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -55.68 -24.25 33.13 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.731 -177.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 225' ' ' ASP . . . . . 0.446 ' HB3' ' CZ2' ' A' ' 267' ' ' TRP . 8.9 m-20 -86.0 -32.14 21.65 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.955 -178.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.838 HD23 ' HZ ' ' A' ' 248' ' ' PHE . 7.3 mp -104.99 -15.1 15.21 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.959 -0.297 . . . . 0.0 111.669 -172.095 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 227' ' ' GLU . . . . . 0.638 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 42.7 mm-40 -61.46 -36.58 33.38 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -177.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 228' ' ' PRO . . . . . 0.638 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 97.5 Cg_endo -67.13 -27.03 42.18 Favored 'Trans proline' 0 C--N 1.358 1.03 0 C-N-CA 121.66 1.573 . . . . 0.0 112.377 -173.002 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . 0.519 ' CE1' ' HA ' ' A' ' 226' ' ' LEU . 2.9 p90 -110.78 -14.14 14.05 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.411 -0.516 . . . . 0.0 111.825 176.025 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . 0.469 ' CA ' ' HB1' ' A' ' 253' ' ' ALA . . . -164.08 97.73 0.15 Allowed Glycine 0 N--CA 1.44 -1.099 0 C-N-CA 120.479 -0.867 . . . . 0.0 112.05 -174.176 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -65.05 135.68 44.89 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 121.747 1.631 . . . . 0.0 111.136 178.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.596 HG21 HG12 ' A' ' 246' ' ' VAL . 2.4 mp -112.11 148.95 14.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.919 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 233' ' ' ASP . . . . . 0.487 ' OD2' HD22 ' A' ' 249' ' ' LEU . 8.8 m-20 -109.3 -24.66 10.97 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.111 0.481 . . . . 0.0 110.369 178.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . 0.594 ' HB3' ' HB2' ' A' ' 247' ' ' HIS . 22.9 tt0 -142.09 122.01 13.62 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.543 -174.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . 0.784 HD12 ' HG3' ' A' ' 223' ' ' ARG . 8.1 mt -135.52 105.52 5.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 121.512 0.672 . . . . 0.0 109.927 178.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -108.35 107.51 18.12 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.993 -177.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 237' ' ' ILE . . . . . 0.65 HG21 HG23 ' A' ' 217' ' ' ILE . 81.3 mt -101.19 125.43 55.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.947 -178.287 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.545 ' HB ' HG13 ' A' ' 243' ' ' ILE . 41.2 t -109.67 88.05 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 170.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 15.3 t -69.94 -12.34 61.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.356 -176.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -69.02 -35.26 76.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.311 176.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . 0.626 ' HB2' HG12 ' A' ' 243' ' ' ILE . 90.7 mtt180 -113.75 5.12 16.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.6 -178.238 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 68.06 24.84 7.66 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.381 176.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.626 HG12 ' HB2' ' A' ' 241' ' ' ARG . 1.5 pt -122.31 150.79 25.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.823 -173.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . 0.424 ' HB3' ' HB2' ' A' ' 210' ' ' LEU . . . -144.13 137.78 27.73 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.243 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -107.19 110.98 23.18 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.539 177.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . 0.596 HG12 HG21 ' A' ' 232' ' ' ILE . 1.5 t -107.86 134.91 48.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.872 -177.01 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 247' ' ' HIS . . . . . 0.879 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 36.2 m170 -113.87 101.93 9.73 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.358 0.599 . . . . 0.0 111.382 177.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . 0.838 ' HZ ' HD23 ' A' ' 226' ' ' LEU . 35.1 m-85 -85.39 101.27 12.45 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.952 178.031 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.514 ' H ' HD23 ' A' ' 249' ' ' LEU . 0.1 OUTLIER -43.96 -38.94 3.73 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 124.293 0.996 . . . . 0.0 112.881 -174.41 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 250' ' ' ASN . . . . . 0.43 ' HB2' ' HB2' ' A' ' 253' ' ' ALA . 2.6 m-20 -94.34 139.19 31.4 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 176.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 251' ' ' ILE . . . . . 0.6 ' O ' HG13 ' A' ' 255' ' ' ILE . 0.2 OUTLIER -62.71 -41.24 91.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.962 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -72.08 -28.66 63.45 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.741 -177.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . 0.469 ' HB1' ' CA ' ' A' ' 230' ' ' GLY . . . -61.34 -41.37 96.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.25 178.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 254' ' ' ALA . . . . . 0.545 ' HB2' ' HB2' ' A' ' 248' ' ' PHE . . . -68.7 -40.74 79.87 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.724 178.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.6 HG13 ' O ' ' A' ' 251' ' ' ILE . 7.5 mt -56.14 -60.59 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.348 -178.247 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . 0.43 ' O ' ' HG2' ' A' ' 260' ' ' GLU . 9.9 ptmt -61.36 -41.49 97.16 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.513 -177.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -62.14 -49.81 74.39 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.693 0.283 . . . . 0.0 111.464 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . 0.453 HG13 HG12 ' A' ' 272' ' ' ILE . 41.2 t -64.84 -26.52 40.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.897 0.38 . . . . 0.0 111.121 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . 0.401 ' HG3' ' O ' ' A' ' 255' ' ' ILE . 53.3 mt-30 -84.64 -23.08 29.66 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 178.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . 0.43 ' HG2' ' O ' ' A' ' 256' ' ' LYS . 49.5 mm-40 -95.31 -32.48 12.95 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.611 0.243 . . . . 0.0 111.158 -176.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.782 HD12 ' CE3' ' A' ' 267' ' ' TRP . 0.6 OUTLIER -50.44 -49.92 74.63 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.549 179.506 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 262' ' ' PRO . . . . . 0.579 ' HD2' ' N ' ' A' ' 261' ' ' LEU . 40.4 Cg_endo -67.25 -17.14 49.84 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.416 2.078 . . . . 0.0 112.972 -178.422 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 55.2 mt -91.63 -3.56 56.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.248 0.547 . . . . 0.0 111.493 -178.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -106.64 148.82 37.53 Favored Pre-proline 0 C--N 1.314 -0.962 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.839 -175.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -65.41 -35.98 37.0 Favored 'Trans proline' 0 C--O 1.23 0.108 0 C-N-CA 123.557 2.838 . . . . 0.0 112.902 -169.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 9.7 mtpt -86.53 -45.08 11.42 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.671 0.748 . . . . 0.0 109.685 -177.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 267' ' ' TRP . . . . . 0.782 ' CE3' HD12 ' A' ' 261' ' ' LEU . 11.6 m0 -76.34 -29.35 57.21 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.87 -173.34 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 38.0 t -62.32 -21.98 65.69 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.822 0.344 . . . . 0.0 110.853 178.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -71.46 -16.59 62.38 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.106 0.479 . . . . 0.0 110.276 177.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 270' ' ' ARG . . . . . 0.576 ' HG3' ' HA ' ' A' ' 213' ' ' LEU . 0.0 OUTLIER -100.26 146.31 27.06 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.495 178.554 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . 0.407 ' HG2' ' HB2' ' A' ' 212' ' ' ASN . 9.9 mmp_? -95.4 105.92 17.93 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 176.106 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . 0.721 HG21 HD23 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -115.86 141.87 31.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.546 0.688 . . . . 0.0 111.285 -177.952 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -151.69 169.24 22.65 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.354 -0.839 . . . . 0.0 108.966 172.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 274' ' ' TYR . . . . . 0.466 ' OH ' ' HA ' ' A' ' 255' ' ' ILE . 75.6 m-85 . . . . . 0 C--N 1.323 -0.586 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 173.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' ARG . . . . . 0.774 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 48.7 mtp180 . . . . . 0 C--O 1.221 -0.4 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -116.25 107.41 14.82 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.805 0.336 . . . . 0.0 111.19 -173.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.555 ' HB ' ' HB ' ' A' ' 246' ' ' VAL . 99.7 t -135.68 124.89 40.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.726 179.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' PHE . . . . . 0.406 ' O ' ' HA ' ' A' ' 272' ' ' ILE . 3.9 t80 -117.27 122.93 45.31 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.744 0.307 . . . . 0.0 110.446 -177.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.701 ' HG ' HG22 ' A' ' 272' ' ' ILE . 5.5 mp -106.01 132.76 51.71 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.039 176.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . 0.68 ' HA2' HG22 ' A' ' 243' ' ' ILE . . . -140.75 59.32 0.57 Allowed Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.441 -0.885 . . . . 0.0 113.475 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . 0.552 ' HB3' ' HA ' ' A' ' 270' ' ' ARG . 57.5 t30 -179.17 33.4 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.328 0.585 . . . . 0.0 110.156 175.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.612 HD23 ' HG2' ' A' ' 270' ' ' ARG . 2.0 mt -76.27 161.13 76.13 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.113 -177.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.424 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 66.3 Cg_endo -73.98 162.18 39.62 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.253 1.969 . . . . 0.0 111.023 174.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -77.6 120.99 23.33 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 178.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 106.94 -1.58 35.7 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.193 -1.003 . . . . 0.0 113.046 -179.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' ILE . . . . . 0.675 HG23 HG21 ' A' ' 237' ' ' ILE . 4.5 tp -59.31 128.48 20.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.961 0.41 . . . . 0.0 110.803 179.036 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . 0.476 HG22 ' HG3' ' A' ' 221' ' ' GLU . 9.8 t -113.56 158.84 20.27 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-O 121.296 0.569 . . . . 0.0 110.91 -178.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.533 ' CD ' ' H ' ' A' ' 219' ' ' GLU . 7.0 mp0 -62.39 -39.33 92.87 Favored 'General case' 0 C--O 1.21 -0.978 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.138 -174.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 220' ' ' ASP . . . . . 0.455 ' O ' ' HG2' ' A' ' 224' ' ' GLU . 16.3 t70 -54.22 -35.04 62.0 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 123.429 0.455 . . . . 0.0 110.987 -178.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . 0.476 ' HG3' HG22 ' A' ' 218' ' ' THR . 45.9 mt-10 -67.27 -57.2 7.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.325 178.22 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . 0.564 HD12 HD11 ' A' ' 237' ' ' ILE . 6.9 mt -60.28 -41.79 88.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.563 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' ARG . . . . . 0.751 ' HG3' HD12 ' A' ' 235' ' ' ILE . 64.0 mtp180 -53.19 -62.8 1.42 Allowed 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 174.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.455 ' HG2' ' O ' ' A' ' 220' ' ' ASP . 8.8 pt-20 -58.53 -23.51 58.4 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.849 -176.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -88.55 -31.75 18.51 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.697 -176.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.775 HD23 ' HZ ' ' A' ' 248' ' ' PHE . 8.0 mp -105.7 -19.31 13.8 Favored 'General case' 0 CA--C 1.517 -0.307 0 C-N-CA 120.684 -0.406 . . . . 0.0 112.085 -171.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 227' ' ' GLU . . . . . 0.662 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 33.9 mt-10 -64.82 -33.55 8.68 Favored Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -176.471 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 228' ' ' PRO . . . . . 0.662 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 75.8 Cg_endo -65.63 -29.16 52.2 Favored 'Trans proline' 0 C--N 1.358 1.05 0 C-N-CA 121.34 1.36 . . . . 0.0 112.014 -175.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . 0.526 ' CE1' ' HA ' ' A' ' 226' ' ' LEU . 4.4 p90 -111.16 3.97 18.91 Favored 'General case' 0 C--O 1.223 -0.338 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.366 174.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . 0.573 ' CA ' ' HB1' ' A' ' 253' ' ' ALA . . . 178.8 99.88 0.13 Allowed Glycine 0 N--CA 1.441 -1.007 0 C-N-CA 120.045 -1.074 . . . . 0.0 112.725 -177.168 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -66.34 134.98 38.03 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 121.833 1.689 . . . . 0.0 111.28 178.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.634 HG21 HG12 ' A' ' 235' ' ' ILE . 3.5 mp -106.48 151.96 8.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.28 178.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 233' ' ' ASP . . . . . 0.552 ' OD2' ' HB3' ' A' ' 249' ' ' LEU . 8.9 m-20 -104.54 -28.8 11.07 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.3 179.215 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . 0.494 ' H ' HG22 ' A' ' 232' ' ' ILE . 13.1 tt0 -151.66 130.55 12.5 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.825 -173.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . 0.751 HD12 ' HG3' ' A' ' 223' ' ' ARG . 15.0 mt -136.7 110.26 8.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.923 -179.322 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.421 ' O ' ' HA ' ' A' ' 244' ' ' ALA . 84.9 tttt -111.29 112.42 24.17 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.131 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 237' ' ' ILE . . . . . 0.675 HG21 HG23 ' A' ' 217' ' ' ILE . 78.2 mt -104.79 118.06 51.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 121.084 0.468 . . . . 0.0 111.12 -179.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.589 ' HB ' HG13 ' A' ' 243' ' ' ILE . 46.8 t -99.2 87.81 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 171.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 9.5 t -64.94 -21.03 66.76 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.466 -175.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -58.13 -38.71 77.04 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.718 175.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . 0.72 ' HB2' HG12 ' A' ' 243' ' ' ILE . 72.4 mtp180 -112.41 3.0 16.66 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.39 -177.134 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 14.8 m120 66.07 28.87 10.24 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.877 0.37 . . . . 0.0 110.543 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.72 HG12 ' HB2' ' A' ' 241' ' ' ARG . 1.2 pt -121.35 150.34 24.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.312 -174.24 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . 0.522 ' HB3' ' HB2' ' A' ' 210' ' ' LEU . . . -144.75 140.7 28.7 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.674 -178.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -111.19 115.51 29.5 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.433 177.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . 0.57 HG13 HG12 ' A' ' 235' ' ' ILE . 1.6 t -113.48 139.63 37.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.312 -174.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 247' ' ' HIS . . . . . 0.774 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 59.4 m170 -111.38 101.93 10.35 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.459 176.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . 0.775 ' HZ ' HD23 ' A' ' 226' ' ' LEU . 39.6 m-85 -89.28 98.52 11.81 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.164 176.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.661 ' HA ' ' HE ' ' A' ' 206' ' ' ARG . 0.2 OUTLIER -47.58 -44.62 26.46 Favored 'General case' 0 N--CA 1.464 0.232 0 O-C-N 124.24 0.962 . . . . 0.0 112.618 -173.509 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 250' ' ' ASN . . . . . 0.425 ' HB2' ' HB2' ' A' ' 253' ' ' ALA . 12.5 m120 -85.81 135.78 33.58 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 176.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 251' ' ' ILE . . . . . 0.598 ' O ' HG13 ' A' ' 255' ' ' ILE . 0.2 OUTLIER -62.63 -40.69 89.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 -177.411 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -70.78 -27.38 63.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.524 -177.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . 0.573 ' HB1' ' CA ' ' A' ' 230' ' ' GLY . . . -62.87 -41.36 99.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.106 -179.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 254' ' ' ALA . . . . . 0.59 ' HB2' ' HB2' ' A' ' 248' ' ' PHE . . . -69.13 -41.04 77.87 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.561 178.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.598 HG13 ' O ' ' A' ' 251' ' ' ILE . 11.0 mt -56.05 -60.74 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.045 -178.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . 0.454 ' HE2' ' HB2' ' A' ' 229' ' ' PHE . 13.5 ptmt -63.3 -39.78 95.52 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.496 -176.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -61.29 -48.16 82.67 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.71 0.29 . . . . 0.0 111.351 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . 0.532 HG13 HG12 ' A' ' 272' ' ' ILE . 54.9 t -66.76 -24.38 32.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.995 179.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 16.5 mm100 -84.52 -25.94 28.42 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 177.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . 0.438 ' HG2' ' O ' ' A' ' 256' ' ' LYS . 59.3 mm-40 -93.89 -33.96 13.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.634 0.254 . . . . 0.0 110.987 -175.243 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.807 HD23 HG21 ' A' ' 272' ' ' ILE . 0.8 OUTLIER -51.6 -51.32 70.78 Favored Pre-proline 0 CA--C 1.537 0.478 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.515 -179.619 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 262' ' ' PRO . . . . . 0.595 ' HD3' HD11 ' A' ' 272' ' ' ILE . 43.1 Cg_endo -66.75 -17.57 52.41 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.381 2.054 . . . . 0.0 112.762 -177.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 62.9 mt -95.22 -1.19 52.16 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.274 0.559 . . . . 0.0 111.525 -176.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 264' ' ' ASN . . . . . 0.489 ' O ' ' HB2' ' A' ' 268' ' ' SER . 14.4 m-80 -105.62 148.69 36.84 Favored Pre-proline 0 C--N 1.317 -0.846 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.244 -178.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -63.05 -40.84 31.6 Favored 'Trans proline' 0 C--N 1.335 -0.143 0 C-N-CA 123.298 2.666 . . . . 0.0 112.74 -169.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 12.6 mtpt -86.2 -42.71 13.59 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.461 0.648 . . . . 0.0 110.133 -176.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 267' ' ' TRP . . . . . 0.726 ' CE3' HD12 ' A' ' 261' ' ' LEU . 17.1 m0 -73.98 -28.04 61.28 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.835 -176.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . 0.489 ' HB2' ' O ' ' A' ' 264' ' ' ASN . 12.8 t -65.71 -18.32 65.25 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.186 0.517 . . . . 0.0 110.577 177.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -71.71 -9.04 57.68 Favored 'General case' 0 C--O 1.225 -0.224 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.105 174.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 270' ' ' ARG . . . . . 0.612 ' HG2' HD23 ' A' ' 213' ' ' LEU . 0.0 OUTLIER -112.86 143.17 44.57 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.392 -179.745 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 35.5 mmt180 -94.2 109.0 20.83 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.283 177.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . 0.807 HG21 HD23 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -121.91 140.91 44.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.418 0.628 . . . . 0.0 111.38 -178.627 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -152.26 169.86 21.45 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.372 174.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 274' ' ' TYR . . . . . 0.488 ' OH ' ' HA ' ' A' ' 255' ' ' ILE . 74.2 m-85 . . . . . 0 C--N 1.321 -0.662 0 CA-C-O 121.224 0.535 . . . . 0.0 109.827 176.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' ARG . . . . . 0.789 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 29.8 mtm180 . . . . . 0 C--O 1.223 -0.339 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 18.9 m-80 -108.18 106.19 16.26 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-O 121.232 0.539 . . . . 0.0 111.385 -173.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.481 ' HB ' ' HB ' ' A' ' 246' ' ' VAL . 61.1 t -134.56 111.93 14.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.012 177.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' PHE . . . . . 0.427 ' HE1' ' HB ' ' A' ' 243' ' ' ILE . 1.7 t80 -109.96 122.08 46.74 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.973 0.416 . . . . 0.0 110.361 -174.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.53 ' HG ' HG22 ' A' ' 272' ' ' ILE . 6.2 mp -106.81 133.93 50.73 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.613 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . 0.643 ' HA2' HG22 ' A' ' 243' ' ' ILE . . . -136.92 61.3 0.61 Allowed Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.548 -0.834 . . . . 0.0 113.097 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . 0.425 ' HB2' ' O ' ' A' ' 211' ' ' GLY . 2.3 t30 175.61 53.92 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.066 0.46 . . . . 0.0 110.612 175.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.625 HD23 ' HG2' ' A' ' 270' ' ' ARG . 0.7 OUTLIER -102.53 155.6 36.31 Favored Pre-proline 0 C--N 1.316 -0.862 0 N-CA-C 110.043 -0.355 . . . . 0.0 110.043 178.012 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -77.18 165.82 27.36 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.502 2.135 . . . . 0.0 112.163 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -75.94 118.82 19.12 Favored 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 177.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 109.51 2.59 30.93 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.255 -0.974 . . . . 0.0 112.56 -178.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 217' ' ' ILE . . . . . 0.652 HG23 HG21 ' A' ' 237' ' ' ILE . 6.3 tp -68.23 129.03 32.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.941 0.401 . . . . 0.0 110.36 175.306 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . 0.465 ' CG2' ' HG3' ' A' ' 221' ' ' GLU . 10.6 t -113.65 156.84 23.0 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-O 121.397 0.618 . . . . 0.0 111.041 179.147 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.561 ' CD ' ' H ' ' A' ' 219' ' ' GLU . 5.1 mp0 -60.92 -35.98 78.11 Favored 'General case' 0 C--O 1.21 -0.986 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.615 -179.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -54.39 -35.69 63.12 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.845 -179.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . 0.465 ' HG3' ' CG2' ' A' ' 218' ' ' THR . 42.9 mt-10 -69.91 -57.65 4.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.565 178.426 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . 0.532 HD12 HD11 ' A' ' 237' ' ' ILE . 8.1 mt -59.49 -42.81 89.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.488 -178.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 223' ' ' ARG . . . . . 0.839 ' HG3' HD12 ' A' ' 235' ' ' ILE . 45.0 mtp85 -55.86 -61.92 2.04 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 176.197 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -57.19 -21.73 35.49 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.925 -178.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -89.67 -30.73 17.89 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 116.021 -0.536 . . . . 0.0 112.055 -178.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.713 HD23 ' HZ ' ' A' ' 248' ' ' PHE . 8.4 mp -106.41 -19.26 13.74 Favored 'General case' 0 C--O 1.225 -0.215 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -171.207 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 227' ' ' GLU . . . . . 0.669 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 41.4 mt-10 -66.87 -31.43 3.99 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -175.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 228' ' ' PRO . . . . . 0.669 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 71.7 Cg_endo -65.73 -28.13 51.99 Favored 'Trans proline' 0 C--N 1.357 1.013 0 C-N-CA 121.442 1.428 . . . . 0.0 112.16 -176.225 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . 0.48 ' CE1' ' HA ' ' A' ' 226' ' ' LEU . 3.8 p90 -111.04 -0.72 16.55 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.752 0.31 . . . . 0.0 111.399 173.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . 0.568 ' CA ' ' HB1' ' A' ' 253' ' ' ALA . . . -175.43 95.51 0.1 Allowed Glycine 0 N--CA 1.442 -0.914 0 C-N-CA 120.128 -1.034 . . . . 0.0 112.466 -176.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -62.45 130.47 30.19 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.12 1.88 . . . . 0.0 111.634 178.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.656 HG21 HG12 ' A' ' 246' ' ' VAL . 2.4 mp -109.47 148.26 13.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.315 178.166 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 233' ' ' ASP . . . . . 0.487 ' CG ' HD22 ' A' ' 249' ' ' LEU . 44.4 m-20 -110.18 -24.26 10.8 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.003 0.43 . . . . 0.0 110.704 179.106 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . 0.43 ' H ' HG22 ' A' ' 232' ' ' ILE . 15.7 tt0 -142.8 122.13 13.08 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.548 -174.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . 0.839 HD12 ' HG3' ' A' ' 223' ' ' ARG . 10.5 mt -135.95 110.96 11.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.912 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.428 ' O ' ' HA ' ' A' ' 244' ' ' ALA . 62.4 tttp -113.31 110.55 20.54 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.541 -176.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 237' ' ' ILE . . . . . 0.652 HG21 HG23 ' A' ' 217' ' ' ILE . 76.2 mt -101.84 119.51 50.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.115 0.484 . . . . 0.0 111.041 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.57 ' HB ' HG13 ' A' ' 243' ' ' ILE . 43.6 t -103.98 88.24 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 173.395 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 10.0 t -62.48 -25.13 67.84 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.16 -177.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -55.59 -39.98 71.44 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 121.069 0.462 . . . . 0.0 110.392 176.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . 0.737 ' HB2' HG12 ' A' ' 243' ' ' ILE . 99.2 mtt180 -111.31 5.86 20.09 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.847 -178.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 16.6 m120 62.93 28.76 16.44 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.083 177.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.737 HG12 ' HB2' ' A' ' 241' ' ' ARG . 1.3 pt -121.28 154.22 25.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.104 -173.025 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . 0.444 ' HB3' ' HB2' ' A' ' 210' ' ' LEU . . . -144.92 138.37 26.85 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.441 -178.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -107.09 114.17 28.08 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.394 177.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . 0.656 HG12 HG21 ' A' ' 232' ' ' ILE . 0.7 OUTLIER -109.83 127.82 66.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -179.229 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 247' ' ' HIS . . . . . 0.789 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 48.9 m170 -107.95 101.83 11.06 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.038 -0.665 . . . . 0.0 111.319 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . 0.713 ' HZ ' HD23 ' A' ' 226' ' ' LEU . 34.1 m-85 -87.49 99.18 11.84 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.149 178.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.501 ' H ' HD23 ' A' ' 249' ' ' LEU . 0.1 OUTLIER -42.27 -43.3 3.39 Favored 'General case' 0 N--CA 1.467 0.375 0 O-C-N 124.564 1.165 . . . . 0.0 112.651 -177.612 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 57.1 m-20 -90.87 135.36 33.78 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 177.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 251' ' ' ILE . . . . . 0.561 ' O ' HG13 ' A' ' 255' ' ' ILE . 0.2 OUTLIER -62.99 -40.96 91.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -178.69 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -69.06 -31.77 70.77 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 120.786 0.327 . . . . 0.0 110.662 -177.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . 0.568 ' HB1' ' CA ' ' A' ' 230' ' ' GLY . . . -59.53 -42.14 91.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.353 179.095 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 254' ' ' ALA . . . . . 0.587 ' HB2' ' HB2' ' A' ' 248' ' ' PHE . . . -68.24 -40.52 81.96 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.655 178.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.561 HG13 ' O ' ' A' ' 251' ' ' ILE . 6.9 mt -56.49 -61.13 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.272 -178.305 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 12.8 ptmt -62.3 -39.23 92.32 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.439 -177.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -62.09 -48.88 78.2 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.639 0.257 . . . . 0.0 111.508 179.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . 0.546 HG13 HG12 ' A' ' 272' ' ' ILE . 70.1 t -66.3 -23.34 31.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.009 0.433 . . . . 0.0 111.05 179.062 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -85.06 -21.76 29.24 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 177.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -95.32 -36.75 11.27 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.895 0.379 . . . . 0.0 110.911 -177.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.749 HD23 HG21 ' A' ' 272' ' ' ILE . 1.1 mp -51.94 -47.74 90.22 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.956 -177.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 262' ' ' PRO . . . . . 0.575 ' HD2' ' N ' ' A' ' 261' ' ' LEU . 41.1 Cg_endo -67.49 -19.05 49.27 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.145 1.896 . . . . 0.0 112.711 -178.592 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 65.6 mt -95.53 -3.72 46.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.971 0.415 . . . . 0.0 111.811 -175.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 264' ' ' ASN . . . . . 0.494 ' O ' ' HB2' ' A' ' 268' ' ' SER . 14.1 m-80 -105.65 148.42 36.38 Favored Pre-proline 0 C--N 1.316 -0.878 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.761 -176.408 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -67.32 -32.97 31.65 Favored 'Trans proline' 0 N--CA 1.466 -0.098 0 C-N-CA 123.255 2.636 . . . . 0.0 112.652 -169.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.2 -45.13 12.3 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-O 121.825 0.821 . . . . 0.0 109.289 -178.31 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 267' ' ' TRP . . . . . 0.727 ' CE3' HD12 ' A' ' 261' ' ' LEU . 10.2 m0 -78.76 -25.23 44.43 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.947 -172.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . 0.494 ' HB2' ' O ' ' A' ' 264' ' ' ASN . 12.5 t -66.8 -19.13 65.68 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.834 0.35 . . . . 0.0 110.782 178.199 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -71.7 -21.51 61.77 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 121.013 0.435 . . . . 0.0 110.239 175.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 270' ' ' ARG . . . . . 0.625 ' HG2' HD23 ' A' ' 213' ' ' LEU . 2.6 mpt_? -99.76 141.43 32.58 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.424 -178.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . 0.412 ' HD3' ' HA ' ' A' ' 271' ' ' ARG . 26.7 mmt180 -94.13 106.2 18.18 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 179.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . 0.749 HG21 HD23 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -112.48 141.38 28.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.992 0.425 . . . . 0.0 111.207 -176.093 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -152.6 168.86 24.2 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.158 171.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 274' ' ' TYR . . . . . 0.541 ' OH ' ' HA ' ' A' ' 255' ' ' ILE . 64.7 m-85 . . . . . 0 C--N 1.325 -0.473 0 CA-C-O 120.81 0.338 . . . . 0.0 110.577 173.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' ARG . . . . . 0.851 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 30.7 mtm180 . . . . . 0 C--O 1.22 -0.477 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -104.42 105.16 15.18 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 119.974 -0.691 . . . . 0.0 111.496 -171.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 61.9 t -136.14 116.33 17.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.384 177.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' PHE . . . . . 0.429 ' O ' ' HA ' ' A' ' 272' ' ' ILE . 3.4 t80 -113.5 126.52 55.4 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.447 -176.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.742 ' HG ' HG22 ' A' ' 272' ' ' ILE . 5.6 mp -110.65 131.37 55.11 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.553 178.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . 0.593 ' HA2' HG22 ' A' ' 243' ' ' ILE . . . -139.07 66.46 0.52 Allowed Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.621 -0.799 . . . . 0.0 113.396 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . 0.556 ' HB3' ' HA ' ' A' ' 270' ' ' ARG . 40.2 t30 177.08 36.47 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.183 0.516 . . . . 0.0 110.014 176.437 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.842 HD23 ' HG2' ' A' ' 270' ' ' ARG . 1.3 mt -89.16 158.27 46.9 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.466 -178.131 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -81.98 163.96 17.88 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.541 2.16 . . . . 0.0 111.42 176.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . 0.532 ' HA ' ' OG1' ' A' ' 239' ' ' THR . 14.8 m120 -78.42 127.89 32.84 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.104 178.334 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 108.76 -8.87 34.41 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.473 -177.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 217' ' ' ILE . . . . . 0.668 HG23 HG21 ' A' ' 237' ' ' ILE . 4.3 tp -61.41 126.85 20.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-O 121.146 0.498 . . . . 0.0 110.376 178.063 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . 0.562 HG22 ' HG3' ' A' ' 221' ' ' GLU . 5.1 t -113.77 161.2 17.83 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 121.35 0.595 . . . . 0.0 110.999 -178.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.554 ' CD ' ' H ' ' A' ' 219' ' ' GLU . 7.7 mp0 -62.84 -41.7 99.45 Favored 'General case' 0 C--O 1.209 -1.035 0 CA-C-N 115.113 -0.948 . . . . 0.0 109.887 -175.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -50.33 -37.16 35.34 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 123.584 0.553 . . . . 0.0 111.175 -179.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . 0.562 ' HG3' HG22 ' A' ' 218' ' ' THR . 44.6 mt-10 -68.44 -56.23 9.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.553 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . 0.543 HD12 HD11 ' A' ' 237' ' ' ILE . 6.9 mt -62.17 -40.64 88.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.382 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 223' ' ' ARG . . . . . 0.634 ' HG3' HD12 ' A' ' 235' ' ' ILE . 25.6 mtp85 -53.15 -64.12 0.92 Allowed 'General case' 0 CA--C 1.509 -0.631 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 174.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -58.04 -21.02 43.44 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.855 -176.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -86.22 -33.31 20.79 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.703 -178.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.786 HD23 ' HZ ' ' A' ' 248' ' ' PHE . 7.5 mp -107.2 -14.44 14.9 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -171.173 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 227' ' ' GLU . . . . . 0.628 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 24.5 mm-40 -61.01 -37.68 46.87 Favored Pre-proline 0 C--N 1.328 -0.353 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -178.322 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 228' ' ' PRO . . . . . 0.628 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 97.2 Cg_endo -66.52 -27.51 46.25 Favored 'Trans proline' 0 C--N 1.36 1.134 0 C-N-CA 121.687 1.591 . . . . 0.0 112.295 -171.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . 0.54 ' CZ ' ' HA ' ' A' ' 226' ' ' LEU . 3.8 p90 -110.91 -7.05 14.6 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.686 176.308 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . 0.411 ' CA ' ' HB1' ' A' ' 253' ' ' ALA . . . -171.8 98.72 0.13 Allowed Glycine 0 N--CA 1.442 -0.906 0 C-N-CA 120.045 -1.074 . . . . 0.0 112.347 -175.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . 0.403 ' HD2' ' HA2' ' A' ' 230' ' ' GLY . 18.2 Cg_endo -63.9 133.17 37.59 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 121.904 1.736 . . . . 0.0 111.256 177.452 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.811 HG21 HG12 ' A' ' 246' ' ' VAL . 2.4 mp -109.54 147.7 13.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.905 178.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 233' ' ' ASP . . . . . 0.476 ' CG ' HD22 ' A' ' 249' ' ' LEU . 14.4 m-20 -108.89 -24.46 11.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.731 178.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . 0.597 ' HB3' ' HB2' ' A' ' 247' ' ' HIS . 21.4 tt0 -140.06 121.81 15.4 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.305 -173.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . 0.634 HD12 ' HG3' ' A' ' 223' ' ' ARG . 18.6 mt -136.83 111.14 9.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.111 0.481 . . . . 0.0 110.158 -178.357 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 22.1 ttmm -115.77 109.34 17.54 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.41 -179.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 237' ' ' ILE . . . . . 0.668 HG21 HG23 ' A' ' 217' ' ' ILE . 73.2 mt -99.72 118.24 46.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-O 121.043 0.449 . . . . 0.0 110.323 177.156 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.552 ' HB ' HG13 ' A' ' 243' ' ' ILE . 40.8 t -102.14 86.1 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 172.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . 0.532 ' OG1' ' HA ' ' A' ' 215' ' ' ASN . 8.9 t -70.19 -19.02 63.2 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.274 -176.045 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -60.83 -33.62 73.31 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.951 174.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . 0.46 ' HB2' HG12 ' A' ' 243' ' ' ILE . 98.9 mtt180 -114.94 4.24 14.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.791 -179.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 17.3 m120 65.93 27.76 10.77 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.23 0.612 . . . . 0.0 111.419 176.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.593 HG22 ' HA2' ' A' ' 211' ' ' GLY . 1.4 pt -123.07 155.08 28.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.294 -175.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . 0.475 ' HB3' ' HB2' ' A' ' 210' ' ' LEU . . . -144.38 141.47 29.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.989 0.423 . . . . 0.0 111.569 179.284 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -112.73 115.41 28.49 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.64 176.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . 0.811 HG12 HG21 ' A' ' 232' ' ' ILE . 0.3 OUTLIER -111.48 129.41 66.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 -179.124 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 247' ' ' HIS . . . . . 0.851 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 32.4 m170 -107.79 102.78 11.96 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.006 -0.677 . . . . 0.0 111.357 178.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . 0.786 ' HZ ' HD23 ' A' ' 226' ' ' LEU . 33.2 m-85 -84.82 103.17 13.66 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.811 177.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.476 HD22 ' CG ' ' A' ' 233' ' ' ASP . 0.1 OUTLIER -43.29 -39.46 3.06 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 124.505 1.128 . . . . 0.0 113.068 -174.306 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -99.71 137.94 37.49 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 176.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 251' ' ' ILE . . . . . 0.605 ' O ' HG13 ' A' ' 255' ' ' ILE . 0.2 OUTLIER -58.51 -41.65 82.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.918 -179.289 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -69.22 -30.67 68.88 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 116.756 -0.202 . . . . 0.0 111.09 -176.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . 0.411 ' HB1' ' CA ' ' A' ' 230' ' ' GLY . . . -62.35 -39.14 92.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.221 178.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 254' ' ' ALA . . . . . 0.6 ' HB2' ' HB2' ' A' ' 248' ' ' PHE . . . -69.53 -41.79 75.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.799 178.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.605 HG13 ' O ' ' A' ' 251' ' ' ILE . 11.4 mt -56.11 -60.61 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.105 -178.049 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . 0.521 ' O ' ' HG2' ' A' ' 260' ' ' GLU . 12.3 ptmt -61.22 -39.73 91.34 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.515 -178.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -62.61 -47.9 81.75 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.628 0.252 . . . . 0.0 111.4 179.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . 0.484 HG13 HG12 ' A' ' 272' ' ' ILE . 53.7 t -66.63 -26.27 36.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.9 0.381 . . . . 0.0 111.221 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . 0.523 ' HA ' ' OE1' ' A' ' 259' ' ' GLN . 10.4 mm-40 -84.3 -28.71 26.94 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 177.469 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . 0.521 ' HG2' ' O ' ' A' ' 256' ' ' LYS . 37.1 mm-40 -92.91 -26.02 17.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.445 0.164 . . . . 0.0 111.423 -175.279 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.803 HD23 HG21 ' A' ' 272' ' ' ILE . 0.6 OUTLIER -54.23 -52.55 67.84 Favored Pre-proline 0 CA--C 1.537 0.465 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.981 176.412 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 262' ' ' PRO . . . . . 0.554 ' HD2' ' N ' ' A' ' 261' ' ' LEU . 37.7 Cg_endo -67.18 -15.92 47.45 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.503 2.135 . . . . 0.0 112.828 -178.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' A' ' 259' ' ' GLN . 46.1 mt -85.06 -9.07 58.36 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.126 0.489 . . . . 0.0 111.151 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 -105.15 148.7 36.64 Favored Pre-proline 0 C--N 1.316 -0.887 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.108 -175.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -66.38 -34.73 33.81 Favored 'Trans proline' 0 C--N 1.336 -0.085 0 C-N-CA 123.546 2.831 . . . . 0.0 112.689 -170.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 5.1 mtpt -86.25 -45.22 11.48 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 121.465 0.65 . . . . 0.0 109.714 -177.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 267' ' ' TRP . . . . . 0.795 ' HE3' ' HA ' ' A' ' 261' ' ' LEU . 14.3 m0 -75.97 -30.11 58.5 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.757 -173.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 29.5 t -65.9 -18.81 65.59 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.958 0.409 . . . . 0.0 110.749 178.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . 0.408 ' C ' ' HD2' ' A' ' 270' ' ' ARG . 96.8 mttt -77.3 -8.38 57.54 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 121.139 0.495 . . . . 0.0 110.206 176.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 270' ' ' ARG . . . . . 0.842 ' HG2' HD23 ' A' ' 213' ' ' LEU . 3.6 mpt_? -111.11 141.51 44.51 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 178.061 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 31.9 mmm180 -92.36 110.27 21.67 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 -176.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . 0.803 HG21 HD23 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -121.46 142.41 37.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.534 0.683 . . . . 0.0 111.571 -178.259 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -151.76 169.31 22.51 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.679 173.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 . . . . . 0 C--N 1.324 -0.533 0 O-C-N 123.117 0.261 . . . . 0.0 110.301 175.221 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' ARG . . . . . 0.832 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 59.6 mtm180 . . . . . 0 C--O 1.222 -0.383 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -100.08 104.66 16.24 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 119.743 -0.783 . . . . 0.0 111.213 -172.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 67.8 t -137.45 123.73 27.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.134 176.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' PHE . . . . . 0.43 ' HE1' ' HB ' ' A' ' 243' ' ' ILE . 4.2 t80 -121.38 125.41 46.89 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 120.752 0.311 . . . . 0.0 110.251 -177.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.484 HD22 HD21 ' A' ' 213' ' ' LEU . 4.6 mp -108.28 126.09 52.43 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.39 177.427 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . 0.628 ' HA2' HG22 ' A' ' 243' ' ' ILE . . . -129.76 57.52 0.72 Allowed Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.304 -0.951 . . . . 0.0 113.343 -178.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . 0.542 ' HB3' ' HA ' ' A' ' 270' ' ' ARG . 2.1 t30 178.19 45.12 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.045 0.45 . . . . 0.0 111.027 178.166 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.484 HD21 HD22 ' A' ' 210' ' ' LEU . 0.7 OUTLIER -92.94 160.99 32.72 Favored Pre-proline 0 C--N 1.317 -0.814 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 176.971 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.444 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 87.9 Cg_endo -80.17 165.23 21.58 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.527 2.151 . . . . 0.0 111.188 176.06 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . 0.519 ' HA ' ' OG1' ' A' ' 239' ' ' THR . 28.2 t-20 -78.72 128.19 33.09 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 106.6 -2.98 36.57 Favored Glycine 0 C--N 1.315 -0.622 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.589 -178.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 217' ' ' ILE . . . . . 0.73 HG23 HG21 ' A' ' 237' ' ' ILE . 4.5 tp -64.71 127.99 26.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.224 0.535 . . . . 0.0 110.71 177.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 14.1 t -113.92 155.75 25.24 Favored 'General case' 0 C--O 1.24 0.602 0 CA-C-O 121.328 0.585 . . . . 0.0 111.075 -178.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.428 ' H ' ' CD ' ' A' ' 219' ' ' GLU . 1.5 mp0 -61.25 -37.26 82.44 Favored 'General case' 0 C--O 1.209 -1.055 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.365 -177.152 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -51.71 -36.0 45.15 Favored 'General case' 0 C--N 1.321 -0.632 0 O-C-N 123.464 0.478 . . . . 0.0 111.064 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -73.58 -55.56 6.15 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.316 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . 0.584 HD12 HD11 ' A' ' 237' ' ' ILE . 11.1 mt -60.17 -43.66 93.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.63 -179.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 223' ' ' ARG . . . . . 0.673 ' HG3' HD12 ' A' ' 235' ' ' ILE . 51.2 mtp180 -52.19 -63.11 1.25 Allowed 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 175.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -60.13 -19.46 53.69 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.077 -177.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 225' ' ' ASP . . . . . 0.478 ' HB3' ' CZ2' ' A' ' 267' ' ' TRP . 19.6 m-20 -87.32 -33.18 19.3 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.569 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.787 HD23 ' HZ ' ' A' ' 248' ' ' PHE . 8.2 mp -106.73 -18.25 14.0 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -170.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 227' ' ' GLU . . . . . 0.676 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 40.6 mt-10 -71.16 -24.41 0.72 Allowed Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -175.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 228' ' ' PRO . . . . . 0.676 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 74.7 Cg_endo -67.73 -26.76 38.69 Favored 'Trans proline' 0 C--N 1.36 1.184 0 C-N-CA 121.286 1.324 . . . . 0.0 112.05 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . 0.527 ' CZ ' ' HA ' ' A' ' 226' ' ' LEU . 3.6 p90 -110.55 -12.82 14.32 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.674 174.217 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . 0.448 ' HA2' ' HB1' ' A' ' 253' ' ' ALA . . . -165.01 96.06 0.13 Allowed Glycine 0 N--CA 1.441 -1.021 0 C-N-CA 120.319 -0.943 . . . . 0.0 111.939 -175.13 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . 0.4 ' HD2' ' HA2' ' A' ' 230' ' ' GLY . 18.9 Cg_endo -63.36 130.55 28.85 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.157 1.905 . . . . 0.0 111.423 178.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.934 HG21 HG12 ' A' ' 246' ' ' VAL . 2.1 mp -109.8 146.3 15.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.387 178.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 233' ' ' ASP . . . . . 0.541 ' OD2' HD22 ' A' ' 249' ' ' LEU . 7.7 m-20 -109.92 -22.43 11.86 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.909 0.385 . . . . 0.0 110.755 177.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . 0.617 ' HB3' ' HB2' ' A' ' 247' ' ' HIS . 30.9 tt0 -135.23 119.5 17.78 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.404 -176.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . 0.673 HD12 ' HG3' ' A' ' 223' ' ' ARG . 15.2 mt -136.96 106.57 4.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.852 -179.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -112.46 108.55 17.73 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.37 -179.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 237' ' ' ILE . . . . . 0.73 HG21 HG23 ' A' ' 217' ' ' ILE . 66.3 mt -99.99 117.77 45.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.548 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.607 ' HB ' HG13 ' A' ' 243' ' ' ILE . 45.2 t -100.1 87.44 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 172.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . 0.519 ' OG1' ' HA ' ' A' ' 215' ' ' ASN . 14.0 t -64.77 -20.68 66.5 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.647 -175.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -67.74 -28.32 67.54 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.896 178.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . 0.578 ' HB2' HG12 ' A' ' 243' ' ' ILE . 81.9 mtt180 -120.13 5.12 10.82 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.653 -176.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 18.2 m120 66.12 24.75 10.86 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.33 175.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.628 HG22 ' HA2' ' A' ' 211' ' ' GLY . 1.6 pt -122.01 149.45 25.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.51 -173.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . 0.45 ' HB3' ' HB2' ' A' ' 210' ' ' LEU . . . -141.58 135.31 29.93 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.187 179.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -107.06 112.87 26.0 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.579 177.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . 0.934 HG12 HG21 ' A' ' 232' ' ' ILE . 0.1 OUTLIER -112.5 128.81 68.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.876 -176.944 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 247' ' ' HIS . . . . . 0.832 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 27.4 m170 -109.57 104.04 13.01 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.362 0.601 . . . . 0.0 111.313 178.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . 0.787 ' HZ ' HD23 ' A' ' 226' ' ' LEU . 30.4 m-85 -86.49 99.99 12.06 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.669 178.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.541 HD22 ' OD2' ' A' ' 233' ' ' ASP . 0.0 OUTLIER -37.37 -49.3 0.98 Allowed 'General case' 0 N--CA 1.469 0.511 0 O-C-N 124.654 1.221 . . . . 0.0 113.334 -176.131 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -90.95 139.48 30.72 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.109 177.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 251' ' ' ILE . . . . . 0.527 ' O ' HG13 ' A' ' 255' ' ' ILE . 0.2 OUTLIER -59.55 -41.35 84.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.047 -176.795 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -71.99 -30.88 65.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.981 -175.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . 0.448 ' HB1' ' HA2' ' A' ' 230' ' ' GLY . . . -59.33 -39.58 83.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.391 178.06 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 254' ' ' ALA . . . . . 0.621 ' HB2' ' HB2' ' A' ' 248' ' ' PHE . . . -69.19 -41.91 76.53 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.693 178.229 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.527 HG13 ' O ' ' A' ' 251' ' ' ILE . 8.4 mt -56.97 -60.85 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.247 -177.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . 0.488 ' O ' ' HG2' ' A' ' 260' ' ' GLU . 10.8 ptmt -61.17 -38.5 86.7 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.339 -177.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -61.95 -48.53 80.0 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.625 0.25 . . . . 0.0 111.344 178.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . 0.519 HG13 HG12 ' A' ' 272' ' ' ILE . 55.3 t -68.37 -24.02 29.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.878 0.371 . . . . 0.0 111.057 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -84.52 -23.78 29.63 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 177.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . 0.488 ' HG2' ' O ' ' A' ' 256' ' ' LYS . 68.7 mm-40 -95.83 -31.68 13.04 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.679 0.276 . . . . 0.0 110.972 -176.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.755 ' HA ' ' HE3' ' A' ' 267' ' ' TRP . 0.7 OUTLIER -52.46 -49.13 87.29 Favored Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.689 179.849 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 262' ' ' PRO . . . . . 0.577 ' HD2' ' N ' ' A' ' 261' ' ' LEU . 48.6 Cg_endo -67.75 -15.7 44.81 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.352 2.035 . . . . 0.0 112.81 -178.434 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 56.4 mt -87.45 -8.66 56.23 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.499 0.666 . . . . 0.0 111.072 -178.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 -106.77 149.64 38.7 Favored Pre-proline 0 C--N 1.311 -1.065 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.133 -171.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -65.36 -39.44 22.44 Favored 'Trans proline' 0 C--O 1.231 0.137 0 C-N-CA 123.424 2.749 . . . . 0.0 112.768 -168.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 10.1 mtpt -86.33 -44.42 12.1 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.385 0.612 . . . . 0.0 109.615 -176.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 267' ' ' TRP . . . . . 0.755 ' HE3' ' HA ' ' A' ' 261' ' ' LEU . 17.7 m0 -70.98 -32.34 69.16 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.008 -0.997 . . . . 0.0 110.869 -175.414 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 22.7 t -64.19 -24.26 67.61 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.739 0.305 . . . . 0.0 110.799 179.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -71.02 -15.6 62.57 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.239 0.543 . . . . 0.0 110.124 177.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 270' ' ' ARG . . . . . 0.542 ' HA ' ' HB3' ' A' ' 212' ' ' ASN . 1.6 mpt_? -93.84 156.03 16.87 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.13 174.17 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 6.1 mmp_? -103.82 105.54 15.78 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 173.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . 0.714 HG21 HD23 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -113.45 138.25 43.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.303 0.573 . . . . 0.0 110.667 -176.571 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -152.85 167.77 27.98 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.149 175.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 274' ' ' TYR . . . . . 0.512 ' OH ' ' HA ' ' A' ' 255' ' ' ILE . 80.6 m-85 . . . . . 0 C--N 1.321 -0.645 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.537 173.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 206' ' ' ARG . . . . . 0.839 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 44.0 mtp180 . . . . . 0 C--O 1.219 -0.505 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -97.5 106.34 18.64 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 119.246 0.93 . . . . 0.0 112.146 -169.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.505 ' HB ' ' HB ' ' A' ' 246' ' ' VAL . 57.3 t -137.28 121.21 22.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.076 -0.966 . . . . 0.0 109.819 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 209' ' ' PHE . . . . . 0.43 ' O ' ' HA ' ' A' ' 272' ' ' ILE . 10.5 t80 -114.57 126.81 55.34 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.743 0.306 . . . . 0.0 110.906 -178.244 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.738 ' HG ' HG22 ' A' ' 272' ' ' ILE . 4.8 mp -110.3 128.07 55.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.372 175.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . 0.596 ' HA2' HG22 ' A' ' 243' ' ' ILE . . . -137.82 66.32 0.54 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.383 -0.913 . . . . 0.0 113.046 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . 0.59 ' HB3' ' HA ' ' A' ' 270' ' ' ARG . 3.4 t30 177.58 43.07 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.332 0.586 . . . . 0.0 110.004 176.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.688 HD23 ' HG2' ' A' ' 270' ' ' ARG . 1.1 mt -94.83 161.16 29.48 Favored Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.966 -179.474 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -83.05 167.9 13.9 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.458 2.105 . . . . 0.0 111.533 176.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . 0.484 ' HA ' ' OG1' ' A' ' 239' ' ' THR . 53.7 t30 -78.28 124.69 28.37 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.078 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 107.78 -4.38 34.32 Favored Glycine 0 C--N 1.314 -0.663 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.925 -177.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 217' ' ' ILE . . . . . 0.676 HG23 HG21 ' A' ' 237' ' ' ILE . 5.1 tp -60.75 126.74 19.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.05 0.453 . . . . 0.0 110.384 177.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . 0.488 HG22 ' HG3' ' A' ' 221' ' ' GLU . 15.1 t -114.43 158.77 21.11 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.076 0.465 . . . . 0.0 111.077 -178.116 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.627 ' HB3' ' HD2' ' A' ' 223' ' ' ARG . 2.3 mp0 -57.88 -44.46 86.68 Favored 'General case' 0 C--O 1.205 -1.274 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.523 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -42.75 -39.69 2.54 Favored 'General case' 0 C--N 1.319 -0.728 0 O-C-N 123.959 0.787 . . . . 0.0 111.66 178.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . 0.488 ' HG3' HG22 ' A' ' 218' ' ' THR . 43.7 mt-10 -70.74 -60.54 2.19 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.876 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . 0.644 HD12 HD11 ' A' ' 237' ' ' ILE . 10.8 mt -62.64 -41.6 92.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.665 -176.393 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 223' ' ' ARG . . . . . 0.854 ' HG3' HD12 ' A' ' 235' ' ' ILE . 46.3 mtt-85 -54.85 -62.28 1.76 Allowed 'General case' 0 CA--C 1.507 -0.678 0 CA-C-N 116.21 -0.45 . . . . 0.0 112.162 176.163 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -56.03 -25.23 43.89 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.47 -178.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 225' ' ' ASP . . . . . 0.466 ' HB3' ' CZ2' ' A' ' 267' ' ' TRP . 19.3 m-20 -83.22 -33.3 26.14 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.615 -176.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.808 HD23 ' HZ ' ' A' ' 248' ' ' PHE . 7.2 mp -106.72 -12.16 15.61 Favored 'General case' 0 C--O 1.224 -0.242 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -171.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 227' ' ' GLU . . . . . 0.65 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 15.1 mm-40 -62.31 -37.23 34.81 Favored Pre-proline 0 C--N 1.327 -0.387 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.211 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 228' ' ' PRO . . . . . 0.65 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 71.7 Cg_endo -65.33 -30.3 53.93 Favored 'Trans proline' 0 C--N 1.358 1.046 0 C-N-CA 121.569 1.513 . . . . 0.0 112.248 -172.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . 0.512 ' CE1' ' HA ' ' A' ' 226' ' ' LEU . 3.5 p90 -110.53 -6.69 14.84 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.935 177.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . 0.493 ' CA ' ' HB1' ' A' ' 253' ' ' ALA . . . -170.2 96.19 0.11 Allowed Glycine 0 N--CA 1.441 -1.006 0 C-N-CA 119.849 -1.167 . . . . 0.0 112.395 -176.139 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . 0.458 ' HA ' ' OE2' ' A' ' 227' ' ' GLU . 17.9 Cg_endo -63.21 129.76 26.59 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 121.704 1.603 . . . . 0.0 111.41 178.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.586 HG21 HG12 ' A' ' 246' ' ' VAL . 2.3 mp -107.38 151.99 9.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.644 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 233' ' ' ASP . . . . . 0.423 ' CG ' HD22 ' A' ' 249' ' ' LEU . 26.2 m-20 -114.51 -21.77 10.15 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.645 177.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . 0.458 ' H ' HG22 ' A' ' 232' ' ' ILE . 21.5 tt0 -141.19 120.42 12.99 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.648 -178.011 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . 0.854 HD12 ' HG3' ' A' ' 223' ' ' ARG . 6.1 mt -134.61 106.23 7.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.311 177.292 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.423 ' O ' ' HA ' ' A' ' 244' ' ' ALA . 35.0 ttmt -106.58 107.46 18.48 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.981 -177.314 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 237' ' ' ILE . . . . . 0.676 HG21 HG23 ' A' ' 217' ' ' ILE . 87.9 mt -100.62 114.31 39.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-O 121.267 0.556 . . . . 0.0 110.52 -179.394 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.532 ' HB ' HG13 ' A' ' 243' ' ' ILE . 45.9 t -100.52 85.87 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 173.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . 0.484 ' OG1' ' HA ' ' A' ' 215' ' ' ASN . 12.3 t -71.75 -13.04 61.59 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.075 -176.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -57.37 -41.83 80.95 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.804 170.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . 0.537 ' HB2' HG12 ' A' ' 243' ' ' ILE . 75.3 mtt180 -116.06 8.79 14.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.126 -177.271 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 68.7 25.9 6.3 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.298 174.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.596 HG22 ' HA2' ' A' ' 211' ' ' GLY . 2.1 pt -122.23 151.14 25.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.33 -173.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . 0.47 ' HB3' ' HB2' ' A' ' 210' ' ' LEU . . . -141.52 135.61 30.35 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.977 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -108.8 115.08 29.4 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.688 177.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . 0.586 HG12 HG21 ' A' ' 232' ' ' ILE . 1.5 t -108.71 141.02 25.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.612 -176.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 247' ' ' HIS . . . . . 0.839 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 11.5 m80 -122.39 101.94 7.8 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.584 0.707 . . . . 0.0 111.668 174.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . 0.808 ' HZ ' HD23 ' A' ' 226' ' ' LEU . 33.2 m-85 -84.87 101.95 12.7 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 114.581 -1.19 . . . . 0.0 110.896 178.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.485 ' H ' HD23 ' A' ' 249' ' ' LEU . 0.1 OUTLIER -43.62 -39.37 3.5 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 124.344 1.028 . . . . 0.0 112.882 -175.92 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 250' ' ' ASN . . . . . 0.413 ' HB2' ' HB2' ' A' ' 253' ' ' ALA . 37.5 m-20 -93.73 140.17 29.96 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.128 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 251' ' ' ILE . . . . . 0.547 ' O ' HG13 ' A' ' 255' ' ' ILE . 0.2 OUTLIER -63.4 -43.95 98.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -178.75 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . 0.41 ' O ' ' HG2' ' A' ' 256' ' ' LYS . . . -70.16 -30.72 67.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.647 0.26 . . . . 0.0 110.617 -177.303 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . 0.493 ' HB1' ' CA ' ' A' ' 230' ' ' GLY . . . -58.14 -44.12 87.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.261 178.487 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 254' ' ' ALA . . . . . 0.573 ' HB2' ' HB2' ' A' ' 248' ' ' PHE . . . -68.56 -39.58 81.0 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.566 178.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.699 ' HA ' ' OH ' ' A' ' 274' ' ' TYR . 3.5 mt -57.37 -60.89 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.513 -179.219 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . 0.417 ' O ' ' HG2' ' A' ' 260' ' ' GLU . 13.2 ptmt -62.92 -38.67 91.9 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.184 -176.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -61.96 -49.95 74.08 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.514 0.19 . . . . 0.0 111.514 179.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . 0.508 HG13 HG12 ' A' ' 272' ' ' ILE . 53.0 t -64.21 -27.19 42.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.1 0.476 . . . . 0.0 110.998 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -84.53 -21.25 30.58 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 178.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . 0.417 ' HG2' ' O ' ' A' ' 256' ' ' LYS . 67.1 mm-40 -94.81 -33.27 12.93 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 122.677 0.391 . . . . 0.0 110.989 -177.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.876 HD23 HG21 ' A' ' 272' ' ' ILE . 0.7 OUTLIER -51.84 -50.67 76.58 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.666 -178.915 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 262' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 261' ' ' LEU . 37.1 Cg_endo -66.76 -17.12 51.99 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.442 2.094 . . . . 0.0 112.807 -178.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 54.0 mt -90.27 -5.82 55.88 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.138 0.494 . . . . 0.0 111.624 -177.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 264' ' ' ASN . . . . . 0.417 ' HB2' ' CE3' ' A' ' 267' ' ' TRP . 17.1 m-80 -107.13 149.73 39.0 Favored Pre-proline 0 C--N 1.315 -0.922 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.507 -174.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -65.51 -37.57 29.15 Favored 'Trans proline' 0 N--CA 1.465 -0.16 0 C-N-CA 123.432 2.754 . . . . 0.0 112.825 -171.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . 0.435 ' HE3' ' HB2' ' A' ' 266' ' ' LYS . 0.0 OUTLIER -82.8 -44.77 15.14 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 121.736 0.779 . . . . 0.0 109.251 -177.139 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 267' ' ' TRP . . . . . 0.758 ' HE3' ' HA ' ' A' ' 261' ' ' LEU . 10.4 m0 -77.29 -29.39 53.72 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.581 -1.19 . . . . 0.0 111.115 -172.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 19.4 t -66.4 -17.56 64.85 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.976 0.417 . . . . 0.0 110.406 178.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -78.02 -8.08 57.72 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.237 0.542 . . . . 0.0 110.182 176.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 270' ' ' ARG . . . . . 0.688 ' HG2' HD23 ' A' ' 213' ' ' LEU . 3.6 mpt_? -108.97 165.02 11.89 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.816 177.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -111.59 119.12 37.63 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 177.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . 0.876 HG21 HD23 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -128.97 143.25 41.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.139 0.495 . . . . 0.0 111.476 -179.276 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -151.69 169.5 22.01 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.942 170.414 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 274' ' ' TYR . . . . . 0.699 ' OH ' ' HA ' ' A' ' 255' ' ' ILE . 69.9 m-85 . . . . . 0 C--N 1.324 -0.53 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 172.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 206' ' ' ARG . . . . . 0.79 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 19.0 mtm180 . . . . . 0 C--O 1.223 -0.33 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 16.9 m-80 -105.93 105.64 15.77 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 118.816 0.734 . . . . 0.0 111.644 -172.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 61.5 t -134.36 109.16 11.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.035 176.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 209' ' ' PHE . . . . . 0.451 ' HE1' ' HB ' ' A' ' 243' ' ' ILE . 2.6 t80 -106.33 124.7 49.99 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.183 -175.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.565 ' HG ' HG22 ' A' ' 272' ' ' ILE . 6.1 mp -109.17 132.87 53.71 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.167 178.388 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . 0.676 ' HA2' HG22 ' A' ' 243' ' ' ILE . . . -138.05 60.7 0.59 Allowed Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.235 -0.983 . . . . 0.0 113.326 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . 0.536 ' HB3' ' HA ' ' A' ' 270' ' ' ARG . 2.5 t30 179.95 41.38 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.938 0.399 . . . . 0.0 110.67 177.103 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.464 HD21 HD22 ' A' ' 210' ' ' LEU . 1.4 mp -93.77 157.29 38.41 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.545 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.415 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 86.9 Cg_endo -77.72 169.87 20.06 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.764 2.31 . . . . 0.0 112.472 179.39 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . 0.589 ' HA ' ' OG1' ' A' ' 239' ' ' THR . 13.9 m120 -78.36 123.76 27.35 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.634 176.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 108.75 -8.75 34.36 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.358 -0.925 . . . . 0.0 112.865 179.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 217' ' ' ILE . . . . . 0.627 HG23 HG21 ' A' ' 237' ' ' ILE . 4.8 tp -58.99 128.69 20.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.889 0.345 . . . . 0.0 110.107 178.347 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . 0.461 HG22 ' HG3' ' A' ' 221' ' ' GLU . 7.1 t -114.1 161.62 17.52 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.447 0.641 . . . . 0.0 111.235 -179.449 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.564 ' CD ' ' H ' ' A' ' 219' ' ' GLU . 1.6 mp0 -64.31 -40.4 95.84 Favored 'General case' 0 C--O 1.21 -0.99 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.849 -175.171 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 220' ' ' ASP . . . . . 0.529 ' O ' ' HG2' ' A' ' 224' ' ' GLU . 38.6 t70 -48.46 -41.44 29.54 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 123.803 0.689 . . . . 0.0 111.187 178.215 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . 0.461 ' HG3' HG22 ' A' ' 218' ' ' THR . 43.4 mt-10 -65.45 -56.81 10.43 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.332 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . 0.51 HD12 HD11 ' A' ' 237' ' ' ILE . 7.5 mt -61.07 -39.92 83.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.668 -179.117 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 223' ' ' ARG . . . . . 0.856 ' HG3' HD12 ' A' ' 235' ' ' ILE . 26.0 mtp180 -55.83 -62.77 1.47 Allowed 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 175.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.529 ' HG2' ' O ' ' A' ' 220' ' ' ASP . 9.1 pt-20 -60.92 -18.03 54.41 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.958 -178.057 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 225' ' ' ASP . . . . . 0.501 ' HB3' ' CZ2' ' A' ' 267' ' ' TRP . 44.0 m-20 -88.11 -35.2 17.6 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.288 -179.059 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.707 HD23 ' HZ ' ' A' ' 248' ' ' PHE . 8.0 mp -107.05 -17.63 14.12 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -169.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 227' ' ' GLU . . . . . 0.676 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 41.4 mt-10 -68.81 -27.27 1.33 Allowed Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -176.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 228' ' ' PRO . . . . . 0.676 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 71.6 Cg_endo -66.61 -27.83 45.33 Favored 'Trans proline' 0 C--N 1.36 1.171 0 C-N-CA 121.319 1.346 . . . . 0.0 111.94 -178.308 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . 0.541 ' CZ ' ' HA ' ' A' ' 226' ' ' LEU . 3.7 p90 -110.82 -7.6 14.6 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-O 120.734 0.302 . . . . 0.0 111.631 174.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . -170.09 95.55 0.11 Allowed Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.373 -0.918 . . . . 0.0 111.957 -175.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -60.94 132.43 42.15 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.016 1.811 . . . . 0.0 111.578 178.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.72 HG21 HG12 ' A' ' 246' ' ' VAL . 2.6 mp -109.99 149.92 12.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.766 178.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 233' ' ' ASP . . . . . 0.468 ' OD2' HD22 ' A' ' 249' ' ' LEU . 15.3 m-20 -115.63 -14.73 11.45 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.412 179.034 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . 0.497 ' H ' HG22 ' A' ' 232' ' ' ILE . 29.7 tt0 -148.35 120.87 8.52 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.518 -179.293 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . 0.856 HD12 ' HG3' ' A' ' 223' ' ' ARG . 17.1 mt -134.32 107.94 10.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.001 179.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -112.73 115.72 28.97 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.582 -177.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 237' ' ' ILE . . . . . 0.627 HG21 HG23 ' A' ' 217' ' ' ILE . 68.8 mt -104.74 121.88 57.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.932 -178.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 45.1 t -110.57 86.82 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 171.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . 0.589 ' OG1' ' HA ' ' A' ' 215' ' ' ASN . 8.2 t -68.16 -19.89 64.83 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.405 -175.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -56.19 -37.57 69.79 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.359 174.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . 0.493 ' HB2' HG12 ' A' ' 243' ' ' ILE . 98.8 mtt180 -107.05 0.25 23.45 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.776 179.215 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 242' ' ' ASN . . . . . 0.439 ' O ' HD12 ' A' ' 213' ' ' LEU . 18.7 m120 65.63 29.12 11.06 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.472 -179.284 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.676 HG22 ' HA2' ' A' ' 211' ' ' GLY . 1.7 pp -122.22 157.24 26.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.604 -174.255 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -149.13 141.05 23.73 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.034 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -109.81 113.77 26.78 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.851 177.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . 0.72 HG12 HG21 ' A' ' 232' ' ' ILE . 0.2 OUTLIER -107.47 126.33 63.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.434 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 247' ' ' HIS . . . . . 0.79 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 51.8 m170 -105.83 102.6 12.03 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.183 -0.607 . . . . 0.0 111.244 179.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . 0.707 ' HZ ' HD23 ' A' ' 226' ' ' LEU . 34.6 m-85 -87.38 102.37 14.47 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.887 -1.051 . . . . 0.0 111.274 178.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.508 ' H ' HD23 ' A' ' 249' ' ' LEU . 0.0 OUTLIER -40.94 -47.21 2.96 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 124.512 1.132 . . . . 0.0 113.382 -174.881 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -93.84 144.68 25.21 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.252 177.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 251' ' ' ILE . . . . . 0.596 ' O ' HG13 ' A' ' 255' ' ' ILE . 0.2 OUTLIER -61.33 -41.82 91.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.328 -177.167 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -71.34 -30.39 66.13 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 120.58 0.228 . . . . 0.0 110.952 -175.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -57.27 -41.59 79.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.208 177.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 254' ' ' ALA . . . . . 0.546 ' HB2' ' HB2' ' A' ' 248' ' ' PHE . . . -69.77 -40.64 75.96 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.594 178.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.596 HG13 ' O ' ' A' ' 251' ' ' ILE . 12.8 mt -57.38 -60.85 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.249 -178.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 10.6 ptmt -61.77 -38.12 86.84 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.552 -176.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -62.98 -49.38 74.91 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 111.556 0.206 . . . . 0.0 111.556 178.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . 0.436 HG13 HG12 ' A' ' 272' ' ' ILE . 52.3 t -65.21 -23.47 33.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.985 0.421 . . . . 0.0 110.86 179.251 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -83.75 -25.91 30.14 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 177.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -94.27 -33.09 13.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.842 0.353 . . . . 0.0 111.069 -175.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.706 HD12 ' CE3' ' A' ' 267' ' ' TRP . 0.7 OUTLIER -52.15 -49.63 83.51 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.483 -179.703 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 262' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 261' ' ' LEU . 50.6 Cg_endo -68.63 -14.18 38.85 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.486 2.124 . . . . 0.0 112.863 -178.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 60.1 mt -91.19 -6.22 53.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.476 0.655 . . . . 0.0 111.207 -179.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -106.64 149.13 38.02 Favored Pre-proline 0 C--N 1.315 -0.93 0 CA-C-N 115.346 -0.843 . . . . 0.0 112.272 -174.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -66.46 -36.92 24.77 Favored 'Trans proline' 0 CA--C 1.527 0.136 0 C-N-CA 123.429 2.753 . . . . 0.0 112.919 -171.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -86.07 -44.28 12.41 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-O 121.579 0.704 . . . . 0.0 109.935 -178.27 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 267' ' ' TRP . . . . . 0.706 ' CE3' HD12 ' A' ' 261' ' ' LEU . 15.9 m0 -74.54 -27.97 60.75 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.873 -174.503 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 33.1 t -67.8 -18.11 64.74 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.889 0.376 . . . . 0.0 110.679 176.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -71.34 -19.3 62.32 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.394 0.616 . . . . 0.0 109.571 175.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 270' ' ' ARG . . . . . 0.536 ' HA ' ' HB3' ' A' ' 212' ' ' ASN . 5.0 mpt_? -95.09 156.11 16.45 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.537 177.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . 0.431 ' NE ' ' HA ' ' A' ' 271' ' ' ARG . 4.9 mmp_? -105.48 106.3 16.74 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 172.452 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . 0.667 HG21 HD23 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -115.62 138.42 46.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.401 0.619 . . . . 0.0 111.155 -175.407 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -151.6 169.11 22.92 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.857 174.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 274' ' ' TYR . . . . . 0.468 ' OH ' ' HA ' ' A' ' 255' ' ' ILE . 77.8 m-85 . . . . . 0 C--N 1.321 -0.652 0 CA-C-O 120.862 0.363 . . . . 0.0 110.496 175.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 206' ' ' ARG . . . . . 0.788 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 31.2 mtm180 . . . . . 0 C--O 1.223 -0.312 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -105.51 104.95 14.78 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.156 0.503 . . . . 0.0 111.472 -172.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.451 ' HB ' ' HB ' ' A' ' 246' ' ' VAL . 58.8 t -134.63 117.43 23.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.33 177.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 209' ' ' PHE . . . . . 0.414 ' HE1' ' HB ' ' A' ' 243' ' ' ILE . 3.1 t80 -114.46 123.97 50.75 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 120.951 0.405 . . . . 0.0 110.463 -177.024 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.549 ' HG ' HG22 ' A' ' 272' ' ' ILE . 6.1 mp -107.86 135.21 49.65 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.172 176.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . 0.624 ' HA2' HG22 ' A' ' 243' ' ' ILE . . . -142.9 61.74 0.52 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.229 -0.986 . . . . 0.0 113.249 179.247 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 37.7 t30 179.03 41.94 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.928 0.394 . . . . 0.0 110.253 178.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.475 HD12 ' O ' ' A' ' 242' ' ' ASN . 1.1 mp -92.51 159.93 35.72 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.392 -179.304 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.44 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 91.6 Cg_endo -79.63 162.84 24.34 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.541 2.161 . . . . 0.0 111.739 176.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -77.41 119.92 21.69 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.541 179.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 109.72 0.52 30.58 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.473 -0.87 . . . . 0.0 112.615 -177.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 217' ' ' ILE . . . . . 0.608 HG23 HG21 ' A' ' 237' ' ' ILE . 5.5 tp -64.49 129.01 27.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.863 0.364 . . . . 0.0 110.163 175.174 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . 0.446 ' CG2' ' HG3' ' A' ' 221' ' ' GLU . 15.1 t -113.66 154.27 27.52 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 121.523 0.678 . . . . 0.0 110.917 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.475 ' CD ' ' H ' ' A' ' 219' ' ' GLU . 2.1 mp0 -62.78 -33.56 75.44 Favored 'General case' 0 C--O 1.206 -1.193 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.934 -178.319 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 220' ' ' ASP . . . . . 0.43 ' O ' ' HG2' ' A' ' 224' ' ' GLU . 15.7 t70 -49.48 -38.89 31.64 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.021 0.439 . . . . 0.0 110.811 176.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . 0.446 ' HG3' ' CG2' ' A' ' 218' ' ' THR . 42.1 mt-10 -70.77 -58.09 3.98 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.314 179.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . 0.509 HD12 HD11 ' A' ' 237' ' ' ILE . 8.6 mt -58.5 -41.79 82.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.815 -178.446 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 223' ' ' ARG . . . . . 0.671 ' HG3' HD12 ' A' ' 235' ' ' ILE . 49.4 mtp180 -57.61 -62.24 1.93 Allowed 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 177.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.43 ' HG2' ' O ' ' A' ' 220' ' ' ASP . 6.4 pt-20 -57.57 -24.23 55.07 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.731 -178.51 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -86.79 -31.42 20.9 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.854 -176.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.708 HD23 ' HZ ' ' A' ' 248' ' ' PHE . 8.0 mp -105.39 -20.21 13.56 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 120.609 -0.436 . . . . 0.0 112.167 -171.401 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 227' ' ' GLU . . . . . 0.677 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 36.6 mt-10 -68.99 -27.71 1.41 Allowed Pre-proline 0 C--N 1.325 -0.492 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -176.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 228' ' ' PRO . . . . . 0.677 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 71.5 Cg_endo -66.72 -28.77 43.66 Favored 'Trans proline' 0 C--N 1.359 1.081 0 C-N-CA 121.254 1.302 . . . . 0.0 112.07 -178.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . 0.501 ' CE1' ' HA ' ' A' ' 226' ' ' LEU . 3.9 p90 -111.15 4.13 19.06 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-O 120.69 0.281 . . . . 0.0 111.353 173.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . 0.488 ' CA ' ' HB1' ' A' ' 253' ' ' ALA . . . 177.25 98.9 0.11 Allowed Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 119.837 -1.173 . . . . 0.0 112.748 -177.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . 0.557 ' HA ' ' HG2' ' A' ' 227' ' ' GLU . 22.7 Cg_endo -63.38 134.29 44.32 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 121.904 1.736 . . . . 0.0 111.34 177.213 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.642 HG21 HG12 ' A' ' 246' ' ' VAL . 3.2 mp -107.7 151.06 9.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.642 178.208 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 233' ' ' ASP . . . . . 0.532 ' CG ' HD22 ' A' ' 249' ' ' LEU . 9.9 m-20 -106.84 -25.33 11.73 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.05 0.452 . . . . 0.0 110.319 178.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . 0.471 ' H ' HG22 ' A' ' 232' ' ' ILE . 30.8 tt0 -145.15 122.85 11.84 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.862 -175.057 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . 0.671 HD12 ' HG3' ' A' ' 223' ' ' ARG . 13.5 mt -136.13 109.35 8.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.909 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -119.21 120.42 37.01 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.475 -178.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 237' ' ' ILE . . . . . 0.608 HG21 HG23 ' A' ' 217' ' ' ILE . 64.7 mt -106.19 117.46 51.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.596 179.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.582 ' HB ' HG13 ' A' ' 243' ' ' ILE . 42.4 t -97.7 86.52 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 173.327 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 3.8 t -64.44 -23.15 67.19 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.291 -177.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -59.48 -36.08 75.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.073 0.463 . . . . 0.0 110.396 176.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . 0.684 ' HB2' HG12 ' A' ' 243' ' ' ILE . 74.6 mtt180 -113.91 3.37 15.39 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.632 -176.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 242' ' ' ASN . . . . . 0.475 ' O ' HD12 ' A' ' 213' ' ' LEU . 14.1 m120 66.42 27.36 9.92 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.996 176.502 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.684 HG12 ' HB2' ' A' ' 241' ' ' ARG . 1.5 pt -122.28 153.25 26.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.088 -174.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . 0.446 ' HB3' ' HB2' ' A' ' 210' ' ' LEU . . . -143.78 140.45 29.92 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.012 0.434 . . . . 0.0 111.083 -179.11 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -110.57 117.89 34.75 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.788 178.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . 0.642 HG12 HG21 ' A' ' 232' ' ' ILE . 0.6 OUTLIER -113.41 129.25 69.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -179.594 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 247' ' ' HIS . . . . . 0.788 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 48.2 m170 -109.33 101.9 10.85 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.064 -0.654 . . . . 0.0 111.414 178.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . 0.708 ' HZ ' HD23 ' A' ' 226' ' ' LEU . 41.5 m-85 -87.14 100.88 12.98 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.18 178.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.556 ' H ' HD23 ' A' ' 249' ' ' LEU . 0.1 OUTLIER -43.86 -45.77 7.64 Favored 'General case' 0 N--CA 1.463 0.217 0 O-C-N 124.464 1.102 . . . . 0.0 112.62 -176.174 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 250' ' ' ASN . . . . . 0.401 ' HB2' ' HB2' ' A' ' 253' ' ' ALA . 13.4 m120 -86.35 136.88 32.97 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 177.313 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 251' ' ' ILE . . . . . 0.589 ' O ' HG13 ' A' ' 255' ' ' ILE . 0.2 OUTLIER -60.76 -43.17 94.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.272 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -69.23 -30.74 68.96 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.027 -177.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . 0.488 ' HB1' ' CA ' ' A' ' 230' ' ' GLY . . . -61.69 -39.98 93.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.384 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 254' ' ' ALA . . . . . 0.61 ' HB2' ' HB2' ' A' ' 248' ' ' PHE . . . -69.14 -41.91 76.7 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.59 178.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.589 HG13 ' O ' ' A' ' 251' ' ' ILE . 11.7 mt -55.89 -60.91 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.054 -177.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 13.7 ptmt -62.17 -38.12 87.85 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.607 -176.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -64.7 -48.63 73.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.587 0.232 . . . . 0.0 111.422 178.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . 0.421 HG13 HG12 ' A' ' 272' ' ' ILE . 43.0 t -65.96 -23.27 31.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 120.865 0.365 . . . . 0.0 110.96 179.558 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . 0.547 ' HA ' ' OE1' ' A' ' 259' ' ' GLN . 9.9 mm-40 -84.83 -25.81 27.86 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 176.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 48.9 mm-40 -89.5 -36.44 15.39 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-O 120.791 0.329 . . . . 0.0 111.026 -177.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.739 HD12 ' CE3' ' A' ' 267' ' ' TRP . 0.8 OUTLIER -51.71 -48.3 87.69 Favored Pre-proline 0 CA--C 1.54 0.568 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.656 -178.808 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 262' ' ' PRO . . . . . 0.611 ' HD3' HD11 ' A' ' 272' ' ' ILE . 55.9 Cg_endo -69.67 -16.53 37.99 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.5 2.133 . . . . 0.0 112.926 -179.229 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 66.2 mt -92.8 -3.62 54.39 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.344 0.592 . . . . 0.0 111.162 -177.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -106.14 149.95 38.76 Favored Pre-proline 0 C--N 1.313 -1.002 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.376 -176.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -65.56 -41.47 15.02 Favored 'Trans proline' 0 C--N 1.34 0.124 0 C-N-CA 123.284 2.656 . . . . 0.0 112.774 -168.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 16.0 mtpt -86.89 -44.67 11.49 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.198 0.523 . . . . 0.0 109.799 -175.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 267' ' ' TRP . . . . . 0.739 ' CE3' HD12 ' A' ' 261' ' ' LEU . 24.4 m0 -67.81 -33.51 74.93 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.802 -176.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 29.1 t -63.94 -24.29 67.67 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.99 0.424 . . . . 0.0 111.014 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -71.78 -16.44 62.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.188 0.518 . . . . 0.0 110.134 177.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 270' ' ' ARG . . . . . 0.439 ' HB3' HD23 ' A' ' 210' ' ' LEU . 5.2 mpt_? -93.99 144.88 25.07 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 173.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . 0.486 ' NE ' ' HA ' ' A' ' 271' ' ' ARG . 5.0 mmp_? -94.2 105.76 17.75 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 177.05 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . 0.701 HG21 HD23 ' A' ' 261' ' ' LEU . 0.1 OUTLIER -116.93 136.56 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 CA-C-O 121.634 0.73 . . . . 0.0 111.24 -177.665 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -152.07 167.99 26.68 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.826 173.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 274' ' ' TYR . . . . . 0.541 ' OH ' ' HA ' ' A' ' 255' ' ' ILE . 90.9 m-85 . . . . . 0 C--N 1.319 -0.735 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.244 173.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 56.8 m-80 . . . . . 0 N--CA 1.48 1.052 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 21.8 t -139.84 94.44 2.77 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -149.4 -179.49 7.11 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.989 -176.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . 0.585 ' HA ' HD23 ' A' ' 196' ' ' LEU . 20.8 m -76.2 -51.94 11.07 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.804 -179.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 64.86 -88.64 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.016 0.526 . . . . 0.0 110.508 -177.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 5.1 p -127.38 6.86 6.37 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.395 0.617 . . . . 0.0 109.98 175.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . 0.449 ' O ' ' HB3' ' A' ' 191' ' ' SER . 6.2 m -100.03 138.02 37.68 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.628 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 3.3 m -86.37 90.37 3.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-O 121.523 0.678 . . . . 0.0 112.166 -179.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.603 ' O ' HG22 ' A' ' 199' ' ' VAL . 4.1 mm? -78.53 -16.05 57.91 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.497 0.665 . . . . 0.0 109.522 174.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 63.2 tp -64.85 -18.31 65.03 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.273 173.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -91.17 -27.96 18.17 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.307 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.603 HG22 ' O ' ' A' ' 196' ' ' LEU . 4.3 m -76.86 -11.27 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.119 0 CA-C-O 121.171 0.51 . . . . 0.0 110.643 -174.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 14.7 mm-40 -99.81 14.67 29.52 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.539 -179.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . 0.49 ' HB2' ' HD2' ' A' ' 274' ' ' TYR . 26.1 mm-40 -112.3 162.78 15.14 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.2 -177.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 7.8 t -167.32 -173.71 2.35 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 177.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 74.32 49.82 11.29 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.787 178.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -156.29 107.32 2.44 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.671 0.272 . . . . 0.0 110.424 178.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' CYS . . . . . 0.565 ' HB3' HG12 ' A' ' 251' ' ' ILE . 19.2 p -87.68 146.47 25.68 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 178.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . 0.821 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 45.2 mtm180 56.59 0.69 0.07 Allowed 'General case' 0 C--O 1.222 -0.381 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 177.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -103.23 105.17 15.4 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 118.984 0.811 . . . . 0.0 111.759 -170.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.455 ' HB ' ' HB ' ' A' ' 246' ' ' VAL . 61.3 t -138.31 126.76 30.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.571 179.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' PHE . . . . . 0.575 ' O ' ' HA ' ' A' ' 272' ' ' ILE . 17.9 t80 -117.31 131.73 56.75 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.659 178.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.685 ' HG ' HG22 ' A' ' 272' ' ' ILE . 2.5 mp -112.85 115.18 28.06 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.46 175.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . 0.652 ' HA2' HG22 ' A' ' 243' ' ' ILE . . . -124.59 67.18 0.52 Allowed Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.664 -0.779 . . . . 0.0 113.227 -177.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . 0.61 ' HB2' ' HG3' ' A' ' 271' ' ' ARG . 2.5 t30 168.93 51.29 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.124 0.57 . . . . 0.0 110.039 172.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.503 HD21 HD22 ' A' ' 210' ' ' LEU . 1.0 OUTLIER -92.38 162.75 29.04 Favored Pre-proline 0 C--N 1.313 -0.983 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.108 -179.972 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.438 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 71.9 Cg_endo -79.66 156.09 24.37 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 122.109 1.872 . . . . 0.0 111.333 174.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 39.6 t-20 -70.61 128.01 34.63 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 178.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 106.07 -7.04 40.6 Favored Glycine 0 C--N 1.315 -0.606 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.88 -178.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . 0.624 HG23 HG21 ' A' ' 237' ' ' ILE . 5.2 tp -59.83 126.71 18.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.124 0.488 . . . . 0.0 110.649 178.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . 0.547 HG22 ' HG3' ' A' ' 221' ' ' GLU . 6.9 t -112.43 154.87 25.16 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-O 121.251 0.548 . . . . 0.0 110.581 -179.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.458 ' CD ' ' H ' ' A' ' 219' ' ' GLU . 1.6 mp0 -58.88 -40.86 85.64 Favored 'General case' 0 C--O 1.21 -0.979 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.867 -176.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -50.74 -36.81 38.32 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 123.727 0.642 . . . . 0.0 111.262 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . 0.547 ' HG3' HG22 ' A' ' 218' ' ' THR . 42.2 mt-10 -68.47 -53.98 19.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.599 179.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.589 HD12 HD11 ' A' ' 237' ' ' ILE . 7.2 mt -61.96 -40.86 88.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.429 179.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . 0.776 ' HG3' HD12 ' A' ' 235' ' ' ILE . 61.7 mtp180 -53.99 -62.07 1.89 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.976 0.417 . . . . 0.0 111.955 174.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -59.03 -22.76 61.2 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.27 -178.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -89.07 -31.3 18.1 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.864 -177.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.832 HD23 ' HZ ' ' A' ' 248' ' ' PHE . 8.6 mp -106.56 -19.54 13.64 Favored 'General case' 0 C--O 1.223 -0.298 0 N-CA-C 112.257 0.465 . . . . 0.0 112.257 -170.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . 0.683 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 38.7 mt-10 -70.82 -26.35 0.95 Allowed Pre-proline 0 C--N 1.323 -0.556 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -175.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . 0.683 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 74.1 Cg_endo -65.33 -25.86 56.43 Favored 'Trans proline' 0 C--N 1.36 1.139 0 C-N-CA 121.202 1.268 . . . . 0.0 111.908 -178.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . 0.483 ' CE1' ' HA ' ' A' ' 226' ' ' LEU . 2.7 p90 -111.01 -17.37 13.29 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.726 173.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . -162.33 93.49 0.12 Allowed Glycine 0 N--CA 1.442 -0.949 0 C-N-CA 120.397 -0.906 . . . . 0.0 111.897 -173.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.542 ' HA ' ' HG2' ' A' ' 227' ' ' GLU . 17.5 Cg_endo -60.93 136.6 66.88 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.136 1.891 . . . . 0.0 111.677 178.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.76 HG21 HG12 ' A' ' 246' ' ' VAL . 2.8 mp -113.07 148.81 15.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.867 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . 0.429 ' CG ' HD22 ' A' ' 249' ' ' LEU . 11.5 m-20 -109.9 -20.2 12.84 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 120.894 0.378 . . . . 0.0 110.964 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . 0.564 ' HB3' ' HB2' ' A' ' 247' ' ' HIS . 31.3 tt0 -143.39 121.78 12.37 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.58 -176.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.776 HD12 ' HG3' ' A' ' 223' ' ' ARG . 14.2 mt -137.7 107.48 4.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.601 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 54.7 tttp -113.33 112.53 23.84 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.442 -178.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' ILE . . . . . 0.624 HG21 HG23 ' A' ' 217' ' ' ILE . 86.3 mt -103.2 121.72 54.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.902 -178.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.578 ' HB ' HG13 ' A' ' 243' ' ' ILE . 41.5 t -101.84 86.71 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 170.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 13.8 t -64.87 -22.22 66.95 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.792 -176.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -62.82 -30.92 71.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.534 177.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . 0.615 ' HB2' HG12 ' A' ' 243' ' ' ILE . 83.2 mtt180 -117.45 3.75 12.48 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.732 -176.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 16.8 m120 67.14 27.24 8.6 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.086 175.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.652 HG22 ' HA2' ' A' ' 211' ' ' GLY . 1.4 pt -122.73 151.54 26.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.526 -175.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . 0.468 ' HB3' ' HB2' ' A' ' 210' ' ' LEU . . . -143.7 138.04 28.59 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.227 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' PHE . . . . . 0.782 ' HZ ' ' HB ' ' A' ' 281' ' ' VAL . 21.5 m-85 -108.52 117.54 34.43 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.478 178.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.76 HG12 HG21 ' A' ' 232' ' ' ILE . 0.4 OUTLIER -113.94 138.47 43.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -176.209 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' HIS . . . . . 0.821 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 55.1 m170 -118.39 102.95 9.33 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.337 0.589 . . . . 0.0 111.147 175.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . 0.832 ' HZ ' HD23 ' A' ' 226' ' ' LEU . 33.6 m-85 -85.5 105.38 16.06 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.215 178.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.506 ' H ' HD23 ' A' ' 249' ' ' LEU . 0.1 OUTLIER -44.15 -45.34 8.22 Favored 'General case' 0 N--CA 1.467 0.398 0 O-C-N 124.389 1.056 . . . . 0.0 113.108 -173.474 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -95.86 142.89 27.57 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.401 -0.52 . . . . 0.0 110.209 177.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . 0.608 ' O ' HG13 ' A' ' 255' ' ' ILE . 0.2 OUTLIER -61.2 -42.5 93.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 -178.045 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -70.7 -28.38 64.7 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.001 -176.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -61.32 -41.48 97.08 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.146 178.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . 0.574 ' HB2' ' HB2' ' A' ' 248' ' ' PHE . . . -68.51 -41.45 79.94 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.67 178.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.615 ' HA ' ' OH ' ' A' ' 274' ' ' TYR . 11.4 mt -56.41 -59.89 2.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.402 -177.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . 0.49 ' O ' ' HG2' ' A' ' 260' ' ' GLU . 12.2 ptmt -61.63 -40.47 95.0 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.254 -177.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -63.3 -48.86 76.3 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 111.686 0.254 . . . . 0.0 111.686 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . 0.409 HG13 HG12 ' A' ' 272' ' ' ILE . 50.5 t -66.45 -24.0 32.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.957 0.408 . . . . 0.0 111.114 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 19.3 mm-40 -83.8 -24.82 30.86 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 177.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . 0.49 ' HG2' ' O ' ' A' ' 256' ' ' LYS . 27.5 mm-40 -95.17 -31.43 13.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.611 0.243 . . . . 0.0 111.273 -176.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.818 ' HA ' ' HE3' ' A' ' 267' ' ' TRP . 0.7 OUTLIER -52.17 -50.92 76.3 Favored Pre-proline 0 CA--C 1.537 0.471 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.255 179.362 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' A' ' 261' ' ' LEU . 42.0 Cg_endo -67.47 -17.87 49.02 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.441 2.094 . . . . 0.0 112.97 -178.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 59.0 mt -91.57 -5.58 53.78 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.068 0.461 . . . . 0.0 111.561 -177.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' ASN . . . . . 0.434 ' O ' ' HB2' ' A' ' 268' ' ' SER . 13.7 m-80 -105.34 145.89 31.68 Favored Pre-proline 0 C--N 1.313 -1.017 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.712 -175.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' PRO . . . . . 0.403 ' O ' ' HE3' ' A' ' 269' ' ' LYS . 51.9 Cg_endo -68.18 -26.65 36.03 Favored 'Trans proline' 0 C--N 1.334 -0.229 0 C-N-CA 123.332 2.688 . . . . 0.0 112.583 -170.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.463 ' HE3' ' NE1' ' A' ' 267' ' ' TRP . 0.0 OUTLIER -86.17 -46.3 10.53 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.958 0.885 . . . . 0.0 109.25 -178.837 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' TRP . . . . . 0.818 ' HE3' ' HA ' ' A' ' 261' ' ' LEU . 8.0 m0 -82.52 -24.12 34.25 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.478 -1.237 . . . . 0.0 110.6 -172.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . 0.434 ' HB2' ' O ' ' A' ' 264' ' ' ASN . 22.4 t -65.58 -18.01 65.0 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.034 0.445 . . . . 0.0 110.581 176.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . 0.403 ' HE3' ' O ' ' A' ' 265' ' ' PRO . 94.3 mttt -73.65 -13.75 61.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.316 0.579 . . . . 0.0 109.879 176.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' ARG . . . . . 0.529 ' HA ' ' HB3' ' A' ' 212' ' ' ASN . 0.0 OUTLIER -109.95 147.4 33.51 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.742 -179.705 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . 0.61 ' HG3' ' HB2' ' A' ' 212' ' ' ASN . 40.6 mtm180 -98.06 106.15 18.4 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.106 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . 0.721 HG21 HD23 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -116.61 143.33 27.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.147 -177.451 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' TYR . . . . . 0.413 ' CZ ' ' HD2' ' A' ' 209' ' ' PHE . 1.5 p90 -150.57 167.75 26.32 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.4 172.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' TYR . . . . . 0.615 ' OH ' ' HA ' ' A' ' 255' ' ' ILE . 74.2 m-85 -66.66 118.53 10.35 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.948 172.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -73.64 115.36 5.0 Favored Glycine 0 N--CA 1.44 -1.077 0 C-N-CA 120.334 -0.936 . . . . 0.0 112.205 -177.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . 0.718 ' HB2' ' HB2' ' A' ' 284' ' ' LYS . 38.8 mmt180 -77.27 133.04 38.94 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 174.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' ASP . . . . . 0.584 ' CG ' ' H ' ' A' ' 278' ' ' ARG . 30.0 t70 59.56 -164.96 0.2 Allowed 'General case' 0 CA--C 1.539 0.553 0 O-C-N 123.7 0.625 . . . . 0.0 109.761 -174.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' ARG . . . . . 0.584 ' H ' ' CG ' ' A' ' 277' ' ' ASP . 3.8 mpt_? -99.26 -19.94 16.83 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.264 0.555 . . . . 0.0 109.662 -177.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' CYS . . . . . . . . . . . . . 24.1 m -95.44 31.15 2.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.142 -175.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -74.45 82.23 1.95 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.777 -178.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' VAL . . . . . 0.782 ' HB ' ' HZ ' ' A' ' 245' ' ' PHE . 11.7 p -126.94 -26.32 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.149 173.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -152.82 -50.33 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 177.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 91.7 mt -107.62 101.47 10.79 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 175.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . 0.718 ' HB2' ' HB2' ' A' ' 276' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.662 -0.685 . . . . 0.0 110.285 -177.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 . . . . . 0 N--CA 1.479 0.979 0 CA-C-O 121.017 0.436 . . . . 0.0 110.471 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 40.9 m -114.65 -18.25 11.45 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.792 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.545 ' HB3' HD23 ' A' ' 263' ' ' LEU . . . -155.89 -179.28 7.98 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.573 -178.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 43.8 m -98.61 -42.36 7.3 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.887 0.375 . . . . 0.0 110.121 177.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -159.1 -56.25 0.06 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.048 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 71.5 m 62.89 81.92 0.19 Allowed 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.528 0.68 . . . . 0.0 109.463 -170.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 16.1 m -73.54 179.33 4.14 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.346 -174.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . 0.795 HG21 ' HE2' ' A' ' 274' ' ' TYR . 0.0 OUTLIER -127.78 51.12 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.397 -178.734 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 26.4 tp 60.9 29.47 19.03 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.645 0.736 . . . . 0.0 109.67 -179.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 9.2 mp 65.03 14.58 9.46 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 114.752 -1.113 . . . . 0.0 111.204 -177.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . 60.41 24.12 13.68 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.665 179.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.482 HG23 ' HG3' ' A' ' 200' ' ' GLN . 31.5 m -65.41 -22.71 31.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.767 0.318 . . . . 0.0 111.624 -178.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' GLN . . . . . 0.482 ' HG3' HG23 ' A' ' 199' ' ' VAL . 46.1 mt-30 -117.98 13.49 13.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.105 0.479 . . . . 0.0 110.122 176.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 -145.72 31.96 1.05 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.557 -173.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 17.5 m -69.49 -37.87 77.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.135 -176.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.405 ' HA3' ' NH1' ' A' ' 278' ' ' ARG . . . -118.76 39.97 2.4 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 120.366 -0.921 . . . . 0.0 112.429 -175.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -87.19 88.62 7.74 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 121.164 0.507 . . . . 0.0 109.645 178.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' CYS . . . . . 0.561 ' HA ' HG12 ' A' ' 251' ' ' ILE . 5.4 m -87.05 145.56 26.43 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.222 -176.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . 0.832 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 7.7 mtp180 55.15 6.65 0.15 Allowed 'General case' 0 C--O 1.219 -0.549 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 70.5 m-20 -106.6 105.8 16.01 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 118.953 0.797 . . . . 0.0 111.9 -172.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.487 ' HB ' ' HB ' ' A' ' 246' ' ' VAL . 59.4 t -135.4 118.19 22.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.041 177.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' PHE . . . . . 0.44 ' HE1' ' HB ' ' A' ' 243' ' ' ILE . 2.3 t80 -116.92 125.13 51.01 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.263 -176.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.579 ' HG ' HG22 ' A' ' 272' ' ' ILE . 5.6 mp -107.65 132.19 53.58 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.265 178.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . 0.624 ' HA2' HG22 ' A' ' 243' ' ' ILE . . . -137.64 62.09 0.58 Allowed Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.309 -0.948 . . . . 0.0 113.326 -179.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . 0.579 ' HB2' ' HG2' ' A' ' 271' ' ' ARG . 38.8 t30 177.64 38.38 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.775 0.321 . . . . 0.0 110.598 175.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.531 HD21 HD22 ' A' ' 210' ' ' LEU . 1.0 OUTLIER -87.26 158.82 51.8 Favored Pre-proline 0 C--N 1.319 -0.74 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 178.828 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.409 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 83.8 Cg_endo -78.42 161.47 28.47 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.403 2.068 . . . . 0.0 110.994 176.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . 0.59 ' HA ' ' OG1' ' A' ' 239' ' ' THR . 9.1 t-20 -78.41 127.46 32.22 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -179.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 108.21 -6.27 34.33 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.485 -176.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . 0.639 HG23 HG21 ' A' ' 237' ' ' ILE . 4.5 tp -61.57 129.41 24.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.884 0.373 . . . . 0.0 110.309 177.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . 0.475 ' CG2' ' HG3' ' A' ' 221' ' ' GLU . 15.2 t -112.83 155.9 23.84 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.4 0.619 . . . . 0.0 110.605 -179.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.494 ' CD ' ' H ' ' A' ' 219' ' ' GLU . 8.0 mp0 -63.95 -34.77 78.73 Favored 'General case' 0 C--O 1.206 -1.211 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.936 -176.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -54.69 -35.67 63.84 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 123.335 0.397 . . . . 0.0 110.591 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . 0.535 ' O ' ' HG2' ' A' ' 224' ' ' GLU . 46.1 mt-10 -67.03 -58.64 4.54 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.276 177.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.654 HD12 HD11 ' A' ' 237' ' ' ILE . 7.8 mt -61.24 -38.48 79.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.63 -178.068 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . 0.725 ' HG3' HD12 ' A' ' 235' ' ' ILE . 51.2 mtp180 -54.17 -63.14 1.25 Allowed 'General case' 0 CA--C 1.508 -0.645 0 CA-C-O 121.125 0.488 . . . . 0.0 111.693 174.358 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.535 ' HG2' ' O ' ' A' ' 221' ' ' GLU . 17.7 pt-20 -60.48 -17.38 44.69 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.03 -177.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' ASP . . . . . 0.501 ' HB3' ' CZ2' ' A' ' 267' ' ' TRP . 13.7 m-20 -89.23 -33.76 16.87 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.371 -179.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.71 HD23 ' HZ ' ' A' ' 248' ' ' PHE . 7.7 mp -106.98 -11.48 15.67 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 111.979 0.362 . . . . 0.0 111.979 -171.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . 0.641 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 53.3 mm-40 -62.97 -36.0 22.19 Favored Pre-proline 0 C--N 1.325 -0.468 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -178.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . 0.641 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 85.7 Cg_endo -66.21 -31.1 45.31 Favored 'Trans proline' 0 C--N 1.358 1.071 0 C-N-CA 121.43 1.42 . . . . 0.0 112.163 -173.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . 0.508 ' CZ ' ' HA ' ' A' ' 226' ' ' LEU . 4.0 p90 -110.21 -0.73 17.7 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.628 177.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . 0.429 ' HA2' ' HD2' ' A' ' 231' ' ' PRO . . . -177.21 94.61 0.1 OUTLIER Glycine 0 N--CA 1.441 -1.002 0 C-N-CA 119.658 -1.258 . . . . 0.0 112.64 -178.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.429 ' HD2' ' HA2' ' A' ' 230' ' ' GLY . 17.1 Cg_endo -59.53 131.54 40.98 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 121.877 1.718 . . . . 0.0 111.246 175.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.64 HG21 HG12 ' A' ' 246' ' ' VAL . 2.7 mp -106.86 151.9 8.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.423 178.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . 0.527 ' CG ' HD22 ' A' ' 249' ' ' LEU . 34.2 m-20 -109.93 -23.62 11.25 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.786 0.326 . . . . 0.0 110.223 179.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . 0.459 ' H ' HG22 ' A' ' 232' ' ' ILE . 13.7 tt0 -143.43 126.83 16.77 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.843 -177.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.725 HD12 ' HG3' ' A' ' 223' ' ' ARG . 15.6 mt -139.52 113.49 6.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.903 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -121.12 116.67 25.43 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.33 -178.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' ILE . . . . . 0.654 HD11 HD12 ' A' ' 222' ' ' ILE . 86.7 mt -104.76 126.01 59.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.434 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.578 ' HB ' HG13 ' A' ' 243' ' ' ILE . 42.1 t -103.8 85.51 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.046 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 169.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . 0.59 ' OG1' ' HA ' ' A' ' 215' ' ' ASN . 11.7 t -71.04 -16.56 62.61 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.637 -173.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -65.36 -33.0 74.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.117 174.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . 0.545 ' HB2' HG12 ' A' ' 243' ' ' ILE . 71.1 mtt180 -110.74 3.18 18.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.085 -178.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' ASN . . . . . 0.456 ' O ' HD12 ' A' ' 213' ' ' LEU . 16.1 m120 68.35 23.7 7.55 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.108 177.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.624 HG22 ' HA2' ' A' ' 211' ' ' GLY . 1.5 pt -122.43 150.65 26.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.466 -174.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . 0.449 ' HB3' ' HB2' ' A' ' 210' ' ' LEU . . . -143.19 139.47 30.32 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.053 0.454 . . . . 0.0 111.668 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -109.3 115.78 30.63 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.765 178.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.64 HG12 HG21 ' A' ' 232' ' ' ILE . 1.3 t -112.3 134.89 53.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -179.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' HIS . . . . . 0.832 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 33.5 m170 -112.98 101.7 9.72 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.016 -0.674 . . . . 0.0 111.309 177.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . 0.71 ' HZ ' HD23 ' A' ' 226' ' ' LEU . 34.5 m-85 -86.28 104.25 15.63 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-N 115.089 -0.96 . . . . 0.0 111.651 179.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.527 HD22 ' CG ' ' A' ' 233' ' ' ASP . 0.0 OUTLIER -42.85 -48.17 5.71 Favored 'General case' 0 N--CA 1.465 0.306 0 O-C-N 124.506 1.129 . . . . 0.0 112.975 -175.192 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 -93.37 141.4 28.49 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.112 176.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . 0.642 ' O ' HG13 ' A' ' 255' ' ' ILE . 0.3 OUTLIER -61.71 -39.94 85.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.027 -178.549 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -68.64 -31.72 71.07 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.995 -176.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . 0.423 ' HB1' ' CA ' ' A' ' 230' ' ' GLY . . . -61.68 -41.81 98.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.298 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . 0.56 ' HB2' ' HB2' ' A' ' 248' ' ' PHE . . . -67.17 -41.72 85.47 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.409 178.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.642 HG13 ' O ' ' A' ' 251' ' ' ILE . 10.6 mt -57.37 -59.45 3.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.065 -178.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . 0.421 ' O ' ' HG2' ' A' ' 260' ' ' GLU . 13.9 ptmt -62.27 -40.33 95.86 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.305 -177.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -61.55 -48.93 78.74 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.668 0.271 . . . . 0.0 111.184 178.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . 0.514 HG13 HG12 ' A' ' 272' ' ' ILE . 53.5 t -65.86 -26.33 38.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.907 0.384 . . . . 0.0 111.107 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 28.7 mm-40 -84.94 -24.61 28.31 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 178.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . 0.421 ' HG2' ' O ' ' A' ' 256' ' ' LYS . 71.9 mm-40 -95.3 -31.42 13.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.595 0.236 . . . . 0.0 111.026 -176.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.707 HD12 ' CE3' ' A' ' 267' ' ' TRP . 0.4 OUTLIER -50.91 -51.04 70.78 Favored Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.266 178.727 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' PRO . . . . . 0.566 ' HD2' ' N ' ' A' ' 261' ' ' LEU . 43.3 Cg_endo -67.42 -14.62 43.16 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.465 2.11 . . . . 0.0 112.698 -177.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . 0.545 HD23 ' HB3' ' A' ' 190' ' ' ALA . 52.6 mt -92.43 -4.69 53.34 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.175 0.512 . . . . 0.0 111.367 -179.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' ASN . . . . . 0.433 ' O ' ' HB2' ' A' ' 268' ' ' SER . 10.9 m-80 -106.18 149.42 38.15 Favored Pre-proline 0 C--N 1.315 -0.929 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.998 -175.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -63.9 -38.58 37.74 Favored 'Trans proline' 0 N--CA 1.465 -0.171 0 C-N-CA 123.421 2.747 . . . . 0.0 112.534 -169.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 7.1 mtpt -84.62 -45.09 12.86 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 121.648 0.737 . . . . 0.0 109.376 -177.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' TRP . . . . . 0.707 ' CE3' HD12 ' A' ' 261' ' ' LEU . 12.9 m0 -77.37 -27.6 52.63 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.737 -1.12 . . . . 0.0 111.058 -171.078 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . 0.451 ' HA ' ' HA ' ' A' ' 262' ' ' PRO . 12.0 t -65.47 -21.93 66.69 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.934 0.397 . . . . 0.0 110.547 178.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -72.7 -22.66 60.86 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.301 0.572 . . . . 0.0 110.069 177.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' ARG . . . . . 0.474 ' HA ' ' HB3' ' A' ' 212' ' ' ASN . 5.4 mpt_? -92.98 141.3 28.56 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 178.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . 0.579 ' HG2' ' HB2' ' A' ' 212' ' ' ASN . 37.5 mmt180 -93.02 105.93 17.96 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 178.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . 0.703 HG21 HD23 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -114.33 142.65 26.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.242 0.544 . . . . 0.0 111.42 -176.902 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -152.35 169.29 22.89 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.55 173.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 274' ' ' TYR . . . . . 0.795 ' HE2' HG21 ' A' ' 195' ' ' VAL . 85.2 m-85 -64.3 136.93 57.62 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.692 0.282 . . . . 0.0 110.41 173.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -65.93 171.46 26.96 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.053 176.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . 0.472 ' O ' ' HB3' ' A' ' 277' ' ' ASP . 16.5 mmt180 -87.49 152.67 22.03 Favored 'General case' 0 C--N 1.32 -0.702 0 O-C-N 122.735 -0.273 . . . . 0.0 110.335 -177.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 277' ' ' ASP . . . . . 0.472 ' HB3' ' O ' ' A' ' 276' ' ' ARG . 8.9 t70 68.55 150.07 0.07 Allowed 'General case' 0 CA--C 1.533 0.326 0 O-C-N 124.106 0.879 . . . . 0.0 110.678 -173.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 278' ' ' ARG . . . . . 0.405 ' NH1' ' HA3' ' A' ' 203' ' ' GLY . 60.9 mtt-85 -73.78 -35.08 64.92 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 122.082 -0.386 . . . . 0.0 111.626 -177.172 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' CYS . . . . . . . . . . . . . 73.1 m 59.71 25.15 14.09 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.299 0.571 . . . . 0.0 110.769 -175.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -110.5 18.8 19.4 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.144 -179.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 9.2 p -88.86 -19.16 7.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.655 -177.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -135.96 63.94 0.58 Allowed Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.118 178.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 83.4 mt -103.78 130.48 51.32 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.844 0.354 . . . . 0.0 110.552 178.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . 0.789 ' HE2' ' HA ' ' A' ' 284' ' ' LYS . 0.5 OUTLIER . . . . . 0 C--O 1.247 0.947 0 CA-C-O 118.511 -0.756 . . . . 0.0 109.941 178.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 . . . . . 0 N--CA 1.482 1.163 0 CA-C-O 120.734 0.302 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 17.0 p -87.33 -41.52 13.57 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.308 0.575 . . . . 0.0 110.119 176.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -118.47 -179.13 3.7 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.844 177.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 25.1 m 66.83 17.72 10.58 Favored 'General case' 0 N--CA 1.463 0.186 0 O-C-N 123.552 0.533 . . . . 0.0 110.682 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -93.6 160.37 14.81 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 178.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 13.3 m -73.41 92.56 1.86 Allowed 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.409 178.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 17.5 m -70.43 95.49 1.05 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 176.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 16.5 m -134.94 139.84 46.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.149 -175.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 89.0 mt -80.33 -4.0 51.71 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 167.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 56.9 tp -64.77 -23.37 67.22 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.742 -1.117 . . . . 0.0 109.165 169.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -64.34 -32.59 74.25 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.364 177.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 33.2 m -103.51 12.32 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 177.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 47.66 30.03 1.66 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.937 1.295 . . . . 0.0 113.203 177.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -139.33 124.89 19.34 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.17 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 48.7 m -159.42 127.88 5.09 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.375 -179.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.404 ' O ' HG12 ' A' ' 281' ' ' VAL . . . -82.87 48.17 3.96 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.939 -0.648 . . . . 0.0 111.986 177.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . 0.745 ' HA ' ' HA ' ' A' ' 280' ' ' ALA . . . -111.67 101.61 9.97 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 -179.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' CYS . . . . . 0.522 ' HA ' HG12 ' A' ' 251' ' ' ILE . 2.4 m -87.27 145.58 26.31 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -177.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . 0.912 ' HE ' ' HA ' ' A' ' 249' ' ' LEU . 16.9 mtp180 54.2 9.14 0.21 Allowed 'General case' 0 C--O 1.22 -0.483 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 176.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . 0.644 HD21 ' HB2' ' A' ' 277' ' ' ASP . 11.0 m120 -109.9 107.02 16.8 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-N 118.988 0.813 . . . . 0.0 112.493 -174.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.551 ' HB ' ' HB ' ' A' ' 246' ' ' VAL . 60.8 t -135.3 127.11 46.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 114.878 -1.055 . . . . 0.0 109.148 177.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' PHE . . . . . 0.446 ' O ' ' HA ' ' A' ' 272' ' ' ILE . 6.8 t80 -122.37 127.41 49.71 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-O 120.725 0.298 . . . . 0.0 110.307 -178.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.575 ' HG ' HG22 ' A' ' 272' ' ' ILE . 4.7 mp -109.77 126.03 53.32 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.335 176.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . 0.713 ' HA2' HG22 ' A' ' 243' ' ' ILE . . . -130.65 57.49 0.72 Allowed Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.265 -0.969 . . . . 0.0 113.373 -178.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . 0.498 ' HB3' ' HA ' ' A' ' 270' ' ' ARG . 2.8 t30 177.4 49.74 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.061 0.458 . . . . 0.0 110.509 177.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.556 HD21 HD22 ' A' ' 210' ' ' LEU . 1.0 OUTLIER -97.39 159.05 32.09 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.184 178.722 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.425 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 95.8 Cg_endo -79.85 154.46 23.09 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.326 2.017 . . . . 0.0 112.15 178.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . 0.545 ' HA ' ' OG1' ' A' ' 239' ' ' THR . 8.8 m120 -66.31 121.21 14.74 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.032 177.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 108.86 -1.97 31.86 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.451 -0.88 . . . . 0.0 112.876 -177.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . 0.583 HG23 HG21 ' A' ' 237' ' ' ILE . 5.7 tp -64.08 128.0 25.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.046 0.451 . . . . 0.0 110.525 175.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . 0.55 HG22 ' HG3' ' A' ' 221' ' ' GLU . 4.9 t -114.22 157.55 22.54 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.119 0.485 . . . . 0.0 110.575 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.425 ' CD ' ' H ' ' A' ' 219' ' ' GLU . 3.3 mp0 -61.66 -40.31 94.48 Favored 'General case' 0 C--O 1.208 -1.11 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.41 -175.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -51.46 -35.81 41.44 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 123.514 0.509 . . . . 0.0 111.029 -179.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . 0.55 ' HG3' HG22 ' A' ' 218' ' ' THR . 43.4 mt-10 -67.65 -55.9 11.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.303 178.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.572 HD12 HD11 ' A' ' 237' ' ' ILE . 8.0 mt -60.95 -41.21 88.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.537 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . 0.639 ' HG3' HD12 ' A' ' 235' ' ' ILE . 26.1 mtp180 -56.55 -61.81 2.16 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 175.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -57.16 -21.64 34.43 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.625 -178.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' ASP . . . . . 0.425 ' HB3' ' CZ2' ' A' ' 267' ' ' TRP . 12.8 m-20 -87.27 -33.98 19.07 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.746 -178.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.785 HD23 ' HZ ' ' A' ' 248' ' ' PHE . 7.7 mp -106.83 -18.01 14.05 Favored 'General case' 0 C--O 1.224 -0.247 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -170.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . 0.679 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 35.7 mt-10 -65.79 -31.58 4.95 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -175.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . 0.679 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 72.0 Cg_endo -65.94 -29.94 48.94 Favored 'Trans proline' 0 C--N 1.359 1.085 0 C-N-CA 121.459 1.439 . . . . 0.0 112.3 -176.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . 0.489 ' CE1' ' HA ' ' A' ' 226' ' ' LEU . 3.6 p90 -111.06 -4.22 15.18 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.579 176.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . -172.08 95.73 0.11 Allowed Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.127 -1.035 . . . . 0.0 112.478 -176.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -61.58 133.64 46.68 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.174 1.916 . . . . 0.0 111.43 177.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.698 HG21 HG12 ' A' ' 246' ' ' VAL . 2.5 mp -110.42 151.3 12.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.925 178.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . 0.462 ' OD2' HD22 ' A' ' 249' ' ' LEU . 6.7 m-20 -110.89 -25.49 9.82 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.92 177.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . 0.626 ' HB3' ' HB2' ' A' ' 247' ' ' HIS . 16.8 tt0 -138.82 120.57 15.3 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.551 -174.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.639 HD12 ' HG3' ' A' ' 223' ' ' ARG . 11.1 mt -137.08 107.73 5.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.99 178.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 63.1 tttp -115.81 113.79 23.87 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.364 -177.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' ILE . . . . . 0.583 HG21 HG23 ' A' ' 217' ' ' ILE . 86.4 mt -102.13 125.71 56.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-O 121.134 0.492 . . . . 0.0 110.955 -179.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.552 ' HB ' HG13 ' A' ' 243' ' ' ILE . 57.7 t -108.81 87.31 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 171.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . 0.545 ' OG1' ' HA ' ' A' ' 215' ' ' ASN . 14.4 t -68.91 -12.62 61.79 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.529 -177.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 18.6 mp0 -63.01 -35.48 80.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.986 175.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . 0.7 ' HB2' HG12 ' A' ' 243' ' ' ILE . 66.8 mtp180 -115.58 4.2 14.13 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.1 179.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' ASN . . . . . 0.446 ' O ' HD12 ' A' ' 213' ' ' LEU . 15.9 m120 65.85 30.56 9.93 Favored 'General case' 0 N--CA 1.465 0.278 0 O-C-N 123.446 0.466 . . . . 0.0 110.743 178.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.713 HG22 ' HA2' ' A' ' 211' ' ' GLY . 1.3 pt -122.06 149.72 25.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.158 -175.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -142.36 138.14 30.98 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.048 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -109.54 120.79 43.57 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.881 179.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.698 HG12 HG21 ' A' ' 232' ' ' ILE . 0.5 OUTLIER -116.3 136.16 54.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.981 -176.385 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' HIS . . . . . 0.827 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 20.1 m170 -114.45 102.97 10.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.191 0.519 . . . . 0.0 111.23 175.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . 0.785 ' HZ ' HD23 ' A' ' 226' ' ' LEU . 29.7 m-85 -85.76 103.79 14.86 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.014 178.006 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.912 ' HA ' ' HE ' ' A' ' 206' ' ' ARG . 0.1 OUTLIER -44.64 -39.28 4.91 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 124.218 0.949 . . . . 0.0 113.311 -172.998 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 57.9 m-20 -100.17 144.71 28.88 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 178.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . 0.584 ' O ' HG13 ' A' ' 255' ' ' ILE . 0.3 OUTLIER -63.89 -43.3 97.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -176.618 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -68.63 -31.12 70.04 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.111 -177.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -58.25 -42.88 87.39 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.541 179.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . 0.596 ' HB2' ' HB2' ' A' ' 248' ' ' PHE . . . -68.52 -41.67 79.63 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.614 178.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.584 HG13 ' O ' ' A' ' 251' ' ' ILE . 8.4 mt -57.03 -58.47 5.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.456 -177.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . 0.414 ' O ' ' HG2' ' A' ' 260' ' ' GLU . 11.1 ptmt -63.81 -38.79 92.42 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.395 -177.201 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -63.19 -49.83 72.72 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.632 0.253 . . . . 0.0 111.297 178.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . 0.57 HG13 HG12 ' A' ' 272' ' ' ILE . 70.3 t -66.8 -22.9 30.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 120.883 0.373 . . . . 0.0 111.09 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . 0.423 ' HG3' ' O ' ' A' ' 255' ' ' ILE . 63.9 mt-30 -83.53 -24.1 31.8 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 176.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . 0.414 ' HG2' ' O ' ' A' ' 256' ' ' LYS . 42.4 mm-40 -94.75 -33.61 12.84 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.868 0.366 . . . . 0.0 110.893 -176.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.709 HD12 ' CE3' ' A' ' 267' ' ' TRP . 0.9 OUTLIER -51.57 -50.91 74.23 Favored Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.508 -179.777 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' PRO . . . . . 0.567 ' HD3' HD11 ' A' ' 272' ' ' ILE . 44.5 Cg_endo -67.5 -15.4 45.08 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.378 2.052 . . . . 0.0 112.679 -177.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 59.2 mt -96.66 0.55 49.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.062 0.458 . . . . 0.0 111.673 -177.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 -107.05 148.6 37.31 Favored Pre-proline 0 C--N 1.314 -0.94 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.34 -177.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -64.11 -35.28 54.19 Favored 'Trans proline' 0 C--O 1.23 0.092 0 C-N-CA 123.509 2.806 . . . . 0.0 112.411 -172.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 3.5 mtpt -86.11 -45.17 11.63 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 121.643 0.735 . . . . 0.0 109.738 -178.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' TRP . . . . . 0.709 ' CE3' HD12 ' A' ' 261' ' ' LEU . 15.4 m0 -78.03 -28.53 49.06 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 114.772 -1.104 . . . . 0.0 111.14 -172.222 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 23.0 t -68.51 -15.11 63.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.797 0.332 . . . . 0.0 110.812 178.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -73.76 -17.32 61.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.41 0.624 . . . . 0.0 109.631 174.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' ARG . . . . . 0.498 ' HA ' ' HB3' ' A' ' 212' ' ' ASN . 4.7 mpt_? -97.43 154.72 17.29 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.444 177.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . 0.421 HH11 ' HD3' ' A' ' 271' ' ' ARG . 39.5 mmt-85 -104.5 105.78 16.02 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 174.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . 0.657 HG21 HD23 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -115.65 141.14 34.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-O 121.306 0.574 . . . . 0.0 111.536 -177.09 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -152.37 169.8 21.65 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.363 171.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 274' ' ' TYR . . . . . 0.418 ' OH ' ' HA ' ' A' ' 255' ' ' ILE . 84.4 m-85 -63.5 124.71 22.03 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.983 0.42 . . . . 0.0 110.755 176.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -76.28 -175.02 39.09 Favored Glycine 0 CA--C 1.518 0.221 0 CA-C-N 115.62 -0.718 . . . . 0.0 113.726 -172.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . 0.487 ' HG2' HD22 ' A' ' 283' ' ' LEU . 49.9 mtm180 -103.21 131.53 50.17 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.681 0.277 . . . . 0.0 111.094 -176.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 277' ' ' ASP . . . . . 0.644 ' HB2' HD21 ' A' ' 207' ' ' ASN . 26.3 t70 -172.4 165.66 5.77 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.833 -179.026 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 278' ' ' ARG . . . . . 0.481 ' HD2' ' N ' ' A' ' 279' ' ' CYS . 7.1 ppt_? -69.87 -20.09 63.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.323 179.015 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' CYS . . . . . 0.481 ' N ' ' HD2' ' A' ' 278' ' ' ARG . 35.2 t -101.51 21.55 14.1 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.532 0.682 . . . . 0.0 109.826 178.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . 0.745 ' HA ' ' HA ' ' A' ' 204' ' ' ALA . . . -125.83 93.06 3.73 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.785 -178.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 281' ' ' VAL . . . . . 0.404 HG12 ' O ' ' A' ' 203' ' ' GLY . 7.8 p -88.62 17.45 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 122.097 0.951 . . . . 0.0 109.727 178.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -85.83 -1.56 87.03 Favored Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.021 173.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 283' ' ' LEU . . . . . 0.487 HD22 ' HG2' ' A' ' 276' ' ' ARG . 33.4 tp -100.29 88.25 3.64 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.053 -0.573 . . . . 0.0 109.93 179.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 61.8 tttm . . . . . 0 C--O 1.247 0.943 0 CA-C-O 118.254 -0.879 . . . . 0.0 109.94 -178.008 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 . . . . . 0 N--CA 1.479 0.986 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . 0.43 ' HB3' ' HB2' ' A' ' 192' ' ' ASN . 12.7 m -55.27 -64.14 0.94 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.359 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . 68.88 -59.34 0.47 Allowed 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.474 0.71 . . . . 0.0 111.485 -176.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 17.0 m -90.8 30.1 1.24 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.6 0.238 . . . . 0.0 111.48 -177.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . 0.43 ' HB2' ' HB3' ' A' ' 189' ' ' SER . 4.5 t30 -121.63 -45.51 2.29 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.445 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 17.2 m 69.5 -84.28 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.058 175.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 11.5 m -64.06 149.65 47.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.61 0.243 . . . . 0.0 111.217 -174.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . 0.652 HG13 ' HB2' ' A' ' 273' ' ' TYR . 3.5 m -101.55 -3.23 9.44 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.612 0 CA-C-O 120.827 0.346 . . . . 0.0 111.516 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.494 ' O ' HD23 ' A' ' 196' ' ' LEU . 2.4 tt 51.79 71.22 0.47 Allowed 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.911 -176.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 27.7 tp 61.26 9.83 2.72 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.812 -178.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.563 ' HA ' ' HB ' ' A' ' 195' ' ' VAL . . . 63.74 20.16 12.09 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 123.065 0.546 . . . . 0.0 111.657 178.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.438 HG22 ' O ' ' A' ' 196' ' ' LEU . 31.3 m -98.68 22.99 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.086 0.469 . . . . 0.0 110.968 -178.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 25.9 mm-40 -115.01 28.82 8.45 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.185 -178.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 50.95 76.81 0.14 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-O 121.254 0.549 . . . . 0.0 111.137 -176.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 20.3 m -127.04 21.81 6.76 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.278 -177.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -59.25 94.52 0.06 OUTLIER Glycine 0 C--N 1.334 0.419 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.986 -175.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -103.01 149.49 24.49 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.565 -0.317 . . . . 0.0 110.161 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' CYS . . . . . 0.689 ' HB2' HG12 ' A' ' 251' ' ' ILE . 35.7 t -91.16 145.61 24.53 Favored 'General case' 0 CA--C 1.508 -0.666 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.13 -178.136 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . 0.762 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 39.4 mtm180 48.97 1.13 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -108.96 105.63 15.24 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 119.053 0.842 . . . . 0.0 111.824 -170.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 63.4 t -137.43 123.09 26.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 114.605 -1.179 . . . . 0.0 109.18 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' PHE . . . . . 0.444 ' CE1' ' HB ' ' A' ' 243' ' ' ILE . 4.0 t80 -120.0 128.18 53.3 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.723 0.297 . . . . 0.0 110.655 -178.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.665 ' HG ' HG22 ' A' ' 272' ' ' ILE . 4.8 mp -108.27 126.53 52.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.534 177.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . 0.69 ' HA2' HG22 ' A' ' 243' ' ' ILE . . . -132.92 59.96 0.68 Allowed Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.702 -0.761 . . . . 0.0 113.445 -178.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . 0.497 ' HB3' ' HA ' ' A' ' 270' ' ' ARG . 3.4 t30 178.22 42.11 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.279 0.561 . . . . 0.0 109.815 177.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.725 HD23 ' HG2' ' A' ' 270' ' ' ARG . 1.0 OUTLIER -89.57 163.52 32.86 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.098 -179.94 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.499 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 89.2 Cg_endo -81.62 161.65 19.23 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 122.383 2.055 . . . . 0.0 111.342 175.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -72.94 128.19 34.75 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.574 176.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 103.94 -5.56 46.65 Favored Glycine 0 C--N 1.313 -0.722 0 C-N-CA 120.446 -0.883 . . . . 0.0 113.039 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . 0.626 HG23 HG21 ' A' ' 237' ' ' ILE . 5.1 tp -58.56 128.36 19.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.973 0.416 . . . . 0.0 110.734 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . 0.431 ' CG2' ' HG3' ' A' ' 221' ' ' GLU . 14.9 t -112.28 157.24 21.19 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-O 121.394 0.616 . . . . 0.0 110.975 -178.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.496 ' CD ' ' H ' ' A' ' 219' ' ' GLU . 3.9 mp0 -62.36 -36.7 83.09 Favored 'General case' 0 C--O 1.207 -1.16 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.591 -177.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' ASP . . . . . 0.45 ' O ' ' HG2' ' A' ' 224' ' ' GLU . 37.4 t70 -50.1 -40.14 44.89 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 123.745 0.653 . . . . 0.0 111.144 179.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . 0.431 ' HG3' ' CG2' ' A' ' 218' ' ' THR . 41.6 mt-10 -68.74 -56.96 6.41 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.326 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.539 HD12 HD11 ' A' ' 237' ' ' ILE . 7.5 mt -60.05 -42.25 89.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.743 -179.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . 0.753 ' HG3' HD12 ' A' ' 235' ' ' ILE . 53.9 mtp85 -54.3 -63.56 1.11 Allowed 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 176.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.45 ' HG2' ' O ' ' A' ' 220' ' ' ASP . 14.4 pt-20 -60.52 -20.36 59.98 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.975 -176.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -88.69 -32.29 18.06 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.553 -177.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.696 HD23 ' HZ ' ' A' ' 248' ' ' PHE . 8.6 mp -107.32 -18.76 13.79 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -170.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . 0.687 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 31.5 mt-10 -71.48 -25.33 0.78 Allowed Pre-proline 0 C--N 1.324 -0.5 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -175.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . 0.687 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 74.2 Cg_endo -65.76 -28.84 51.35 Favored 'Trans proline' 0 C--N 1.359 1.102 0 CA-C-N 120.692 1.283 . . . . 0.0 112.019 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . 0.463 ' CE1' ' HA ' ' A' ' 226' ' ' LEU . 3.7 p90 -110.92 -2.08 16.17 Favored 'General case' 0 C--O 1.224 -0.249 0 C-N-CA 120.921 -0.311 . . . . 0.0 111.463 174.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . 0.452 ' O ' ' HA ' ' A' ' 227' ' ' GLU . . . -174.21 94.31 0.1 OUTLIER Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 120.249 -0.977 . . . . 0.0 112.23 -177.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.421 ' HA ' ' HG2' ' A' ' 227' ' ' GLU . 21.0 Cg_endo -62.74 130.14 28.59 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 121.975 1.784 . . . . 0.0 111.401 178.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.736 HG21 HG12 ' A' ' 246' ' ' VAL . 2.8 mp -106.4 152.33 8.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.442 178.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . 0.422 ' CG ' HD22 ' A' ' 249' ' ' LEU . 23.4 m-20 -111.29 -26.98 8.87 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.762 176.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . 0.44 ' HB3' ' HB2' ' A' ' 247' ' ' HIS . 20.4 tt0 -136.97 120.51 17.12 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.635 -175.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.753 HD12 ' HG3' ' A' ' 223' ' ' ARG . 20.0 mt -134.99 105.8 6.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.675 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.411 ' HE2' HD21 ' A' ' 283' ' ' LEU . 86.8 tttt -111.58 109.45 19.37 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.321 -175.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' ILE . . . . . 0.626 HG21 HG23 ' A' ' 217' ' ' ILE . 87.4 mt -101.23 122.28 53.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 121.286 0.565 . . . . 0.0 111.155 -177.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.58 ' HB ' HG13 ' A' ' 243' ' ' ILE . 46.5 t -103.63 87.39 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 170.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 11.6 t -67.5 -19.31 65.31 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.463 -176.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -65.98 -29.56 69.97 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.696 176.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . 0.559 ' HB2' HG12 ' A' ' 243' ' ' ILE . 98.9 mtt180 -117.39 4.85 12.52 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.803 -179.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 15.9 m120 64.81 27.24 12.96 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.988 176.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.69 HG22 ' HA2' ' A' ' 211' ' ' GLY . 1.4 pt -122.4 148.9 25.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.165 -175.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -142.41 137.58 30.51 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.969 0.414 . . . . 0.0 111.556 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' PHE . . . . . 0.45 ' HE2' ' HB1' ' A' ' 280' ' ' ALA . 34.1 m-85 -105.51 120.31 41.31 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.894 177.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.736 HG12 HG21 ' A' ' 232' ' ' ILE . 0.2 OUTLIER -115.11 132.15 65.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -178.558 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' HIS . . . . . 0.762 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 50.1 m170 -111.43 102.58 10.94 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.164 -0.614 . . . . 0.0 111.311 176.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . 0.696 ' HZ ' HD23 ' A' ' 226' ' ' LEU . 33.2 m-85 -86.04 103.28 14.58 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.068 178.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.486 ' H ' HD23 ' A' ' 249' ' ' LEU . 0.1 OUTLIER -43.7 -39.52 3.7 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 124.139 0.899 . . . . 0.0 113.342 -175.8 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -96.51 144.92 26.16 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.512 177.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . 0.689 HG12 ' HB2' ' A' ' 205' ' ' CYS . 0.2 OUTLIER -64.06 -43.22 97.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.723 -178.83 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -72.03 -30.78 65.54 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.672 -176.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . 0.452 ' HB1' ' CA ' ' A' ' 230' ' ' GLY . . . -58.72 -41.93 87.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.217 178.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . 0.598 ' HB2' ' HB2' ' A' ' 248' ' ' PHE . . . -69.24 -40.61 77.81 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.821 178.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.566 HG13 ' O ' ' A' ' 251' ' ' ILE . 6.5 mt -57.84 -60.85 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.453 -177.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . 0.454 ' O ' ' HG2' ' A' ' 260' ' ' GLU . 11.8 ptmt -61.98 -38.45 88.62 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.396 -177.062 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -61.47 -48.51 80.78 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.617 0.246 . . . . 0.0 111.182 178.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . 0.548 HG13 HG12 ' A' ' 272' ' ' ILE . 69.7 t -66.92 -23.97 31.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.892 0.377 . . . . 0.0 110.972 179.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -83.42 -26.93 29.93 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 177.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . 0.454 ' HG2' ' O ' ' A' ' 256' ' ' LYS . 51.1 mm-40 -94.74 -30.97 14.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.72 0.295 . . . . 0.0 111.223 -174.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.741 HD23 HG21 ' A' ' 272' ' ' ILE . 0.6 OUTLIER -52.85 -50.74 79.78 Favored Pre-proline 0 CA--C 1.538 0.51 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.375 179.366 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' PRO . . . . . 0.558 ' HD2' ' N ' ' A' ' 261' ' ' LEU . 41.2 Cg_endo -67.47 -16.46 47.53 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.357 2.038 . . . . 0.0 112.667 -178.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 59.1 mt -89.77 -7.83 53.56 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.235 0.54 . . . . 0.0 111.574 -177.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' ASN . . . . . 0.4 ' O ' ' HB2' ' A' ' 268' ' ' SER . 14.1 m-80 -106.38 148.17 36.24 Favored Pre-proline 0 C--N 1.311 -1.068 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.897 -174.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -64.1 -36.4 48.05 Favored 'Trans proline' 0 C--N 1.334 -0.208 0 C-N-CA 123.512 2.808 . . . . 0.0 112.584 -169.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 8.2 mtpt -86.23 -44.58 12.04 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 121.558 0.694 . . . . 0.0 109.791 -176.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' TRP . . . . . 0.694 ' CE3' HD12 ' A' ' 261' ' ' LEU . 11.2 m0 -76.49 -28.57 56.51 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.519 -174.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . 0.4 ' HB2' ' O ' ' A' ' 264' ' ' ASN . 22.9 t -64.18 -21.61 66.63 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.712 0.292 . . . . 0.0 110.532 177.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 64.2 mttm -70.53 -16.67 62.91 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-O 121.299 0.571 . . . . 0.0 110.087 176.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' ARG . . . . . 0.725 ' HG2' HD23 ' A' ' 213' ' ' LEU . 3.1 mpt_? -103.4 146.25 28.78 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.646 -179.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . 0.454 ' NE ' ' HA ' ' A' ' 271' ' ' ARG . 4.9 mmp_? -97.44 107.59 20.13 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 178.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . 0.741 HG21 HD23 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -116.15 142.22 30.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.141 0.496 . . . . 0.0 111.174 -176.967 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 273' ' ' TYR . . . . . 0.652 ' HB2' HG13 ' A' ' 195' ' ' VAL . 3.0 p90 -150.93 167.68 26.83 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.661 172.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 274' ' ' TYR . . . . . 0.539 ' OH ' ' HA ' ' A' ' 255' ' ' ILE . 87.2 m-85 -67.35 138.78 57.02 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.072 173.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -88.4 107.55 3.35 Favored Glycine 0 N--CA 1.441 -0.968 0 C-N-CA 120.172 -1.013 . . . . 0.0 112.34 -178.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . 0.418 ' N ' ' HD3' ' A' ' 276' ' ' ARG . 0.0 OUTLIER -123.42 101.06 7.14 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.689 0.757 . . . . 0.0 110.254 175.834 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 26.2 t70 179.28 144.37 0.15 Allowed 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.363 -1.289 . . . . 0.0 109.442 -173.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 278' ' ' ARG . . . . . . . . . . . . . 34.6 ptt85 -89.58 -13.6 36.89 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -175.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' CYS . . . . . . . . . . . . . 68.7 m -97.22 -2.41 42.86 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.441 0.639 . . . . 0.0 110.031 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . 0.45 ' HB1' ' HE2' ' A' ' 245' ' ' PHE . . . -86.84 13.87 8.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.935 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 14.7 p -88.4 -18.62 7.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.39 176.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -160.2 100.82 0.19 Allowed Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.835 178.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 283' ' ' LEU . . . . . 0.411 HD21 ' HE2' ' A' ' 236' ' ' LYS . 3.9 pp -73.05 153.08 41.0 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.053 0.454 . . . . 0.0 111.309 -173.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.245 0.866 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.443 179.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 . . . . . 0 N--CA 1.479 1.007 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 21.6 m -98.3 115.23 27.97 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.985 0.421 . . . . 0.0 110.698 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -88.27 -16.45 33.12 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.028 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 47.4 m -116.97 163.68 15.85 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.386 178.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -96.39 131.75 42.62 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.171 -178.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 17.0 m -109.71 133.34 53.24 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.143 177.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 73.2 m 59.43 -171.03 0.13 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.513 -176.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . 0.483 HG11 ' HG3' ' A' ' 262' ' ' PRO . 3.3 m -126.94 78.35 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 121.61 0.719 . . . . 0.0 111.777 176.096 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.582 ' O ' HG22 ' A' ' 199' ' ' VAL . 65.9 mt -77.51 -13.97 59.79 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 122.089 0.947 . . . . 0.0 108.836 174.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 1.046 ' HB3' ' HB3' ' A' ' 273' ' ' TYR . 98.3 mt -70.5 -13.49 62.13 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.327 -1.306 . . . . 0.0 109.531 172.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -111.43 -3.79 15.09 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.353 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.582 HG22 ' O ' ' A' ' 196' ' ' LEU . 13.6 m -86.53 -11.1 11.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.052 178.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -81.01 66.3 6.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.856 0.836 . . . . 0.0 109.813 175.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -79.1 95.04 5.45 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.147 -177.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 16.9 m -105.9 28.06 7.94 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.805 179.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 68.25 48.25 53.59 Favored Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.357 -176.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . 0.653 ' HB1' ' HB2' ' A' ' 207' ' ' ASN . . . -91.0 89.34 7.39 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 121.208 0.528 . . . . 0.0 111.322 -175.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' CYS . . . . . 0.523 ' HB3' HG12 ' A' ' 251' ' ' ILE . 10.1 p -88.02 146.98 25.22 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 173.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . 0.815 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 41.9 mtm180 56.81 5.03 0.19 Allowed 'General case' 0 C--O 1.221 -0.404 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -178.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . 0.653 ' HB2' ' HB1' ' A' ' 204' ' ' ALA . 82.6 m-20 -106.0 105.34 15.33 Favored 'General case' 0 CA--C 1.511 -0.542 0 C-N-CA 120.166 -0.614 . . . . 0.0 111.128 -171.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.46 ' HB ' ' HB ' ' A' ' 246' ' ' VAL . 64.6 t -137.24 115.25 13.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.361 177.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' PHE . . . . . 0.537 ' HB2' ' HA2' ' A' ' 275' ' ' GLY . 3.2 t80 -111.68 124.77 53.02 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.364 -175.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.702 ' HG ' HG22 ' A' ' 272' ' ' ILE . 5.6 mp -107.34 129.48 54.9 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.561 177.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . 0.663 ' HA2' HG22 ' A' ' 243' ' ' ILE . . . -138.26 63.28 0.56 Allowed Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.656 -0.783 . . . . 0.0 113.208 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . 0.546 ' HB3' ' HA ' ' A' ' 270' ' ' ARG . 3.5 t30 -179.01 34.86 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.355 0.597 . . . . 0.0 109.969 178.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.809 HD23 ' HG2' ' A' ' 270' ' ' ARG . 1.2 mt -87.77 163.73 37.12 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.868 -179.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.44 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 91.3 Cg_endo -81.98 165.83 17.14 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 122.261 1.974 . . . . 0.0 110.772 172.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -78.7 129.21 34.44 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 177.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 105.25 -6.29 42.46 Favored Glycine 0 C--N 1.315 -0.617 0 C-N-CA 120.557 -0.83 . . . . 0.0 113.211 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . 0.715 HG23 HG21 ' A' ' 237' ' ' ILE . 4.6 tp -58.88 131.19 23.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-O 120.929 0.395 . . . . 0.0 110.743 179.083 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . 0.446 ' CG2' ' HG3' ' A' ' 221' ' ' GLU . 10.7 t -112.39 157.44 21.04 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-O 121.625 0.726 . . . . 0.0 111.206 -179.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.461 ' CD ' ' H ' ' A' ' 219' ' ' GLU . 4.2 mp0 -62.79 -34.72 77.85 Favored 'General case' 0 C--O 1.209 -1.075 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.987 -177.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -54.4 -36.19 63.68 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.924 0.392 . . . . 0.0 110.81 -179.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . 0.446 ' HG3' ' CG2' ' A' ' 218' ' ' THR . 44.4 mt-10 -70.56 -55.47 8.8 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.371 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.537 HD12 HD11 ' A' ' 237' ' ' ILE . 6.7 mt -62.03 -40.56 87.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.693 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . 0.847 ' HG3' HD12 ' A' ' 235' ' ' ILE . 17.2 mtp180 -54.22 -62.34 1.72 Allowed 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 175.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -57.74 -21.31 40.42 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.962 -178.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' ASP . . . . . 0.454 ' CG ' ' HE1' ' A' ' 267' ' ' TRP . 24.9 m-20 -87.77 -33.02 18.81 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.978 -178.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.702 HD23 ' HZ ' ' A' ' 248' ' ' PHE . 8.1 mp -107.98 -17.83 13.95 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -169.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . 0.667 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 46.1 mt-10 -69.79 -26.03 1.01 Allowed Pre-proline 0 C--N 1.324 -0.517 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -175.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . 0.667 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 84.7 Cg_endo -67.64 -27.28 38.74 Favored 'Trans proline' 0 C--N 1.36 1.139 0 C-N-CA 121.359 1.373 . . . . 0.0 112.488 -178.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . 0.479 ' CZ ' ' HA ' ' A' ' 226' ' ' LEU . 2.6 p90 -110.64 -14.66 14.01 Favored 'General case' 0 C--O 1.222 -0.364 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.557 175.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . 0.413 ' HA2' ' HD2' ' A' ' 231' ' ' PRO . . . -161.27 91.97 0.11 Allowed Glycine 0 N--CA 1.438 -1.178 0 C-N-CA 120.441 -0.885 . . . . 0.0 111.223 -175.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.413 ' HD2' ' HA2' ' A' ' 230' ' ' GLY . 13.4 Cg_endo -58.72 131.8 44.28 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 121.859 1.706 . . . . 0.0 111.155 178.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.594 HG21 HG12 ' A' ' 246' ' ' VAL . 2.7 mp -108.17 151.7 10.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.92 177.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . 0.498 ' CG ' HD22 ' A' ' 249' ' ' LEU . 15.6 m-20 -112.77 -23.06 10.37 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 120.915 0.388 . . . . 0.0 110.147 178.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . 0.58 ' HB3' ' HB2' ' A' ' 247' ' ' HIS . 36.1 tt0 -143.99 120.1 10.77 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.841 -176.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.847 HD12 ' HG3' ' A' ' 223' ' ' ARG . 14.8 mt -131.52 115.63 29.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.92 178.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 65.9 tttp -120.81 113.66 20.48 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.37 -178.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' ILE . . . . . 0.715 HG21 HG23 ' A' ' 217' ' ' ILE . 80.8 mt -102.85 123.71 56.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.683 -179.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.559 ' HB ' HG13 ' A' ' 243' ' ' ILE . 39.9 t -102.06 87.09 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 172.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 13.9 t -65.33 -18.21 65.13 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.726 -177.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -64.93 -31.05 72.09 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.538 176.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . 0.778 ' HB2' HG12 ' A' ' 243' ' ' ILE . 48.7 mtt180 -116.29 3.53 13.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.944 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 13.3 m120 66.91 27.28 9.0 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.81 177.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.778 HG12 ' HB2' ' A' ' 241' ' ' ARG . 1.7 pt -122.2 155.53 27.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.156 -173.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . 0.475 ' HB3' ' HB2' ' A' ' 210' ' ' LEU . . . -143.92 138.3 28.43 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.019 0.438 . . . . 0.0 111.579 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -107.68 109.11 20.63 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.702 176.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.594 HG12 HG21 ' A' ' 232' ' ' ILE . 1.3 t -103.2 133.3 47.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' HIS . . . . . 0.815 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 40.9 m170 -112.49 101.56 9.72 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.496 0.665 . . . . 0.0 111.128 178.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . 0.702 ' HZ ' HD23 ' A' ' 226' ' ' LEU . 33.5 m-85 -85.87 102.92 14.14 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.744 -1.116 . . . . 0.0 111.429 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.498 HD22 ' CG ' ' A' ' 233' ' ' ASP . 0.1 OUTLIER -40.27 -46.45 2.29 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 124.422 1.076 . . . . 0.0 113.117 -174.835 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -97.39 139.54 33.18 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.858 0.361 . . . . 0.0 110.325 177.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . 0.663 ' O ' HG13 ' A' ' 255' ' ' ILE . 0.2 OUTLIER -57.53 -40.62 75.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.675 179.995 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -68.93 -33.15 73.27 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.183 -176.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -59.85 -40.28 88.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.483 179.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . 0.532 ' HB2' ' HB2' ' A' ' 248' ' ' PHE . . . -68.88 -41.58 78.14 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.757 178.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.663 HG13 ' O ' ' A' ' 251' ' ' ILE . 14.4 mt -56.06 -59.62 2.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.293 -177.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . 0.401 ' O ' ' HG2' ' A' ' 260' ' ' GLU . 12.6 ptmt -62.28 -40.19 95.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.422 -177.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -62.05 -49.28 76.63 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.586 0.231 . . . . 0.0 111.323 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . 0.467 HG13 HG12 ' A' ' 272' ' ' ILE . 53.7 t -64.89 -24.38 35.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.078 0.465 . . . . 0.0 110.892 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 71.6 mm-40 -84.83 -24.53 28.59 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 178.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . 0.401 ' HG2' ' O ' ' A' ' 256' ' ' LYS . 58.4 mm-40 -95.89 -33.89 12.03 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.769 0.319 . . . . 0.0 111.081 -175.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.749 HD23 HG21 ' A' ' 272' ' ' ILE . 0.6 OUTLIER -52.05 -49.54 83.69 Favored Pre-proline 0 CA--C 1.539 0.523 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.724 -179.013 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' PRO . . . . . 0.575 ' HD2' ' N ' ' A' ' 261' ' ' LEU . 43.6 Cg_endo -67.46 -15.25 44.85 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.446 2.097 . . . . 0.0 113.052 -178.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 54.3 mt -92.09 -4.99 53.61 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.269 0.557 . . . . 0.0 111.449 -178.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 -106.94 149.97 39.21 Favored Pre-proline 0 C--N 1.312 -1.029 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.367 -173.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.25 -37.66 30.56 Favored 'Trans proline' 0 N--CA 1.465 -0.159 0 C-N-CA 123.172 2.581 . . . . 0.0 112.79 -169.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 12.6 mtpt -86.63 -44.33 11.95 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 121.531 0.682 . . . . 0.0 109.788 -177.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' TRP . . . . . 0.742 ' CE3' HD12 ' A' ' 261' ' ' LEU . 10.6 m0 -75.34 -28.85 59.77 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.9 -173.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 34.7 t -65.02 -20.89 66.72 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.151 0.501 . . . . 0.0 110.555 176.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . 0.422 ' C ' ' HD2' ' A' ' 270' ' ' ARG . 97.6 mttt -76.84 -6.2 51.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.238 176.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' ARG . . . . . 0.809 ' HG2' HD23 ' A' ' 213' ' ' LEU . 3.3 mpt_? -114.97 141.64 47.7 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.021 177.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . 0.814 ' HE ' ' HA ' ' A' ' 271' ' ' ARG . 0.8 OUTLIER -93.05 108.36 19.96 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 -179.769 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . 0.749 HG21 HD23 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -117.31 140.91 38.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.361 0.6 . . . . 0.0 110.823 -178.556 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 273' ' ' TYR . . . . . 1.046 ' HB3' ' HB3' ' A' ' 197' ' ' LEU . 5.2 p90 -152.42 170.15 20.81 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.55 173.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -53.32 115.54 1.96 Allowed 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 171.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 275' ' ' GLY . . . . . 0.537 ' HA2' ' HB2' ' A' ' 209' ' ' PHE . . . -52.83 129.35 38.4 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.363 -0.835 . . . . 0.0 113.439 -173.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 65.2 mtt180 -94.92 121.66 36.75 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 178.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -159.02 136.18 9.78 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.131 -178.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 278' ' ' ARG . . . . . 0.486 ' HD3' ' SG ' ' A' ' 279' ' ' CYS . 0.1 OUTLIER -80.37 -7.19 58.99 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.407 -172.272 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 279' ' ' CYS . . . . . 0.486 ' SG ' ' HD3' ' A' ' 278' ' ' ARG . 80.9 m -105.18 -4.64 21.53 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.103 0.478 . . . . 0.0 110.599 177.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . 0.546 ' HB1' HD21 ' A' ' 207' ' ' ASN . . . -102.18 90.46 3.94 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.365 -177.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 3.3 m -86.25 -44.31 16.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.225 177.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 166.07 -141.83 7.25 Favored Glycine 0 N--CA 1.431 -1.662 0 C-N-CA 120.653 -0.784 . . . . 0.0 111.627 -178.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 96.5 mt -86.95 85.42 7.26 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.134 0.492 . . . . 0.0 110.634 -178.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . 0.41 ' HB3' ' HE3' ' A' ' 284' ' ' LYS . 1.3 tmmt? . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.193 -0.908 . . . . 0.0 109.144 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 . . . . . 0 N--CA 1.481 1.113 0 N-CA-C 111.053 0.02 . . . . 0.0 111.053 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 50.7 m 57.46 87.2 0.07 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.418 0.628 . . . . 0.0 111.014 -177.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -97.72 10.81 39.1 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.824 -177.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 75.5 m 66.34 178.49 0.21 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.26 -178.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -133.16 107.77 8.39 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 177.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . 0.985 ' HB2' ' HB3' ' A' ' 271' ' ' ARG . 45.1 m -152.7 95.0 1.95 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.281 0.562 . . . . 0.0 110.492 -175.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . 0.466 ' HA ' ' O ' ' A' ' 272' ' ' ILE . 55.6 m -156.31 -165.04 1.81 Allowed 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 177.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . 0.516 ' HB ' ' HA ' ' A' ' 198' ' ' ALA . 3.7 m -73.31 89.46 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 C-N-CA 120.53 -0.468 . . . . 0.0 109.743 172.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.626 HD22 ' H ' ' A' ' 196' ' ' LEU . 1.7 mm? -53.76 93.95 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.455 -176.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 6.4 mp 51.62 25.05 2.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.273 0.559 . . . . 0.0 110.317 -174.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.516 ' HA ' ' HB ' ' A' ' 195' ' ' VAL . . . 65.03 25.11 12.62 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 114.901 -1.045 . . . . 0.0 112.567 -178.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.523 HG22 ' O ' ' A' ' 196' ' ' LEU . 22.6 m -75.46 -24.21 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.987 177.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' GLN . . . . . 0.445 ' HG3' HG23 ' A' ' 199' ' ' VAL . 46.6 mt-30 -124.77 92.1 3.58 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.328 177.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -101.23 -36.72 8.82 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.279 174.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 46.5 m 67.59 -5.44 0.78 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.559 176.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 60.25 49.47 78.23 Favored Glycine 0 C--N 1.333 0.365 0 N-CA-C 111.639 -0.584 . . . . 0.0 111.639 -177.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . 0.852 ' HB1' ' HB2' ' A' ' 207' ' ' ASN . . . -92.07 130.56 37.77 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -172.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' CYS . . . . . 0.87 ' HB3' HG12 ' A' ' 251' ' ' ILE . 9.8 p -108.33 147.65 31.19 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 169.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . 0.756 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 46.3 mtp180 57.65 5.04 0.29 Allowed 'General case' 0 C--O 1.223 -0.337 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -179.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . 0.852 ' HB2' ' HB1' ' A' ' 204' ' ' ALA . 84.6 m-20 -110.93 106.34 15.43 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.1 0.476 . . . . 0.0 111.643 -171.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.478 ' HB ' ' HB ' ' A' ' 246' ' ' VAL . 57.7 t -136.87 117.97 18.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.552 179.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' PHE . . . . . 0.504 ' O ' ' HA ' ' A' ' 272' ' ' ILE . 5.8 t80 -113.28 125.35 54.2 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.463 -177.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.84 ' HG ' HG22 ' A' ' 272' ' ' ILE . 5.5 mp -107.8 130.09 55.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.595 177.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . 0.734 ' HA2' HG22 ' A' ' 243' ' ' ILE . . . -132.13 53.01 0.81 Allowed Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.503 -0.856 . . . . 0.0 113.951 -178.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . 0.441 ' HB3' ' HA ' ' A' ' 270' ' ' ARG . 36.3 t30 179.72 52.73 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.037 0.446 . . . . 0.0 111.288 174.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.585 HD21 HD22 ' A' ' 210' ' ' LEU . 1.0 OUTLIER -94.65 159.43 33.55 Favored Pre-proline 0 C--N 1.314 -0.96 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.444 177.509 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.462 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 87.1 Cg_endo -78.42 169.48 19.93 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 122.701 2.267 . . . . 0.0 111.638 178.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . 0.504 ' HA ' ' OG1' ' A' ' 239' ' ' THR . 3.9 p-10 -77.49 134.02 38.43 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 98.27 -6.27 61.41 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.398 -0.906 . . . . 0.0 112.857 178.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . 0.707 HG23 HG21 ' A' ' 237' ' ' ILE . 4.1 tp -58.15 126.11 15.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 CA-C-O 121.294 0.568 . . . . 0.0 110.724 -178.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . 0.492 ' CG2' ' HG3' ' A' ' 221' ' ' GLU . 8.8 t -109.22 157.49 18.76 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 121.429 0.633 . . . . 0.0 110.847 -178.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.502 ' CD ' ' H ' ' A' ' 219' ' ' GLU . 2.6 mp0 -62.05 -36.24 81.03 Favored 'General case' 0 C--O 1.209 -1.028 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.455 -177.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' ASP . . . . . 0.536 ' O ' ' HG2' ' A' ' 224' ' ' GLU . 30.7 t70 -55.08 -37.56 66.96 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 123.741 0.651 . . . . 0.0 110.683 -178.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . 0.492 ' HG3' ' CG2' ' A' ' 218' ' ' THR . 45.9 mt-10 -65.97 -55.24 17.78 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.02 179.184 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.486 HD12 HD11 ' A' ' 237' ' ' ILE . 6.7 mt -62.52 -38.84 82.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.656 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . 0.872 ' HG3' HD12 ' A' ' 235' ' ' ILE . 63.4 mtp180 -56.47 -62.53 1.66 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.981 0.42 . . . . 0.0 112.066 175.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.536 ' HG2' ' O ' ' A' ' 220' ' ' ASP . 7.0 pt-20 -58.73 -24.74 62.08 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.149 -178.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' ASP . . . . . 0.469 ' HB3' ' CZ2' ' A' ' 267' ' ' TRP . 8.0 m-20 -85.98 -32.5 21.5 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.596 -176.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.742 HD23 ' HZ ' ' A' ' 248' ' ' PHE . 8.4 mp -107.11 -17.49 14.15 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -170.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . 0.675 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 37.6 mt-10 -70.71 -27.96 1.2 Allowed Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -176.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . 0.675 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 74.4 Cg_endo -65.47 -27.09 54.58 Favored 'Trans proline' 0 C--N 1.359 1.089 0 C-N-CA 121.313 1.342 . . . . 0.0 111.818 -177.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . 0.475 ' CE1' ' HA ' ' A' ' 226' ' ' LEU . 3.2 p90 -111.01 -7.89 14.5 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.879 -0.328 . . . . 0.0 111.65 173.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . 0.482 ' CA ' ' HB1' ' A' ' 253' ' ' ALA . . . -169.69 93.8 0.1 Allowed Glycine 0 N--CA 1.442 -0.954 0 C-N-CA 120.104 -1.046 . . . . 0.0 112.454 -174.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.461 ' HA ' ' HG2' ' A' ' 227' ' ' GLU . 15.3 Cg_endo -59.52 131.79 42.43 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 122.038 1.825 . . . . 0.0 111.759 178.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.603 HG21 HG12 ' A' ' 246' ' ' VAL . 2.8 mp -108.53 152.95 10.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.108 177.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . 0.455 ' OD2' HD22 ' A' ' 249' ' ' LEU . 16.3 m-20 -116.1 -18.39 10.63 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 120.708 0.289 . . . . 0.0 111.059 178.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . 0.49 ' H ' HG22 ' A' ' 232' ' ' ILE . 23.0 tt0 -145.57 121.69 10.78 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.033 -179.118 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.872 HD12 ' HG3' ' A' ' 223' ' ' ARG . 13.6 mt -133.65 109.79 13.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.045 177.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -113.93 121.29 43.49 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.363 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' ILE . . . . . 0.707 HG21 HG23 ' A' ' 217' ' ' ILE . 53.7 mt -111.85 127.97 68.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.361 -177.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.577 ' HB ' HG13 ' A' ' 243' ' ' ILE . 44.8 t -109.58 88.07 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 170.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . 0.504 ' OG1' ' HA ' ' A' ' 215' ' ' ASN . 12.4 t -64.0 -24.66 67.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.643 -175.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -61.8 -39.0 90.19 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.084 0.469 . . . . 0.0 110.647 178.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . 0.691 ' HB2' HG12 ' A' ' 243' ' ' ILE . 63.9 mtt180 -104.28 0.11 28.92 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.47 -177.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 69.01 25.7 5.85 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.054 177.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.734 HG22 ' HA2' ' A' ' 211' ' ' GLY . 1.4 pt -121.71 151.29 25.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-O 120.835 0.35 . . . . 0.0 111.579 -172.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -145.89 141.5 27.88 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.169 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -111.15 114.42 27.66 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.91 178.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.603 HG12 HG21 ' A' ' 232' ' ' ILE . 1.4 t -108.67 138.35 36.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.665 -178.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' HIS . . . . . 0.756 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 27.1 m170 -115.89 102.15 9.42 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.113 -0.635 . . . . 0.0 111.182 177.016 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . 0.742 ' HZ ' HD23 ' A' ' 226' ' ' LEU . 35.3 m-85 -86.86 100.74 12.77 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.22 179.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.474 ' H ' HD23 ' A' ' 249' ' ' LEU . 0.1 OUTLIER -43.24 -41.55 3.92 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 124.533 1.146 . . . . 0.0 112.693 -175.841 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . 0.418 ' HB2' ' HB2' ' A' ' 253' ' ' ALA . 59.4 m-20 -94.6 137.89 33.14 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . 0.87 HG12 ' HB3' ' A' ' 205' ' ' CYS . 0.2 OUTLIER -60.98 -43.51 96.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -178.933 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -71.32 -27.52 63.45 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.666 -176.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . 0.482 ' HB1' ' CA ' ' A' ' 230' ' ' GLY . . . -62.73 -42.37 99.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.204 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . 0.556 ' HB2' ' HB2' ' A' ' 248' ' ' PHE . . . -67.38 -41.89 84.26 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.614 178.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.588 HG13 ' O ' ' A' ' 251' ' ' ILE . 9.8 mt -56.17 -60.26 2.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.285 -177.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 12.7 ptmt -62.6 -36.22 82.06 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.553 -176.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -65.73 -49.41 68.55 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 122.981 0.176 . . . . 0.0 111.438 178.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . 0.581 HG13 HG12 ' A' ' 272' ' ' ILE . 60.9 t -63.5 -25.5 38.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.976 0.417 . . . . 0.0 110.838 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -83.96 -25.45 30.04 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.11 -0.495 . . . . 0.0 112.187 178.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 46.5 mm-40 -95.05 -30.88 13.85 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-O 120.665 0.269 . . . . 0.0 111.283 -175.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.826 HD23 HG21 ' A' ' 272' ' ' ILE . 1.0 OUTLIER -52.42 -50.45 79.83 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.251 179.625 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' PRO . . . . . 0.571 ' HD2' ' N ' ' A' ' 261' ' ' LEU . 43.2 Cg_endo -66.99 -14.48 43.81 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.399 2.066 . . . . 0.0 112.909 -178.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 55.6 mt -96.34 -3.91 42.96 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.899 0.381 . . . . 0.0 111.827 -178.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' ASN . . . . . 0.447 ' HB2' ' CE3' ' A' ' 267' ' ' TRP . 13.1 m-80 -106.72 149.78 38.85 Favored Pre-proline 0 C--N 1.317 -0.84 0 N-CA-C 112.662 0.615 . . . . 0.0 112.662 -174.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -63.22 -35.66 62.09 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 123.771 2.981 . . . . 0.0 113.189 -168.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.463 ' HE3' ' HB2' ' A' ' 266' ' ' LYS . 0.0 OUTLIER -86.93 -45.74 10.53 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 121.791 0.805 . . . . 0.0 109.298 -179.616 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' TRP . . . . . 0.729 ' CE3' HD12 ' A' ' 261' ' ' LEU . 9.1 m0 -76.46 -29.29 56.86 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 114.362 -1.29 . . . . 0.0 111.309 -170.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . 0.419 ' HA ' ' HA ' ' A' ' 262' ' ' PRO . 23.2 t -64.92 -16.54 63.42 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.742 0.306 . . . . 0.0 111.547 -179.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -87.17 -13.16 44.82 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.095 0.474 . . . . 0.0 110.183 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 270' ' ' ARG . . . . . 0.441 ' HA ' ' HB3' ' A' ' 212' ' ' ASN . 6.9 mpt_? -88.32 166.75 14.07 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 173.11 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . 0.985 ' HB3' ' HB2' ' A' ' 193' ' ' SER . 45.1 mmt-85 -120.4 106.58 11.98 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 177.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . 0.84 HG22 ' HG ' ' A' ' 210' ' ' LEU . 0.2 OUTLIER -119.58 141.94 37.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.461 0.648 . . . . 0.0 111.903 -174.411 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -151.76 169.73 21.49 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.613 171.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 274' ' ' TYR . . . . . 0.655 ' HB3' ' HB3' ' A' ' 204' ' ' ALA . 72.0 m-85 -63.23 127.74 32.65 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.873 0.368 . . . . 0.0 110.49 176.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -82.13 159.06 38.97 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.997 -0.621 . . . . 0.0 113.22 -175.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 58.7 mtt180 -98.18 6.1 47.83 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 122.162 0.982 . . . . 0.0 109.746 177.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -68.35 174.94 3.61 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 113.35 -1.75 . . . . 0.0 109.886 176.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 278' ' ' ARG . . . . . . . . . . . . . 13.7 ptt180 -147.45 8.5 0.91 Allowed 'General case' 0 C--N 1.327 -0.402 0 O-C-N 121.9 -0.5 . . . . 0.0 111.653 177.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 279' ' ' CYS . . . . . . . . . . . . . 22.7 t 64.43 21.97 12.61 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.664 177.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . 0.679 ' HB1' HD11 ' A' ' 283' ' ' LEU . . . -163.28 98.06 0.91 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.685 -175.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 281' ' ' VAL . . . . . 0.401 ' O ' HG13 ' A' ' 281' ' ' VAL . 6.1 p -136.35 99.73 2.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 121.756 0.788 . . . . 0.0 110.137 178.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 79.85 80.18 0.81 Allowed Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.535 -0.84 . . . . 0.0 111.217 -176.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 283' ' ' LEU . . . . . 0.679 HD11 ' HB1' ' A' ' 280' ' ' ALA . 5.4 mp -98.48 13.6 31.18 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.653 0.74 . . . . 0.0 109.992 -177.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . 0.404 ' NZ ' ' HB3' ' A' ' 284' ' ' LYS . 6.6 ttpm? . . . . . 0 C--N 1.315 -0.907 0 CA-C-N 114.743 -1.117 . . . . 0.0 108.899 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 47.6 t30 . . . . . 0 N--CA 1.479 1.019 0 CA-C-O 120.653 0.263 . . . . 0.0 110.503 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 11.6 p -90.76 164.74 13.99 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 175.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -80.83 99.13 8.14 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.831 0.348 . . . . 0.0 110.789 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 51.2 m -89.32 108.51 19.67 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.133 178.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -163.06 172.19 15.33 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.639 -175.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 12.9 t -74.58 -173.79 1.89 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 176.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 18.3 m -84.68 39.13 0.73 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.63 0.729 . . . . 0.0 110.93 -178.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 1.7 m -101.92 137.46 29.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.252 -178.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.483 ' O ' HG22 ' A' ' 199' ' ' VAL . 7.4 tt -59.29 95.36 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 O-C-N 123.725 0.641 . . . . 0.0 109.426 177.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 4.0 mm? 55.11 20.24 3.22 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.339 -0.846 . . . . 0.0 112.608 178.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . 57.26 16.69 3.21 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.483 HG22 ' O ' ' A' ' 196' ' ' LEU . 35.5 m -95.89 4.54 8.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.173 0.511 . . . . 0.0 110.366 -179.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -107.01 87.58 2.54 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-O 121.756 0.789 . . . . 0.0 110.249 177.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -116.35 -7.82 11.7 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.109 -0.95 . . . . 0.0 108.896 173.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 8.6 t -159.0 177.12 11.47 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 114.305 -1.316 . . . . 0.0 107.676 177.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 91.68 -53.37 3.03 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.388 -0.911 . . . . 0.0 112.807 178.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -64.09 114.1 3.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.899 0.38 . . . . 0.0 110.838 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' CYS . . . . . 0.688 ' SG ' ' HG3' ' A' ' 206' ' ' ARG . 40.4 t -97.7 150.32 21.33 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.873 -176.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . 0.822 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 8.0 mtm180 55.43 -0.61 0.04 OUTLIER 'General case' 0 C--O 1.221 -0.398 0 N-CA-C 114.579 1.325 . . . . 0.0 114.579 177.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . 0.408 ' ND2' ' HB2' ' A' ' 277' ' ' ASP . 13.3 m-80 -104.98 105.6 15.71 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 119.09 0.859 . . . . 0.0 112.161 -172.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.502 ' HB ' ' HB ' ' A' ' 246' ' ' VAL . 65.1 t -133.69 114.7 20.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 114.569 -1.196 . . . . 0.0 109.199 177.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' PHE . . . . . 0.449 ' HE1' ' HB ' ' A' ' 243' ' ' ILE . 1.5 t80 -113.6 122.64 47.83 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.061 -176.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.683 ' HG ' HG22 ' A' ' 272' ' ' ILE . 6.4 mp -105.35 136.95 43.95 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.463 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . 0.567 ' HA2' HG22 ' A' ' 243' ' ' ILE . . . -144.58 68.55 0.42 Allowed Glycine 0 N--CA 1.448 -0.567 0 C-N-CA 120.422 -0.894 . . . . 0.0 113.19 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . 0.554 ' HB3' ' HA ' ' A' ' 270' ' ' ARG . 20.5 t30 173.66 37.57 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.092 0.473 . . . . 0.0 109.992 176.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.795 HD23 ' HG2' ' A' ' 270' ' ' ARG . 0.9 OUTLIER -86.59 159.91 51.67 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.71 -176.758 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.489 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 98.6 Cg_endo -77.67 162.94 29.67 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.76 2.307 . . . . 0.0 112.046 178.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -76.04 117.68 18.0 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.771 178.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 109.02 -0.94 31.53 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.292 -0.956 . . . . 0.0 113.011 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . 0.712 HG23 HG21 ' A' ' 237' ' ' ILE . 6.2 tp -60.76 130.19 24.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.046 0.451 . . . . 0.0 110.852 177.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . 0.436 ' CG2' ' HG3' ' A' ' 221' ' ' GLU . 12.1 t -114.07 156.24 24.51 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 121.722 0.772 . . . . 0.0 110.969 178.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -60.74 -35.31 76.06 Favored 'General case' 0 C--O 1.208 -1.089 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.093 -178.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -56.11 -35.68 67.35 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 123.433 0.458 . . . . 0.0 110.689 -178.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . 0.436 ' HG3' ' CG2' ' A' ' 218' ' ' THR . 43.6 mt-10 -68.44 -56.43 8.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.122 178.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.523 HD12 HD11 ' A' ' 237' ' ' ILE . 7.6 mt -60.45 -39.66 81.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.434 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . 0.774 ' HG3' HD12 ' A' ' 235' ' ' ILE . 33.6 mtp180 -55.88 -63.1 1.29 Allowed 'General case' 0 CA--C 1.509 -0.627 0 CA-C-O 120.935 0.398 . . . . 0.0 112.05 175.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -58.04 -22.1 48.5 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.813 -177.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -86.44 -34.21 20.19 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.621 -177.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.699 HD23 ' HZ ' ' A' ' 248' ' ' PHE . 8.1 mp -105.98 -18.54 14.01 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -169.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . 0.662 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 53.7 mt-10 -67.52 -30.32 2.89 Favored Pre-proline 0 C--N 1.326 -0.432 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -176.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . 0.662 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 71.7 Cg_endo -65.29 -28.71 55.2 Favored 'Trans proline' 0 C--N 1.36 1.146 0 C-N-CA 121.147 1.231 . . . . 0.0 112.089 -176.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . 0.506 ' CE1' ' HA ' ' A' ' 226' ' ' LEU . 3.1 p90 -110.84 -4.7 15.13 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.737 0.303 . . . . 0.0 111.725 175.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . 0.431 ' CA ' ' HB1' ' A' ' 253' ' ' ALA . . . -171.95 97.83 0.12 Allowed Glycine 0 N--CA 1.443 -0.895 0 C-N-CA 120.274 -0.965 . . . . 0.0 112.311 -175.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -64.65 131.45 29.52 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 121.778 1.652 . . . . 0.0 111.527 178.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.617 HG21 HG12 ' A' ' 246' ' ' VAL . 2.7 mp -107.77 151.97 9.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.563 177.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . 0.448 ' CG ' HD22 ' A' ' 249' ' ' LEU . 10.6 m-20 -109.42 -28.56 8.87 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.122 0.487 . . . . 0.0 110.168 176.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . 0.623 ' HB3' ' HB2' ' A' ' 247' ' ' HIS . 26.6 tt0 -136.28 122.54 20.49 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.748 -174.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.774 HD12 ' HG3' ' A' ' 223' ' ' ARG . 14.1 mt -138.45 112.99 8.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.763 178.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -125.35 118.23 25.47 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.41 -179.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' ILE . . . . . 0.712 HG21 HG23 ' A' ' 217' ' ' ILE . 44.9 mt -104.97 115.64 47.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.821 -178.137 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.547 ' HB ' HG13 ' A' ' 243' ' ' ILE . 21.9 t -94.08 87.77 2.22 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 173.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 11.1 t -64.28 -23.69 67.39 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.393 -176.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -64.27 -23.4 67.29 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.152 178.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . 0.729 ' HB2' HG12 ' A' ' 243' ' ' ILE . 97.1 mtt180 -120.21 -0.13 10.54 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.244 176.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 19.2 m120 63.55 29.65 15.24 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.137 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.729 HG12 ' HB2' ' A' ' 241' ' ' ARG . 1.2 pt -121.78 154.33 26.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.76 -175.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . 0.537 ' HB3' ' HB2' ' A' ' 210' ' ' LEU . . . -142.29 138.8 31.59 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.11 0.481 . . . . 0.0 111.788 -178.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -106.33 113.81 27.56 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.62 177.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.617 HG12 HG21 ' A' ' 232' ' ' ILE . 1.0 OUTLIER -112.77 130.58 66.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -179.817 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' HIS . . . . . 0.822 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 28.0 m170 -111.19 102.44 10.87 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.024 -0.67 . . . . 0.0 111.373 177.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . 0.699 ' HZ ' HD23 ' A' ' 226' ' ' LEU . 36.9 m-85 -84.61 101.92 12.51 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.599 177.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.478 ' H ' HD23 ' A' ' 249' ' ' LEU . 0.1 OUTLIER -44.43 -39.12 4.49 Favored 'General case' 0 N--CA 1.465 0.294 0 O-C-N 124.568 1.167 . . . . 0.0 112.956 -174.875 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 50.5 m-20 -99.88 143.16 30.42 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.056 178.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . 0.628 ' O ' HG13 ' A' ' 255' ' ' ILE . 0.2 OUTLIER -63.76 -44.62 98.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.138 -176.56 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -68.35 -29.93 68.77 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 120.606 0.241 . . . . 0.0 110.768 -176.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . 0.431 ' HB1' ' CA ' ' A' ' 230' ' ' GLY . . . -61.25 -42.41 98.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.285 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . 0.572 ' HB2' ' HB2' ' A' ' 248' ' ' PHE . . . -67.33 -41.33 85.42 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.719 178.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.71 ' O ' ' HG2' ' A' ' 259' ' ' GLN . 15.1 mt -57.05 -62.41 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.096 -177.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . 0.484 ' O ' ' HG2' ' A' ' 260' ' ' GLU . 10.1 ptmt -59.81 -38.42 81.93 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.109 -176.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -63.19 -49.76 72.98 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.59 0.233 . . . . 0.0 111.428 178.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . 0.478 HG13 HG12 ' A' ' 272' ' ' ILE . 52.7 t -66.36 -24.43 33.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.048 0.451 . . . . 0.0 111.119 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . 0.71 ' HG2' ' O ' ' A' ' 255' ' ' ILE . 78.9 mm-40 -84.13 -26.87 28.56 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.933 178.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . 0.484 ' HG2' ' O ' ' A' ' 256' ' ' LYS . 53.3 mm-40 -95.52 -31.65 13.23 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 122.702 0.401 . . . . 0.0 111.532 -175.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.807 ' HA ' ' HE3' ' A' ' 267' ' ' TRP . 0.7 OUTLIER -50.81 -51.03 70.2 Favored Pre-proline 0 CA--C 1.537 0.445 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.501 178.888 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' PRO . . . . . 0.619 ' HD3' HD11 ' A' ' 272' ' ' ILE . 37.8 Cg_endo -66.11 -15.69 49.43 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.287 1.991 . . . . 0.0 112.538 -177.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 57.6 mt -88.66 -9.34 52.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.967 0.413 . . . . 0.0 111.745 -177.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -105.44 148.82 36.99 Favored Pre-proline 0 C--N 1.314 -0.968 0 N-CA-C 112.586 0.588 . . . . 0.0 112.586 -172.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -61.52 -36.11 78.47 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 123.711 2.941 . . . . 0.0 112.61 -171.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 7.6 mtpt -85.99 -45.07 11.81 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 121.542 0.687 . . . . 0.0 109.608 -176.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' TRP . . . . . 0.807 ' HE3' ' HA ' ' A' ' 261' ' ' LEU . 11.2 m0 -78.29 -28.16 47.49 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.686 -173.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 23.9 t -63.94 -17.96 63.77 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.802 0.334 . . . . 0.0 110.802 177.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -73.81 -21.71 60.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.23 0.538 . . . . 0.0 110.097 176.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 270' ' ' ARG . . . . . 0.795 ' HG2' HD23 ' A' ' 213' ' ' LEU . 3.1 mpt_? -102.19 141.7 34.61 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.913 -176.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . 0.477 ' HG2' ' HB2' ' A' ' 212' ' ' ASN . 26.5 mmt180 -93.17 109.45 20.95 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . 0.748 HG21 HD23 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -117.95 139.31 45.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.424 0.63 . . . . 0.0 111.012 -177.203 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 273' ' ' TYR . . . . . 0.448 ' CE1' ' HB3' ' A' ' 209' ' ' PHE . 6.0 p90 -151.78 168.79 23.97 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.73 176.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 274' ' ' TYR . . . . . 0.419 ' OH ' ' HA ' ' A' ' 255' ' ' ILE . 85.5 m-85 -68.09 135.96 53.01 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.895 0.378 . . . . 0.0 110.523 174.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -79.37 -137.94 1.56 Allowed Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.908 -0.663 . . . . 0.0 111.536 176.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 73.5 mmt-85 -124.76 118.68 26.96 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 179.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 277' ' ' ASP . . . . . 0.408 ' HB2' ' ND2' ' A' ' 207' ' ' ASN . 9.4 t0 -115.79 138.91 50.68 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.765 -168.151 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 278' ' ' ARG . . . . . 0.53 ' HA ' HD11 ' A' ' 283' ' ' LEU . 54.4 mtm180 -103.66 -11.85 17.4 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.584 -176.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 279' ' ' CYS . . . . . 0.556 ' SG ' ' HB3' ' A' ' 205' ' ' CYS . 29.4 p -87.98 36.34 0.77 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.453 0.644 . . . . 0.0 110.458 -177.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -142.49 159.13 42.84 Favored 'General case' 0 N--CA 1.429 -1.521 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 3.7 p -70.47 76.91 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-O 122.277 1.037 . . . . 0.0 111.054 179.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -144.34 15.03 2.07 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.202 175.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 283' ' ' LEU . . . . . 0.53 HD11 ' HA ' ' A' ' 278' ' ' ARG . 9.3 mp -115.36 95.69 5.29 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.329 -0.435 . . . . 0.0 109.94 -178.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . 0.582 ' NZ ' ' HB3' ' A' ' 284' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.869 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -178.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 . . . . . 0 N--CA 1.482 1.142 0 CA-C-O 120.892 0.377 . . . . 0.0 111.028 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . 0.406 ' HB3' HD21 ' A' ' 263' ' ' LEU . 53.7 m -125.16 -32.7 2.96 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.181 175.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -139.19 178.57 7.08 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.362 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 17.2 m -62.97 -40.6 98.2 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.068 0.461 . . . . 0.0 110.18 177.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 -153.47 119.64 5.45 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.354 178.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 64.4 m -81.58 10.37 6.07 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -178.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 42.5 m 69.89 13.77 7.96 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 122.789 0.436 . . . . 0.0 112.035 175.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . 0.428 ' HB ' ' HA ' ' A' ' 198' ' ' ALA . 4.8 m -112.31 116.11 51.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.142 0.496 . . . . 0.0 111.536 178.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.468 ' O ' HG22 ' A' ' 199' ' ' VAL . 10.0 tt -60.46 101.57 0.14 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.669 175.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 8.3 mp 53.03 23.56 3.0 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.842 178.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.428 ' HA ' ' HB ' ' A' ' 195' ' ' VAL . . . 56.51 31.04 18.22 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.108 -179.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.468 HG22 ' O ' ' A' ' 196' ' ' LEU . 29.0 m -77.37 6.48 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 121.157 0.503 . . . . 0.0 111.34 179.08 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' GLN . . . . . 0.424 ' HA ' ' OE1' ' A' ' 200' ' ' GLN . 11.2 mm-40 -96.47 105.13 17.17 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 176.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . 0.481 ' OE1' ' HG3' ' A' ' 278' ' ' ARG . 96.1 mt-30 -28.72 105.58 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 O-C-N 125.34 1.65 . . . . 0.0 112.268 179.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 61.8 p -65.57 -34.13 77.53 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 121.231 0.538 . . . . 0.0 110.114 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -90.01 53.15 3.6 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.523 177.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -106.74 122.0 45.5 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 178.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' CYS . . . . . 0.64 ' HB3' HG12 ' A' ' 251' ' ' ILE . 7.6 p -86.78 146.35 26.28 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.673 -0.411 . . . . 0.0 109.979 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . 0.748 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 63.4 mtm180 56.71 -3.73 0.04 OUTLIER 'General case' 0 C--O 1.223 -0.319 0 N-CA-C 114.579 1.325 . . . . 0.0 114.579 176.143 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . 0.429 ' ND2' ' HA ' ' A' ' 278' ' ' ARG . 77.4 m-20 -100.78 105.81 17.16 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 118.95 0.795 . . . . 0.0 111.528 -171.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.474 ' HB ' ' HB ' ' A' ' 246' ' ' VAL . 58.4 t -137.22 125.91 34.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.362 176.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' PHE . . . . . 0.474 ' HE1' ' HB ' ' A' ' 243' ' ' ILE . 3.3 t80 -125.61 121.37 33.36 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.75 -176.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.611 ' HG ' HG22 ' A' ' 272' ' ' ILE . 5.4 mp -103.79 134.67 46.7 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.298 177.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . 0.613 ' HA2' HG22 ' A' ' 243' ' ' ILE . . . -143.13 65.96 0.47 Allowed Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.493 -0.86 . . . . 0.0 112.908 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . 0.529 ' HB3' ' HA ' ' A' ' 270' ' ' ARG . 1.6 t-20 174.83 39.54 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.252 0.549 . . . . 0.0 110.125 178.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.476 ' HB3' ' HD2' ' A' ' 214' ' ' PRO . 0.5 OUTLIER -89.96 162.82 34.33 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.985 -179.617 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.476 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 74.9 Cg_endo -83.8 169.27 12.0 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.739 2.293 . . . . 0.0 111.396 175.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -78.92 134.58 36.86 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 177.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 103.32 -9.78 53.89 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.468 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . 0.601 HG23 HG21 ' A' ' 237' ' ' ILE . 4.9 tp -59.85 128.08 20.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-O 121.071 0.462 . . . . 0.0 110.494 178.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . 0.447 ' CG2' ' HG2' ' A' ' 221' ' ' GLU . 9.0 t -114.43 158.28 21.77 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-O 121.252 0.548 . . . . 0.0 110.575 179.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.458 ' CD ' ' H ' ' A' ' 219' ' ' GLU . 1.3 mp0 -62.3 -39.35 92.68 Favored 'General case' 0 C--O 1.21 -0.975 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.809 -175.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -52.33 -37.82 56.98 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 123.676 0.61 . . . . 0.0 111.234 -178.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . 0.447 ' HG2' ' CG2' ' A' ' 218' ' ' THR . 47.5 mm-40 -68.16 -53.57 24.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.367 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.583 HD12 HD11 ' A' ' 237' ' ' ILE . 8.0 mt -62.0 -42.33 94.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.254 179.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . 0.705 ' HG3' HD12 ' A' ' 235' ' ' ILE . 66.4 mtp180 -53.27 -63.15 1.24 Allowed 'General case' 0 CA--C 1.507 -0.7 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 175.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -57.16 -23.91 50.72 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.782 -177.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -83.37 -33.1 25.88 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.592 -178.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.773 HD23 ' HZ ' ' A' ' 248' ' ' PHE . 7.7 mp -106.0 -15.51 14.88 Favored 'General case' 0 C--O 1.224 -0.253 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -171.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . 0.649 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 43.6 mm-40 -61.62 -37.62 42.67 Favored Pre-proline 0 C--N 1.328 -0.366 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -177.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . 0.649 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 85.1 Cg_endo -66.08 -29.07 48.6 Favored 'Trans proline' 0 C--N 1.358 1.039 0 C-N-CA 121.638 1.558 . . . . 0.0 112.414 -172.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . 0.52 ' CE1' ' HA ' ' A' ' 226' ' ' LEU . 3.5 p90 -110.56 -11.06 14.5 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.449 -0.5 . . . . 0.0 111.999 176.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . 0.415 ' CA ' ' HB1' ' A' ' 253' ' ' ALA . . . -164.93 92.4 0.11 Allowed Glycine 0 N--CA 1.44 -1.048 0 C-N-CA 120.282 -0.961 . . . . 0.0 112.01 -175.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -60.41 130.18 32.75 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.126 1.884 . . . . 0.0 111.319 178.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.784 HG21 HG12 ' A' ' 246' ' ' VAL . 2.3 mp -109.17 152.22 11.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.898 179.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . 0.421 ' CG ' HD22 ' A' ' 249' ' ' LEU . 27.7 m-20 -112.99 -23.47 10.04 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.985 0.421 . . . . 0.0 110.675 176.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . 0.554 ' HB3' ' HB2' ' A' ' 247' ' ' HIS . 35.1 tt0 -139.36 120.47 14.67 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.721 -175.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.705 HD12 ' HG3' ' A' ' 223' ' ' ARG . 13.7 mt -136.61 112.3 11.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.037 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -120.32 110.74 16.91 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.57 -177.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' ILE . . . . . 0.601 HG21 HG23 ' A' ' 217' ' ' ILE . 72.6 mt -98.85 117.55 44.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.791 -178.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.609 ' HB ' HG13 ' A' ' 243' ' ' ILE . 24.3 t -97.97 88.29 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 174.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 8.8 t -65.04 -24.33 67.45 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.455 -175.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -66.93 -21.49 65.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.329 0.585 . . . . 0.0 110.339 178.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . 0.624 ' CB ' HG12 ' A' ' 243' ' ' ILE . 33.4 mmt180 -117.91 -2.73 11.26 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.906 -178.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 17.4 m120 66.35 25.33 10.41 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.73 178.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.624 HG12 ' CB ' ' A' ' 241' ' ' ARG . 2.8 pt -122.33 153.1 26.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.01 -173.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . 0.486 ' HB3' ' HB2' ' A' ' 210' ' ' LEU . . . -142.14 134.92 28.47 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.897 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -105.89 120.13 40.95 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.821 178.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.784 HG12 HG21 ' A' ' 232' ' ' ILE . 0.2 OUTLIER -116.95 133.38 63.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -177.079 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' HIS . . . . . 0.748 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 41.3 m170 -115.05 102.81 10.29 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.067 -0.653 . . . . 0.0 111.195 177.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . 0.773 ' HZ ' HD23 ' A' ' 226' ' ' LEU . 28.2 m-85 -86.67 104.52 16.15 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.333 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.507 ' H ' HD23 ' A' ' 249' ' ' LEU . 0.1 OUTLIER -41.92 -46.44 4.05 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 124.405 1.066 . . . . 0.0 113.111 -175.766 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . 0.412 HD22 ' N ' ' A' ' 250' ' ' ASN . 0.9 OUTLIER -94.02 145.64 24.51 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.296 178.092 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . 0.64 HG12 ' HB3' ' A' ' 205' ' ' CYS . 0.2 OUTLIER -63.38 -41.72 93.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -179.705 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -70.69 -31.2 68.0 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 120.783 0.325 . . . . 0.0 110.57 -174.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . 0.415 ' HB1' ' CA ' ' A' ' 230' ' ' GLY . . . -59.5 -43.56 93.33 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.253 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . 0.594 ' HB2' ' HB2' ' A' ' 248' ' ' PHE . . . -68.44 -39.73 81.42 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.915 179.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.614 HG13 ' O ' ' A' ' 251' ' ' ILE . 7.9 mt -56.95 -61.97 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.21 -177.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . 0.511 ' O ' ' HG2' ' A' ' 260' ' ' GLU . 10.7 ptmt -61.43 -40.57 94.93 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.512 -176.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -60.44 -49.53 77.21 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.72 0.295 . . . . 0.0 111.365 178.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . 0.451 HG13 HG12 ' A' ' 272' ' ' ILE . 51.7 t -67.24 -23.34 30.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 120.98 0.419 . . . . 0.0 111.206 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . 0.518 ' HG3' ' O ' ' A' ' 255' ' ' ILE . 54.2 mt-30 -83.28 -27.39 29.86 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 122.193 -0.317 . . . . 0.0 111.54 177.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . 0.511 ' HG2' ' O ' ' A' ' 256' ' ' LYS . 30.2 mm-40 -95.62 -30.16 13.94 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.33 -173.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.714 ' HA ' ' HE3' ' A' ' 267' ' ' TRP . 0.7 OUTLIER -51.79 -51.41 70.61 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.382 178.096 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 261' ' ' LEU . 42.6 Cg_endo -67.07 -15.83 47.68 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.408 2.072 . . . . 0.0 112.84 -177.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . 0.406 HD21 ' HB3' ' A' ' 189' ' ' SER . 60.6 mt -94.94 -3.09 49.24 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.291 0.567 . . . . 0.0 111.832 -177.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' ASN . . . . . 0.486 ' O ' ' HB2' ' A' ' 268' ' ' SER . 13.3 m-80 -105.91 147.99 35.73 Favored Pre-proline 0 C--N 1.314 -0.947 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.321 -177.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -66.92 -32.87 34.71 Favored 'Trans proline' 0 C--N 1.334 -0.195 0 C-N-CA 123.35 2.7 . . . . 0.0 112.733 -168.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 3.8 mtpt -86.21 -44.53 12.1 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.517 0.675 . . . . 0.0 109.51 -178.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' TRP . . . . . 0.714 ' HE3' ' HA ' ' A' ' 261' ' ' LEU . 13.5 m0 -77.16 -28.15 54.02 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.874 -174.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . 0.486 ' HB2' ' O ' ' A' ' 264' ' ' ASN . 8.0 t -68.68 -15.12 63.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.035 0.445 . . . . 0.0 110.504 178.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -74.65 -14.67 60.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.856 174.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 270' ' ' ARG . . . . . 0.529 ' HA ' ' HB3' ' A' ' 212' ' ' ASN . 4.1 mpt_? -99.37 162.65 12.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.838 178.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . 0.424 ' HG2' ' CB ' ' A' ' 212' ' ' ASN . 36.7 mmt180 -112.14 105.76 14.2 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 174.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . 0.693 HG21 HD23 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -116.87 140.91 37.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.373 0.606 . . . . 0.0 111.34 -175.817 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 273' ' ' TYR . . . . . 0.406 ' HB2' ' HG3' ' A' ' 200' ' ' GLN . 2.0 p90 -151.66 167.99 26.41 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.805 172.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 274' ' ' TYR . . . . . 0.591 ' OH ' ' HA ' ' A' ' 255' ' ' ILE . 85.9 m-85 -67.09 138.0 56.79 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.402 174.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 275' ' ' GLY . . . . . 0.416 ' H ' ' HB3' ' A' ' 207' ' ' ASN . . . -60.44 118.13 13.78 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.724 -0.75 . . . . 0.0 111.593 178.084 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . 0.463 ' N ' ' HD3' ' A' ' 276' ' ' ARG . 0.1 OUTLIER -52.25 126.86 20.21 Favored 'General case' 0 C--O 1.238 0.46 0 O-C-N 123.915 0.421 . . . . 0.0 111.069 -178.295 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 12.0 t70 67.4 122.95 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 O-C-N 124.307 1.004 . . . . 0.0 111.459 -176.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 278' ' ' ARG . . . . . 0.481 ' HG3' ' OE1' ' A' ' 201' ' ' GLN . 25.2 mtp180 -67.48 -18.65 65.15 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.653 -174.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 279' ' ' CYS . . . . . . . . . . . . . 11.4 m -91.51 20.75 5.08 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.85 0.357 . . . . 0.0 110.396 -179.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -67.01 91.97 0.22 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.789 178.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 11.0 p -124.65 -8.37 6.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.759 -178.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -84.44 67.08 3.76 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.383 -177.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 82.8 mt -105.74 79.79 1.48 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.087 0.47 . . . . 0.0 110.648 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.622 -0.704 . . . . 0.0 110.111 178.974 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 . . . . . 0 N--CA 1.48 1.056 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 47.4 t -167.32 111.84 0.71 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.92 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -86.8 109.2 19.11 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.032 177.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 8.1 p -98.89 129.62 45.25 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.797 -179.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -74.93 132.75 41.66 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.967 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 14.9 m -84.19 64.94 8.53 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.728 0.299 . . . . 0.0 110.724 -177.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . 0.771 ' HA ' ' HD2' ' A' ' 273' ' ' TYR . 7.4 m 60.86 -168.53 0.17 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.108 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . 0.526 HG12 ' HG3' ' A' ' 200' ' ' GLN . 3.8 m -86.31 123.58 39.74 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.453 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.187 173.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 9.0 tt -62.48 99.13 0.13 Allowed 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 176.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 81.5 mt 55.39 24.87 7.03 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.382 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.489 ' HA ' ' HB ' ' A' ' 195' ' ' VAL . . . 57.1 35.04 25.8 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.778 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 29.8 m -69.46 -24.25 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-O 120.754 0.312 . . . . 0.0 111.245 178.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' GLN . . . . . 0.526 ' HG3' HG12 ' A' ' 195' ' ' VAL . 7.4 pt20 -108.35 82.02 1.56 Allowed 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 121.449 0.642 . . . . 0.0 110.999 176.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . 0.44 ' HG3' ' O ' ' A' ' 198' ' ' ALA . 25.6 mt-30 -103.14 40.16 1.44 Allowed 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 174.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 20.8 m -58.09 150.01 22.17 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.812 -177.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -74.4 72.66 1.43 Allowed Glycine 0 N--CA 1.449 -0.462 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.599 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -91.55 122.54 34.22 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 175.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' CYS . . . . . 0.702 ' HB3' HG12 ' A' ' 251' ' ' ILE . 15.6 p -87.15 145.96 26.21 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.644 -177.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . 0.804 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 57.1 mtp180 56.25 3.97 0.12 Allowed 'General case' 0 C--O 1.224 -0.281 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 175.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . 0.497 HD21 ' HB3' ' A' ' 277' ' ' ASP . 4.4 m-20 -108.36 105.79 15.64 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 119.85 -0.74 . . . . 0.0 112.041 -175.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.449 ' HB ' ' HB ' ' A' ' 246' ' ' VAL . 67.9 t -133.49 113.48 18.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 114.691 -1.141 . . . . 0.0 109.153 176.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' PHE . . . . . 0.45 ' HE1' ' HB ' ' A' ' 243' ' ' ILE . 1.7 t80 -112.05 122.37 47.58 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.094 -175.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.641 ' HG ' HG22 ' A' ' 272' ' ' ILE . 5.4 mp -104.8 131.13 52.64 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.257 178.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . 0.654 ' HA2' HG22 ' A' ' 243' ' ' ILE . . . -137.16 64.1 0.57 Allowed Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.217 -0.992 . . . . 0.0 113.636 -178.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . 0.53 ' HB3' ' HA ' ' A' ' 270' ' ' ARG . 30.6 t30 175.81 37.15 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.055 0.455 . . . . 0.0 109.93 174.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.551 HD23 ' HG2' ' A' ' 270' ' ' ARG . 1.0 OUTLIER -81.8 158.26 68.17 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.849 -176.792 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.434 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 73.4 Cg_endo -74.89 152.47 41.38 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 122.351 2.034 . . . . 0.0 111.522 177.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -70.04 116.17 10.1 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.237 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 108.5 1.68 32.88 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.487 -0.863 . . . . 0.0 112.639 -177.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . 0.71 HG23 HG21 ' A' ' 237' ' ' ILE . 5.1 tp -60.66 130.54 24.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.0 0.428 . . . . 0.0 110.502 176.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . 0.498 HG22 ' HG3' ' A' ' 221' ' ' GLU . 11.6 t -113.5 158.45 20.7 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.379 0.609 . . . . 0.0 110.949 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.541 ' CD ' ' H ' ' A' ' 219' ' ' GLU . 5.8 mp0 -61.85 -42.5 99.11 Favored 'General case' 0 C--O 1.21 -1.023 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.581 -176.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -48.18 -38.42 18.1 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 123.839 0.712 . . . . 0.0 111.547 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . 0.498 ' HG3' HG22 ' A' ' 218' ' ' THR . 42.3 mt-10 -66.22 -57.9 6.56 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.281 178.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.585 HD12 HD11 ' A' ' 237' ' ' ILE . 8.4 mt -61.45 -41.3 89.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.602 -178.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . 0.754 ' HG3' HD12 ' A' ' 235' ' ' ILE . 48.7 mtp180 -53.63 -62.7 1.48 Allowed 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 175.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -58.27 -22.89 54.33 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.756 -177.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' ASP . . . . . 0.463 ' HB3' ' CZ2' ' A' ' 267' ' ' TRP . 10.7 m-20 -86.2 -32.26 21.3 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.844 -177.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.789 HD23 ' HZ ' ' A' ' 248' ' ' PHE . 7.7 mp -106.68 -15.31 14.79 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -170.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . 0.631 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 23.2 mm-40 -60.4 -38.38 57.16 Favored Pre-proline 0 C--N 1.327 -0.393 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -178.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . 0.631 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 96.1 Cg_endo -66.78 -26.47 45.12 Favored 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 121.587 1.525 . . . . 0.0 112.485 -171.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . 0.524 ' CZ ' ' HA ' ' A' ' 226' ' ' LEU . 3.6 p90 -111.21 -9.19 14.33 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.958 175.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . 0.434 ' CA ' ' HB1' ' A' ' 253' ' ' ALA . . . -169.05 99.1 0.15 Allowed Glycine 0 N--CA 1.442 -0.942 0 C-N-CA 120.033 -1.079 . . . . 0.0 112.268 -175.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.441 ' HA ' ' OE2' ' A' ' 227' ' ' GLU . 18.5 Cg_endo -65.86 131.43 27.32 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 121.808 1.672 . . . . 0.0 111.532 178.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.709 HG21 HG12 ' A' ' 246' ' ' VAL . 2.1 mp -108.68 151.51 10.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.437 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . 0.458 ' CG ' HD22 ' A' ' 249' ' ' LEU . 38.0 m-20 -114.56 -19.89 10.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.848 0.356 . . . . 0.0 110.75 177.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . 0.492 ' HB3' ' HB2' ' A' ' 247' ' ' HIS . 9.4 tt0 -143.62 121.22 11.8 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.73 -177.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.754 HD12 ' HG3' ' A' ' 223' ' ' ARG . 12.1 mt -135.09 108.52 9.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.964 -179.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 61.9 tttp -115.9 112.47 21.94 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.411 -178.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' ILE . . . . . 0.71 HG21 HG23 ' A' ' 217' ' ' ILE . 67.0 mt -102.35 124.1 56.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-O 121.017 0.436 . . . . 0.0 110.783 -179.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.532 ' HB ' HG13 ' A' ' 243' ' ' ILE . 61.2 t -105.23 87.68 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 171.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 13.2 t -69.84 -16.53 63.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.381 -177.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -62.06 -34.04 75.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.202 175.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . 0.774 ' HB2' HG12 ' A' ' 243' ' ' ILE . 77.0 mtt180 -112.88 -0.28 14.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.527 178.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 17.9 m120 67.46 29.64 7.2 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.847 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.774 HG12 ' HB2' ' A' ' 241' ' ' ARG . 1.3 pt -122.3 151.68 26.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.037 -175.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . 0.46 ' HB3' ' HB2' ' A' ' 210' ' ' LEU . . . -141.3 138.19 32.98 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.046 0.451 . . . . 0.0 111.849 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -107.27 108.05 19.28 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.836 177.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.709 HG12 HG21 ' A' ' 232' ' ' ILE . 0.9 OUTLIER -106.12 133.57 50.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 -179.288 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' HIS . . . . . 0.804 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 41.8 m170 -112.27 101.97 10.16 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.486 0.66 . . . . 0.0 111.295 178.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . 0.789 ' HZ ' HD23 ' A' ' 226' ' ' LEU . 33.7 m-85 -86.65 101.28 13.11 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.99 -1.004 . . . . 0.0 111.33 179.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.483 ' H ' HD23 ' A' ' 249' ' ' LEU . 0.1 OUTLIER -42.26 -48.05 4.88 Favored 'General case' 0 N--CA 1.465 0.312 0 O-C-N 124.367 1.042 . . . . 0.0 112.583 -176.611 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -84.95 138.18 32.65 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 178.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . 0.702 HG12 ' HB3' ' A' ' 205' ' ' CYS . 0.2 OUTLIER -62.38 -43.69 98.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -179.609 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -68.98 -30.12 68.47 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.901 -177.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . 0.434 ' HB1' ' CA ' ' A' ' 230' ' ' GLY . . . -60.72 -41.74 95.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.32 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . 0.594 ' HB2' ' HB2' ' A' ' 248' ' ' PHE . . . -67.87 -41.29 83.08 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.591 178.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.584 HG13 ' O ' ' A' ' 251' ' ' ILE . 11.7 mt -56.05 -60.84 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.159 -178.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 10.0 ptmt -62.66 -38.84 91.92 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.622 -176.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -61.96 -47.97 82.46 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.557 0.218 . . . . 0.0 111.349 178.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . 0.557 HG13 HG12 ' A' ' 272' ' ' ILE . 54.6 t -65.15 -25.14 36.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.878 0.371 . . . . 0.0 110.931 178.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -83.71 -23.61 31.59 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 178.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -94.93 -34.93 12.21 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.826 0.345 . . . . 0.0 110.689 -175.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.732 ' HA ' ' HE3' ' A' ' 267' ' ' TRP . 0.7 OUTLIER -51.57 -50.48 76.73 Favored Pre-proline 0 CA--C 1.538 0.503 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.578 -178.296 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' PRO . . . . . 0.586 ' HD3' HD11 ' A' ' 272' ' ' ILE . 37.3 Cg_endo -66.35 -20.6 55.02 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.222 1.948 . . . . 0.0 112.544 -177.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 65.8 mt -90.65 -2.22 57.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.292 0.568 . . . . 0.0 111.551 -175.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' ASN . . . . . 0.403 ' O ' ' HB2' ' A' ' 268' ' ' SER . 12.2 m-80 -106.71 148.93 37.77 Favored Pre-proline 0 C--N 1.315 -0.916 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.938 -176.115 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -65.59 -34.2 42.82 Favored 'Trans proline' 0 C--O 1.23 0.11 0 C-N-CA 123.367 2.711 . . . . 0.0 112.604 -171.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 5.1 mtpt -86.05 -45.23 11.62 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 121.812 0.815 . . . . 0.0 109.747 -177.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' TRP . . . . . 0.732 ' HE3' ' HA ' ' A' ' 261' ' ' LEU . 11.3 m0 -78.75 -26.02 44.57 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.722 -172.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . 0.403 ' HB2' ' O ' ' A' ' 264' ' ' ASN . 37.3 t -61.41 -22.15 64.75 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.758 0.313 . . . . 0.0 111.01 177.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -71.15 -18.08 62.52 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.242 0.544 . . . . 0.0 110.481 176.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 270' ' ' ARG . . . . . 0.551 ' HG2' HD23 ' A' ' 213' ' ' LEU . 0.0 OUTLIER -101.9 140.56 36.02 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.475 -179.932 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . 0.779 ' HE ' ' HA ' ' A' ' 271' ' ' ARG . 0.2 OUTLIER -95.62 105.77 17.8 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.777 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . 0.717 HG21 HD23 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -115.24 144.07 23.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.352 0.596 . . . . 0.0 111.285 -174.693 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 273' ' ' TYR . . . . . 0.771 ' HD2' ' HA ' ' A' ' 194' ' ' SER . 5.0 p90 -151.87 169.46 22.22 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.421 174.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -62.34 115.0 3.81 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 171.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -83.13 169.15 47.69 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.717 -0.754 . . . . 0.0 113.111 -170.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 24.7 ptt180 -110.24 141.45 43.19 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 176.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 277' ' ' ASP . . . . . 0.497 ' HB3' HD21 ' A' ' 207' ' ' ASN . 21.9 t70 -159.21 164.27 35.21 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.822 0.344 . . . . 0.0 110.93 -170.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 278' ' ' ARG . . . . . . . . . . . . . 21.5 ptt180 -56.55 -33.71 66.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.386 -0.825 . . . . 0.0 112.21 179.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 279' ' ' CYS . . . . . . . . . . . . . 42.7 t -110.17 67.19 0.64 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -176.66 -171.91 0.41 Allowed 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.408 -176.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 2.9 p -151.39 110.06 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 115.025 -0.988 . . . . 0.0 110.055 178.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -75.8 -76.75 0.77 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.805 178.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 32.5 tp -140.09 90.56 2.38 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 177.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 60.7 tttm . . . . . 0 C--O 1.247 0.941 0 CA-C-O 118.376 -0.821 . . . . 0.0 109.832 -175.462 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 15.6 m120 . . . . . 0 N--CA 1.479 1.018 0 CA-C-O 120.806 0.336 . . . . 0.0 110.582 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 9.0 t -150.79 100.76 2.85 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 176.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -100.74 -21.24 15.25 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.925 -173.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 50.7 p 50.71 -84.43 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.976 0.91 . . . . 0.0 112.119 -176.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 63.0 t30 70.57 -70.11 0.16 Allowed 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.836 0.855 . . . . 0.0 111.981 176.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 5.6 p -80.31 -1.76 42.37 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.093 0.473 . . . . 0.0 111.14 -178.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 3.9 m -109.56 74.7 0.91 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.888 177.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . 0.536 ' HB ' ' HA ' ' A' ' 198' ' ' ALA . 13.9 m 35.27 100.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 -177.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.549 ' O ' HG22 ' A' ' 199' ' ' VAL . 8.3 tt -55.32 102.81 0.08 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.596 174.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 94.7 mt 54.27 16.24 1.17 Allowed 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.407 0.683 . . . . 0.0 112.364 178.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.536 ' HA ' ' HB ' ' A' ' 195' ' ' VAL . . . 57.62 17.71 4.19 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.055 0.542 . . . . 0.0 112.042 -176.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.549 HG22 ' O ' ' A' ' 196' ' ' LEU . 33.7 m -84.17 -21.56 8.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.298 0.571 . . . . 0.0 110.465 -179.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -92.53 75.0 5.14 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.475 0.655 . . . . 0.0 110.65 -179.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -124.39 111.08 15.35 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.744 178.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . 0.552 ' HA ' ' HA ' ' A' ' 281' ' ' VAL . 15.0 m -85.25 -56.21 3.65 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 174.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.535 ' HA3' ' HG ' ' A' ' 283' ' ' LEU . . . 160.35 51.75 0.01 OUTLIER Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.642 -179.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.3 101.72 1.26 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.015 0.436 . . . . 0.0 110.404 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' CYS . . . . . 0.462 ' SG ' HG12 ' A' ' 251' ' ' ILE . 2.5 m -87.48 146.16 25.94 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.984 -0.746 . . . . 0.0 108.984 -178.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . 0.82 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 24.7 mtp-105 55.52 4.98 0.11 Allowed 'General case' 0 C--O 1.222 -0.388 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 177.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -101.3 106.04 17.18 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 118.681 0.673 . . . . 0.0 111.562 -172.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.413 ' HB ' ' HB ' ' A' ' 246' ' ' VAL . 60.0 t -138.57 119.69 16.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.936 176.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' PHE . . . . . 0.437 ' O ' ' HA ' ' A' ' 272' ' ' ILE . 4.3 t80 -116.31 125.64 52.43 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.49 -177.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.625 ' HG ' HG22 ' A' ' 272' ' ' ILE . 6.2 mp -110.7 133.96 52.88 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.612 178.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . 0.569 ' HA2' HG22 ' A' ' 243' ' ' ILE . . . -138.94 65.9 0.53 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.591 -0.814 . . . . 0.0 113.351 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . 0.462 ' HB2' ' O ' ' A' ' 211' ' ' GLY . 25.1 t30 172.05 42.77 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.831 0.348 . . . . 0.0 110.617 177.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.473 HD21 HD22 ' A' ' 210' ' ' LEU . 1.2 mp -91.23 160.32 37.57 Favored Pre-proline 0 C--N 1.322 -0.591 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.268 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.413 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 92.7 Cg_endo -82.49 166.76 15.62 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 122.637 2.225 . . . . 0.0 112.202 177.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -73.36 125.87 28.83 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.324 0.583 . . . . 0.0 111.139 178.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 106.01 -8.78 42.6 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.839 178.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . 0.8 HG23 HG21 ' A' ' 237' ' ' ILE . 5.0 tp -57.99 125.92 14.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.338 0.59 . . . . 0.0 110.625 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . 0.457 ' CG2' ' HG3' ' A' ' 221' ' ' GLU . 11.1 t -114.42 157.88 22.3 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.751 -178.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -61.34 -35.53 77.67 Favored 'General case' 0 C--O 1.209 -1.056 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.936 -177.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' ASP . . . . . 0.42 ' O ' ' HG2' ' A' ' 224' ' ' GLU . 29.5 t70 -51.32 -40.0 58.14 Favored 'General case' 0 C--N 1.32 -0.702 0 O-C-N 123.632 0.582 . . . . 0.0 111.109 178.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . 0.457 ' HG3' ' CG2' ' A' ' 218' ' ' THR . 44.4 mt-10 -70.01 -54.13 14.59 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.562 -179.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.584 HD12 HD11 ' A' ' 237' ' ' ILE . 11.8 mt -60.98 -42.29 92.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.616 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . 0.831 ' HG3' HD12 ' A' ' 235' ' ' ILE . 38.9 mtp180 -53.87 -63.09 1.26 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 174.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.42 ' HG2' ' O ' ' A' ' 220' ' ' ASP . 15.4 pt-20 -57.7 -22.16 44.67 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.19 -177.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' ASP . . . . . 0.481 ' HB3' ' CZ2' ' A' ' 267' ' ' TRP . 27.0 m-20 -89.62 -31.88 17.34 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.973 -177.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.854 HD23 ' HZ ' ' A' ' 248' ' ' PHE . 8.3 mp -107.05 -17.46 14.17 Favored 'General case' 0 C--O 1.224 -0.282 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -169.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . 0.679 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 58.6 mt-10 -69.6 -26.91 1.15 Allowed Pre-proline 0 C--N 1.323 -0.568 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -175.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . 0.679 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 72.3 Cg_endo -66.25 -27.84 48.06 Favored 'Trans proline' 0 C--N 1.36 1.179 0 C-N-CA 121.247 1.298 . . . . 0.0 111.916 -178.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . 0.489 ' CZ ' ' HA ' ' A' ' 226' ' ' LEU . 3.6 p90 -110.6 -9.36 14.55 Favored 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.66 174.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . 0.404 ' HA2' ' HD2' ' A' ' 231' ' ' PRO . . . -168.35 93.77 0.11 Allowed Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 120.18 -1.01 . . . . 0.0 112.109 -175.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.404 ' HD2' ' HA2' ' A' ' 230' ' ' GLY . 16.9 Cg_endo -59.76 133.59 52.08 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.214 1.943 . . . . 0.0 111.393 177.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.726 HG21 HG12 ' A' ' 246' ' ' VAL . 2.4 mp -111.4 151.59 13.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.309 177.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . 0.435 ' OD2' HD22 ' A' ' 249' ' ' LEU . 14.9 m-20 -115.51 -20.08 10.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.76 0.314 . . . . 0.0 111.227 177.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . 0.543 ' HB3' ' HB2' ' A' ' 247' ' ' HIS . 22.9 tt0 -142.77 120.48 11.86 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.279 -176.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.831 HD12 ' HG3' ' A' ' 223' ' ' ARG . 17.2 mt -136.3 116.28 17.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.889 -179.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -122.2 116.11 23.58 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.849 0.357 . . . . 0.0 110.457 178.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' ILE . . . . . 0.8 HG21 HG23 ' A' ' 217' ' ' ILE . 33.4 mt -104.57 115.47 46.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.248 179.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.575 ' HB ' HG13 ' A' ' 243' ' ' ILE . 45.5 t -94.26 87.0 2.04 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.152 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 173.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 8.8 t -65.32 -22.29 66.81 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.482 -177.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -60.32 -29.12 68.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.565 176.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . 0.786 ' HB2' HG12 ' A' ' 243' ' ' ILE . 73.9 mtt180 -120.0 0.43 10.77 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.797 -179.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' ASN . . . . . 0.472 ' O ' HD12 ' A' ' 213' ' ' LEU . 92.1 m-20 66.16 29.72 9.66 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.194 179.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.786 HG12 ' HB2' ' A' ' 241' ' ' ARG . 1.3 pt -121.92 151.34 25.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.792 -176.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . 0.552 ' HB3' ' HB2' ' A' ' 210' ' ' LEU . . . -141.55 138.77 32.92 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.103 0.477 . . . . 0.0 111.55 -178.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -110.78 111.43 22.6 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.677 176.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.726 HG12 HG21 ' A' ' 232' ' ' ILE . 0.8 OUTLIER -108.16 134.89 48.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -179.234 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' HIS . . . . . 0.82 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 46.1 m80 -116.06 101.72 9.0 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 119.995 -0.682 . . . . 0.0 111.457 178.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . 0.854 ' HZ ' HD23 ' A' ' 226' ' ' LEU . 29.9 m-85 -84.67 104.67 14.85 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.716 -1.129 . . . . 0.0 111.113 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.577 ' HA ' ' HE ' ' A' ' 206' ' ' ARG . 0.1 OUTLIER -42.82 -42.56 3.66 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 124.194 0.934 . . . . 0.0 113.058 -174.11 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 47.4 m-20 -95.51 143.8 26.53 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . 0.533 ' O ' HG13 ' A' ' 255' ' ' ILE . 0.2 OUTLIER -63.56 -45.0 98.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -177.594 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -70.79 -29.14 65.25 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-O 120.625 0.25 . . . . 0.0 110.791 -176.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -58.6 -42.7 88.71 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.36 178.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . 0.594 ' HB2' ' HB2' ' A' ' 248' ' ' PHE . . . -67.29 -42.0 84.49 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.626 178.025 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.533 HG13 ' O ' ' A' ' 251' ' ' ILE . 8.5 mt -56.95 -61.31 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.539 -177.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . 0.406 ' O ' ' HG2' ' A' ' 260' ' ' GLU . 12.3 ptmt -60.41 -38.52 84.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.271 -177.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -62.75 -47.91 81.47 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.741 0.305 . . . . 0.0 111.211 178.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 44.4 t -66.18 -23.54 32.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.011 0.434 . . . . 0.0 111.023 179.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . 0.484 ' HG3' ' O ' ' A' ' 255' ' ' ILE . 50.8 mt-30 -83.53 -27.8 29.09 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.825 177.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . 0.406 ' HG2' ' O ' ' A' ' 256' ' ' LYS . 50.9 mm-40 -96.02 -28.89 14.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.69 0.281 . . . . 0.0 111.59 -173.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.731 ' HA ' ' HE3' ' A' ' 267' ' ' TRP . 0.7 OUTLIER -54.1 -50.04 86.62 Favored Pre-proline 0 CA--C 1.536 0.437 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.516 179.252 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' PRO . . . . . 0.581 ' HD2' ' N ' ' A' ' 261' ' ' LEU . 41.2 Cg_endo -66.41 -13.76 41.27 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.271 1.981 . . . . 0.0 112.419 -179.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 60.8 mt -91.15 -8.0 49.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.929 0.395 . . . . 0.0 112.0 -178.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' ASN . . . . . 0.405 ' O ' ' HB2' ' A' ' 268' ' ' SER . 3.2 m-20 -106.11 149.8 38.57 Favored Pre-proline 0 C--O 1.211 -0.964 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.974 -177.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 265' ' ' PRO . . . . . 0.427 ' O ' ' HG3' ' A' ' 269' ' ' LYS . 47.3 Cg_endo -67.28 -33.28 30.98 Favored 'Trans proline' 0 C--O 1.224 -0.21 0 C-N-CA 123.325 2.684 . . . . 0.0 112.804 -171.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.461 ' HB2' ' HE3' ' A' ' 266' ' ' LYS . 0.0 OUTLIER -83.35 -45.91 13.19 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 121.732 0.777 . . . . 0.0 109.224 -179.376 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' TRP . . . . . 0.731 ' HE3' ' HA ' ' A' ' 261' ' ' LEU . 14.3 m0 -76.49 -29.75 56.96 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.909 -172.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . 0.405 ' HB2' ' O ' ' A' ' 264' ' ' ASN . 24.1 t -63.84 -23.12 67.23 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.896 0.379 . . . . 0.0 110.72 178.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . 0.427 ' HG3' ' O ' ' A' ' 265' ' ' PRO . 93.4 mttt -70.82 -19.08 62.7 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.283 0.563 . . . . 0.0 109.695 178.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 270' ' ' ARG . . . . . 0.432 ' HA ' ' HB3' ' A' ' 212' ' ' ASN . 4.7 mpt_? -93.25 146.49 23.66 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.476 176.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 6.6 mmp_? -99.33 106.07 18.13 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 173.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . 0.679 HG21 HD23 ' A' ' 261' ' ' LEU . 0.1 OUTLIER -117.73 142.34 32.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.336 0.589 . . . . 0.0 111.552 -176.673 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -150.61 168.87 23.0 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.254 170.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -58.74 132.59 54.35 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 175.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -72.89 78.22 0.77 Allowed Glycine 0 CA--C 1.507 -0.459 0 C-N-CA 121.173 -0.537 . . . . 0.0 112.131 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 76.9 mtp180 64.41 135.54 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.874 0 C-N-CA 124.4 1.08 . . . . 0.0 113.207 -176.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -141.96 151.64 42.74 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.172 -1.376 . . . . 0.0 108.638 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 278' ' ' ARG . . . . . . . . . . . . . 65.0 mtp180 -64.5 -24.85 67.75 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 111.614 0.228 . . . . 0.0 111.614 -175.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 279' ' ' CYS . . . . . . . . . . . . . 77.5 m 52.31 45.88 27.67 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.384 0.611 . . . . 0.0 110.288 -175.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -141.11 24.19 2.16 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.308 -177.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 281' ' ' VAL . . . . . 0.552 ' HA ' ' HA ' ' A' ' 202' ' ' SER . 7.6 p 38.29 86.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 124.325 1.05 . . . . 0.0 113.045 -177.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 178.16 131.14 1.5 Allowed Glycine 0 N--CA 1.447 -0.567 0 CA-C-N 115.131 -0.94 . . . . 0.0 111.248 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 283' ' ' LEU . . . . . 0.535 ' HG ' ' HA3' ' A' ' 203' ' ' GLY . 5.1 mp -93.51 -170.58 2.4 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.862 0.331 . . . . 0.0 110.461 -176.026 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 10.8 ptmm? . . . . . 0 C--O 1.247 0.929 0 CA-C-O 118.296 -0.859 . . . . 0.0 110.883 178.578 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 9.7 t30 . . . . . 0 N--CA 1.479 1.007 0 CA-C-O 120.896 0.379 . . . . 0.0 110.758 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . 0.511 ' HB3' ' HA ' ' A' ' 192' ' ' ASN . 17.3 m -109.05 93.7 4.65 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 175.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -66.07 -63.68 1.03 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.643 -178.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 39.7 t -84.16 -25.86 29.28 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 177.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . 0.511 ' HA ' ' HB3' ' A' ' 189' ' ' SER . 49.5 t30 63.89 91.53 0.07 Allowed 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.419 -175.244 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 33.8 m -85.55 6.75 25.78 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.981 -178.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 15.4 m 60.9 30.58 19.72 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.604 174.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . 0.548 ' CG2' ' HA ' ' A' ' 198' ' ' ALA . 0.3 OUTLIER -125.79 150.28 31.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.396 -176.77 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.638 ' O ' HG22 ' A' ' 199' ' ' VAL . 5.5 tt -60.85 97.13 0.05 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 176.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 98.4 mt 52.21 25.11 3.13 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.212 -0.904 . . . . 0.0 112.682 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.548 ' HA ' ' CG2' ' A' ' 195' ' ' VAL . . . 59.01 18.17 6.06 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 179.18 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.638 HG22 ' O ' ' A' ' 196' ' ' LEU . 21.3 m -91.54 -7.84 10.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.351 0.596 . . . . 0.0 110.16 177.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -83.86 78.66 9.68 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.347 178.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . 0.428 ' HA ' ' OE1' ' A' ' 201' ' ' GLN . 15.4 mm-40 -92.05 -4.19 54.76 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.644 0.735 . . . . 0.0 109.625 174.227 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 28.1 m -150.89 168.92 23.03 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.032 -0.986 . . . . 0.0 109.24 176.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.448 ' C ' ' HA ' ' A' ' 279' ' ' CYS . . . 98.11 -48.33 1.44 Allowed Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.811 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . 0.53 ' HA ' ' OD2' ' A' ' 277' ' ' ASP . . . -67.19 102.89 1.11 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.95 0.405 . . . . 0.0 110.49 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' CYS . . . . . 0.575 ' SG ' ' HG3' ' A' ' 206' ' ' ARG . 35.2 t -88.48 148.27 24.25 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.74 -176.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . 0.748 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 15.0 mtm180 51.86 -0.7 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 179.182 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 19.3 m-80 -100.65 105.64 17.03 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 118.876 0.762 . . . . 0.0 111.332 -172.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.504 ' HB ' ' HB ' ' A' ' 246' ' ' VAL . 60.3 t -137.36 127.76 38.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.24 176.375 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' PHE . . . . . 0.591 ' HB3' ' CE1' ' A' ' 273' ' ' TYR . 1.8 t80 -127.44 128.18 45.33 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 -177.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.489 ' HG ' HG22 ' A' ' 272' ' ' ILE . 5.9 mp -111.02 134.0 52.96 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.505 179.032 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . 0.595 ' HA2' HG22 ' A' ' 243' ' ' ILE . . . -138.94 65.68 0.53 Allowed Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.098 -1.048 . . . . 0.0 113.328 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . 0.581 ' HB2' ' HG3' ' A' ' 271' ' ' ARG . 3.3 t30 174.83 40.92 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.24 0.543 . . . . 0.0 110.105 175.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.623 ' HA ' ' HG3' ' A' ' 270' ' ' ARG . 1.0 OUTLIER -85.81 155.85 58.53 Favored Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.811 -177.693 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -79.79 169.14 18.5 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.81 2.34 . . . . 0.0 112.059 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -78.69 124.05 27.79 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 108.52 -2.83 32.53 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.592 -0.814 . . . . 0.0 112.613 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . 0.403 HG23 HG21 ' A' ' 237' ' ' ILE . 6.0 tp -65.14 125.18 21.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-O 121.255 0.55 . . . . 0.0 111.194 179.001 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . 0.465 HG22 ' HG3' ' A' ' 221' ' ' GLU . 15.0 t -114.4 161.05 18.45 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.561 177.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.449 ' CD ' ' H ' ' A' ' 219' ' ' GLU . 9.3 mp0 -62.81 -38.04 89.11 Favored 'General case' 0 C--O 1.208 -1.105 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.059 -178.411 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' ASP . . . . . 0.483 ' O ' ' HG2' ' A' ' 224' ' ' GLU . 26.2 t70 -51.63 -37.87 52.21 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 123.618 0.574 . . . . 0.0 110.813 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . 0.465 ' HG3' HG22 ' A' ' 218' ' ' THR . 41.9 mt-10 -67.49 -57.5 6.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.4 178.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.533 HG23 HD22 ' A' ' 226' ' ' LEU . 6.9 mt -58.29 -41.67 81.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.351 -179.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . 0.729 ' HG3' HD12 ' A' ' 235' ' ' ILE . 37.3 mtp180 -57.12 -62.84 1.47 Allowed 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 175.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.483 ' HG2' ' O ' ' A' ' 220' ' ' ASP . 11.1 pt-20 -59.32 -20.8 57.49 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.083 -177.023 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' ASP . . . . . 0.462 ' HB3' ' CZ2' ' A' ' 267' ' ' TRP . 3.3 m-20 -90.58 -31.43 16.69 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.637 -177.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.681 HD23 ' HZ ' ' A' ' 248' ' ' PHE . 8.2 mp -107.45 -19.1 13.68 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -171.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . 0.693 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 48.1 mt-10 -73.34 -22.24 0.49 Allowed Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 113.264 0.839 . . . . 0.0 113.264 -175.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . 0.693 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 74.3 Cg_endo -66.59 -28.17 45.21 Favored 'Trans proline' 0 C--N 1.361 1.223 0 CA-C-N 120.747 1.302 . . . . 0.0 111.895 178.357 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . 0.482 ' CE1' ' HA ' ' A' ' 226' ' ' LEU . 2.9 p90 -110.71 -5.66 14.96 Favored 'General case' 0 C--O 1.225 -0.237 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.609 174.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . 0.482 ' CA ' ' HB1' ' A' ' 253' ' ' ALA . . . -174.6 95.59 0.1 Allowed Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 119.945 -1.121 . . . . 0.0 112.554 -175.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.487 ' HA ' ' HG2' ' A' ' 227' ' ' GLU . 19.2 Cg_endo -60.75 135.69 61.7 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.264 1.976 . . . . 0.0 111.584 177.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.632 HG21 HG12 ' A' ' 246' ' ' VAL . 3.3 mp -108.6 151.31 10.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.488 178.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . 0.489 ' CG ' HD22 ' A' ' 249' ' ' LEU . 12.7 m-20 -107.07 -25.58 11.52 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.001 0.429 . . . . 0.0 110.831 178.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . 0.473 ' H ' HG22 ' A' ' 232' ' ' ILE . 12.9 tt0 -145.1 120.28 10.15 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.749 -173.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.729 HD12 ' HG3' ' A' ' 223' ' ' ARG . 24.0 mt -133.04 107.59 11.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.8 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -113.75 110.58 20.38 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.605 -175.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' ILE . . . . . 0.485 HD11 HD12 ' A' ' 222' ' ' ILE . 89.3 mt -100.76 121.52 51.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.262 0.553 . . . . 0.0 111.188 -178.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.499 ' HB ' HG13 ' A' ' 243' ' ' ILE . 46.1 t -108.97 87.22 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 172.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 13.9 t -68.33 -20.36 64.73 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.193 -177.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -57.91 -30.84 66.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.154 175.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . 0.696 ' HB2' HG12 ' A' ' 243' ' ' ILE . 98.8 mtt180 -118.26 4.41 11.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.732 177.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 17.5 m120 64.71 29.14 12.95 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.224 178.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.696 HG12 ' HB2' ' A' ' 241' ' ' ARG . 1.3 pt -122.19 151.64 26.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.31 -174.448 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -142.02 135.9 29.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.005 0.431 . . . . 0.0 111.446 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -103.91 114.42 28.66 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.702 178.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.632 HG12 HG21 ' A' ' 232' ' ' ILE . 0.4 OUTLIER -110.35 132.17 59.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -179.349 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' HIS . . . . . 0.748 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 28.1 m80 -114.81 102.76 10.3 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 119.96 -0.696 . . . . 0.0 111.348 177.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . 0.681 ' HZ ' HD23 ' A' ' 226' ' ' LEU . 37.4 m-85 -86.18 102.98 14.39 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 114.887 -1.051 . . . . 0.0 111.33 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.489 HD22 ' CG ' ' A' ' 233' ' ' ASP . 0.2 OUTLIER -46.28 -37.9 7.92 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 124.437 1.086 . . . . 0.0 112.797 -175.789 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . 0.432 ' HB2' ' HB2' ' A' ' 253' ' ' ALA . 55.0 m-20 -97.27 136.32 37.93 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 178.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . 0.612 ' O ' HG13 ' A' ' 255' ' ' ILE . 0.2 OUTLIER -60.62 -43.41 94.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -179.094 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -70.96 -27.82 64.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.903 -176.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . 0.482 ' HB1' ' CA ' ' A' ' 230' ' ' GLY . . . -62.5 -41.72 99.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.215 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . 0.577 ' HB2' ' HB2' ' A' ' 248' ' ' PHE . . . -67.41 -41.96 84.04 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.645 178.391 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.675 ' HA ' ' OH ' ' A' ' 274' ' ' TYR . 13.5 mt -55.9 -61.25 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.297 -177.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 13.3 ptmt -62.37 -38.23 88.77 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.425 -176.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -64.48 -49.98 69.26 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 111.512 0.189 . . . . 0.0 111.512 179.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . 0.484 HG13 HG12 ' A' ' 272' ' ' ILE . 53.3 t -66.47 -22.79 30.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.01 0.434 . . . . 0.0 111.081 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -84.44 -24.61 29.47 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 175.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -90.55 -35.63 14.94 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.884 0.373 . . . . 0.0 111.032 -178.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.769 HD12 ' CE3' ' A' ' 267' ' ' TRP . 0.9 OUTLIER -52.24 -47.17 93.25 Favored Pre-proline 0 CA--C 1.54 0.576 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.79 -178.252 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 262' ' ' PRO . . . . . 0.563 ' HD3' HD11 ' A' ' 272' ' ' ILE . 39.1 Cg_endo -69.38 -21.86 34.64 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.257 1.971 . . . . 0.0 112.74 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 57.0 mt -90.02 -0.35 57.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.4 0.619 . . . . 0.0 111.114 -176.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 264' ' ' ASN . . . . . 0.474 ' O ' ' HB2' ' A' ' 268' ' ' SER . 12.1 m-80 -107.0 148.92 37.89 Favored Pre-proline 0 C--N 1.316 -0.857 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.757 -178.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -67.54 -41.74 8.18 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 123.074 2.516 . . . . 0.0 112.474 -171.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.433 ' HE2' ' HB2' ' A' ' 266' ' ' LYS . 2.6 mtpt -80.9 -45.1 17.29 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-O 121.615 0.722 . . . . 0.0 109.784 -175.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 267' ' ' TRP . . . . . 0.769 ' CE3' HD12 ' A' ' 261' ' ' LEU . 22.6 m0 -72.83 -28.79 62.76 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.549 -175.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . 0.474 ' HB2' ' O ' ' A' ' 264' ' ' ASN . 23.1 t -66.57 -20.05 65.92 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 120.952 -0.299 . . . . 0.0 111.013 178.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -71.44 -15.73 62.35 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.336 0.589 . . . . 0.0 109.721 175.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 270' ' ' ARG . . . . . 0.623 ' HG3' ' HA ' ' A' ' 213' ' ' LEU . 0.0 OUTLIER -104.09 139.9 38.53 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.713 175.71 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . 0.581 ' HG3' ' HB2' ' A' ' 212' ' ' ASN . 15.3 mtm180 -93.22 105.36 17.45 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . 0.662 HG21 HD23 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -110.21 141.88 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-O 121.423 0.63 . . . . 0.0 110.857 -175.14 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 273' ' ' TYR . . . . . 0.591 ' CE1' ' HB3' ' A' ' 209' ' ' PHE . 4.6 p90 -152.78 167.75 27.98 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.83 174.136 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 274' ' ' TYR . . . . . 0.675 ' OH ' ' HA ' ' A' ' 255' ' ' ILE . 90.1 m-85 -69.38 136.49 51.75 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.266 172.323 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -67.99 -177.71 12.57 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.815 -0.707 . . . . 0.0 111.628 176.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 17.6 ptt180 -78.16 111.38 14.04 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.954 0.883 . . . . 0.0 110.81 -177.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 277' ' ' ASP . . . . . 0.53 ' OD2' ' HA ' ' A' ' 204' ' ' ALA . 31.3 t70 -157.59 146.68 19.75 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 114.475 -1.238 . . . . 0.0 109.205 -177.095 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 278' ' ' ARG . . . . . . . . . . . . . 74.5 mtt180 -104.26 50.56 0.79 Allowed 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.451 0.644 . . . . 0.0 110.424 -177.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 279' ' ' CYS . . . . . 0.448 ' HA ' ' C ' ' A' ' 203' ' ' GLY . 81.1 m 56.5 58.65 4.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.602 179.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -114.78 94.91 4.98 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.989 -177.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 6.4 p -90.72 -32.55 5.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.115 178.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -142.26 -119.86 1.52 Allowed Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.567 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 3.6 tt -136.24 95.62 3.22 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 63.9 tttm . . . . . 0 C--O 1.247 0.931 0 CA-C-O 118.43 -0.795 . . . . 0.0 109.774 -177.235 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 . . . . . 0 N--CA 1.48 1.049 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 43.9 m -76.63 -32.25 57.89 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.958 0.409 . . . . 0.0 110.443 178.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -83.46 -177.23 6.66 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.338 177.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 22.2 m -54.85 122.48 10.89 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.352 176.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -79.83 77.84 6.46 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.698 0.285 . . . . 0.0 110.593 -178.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . 0.453 ' HA ' ' OE1' ' A' ' 259' ' ' GLN . 6.7 p -156.53 140.59 16.37 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.729 179.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . 0.498 ' HB3' ' HG3' ' A' ' 262' ' ' PRO . 12.9 p -100.18 -0.7 38.28 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.311 0.577 . . . . 0.0 110.928 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 3.1 m -111.69 128.34 68.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.62 -177.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 7.1 tt -56.77 95.96 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.539 175.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 9.8 mp 53.48 18.08 1.29 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.632 179.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . 50.64 36.83 14.84 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 120.906 0.384 . . . . 0.0 111.158 -177.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 27.0 m -63.55 -22.38 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -175.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -78.49 72.38 5.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.841 0.353 . . . . 0.0 111.396 -179.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . 0.709 HE22 ' HB2' ' A' ' 283' ' ' LEU . 76.8 mt-30 54.46 33.03 17.86 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.377 -0.829 . . . . 0.0 112.139 175.174 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 37.2 t 71.12 -67.87 0.24 Allowed 'General case' 0 N--CA 1.465 0.29 0 O-C-N 123.843 0.715 . . . . 0.0 111.606 177.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -154.93 132.32 3.42 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.299 -176.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -102.49 145.59 29.35 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 110.008 -0.368 . . . . 0.0 110.008 178.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' CYS . . . . . 0.916 ' HB3' HG12 ' A' ' 251' ' ' ILE . 26.1 p -87.63 145.82 26.01 Favored 'General case' 0 CA--C 1.51 -0.567 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 177.289 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . 0.82 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 49.0 mtp180 57.04 -5.99 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 177.241 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 69.6 m-20 -100.86 106.13 17.47 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 119.125 0.875 . . . . 0.0 112.041 -173.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.5 ' HB ' ' HB ' ' A' ' 246' ' ' VAL . 59.5 t -136.02 117.6 19.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.607 178.094 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -115.47 123.38 48.42 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.752 0.31 . . . . 0.0 110.5 -177.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.74 ' HG ' HG22 ' A' ' 272' ' ' ILE . 5.9 mp -106.89 133.81 50.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.57 178.064 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . 0.557 ' HA2' HG22 ' A' ' 243' ' ' ILE . . . -143.39 65.78 0.47 Allowed Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.618 -0.801 . . . . 0.0 113.088 179.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . 0.52 ' HB3' ' HA ' ' A' ' 270' ' ' ARG . 50.5 t30 177.05 39.85 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.325 0.583 . . . . 0.0 109.733 177.315 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.764 HD23 ' HG2' ' A' ' 270' ' ' ARG . 1.2 mt -89.53 165.2 26.55 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.156 -179.269 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.496 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 78.5 Cg_endo -83.66 167.77 13.0 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 122.423 2.082 . . . . 0.0 111.14 174.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . 0.483 ' HA ' ' OG1' ' A' ' 239' ' ' THR . 40.9 t-20 -79.21 125.71 29.82 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 177.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 105.96 -3.92 38.7 Favored Glycine 0 C--N 1.314 -0.661 0 C-N-CA 120.458 -0.877 . . . . 0.0 113.082 -179.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . 0.696 HG23 HG21 ' A' ' 237' ' ' ILE . 5.0 tp -59.29 126.32 16.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.041 0.448 . . . . 0.0 110.436 178.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . 0.477 ' CG2' ' HG3' ' A' ' 221' ' ' GLU . 10.6 t -111.11 156.81 20.8 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.321 0.582 . . . . 0.0 110.839 -178.041 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.508 ' CD ' ' H ' ' A' ' 219' ' ' GLU . 18.4 mp0 -62.28 -36.59 82.55 Favored 'General case' 0 C--O 1.21 -1.011 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.449 -177.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -50.98 -36.37 38.75 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.018 178.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . 0.477 ' HG3' ' CG2' ' A' ' 218' ' ' THR . 42.3 mt-10 -70.94 -59.46 2.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.798 178.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.593 HD12 HD11 ' A' ' 237' ' ' ILE . 7.6 mt -60.21 -39.85 81.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.469 -178.189 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . 0.666 ' HG3' HD12 ' A' ' 235' ' ' ILE . 52.1 mtp180 -55.2 -62.27 1.78 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 174.088 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -55.71 -25.17 38.71 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.82 -178.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -86.3 -31.62 21.5 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.435 -176.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.78 HD23 ' HZ ' ' A' ' 248' ' ' PHE . 7.3 mp -108.43 -16.03 14.32 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -171.379 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . 0.639 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 34.8 mm-40 -61.55 -37.25 39.27 Favored Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -177.108 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . 0.639 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 96.7 Cg_endo -66.3 -30.57 45.13 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 121.5 1.467 . . . . 0.0 112.247 -172.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . 0.496 ' CE1' ' HA ' ' A' ' 226' ' ' LEU . 4.3 p90 -110.88 3.22 18.73 Favored 'General case' 0 C--O 1.221 -0.43 0 C-N-CA 120.591 -0.443 . . . . 0.0 111.346 176.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . 0.454 ' CA ' ' HB1' ' A' ' 253' ' ' ALA . . . -179.82 97.13 0.11 Allowed Glycine 0 N--CA 1.44 -1.041 0 C-N-CA 119.666 -1.254 . . . . 0.0 112.609 -178.061 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.41 ' HD2' ' HA2' ' A' ' 230' ' ' GLY . 29.0 Cg_endo -64.17 134.31 41.91 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 121.772 1.648 . . . . 0.0 111.031 177.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.638 HG21 HG12 ' A' ' 246' ' ' VAL . 2.9 mp -108.59 150.65 11.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.97 178.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . 0.519 ' CG ' HD22 ' A' ' 249' ' ' LEU . 20.7 m-20 -107.44 -26.96 10.72 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.153 0.502 . . . . 0.0 110.446 178.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . 0.52 ' HB3' ' HB2' ' A' ' 247' ' ' HIS . 29.5 tt0 -142.24 120.31 12.13 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.612 -173.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.666 HD12 ' HG3' ' A' ' 223' ' ' ARG . 13.5 mt -134.17 111.89 15.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.001 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 35.2 ttmt -115.66 112.61 22.36 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.349 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' ILE . . . . . 0.696 HG21 HG23 ' A' ' 217' ' ' ILE . 85.3 mt -102.13 121.62 53.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-O 121.1 0.476 . . . . 0.0 110.841 178.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.557 ' HB ' HG13 ' A' ' 243' ' ' ILE . 39.2 t -104.46 87.07 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 172.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . 0.483 ' OG1' ' HA ' ' A' ' 215' ' ' ASN . 9.6 t -70.04 -15.33 62.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.222 -175.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -66.7 -32.73 74.23 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.133 175.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . 0.573 ' HB2' HG12 ' A' ' 243' ' ' ILE . 81.1 mtt180 -114.98 3.25 14.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.859 -178.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 67.66 24.87 8.32 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.288 176.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.573 HG12 ' HB2' ' A' ' 241' ' ' ARG . 1.8 pt -122.33 153.27 26.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.293 -175.009 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . 0.471 ' HB3' ' HB2' ' A' ' 210' ' ' LEU . . . -143.7 140.05 29.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.119 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -111.03 115.13 28.93 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.757 177.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.638 HG12 HG21 ' A' ' 232' ' ' ILE . 1.1 t -111.81 136.05 49.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 -178.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' HIS . . . . . 0.82 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 44.0 m80 -117.41 102.62 9.37 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.594 0.711 . . . . 0.0 111.287 176.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . 0.78 ' HZ ' HD23 ' A' ' 226' ' ' LEU . 34.7 m-85 -85.38 104.61 15.35 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.634 -1.166 . . . . 0.0 111.516 -179.435 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.519 HD22 ' CG ' ' A' ' 233' ' ' ASP . 0.2 OUTLIER -46.57 -39.5 11.17 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 124.41 1.069 . . . . 0.0 112.929 -174.526 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . 0.424 ' HB2' ' HB2' ' A' ' 253' ' ' ALA . 47.5 m-80 -92.93 141.51 28.33 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 177.045 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . 0.916 HG12 ' HB3' ' A' ' 205' ' ' CYS . 0.1 OUTLIER -62.84 -44.05 99.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.316 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -70.1 -29.8 66.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.91 -176.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . 0.454 ' HB1' ' CA ' ' A' ' 230' ' ' GLY . . . -60.36 -42.84 96.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.135 179.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . 0.56 ' HB2' ' HB2' ' A' ' 248' ' ' PHE . . . -67.96 -41.68 82.05 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.479 179.23 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.597 HG13 ' O ' ' A' ' 251' ' ' ILE . 11.2 mt -56.69 -60.78 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.108 -177.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . 0.496 ' HE2' ' HB2' ' A' ' 229' ' ' PHE . 15.0 ptmt -62.25 -38.74 90.43 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.406 -177.275 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -62.9 -49.99 72.63 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.661 0.267 . . . . 0.0 111.45 178.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . 0.514 HG13 HG12 ' A' ' 272' ' ' ILE . 55.6 t -65.07 -26.48 40.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.805 0.336 . . . . 0.0 110.994 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . 0.453 ' OE1' ' HA ' ' A' ' 193' ' ' SER . 16.9 mm-40 -84.64 -23.04 29.68 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 178.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . 0.406 ' HG2' ' O ' ' A' ' 256' ' ' LYS . 62.1 mm-40 -94.7 -32.03 13.54 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.813 0.34 . . . . 0.0 111.158 -176.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.796 HD23 HG21 ' A' ' 272' ' ' ILE . 0.8 OUTLIER -52.49 -49.54 85.15 Favored Pre-proline 0 CA--C 1.541 0.614 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.511 179.769 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 262' ' ' PRO . . . . . 0.611 ' HD3' HD11 ' A' ' 272' ' ' ILE . 53.3 Cg_endo -69.16 -11.0 30.56 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.512 2.142 . . . . 0.0 112.565 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 43.5 mt -92.07 -9.09 43.94 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.037 0.446 . . . . 0.0 111.555 -179.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 264' ' ' ASN . . . . . 0.421 ' HB2' ' CE3' ' A' ' 267' ' ' TRP . 3.5 m-20 -106.9 149.7 38.85 Favored Pre-proline 0 C--N 1.314 -0.942 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.258 -176.315 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 265' ' ' PRO . . . . . 0.402 ' O ' ' HG3' ' A' ' 269' ' ' LYS . 54.8 Cg_endo -67.73 -32.04 31.0 Favored 'Trans proline' 0 CA--C 1.521 -0.129 0 C-N-CA 123.383 2.722 . . . . 0.0 112.738 -171.167 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.432 ' HE3' ' HB2' ' A' ' 266' ' ' LYS . 0.0 OUTLIER -84.77 -45.64 12.18 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 121.574 0.702 . . . . 0.0 109.24 -179.113 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 267' ' ' TRP . . . . . 0.743 ' HE3' ' HA ' ' A' ' 261' ' ' LEU . 12.6 m0 -76.88 -31.07 56.51 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.934 -172.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 17.7 t -68.3 -15.96 63.77 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.617 179.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . 0.402 ' HG3' ' O ' ' A' ' 265' ' ' PRO . 89.6 mttt -77.05 -7.71 56.16 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.218 0.533 . . . . 0.0 109.953 174.36 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 270' ' ' ARG . . . . . 0.764 ' HG2' HD23 ' A' ' 213' ' ' LEU . 3.7 mpt_? -110.82 143.89 40.69 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.92 178.303 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 36.0 mmt180 -91.99 106.42 18.44 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 110.021 -0.362 . . . . 0.0 110.021 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . 0.796 HG21 HD23 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -118.27 140.35 42.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.377 0.608 . . . . 0.0 110.718 179.701 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -152.39 168.96 23.77 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.38 173.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -61.13 119.63 8.75 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.713 0.292 . . . . 0.0 110.257 174.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -84.16 -173.27 49.69 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.864 -0.684 . . . . 0.0 111.906 178.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . 0.604 ' O ' ' HD2' ' A' ' 276' ' ' ARG . 0.2 OUTLIER -124.62 143.69 50.58 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.052 0.453 . . . . 0.0 111.081 -178.821 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -172.3 140.5 1.13 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.516 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 278' ' ' ARG . . . . . 0.56 ' HD2' ' N ' ' A' ' 278' ' ' ARG . 6.6 mpt_? -90.01 -2.76 58.19 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.257 -170.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 279' ' ' CYS . . . . . . . . . . . . . 63.5 m -104.92 0.04 27.46 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.307 0.575 . . . . 0.0 109.913 175.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -130.88 29.23 4.75 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.676 -177.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 281' ' ' VAL . . . . . 0.423 HG22 ' O ' ' A' ' 281' ' ' VAL . 14.5 p 37.34 44.62 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-O 122.499 1.142 . . . . 0.0 112.359 -177.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -115.12 85.98 0.4 Allowed Glycine 0 N--CA 1.444 -0.788 0 N-CA-C 110.244 -1.142 . . . . 0.0 110.244 175.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 283' ' ' LEU . . . . . 0.709 ' HB2' HE22 ' A' ' 201' ' ' GLN . 76.9 mt -89.46 159.32 17.33 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.022 0.439 . . . . 0.0 111.409 -173.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 62.4 tttp . . . . . 0 C--O 1.246 0.917 0 CA-C-O 118.408 -0.806 . . . . 0.0 109.488 177.591 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 33.6 t30 . . . . . 0 N--CA 1.481 1.095 0 CA-C-O 120.859 0.361 . . . . 0.0 110.411 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 15.3 p -106.03 -14.23 15.24 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.057 0.456 . . . . 0.0 110.309 179.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -77.93 6.8 6.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.481 -177.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 22.7 t -75.59 -27.22 58.46 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 177.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 67.1 t30 59.04 32.18 22.0 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 121.458 0.646 . . . . 0.0 110.669 178.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 28.4 m -74.06 -25.84 60.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.88 0.847 . . . . 0.0 108.844 175.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 19.7 m -135.81 175.27 9.74 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 171.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . 0.455 ' HB ' ' HA ' ' A' ' 198' ' ' ALA . 4.9 m -62.68 114.72 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 C-N-CA 120.01 -0.676 . . . . 0.0 110.402 176.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 9.4 tt -55.38 94.74 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.665 177.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.612 ' HB2' HG22 ' A' ' 199' ' ' VAL . 7.7 mp 53.59 10.34 0.22 Allowed 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.164 -177.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.455 ' HA ' ' HB ' ' A' ' 195' ' ' VAL . . . 58.15 20.32 6.91 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 123.023 0.529 . . . . 0.0 111.21 -173.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.612 HG22 ' HB2' ' A' ' 197' ' ' LEU . 35.9 m -108.89 19.4 6.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.631 -175.245 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -77.09 30.67 0.14 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.005 0.431 . . . . 0.0 111.095 178.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . 0.678 ' HA ' ' CE2' ' A' ' 274' ' ' TYR . 49.3 mt-30 -80.4 127.57 32.56 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.281 -178.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 50.8 m -144.57 177.34 8.74 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.687 178.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -70.42 90.97 0.38 Allowed Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.806 -0.712 . . . . 0.0 111.858 178.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . 0.694 ' HB1' ' HB2' ' A' ' 207' ' ' ASN . . . -147.7 107.11 3.91 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.592 0.234 . . . . 0.0 110.824 -179.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' CYS . . . . . 0.513 ' HB3' HG12 ' A' ' 251' ' ' ILE . 25.5 p -98.44 145.87 26.31 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 174.235 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . 0.879 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 0.6 OUTLIER 57.54 6.21 0.39 Allowed 'General case' 0 C--O 1.219 -0.539 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -178.079 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . 0.694 ' HB2' ' HB1' ' A' ' 204' ' ' ALA . 6.5 m-20 -106.38 105.95 16.24 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 118.555 0.616 . . . . 0.0 111.442 -173.094 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.526 ' HB ' ' HB ' ' A' ' 246' ' ' VAL . 66.5 t -137.62 119.75 18.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.309 177.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -115.22 124.32 51.11 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.816 0.341 . . . . 0.0 110.469 -177.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.687 ' HG ' HG22 ' A' ' 272' ' ' ILE . 5.4 mp -107.31 129.44 54.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.275 177.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . 0.623 ' HA2' HG22 ' A' ' 243' ' ' ILE . . . -136.65 59.43 0.64 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.394 -0.908 . . . . 0.0 113.266 -178.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . 0.551 ' HB3' ' HA ' ' A' ' 270' ' ' ARG . 1.7 t30 177.03 43.53 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.027 0.442 . . . . 0.0 110.063 177.017 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.576 ' HA ' ' HG3' ' A' ' 270' ' ' ARG . 1.2 mt -87.01 164.09 37.8 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.041 -177.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.54 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 73.0 Cg_endo -76.51 169.03 22.65 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.365 2.043 . . . . 0.0 111.763 175.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 -78.5 130.17 35.7 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.897 179.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 91.48 3.78 68.79 Favored Glycine 0 C--N 1.317 -0.499 0 C-N-CA 120.732 -0.747 . . . . 0.0 113.188 177.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . 0.65 HG23 HG21 ' A' ' 237' ' ' ILE . 4.5 tp -58.82 128.55 19.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.34 0.591 . . . . 0.0 111.153 -178.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . 0.465 ' CG2' ' HG3' ' A' ' 221' ' ' GLU . 14.5 t -111.91 156.17 22.49 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 121.367 0.603 . . . . 0.0 110.839 -178.248 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -62.41 -35.45 79.26 Favored 'General case' 0 C--O 1.209 -1.052 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.654 -177.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -48.89 -40.63 30.57 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.033 177.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . 0.465 ' HG3' ' CG2' ' A' ' 218' ' ' THR . 43.2 mt-10 -70.69 -56.01 7.38 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.751 -178.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.59 HD12 HD11 ' A' ' 237' ' ' ILE . 10.6 mt -61.41 -45.21 99.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.632 -178.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . 0.784 ' HG3' HD12 ' A' ' 235' ' ' ILE . 64.2 mtp180 -54.01 -62.46 1.64 Allowed 'General case' 0 CA--C 1.505 -0.786 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 176.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -55.68 -24.25 33.13 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.731 -177.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' ASP . . . . . 0.446 ' HB3' ' CZ2' ' A' ' 267' ' ' TRP . 8.9 m-20 -86.0 -32.14 21.65 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.955 -178.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.838 HD23 ' HZ ' ' A' ' 248' ' ' PHE . 7.3 mp -104.99 -15.1 15.21 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.959 -0.297 . . . . 0.0 111.669 -172.095 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . 0.638 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 42.7 mm-40 -61.46 -36.58 33.38 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -177.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . 0.638 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 97.5 Cg_endo -67.13 -27.03 42.18 Favored 'Trans proline' 0 C--N 1.358 1.03 0 C-N-CA 121.66 1.573 . . . . 0.0 112.377 -173.002 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . 0.519 ' CE1' ' HA ' ' A' ' 226' ' ' LEU . 2.9 p90 -110.78 -14.14 14.05 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.411 -0.516 . . . . 0.0 111.825 176.025 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . 0.469 ' CA ' ' HB1' ' A' ' 253' ' ' ALA . . . -164.08 97.73 0.15 Allowed Glycine 0 N--CA 1.44 -1.099 0 C-N-CA 120.479 -0.867 . . . . 0.0 112.05 -174.176 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -65.05 135.68 44.89 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 121.747 1.631 . . . . 0.0 111.136 178.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.596 HG21 HG12 ' A' ' 246' ' ' VAL . 2.4 mp -112.11 148.95 14.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.919 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . 0.487 ' OD2' HD22 ' A' ' 249' ' ' LEU . 8.8 m-20 -109.3 -24.66 10.97 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.111 0.481 . . . . 0.0 110.369 178.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . 0.594 ' HB3' ' HB2' ' A' ' 247' ' ' HIS . 22.9 tt0 -142.09 122.01 13.62 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.543 -174.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.784 HD12 ' HG3' ' A' ' 223' ' ' ARG . 8.1 mt -135.52 105.52 5.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 121.512 0.672 . . . . 0.0 109.927 178.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -108.35 107.51 18.12 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.993 -177.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' ILE . . . . . 0.65 HG21 HG23 ' A' ' 217' ' ' ILE . 81.3 mt -101.19 125.43 55.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.947 -178.287 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.545 ' HB ' HG13 ' A' ' 243' ' ' ILE . 41.2 t -109.67 88.05 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 170.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 15.3 t -69.94 -12.34 61.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.356 -176.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -69.02 -35.26 76.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.311 176.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . 0.626 ' HB2' HG12 ' A' ' 243' ' ' ILE . 90.7 mtt180 -113.75 5.12 16.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.6 -178.238 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 68.06 24.84 7.66 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.381 176.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.626 HG12 ' HB2' ' A' ' 241' ' ' ARG . 1.5 pt -122.31 150.79 25.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.823 -173.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . 0.424 ' HB3' ' HB2' ' A' ' 210' ' ' LEU . . . -144.13 137.78 27.73 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.243 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -107.19 110.98 23.18 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.539 177.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.596 HG12 HG21 ' A' ' 232' ' ' ILE . 1.5 t -107.86 134.91 48.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.872 -177.01 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' HIS . . . . . 0.879 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 36.2 m170 -113.87 101.93 9.73 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.358 0.599 . . . . 0.0 111.382 177.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . 0.838 ' HZ ' HD23 ' A' ' 226' ' ' LEU . 35.1 m-85 -85.39 101.27 12.45 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.952 178.031 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.514 ' H ' HD23 ' A' ' 249' ' ' LEU . 0.1 OUTLIER -43.96 -38.94 3.73 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 124.293 0.996 . . . . 0.0 112.881 -174.41 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . 0.43 ' HB2' ' HB2' ' A' ' 253' ' ' ALA . 2.6 m-20 -94.34 139.19 31.4 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 176.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . 0.6 ' O ' HG13 ' A' ' 255' ' ' ILE . 0.2 OUTLIER -62.71 -41.24 91.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.962 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -72.08 -28.66 63.45 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.741 -177.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . 0.469 ' HB1' ' CA ' ' A' ' 230' ' ' GLY . . . -61.34 -41.37 96.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.25 178.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . 0.545 ' HB2' ' HB2' ' A' ' 248' ' ' PHE . . . -68.7 -40.74 79.87 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.724 178.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.6 HG13 ' O ' ' A' ' 251' ' ' ILE . 7.5 mt -56.14 -60.59 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.348 -178.247 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . 0.43 ' O ' ' HG2' ' A' ' 260' ' ' GLU . 9.9 ptmt -61.36 -41.49 97.16 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.513 -177.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -62.14 -49.81 74.39 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.693 0.283 . . . . 0.0 111.464 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . 0.453 HG13 HG12 ' A' ' 272' ' ' ILE . 41.2 t -64.84 -26.52 40.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.897 0.38 . . . . 0.0 111.121 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . 0.401 ' HG3' ' O ' ' A' ' 255' ' ' ILE . 53.3 mt-30 -84.64 -23.08 29.66 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 178.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . 0.43 ' HG2' ' O ' ' A' ' 256' ' ' LYS . 49.5 mm-40 -95.31 -32.48 12.95 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.611 0.243 . . . . 0.0 111.158 -176.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.782 HD12 ' CE3' ' A' ' 267' ' ' TRP . 0.6 OUTLIER -50.44 -49.92 74.63 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.549 179.506 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 262' ' ' PRO . . . . . 0.579 ' HD2' ' N ' ' A' ' 261' ' ' LEU . 40.4 Cg_endo -67.25 -17.14 49.84 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.416 2.078 . . . . 0.0 112.972 -178.422 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 55.2 mt -91.63 -3.56 56.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.248 0.547 . . . . 0.0 111.493 -178.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -106.64 148.82 37.53 Favored Pre-proline 0 C--N 1.314 -0.962 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.839 -175.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -65.41 -35.98 37.0 Favored 'Trans proline' 0 C--O 1.23 0.108 0 C-N-CA 123.557 2.838 . . . . 0.0 112.902 -169.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 9.7 mtpt -86.53 -45.08 11.42 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.671 0.748 . . . . 0.0 109.685 -177.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 267' ' ' TRP . . . . . 0.782 ' CE3' HD12 ' A' ' 261' ' ' LEU . 11.6 m0 -76.34 -29.35 57.21 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.87 -173.34 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 38.0 t -62.32 -21.98 65.69 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.822 0.344 . . . . 0.0 110.853 178.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -71.46 -16.59 62.38 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.106 0.479 . . . . 0.0 110.276 177.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 270' ' ' ARG . . . . . 0.576 ' HG3' ' HA ' ' A' ' 213' ' ' LEU . 0.0 OUTLIER -100.26 146.31 27.06 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.495 178.554 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . 0.407 ' HG2' ' HB2' ' A' ' 212' ' ' ASN . 9.9 mmp_? -95.4 105.92 17.93 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 176.106 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . 0.721 HG21 HD23 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -115.86 141.87 31.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.546 0.688 . . . . 0.0 111.285 -177.952 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -151.69 169.24 22.65 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.354 -0.839 . . . . 0.0 108.966 172.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 274' ' ' TYR . . . . . 0.678 ' CE2' ' HA ' ' A' ' 201' ' ' GLN . 75.6 m-85 -58.68 116.16 3.53 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 173.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 275' ' ' GLY . . . . . 0.463 ' O ' ' HB3' ' A' ' 207' ' ' ASN . . . -68.94 147.82 46.96 Favored Glycine 0 N--CA 1.443 -0.89 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.783 -176.3 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . 0.422 HH11 ' HD3' ' A' ' 276' ' ' ARG . 44.1 mtt180 -115.17 109.0 17.35 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.834 0.826 . . . . 0.0 110.101 177.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -173.98 147.3 1.28 Allowed 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 113.857 -1.52 . . . . 0.0 108.49 -172.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 278' ' ' ARG . . . . . . . . . . . . . 19.9 mmm180 -98.22 -1.58 41.7 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.681 0.277 . . . . 0.0 110.705 -172.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 279' ' ' CYS . . . . . . . . . . . . . 16.1 t 63.77 30.88 14.5 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.658 0.742 . . . . 0.0 109.874 -177.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -123.78 35.31 4.87 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.502 -177.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 7.7 p 40.48 83.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-O 122.32 1.057 . . . . 0.0 112.5 -175.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 125.41 139.51 5.2 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 114.915 -1.039 . . . . 0.0 111.967 178.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 84.3 mt -74.06 118.46 17.05 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.884 0.373 . . . . 0.0 110.435 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? . . . . . 0 C--O 1.247 0.935 0 CA-C-O 118.336 -0.84 . . . . 0.0 109.546 177.951 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 . . . . . 0 N--CA 1.48 1.051 0 CA-C-O 120.624 0.25 . . . . 0.0 110.361 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 33.0 p -105.95 126.38 52.12 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.898 -178.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -89.84 111.88 23.04 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.249 178.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 26.2 m -78.37 -7.73 57.64 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -173.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -68.81 -20.93 64.34 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 176.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 22.3 m -109.45 130.97 55.47 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.426 175.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 33.5 p -108.41 152.38 24.76 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.787 0.327 . . . . 0.0 110.867 -179.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 3.1 m -140.7 83.85 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.818 178.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.607 ' HA ' HG22 ' A' ' 199' ' ' VAL . 66.7 mt -75.22 -20.66 59.13 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.526 0.679 . . . . 0.0 109.68 178.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 96.7 mt -68.03 -9.66 47.59 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.833 173.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -106.8 -9.28 16.45 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.304 178.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.607 HG22 ' HA ' ' A' ' 196' ' ' LEU . 16.0 m -105.12 2.37 10.41 Favored 'Isoleucine or valine' 0 C--O 1.231 0.084 0 C-N-CA 120.344 -0.542 . . . . 0.0 111.047 -178.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' GLN . . . . . 0.492 ' HB2' ' HA3' ' A' ' 203' ' ' GLY . 3.2 pt20 -104.07 77.5 1.44 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.493 0.663 . . . . 0.0 110.916 -179.155 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -70.03 -27.65 64.84 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.038 -179.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 27.0 p -97.72 13.32 30.74 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.93 174.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.492 ' HA3' ' HB2' ' A' ' 200' ' ' GLN . . . -101.1 -15.75 27.37 Favored Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.801 -176.409 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . 0.58 ' HB1' ' HB2' ' A' ' 207' ' ' ASN . . . -149.08 143.41 26.02 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.006 0.431 . . . . 0.0 111.151 -179.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' CYS . . . . . 0.758 ' HB3' HG12 ' A' ' 251' ' ' ILE . 5.9 p -127.92 145.7 50.87 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 172.152 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . 0.774 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 48.7 mtp180 52.73 12.33 0.25 Allowed 'General case' 0 C--O 1.221 -0.4 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -176.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . 0.58 ' HB2' ' HB1' ' A' ' 204' ' ' ALA . 0.9 OUTLIER -116.25 107.41 14.82 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.805 0.336 . . . . 0.0 111.19 -173.721 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.555 ' HB ' ' HB ' ' A' ' 246' ' ' VAL . 99.7 t -135.68 124.89 40.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.726 179.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' PHE . . . . . 0.406 ' O ' ' HA ' ' A' ' 272' ' ' ILE . 3.9 t80 -117.27 122.93 45.31 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.744 0.307 . . . . 0.0 110.446 -177.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.701 ' HG ' HG22 ' A' ' 272' ' ' ILE . 5.5 mp -106.01 132.76 51.71 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.039 176.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . 0.68 ' HA2' HG22 ' A' ' 243' ' ' ILE . . . -140.75 59.32 0.57 Allowed Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.441 -0.885 . . . . 0.0 113.475 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . 0.552 ' HB3' ' HA ' ' A' ' 270' ' ' ARG . 57.5 t30 -179.17 33.4 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.328 0.585 . . . . 0.0 110.156 175.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.612 HD23 ' HG2' ' A' ' 270' ' ' ARG . 2.0 mt -76.27 161.13 76.13 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.113 -177.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.424 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 66.3 Cg_endo -73.98 162.18 39.62 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.253 1.969 . . . . 0.0 111.023 174.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -77.6 120.99 23.33 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 178.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 106.94 -1.58 35.7 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.193 -1.003 . . . . 0.0 113.046 -179.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . 0.675 HG23 HG21 ' A' ' 237' ' ' ILE . 4.5 tp -59.31 128.48 20.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.961 0.41 . . . . 0.0 110.803 179.036 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . 0.476 HG22 ' HG3' ' A' ' 221' ' ' GLU . 9.8 t -113.56 158.84 20.27 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-O 121.296 0.569 . . . . 0.0 110.91 -178.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.533 ' CD ' ' H ' ' A' ' 219' ' ' GLU . 7.0 mp0 -62.39 -39.33 92.87 Favored 'General case' 0 C--O 1.21 -0.978 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.138 -174.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' ASP . . . . . 0.455 ' O ' ' HG2' ' A' ' 224' ' ' GLU . 16.3 t70 -54.22 -35.04 62.0 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 123.429 0.455 . . . . 0.0 110.987 -178.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . 0.476 ' HG3' HG22 ' A' ' 218' ' ' THR . 45.9 mt-10 -67.27 -57.2 7.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.325 178.22 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.564 HD12 HD11 ' A' ' 237' ' ' ILE . 6.9 mt -60.28 -41.79 88.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.563 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . 0.751 ' HG3' HD12 ' A' ' 235' ' ' ILE . 64.0 mtp180 -53.19 -62.8 1.42 Allowed 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 174.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.455 ' HG2' ' O ' ' A' ' 220' ' ' ASP . 8.8 pt-20 -58.53 -23.51 58.4 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.849 -176.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -88.55 -31.75 18.51 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.697 -176.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.775 HD23 ' HZ ' ' A' ' 248' ' ' PHE . 8.0 mp -105.7 -19.31 13.8 Favored 'General case' 0 CA--C 1.517 -0.307 0 C-N-CA 120.684 -0.406 . . . . 0.0 112.085 -171.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . 0.662 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 33.9 mt-10 -64.82 -33.55 8.68 Favored Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -176.471 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . 0.662 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 75.8 Cg_endo -65.63 -29.16 52.2 Favored 'Trans proline' 0 C--N 1.358 1.05 0 C-N-CA 121.34 1.36 . . . . 0.0 112.014 -175.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . 0.526 ' CE1' ' HA ' ' A' ' 226' ' ' LEU . 4.4 p90 -111.16 3.97 18.91 Favored 'General case' 0 C--O 1.223 -0.338 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.366 174.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . 0.573 ' CA ' ' HB1' ' A' ' 253' ' ' ALA . . . 178.8 99.88 0.13 Allowed Glycine 0 N--CA 1.441 -1.007 0 C-N-CA 120.045 -1.074 . . . . 0.0 112.725 -177.168 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -66.34 134.98 38.03 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 121.833 1.689 . . . . 0.0 111.28 178.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.634 HG21 HG12 ' A' ' 235' ' ' ILE . 3.5 mp -106.48 151.96 8.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.28 178.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . 0.552 ' OD2' ' HB3' ' A' ' 249' ' ' LEU . 8.9 m-20 -104.54 -28.8 11.07 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.3 179.215 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . 0.494 ' H ' HG22 ' A' ' 232' ' ' ILE . 13.1 tt0 -151.66 130.55 12.5 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.825 -173.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.751 HD12 ' HG3' ' A' ' 223' ' ' ARG . 15.0 mt -136.7 110.26 8.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.923 -179.322 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.421 ' O ' ' HA ' ' A' ' 244' ' ' ALA . 84.9 tttt -111.29 112.42 24.17 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.131 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' ILE . . . . . 0.675 HG21 HG23 ' A' ' 217' ' ' ILE . 78.2 mt -104.79 118.06 51.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 121.084 0.468 . . . . 0.0 111.12 -179.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.589 ' HB ' HG13 ' A' ' 243' ' ' ILE . 46.8 t -99.2 87.81 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 171.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 9.5 t -64.94 -21.03 66.76 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.466 -175.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -58.13 -38.71 77.04 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.718 175.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . 0.72 ' HB2' HG12 ' A' ' 243' ' ' ILE . 72.4 mtp180 -112.41 3.0 16.66 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.39 -177.134 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 14.8 m120 66.07 28.87 10.24 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.877 0.37 . . . . 0.0 110.543 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.72 HG12 ' HB2' ' A' ' 241' ' ' ARG . 1.2 pt -121.35 150.34 24.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.312 -174.24 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . 0.522 ' HB3' ' HB2' ' A' ' 210' ' ' LEU . . . -144.75 140.7 28.7 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.674 -178.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -111.19 115.51 29.5 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.433 177.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.57 HG13 HG12 ' A' ' 235' ' ' ILE . 1.6 t -113.48 139.63 37.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.312 -174.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' HIS . . . . . 0.774 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 59.4 m170 -111.38 101.93 10.35 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.459 176.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . 0.775 ' HZ ' HD23 ' A' ' 226' ' ' LEU . 39.6 m-85 -89.28 98.52 11.81 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.164 176.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.661 ' HA ' ' HE ' ' A' ' 206' ' ' ARG . 0.2 OUTLIER -47.58 -44.62 26.46 Favored 'General case' 0 N--CA 1.464 0.232 0 O-C-N 124.24 0.962 . . . . 0.0 112.618 -173.509 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . 0.425 ' HB2' ' HB2' ' A' ' 253' ' ' ALA . 12.5 m120 -85.81 135.78 33.58 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 176.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . 0.758 HG12 ' HB3' ' A' ' 205' ' ' CYS . 0.2 OUTLIER -62.63 -40.69 89.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 -177.411 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -70.78 -27.38 63.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.524 -177.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . 0.573 ' HB1' ' CA ' ' A' ' 230' ' ' GLY . . . -62.87 -41.36 99.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.106 -179.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . 0.59 ' HB2' ' HB2' ' A' ' 248' ' ' PHE . . . -69.13 -41.04 77.87 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.561 178.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.598 HG13 ' O ' ' A' ' 251' ' ' ILE . 11.0 mt -56.05 -60.74 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.045 -178.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . 0.454 ' HE2' ' HB2' ' A' ' 229' ' ' PHE . 13.5 ptmt -63.3 -39.78 95.52 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.496 -176.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -61.29 -48.16 82.67 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.71 0.29 . . . . 0.0 111.351 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . 0.532 HG13 HG12 ' A' ' 272' ' ' ILE . 54.9 t -66.76 -24.38 32.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.995 179.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 16.5 mm100 -84.52 -25.94 28.42 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 177.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . 0.438 ' HG2' ' O ' ' A' ' 256' ' ' LYS . 59.3 mm-40 -93.89 -33.96 13.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.634 0.254 . . . . 0.0 110.987 -175.243 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.807 HD23 HG21 ' A' ' 272' ' ' ILE . 0.8 OUTLIER -51.6 -51.32 70.78 Favored Pre-proline 0 CA--C 1.537 0.478 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.515 -179.619 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 262' ' ' PRO . . . . . 0.595 ' HD3' HD11 ' A' ' 272' ' ' ILE . 43.1 Cg_endo -66.75 -17.57 52.41 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.381 2.054 . . . . 0.0 112.762 -177.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 62.9 mt -95.22 -1.19 52.16 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.274 0.559 . . . . 0.0 111.525 -176.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 264' ' ' ASN . . . . . 0.489 ' O ' ' HB2' ' A' ' 268' ' ' SER . 14.4 m-80 -105.62 148.69 36.84 Favored Pre-proline 0 C--N 1.317 -0.846 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.244 -178.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -63.05 -40.84 31.6 Favored 'Trans proline' 0 C--N 1.335 -0.143 0 C-N-CA 123.298 2.666 . . . . 0.0 112.74 -169.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 12.6 mtpt -86.2 -42.71 13.59 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.461 0.648 . . . . 0.0 110.133 -176.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 267' ' ' TRP . . . . . 0.726 ' CE3' HD12 ' A' ' 261' ' ' LEU . 17.1 m0 -73.98 -28.04 61.28 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.835 -176.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . 0.489 ' HB2' ' O ' ' A' ' 264' ' ' ASN . 12.8 t -65.71 -18.32 65.25 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.186 0.517 . . . . 0.0 110.577 177.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -71.71 -9.04 57.68 Favored 'General case' 0 C--O 1.225 -0.224 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.105 174.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 270' ' ' ARG . . . . . 0.612 ' HG2' HD23 ' A' ' 213' ' ' LEU . 0.0 OUTLIER -112.86 143.17 44.57 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.392 -179.745 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 35.5 mmt180 -94.2 109.0 20.83 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.283 177.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . 0.807 HG21 HD23 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -121.91 140.91 44.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.418 0.628 . . . . 0.0 111.38 -178.627 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -152.26 169.86 21.45 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.372 174.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 274' ' ' TYR . . . . . 0.571 ' HB3' ' HB3' ' A' ' 204' ' ' ALA . 74.2 m-85 -64.5 119.99 11.47 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.224 0.535 . . . . 0.0 109.827 176.292 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -95.07 174.04 32.29 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 115.362 -0.835 . . . . 0.0 112.621 -173.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -110.5 109.4 19.73 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 122.001 0.905 . . . . 0.0 110.787 176.219 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -152.35 141.21 21.07 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 114.279 -1.328 . . . . 0.0 109.72 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 278' ' ' ARG . . . . . 0.419 HH11 ' HD2' ' A' ' 278' ' ' ARG . 32.7 mtp85 -103.99 13.35 32.82 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.405 -171.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 279' ' ' CYS . . . . . . . . . . . . . 55.6 m 61.62 24.97 14.97 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.353 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . 0.412 ' HB1' ' HB3' ' A' ' 283' ' ' LEU . . . -162.2 125.89 3.09 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.146 -175.349 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 28.7 m -86.15 -33.46 7.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 120.855 0.36 . . . . 0.0 111.14 -178.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -124.06 24.06 6.4 Favored Glycine 0 N--CA 1.442 -0.923 0 C-N-CA 120.459 -0.877 . . . . 0.0 112.459 -175.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 283' ' ' LEU . . . . . 0.412 ' HB3' ' HB1' ' A' ' 280' ' ' ALA . 1.7 tm? -124.93 97.64 5.35 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 178.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp . . . . . 0 C--O 1.247 0.944 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.533 -179.196 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 43.3 t30 . . . . . 0 N--CA 1.48 1.069 0 CA-C-O 120.491 0.186 . . . . 0.0 110.53 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 19.9 m -130.2 -2.96 4.47 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 121.069 -0.252 . . . . 0.0 111.165 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . 62.02 92.18 0.06 Allowed 'General case' 0 N--CA 1.462 0.149 0 O-C-N 123.714 0.634 . . . . 0.0 111.095 -178.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 23.7 m -68.63 -23.15 64.4 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.795 -177.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -137.55 137.79 38.95 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 177.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 50.9 m -65.54 147.93 52.59 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.896 0.379 . . . . 0.0 111.037 -179.065 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 17.2 m -71.78 113.38 8.76 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.973 -176.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . 0.498 HG21 ' CD2' ' A' ' 273' ' ' TYR . 3.3 m -104.62 76.57 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.416 0.627 . . . . 0.0 110.767 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.536 HD22 ' H ' ' A' ' 196' ' ' LEU . 2.5 mm? -59.04 94.21 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.893 -175.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 8.3 mp 51.68 25.76 3.04 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.704 0.287 . . . . 0.0 111.31 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . 65.76 23.56 11.49 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.602 -178.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.485 HG22 ' HB2' ' A' ' 196' ' ' LEU . 32.6 m -67.91 -15.8 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 O-C-N 121.688 -0.632 . . . . 0.0 110.178 174.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -69.27 -1.24 7.57 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.241 -0.89 . . . . 0.0 112.212 178.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -142.32 160.87 39.41 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.247 178.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 20.0 m -87.14 -34.35 19.1 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.898 0.38 . . . . 0.0 111.24 -178.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 173.7 136.86 2.29 Favored Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 -178.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . 0.866 ' HB1' ' HB2' ' A' ' 207' ' ' ASN . . . -126.79 111.2 13.94 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.988 0.423 . . . . 0.0 112.079 -175.081 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' CYS . . . . . 0.603 ' HB3' HG12 ' A' ' 251' ' ' ILE . 3.4 p -101.04 145.77 28.29 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 167.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . 0.789 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 29.8 mtm180 55.08 5.33 0.1 Allowed 'General case' 0 C--O 1.223 -0.339 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -175.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . 0.866 ' HB2' ' HB1' ' A' ' 204' ' ' ALA . 18.9 m-80 -108.18 106.19 16.26 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-O 121.232 0.539 . . . . 0.0 111.385 -173.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.481 ' HB ' ' HB ' ' A' ' 246' ' ' VAL . 61.1 t -134.56 111.93 14.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.012 177.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' PHE . . . . . 0.427 ' HE1' ' HB ' ' A' ' 243' ' ' ILE . 1.7 t80 -109.96 122.08 46.74 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.973 0.416 . . . . 0.0 110.361 -174.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.53 ' HG ' HG22 ' A' ' 272' ' ' ILE . 6.2 mp -106.81 133.93 50.73 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.613 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . 0.643 ' HA2' HG22 ' A' ' 243' ' ' ILE . . . -136.92 61.3 0.61 Allowed Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.548 -0.834 . . . . 0.0 113.097 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . 0.425 ' HB2' ' O ' ' A' ' 211' ' ' GLY . 2.3 t30 175.61 53.92 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.066 0.46 . . . . 0.0 110.612 175.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.625 HD23 ' HG2' ' A' ' 270' ' ' ARG . 0.7 OUTLIER -102.53 155.6 36.31 Favored Pre-proline 0 C--N 1.316 -0.862 0 N-CA-C 110.043 -0.355 . . . . 0.0 110.043 178.012 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -77.18 165.82 27.36 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.502 2.135 . . . . 0.0 112.163 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -75.94 118.82 19.12 Favored 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 177.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 109.51 2.59 30.93 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.255 -0.974 . . . . 0.0 112.56 -178.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . 0.652 HG23 HG21 ' A' ' 237' ' ' ILE . 6.3 tp -68.23 129.03 32.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.941 0.401 . . . . 0.0 110.36 175.306 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . 0.465 ' CG2' ' HG3' ' A' ' 221' ' ' GLU . 10.6 t -113.65 156.84 23.0 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-O 121.397 0.618 . . . . 0.0 111.041 179.147 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.561 ' CD ' ' H ' ' A' ' 219' ' ' GLU . 5.1 mp0 -60.92 -35.98 78.11 Favored 'General case' 0 C--O 1.21 -0.986 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.615 -179.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -54.39 -35.69 63.12 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.845 -179.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . 0.465 ' HG3' ' CG2' ' A' ' 218' ' ' THR . 42.9 mt-10 -69.91 -57.65 4.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.565 178.426 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.532 HD12 HD11 ' A' ' 237' ' ' ILE . 8.1 mt -59.49 -42.81 89.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.488 -178.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . 0.839 ' HG3' HD12 ' A' ' 235' ' ' ILE . 45.0 mtp85 -55.86 -61.92 2.04 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 176.197 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -57.19 -21.73 35.49 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.925 -178.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -89.67 -30.73 17.89 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 116.021 -0.536 . . . . 0.0 112.055 -178.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.713 HD23 ' HZ ' ' A' ' 248' ' ' PHE . 8.4 mp -106.41 -19.26 13.74 Favored 'General case' 0 C--O 1.225 -0.215 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -171.207 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . 0.669 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 41.4 mt-10 -66.87 -31.43 3.99 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -175.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . 0.669 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 71.7 Cg_endo -65.73 -28.13 51.99 Favored 'Trans proline' 0 C--N 1.357 1.013 0 C-N-CA 121.442 1.428 . . . . 0.0 112.16 -176.225 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . 0.48 ' CE1' ' HA ' ' A' ' 226' ' ' LEU . 3.8 p90 -111.04 -0.72 16.55 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.752 0.31 . . . . 0.0 111.399 173.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . 0.568 ' CA ' ' HB1' ' A' ' 253' ' ' ALA . . . -175.43 95.51 0.1 Allowed Glycine 0 N--CA 1.442 -0.914 0 C-N-CA 120.128 -1.034 . . . . 0.0 112.466 -176.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -62.45 130.47 30.19 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.12 1.88 . . . . 0.0 111.634 178.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.656 HG21 HG12 ' A' ' 246' ' ' VAL . 2.4 mp -109.47 148.26 13.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.315 178.166 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . 0.487 ' CG ' HD22 ' A' ' 249' ' ' LEU . 44.4 m-20 -110.18 -24.26 10.8 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.003 0.43 . . . . 0.0 110.704 179.106 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . 0.43 ' H ' HG22 ' A' ' 232' ' ' ILE . 15.7 tt0 -142.8 122.13 13.08 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.548 -174.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.839 HD12 ' HG3' ' A' ' 223' ' ' ARG . 10.5 mt -135.95 110.96 11.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.912 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.428 ' O ' ' HA ' ' A' ' 244' ' ' ALA . 62.4 tttp -113.31 110.55 20.54 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.541 -176.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' ILE . . . . . 0.652 HG21 HG23 ' A' ' 217' ' ' ILE . 76.2 mt -101.84 119.51 50.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.115 0.484 . . . . 0.0 111.041 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.57 ' HB ' HG13 ' A' ' 243' ' ' ILE . 43.6 t -103.98 88.24 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 173.395 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 10.0 t -62.48 -25.13 67.84 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.16 -177.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -55.59 -39.98 71.44 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 121.069 0.462 . . . . 0.0 110.392 176.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . 0.737 ' HB2' HG12 ' A' ' 243' ' ' ILE . 99.2 mtt180 -111.31 5.86 20.09 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.847 -178.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 16.6 m120 62.93 28.76 16.44 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.083 177.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.737 HG12 ' HB2' ' A' ' 241' ' ' ARG . 1.3 pt -121.28 154.22 25.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.104 -173.025 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . 0.444 ' HB3' ' HB2' ' A' ' 210' ' ' LEU . . . -144.92 138.37 26.85 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.441 -178.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -107.09 114.17 28.08 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.394 177.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.656 HG12 HG21 ' A' ' 232' ' ' ILE . 0.7 OUTLIER -109.83 127.82 66.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -179.229 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' HIS . . . . . 0.789 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 48.9 m170 -107.95 101.83 11.06 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.038 -0.665 . . . . 0.0 111.319 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . 0.713 ' HZ ' HD23 ' A' ' 226' ' ' LEU . 34.1 m-85 -87.49 99.18 11.84 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.149 178.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.501 ' H ' HD23 ' A' ' 249' ' ' LEU . 0.1 OUTLIER -42.27 -43.3 3.39 Favored 'General case' 0 N--CA 1.467 0.375 0 O-C-N 124.564 1.165 . . . . 0.0 112.651 -177.612 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 57.1 m-20 -90.87 135.36 33.78 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 177.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . 0.603 HG12 ' HB3' ' A' ' 205' ' ' CYS . 0.2 OUTLIER -62.99 -40.96 91.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -178.69 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -69.06 -31.77 70.77 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 120.786 0.327 . . . . 0.0 110.662 -177.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . 0.568 ' HB1' ' CA ' ' A' ' 230' ' ' GLY . . . -59.53 -42.14 91.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.353 179.095 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . 0.587 ' HB2' ' HB2' ' A' ' 248' ' ' PHE . . . -68.24 -40.52 81.96 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.655 178.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.561 HG13 ' O ' ' A' ' 251' ' ' ILE . 6.9 mt -56.49 -61.13 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.272 -178.305 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 12.8 ptmt -62.3 -39.23 92.32 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.439 -177.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -62.09 -48.88 78.2 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.639 0.257 . . . . 0.0 111.508 179.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . 0.546 HG13 HG12 ' A' ' 272' ' ' ILE . 70.1 t -66.3 -23.34 31.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.009 0.433 . . . . 0.0 111.05 179.062 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -85.06 -21.76 29.24 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 177.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -95.32 -36.75 11.27 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.895 0.379 . . . . 0.0 110.911 -177.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.749 HD23 HG21 ' A' ' 272' ' ' ILE . 1.1 mp -51.94 -47.74 90.22 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.956 -177.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 262' ' ' PRO . . . . . 0.575 ' HD2' ' N ' ' A' ' 261' ' ' LEU . 41.1 Cg_endo -67.49 -19.05 49.27 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.145 1.896 . . . . 0.0 112.711 -178.592 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 65.6 mt -95.53 -3.72 46.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.971 0.415 . . . . 0.0 111.811 -175.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 264' ' ' ASN . . . . . 0.494 ' O ' ' HB2' ' A' ' 268' ' ' SER . 14.1 m-80 -105.65 148.42 36.38 Favored Pre-proline 0 C--N 1.316 -0.878 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.761 -176.408 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -67.32 -32.97 31.65 Favored 'Trans proline' 0 N--CA 1.466 -0.098 0 C-N-CA 123.255 2.636 . . . . 0.0 112.652 -169.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.2 -45.13 12.3 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-O 121.825 0.821 . . . . 0.0 109.289 -178.31 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 267' ' ' TRP . . . . . 0.727 ' CE3' HD12 ' A' ' 261' ' ' LEU . 10.2 m0 -78.76 -25.23 44.43 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.947 -172.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . 0.494 ' HB2' ' O ' ' A' ' 264' ' ' ASN . 12.5 t -66.8 -19.13 65.68 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.834 0.35 . . . . 0.0 110.782 178.199 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -71.7 -21.51 61.77 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 121.013 0.435 . . . . 0.0 110.239 175.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 270' ' ' ARG . . . . . 0.625 ' HG2' HD23 ' A' ' 213' ' ' LEU . 2.6 mpt_? -99.76 141.43 32.58 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.424 -178.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . 0.412 ' HD3' ' HA ' ' A' ' 271' ' ' ARG . 26.7 mmt180 -94.13 106.2 18.18 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 179.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . 0.749 HG21 HD23 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -112.48 141.38 28.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.992 0.425 . . . . 0.0 111.207 -176.093 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 273' ' ' TYR . . . . . 0.498 ' CD2' HG21 ' A' ' 195' ' ' VAL . 7.8 p90 -152.6 168.86 24.2 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.158 171.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 274' ' ' TYR . . . . . 0.541 ' OH ' ' HA ' ' A' ' 255' ' ' ILE . 64.7 m-85 -65.11 133.9 52.6 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.81 0.338 . . . . 0.0 110.577 173.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -72.12 164.26 54.39 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.301 178.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 76.8 mtt85 -87.07 126.16 34.58 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -178.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -165.98 154.72 11.31 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.089 -174.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 278' ' ' ARG . . . . . 0.414 HH11 ' HD3' ' A' ' 278' ' ' ARG . 64.2 mtt-85 -93.37 14.76 17.45 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 111.52 0.193 . . . . 0.0 111.52 -174.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 279' ' ' CYS . . . . . . . . . . . . . 37.0 m 66.55 25.8 9.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.158 0.504 . . . . 0.0 110.385 178.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -117.39 108.98 16.22 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.432 0.634 . . . . 0.0 110.381 -176.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 7.3 p -92.66 -24.24 5.36 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.725 178.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -148.61 -91.6 0.1 OUTLIER Glycine 0 N--CA 1.446 -0.689 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.58 177.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -104.06 159.16 15.91 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 178.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . 0.453 ' NZ ' ' HB3' ' A' ' 284' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.877 0 CA-C-O 118.64 -0.695 . . . . 0.0 109.283 -179.04 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 49.4 t30 . . . . . 0 N--CA 1.48 1.067 0 N-CA-C 110.251 -0.277 . . . . 0.0 110.251 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 13.2 t 63.23 77.68 0.32 Allowed 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.475 0.655 . . . . 0.0 110.732 -179.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -76.01 135.71 39.97 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.31 178.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 10.6 m -80.4 109.14 14.62 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.492 -177.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -117.39 160.84 20.51 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -178.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 19.6 m -51.42 102.86 0.05 OUTLIER 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.941 0.401 . . . . 0.0 110.163 176.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 15.2 m -89.89 115.19 27.02 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.673 -169.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 1.1 m -137.16 17.79 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.707 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.664 174.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.549 HD23 ' HG3' ' A' ' 200' ' ' GLN . 27.3 tp 64.68 34.76 9.44 Favored 'General case' 0 C--N 1.319 -0.735 0 O-C-N 124.028 0.83 . . . . 0.0 109.347 -175.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 66.3 mt 63.13 16.08 9.06 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.161 -174.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . 62.85 22.01 13.15 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.584 178.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.407 HG22 ' O ' ' A' ' 196' ' ' LEU . 16.5 m -74.25 -2.98 4.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 121.205 0.526 . . . . 0.0 110.531 178.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' GLN . . . . . 0.549 ' HG3' HD23 ' A' ' 196' ' ' LEU . 51.7 mt-30 -77.99 39.13 0.29 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.614 177.331 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . 0.476 ' HA ' HD11 ' A' ' 255' ' ' ILE . 3.5 pt20 -63.86 -20.25 65.67 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.85 -176.266 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 35.0 m -135.52 16.22 3.39 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 171.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -92.16 -50.44 2.62 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 114.944 -1.025 . . . . 0.0 112.574 -174.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -122.79 93.48 3.98 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 121.174 0.511 . . . . 0.0 110.725 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' CYS . . . . . 0.569 ' HA ' HG12 ' A' ' 251' ' ' ILE . 3.3 m -88.44 146.93 24.95 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.192 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . 0.851 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 30.7 mtm180 55.29 6.05 0.14 Allowed 'General case' 0 C--O 1.22 -0.477 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 178.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -104.42 105.16 15.18 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 119.974 -0.691 . . . . 0.0 111.496 -171.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 61.9 t -136.14 116.33 17.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.384 177.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' PHE . . . . . 0.429 ' O ' ' HA ' ' A' ' 272' ' ' ILE . 3.4 t80 -113.5 126.52 55.4 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.447 -176.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.742 ' HG ' HG22 ' A' ' 272' ' ' ILE . 5.6 mp -110.65 131.37 55.11 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.553 178.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . 0.593 ' HA2' HG22 ' A' ' 243' ' ' ILE . . . -139.07 66.46 0.52 Allowed Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.621 -0.799 . . . . 0.0 113.396 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . 0.556 ' HB3' ' HA ' ' A' ' 270' ' ' ARG . 40.2 t30 177.08 36.47 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.183 0.516 . . . . 0.0 110.014 176.437 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.842 HD23 ' HG2' ' A' ' 270' ' ' ARG . 1.3 mt -89.16 158.27 46.9 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.466 -178.131 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -81.98 163.96 17.88 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.541 2.16 . . . . 0.0 111.42 176.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . 0.532 ' HA ' ' OG1' ' A' ' 239' ' ' THR . 14.8 m120 -78.42 127.89 32.84 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.104 178.334 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 108.76 -8.87 34.41 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.473 -177.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . 0.668 HG23 HG21 ' A' ' 237' ' ' ILE . 4.3 tp -61.41 126.85 20.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-O 121.146 0.498 . . . . 0.0 110.376 178.063 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . 0.562 HG22 ' HG3' ' A' ' 221' ' ' GLU . 5.1 t -113.77 161.2 17.83 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 121.35 0.595 . . . . 0.0 110.999 -178.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.554 ' CD ' ' H ' ' A' ' 219' ' ' GLU . 7.7 mp0 -62.84 -41.7 99.45 Favored 'General case' 0 C--O 1.209 -1.035 0 CA-C-N 115.113 -0.948 . . . . 0.0 109.887 -175.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -50.33 -37.16 35.34 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 123.584 0.553 . . . . 0.0 111.175 -179.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . 0.562 ' HG3' HG22 ' A' ' 218' ' ' THR . 44.6 mt-10 -68.44 -56.23 9.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.553 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.543 HD12 HD11 ' A' ' 237' ' ' ILE . 6.9 mt -62.17 -40.64 88.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.382 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . 0.634 ' HG3' HD12 ' A' ' 235' ' ' ILE . 25.6 mtp85 -53.15 -64.12 0.92 Allowed 'General case' 0 CA--C 1.509 -0.631 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 174.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -58.04 -21.02 43.44 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.855 -176.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -86.22 -33.31 20.79 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.703 -178.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.786 HD23 ' HZ ' ' A' ' 248' ' ' PHE . 7.5 mp -107.2 -14.44 14.9 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -171.173 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . 0.628 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 24.5 mm-40 -61.01 -37.68 46.87 Favored Pre-proline 0 C--N 1.328 -0.353 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -178.322 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . 0.628 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 97.2 Cg_endo -66.52 -27.51 46.25 Favored 'Trans proline' 0 C--N 1.36 1.134 0 C-N-CA 121.687 1.591 . . . . 0.0 112.295 -171.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . 0.54 ' CZ ' ' HA ' ' A' ' 226' ' ' LEU . 3.8 p90 -110.91 -7.05 14.6 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.686 176.308 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . 0.411 ' CA ' ' HB1' ' A' ' 253' ' ' ALA . . . -171.8 98.72 0.13 Allowed Glycine 0 N--CA 1.442 -0.906 0 C-N-CA 120.045 -1.074 . . . . 0.0 112.347 -175.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.403 ' HD2' ' HA2' ' A' ' 230' ' ' GLY . 18.2 Cg_endo -63.9 133.17 37.59 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 121.904 1.736 . . . . 0.0 111.256 177.452 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.811 HG21 HG12 ' A' ' 246' ' ' VAL . 2.4 mp -109.54 147.7 13.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.905 178.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . 0.476 ' CG ' HD22 ' A' ' 249' ' ' LEU . 14.4 m-20 -108.89 -24.46 11.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.731 178.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . 0.597 ' HB3' ' HB2' ' A' ' 247' ' ' HIS . 21.4 tt0 -140.06 121.81 15.4 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.305 -173.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.634 HD12 ' HG3' ' A' ' 223' ' ' ARG . 18.6 mt -136.83 111.14 9.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.111 0.481 . . . . 0.0 110.158 -178.357 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 22.1 ttmm -115.77 109.34 17.54 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.41 -179.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' ILE . . . . . 0.668 HG21 HG23 ' A' ' 217' ' ' ILE . 73.2 mt -99.72 118.24 46.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-O 121.043 0.449 . . . . 0.0 110.323 177.156 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.552 ' HB ' HG13 ' A' ' 243' ' ' ILE . 40.8 t -102.14 86.1 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 172.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . 0.532 ' OG1' ' HA ' ' A' ' 215' ' ' ASN . 8.9 t -70.19 -19.02 63.2 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.274 -176.045 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -60.83 -33.62 73.31 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.951 174.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . 0.46 ' HB2' HG12 ' A' ' 243' ' ' ILE . 98.9 mtt180 -114.94 4.24 14.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.791 -179.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 17.3 m120 65.93 27.76 10.77 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.23 0.612 . . . . 0.0 111.419 176.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.593 HG22 ' HA2' ' A' ' 211' ' ' GLY . 1.4 pt -123.07 155.08 28.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.294 -175.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . 0.475 ' HB3' ' HB2' ' A' ' 210' ' ' LEU . . . -144.38 141.47 29.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.989 0.423 . . . . 0.0 111.569 179.284 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -112.73 115.41 28.49 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.64 176.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.811 HG12 HG21 ' A' ' 232' ' ' ILE . 0.3 OUTLIER -111.48 129.41 66.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 -179.124 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 247' ' ' HIS . . . . . 0.851 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 32.4 m170 -107.79 102.78 11.96 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.006 -0.677 . . . . 0.0 111.357 178.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . 0.786 ' HZ ' HD23 ' A' ' 226' ' ' LEU . 33.2 m-85 -84.82 103.17 13.66 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.811 177.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.476 HD22 ' CG ' ' A' ' 233' ' ' ASP . 0.1 OUTLIER -43.29 -39.46 3.06 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 124.505 1.128 . . . . 0.0 113.068 -174.306 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -99.71 137.94 37.49 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 176.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . 0.605 ' O ' HG13 ' A' ' 255' ' ' ILE . 0.2 OUTLIER -58.51 -41.65 82.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.918 -179.289 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -69.22 -30.67 68.88 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 116.756 -0.202 . . . . 0.0 111.09 -176.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . 0.411 ' HB1' ' CA ' ' A' ' 230' ' ' GLY . . . -62.35 -39.14 92.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.221 178.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . 0.6 ' HB2' ' HB2' ' A' ' 248' ' ' PHE . . . -69.53 -41.79 75.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.799 178.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.605 HG13 ' O ' ' A' ' 251' ' ' ILE . 11.4 mt -56.11 -60.61 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.105 -178.049 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . 0.521 ' O ' ' HG2' ' A' ' 260' ' ' GLU . 12.3 ptmt -61.22 -39.73 91.34 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.515 -178.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -62.61 -47.9 81.75 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.628 0.252 . . . . 0.0 111.4 179.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . 0.484 HG13 HG12 ' A' ' 272' ' ' ILE . 53.7 t -66.63 -26.27 36.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.9 0.381 . . . . 0.0 111.221 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . 0.523 ' HA ' ' OE1' ' A' ' 259' ' ' GLN . 10.4 mm-40 -84.3 -28.71 26.94 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 177.469 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . 0.521 ' HG2' ' O ' ' A' ' 256' ' ' LYS . 37.1 mm-40 -92.91 -26.02 17.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.445 0.164 . . . . 0.0 111.423 -175.279 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.803 HD23 HG21 ' A' ' 272' ' ' ILE . 0.6 OUTLIER -54.23 -52.55 67.84 Favored Pre-proline 0 CA--C 1.537 0.465 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.981 176.412 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 262' ' ' PRO . . . . . 0.554 ' HD2' ' N ' ' A' ' 261' ' ' LEU . 37.7 Cg_endo -67.18 -15.92 47.45 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.503 2.135 . . . . 0.0 112.828 -178.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' A' ' 259' ' ' GLN . 46.1 mt -85.06 -9.07 58.36 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.126 0.489 . . . . 0.0 111.151 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 -105.15 148.7 36.64 Favored Pre-proline 0 C--N 1.316 -0.887 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.108 -175.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -66.38 -34.73 33.81 Favored 'Trans proline' 0 C--N 1.336 -0.085 0 C-N-CA 123.546 2.831 . . . . 0.0 112.689 -170.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 5.1 mtpt -86.25 -45.22 11.48 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 121.465 0.65 . . . . 0.0 109.714 -177.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 267' ' ' TRP . . . . . 0.795 ' HE3' ' HA ' ' A' ' 261' ' ' LEU . 14.3 m0 -75.97 -30.11 58.5 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.757 -173.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 29.5 t -65.9 -18.81 65.59 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.958 0.409 . . . . 0.0 110.749 178.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . 0.408 ' C ' ' HD2' ' A' ' 270' ' ' ARG . 96.8 mttt -77.3 -8.38 57.54 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 121.139 0.495 . . . . 0.0 110.206 176.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 270' ' ' ARG . . . . . 0.842 ' HG2' HD23 ' A' ' 213' ' ' LEU . 3.6 mpt_? -111.11 141.51 44.51 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 178.061 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 31.9 mmm180 -92.36 110.27 21.67 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 -176.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . 0.803 HG21 HD23 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -121.46 142.41 37.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.534 0.683 . . . . 0.0 111.571 -178.259 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -151.76 169.31 22.51 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.679 173.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -62.18 127.87 33.4 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 123.117 0.261 . . . . 0.0 110.301 175.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -59.65 153.42 33.06 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.936 -0.649 . . . . 0.0 111.743 176.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 8.2 mtp180 -85.71 130.71 34.49 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.17 0.509 . . . . 0.0 110.132 -176.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -159.68 152.35 21.43 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.987 -171.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 278' ' ' ARG . . . . . 0.565 ' HG3' ' O ' ' A' ' 283' ' ' LEU . 22.8 mmt180 -78.79 0.3 27.51 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -172.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 279' ' ' CYS . . . . . . . . . . . . . 86.1 m 64.98 26.24 12.72 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.808 0.813 . . . . 0.0 109.257 -175.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -167.89 123.56 1.04 Allowed 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 114.423 -1.262 . . . . 0.0 109.469 -176.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 6.1 p -82.93 80.16 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 122.254 1.026 . . . . 0.0 110.653 -178.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -155.64 -96.24 0.12 Allowed Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.759 177.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 283' ' ' LEU . . . . . 0.565 ' O ' ' HG3' ' A' ' 278' ' ' ARG . 4.5 mm? -79.37 94.33 5.49 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.852 0.358 . . . . 0.0 110.518 177.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.514 -0.755 . . . . 0.0 109.746 178.523 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 . . . . . 0 N--CA 1.481 1.113 0 CA-C-O 120.658 0.265 . . . . 0.0 110.472 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 45.0 m -78.35 103.85 8.56 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.963 0.411 . . . . 0.0 110.454 178.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -108.46 150.87 26.82 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.425 178.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 7.0 m -76.59 113.17 13.92 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.312 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 44.4 t-20 -60.55 113.32 2.37 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.327 0.584 . . . . 0.0 110.037 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . 0.9 ' HA ' ' HB2' ' A' ' 262' ' ' PRO . 6.6 m -105.52 13.7 29.68 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.678 -175.342 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 29.1 m -98.98 106.64 18.92 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.342 0.591 . . . . 0.0 111.238 -177.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -124.9 68.13 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.574 176.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.472 ' HG ' HG22 ' A' ' 199' ' ' VAL . 25.5 tp 60.8 14.72 5.34 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.635 0.731 . . . . 0.0 109.639 -174.148 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 9.2 mp 59.42 21.28 9.65 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.889 -174.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.494 ' HB1' ' CE2' ' A' ' 274' ' ' TYR . . . 57.03 27.64 13.62 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.921 177.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.472 HG22 ' HG ' ' A' ' 196' ' ' LEU . 33.2 m -79.27 -6.47 9.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.691 0.281 . . . . 0.0 111.631 -177.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -80.99 70.02 7.72 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.67 0.748 . . . . 0.0 110.126 176.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -144.26 130.96 20.13 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.89 -176.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 23.3 t -119.28 25.11 10.34 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 176.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 96.81 65.24 0.92 Allowed Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 110.429 -1.069 . . . . 0.0 110.429 -173.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . 0.662 ' HB1' ' HB2' ' A' ' 207' ' ' ASN . . . -99.2 102.13 13.68 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 120.92 0.391 . . . . 0.0 111.508 -172.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' CYS . . . . . 0.523 ' HB3' HG12 ' A' ' 251' ' ' ILE . 25.5 p -93.0 146.66 23.45 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 173.437 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . 0.832 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 59.6 mtm180 58.06 1.41 0.15 Allowed 'General case' 0 C--O 1.222 -0.383 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -179.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . 0.662 ' HB2' ' HB1' ' A' ' 204' ' ' ALA . 95.1 m-20 -100.08 104.66 16.24 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 119.743 -0.783 . . . . 0.0 111.213 -172.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 67.8 t -137.45 123.73 27.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.134 176.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' PHE . . . . . 0.43 ' HE1' ' HB ' ' A' ' 243' ' ' ILE . 4.2 t80 -121.38 125.41 46.89 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 120.752 0.311 . . . . 0.0 110.251 -177.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.484 HD22 HD21 ' A' ' 213' ' ' LEU . 4.6 mp -108.28 126.09 52.43 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.39 177.427 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . 0.628 ' HA2' HG22 ' A' ' 243' ' ' ILE . . . -129.76 57.52 0.72 Allowed Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.304 -0.951 . . . . 0.0 113.343 -178.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . 0.542 ' HB3' ' HA ' ' A' ' 270' ' ' ARG . 2.1 t30 178.19 45.12 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.045 0.45 . . . . 0.0 111.027 178.166 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.484 HD21 HD22 ' A' ' 210' ' ' LEU . 0.7 OUTLIER -92.94 160.99 32.72 Favored Pre-proline 0 C--N 1.317 -0.814 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 176.971 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.444 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 87.9 Cg_endo -80.17 165.23 21.58 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.527 2.151 . . . . 0.0 111.188 176.06 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . 0.519 ' HA ' ' OG1' ' A' ' 239' ' ' THR . 28.2 t-20 -78.72 128.19 33.09 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 106.6 -2.98 36.57 Favored Glycine 0 C--N 1.315 -0.622 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.589 -178.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . 0.73 HG23 HG21 ' A' ' 237' ' ' ILE . 4.5 tp -64.71 127.99 26.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.224 0.535 . . . . 0.0 110.71 177.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 14.1 t -113.92 155.75 25.24 Favored 'General case' 0 C--O 1.24 0.602 0 CA-C-O 121.328 0.585 . . . . 0.0 111.075 -178.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.428 ' H ' ' CD ' ' A' ' 219' ' ' GLU . 1.5 mp0 -61.25 -37.26 82.44 Favored 'General case' 0 C--O 1.209 -1.055 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.365 -177.152 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -51.71 -36.0 45.15 Favored 'General case' 0 C--N 1.321 -0.632 0 O-C-N 123.464 0.478 . . . . 0.0 111.064 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -73.58 -55.56 6.15 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.316 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.584 HD12 HD11 ' A' ' 237' ' ' ILE . 11.1 mt -60.17 -43.66 93.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.63 -179.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . 0.673 ' HG3' HD12 ' A' ' 235' ' ' ILE . 51.2 mtp180 -52.19 -63.11 1.25 Allowed 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 175.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -60.13 -19.46 53.69 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.077 -177.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' ASP . . . . . 0.478 ' HB3' ' CZ2' ' A' ' 267' ' ' TRP . 19.6 m-20 -87.32 -33.18 19.3 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.569 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.787 HD23 ' HZ ' ' A' ' 248' ' ' PHE . 8.2 mp -106.73 -18.25 14.0 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -170.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . 0.676 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 40.6 mt-10 -71.16 -24.41 0.72 Allowed Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -175.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . 0.676 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 74.7 Cg_endo -67.73 -26.76 38.69 Favored 'Trans proline' 0 C--N 1.36 1.184 0 C-N-CA 121.286 1.324 . . . . 0.0 112.05 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . 0.527 ' CZ ' ' HA ' ' A' ' 226' ' ' LEU . 3.6 p90 -110.55 -12.82 14.32 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.674 174.217 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . 0.448 ' HA2' ' HB1' ' A' ' 253' ' ' ALA . . . -165.01 96.06 0.13 Allowed Glycine 0 N--CA 1.441 -1.021 0 C-N-CA 120.319 -0.943 . . . . 0.0 111.939 -175.13 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.4 ' HD2' ' HA2' ' A' ' 230' ' ' GLY . 18.9 Cg_endo -63.36 130.55 28.85 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.157 1.905 . . . . 0.0 111.423 178.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.934 HG21 HG12 ' A' ' 246' ' ' VAL . 2.1 mp -109.8 146.3 15.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.387 178.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . 0.541 ' OD2' HD22 ' A' ' 249' ' ' LEU . 7.7 m-20 -109.92 -22.43 11.86 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.909 0.385 . . . . 0.0 110.755 177.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . 0.617 ' HB3' ' HB2' ' A' ' 247' ' ' HIS . 30.9 tt0 -135.23 119.5 17.78 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.404 -176.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.673 HD12 ' HG3' ' A' ' 223' ' ' ARG . 15.2 mt -136.96 106.57 4.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.852 -179.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -112.46 108.55 17.73 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.37 -179.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' ILE . . . . . 0.73 HG21 HG23 ' A' ' 217' ' ' ILE . 66.3 mt -99.99 117.77 45.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.548 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.607 ' HB ' HG13 ' A' ' 243' ' ' ILE . 45.2 t -100.1 87.44 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 172.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . 0.519 ' OG1' ' HA ' ' A' ' 215' ' ' ASN . 14.0 t -64.77 -20.68 66.5 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.647 -175.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -67.74 -28.32 67.54 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.896 178.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . 0.578 ' HB2' HG12 ' A' ' 243' ' ' ILE . 81.9 mtt180 -120.13 5.12 10.82 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.653 -176.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 18.2 m120 66.12 24.75 10.86 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.33 175.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.628 HG22 ' HA2' ' A' ' 211' ' ' GLY . 1.6 pt -122.01 149.45 25.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.51 -173.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . 0.45 ' HB3' ' HB2' ' A' ' 210' ' ' LEU . . . -141.58 135.31 29.93 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.187 179.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 245' ' ' PHE . . . . . 0.406 ' HE2' ' HB3' ' A' ' 279' ' ' CYS . 25.7 m-85 -107.06 112.87 26.0 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.579 177.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.934 HG12 HG21 ' A' ' 232' ' ' ILE . 0.1 OUTLIER -112.5 128.81 68.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.876 -176.944 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 247' ' ' HIS . . . . . 0.832 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 27.4 m170 -109.57 104.04 13.01 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.362 0.601 . . . . 0.0 111.313 178.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . 0.787 ' HZ ' HD23 ' A' ' 226' ' ' LEU . 30.4 m-85 -86.49 99.99 12.06 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.669 178.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.541 HD22 ' OD2' ' A' ' 233' ' ' ASP . 0.0 OUTLIER -37.37 -49.3 0.98 Allowed 'General case' 0 N--CA 1.469 0.511 0 O-C-N 124.654 1.221 . . . . 0.0 113.334 -176.131 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -90.95 139.48 30.72 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.109 177.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . 0.527 ' O ' HG13 ' A' ' 255' ' ' ILE . 0.2 OUTLIER -59.55 -41.35 84.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.047 -176.795 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -71.99 -30.88 65.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.981 -175.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . 0.448 ' HB1' ' HA2' ' A' ' 230' ' ' GLY . . . -59.33 -39.58 83.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.391 178.06 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . 0.621 ' HB2' ' HB2' ' A' ' 248' ' ' PHE . . . -69.19 -41.91 76.53 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.693 178.229 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.527 HG13 ' O ' ' A' ' 251' ' ' ILE . 8.4 mt -56.97 -60.85 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.247 -177.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . 0.488 ' O ' ' HG2' ' A' ' 260' ' ' GLU . 10.8 ptmt -61.17 -38.5 86.7 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.339 -177.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -61.95 -48.53 80.0 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.625 0.25 . . . . 0.0 111.344 178.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . 0.519 HG13 HG12 ' A' ' 272' ' ' ILE . 55.3 t -68.37 -24.02 29.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.878 0.371 . . . . 0.0 111.057 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -84.52 -23.78 29.63 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 177.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . 0.488 ' HG2' ' O ' ' A' ' 256' ' ' LYS . 68.7 mm-40 -95.83 -31.68 13.04 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.679 0.276 . . . . 0.0 110.972 -176.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.755 ' HA ' ' HE3' ' A' ' 267' ' ' TRP . 0.7 OUTLIER -52.46 -49.13 87.29 Favored Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.689 179.849 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 262' ' ' PRO . . . . . 0.9 ' HB2' ' HA ' ' A' ' 193' ' ' SER . 48.6 Cg_endo -67.75 -15.7 44.81 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.352 2.035 . . . . 0.0 112.81 -178.434 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 56.4 mt -87.45 -8.66 56.23 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.499 0.666 . . . . 0.0 111.072 -178.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 -106.77 149.64 38.7 Favored Pre-proline 0 C--N 1.311 -1.065 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.133 -171.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -65.36 -39.44 22.44 Favored 'Trans proline' 0 C--O 1.231 0.137 0 C-N-CA 123.424 2.749 . . . . 0.0 112.768 -168.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 10.1 mtpt -86.33 -44.42 12.1 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.385 0.612 . . . . 0.0 109.615 -176.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 267' ' ' TRP . . . . . 0.755 ' HE3' ' HA ' ' A' ' 261' ' ' LEU . 17.7 m0 -70.98 -32.34 69.16 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.008 -0.997 . . . . 0.0 110.869 -175.414 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 22.7 t -64.19 -24.26 67.61 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.739 0.305 . . . . 0.0 110.799 179.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -71.02 -15.6 62.57 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.239 0.543 . . . . 0.0 110.124 177.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 270' ' ' ARG . . . . . 0.542 ' HA ' ' HB3' ' A' ' 212' ' ' ASN . 1.6 mpt_? -93.84 156.03 16.87 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.13 174.17 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 6.1 mmp_? -103.82 105.54 15.78 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 173.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . 0.714 HG21 HD23 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -113.45 138.25 43.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.303 0.573 . . . . 0.0 110.667 -176.571 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -152.85 167.77 27.98 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.149 175.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 274' ' ' TYR . . . . . 0.512 ' OH ' ' HA ' ' A' ' 255' ' ' ILE . 80.6 m-85 -65.42 122.46 17.22 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.537 173.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -59.02 130.93 51.7 Favored Glycine 0 N--CA 1.441 -0.97 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.391 176.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . 0.431 HH11 ' HD2' ' A' ' 276' ' ' ARG . 0.0 OUTLIER -95.06 146.51 24.23 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 177.986 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 277' ' ' ASP . . . . . 0.411 ' CG ' ' H ' ' A' ' 278' ' ' ARG . 23.2 t70 60.66 -168.48 0.17 Allowed 'General case' 0 CA--C 1.538 0.503 0 O-C-N 123.761 0.663 . . . . 0.0 109.302 -176.277 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 278' ' ' ARG . . . . . 0.411 ' H ' ' CG ' ' A' ' 277' ' ' ASP . 0.0 OUTLIER -88.63 11.05 18.47 Favored 'General case' 0 C--N 1.321 -0.64 0 O-C-N 121.656 -0.653 . . . . 0.0 110.579 179.4 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 279' ' ' CYS . . . . . 0.406 ' HB3' ' HE2' ' A' ' 245' ' ' PHE . 77.1 m 57.61 69.1 0.77 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.704 -1.135 . . . . 0.0 110.667 178.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . 0.659 ' HB1' ' HB2' ' A' ' 283' ' ' LEU . . . -153.19 127.05 8.9 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.395 -176.171 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 3.4 p -112.66 89.16 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-O 122.032 0.92 . . . . 0.0 109.479 177.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 110.38 -68.42 0.22 Allowed Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.081 -176.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 283' ' ' LEU . . . . . 0.659 ' HB2' ' HB1' ' A' ' 280' ' ' ALA . 0.4 OUTLIER 42.4 78.5 0.05 OUTLIER 'General case' 0 C--O 1.234 0.284 0 C-N-CA 123.863 0.865 . . . . 0.0 111.943 177.829 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 19.3 pttp . . . . . 0 C--O 1.249 1.049 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.157 179.884 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 . . . . . 0 N--CA 1.479 0.987 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 9.9 m -102.63 -10.87 18.88 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.759 -178.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -77.15 -41.06 43.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.296 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 47.8 m -80.58 160.57 25.09 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.333 177.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -86.35 119.86 27.08 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.157 179.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 15.8 m -113.52 90.83 3.45 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.063 0.459 . . . . 0.0 109.926 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . 0.568 ' O ' HD22 ' A' ' 196' ' ' LEU . 23.3 t -176.18 -150.98 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -177.016 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 5.2 m -79.81 81.32 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.157 0.503 . . . . 0.0 111.41 177.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.581 ' O ' HG22 ' A' ' 199' ' ' VAL . 2.0 mm? -59.79 98.32 0.05 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.054 179.308 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 90.4 mt 53.46 26.84 5.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.093 0.473 . . . . 0.0 110.168 -176.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . 63.17 29.32 16.07 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.055 -0.975 . . . . 0.0 112.389 -178.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.581 HG22 ' O ' ' A' ' 196' ' ' LEU . 20.6 m -84.4 -23.45 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.772 174.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' GLN . . . . . 0.469 ' HG2' HG23 ' A' ' 199' ' ' VAL . 17.0 mm-40 -104.01 78.86 1.57 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.408 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -172.91 156.7 3.43 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.642 177.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 37.3 m -151.25 19.74 0.75 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.837 0.351 . . . . 0.0 111.078 -179.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 79.18 33.42 36.06 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.671 -0.776 . . . . 0.0 111.358 -177.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -71.13 114.46 9.21 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.54 -0.33 . . . . 0.0 111.099 -176.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' CYS . . . . . 0.8 ' HB3' HG12 ' A' ' 251' ' ' ILE . 16.6 p -89.34 146.81 24.44 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 176.22 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . 0.839 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 44.0 mtp180 60.26 -10.7 0.05 OUTLIER 'General case' 0 C--O 1.219 -0.505 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 177.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -97.5 106.34 18.64 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 119.246 0.93 . . . . 0.0 112.146 -169.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.505 ' HB ' ' HB ' ' A' ' 246' ' ' VAL . 57.3 t -137.28 121.21 22.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.076 -0.966 . . . . 0.0 109.819 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' PHE . . . . . 0.43 ' O ' ' HA ' ' A' ' 272' ' ' ILE . 10.5 t80 -114.57 126.81 55.34 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.743 0.306 . . . . 0.0 110.906 -178.244 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.738 ' HG ' HG22 ' A' ' 272' ' ' ILE . 4.8 mp -110.3 128.07 55.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.372 175.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . 0.596 ' HA2' HG22 ' A' ' 243' ' ' ILE . . . -137.82 66.32 0.54 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.383 -0.913 . . . . 0.0 113.046 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . 0.59 ' HB3' ' HA ' ' A' ' 270' ' ' ARG . 3.4 t30 177.58 43.07 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.332 0.586 . . . . 0.0 110.004 176.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.688 HD23 ' HG2' ' A' ' 270' ' ' ARG . 1.1 mt -94.83 161.16 29.48 Favored Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.966 -179.474 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -83.05 167.9 13.9 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.458 2.105 . . . . 0.0 111.533 176.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . 0.484 ' HA ' ' OG1' ' A' ' 239' ' ' THR . 53.7 t30 -78.28 124.69 28.37 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.078 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 107.78 -4.38 34.32 Favored Glycine 0 C--N 1.314 -0.663 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.925 -177.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . 0.676 HG23 HG21 ' A' ' 237' ' ' ILE . 5.1 tp -60.75 126.74 19.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.05 0.453 . . . . 0.0 110.384 177.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . 0.488 HG22 ' HG3' ' A' ' 221' ' ' GLU . 15.1 t -114.43 158.77 21.11 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.076 0.465 . . . . 0.0 111.077 -178.116 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.627 ' HB3' ' HD2' ' A' ' 223' ' ' ARG . 2.3 mp0 -57.88 -44.46 86.68 Favored 'General case' 0 C--O 1.205 -1.274 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.523 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -42.75 -39.69 2.54 Favored 'General case' 0 C--N 1.319 -0.728 0 O-C-N 123.959 0.787 . . . . 0.0 111.66 178.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . 0.488 ' HG3' HG22 ' A' ' 218' ' ' THR . 43.7 mt-10 -70.74 -60.54 2.19 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.876 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.644 HD12 HD11 ' A' ' 237' ' ' ILE . 10.8 mt -62.64 -41.6 92.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.665 -176.393 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . 0.854 ' HG3' HD12 ' A' ' 235' ' ' ILE . 46.3 mtt-85 -54.85 -62.28 1.76 Allowed 'General case' 0 CA--C 1.507 -0.678 0 CA-C-N 116.21 -0.45 . . . . 0.0 112.162 176.163 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -56.03 -25.23 43.89 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.47 -178.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' ASP . . . . . 0.466 ' HB3' ' CZ2' ' A' ' 267' ' ' TRP . 19.3 m-20 -83.22 -33.3 26.14 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.615 -176.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.808 HD23 ' HZ ' ' A' ' 248' ' ' PHE . 7.2 mp -106.72 -12.16 15.61 Favored 'General case' 0 C--O 1.224 -0.242 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -171.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . 0.65 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 15.1 mm-40 -62.31 -37.23 34.81 Favored Pre-proline 0 C--N 1.327 -0.387 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.211 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . 0.65 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 71.7 Cg_endo -65.33 -30.3 53.93 Favored 'Trans proline' 0 C--N 1.358 1.046 0 C-N-CA 121.569 1.513 . . . . 0.0 112.248 -172.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . 0.512 ' CE1' ' HA ' ' A' ' 226' ' ' LEU . 3.5 p90 -110.53 -6.69 14.84 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.935 177.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . 0.493 ' CA ' ' HB1' ' A' ' 253' ' ' ALA . . . -170.2 96.19 0.11 Allowed Glycine 0 N--CA 1.441 -1.006 0 C-N-CA 119.849 -1.167 . . . . 0.0 112.395 -176.139 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.458 ' HA ' ' OE2' ' A' ' 227' ' ' GLU . 17.9 Cg_endo -63.21 129.76 26.59 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 121.704 1.603 . . . . 0.0 111.41 178.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.586 HG21 HG12 ' A' ' 246' ' ' VAL . 2.3 mp -107.38 151.99 9.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.644 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . 0.423 ' CG ' HD22 ' A' ' 249' ' ' LEU . 26.2 m-20 -114.51 -21.77 10.15 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.645 177.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . 0.458 ' H ' HG22 ' A' ' 232' ' ' ILE . 21.5 tt0 -141.19 120.42 12.99 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.648 -178.011 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.854 HD12 ' HG3' ' A' ' 223' ' ' ARG . 6.1 mt -134.61 106.23 7.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.311 177.292 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.423 ' O ' ' HA ' ' A' ' 244' ' ' ALA . 35.0 ttmt -106.58 107.46 18.48 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.981 -177.314 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' ILE . . . . . 0.676 HG21 HG23 ' A' ' 217' ' ' ILE . 87.9 mt -100.62 114.31 39.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-O 121.267 0.556 . . . . 0.0 110.52 -179.394 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.532 ' HB ' HG13 ' A' ' 243' ' ' ILE . 45.9 t -100.52 85.87 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 173.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . 0.484 ' OG1' ' HA ' ' A' ' 215' ' ' ASN . 12.3 t -71.75 -13.04 61.59 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.075 -176.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -57.37 -41.83 80.95 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.804 170.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . 0.537 ' HB2' HG12 ' A' ' 243' ' ' ILE . 75.3 mtt180 -116.06 8.79 14.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.126 -177.271 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 68.7 25.9 6.3 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.298 174.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.596 HG22 ' HA2' ' A' ' 211' ' ' GLY . 2.1 pt -122.23 151.14 25.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.33 -173.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . 0.47 ' HB3' ' HB2' ' A' ' 210' ' ' LEU . . . -141.52 135.61 30.35 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.977 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -108.8 115.08 29.4 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.688 177.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.586 HG12 HG21 ' A' ' 232' ' ' ILE . 1.5 t -108.71 141.02 25.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.612 -176.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 247' ' ' HIS . . . . . 0.839 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 11.5 m80 -122.39 101.94 7.8 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.584 0.707 . . . . 0.0 111.668 174.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . 0.808 ' HZ ' HD23 ' A' ' 226' ' ' LEU . 33.2 m-85 -84.87 101.95 12.7 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 114.581 -1.19 . . . . 0.0 110.896 178.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.485 ' H ' HD23 ' A' ' 249' ' ' LEU . 0.1 OUTLIER -43.62 -39.37 3.5 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 124.344 1.028 . . . . 0.0 112.882 -175.92 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . 0.413 ' HB2' ' HB2' ' A' ' 253' ' ' ALA . 37.5 m-20 -93.73 140.17 29.96 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.128 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . 0.8 HG12 ' HB3' ' A' ' 205' ' ' CYS . 0.2 OUTLIER -63.4 -43.95 98.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -178.75 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . 0.41 ' O ' ' HG2' ' A' ' 256' ' ' LYS . . . -70.16 -30.72 67.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.647 0.26 . . . . 0.0 110.617 -177.303 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . 0.493 ' HB1' ' CA ' ' A' ' 230' ' ' GLY . . . -58.14 -44.12 87.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.261 178.487 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . 0.573 ' HB2' ' HB2' ' A' ' 248' ' ' PHE . . . -68.56 -39.58 81.0 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.566 178.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.699 ' HA ' ' OH ' ' A' ' 274' ' ' TYR . 3.5 mt -57.37 -60.89 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.513 -179.219 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . 0.417 ' O ' ' HG2' ' A' ' 260' ' ' GLU . 13.2 ptmt -62.92 -38.67 91.9 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.184 -176.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -61.96 -49.95 74.08 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.514 0.19 . . . . 0.0 111.514 179.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . 0.508 HG13 HG12 ' A' ' 272' ' ' ILE . 53.0 t -64.21 -27.19 42.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.1 0.476 . . . . 0.0 110.998 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -84.53 -21.25 30.58 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 178.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . 0.417 ' HG2' ' O ' ' A' ' 256' ' ' LYS . 67.1 mm-40 -94.81 -33.27 12.93 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 122.677 0.391 . . . . 0.0 110.989 -177.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.876 HD23 HG21 ' A' ' 272' ' ' ILE . 0.7 OUTLIER -51.84 -50.67 76.58 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.666 -178.915 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 262' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 261' ' ' LEU . 37.1 Cg_endo -66.76 -17.12 51.99 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.442 2.094 . . . . 0.0 112.807 -178.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 54.0 mt -90.27 -5.82 55.88 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.138 0.494 . . . . 0.0 111.624 -177.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 264' ' ' ASN . . . . . 0.417 ' HB2' ' CE3' ' A' ' 267' ' ' TRP . 17.1 m-80 -107.13 149.73 39.0 Favored Pre-proline 0 C--N 1.315 -0.922 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.507 -174.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -65.51 -37.57 29.15 Favored 'Trans proline' 0 N--CA 1.465 -0.16 0 C-N-CA 123.432 2.754 . . . . 0.0 112.825 -171.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.435 ' HE3' ' HB2' ' A' ' 266' ' ' LYS . 0.0 OUTLIER -82.8 -44.77 15.14 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 121.736 0.779 . . . . 0.0 109.251 -177.139 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 267' ' ' TRP . . . . . 0.758 ' HE3' ' HA ' ' A' ' 261' ' ' LEU . 10.4 m0 -77.29 -29.39 53.72 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.581 -1.19 . . . . 0.0 111.115 -172.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 19.4 t -66.4 -17.56 64.85 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.976 0.417 . . . . 0.0 110.406 178.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -78.02 -8.08 57.72 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.237 0.542 . . . . 0.0 110.182 176.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 270' ' ' ARG . . . . . 0.688 ' HG2' HD23 ' A' ' 213' ' ' LEU . 3.6 mpt_? -108.97 165.02 11.89 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.816 177.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -111.59 119.12 37.63 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 177.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . 0.876 HG21 HD23 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -128.97 143.25 41.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.139 0.495 . . . . 0.0 111.476 -179.276 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -151.69 169.5 22.01 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.942 170.414 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 274' ' ' TYR . . . . . 0.699 ' OH ' ' HA ' ' A' ' 255' ' ' ILE . 69.9 m-85 -67.54 117.53 9.61 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 172.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -165.95 160.27 33.7 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 119.921 -1.133 . . . . 0.0 113.077 -173.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . 0.451 ' N ' ' HD3' ' A' ' 276' ' ' ARG . 0.0 OUTLIER -138.83 -151.99 0.4 Allowed 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 -179.803 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 277' ' ' ASP . . . . . 0.434 ' C ' ' H ' ' A' ' 279' ' ' CYS . 20.8 t70 -50.85 143.41 10.04 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.717 0.294 . . . . 0.0 110.711 172.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 278' ' ' ARG . . . . . 0.473 ' H ' ' HD2' ' A' ' 278' ' ' ARG . 0.3 OUTLIER -74.16 27.27 0.08 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -177.302 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 279' ' ' CYS . . . . . 0.434 ' H ' ' C ' ' A' ' 277' ' ' ASP . 79.7 m 58.07 47.25 14.96 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.643 0.735 . . . . 0.0 109.304 -176.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . 0.435 ' HB2' ' HD3' ' A' ' 278' ' ' ARG . . . -73.55 92.29 1.9 Allowed 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 114.711 -1.132 . . . . 0.0 110.951 -175.148 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 7.2 p -149.69 7.93 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.952 178.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -82.38 88.69 1.45 Allowed Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.322 -176.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 283' ' ' LEU . . . . . 0.436 ' C ' HD23 ' A' ' 283' ' ' LEU . 8.9 tt -64.72 122.19 16.3 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 175.338 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 63.7 tttp . . . . . 0 C--O 1.248 1.02 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -179.913 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 8.2 t30 . . . . . 0 N--CA 1.48 1.031 0 N-CA-C 109.946 -0.391 . . . . 0.0 109.946 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 36.1 t -114.58 152.34 31.97 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.27 109.11 2.12 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.816 0.341 . . . . 0.0 110.082 178.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 33.3 t -145.56 164.22 32.35 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.015 -175.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 55.2 m-80 -109.23 94.78 5.22 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.044 0.45 . . . . 0.0 110.333 178.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 49.2 m -93.09 25.97 3.04 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.465 178.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 7.4 m -72.04 163.27 28.17 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.406 175.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 4.2 m -81.57 83.52 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.412 0.625 . . . . 0.0 111.378 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.591 ' O ' ' HG2' ' A' ' 200' ' ' GLN . 3.7 mm? -74.04 -20.79 60.19 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 176.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.631 HD23 ' HB2' ' A' ' 274' ' ' TYR . 25.0 tp -64.52 -22.67 67.03 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.61 177.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -78.11 -26.51 48.01 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.229 176.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.526 HG23 ' HA ' ' A' ' 196' ' ' LEU . 2.5 t -80.27 -20.86 11.74 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.662 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' GLN . . . . . 0.591 ' HG2' ' O ' ' A' ' 196' ' ' LEU . 13.5 mm100 -81.95 5.6 18.61 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.943 -174.398 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 59.02 23.22 11.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.391 -178.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 33.0 m -82.59 110.2 17.46 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 121.124 0.488 . . . . 0.0 109.896 177.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -82.65 72.22 2.86 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 121.019 -0.61 . . . . 0.0 111.588 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.95 101.62 1.14 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.085 0.469 . . . . 0.0 110.38 -179.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' CYS . . . . . 0.458 ' HA ' HG12 ' A' ' 251' ' ' ILE . 1.8 m -87.05 146.12 26.21 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -179.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . 0.79 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 19.0 mtm180 55.88 3.48 0.09 Allowed 'General case' 0 C--O 1.223 -0.33 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 179.048 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . 0.438 ' ND2' ' HB3' ' A' ' 277' ' ' ASP . 16.9 m-80 -105.93 105.64 15.77 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 118.816 0.734 . . . . 0.0 111.644 -172.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 61.5 t -134.36 109.16 11.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.035 176.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' PHE . . . . . 0.451 ' HE1' ' HB ' ' A' ' 243' ' ' ILE . 2.6 t80 -106.33 124.7 49.99 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.183 -175.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.565 ' HG ' HG22 ' A' ' 272' ' ' ILE . 6.1 mp -109.17 132.87 53.71 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.167 178.388 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . 0.676 ' HA2' HG22 ' A' ' 243' ' ' ILE . . . -138.05 60.7 0.59 Allowed Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.235 -0.983 . . . . 0.0 113.326 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . 0.536 ' HB3' ' HA ' ' A' ' 270' ' ' ARG . 2.5 t30 179.95 41.38 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.938 0.399 . . . . 0.0 110.67 177.103 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.464 HD21 HD22 ' A' ' 210' ' ' LEU . 1.4 mp -93.77 157.29 38.41 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.545 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.415 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 86.9 Cg_endo -77.72 169.87 20.06 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.764 2.31 . . . . 0.0 112.472 179.39 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . 0.589 ' HA ' ' OG1' ' A' ' 239' ' ' THR . 13.9 m120 -78.36 123.76 27.35 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.634 176.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 108.75 -8.75 34.36 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.358 -0.925 . . . . 0.0 112.865 179.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . 0.627 HG23 HG21 ' A' ' 237' ' ' ILE . 4.8 tp -58.99 128.69 20.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.889 0.345 . . . . 0.0 110.107 178.347 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . 0.461 HG22 ' HG3' ' A' ' 221' ' ' GLU . 7.1 t -114.1 161.62 17.52 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.447 0.641 . . . . 0.0 111.235 -179.449 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.564 ' CD ' ' H ' ' A' ' 219' ' ' GLU . 1.6 mp0 -64.31 -40.4 95.84 Favored 'General case' 0 C--O 1.21 -0.99 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.849 -175.171 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' ASP . . . . . 0.529 ' O ' ' HG2' ' A' ' 224' ' ' GLU . 38.6 t70 -48.46 -41.44 29.54 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 123.803 0.689 . . . . 0.0 111.187 178.215 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . 0.461 ' HG3' HG22 ' A' ' 218' ' ' THR . 43.4 mt-10 -65.45 -56.81 10.43 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.332 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.51 HD12 HD11 ' A' ' 237' ' ' ILE . 7.5 mt -61.07 -39.92 83.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.668 -179.117 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . 0.856 ' HG3' HD12 ' A' ' 235' ' ' ILE . 26.0 mtp180 -55.83 -62.77 1.47 Allowed 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 175.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.529 ' HG2' ' O ' ' A' ' 220' ' ' ASP . 9.1 pt-20 -60.92 -18.03 54.41 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.958 -178.057 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' ASP . . . . . 0.501 ' HB3' ' CZ2' ' A' ' 267' ' ' TRP . 44.0 m-20 -88.11 -35.2 17.6 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.288 -179.059 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.707 HD23 ' HZ ' ' A' ' 248' ' ' PHE . 8.0 mp -107.05 -17.63 14.12 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -169.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . 0.676 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 41.4 mt-10 -68.81 -27.27 1.33 Allowed Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -176.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . 0.676 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 71.6 Cg_endo -66.61 -27.83 45.33 Favored 'Trans proline' 0 C--N 1.36 1.171 0 C-N-CA 121.319 1.346 . . . . 0.0 111.94 -178.308 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . 0.541 ' CZ ' ' HA ' ' A' ' 226' ' ' LEU . 3.7 p90 -110.82 -7.6 14.6 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-O 120.734 0.302 . . . . 0.0 111.631 174.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . -170.09 95.55 0.11 Allowed Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.373 -0.918 . . . . 0.0 111.957 -175.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -60.94 132.43 42.15 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.016 1.811 . . . . 0.0 111.578 178.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.72 HG21 HG12 ' A' ' 246' ' ' VAL . 2.6 mp -109.99 149.92 12.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.766 178.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . 0.468 ' OD2' HD22 ' A' ' 249' ' ' LEU . 15.3 m-20 -115.63 -14.73 11.45 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.412 179.034 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . 0.497 ' H ' HG22 ' A' ' 232' ' ' ILE . 29.7 tt0 -148.35 120.87 8.52 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.518 -179.293 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.856 HD12 ' HG3' ' A' ' 223' ' ' ARG . 17.1 mt -134.32 107.94 10.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.001 179.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -112.73 115.72 28.97 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.582 -177.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 237' ' ' ILE . . . . . 0.627 HG21 HG23 ' A' ' 217' ' ' ILE . 68.8 mt -104.74 121.88 57.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.932 -178.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 45.1 t -110.57 86.82 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 171.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . 0.589 ' OG1' ' HA ' ' A' ' 215' ' ' ASN . 8.2 t -68.16 -19.89 64.83 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.405 -175.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -56.19 -37.57 69.79 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.359 174.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . 0.493 ' HB2' HG12 ' A' ' 243' ' ' ILE . 98.8 mtt180 -107.05 0.25 23.45 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.776 179.215 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 242' ' ' ASN . . . . . 0.439 ' O ' HD12 ' A' ' 213' ' ' LEU . 18.7 m120 65.63 29.12 11.06 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.472 -179.284 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.676 HG22 ' HA2' ' A' ' 211' ' ' GLY . 1.7 pp -122.22 157.24 26.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.604 -174.255 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -149.13 141.05 23.73 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.034 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -109.81 113.77 26.78 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.851 177.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.72 HG12 HG21 ' A' ' 232' ' ' ILE . 0.2 OUTLIER -107.47 126.33 63.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.434 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 247' ' ' HIS . . . . . 0.79 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 51.8 m170 -105.83 102.6 12.03 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.183 -0.607 . . . . 0.0 111.244 179.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . 0.707 ' HZ ' HD23 ' A' ' 226' ' ' LEU . 34.6 m-85 -87.38 102.37 14.47 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.887 -1.051 . . . . 0.0 111.274 178.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.508 ' H ' HD23 ' A' ' 249' ' ' LEU . 0.0 OUTLIER -40.94 -47.21 2.96 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 124.512 1.132 . . . . 0.0 113.382 -174.881 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -93.84 144.68 25.21 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.252 177.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . 0.596 ' O ' HG13 ' A' ' 255' ' ' ILE . 0.2 OUTLIER -61.33 -41.82 91.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.328 -177.167 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -71.34 -30.39 66.13 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 120.58 0.228 . . . . 0.0 110.952 -175.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -57.27 -41.59 79.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.208 177.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . 0.546 ' HB2' ' HB2' ' A' ' 248' ' ' PHE . . . -69.77 -40.64 75.96 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.594 178.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.596 HG13 ' O ' ' A' ' 251' ' ' ILE . 12.8 mt -57.38 -60.85 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.249 -178.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 10.6 ptmt -61.77 -38.12 86.84 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.552 -176.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -62.98 -49.38 74.91 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 111.556 0.206 . . . . 0.0 111.556 178.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . 0.436 HG13 HG12 ' A' ' 272' ' ' ILE . 52.3 t -65.21 -23.47 33.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.985 0.421 . . . . 0.0 110.86 179.251 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -83.75 -25.91 30.14 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 177.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -94.27 -33.09 13.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.842 0.353 . . . . 0.0 111.069 -175.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.706 HD12 ' CE3' ' A' ' 267' ' ' TRP . 0.7 OUTLIER -52.15 -49.63 83.51 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.483 -179.703 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 262' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 261' ' ' LEU . 50.6 Cg_endo -68.63 -14.18 38.85 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.486 2.124 . . . . 0.0 112.863 -178.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 60.1 mt -91.19 -6.22 53.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.476 0.655 . . . . 0.0 111.207 -179.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -106.64 149.13 38.02 Favored Pre-proline 0 C--N 1.315 -0.93 0 CA-C-N 115.346 -0.843 . . . . 0.0 112.272 -174.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -66.46 -36.92 24.77 Favored 'Trans proline' 0 CA--C 1.527 0.136 0 C-N-CA 123.429 2.753 . . . . 0.0 112.919 -171.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -86.07 -44.28 12.41 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-O 121.579 0.704 . . . . 0.0 109.935 -178.27 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 267' ' ' TRP . . . . . 0.706 ' CE3' HD12 ' A' ' 261' ' ' LEU . 15.9 m0 -74.54 -27.97 60.75 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.873 -174.503 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 33.1 t -67.8 -18.11 64.74 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.889 0.376 . . . . 0.0 110.679 176.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -71.34 -19.3 62.32 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.394 0.616 . . . . 0.0 109.571 175.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 270' ' ' ARG . . . . . 0.536 ' HA ' ' HB3' ' A' ' 212' ' ' ASN . 5.0 mpt_? -95.09 156.11 16.45 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.537 177.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . 0.431 ' NE ' ' HA ' ' A' ' 271' ' ' ARG . 4.9 mmp_? -105.48 106.3 16.74 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 172.452 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . 0.667 HG21 HD23 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -115.62 138.42 46.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.401 0.619 . . . . 0.0 111.155 -175.407 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -151.6 169.11 22.92 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.857 174.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 274' ' ' TYR . . . . . 0.631 ' HB2' HD23 ' A' ' 197' ' ' LEU . 77.8 m-85 -65.21 126.95 29.74 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.862 0.363 . . . . 0.0 110.496 175.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -72.65 148.05 41.21 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 177.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . 0.423 HH11 ' HD3' ' A' ' 276' ' ' ARG . 10.2 ptt180 -72.12 111.31 7.23 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.709 0.766 . . . . 0.0 111.311 -178.566 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 277' ' ' ASP . . . . . 0.501 ' O ' ' HB2' ' A' ' 278' ' ' ARG . 24.3 t70 175.59 147.22 0.09 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 113.874 -1.512 . . . . 0.0 108.123 -178.131 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 278' ' ' ARG . . . . . 0.501 ' HB2' ' O ' ' A' ' 277' ' ' ASP . 23.4 mmm180 66.64 4.5 3.4 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 121.476 0.655 . . . . 0.0 109.786 -168.041 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 279' ' ' CYS . . . . . 0.403 ' H ' ' C ' ' A' ' 277' ' ' ASP . 58.2 m -84.86 -11.48 55.56 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.235 175.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -123.0 127.53 48.94 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 114.485 -1.234 . . . . 0.0 108.708 177.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 27.2 m -68.48 -22.7 27.35 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.408 -178.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 176.94 79.24 0.05 OUTLIER Glycine 0 N--CA 1.434 -1.48 0 C-N-CA 120.413 -0.899 . . . . 0.0 112.345 -178.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 30.9 tp -135.91 101.65 4.81 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.051 0.453 . . . . 0.0 110.652 179.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . 0.429 ' N ' ' HD3' ' A' ' 284' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.972 0 CA-C-O 118.446 -0.787 . . . . 0.0 109.91 178.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 46.1 t30 . . . . . 0 N--CA 1.479 1.007 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 20.7 m -74.1 -42.88 59.43 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.793 0.33 . . . . 0.0 110.602 -178.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -98.11 83.71 3.15 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.985 0.422 . . . . 0.0 110.13 178.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 24.6 m -76.74 -53.59 7.76 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.808 -179.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -156.73 128.54 7.22 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.58 177.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.8 p -103.64 116.89 33.18 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.324 176.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 33.5 t 67.45 -81.4 0.03 OUTLIER 'General case' 0 C--O 1.232 0.174 0 O-C-N 123.606 0.566 . . . . 0.0 109.895 -173.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -134.25 135.43 54.36 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.196 175.393 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.46 ' O ' HG22 ' A' ' 199' ' ' VAL . 6.6 tt -61.84 96.03 0.06 Allowed 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 178.323 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 94.7 mt 54.78 19.94 2.79 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.427 -0.806 . . . . 0.0 112.318 179.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . 53.37 31.61 12.28 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.113 -0.494 . . . . 0.0 112.17 -179.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.46 HG22 ' O ' ' A' ' 196' ' ' LEU . 30.4 m -81.51 -7.36 10.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.04 0.448 . . . . 0.0 111.197 -179.033 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -117.69 93.17 4.05 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.713 179.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -129.69 -77.31 0.55 Allowed 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.234 178.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . 0.631 ' HA ' HD11 ' A' ' 251' ' ' ILE . 17.5 m -77.32 -8.36 57.53 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.873 -178.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -68.89 -13.51 66.52 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 121.081 -0.581 . . . . 0.0 112.206 178.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . 0.455 ' HB3' ' HB3' ' A' ' 274' ' ' TYR . . . -142.41 98.33 3.29 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.994 0.426 . . . . 0.0 111.075 177.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' CYS . . . . . 0.832 ' HB3' HG12 ' A' ' 251' ' ' ILE . 14.3 p -96.57 147.41 23.89 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 175.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . 0.788 ' O ' ' HA ' ' A' ' 247' ' ' HIS . 31.2 mtm180 57.53 2.66 0.15 Allowed 'General case' 0 C--O 1.223 -0.312 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -177.228 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . 0.441 ' HB2' ' HB1' ' A' ' 204' ' ' ALA . 6.3 m-20 -105.51 104.95 14.78 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.156 0.503 . . . . 0.0 111.472 -172.118 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.451 ' HB ' ' HB ' ' A' ' 246' ' ' VAL . 58.8 t -134.63 117.43 23.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.33 177.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' PHE . . . . . 0.414 ' HE1' ' HB ' ' A' ' 243' ' ' ILE . 3.1 t80 -114.46 123.97 50.75 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 120.951 0.405 . . . . 0.0 110.463 -177.024 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.549 ' HG ' HG22 ' A' ' 272' ' ' ILE . 6.1 mp -107.86 135.21 49.65 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.172 176.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . 0.624 ' HA2' HG22 ' A' ' 243' ' ' ILE . . . -142.9 61.74 0.52 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.229 -0.986 . . . . 0.0 113.249 179.247 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 37.7 t30 179.03 41.94 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.928 0.394 . . . . 0.0 110.253 178.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.475 HD12 ' O ' ' A' ' 242' ' ' ASN . 1.1 mp -92.51 159.93 35.72 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.392 -179.304 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.44 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 91.6 Cg_endo -79.63 162.84 24.34 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.541 2.161 . . . . 0.0 111.739 176.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -77.41 119.92 21.69 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.541 179.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 109.72 0.52 30.58 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.473 -0.87 . . . . 0.0 112.615 -177.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . 0.608 HG23 HG21 ' A' ' 237' ' ' ILE . 5.5 tp -64.49 129.01 27.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.863 0.364 . . . . 0.0 110.163 175.174 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . 0.446 ' CG2' ' HG3' ' A' ' 221' ' ' GLU . 15.1 t -113.66 154.27 27.52 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 121.523 0.678 . . . . 0.0 110.917 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.475 ' CD ' ' H ' ' A' ' 219' ' ' GLU . 2.1 mp0 -62.78 -33.56 75.44 Favored 'General case' 0 C--O 1.206 -1.193 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.934 -178.319 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' ASP . . . . . 0.43 ' O ' ' HG2' ' A' ' 224' ' ' GLU . 15.7 t70 -49.48 -38.89 31.64 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.021 0.439 . . . . 0.0 110.811 176.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . 0.446 ' HG3' ' CG2' ' A' ' 218' ' ' THR . 42.1 mt-10 -70.77 -58.09 3.98 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.314 179.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.509 HD12 HD11 ' A' ' 237' ' ' ILE . 8.6 mt -58.5 -41.79 82.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.815 -178.446 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . 0.671 ' HG3' HD12 ' A' ' 235' ' ' ILE . 49.4 mtp180 -57.61 -62.24 1.93 Allowed 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 177.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.43 ' HG2' ' O ' ' A' ' 220' ' ' ASP . 6.4 pt-20 -57.57 -24.23 55.07 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.731 -178.51 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -86.79 -31.42 20.9 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.854 -176.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.708 HD23 ' HZ ' ' A' ' 248' ' ' PHE . 8.0 mp -105.39 -20.21 13.56 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 120.609 -0.436 . . . . 0.0 112.167 -171.401 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . 0.677 ' N ' ' HD2' ' A' ' 228' ' ' PRO . 36.6 mt-10 -68.99 -27.71 1.41 Allowed Pre-proline 0 C--N 1.325 -0.492 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -176.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . 0.677 ' HD2' ' N ' ' A' ' 227' ' ' GLU . 71.5 Cg_endo -66.72 -28.77 43.66 Favored 'Trans proline' 0 C--N 1.359 1.081 0 C-N-CA 121.254 1.302 . . . . 0.0 112.07 -178.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . 0.501 ' CE1' ' HA ' ' A' ' 226' ' ' LEU . 3.9 p90 -111.15 4.13 19.06 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-O 120.69 0.281 . . . . 0.0 111.353 173.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . 0.488 ' CA ' ' HB1' ' A' ' 253' ' ' ALA . . . 177.25 98.9 0.11 Allowed Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 119.837 -1.173 . . . . 0.0 112.748 -177.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.557 ' HA ' ' HG2' ' A' ' 227' ' ' GLU . 22.7 Cg_endo -63.38 134.29 44.32 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 121.904 1.736 . . . . 0.0 111.34 177.213 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.642 HG21 HG12 ' A' ' 246' ' ' VAL . 3.2 mp -107.7 151.06 9.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.642 178.208 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . 0.532 ' CG ' HD22 ' A' ' 249' ' ' LEU . 9.9 m-20 -106.84 -25.33 11.73 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.05 0.452 . . . . 0.0 110.319 178.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . 0.471 ' H ' HG22 ' A' ' 232' ' ' ILE . 30.8 tt0 -145.15 122.85 11.84 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.862 -175.057 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.671 HD12 ' HG3' ' A' ' 223' ' ' ARG . 13.5 mt -136.13 109.35 8.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.909 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -119.21 120.42 37.01 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.475 -178.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 237' ' ' ILE . . . . . 0.608 HG21 HG23 ' A' ' 217' ' ' ILE . 64.7 mt -106.19 117.46 51.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.596 179.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.582 ' HB ' HG13 ' A' ' 243' ' ' ILE . 42.4 t -97.7 86.52 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 173.327 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 3.8 t -64.44 -23.15 67.19 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.291 -177.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -59.48 -36.08 75.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.073 0.463 . . . . 0.0 110.396 176.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . 0.684 ' HB2' HG12 ' A' ' 243' ' ' ILE . 74.6 mtt180 -113.91 3.37 15.39 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.632 -176.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 242' ' ' ASN . . . . . 0.475 ' O ' HD12 ' A' ' 213' ' ' LEU . 14.1 m120 66.42 27.36 9.92 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.996 176.502 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.684 HG12 ' HB2' ' A' ' 241' ' ' ARG . 1.5 pt -122.28 153.25 26.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.088 -174.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . 0.446 ' HB3' ' HB2' ' A' ' 210' ' ' LEU . . . -143.78 140.45 29.92 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.012 0.434 . . . . 0.0 111.083 -179.11 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -110.57 117.89 34.75 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.788 178.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.642 HG12 HG21 ' A' ' 232' ' ' ILE . 0.6 OUTLIER -113.41 129.25 69.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -179.594 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 247' ' ' HIS . . . . . 0.788 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 48.2 m170 -109.33 101.9 10.85 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.064 -0.654 . . . . 0.0 111.414 178.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . 0.708 ' HZ ' HD23 ' A' ' 226' ' ' LEU . 41.5 m-85 -87.14 100.88 12.98 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.18 178.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.556 ' H ' HD23 ' A' ' 249' ' ' LEU . 0.1 OUTLIER -43.86 -45.77 7.64 Favored 'General case' 0 N--CA 1.463 0.217 0 O-C-N 124.464 1.102 . . . . 0.0 112.62 -176.174 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . 0.401 ' HB2' ' HB2' ' A' ' 253' ' ' ALA . 13.4 m120 -86.35 136.88 32.97 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 177.313 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . 0.832 HG12 ' HB3' ' A' ' 205' ' ' CYS . 0.2 OUTLIER -60.76 -43.17 94.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.272 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -69.23 -30.74 68.96 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.027 -177.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . 0.488 ' HB1' ' CA ' ' A' ' 230' ' ' GLY . . . -61.69 -39.98 93.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.384 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . 0.61 ' HB2' ' HB2' ' A' ' 248' ' ' PHE . . . -69.14 -41.91 76.7 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.59 178.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.589 HG13 ' O ' ' A' ' 251' ' ' ILE . 11.7 mt -55.89 -60.91 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.054 -177.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 13.7 ptmt -62.17 -38.12 87.85 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.607 -176.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -64.7 -48.63 73.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.587 0.232 . . . . 0.0 111.422 178.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . 0.421 HG13 HG12 ' A' ' 272' ' ' ILE . 43.0 t -65.96 -23.27 31.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 120.865 0.365 . . . . 0.0 110.96 179.558 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . 0.547 ' HA ' ' OE1' ' A' ' 259' ' ' GLN . 9.9 mm-40 -84.83 -25.81 27.86 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 176.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 48.9 mm-40 -89.5 -36.44 15.39 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-O 120.791 0.329 . . . . 0.0 111.026 -177.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.739 HD12 ' CE3' ' A' ' 267' ' ' TRP . 0.8 OUTLIER -51.71 -48.3 87.69 Favored Pre-proline 0 CA--C 1.54 0.568 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.656 -178.808 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 262' ' ' PRO . . . . . 0.611 ' HD3' HD11 ' A' ' 272' ' ' ILE . 55.9 Cg_endo -69.67 -16.53 37.99 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.5 2.133 . . . . 0.0 112.926 -179.229 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 66.2 mt -92.8 -3.62 54.39 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.344 0.592 . . . . 0.0 111.162 -177.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -106.14 149.95 38.76 Favored Pre-proline 0 C--N 1.313 -1.002 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.376 -176.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -65.56 -41.47 15.02 Favored 'Trans proline' 0 C--N 1.34 0.124 0 C-N-CA 123.284 2.656 . . . . 0.0 112.774 -168.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 16.0 mtpt -86.89 -44.67 11.49 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.198 0.523 . . . . 0.0 109.799 -175.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 267' ' ' TRP . . . . . 0.739 ' CE3' HD12 ' A' ' 261' ' ' LEU . 24.4 m0 -67.81 -33.51 74.93 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.802 -176.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 29.1 t -63.94 -24.29 67.67 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.99 0.424 . . . . 0.0 111.014 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -71.78 -16.44 62.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.188 0.518 . . . . 0.0 110.134 177.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 270' ' ' ARG . . . . . 0.439 ' HB3' HD23 ' A' ' 210' ' ' LEU . 5.2 mpt_? -93.99 144.88 25.07 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 173.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . 0.486 ' NE ' ' HA ' ' A' ' 271' ' ' ARG . 5.0 mmp_? -94.2 105.76 17.75 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 177.05 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . 0.701 HG21 HD23 ' A' ' 261' ' ' LEU . 0.1 OUTLIER -116.93 136.56 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 CA-C-O 121.634 0.73 . . . . 0.0 111.24 -177.665 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -152.07 167.99 26.68 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.826 173.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 274' ' ' TYR . . . . . 0.591 ' O ' ' HD3' ' A' ' 276' ' ' ARG . 90.9 m-85 -63.54 134.46 55.6 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.244 173.002 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -77.85 101.97 1.73 Allowed Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.274 -0.965 . . . . 0.0 111.704 177.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . 0.591 ' HD3' ' O ' ' A' ' 274' ' ' TYR . 0.0 OUTLIER -92.25 111.25 22.74 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.515 0.674 . . . . 0.0 110.514 -178.63 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 277' ' ' ASP . . . . . 0.577 ' C ' ' H ' ' A' ' 279' ' ' CYS . 18.9 t70 -144.47 125.31 14.29 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.505 -178.036 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 278' ' ' ARG . . . . . . . . . . . . . 57.5 mtm180 56.29 -7.82 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 O-C-N 124.382 1.051 . . . . 0.0 112.896 -173.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 279' ' ' CYS . . . . . 0.577 ' H ' ' C ' ' A' ' 277' ' ' ASP . 20.0 p -95.94 -9.33 31.5 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.322 0.582 . . . . 0.0 110.231 176.375 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -91.93 94.06 9.11 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.13 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 3.4 p -89.58 82.91 2.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 122.222 1.01 . . . . 0.0 110.3 -179.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -165.73 -116.33 0.36 Allowed Glycine 0 N--CA 1.449 -0.465 0 CA-C-N 114.588 -1.187 . . . . 0.0 111.407 178.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 283' ' ' LEU . . . . . 0.413 HD13 ' HA ' ' A' ' 283' ' ' LEU . 4.0 mm? -87.73 98.52 11.49 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 175.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . 0.808 ' HE2' ' HA ' ' A' ' 284' ' ' LYS . 0.4 OUTLIER . . . . . 0 C--O 1.244 0.806 0 CA-C-O 118.567 -0.73 . . . . 0.0 110.159 -176.342 . . . . . . . . 2 2 . 1 stop_ save_